<SEC-DOCUMENT>0000355019-25-000009.txt : 20250219
<SEC-HEADER>0000355019-25-000009.hdr.sgml : 20250219
<ACCEPTANCE-DATETIME>20250219134849
ACCESSION NUMBER:		0000355019-25-000009
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		68
CONFORMED PERIOD OF REPORT:	20241231
FILED AS OF DATE:		20250219
DATE AS OF CHANGE:		20250219

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			FONAR CORP
		CENTRAL INDEX KEY:			0000355019
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				112464137
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-10248
		FILM NUMBER:		25638650

	BUSINESS ADDRESS:	
		STREET 1:		110 MARCUS DR
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747
		BUSINESS PHONE:		6316942929

	MAIL ADDRESS:	
		STREET 1:		110 MARCUS DRIVE
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>fonar_10-q.htm
<DESCRIPTION>FORM 10-Q
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:FONR="http://fonar.com/20241231">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_021_US%2DGAAP%2D2024%2D(with%2DECD) -->
<!-- Field: Set; Name: xdx; ID: xdx_03E_FONR_fonar.com_20241231 -->
<!-- Field: Set; Name: xdx; ID: xdx_043_20240701_20241231 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0wNi0zMA== -->
<!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DDocumentFiscalPeriodFocus_Q2 -->
<!-- Field: Set; Name: xdx; ID: xdx_05C_edei%2D%2DDocumentFiscalYearFocus_2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_056_edei%2D%2DEntityCentralIndexKey_0000355019 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2024-07-01to2024-12-31" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-07-01to2024-12-31" id="Fact000004" name="dei:CurrentFiscalYearEndDate">--06-30</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-07-01to2024-12-31" id="Fact000005" name="dei:DocumentFiscalPeriodFocus">Q2</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-07-01to2024-12-31" id="Fact000006" name="dei:DocumentFiscalYearFocus">2025</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-07-01to2024-12-31" id="Fact000007" name="dei:EntityCentralIndexKey">0000355019</ix:nonNumeric>
  <ix:nonFraction name="FONR:AccountReceivableRelatedParties" contextRef="AsOf2024-06-30" id="xdx2ixbrl0056" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:UnearnedRevenueOnServiceContractsRelatedParty" contextRef="AsOf2024-06-30" id="xdx2ixbrl0126" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:OtherIncomeRelatedParty" contextRef="From2024-10-012024-12-31" id="xdx2ixbrl0303" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2023-10-012023-12-31" id="xdx2ixbrl0307" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:OtherIncomeRelatedParty" contextRef="From2024-07-01to2024-12-31" id="xdx2ixbrl0417" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2024-07-01to2024-12-31" id="xdx2ixbrl0420" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0473" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-10-012024-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0474" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-10-012024-12-31_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0476" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-10-012024-12-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0477" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0480" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2024-10-012024-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0481" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2024-10-012024-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0482" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2024-10-012024-12-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0484" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:CancellationOfTreasuryStock" contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0489" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:CancellationOfTreasuryStock" contextRef="From2024-10-012024-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0491" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:CancellationOfTreasuryStock" contextRef="From2024-10-012024-12-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0493" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:CancellationOfTreasuryStock" contextRef="From2024-10-012024-12-31" id="xdx2ixbrl0494" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:SaleNonControllingInterests" contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0500" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:SaleNonControllingInterests" contextRef="From2024-10-012024-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0502" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:SaleNonControllingInterests" contextRef="From2024-10-012024-12-31_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0503" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0507" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2024-10-012024-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0508" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2024-10-012024-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0509" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2024-10-012024-12-31_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0510" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0514" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2024-10-012024-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0515" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2024-10-012024-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0516" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2024-10-012024-12-31_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0517" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0543" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-10-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0544" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-10-012023-12-31_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0546" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-10-012023-12-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0547" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0550" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-10-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0551" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-10-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0552" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-10-012023-12-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0554" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0559" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2023-10-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0561" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2023-10-012023-12-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0563" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2023-10-012023-12-31" id="xdx2ixbrl0564" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0570" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-10-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0571" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-10-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0572" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-10-012023-12-31_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0573" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0577" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-10-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0578" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-10-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0579" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-10-012023-12-31_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0580" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-012024-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0606" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-012024-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0607" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-012024-12-31_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0609" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-012024-12-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0610" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2024-07-012024-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0613" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2024-07-012024-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0614" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2024-07-012024-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0615" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2024-07-012024-12-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0617" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:CancellationOfTreasuryStock" contextRef="From2024-07-012024-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0622" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:CancellationOfTreasuryStock" contextRef="From2024-07-012024-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0624" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:CancellationOfTreasuryStock" contextRef="From2024-07-012024-12-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0626" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:CancellationOfTreasuryStock" contextRef="From2024-07-01to2024-12-31" id="xdx2ixbrl0627" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:SaleNonControllingInterests" contextRef="From2024-07-012024-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0633" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:SaleNonControllingInterests" contextRef="From2024-07-012024-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0635" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:SaleNonControllingInterests" contextRef="From2024-07-012024-12-31_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0636" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2024-07-012024-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0640" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2024-07-012024-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0641" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2024-07-012024-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0642" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2024-07-012024-12-31_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0643" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2024-07-012024-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0647" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2024-07-012024-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0648" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2024-07-012024-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0649" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2024-07-012024-12-31_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0650" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0676" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0677" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-12-31_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0679" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-12-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0680" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-07-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0683" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-07-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0684" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-07-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0685" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-07-012023-12-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0687" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2023-07-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0692" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2023-07-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0694" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2023-07-012023-12-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0696" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2023-07-012023-12-31" id="xdx2ixbrl0697" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-07-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0703" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-07-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0704" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-07-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0705" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-07-012023-12-31_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0706" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-07-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0710" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-07-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0711" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-07-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0712" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-07-012023-12-31_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0713" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:GainOnSaleOfEquipmentRelatedParty" contextRef="From2024-07-01to2024-12-31" id="xdx2ixbrl0749" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:IncreaseDecreaseInNotesReceivable" contextRef="From2024-07-01to2024-12-31" id="xdx2ixbrl0758" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:IncreaseDecreaseInNotesReceivableRelatedParty" contextRef="From2023-07-012023-12-31" id="xdx2ixbrl0762" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromSaleOfShortTermInvestments" contextRef="From2023-07-012023-12-31" id="xdx2ixbrl0798" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromMinorityShareholders" contextRef="From2023-07-012023-12-31" id="xdx2ixbrl0813" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:AccountsReceivableNetRelatedParty" contextRef="AsOf2024-12-31_us-gaap_DoubtfulMember" id="xdx2ixbrl1046" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NontradeReceivables" contextRef="AsOf2024-12-31_us-gaap_DoubtfulMember" id="xdx2ixbrl1050" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NontradeReceivables" contextRef="AsOf2024-06-30_us-gaap_DoubtfulMember" id="xdx2ixbrl1066" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2024-12-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" id="xdx2ixbrl1240" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2024-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" id="xdx2ixbrl1291" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccruedPayrollTaxesCurrent" contextRef="AsOf2024-12-31" id="xdx2ixbrl1355" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:SoftwareLicenses" contextRef="AsOf2024-06-30" id="xdx2ixbrl1362" unitRef="USD" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="fonr-20241231.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2024-07-01to2024-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-03_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-03_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-03_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-03_us-gaap_PreferredClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_ClassANonVotingPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_ClassANonVotingPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-012024-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-012023-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-012024-12-31_custom_CommonStockholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:CommonStockholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-012023-12-31_custom_CommonStockholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:CommonStockholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-012024-12-31_custom_ClassANonVotingPreferredStockholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-012023-12-31_custom_ClassANonVotingPreferredStockholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-012024-12-31_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-012023-12-31_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-12-31_custom_CommonStockholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:CommonStockholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-12-31_custom_CommonStockholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:CommonStockholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-12-31_custom_ClassANonVotingPreferredStockholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-12-31_custom_ClassANonVotingPreferredStockholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-12-31_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-12-31_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_CommonStockMember529343609">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-012024-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-012024-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-012024-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-012024-12-31_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-012024-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-012023-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-012023-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-012023-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-012023-12-31_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-012023-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-12-31_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-12-31_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_CommonStockMember529343781">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-07-01_us-gaap_OtherInvesteesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-07-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-07-01_us-gaap_NoncontrollingInterestMember_us-gaap_OtherInvesteesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-07-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_OtherInvesteesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_NoncontrollingInterestMember_us-gaap_OtherInvesteesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-012024-12-31_us-gaap_OtherInvesteesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_OtherInvesteesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_NoncontrollingInterestMember_us-gaap_OtherInvesteesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-012024-12-31_custom_CommercialInsuranceManagedCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-012023-12-31_custom_CommercialInsuranceManagedCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-012024-12-31_custom_MedicareMedicaidMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-012023-12-31_custom_MedicareMedicaidMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-012024-12-31_custom_WorkersCompensationPersonalInjuryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-012023-12-31_custom_WorkersCompensationPersonalInjuryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-012024-12-31_custom_OtherRevenueSourceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-012023-12-31_custom_OtherRevenueSourceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-12-31_custom_CommercialInsuranceManagedCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-12-31_custom_CommercialInsuranceManagedCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-12-31_custom_MedicareMedicaidMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-12-31_custom_MedicareMedicaidMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-12-31_custom_WorkersCompensationPersonalInjuryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-12-31_custom_WorkersCompensationPersonalInjuryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-12-31_custom_OtherRevenueSourceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-12-31_custom_OtherRevenueSourceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_DoubtfulMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:DoubtfulMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_DoubtfulMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:DoubtfulMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_OperatingLeasePaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:OperatingLeasePaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_FinancingLeasePaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:FinancingLeasePaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-12-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-12-31_us-gaap_LicenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_LicenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-12-31_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-12-31_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-12-31_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-012024-12-31_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-012023-12-31_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-012024-12-31_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-012023-12-31_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-12-31_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-12-31_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-012024-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">FONR:ManufacturingAndServiceOfMRIEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-012024-12-31_us-gaap_HealthCareOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-012023-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">FONR:ManufacturingAndServiceOfMRIEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-012023-12-31_us-gaap_HealthCareOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">FONR:ManufacturingAndServiceOfMRIEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-12-31_us-gaap_HealthCareOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">FONR:ManufacturingAndServiceOfMRIEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-12-31_us-gaap_HealthCareOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-26_srt_BoardOfDirectorsChairmanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-12-31_srt_BoardOfDirectorsChairmanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-12-31_srt_BoardOfDirectorsChairmanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_MagneticResonanceManagementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">FONR:MagneticResonanceManagementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-12-31_custom_MagneticResonanceManagementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">FONR:MagneticResonanceManagementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-012024-12-31_custom_MagneticResonanceManagementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">FONR:MagneticResonanceManagementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_MagneticResonanceManagementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">FONR:MagneticResonanceManagementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0; text-indent: 20pt"></p>

<!-- Field: Rule-Page --><div style="margin-top: 10pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 16pt"><b>FORM
<span id="xdx_90E_edei--DocumentType_c20240701__20241231_zRnykDEjMiz5"><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" id="Fact000013" name="dei:DocumentType">10-Q</ix:nonNumeric></span></b></span></p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">SECURITIES
AND EXCHANGE COMMISSION</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Washington,
D.C. 20549</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="xdx_904_edei--DocumentQuarterlyReport_c20240701__20241231_zVDvuKvqqwlj" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" format="ixt:booleantrue" id="Fact000014" name="dei:DocumentQuarterlyReport">&#9746;</ix:nonNumeric>
</span><span style="font: normal 11pt Times New Roman, Times, Serif">QUARTERLY REPORT
UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="xdx_90F_edei--DocumentTransitionReport_c20240701__20241231_zXUQbEUSInx2" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" format="ixt:booleanfalse" id="Fact000015" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 31.5pt; text-align: center; text-indent: -36pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 16pt"><b>For
the quarterly period ended <span id="xdx_90A_edei--DocumentPeriodEndDate_c20240701__20241231_zO5XPpyUlDe1"><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" format="ixt:datemonthdayyearen" id="Fact000016" name="dei:DocumentPeriodEndDate">DECEMBER 31, 2024</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Commission
file number <span id="xdx_90D_edei--EntityFileNumber_c20240701__20241231_z9n1LfyVd22c"><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" id="Fact000017" name="dei:EntityFileNumber">0-10248</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif"><img src="fonar_logo.jpg" alt="" style="height: 26px; width: 170px"/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 24pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="xdx_909_edei--EntityRegistrantName_c20240701__20241231_zQRU0L9cwo37" style="font-family: Times New Roman, Times, Serif; font-size: 16pt"><b><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" id="Fact000018" name="dei:EntityRegistrantName">FONAR
CORPORATION</ix:nonNumeric></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: center"><span id="xdx_908_edei--EntityIncorporationStateCountryCode_c20240701__20241231_zaEa2wraDAdk" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" format="ixt-sec:stateprovnameen" id="Fact000019" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></td>
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span id="xdx_906_edei--EntityTaxIdentificationNumber_c20240701__20241231_zbHYrcEKI4o1" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" id="Fact000020" name="dei:EntityTaxIdentificationNumber">11-2464137</ix:nonNumeric></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(State
    or other jurisdiction of <br/>
    incorporation or organization)</span></td>
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-left: 5.4pt; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(I.R.S.
    Employer <br/>
    Identification No.)</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-left: 5.4pt; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 45%; padding-left: 5.4pt; text-align: center"><span id="xdx_90F_edei--EntityAddressAddressLine1_c20240701__20241231_zigkNZ5Jusp9" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" id="Fact000021" name="dei:EntityAddressAddressLine1">110
    Marcus Drive</ix:nonNumeric></span> <span id="xdx_903_edei--EntityAddressCityOrTown_c20240701__20241231_zrRwzajhcWql" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" id="Fact000022" name="dei:EntityAddressCityOrTown">Melville</ix:nonNumeric></span><span style="font: normal 11pt Times New Roman, Times, Serif">,
    <span id="xdx_90A_edei--EntityAddressStateOrProvince_c20240701__20241231_zBw0D2kQZ2El"><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" format="ixt-sec:stateprovnameen" id="Fact000023" name="dei:EntityAddressStateOrProvince">New York</ix:nonNumeric></span></span></td>
    <td style="width: 10%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 45%; padding-left: 5.4pt; text-align: center"><span id="xdx_901_edei--EntityAddressPostalZipCode_c20240701__20241231_zsHg2Qz23Jv2" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" id="Fact000024" name="dei:EntityAddressPostalZipCode">11747</ix:nonNumeric></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Address
    of principal executive offices)</span></td>
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-left: 5.4pt; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(Zip
    Code)</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-left: 5.4pt; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Registrant&#8217;s
telephone number, including area code: (<span id="xdx_90E_edei--CityAreaCode_c20240701__20241231_zG0NRSmqGPva"><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" id="Fact000025" name="dei:CityAreaCode">631</ix:nonNumeric></span></span><span style="font: normal 11pt Times New Roman, Times, Serif">)
<span id="xdx_90D_edei--LocalPhoneNumber_c20240701__20241231_zcm97iSoCRXf"><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" id="Fact000026" name="dei:LocalPhoneNumber">694-2929</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. YES &#9746; NO &#9744;.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. <span id="xdx_90C_edei--EntityCurrentReportingStatus_c20240701__20241231_zSuSEtcf0cOk"><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" id="Fact000027" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">&#9746;
No &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for shorter period that the registrant was required
to submit such files <span id="xdx_907_edei--EntityInteractiveDataCurrent_c20240701__20241231_zLysqPork9Z1"><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" id="Fact000028" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span></span> <span style="font: normal 11pt Times New Roman, Times, Serif">&#9746;
No &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company,
or an emerging growth company. See definition of accelerated filer, large accelerated filer, smaller reporting company and emerging growth
company in Rule 12b-2 of the Exchange Act. (Check one): Large accelerated filer &#9744; <span id="xdx_90B_edei--EntityFilerCategory_c20240701__20241231_ziPuid1tSOX8"><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" format="ixt-sec:entityfilercategoryen" id="Fact000029" name="dei:EntityFilerCategory">Accelerated
filer</ix:nonNumeric></span></span> <span style="font: normal 11pt Times New Roman, Times, Serif">&#9746;
Non-accelerated filer &#9744;, Smaller reporting company <span id="xdx_900_edei--EntitySmallBusiness_c20240701__20241231_zxf1OsJzMvE"><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" format="ixt:booleantrue" id="Fact000030" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">Emerging
growth company <span id="xdx_909_edei--EntityEmergingGrowthCompany_c20240701__20241231_zjFjyUr00344"><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" format="ixt:booleanfalse" id="Fact000031" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES &#9744; <span id="xdx_904_edei--EntityShellCompany_c20240701__20241231_zGsIMnwJTlG2"><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" format="ixt:booleanfalse" id="Fact000032" name="dei:EntityShellCompany">NO</ix:nonNumeric>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">&#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="border-bottom: Black 1pt solid; text-align: center; width: 34%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;
&#160; Title of each class</span></td>
<td style="width: 4%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: center; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;
&#160; Trading symbol</span></td>
<td style="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: center; width: 37%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Name
of each exchange<br/>
on which registered</span></td></tr>
<tr style="vertical-align: top">
<td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90D_edei--Security12bTitle_c20240701__20241231_zm0jrng2VzCl" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" id="Fact000033" name="dei:Security12bTitle">Common
Stock, $.0001 par value</ix:nonNumeric></span></td>
<td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90C_edei--TradingSymbol_c20240701__20241231_zM14V5t7eFFg" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" id="Fact000034" name="dei:TradingSymbol">FONR</ix:nonNumeric></span></td>
<td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_909_edei--SecurityExchangeName_c20240701__20241231_zNHvYLWB6a96" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" format="ixt-sec:exchnameen" id="Fact000035" name="dei:SecurityExchangeName">NASDAQ</ix:nonNumeric>
</span><span style="font: normal 11pt Times New Roman, Times, Serif">Capital Market</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Indicate
the number of shares outstanding of each of the issuer&#8217;s classes of common stock, as of the close of the latest practicable date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Class</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Outstanding
    at February 3, 2025</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; width: 70%; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Common
    Stock, par value $.0001</span></td><td style="width: 10%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 18%; text-align: right"><span id="xdx_90C_edei--EntityCommonStockSharesOutstanding_iI_c20250203__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zZO9IdjkJ9Wa" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2025-02-03_us-gaap_CommonStockMember" id="Fact000036" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,203,465</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Class
    B Common Stock, par value $.0001</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_90F_edei--EntityCommonStockSharesOutstanding_iI_c20250203__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zdNwtBCzXTw7" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2025-02-03_us-gaap_CommonClassBMember" id="Fact000037" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">146</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Class
    C Common Stock, par value $.0001</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_904_edei--EntityCommonStockSharesOutstanding_iI_c20250203__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zuYC1pJBfSz2" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2025-02-03_us-gaap_CommonClassCMember" id="Fact000038" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Class
    A Preferred Stock, par value $.0001</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_90C_edei--EntityCommonStockSharesOutstanding_iI_c20250203__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember_zcirHSN4gmai" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2025-02-03_us-gaap_PreferredClassAMember" id="Fact000039" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">313,438</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">INDEX</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 87%"><span style="font: normal 11pt Times New Roman, Times, Serif">PART
    I - FINANCIAL INFORMATION</span></td>
    <td style="width: 6%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 7%; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">PAGE</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 40pt; text-indent: -9pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Item
    1. Condensed Consolidated Financial Statements (Unaudited) </span></td>
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 45.05pt; text-indent: -9pt"><span style="font: normal 11pt Times New Roman, Times, Serif"><a href="#BalanceSheet">Condensed Consolidated Balance Sheets &#8211; as of December 31, 2024 and June 30, 2024</a> </span></td>
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">4</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 45.05pt; text-indent: -9pt"><span style="font: normal 11pt Times New Roman, Times, Serif"><a href="#IncomeStatement-3_Months">Condensed Consolidated Statements of Operations for the Three Months Ended December 31, 2024 and December 31, 2023</a> </span></td>
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">7</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 45.05pt; text-indent: -9pt"><span style="font: normal 11pt Times New Roman, Times, Serif"><a href="#IncomeStatement-6_Months">Condensed Consolidated Statements of Operations for the Six Months Ended December 31, 2024 and December 31, 2023</a> </span></td>
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">8</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 45.05pt; text-indent: -9pt"><span style="font: normal 11pt Times New Roman, Times, Serif"><a href="#Changes_in_Equity_3_months">Condensed Consolidated Statements of Changes in Equity for the Three Months Ended December 31, 2024 and December 31, 2023</a> </span></td>
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">9</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 45.05pt; text-indent: -9pt"><span style="font: normal 11pt Times New Roman, Times, Serif"><a href="#Changes_in_Equity_6_months">Condensed Consolidated Statements of Changes in Equity for the Six Months Ended December 31, 2024 and December 31, 2023</a> </span></td>
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">11</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 45.05pt; text-indent: -9pt"><span style="font: normal 11pt Times New Roman, Times, Serif"><a href="#CashFlow">Condensed Consolidated Statements of Cash Flows for the Six Months Ended December 31, 2024 and December 31, 2023</a> </span></td>
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">13</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 45.05pt; text-indent: -9pt"><span style="font: normal 11pt Times New Roman, Times, Serif"><a href="#Notes">Notes to Condensed Consolidated Financial Statements</a> </span></td>
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">14</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 40pt; text-indent: -9pt"><span style="font: normal 11pt Times New Roman, Times, Serif"><a href="#MDA">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></td>
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">31</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 40pt; text-indent: -9pt"><span style="font: normal 11pt Times New Roman, Times, Serif"><a href="#QualitativeDisclosures">Item 3. Quantitative and Qualitative Disclosures About Market Risk</a></span></td>
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">37</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 40pt; text-indent: -9pt"><span style="font: normal 11pt Times New Roman, Times, Serif"><a href="#ControlsAndProcedures">Item 4. Controls and Procedures</a></span></td>
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">38</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt; text-indent: -4.45pt"><span style="font: normal 11pt Times New Roman, Times, Serif"><a href="#PartII">PART II - OTHER INFORMATION</a> </span></td>
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">38</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 40pt; text-indent: -9pt"><span style="font: normal 11pt Times New Roman, Times, Serif"><a href="#LegalProceedings">Item 1. Legal Proceedings</a> </span></td>
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">38</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 40pt; text-indent: -9pt"><span style="font: normal 11pt Times New Roman, Times, Serif"><a href="#RiskFactors">Item 1A. Risk Factors</a> </span></td>
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">38</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 40pt; text-indent: -9pt"><span style="font: normal 11pt Times New Roman, Times, Serif"><a href="#UseOfProceeds">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</a> </span></td>
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">40</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 40pt; text-indent: -9pt"><span style="font: normal 11pt Times New Roman, Times, Serif"><a href="#Defaults">Item 3. Defaults Upon Senior Securities</a> </span></td>
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">41</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 40pt; text-indent: -9pt"><span style="font: normal 11pt Times New Roman, Times, Serif"><a href="#MineSafety">Item 4. Mine Safety Disclosures</a> </span></td>
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">41</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 40pt; text-indent: -9pt"><span style="font: normal 11pt Times New Roman, Times, Serif"><a href="#MoreInformation">Item 5. Other Information</a> </span></td>
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">41</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 40pt; text-indent: -9pt"><span style="font: normal 11pt Times New Roman, Times, Serif"><a href="#Exhibits">Item 6. Exhibits</a> </span></td>
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">41</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 40pt; text-indent: -9pt"><span style="font: normal 11pt Times New Roman, Times, Serif"><a href="#Signatures">Signatures</a></span></td>
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">42</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif"><span id="BalanceSheet"></span>CONDENSED
CONSOLIDATED BALANCE SHEETS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">ASSETS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_308_111_pn3n3_zuPjcB8zYLde" summary="xdx: Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_49C_20241231_za1lAQbBWSa5" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_49C_20240630_zmm31oNenMOe" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">December
    31,<br/> 2024<br/> (Unaudited)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">June
    30,<br/> 2024<br/> (Note 1)</span></td></tr>
  <tr id="xdx_404_eus-gaap--AssetsCurrentAbstract_iB_zKqfpqnAsPVe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Current
    Assets:</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_i01I_maACzhLa_zWG9enrLGnV" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; width: 56%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Cash
    and cash equivalents</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2024-12-31" id="Fact000044" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">53,583</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2024-06-30" id="Fact000045" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">56,341</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--ShortTermInvestments_i01I_maACzhLa_z55VGHze5GI1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Short-term
    investments</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShortTermInvestments" contextRef="AsOf2024-12-31" id="Fact000047" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">121</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShortTermInvestments" contextRef="AsOf2024-06-30" id="Fact000048" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">136</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--AccountsAndOtherReceivablesNetCurrent_i01I_pn3n3_maACzhLa_z2OKOfjaqRc4" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Accounts
    receivable &#8211; net of allowance for credit losses of $<span id="xdx_904_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iI_pn3n3_c20241231_z5YT724X93D"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" contextRef="AsOf2024-12-31" id="Fact000052" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">273</ix:nonFraction>
    </span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
    $<span id="xdx_90C_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iI_pn3n3_c20240630_z1f4ENhI1X9a"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" contextRef="AsOf2024-06-30" id="Fact000053" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">166</ix:nonFraction> </span></span><span style="font: normal 11pt Times New Roman, Times, Serif">at
    December 31, 2024 and June 30, 2024, respectively</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsAndOtherReceivablesNetCurrent" contextRef="AsOf2024-12-31" id="Fact000050" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,390</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsAndOtherReceivablesNetCurrent" contextRef="AsOf2024-06-30" id="Fact000051" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,035</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--AccountReceivableRelatedParties_i01I_maACzhLa_z9rk6ZKtHINd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Accounts
    receivable _ related party</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:AccountReceivableRelatedParties" contextRef="AsOf2024-12-31" id="Fact000055" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">60</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0056">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_ecustom--MedicalReceivable_i01I_pn3n3_maACzhLa_zY9tLi03xlW" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Medical
    receivable &#8211; net</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2024-12-31" id="Fact000058" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23,496</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2024-06-30" id="Fact000059" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23,992</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--AccruedFeesAndOtherRevenueReceivable_i01I_pn3n3_maACzhLa_zYVax2tfYoGj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Management
    and other fees receivable &#8211; net of allowance for credit losses of $<span id="xdx_908_ecustom--ManagementAndOtherReceivableAllowancesForDoubtfulAccounts_iI_pn3n3_c20241231_zS45wYg8253g"><ix:nonFraction name="FONR:ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" contextRef="AsOf2024-12-31" id="Fact000063" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,663</ix:nonFraction>
    </span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
    $<span id="xdx_906_ecustom--ManagementAndOtherReceivableAllowancesForDoubtfulAccounts_iI_pn3n3_c20240630_zx1QEvaCK9wd"><ix:nonFraction name="FONR:ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" contextRef="AsOf2024-06-30" id="Fact000064" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,370</ix:nonFraction> </span></span><span style="font: normal 11pt Times New Roman, Times, Serif">at
    December 31, 2024 and June 30, 2024, respectively</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccruedFeesAndOtherRevenueReceivable" contextRef="AsOf2024-12-31" id="Fact000061" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">42,485</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccruedFeesAndOtherRevenueReceivable" contextRef="AsOf2024-06-30" id="Fact000062" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">41,954</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_i01I_pn3n3_maACzhLa_zvXWwrIKo5r2" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Management
    and other fees receivable &#8211; related medical practices &#8211; net of allowance for credit losses of $<span id="xdx_90B_ecustom--RelatedPartyReceivableAllowancesForDoubtfulAccounts_iI_pn3n3_c20241231_zZmpOJVsCvpf"><ix:nonFraction name="FONR:RelatedPartyReceivableAllowancesForDoubtfulAccounts" contextRef="AsOf2024-12-31" id="Fact000068" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,989</ix:nonFraction>
    </span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
    $<span id="xdx_90C_ecustom--RelatedPartyReceivableAllowancesForDoubtfulAccounts_iI_pn3n3_c20240630_zs7vW4PYyjP"><ix:nonFraction name="FONR:RelatedPartyReceivableAllowancesForDoubtfulAccounts" contextRef="AsOf2024-06-30" id="Fact000069" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,110</ix:nonFraction> </span></span><span style="font: normal 11pt Times New Roman, Times, Serif">at
    December 31, 2024 and June 30, 2024, respectively</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2024-12-31" id="Fact000066" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,677</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2024-06-30" id="Fact000067" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,865</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_i01I_maACzhLa_zpLBenbTzN19" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Inventories</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InventoryFinishedGoodsAndWorkInProcess" contextRef="AsOf2024-12-31" id="Fact000071" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,858</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InventoryFinishedGoodsAndWorkInProcess" contextRef="AsOf2024-06-30" id="Fact000072" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,715</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i01I_maACzhLa_zXfAEEylCeq4" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Prepaid
    expenses and other current assets</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2024-12-31" id="Fact000074" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,962</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2024-06-30" id="Fact000075" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,286</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--AssetsCurrent_i01TI_pn3n3_mtACzhLa_maAzyiF_zKrhKR4Fyphf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Total
    Current Assets</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2024-12-31" id="Fact000077" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">137,632</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2024-06-30" id="Fact000078" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">140,324</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--AccountsReceivableNetLongTerm_i01I_pn3n3_maAzyiF_zwj9fTUHDkE" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Accounts
    receivable &#8211; long term</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:AccountsReceivableNetLongTerm" contextRef="AsOf2024-12-31" id="Fact000080" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">724</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:AccountsReceivableNetLongTerm" contextRef="AsOf2024-06-30" id="Fact000081" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">830</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsDeferredIncome_i01I_maAzyiF_zzH0DEts2Azg" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Deferred
    income tax asset</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsDeferredIncome" contextRef="AsOf2024-12-31" id="Fact000083" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,113</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsDeferredIncome" contextRef="AsOf2024-06-30" id="Fact000084" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,223</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentNet_i01I_pn3n3_maAzyiF_zrCF2xB4Z5Bh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Property
    and equipment &#8211; net</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2024-12-31" id="Fact000086" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,270</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2024-06-30" id="Fact000087" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,709</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--NoteReceivableRelatedParty_i01I_pn3n3_maAzyiF_zi300QSCA6y3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Note
    receivable &#8211; related party</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:NoteReceivableRelatedParty" contextRef="AsOf2024-12-31" id="Fact000089" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">607</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:NoteReceivableRelatedParty" contextRef="AsOf2024-06-30" id="Fact000090" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">581</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--OperatingLeaseRightOfUseAsset_i01I_pn3n3_maAzyiF_zn3gPtVXgAzf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Right-of-use-asset
    &#8211; operating leases</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2024-12-31" id="Fact000092" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">34,946</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2024-06-30" id="Fact000093" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,428</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--FinanceLeaseRightOfUseAsset_i01I_pn3n3_maAzyiF_zuJ2C92UENLi" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Right-of-use-asset
    &#8211; financing lease</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="AsOf2024-12-31" id="Fact000095" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">496</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="AsOf2024-06-30" id="Fact000096" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">531</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--Goodwill_i01I_maAzyiF_z7Hj1eNu4zo9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Goodwill</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2024-12-31" id="Fact000098" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,269</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2024-06-30" id="Fact000099" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,269</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--IntangibleAssetsNetExcludingGoodwill_i01I_pn3n3_maAzyiF_zfrIN3pyuXwd" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Other
    intangible assets &#8211; net</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2024-12-31" id="Fact000101" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,407</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2024-06-30" id="Fact000102" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,870</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--OtherAssets_i01I_maAzyiF_zcOqpNfwLR0e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Other
    assets</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2024-12-31" id="Fact000104" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">493</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2024-06-30" id="Fact000105" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">481</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--Assets_i01TI_pn3n3_mtAzyiF_zHyGWq9qXEbh" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Total
    Assets</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2024-12-31" id="Fact000107" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">207,957</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2024-06-30" id="Fact000108" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">214,246</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">See
accompanying notes to the unaudited condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">CONDENSED
CONSOLIDATED BALANCE SHEETS (CONTINUED)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">LIABILITIES
AND EQUITY</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">December
    31,<br/> 2024<br/> (Unaudited)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">June
    30,<br/> 2024<br/> (Note 1)</span></td></tr>
  <tr id="xdx_400_eus-gaap--LiabilitiesCurrentAbstract_iB_zd4gOy5jajBe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Current
    Liabilities:</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--LongTermDebtCurrent_i01I_maCzaLW_zDvx9m2YyVgc" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; width: 56%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Current
    portion of long-term debt</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2024-12-31" id="Fact000113" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">49</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2024-06-30" id="Fact000114" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">47</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--AccountsPayableCurrent_i01I_maCzaLW_zgYpTuI70ZV2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Accounts
    payable</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2024-12-31" id="Fact000116" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">953</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2024-06-30" id="Fact000117" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,856</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--OtherLiabilitiesCurrent_i01I_maCzaLW_zTSqDiYIAOz9" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Other
    current liabilities</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2024-12-31" id="Fact000119" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,912</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2024-06-30" id="Fact000120" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,941</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--DeferredRevenueCurrent_i01I_maCzaLW_zVc0TlJ0A07g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Unearned
    revenue on service contracts</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2024-12-31" id="Fact000122" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,413</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2024-06-30" id="Fact000123" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,870</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--UnearnedRevenueOnServiceContractsRelatedParty_i01I_pn3n3_maCzaLW_zJvapGgIuRJ9" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Unearned
    revenue on service contracts &#8211; related party</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:UnearnedRevenueOnServiceContractsRelatedParty" contextRef="AsOf2024-12-31" id="Fact000125" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">55</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0126">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--OperatingLeaseLiabilityCurrent_i01I_maCzaLW_z2phxLdcjw6d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Operating
    lease liabilities _ current portion</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2024-12-31" id="Fact000128" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,259</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2024-06-30" id="Fact000129" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,474</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--FinanceLeaseLiabilityCurrent_i01I_maCzaLW_ztK3E5Uzej3c" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Financing
    lease liability _ current portion</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityCurrent" contextRef="AsOf2024-12-31" id="Fact000131" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">244</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityCurrent" contextRef="AsOf2024-06-30" id="Fact000132" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">226</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--CustomerDeposits_i01I_maCzaLW_z5J9lD2std01" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Customer
    deposits</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:CustomerDeposits" contextRef="AsOf2024-12-31" id="Fact000134" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">357</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:CustomerDeposits" contextRef="AsOf2024-06-30" id="Fact000135" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">443</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--LiabilitiesCurrent_i01TI_mtCzaLW_maCzKFi_zqnZtSPae8N2" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Total
    Current Liabilities</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2024-12-31" id="Fact000137" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,242</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2024-06-30" id="Fact000138" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,857</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--LiabilitiesNoncurrentAbstract_iB_zfCiNg3tcFpj" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Long-Term
    Liabilities:</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--DeferredRevenueNoncurrent_i01I_maCzTAP_zVovrTelXkOi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Unearned
    revenue on service contracts</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredRevenueNoncurrent" contextRef="AsOf2024-12-31" id="Fact000143" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,050</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredRevenueNoncurrent" contextRef="AsOf2024-06-30" id="Fact000144" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,175</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_i01I_maCzTAP_z1zOKO1YyTUk" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Deferred
    income tax liability</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" contextRef="AsOf2024-12-31" id="Fact000146" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">371</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" contextRef="AsOf2024-06-30" id="Fact000147" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">371</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--AccountsPayableRelatedPartyNoncurrent_i01I_maCzTAP_z20FPMTBWby8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Due
    to related party medical practices</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:AccountsPayableRelatedPartyNoncurrent" contextRef="AsOf2024-12-31" id="Fact000149" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">93</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:AccountsPayableRelatedPartyNoncurrent" contextRef="AsOf2024-06-30" id="Fact000150" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">93</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_pn3n3_maCzTAP_zssHiTYrynW3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Operating
    lease liabilities &#8211; net of current portion</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2024-12-31" id="Fact000152" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">34,927</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2024-06-30" id="Fact000153" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">37,468</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--FinanceLeaseLiabilityNoncurrent_i01I_pn3n3_maCzTAP_zdYu05y2Tkd9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Financing
    lease liability &#8211; net of current portion</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityNoncurrent" contextRef="AsOf2024-12-31" id="Fact000155" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">290</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityNoncurrent" contextRef="AsOf2024-06-30" id="Fact000156" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">395</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--LongTermDebtNoncurrent_i01I_maCzTAP_zyIA2tjireXa" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Long-term
    debt, less current portion</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" contextRef="AsOf2024-12-31" id="Fact000158" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" contextRef="AsOf2024-06-30" id="Fact000159" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">67</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--OtherLiabilities_i01I_maCzTAP_zcwyDDw6mvZi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Other
    liabilities</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="AsOf2024-12-31" id="Fact000161" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="AsOf2024-06-30" id="Fact000162" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--LiabilitiesNoncurrent_i01TI_mtCzTAP_maCzKFi_zJeK7BW8EUo3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Total
    Long-Term Liabilities</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2024-12-31" id="Fact000164" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">36,764</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2024-06-30" id="Fact000165" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">39,601</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--Liabilities_i01TI_mtCzKFi_maCzAN9_zooXpA3aVWP4" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Total
    Liabilities</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2024-12-31" id="Fact000167" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">49,006</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2024-06-30" id="Fact000168" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">57,458</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">See
accompanying notes to the unaudited condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">CONDENSED
CONSOLIDATED BALANCE SHEETS (CONTINUED)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">LIABILITIES
AND EQUITY (Continued)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr id="xdx_405_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_zxKdMBLyaYG1" style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">EQUITY:</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">December
    31, 2024<br/> (Unaudited)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">June
    30,<br/> 2024<br/> (Note 1)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">Class
                                            A non-voting preferred stock $<span id="xdx_905_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pip0_c20240630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zqz6C593z8j"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-06-30_custom_ClassANonVotingPreferredStockMember" id="Fact000172" decimals="INF" scale="0" unitRef="USDPShares">.0001</ix:nonFraction>
                                            </span></span><span style="font: normal 11pt Times New Roman, Times, Serif">par
                                            value; <span id="xdx_902_eus-gaap--PreferredStockSharesAuthorized_iI_pn3n3_c20240630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zst4IbgEKKN9"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2024-06-30_custom_ClassANonVotingPreferredStockMember" id="Fact000173" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">453</ix:nonFraction>
                                            </span></span><span style="font: normal 11pt Times New Roman, Times, Serif">shares
                                            authorized at December 31, 2024 and June 30, 2024, <span id="xdx_901_eus-gaap--PreferredStockSharesOutstanding_iI_pn3n3_c20240630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zlR6QeCtwHRc"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-06-30_custom_ClassANonVotingPreferredStockMember" id="Fact000174" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">313</ix:nonFraction>
                                            </span></span><span style="font: normal 11pt Times New Roman, Times, Serif">issued
                                            and outstanding at December 31, 2024 and June 30, 2024&#160;</span></p></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--PreferredStockValue_i01I_pn3n3_d0_maSEzybg_c20241231__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zguugXfjA2Pa" title="Preferred stock value" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2024-12-31_custom_ClassANonVotingPreferredStockMember" id="Fact000176" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--PreferredStockValue_i01I_pn3n3_d0_maSEzybg_c20240630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zWzaisDZFa8e" title="Preferred stock value" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2024-06-30_custom_ClassANonVotingPreferredStockMember" id="Fact000178" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Preferred
    stock $<span id="xdx_905_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pip0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zByUqhordzIk"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-06-30_us-gaap_PreferredStockMember" id="Fact000179" decimals="INF" scale="0" unitRef="USDPShares">.001</ix:nonFraction>
    </span></span><span style="font: normal 11pt Times New Roman, Times, Serif">par
    value; <span id="xdx_905_eus-gaap--PreferredStockSharesAuthorized_iI_pn3n3_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zHxEMITgXHs7"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2024-06-30_us-gaap_PreferredStockMember" id="Fact000180" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">567</ix:nonFraction>
    </span></span><span style="font: normal 11pt Times New Roman, Times, Serif">shares
    authorized at December 31, 2024 and June 30, 2024, issued and outstanding &#8211; <span id="xdx_90A_eus-gaap--PreferredStockSharesOutstanding_iI_pn3n3_dn_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zuZiMESa5dDi"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-06-30_us-gaap_PreferredStockMember" id="Fact000181" format="ixt-sec:numwordsen" decimals="-3" scale="3" unitRef="Shares">none</ix:nonFraction></span></span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--PreferredStockValue_i01I_pn3n3_d0_maSEzybg_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zX1UnvkyJZU5" title="Preferred stock value" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2024-12-31_us-gaap_PreferredStockMember" id="Fact000183" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--PreferredStockValue_i01I_pn3n3_d0_maSEzybg_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zPC1irgJ21wk" title="Preferred stock value" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2024-06-30_us-gaap_PreferredStockMember" id="Fact000185" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Common
    Stock $<span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pip0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zn5oDEQgJEqh"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember" id="Fact000186" decimals="INF" scale="0" unitRef="USDPShares">.0001</ix:nonFraction>
    </span></span><span style="font: normal 11pt Times New Roman, Times, Serif">par
    value; <span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_pn3n3_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zZ2sZm8NDUAl"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember" id="Fact000187" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">8,500</ix:nonFraction>
    </span></span><span style="font: normal 11pt Times New Roman, Times, Serif">shares
    authorized at December 31, 2024 and June 30, 2024, <span id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_pn3n3_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zZ7Yy8RmdFod"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-12-31_us-gaap_CommonStockMember" id="Fact000188" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,207</ix:nonFraction>
    </span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
    <span id="xdx_909_eus-gaap--CommonStockSharesIssued_iI_pn3n3_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zR4D7A0LZyXk"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember" id="Fact000189" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,373</ix:nonFraction>
    </span></span><span style="font: normal 11pt Times New Roman, Times, Serif">issued
    at December 31, 2024 and June 30, 2024, respectively, <span id="xdx_902_eus-gaap--CommonStockSharesOutstanding_iI_pn3n3_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zyx70MwO86Mg"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-12-31_us-gaap_CommonStockMember" id="Fact000190" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,203</ix:nonFraction>
    </span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
    <span id="xdx_900_eus-gaap--CommonStockSharesOutstanding_iI_pn3n3_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z3ylQgxRyVL"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember" id="Fact000191" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,328</ix:nonFraction>
    </span></span><span style="font: normal 11pt Times New Roman, Times, Serif">outstanding
    at December 31, 2024 and June 30, 2024, respectively</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--CommonStockValue_i01I_pn3n3_maSEzybg_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zHDBqFUfTB83" title="Common stock value" style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2024-12-31_us-gaap_CommonStockMember" id="Fact000193" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--CommonStockValue_i01I_pn3n3_maSEzybg_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z6ve6Xg4eDvi" title="Common stock value" style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember" id="Fact000195" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Class
    B Common Stock (10 votes per share) $<span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pip0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zDdiMpIlbDA5"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember" id="Fact000196" decimals="INF" scale="0" unitRef="USDPShares">.0001</ix:nonFraction>
    </span></span><span style="font: normal 11pt Times New Roman, Times, Serif">par
    value; <span id="xdx_90C_eus-gaap--CommonStockSharesAuthorized_iI_pn3n3_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zs9SRUBphWp7"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember" id="Fact000197" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">227</ix:nonFraction>
    </span></span><span style="font: normal 11pt Times New Roman, Times, Serif">shares
    authorized at December 31, 2024 and June 30, 2024, <span id="xdx_901_eus-gaap--CommonStockSharesOutstanding_iI_pp0n3_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zSDnXNUMdEA3"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember" id="Fact000198" format="ixt:numdotdecimal" decimals="0" scale="3" unitRef="Shares">0.146</ix:nonFraction>
    </span></span><span style="font: normal 11pt Times New Roman, Times, Serif">issued
    and outstanding at December 31, 2024 and June 30, 2024</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--CommonStockValue_i01I_pn3n3_d0_maSEzybg_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zOsjchEPWdca" title="Common stock value" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2024-12-31_us-gaap_CommonClassBMember" id="Fact000200" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--CommonStockValue_i01I_pn3n3_d0_maSEzybg_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zhLyzkWYI5c1" title="Common stock value" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember" id="Fact000202" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Class
    C Common Stock (25 votes per share) $<span id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pip0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zENcc5d1P1Hg"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-06-30_us-gaap_CommonClassCMember" id="Fact000203" decimals="INF" scale="0" unitRef="USDPShares">.0001</ix:nonFraction>
    </span></span><span style="font: normal 11pt Times New Roman, Times, Serif">par
    value; <span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_iI_pn3n3_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zUgvFZAWD6w4"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2024-06-30_us-gaap_CommonClassCMember" id="Fact000204" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">567</ix:nonFraction>
    </span></span><span style="font: normal 11pt Times New Roman, Times, Serif">shares
    authorized at December 31, 2024 and June 30, 2024, <span id="xdx_906_eus-gaap--CommonStockSharesOutstanding_iI_pn3n3_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zABjrbXC8yy8"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-06-30_us-gaap_CommonClassCMember" id="Fact000205" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction>
    </span></span><span style="font: normal 11pt Times New Roman, Times, Serif">issued
    and outstanding at December 31, 2024 and June 30, 2024</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--CommonStockValue_i01I_pn3n3_d0_maSEzybg_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zXnKifOc8sC6" title="Common stock value" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2024-12-31_us-gaap_CommonClassCMember" id="Fact000207" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--CommonStockValue_i01I_pn3n3_d0_maSEzybg_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zrTJazo9xsDj" title="Common stock value" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2024-06-30_us-gaap_CommonClassCMember" id="Fact000209" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--AdditionalPaidInCapital_i01I_pn3n3_maSEzybg_ztZOwVPJrBr8" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Paid-in
    capital in excess of par value</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2024-12-31" id="Fact000211" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">178,758</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2024-06-30" id="Fact000212" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">180,608</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--RetainedEarningsAccumulatedDeficit_i01I_pn3n3_maSEzybg_zmhvHlLHqZ6c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Accumulated
    deficit</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2024-12-31" id="Fact000214" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">8,525</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2024-06-30" id="Fact000215" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">13,624</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_407_eus-gaap--TreasuryStockValue_i01NI_pn3n3_di_msSEzybg_zPf5K6e2RIVl" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Treasury
    stock, at cost &#8211; <span id="xdx_904_eus-gaap--TreasuryStockCommonShares_iI_pn3n3_c20241231_zkxH5dIENzU4"><ix:nonFraction name="us-gaap:TreasuryStockCommonShares" contextRef="AsOf2024-12-31" id="Fact000219" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">4</ix:nonFraction></span></span> <span style="font: normal 11pt Times New Roman, Times, Serif">shares
    of common stock at December 31, 2024 and <span id="xdx_905_eus-gaap--TreasuryStockCommonShares_iI_pn3n3_c20240630_zz2orCgZDIb1"><ix:nonFraction name="us-gaap:TreasuryStockCommonShares" contextRef="AsOf2024-06-30" id="Fact000220" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">45</ix:nonFraction>
    </span></span><span style="font: normal 11pt Times New Roman, Times, Serif">shares
    of common stock at June 30, 2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:TreasuryStockValue" contextRef="AsOf2024-12-31" id="Fact000217" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">395</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:TreasuryStockValue" contextRef="AsOf2024-06-30" id="Fact000218" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,017</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_404_eus-gaap--StockholdersEquity_i01TI_pn3n3_mtSEzybg_maCzXNf_zL974J0zZrd7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Total
    FONAR Corporation&#8217;s Stockholders&#8217; Equity</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-12-31" id="Fact000222" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">169,839</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30" id="Fact000223" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">165,968</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--MinorityInterest_i01I_maCzXNf_z9HO137BnGq3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Noncontrolling
    interests</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:MinorityInterest" contextRef="AsOf2024-12-31" id="Fact000225" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">10,888</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:MinorityInterest" contextRef="AsOf2024-06-30" id="Fact000226" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">9,180</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40A_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_i01TI_mtCzXNf_maCzAN9_zgGymwvd0LL1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Total
    Equity</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-12-31" id="Fact000228" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">158,951</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30" id="Fact000229" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">156,788</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_mtCzAN9_zz5VGFkye00b" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Total
    Liabilities and Equity</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2024-12-31" id="Fact000231" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">207,957</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2024-06-30" id="Fact000232" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">214,246</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">See
accompanying notes to the unaudited condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 6 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 9pt"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 9pt"><span style="font: normal 11pt Times New Roman, Times, Serif"><span id="IncomeStatement-3_Months"></span>CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 9pt"><span style="font: normal 11pt Times New Roman, Times, Serif">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 9pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_300_113_pn3n3_z3pTalQbFmX4" summary="xdx: Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_493_20241001__20241231_zgd4suwsYdP9" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_49C_20231001__20231231_zL0HCVUCgUr9" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FOR
    THE THREE MONTHS<br/> ENDED DECEMBER 31,<br/> (Unaudited)</span></td></tr>
  <tr id="xdx_403_eus-gaap--RevenuesAbstract_iB_zDcvoLhJsqvg" style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">REVENUES</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">2023</span></td></tr>
  <tr id="xdx_40E_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscounts_i01_maCzrN8_z8eshu0w6Ghk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; width: 56%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Patient
    fee revenue &#8211; net of contractual allowances and discounts</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" contextRef="From2024-10-012024-12-31" id="Fact000237" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,944</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" contextRef="From2023-10-012023-12-31" id="Fact000238" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,221</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--ProductSalesNet_i01_maCzrN8_zG0owFOzUEai" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Product
    sales</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ProductSalesNet" contextRef="From2024-10-012024-12-31" id="Fact000240" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ProductSalesNet" contextRef="From2023-10-012023-12-31" id="Fact000241" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">55</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_ecustom--ServiceAndRepairFeesNet_i01_maCzrN8_zxxg7vimstX8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Service
    and repair fees</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ServiceAndRepairFeesNet" contextRef="From2024-10-012024-12-31" id="Fact000243" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,759</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ServiceAndRepairFeesNet" contextRef="From2023-10-012023-12-31" id="Fact000244" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,778</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--ServiceAndRepairFeesRelatedPartiesNet_i01_maCzrN8_zA8QZPPmwuyd" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Service
    and repair fees _ related parties</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ServiceAndRepairFeesRelatedPartiesNet" contextRef="From2024-10-012024-12-31" id="Fact000246" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">45</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ServiceAndRepairFeesRelatedPartiesNet" contextRef="From2023-10-012023-12-31" id="Fact000247" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--ManagementAndOtherFeesNet_i01_maCzrN8_zuoNxvPEiGik" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Management
    and other fees</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesNet" contextRef="From2024-10-012024-12-31" id="Fact000249" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,189</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesNet" contextRef="From2023-10-012023-12-31" id="Fact000250" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,316</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--ManagementAndOtherFeesRelatedMedicalPracticesNet_i01_maCzrN8_zETO3lKLwUYj" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Management
    and other fees _ related medical practices</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet" contextRef="From2024-10-012024-12-31" id="Fact000252" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,988</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet" contextRef="From2023-10-012023-12-31" id="Fact000253" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,988</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--Revenues_iT_mtCzrN8_maCzmLL_zwlWaCX1hBYe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Total
    Revenues &#8211; Net</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-10-012024-12-31" id="Fact000255" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24,950</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-10-012023-12-31" id="Fact000256" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,386</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--CostsAndExpensesAbstract_iB_za1pQGCYb889" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">COSTS
    AND EXPENSES</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--OtherCostOfOperatingRevenue_i01_maCz4z4_zFGoYz2tdG2l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Costs
    related to patient fee revenue</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherCostOfOperatingRevenue" contextRef="From2024-10-012024-12-31" id="Fact000261" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,623</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherCostOfOperatingRevenue" contextRef="From2023-10-012023-12-31" id="Fact000262" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,602</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--CostsRelatedToProductSales_i01_maCz4z4_zv4kuprU6qX9" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Costs
    related to product sales</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:CostsRelatedToProductSales" contextRef="From2024-10-012024-12-31" id="Fact000264" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">221</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:CostsRelatedToProductSales" contextRef="From2023-10-012023-12-31" id="Fact000265" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">302</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--CostsRelatedToServiceAndRepairFees_i01_maCz4z4_zuJbz5x7V6Ue" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Costs
    related to service and repair fees</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFees" contextRef="From2024-10-012024-12-31" id="Fact000267" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">938</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFees" contextRef="From2023-10-012023-12-31" id="Fact000268" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">784</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--CostsRelatedToServiceAndRepairFeesRelatedParties_i01_maCz4z4_zIM6yOnhSHf3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Costs
    related to service and repair fees _ related parties</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFeesRelatedParties" contextRef="From2024-10-012024-12-31" id="Fact000270" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFeesRelatedParties" contextRef="From2023-10-012023-12-31" id="Fact000271" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--CostsRelatedToManagementAndOtherFees_i01_maCz4z4_zShN7tDKzCWj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Costs
    related to management and other fees</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFees" contextRef="From2024-10-012024-12-31" id="Fact000273" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,801</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFees" contextRef="From2023-10-012023-12-31" id="Fact000274" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,208</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_i01_pn3n3_maCz4z4_zFbiiMF1Ugt8" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Costs
    related to management and other fees &#8211; related medical practices</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" contextRef="From2024-10-012024-12-31" id="Fact000276" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,601</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" contextRef="From2023-10-012023-12-31" id="Fact000277" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,590</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--ResearchAndDevelopmentExpense_i01_maCz4z4_zNmYuIBCbpXa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Research
    and development</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2024-10-012024-12-31" id="Fact000279" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">376</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-10-012023-12-31" id="Fact000280" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">416</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--SellingGeneralAndAdministrativeExpense_i01_maCz4z4_zQmxSggV2dAf" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Selling,
    general and administrative expenses</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2024-10-012024-12-31" id="Fact000282" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,927</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2023-10-012023-12-31" id="Fact000283" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,587</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--CostsAndExpenses_i01T_mtCz4z4_msCzmLL_zRVCDLpH8zVi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Total
    Costs and Expenses</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2024-10-012024-12-31" id="Fact000285" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">22,515</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2023-10-012023-12-31" id="Fact000286" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,501</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_iT_mtCzmLL_maCzyeC_zUb7jjWbQCz3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">INCOME
    FROM OPERATIONS</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" contextRef="From2024-10-012024-12-31" id="Fact000288" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,435</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" contextRef="From2023-10-012023-12-31" id="Fact000289" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,885</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--OtherNonoperatingIncomeExpenseAbstract_iB_z7dTk1ZaMTQb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Other
    income and (expenses)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--InterestExpenseNonoperating_iN_di_msCzyeC_zSL6GxpBcd94" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Interest
    expense</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:InterestExpenseNonoperating" contextRef="From2024-10-012024-12-31" id="Fact000294" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:InterestExpenseNonoperating" contextRef="From2023-10-012023-12-31" id="Fact000295" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_401_ecustom--InvestmentIncomeRelatedParty_pn3n3_d0_maCzyeC_zwJOujZKqOd4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Investment
    income &#8211; related party</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:InvestmentIncomeRelatedParty" contextRef="From2024-10-012024-12-31" id="Fact000297" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:InvestmentIncomeRelatedParty" contextRef="From2023-10-012023-12-31" id="Fact000298" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--InvestmentIncomeNet_maCzyeC_zxKtvVucWWkd" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Investment
    income</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InvestmentIncomeNet" contextRef="From2024-10-012024-12-31" id="Fact000300" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">524</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InvestmentIncomeNet" contextRef="From2023-10-012023-12-31" id="Fact000301" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">534</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--OtherIncomeRelatedParty_maCzyeC_zzG9gYiiw2Ua" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Other
    income &#8211; related party</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0303">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:OtherIncomeRelatedParty" contextRef="From2023-10-012023-12-31" id="Fact000304" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">577</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--OtherNonoperatingIncomeExpense_maCzyeC_zsROXi027jqi" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Other
    income</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2024-10-012024-12-31" id="Fact000306" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0307">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_mtCzyeC_maCzgeC_zbzaWJbrs95l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Income
    Before Provision for Income Taxes and Noncontrolling Interests</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2024-10-012024-12-31" id="Fact000309" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,967</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-10-012023-12-31" id="Fact000310" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,986</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--IncomeTaxExpenseBenefit_iN_di_msCzgeC_zQsApmnYB4K7" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Provision
    for income taxes</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2024-10-012024-12-31" id="Fact000312" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">762</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-10-012023-12-31" id="Fact000313" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,366</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_407_ecustom--ConsolidatedNetIncome_iT_mtCzgeC_maCzrCW_z9FkmHnIVDed" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Consolidated
    Net Income</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ConsolidatedNetIncome" contextRef="From2024-10-012024-12-31" id="Fact000315" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,205</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ConsolidatedNetIncome" contextRef="From2023-10-012023-12-31" id="Fact000316" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,620</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_iN_di_msCzrCW_zty4o1Tspr4a" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Net
    Income - Noncontrolling Interests</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2024-10-012024-12-31" id="Fact000318" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">241</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-10-012023-12-31" id="Fact000319" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">861</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40B_eus-gaap--NetIncomeLoss_iT_mtCzrCW_z36kywyTw8qd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Net
    Income &#8211; Attributable to FONAR</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-10-012024-12-31" id="Fact000321" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,964</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-10-012023-12-31" id="Fact000322" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,759</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Net
    Income Available to Common Stockholders</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_c20241001__20241231__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_zlSA8CeSS2z9" title="Net Income Available to Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OREVOU0VEIENPTlNPTElEQVRFRCBTVEFURU1FTlRTIE9GIE9QRVJBVElPTlMA" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2024-10-012024-12-31_custom_CommonStockholdersMember" id="Fact000324" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,840</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_c20231001__20231231__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_zCKZGKhGJzFb" title="Net Income Available to Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OREVOU0VEIENPTlNPTElEQVRFRCBTVEFURU1FTlRTIE9GIE9QRVJBVElPTlMA" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2023-10-012023-12-31_custom_CommonStockholdersMember" id="Fact000326" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,525</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Net
    Income Available to Class A Non-Voting Preferred Stockholders</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_c20241001__20241231__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockholdersMember_zKLRHn1RA5ul" title="Net Income Available to Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OREVOU0VEIENPTlNPTElEQVRFRCBTVEFURU1FTlRTIE9GIE9QRVJBVElPTlMA" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2024-10-012024-12-31_custom_ClassANonVotingPreferredStockholdersMember" id="Fact000328" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">93</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_c20231001__20231231__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockholdersMember_zczNCxwsKZal" title="Net Income Available to Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OREVOU0VEIENPTlNPTElEQVRFRCBTVEFURU1FTlRTIE9GIE9QRVJBVElPTlMA" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2023-10-012023-12-31_custom_ClassANonVotingPreferredStockholdersMember" id="Fact000330" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">175</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Net
    Income Available to Class C Common Stockholders</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zeOoqIyDzRY7" title="Net Income Available to Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OREVOU0VEIENPTlNPTElEQVRFRCBTVEFURU1FTlRTIE9GIE9QRVJBVElPTlMA" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2024-10-012024-12-31_us-gaap_CommonClassCMember" id="Fact000332" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">31</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zaJo8SumJmj5" title="Net Income Available to Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OREVOU0VEIENPTlNPTElEQVRFRCBTVEFURU1FTlRTIE9GIE9QRVJBVElPTlMA" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2023-10-012023-12-31_us-gaap_CommonClassCMember" id="Fact000334" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">59</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Basic
    Net Income Per Common Share Available to Common Stockholders</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ09OREVOU0VEIENPTlNPTElEQVRFRCBTVEFURU1FTlRTIE9GIE9QRVJBVElPTlMA" id="xdx_908_eus-gaap--EarningsPerShareBasic_pip0_c20241001__20241231__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_z1733ova4dLf" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2024-10-012024-12-31_custom_CommonStockholdersMember" id="Fact000335" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.29</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ09OREVOU0VEIENPTlNPTElEQVRFRCBTVEFURU1FTlRTIE9GIE9QRVJBVElPTlMA" id="xdx_904_eus-gaap--EarningsPerShareBasic_pip0_c20231001__20231231__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_zl8gSgCLZ1K2" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-10-012023-12-31_custom_CommonStockholdersMember" id="Fact000336" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.55</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Diluted
    Net Income Per Common Share Available to Common Stockholders</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ09OREVOU0VEIENPTlNPTElEQVRFRCBTVEFURU1FTlRTIE9GIE9QRVJBVElPTlMA" id="xdx_901_eus-gaap--EarningsPerShareDiluted_pip0_c20241001__20241231__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_zUnmPplO704d" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-10-012024-12-31_custom_CommonStockholdersMember" id="Fact000337" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.29</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ09OREVOU0VEIENPTlNPTElEQVRFRCBTVEFURU1FTlRTIE9GIE9QRVJBVElPTlMA" id="xdx_90B_eus-gaap--EarningsPerShareDiluted_pip0_c20231001__20231231__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_zitGb1qSTz1d" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-10-012023-12-31_custom_CommonStockholdersMember" id="Fact000338" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.54</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Basic
    and Diluted Income Per Share &#8211; Class C Common</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ09OREVOU0VEIENPTlNPTElEQVRFRCBTVEFURU1FTlRTIE9GIE9QRVJBVElPTlMA" id="xdx_901_eus-gaap--EarningsPerShareDiluted_pip0_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zCJGYRGmvwCb" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-10-012024-12-31_us-gaap_CommonClassCMember" id="Fact000339" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.08</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ09OREVOU0VEIENPTlNPTElEQVRFRCBTVEFURU1FTlRTIE9GIE9QRVJBVElPTlMA" id="xdx_903_eus-gaap--EarningsPerShareDiluted_pip0_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zXsKsbEVDaB6" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-10-012023-12-31_us-gaap_CommonClassCMember" id="Fact000340" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.16</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Weighted
    Average Basic Shares Outstanding &#8211; Common Stockholders</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ09OREVOU0VEIENPTlNPTElEQVRFRCBTVEFURU1FTlRTIE9GIE9QRVJBVElPTlMA" id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20241001__20241231__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_zCAAARw9H6Ql" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-10-012024-12-31_custom_CommonStockholdersMember" id="Fact000341" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,303</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ09OREVOU0VEIENPTlNPTElEQVRFRCBTVEFURU1FTlRTIE9GIE9QRVJBVElPTlMA" id="xdx_90B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20231001__20231231__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_zGk7UeyK7wta" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-10-012023-12-31_custom_CommonStockholdersMember" id="Fact000342" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,437</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Weighted
    Average Diluted Shares Outstanding _ Common Stockholders</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ09OREVOU0VEIENPTlNPTElEQVRFRCBTVEFURU1FTlRTIE9GIE9QRVJBVElPTlMA" id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20241001__20241231__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_z5wiXJBhSRh4" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-10-012024-12-31_custom_CommonStockholdersMember" id="Fact000343" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,431</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ09OREVOU0VEIENPTlNPTElEQVRFRCBTVEFURU1FTlRTIE9GIE9QRVJBVElPTlMA" id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20231001__20231231__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_zntaPHspre53" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-10-012023-12-31_custom_CommonStockholdersMember" id="Fact000344" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,565</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Weighted
    Average Basic and Diluted Shares Outstanding _ Class C Common</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ09OREVOU0VEIENPTlNPTElEQVRFRCBTVEFURU1FTlRTIE9GIE9QRVJBVElPTlMA" id="xdx_904_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z5DGhQVknrbl" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-10-012024-12-31_us-gaap_CommonClassCMember" id="Fact000345" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ09OREVOU0VEIENPTlNPTElEQVRFRCBTVEFURU1FTlRTIE9GIE9QRVJBVElPTlMA" id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zT1k4fcV3bhd" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-10-012023-12-31_us-gaap_CommonClassCMember" id="Fact000346" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">See
accompanying notes to the unaudited condensed consolidated financial statements.&#160;</span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Page; Sequence: 7 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif"><br/>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 9pt"><span style="font: normal 11pt Times New Roman, Times, Serif"><span id="IncomeStatement-6_Months"></span>CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 9pt"><span style="font: normal 11pt Times New Roman, Times, Serif">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 9pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_49B_20240701__20241231_zu5VTKx6f4Ve" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_49D_20230701__20231231_zha4OrR9KRI7" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FOR
    THE SIX MONTHS<br/> ENDED DECEMBER 31,<br/> (Unaudited)</span></td></tr>
  <tr id="xdx_403_eus-gaap--RevenuesAbstract_iB_zMkPacECXGV6" style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">REVENUES</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">2023</span></td></tr>
  <tr id="xdx_40E_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscounts_i01_maCz0fM_zUuE2L09mJX7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; width: 56%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Patient
    fee revenue &#8211; net of contractual allowances and discounts</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" contextRef="From2024-07-01to2024-12-31" id="Fact000351" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15,431</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" contextRef="From2023-07-012023-12-31" id="Fact000352" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,896</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--ProductSalesNet_i01_maCz0fM_zlLHnwXyirD9" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Product
    sales</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ProductSalesNet" contextRef="From2024-07-01to2024-12-31" id="Fact000354" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">145</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ProductSalesNet" contextRef="From2023-07-012023-12-31" id="Fact000355" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">219</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_ecustom--ServiceAndRepairFeesNet_i01_maCz0fM_zJoDFGzy1C39" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Service
    and repair fees</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ServiceAndRepairFeesNet" contextRef="From2024-07-01to2024-12-31" id="Fact000357" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,751</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ServiceAndRepairFeesNet" contextRef="From2023-07-012023-12-31" id="Fact000358" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,643</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--ServiceAndRepairFeesRelatedPartiesNet_i01_maCz0fM_zeLlbp3LHiX3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Service
    and repair fees _ related parties</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ServiceAndRepairFeesRelatedPartiesNet" contextRef="From2024-07-01to2024-12-31" id="Fact000360" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">90</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ServiceAndRepairFeesRelatedPartiesNet" contextRef="From2023-07-012023-12-31" id="Fact000361" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">55</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--ManagementAndOtherFeesNet_i01_maCz0fM_znzHGxwx9uL8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Management
    and other fees</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesNet" contextRef="From2024-07-01to2024-12-31" id="Fact000363" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24,518</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesNet" contextRef="From2023-07-012023-12-31" id="Fact000364" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24,436</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--ManagementAndOtherFeesRelatedMedicalPracticesNet_i01_maCz0fM_zftZ2JnbC1jh" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Management
    and other fees _ related medical practices</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet" contextRef="From2024-07-01to2024-12-31" id="Fact000366" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,975</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet" contextRef="From2023-07-012023-12-31" id="Fact000367" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,975</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--Revenues_iT_mtCz0fM_maCzpw5_zHyg8QNdbjh7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Total
    Revenues &#8211; Net</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-07-01to2024-12-31" id="Fact000369" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">49,910</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-07-012023-12-31" id="Fact000370" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">51,224</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--CostsAndExpensesAbstract_iB_zIrAIeULC6U" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">COSTS
    AND EXPENSES</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--OtherCostOfOperatingRevenue_i01_maCzzW8_z3HdZB67FBU1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Costs
    related to patient fee revenue</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherCostOfOperatingRevenue" contextRef="From2024-07-01to2024-12-31" id="Fact000375" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,269</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherCostOfOperatingRevenue" contextRef="From2023-07-012023-12-31" id="Fact000376" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,029</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--CostsRelatedToProductSales_i01_maCzzW8_zgIc6K0iUxq2" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Costs
    related to product sales</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:CostsRelatedToProductSales" contextRef="From2024-07-01to2024-12-31" id="Fact000378" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">442</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:CostsRelatedToProductSales" contextRef="From2023-07-012023-12-31" id="Fact000379" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">405</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--CostsRelatedToServiceAndRepairFees_i01_maCzzW8_zJDYQANM9k37" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Costs
    related to service and repair fees</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFees" contextRef="From2024-07-01to2024-12-31" id="Fact000381" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,029</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFees" contextRef="From2023-07-012023-12-31" id="Fact000382" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,633</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--CostsRelatedToServiceAndRepairFeesRelatedParties_i01_maCzzW8_zu4x0L55irA6" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Costs
    related to service and repair fees _ related parties</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFeesRelatedParties" contextRef="From2024-07-01to2024-12-31" id="Fact000384" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">96</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFeesRelatedParties" contextRef="From2023-07-012023-12-31" id="Fact000385" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--CostsRelatedToManagementAndOtherFees_i01_maCzzW8_zurmeH1tX0rd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Costs
    related to management and other fees</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFees" contextRef="From2024-07-01to2024-12-31" id="Fact000387" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15,111</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFees" contextRef="From2023-07-012023-12-31" id="Fact000388" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,231</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_i01_pn3n3_maCzzW8_zE33K3crn9l9" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Costs
    related to management and other fees &#8211; related medical practices</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" contextRef="From2024-07-01to2024-12-31" id="Fact000390" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,174</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" contextRef="From2023-07-012023-12-31" id="Fact000391" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,109</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--ResearchAndDevelopmentExpense_i01_maCzzW8_zJG2XnBI4oz8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Research
    and development</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2024-07-01to2024-12-31" id="Fact000393" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">683</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-07-012023-12-31" id="Fact000394" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">883</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--SellingGeneralAndAdministrativeExpense_i01_maCzzW8_zTUqXVpktB2b" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Selling,
    general and administrative expenses</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2024-07-01to2024-12-31" id="Fact000396" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,065</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2023-07-012023-12-31" id="Fact000397" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,453</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--CostsAndExpenses_i01T_mtCzzW8_msCzpw5_zZNYfjoCLfZj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Total
    Costs and Expenses</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2024-07-01to2024-12-31" id="Fact000399" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">42,869</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2023-07-012023-12-31" id="Fact000400" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">39,768</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_iT_mtCzpw5_maCz37b_zcnOJKpp36qh" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">INCOME
    FROM OPERATIONS</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" contextRef="From2024-07-01to2024-12-31" id="Fact000402" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,041</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" contextRef="From2023-07-012023-12-31" id="Fact000403" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,456</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--OtherNonoperatingIncomeExpenseAbstract_iB_zjU1iNaedjle" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Other
    income and (expenses)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--InterestExpenseNonoperating_iN_di_msCz37b_zuWTpYpLQoy4" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Interest
    Expense</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:InterestExpenseNonoperating" contextRef="From2024-07-01to2024-12-31" id="Fact000408" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:InterestExpenseNonoperating" contextRef="From2023-07-012023-12-31" id="Fact000409" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">58</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40C_ecustom--InvestmentIncomeRelatedParty_pn3n3_d0_maCz37b_z6ObfLysxwUd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Investment
    income &#8211; related party</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:InvestmentIncomeRelatedParty" contextRef="From2024-07-01to2024-12-31" id="Fact000411" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:InvestmentIncomeRelatedParty" contextRef="From2023-07-012023-12-31" id="Fact000412" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--InvestmentIncomeNet_maCz37b_zqDyjqzq7YBh" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Investment
    income</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InvestmentIncomeNet" contextRef="From2024-07-01to2024-12-31" id="Fact000414" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,163</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InvestmentIncomeNet" contextRef="From2023-07-012023-12-31" id="Fact000415" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,040</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--OtherIncomeRelatedParty_maCz37b_zxVhYrlmbGKb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Other
    income &#8211; related party</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0417">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:OtherIncomeRelatedParty" contextRef="From2023-07-012023-12-31" id="Fact000418" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">577</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--OtherNonoperatingIncomeExpense_maCz37b_zSyw87G4wRea" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Other
    income</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0420">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2023-07-012023-12-31" id="Fact000421" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_mtCz37b_maCzzBi_zaz8wZLERTBe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Income
    Before Provision for Income Taxes and Noncontrolling Interests</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2024-07-01to2024-12-31" id="Fact000423" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,216</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-07-012023-12-31" id="Fact000424" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,016</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--IncomeTaxExpenseBenefit_iN_di_msCzzBi_z3GNoZBXN1l9" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Provision
    for income taxes</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2024-07-01to2024-12-31" id="Fact000426" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,011</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-07-012023-12-31" id="Fact000427" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,036</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_406_ecustom--ConsolidatedNetIncome_iT_maCzrCW_mtCzzBi_zA2xKRq2SV07" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Consolidated
    Net Income</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ConsolidatedNetIncome" contextRef="From2024-07-01to2024-12-31" id="Fact000429" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,205</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ConsolidatedNetIncome" contextRef="From2023-07-012023-12-31" id="Fact000430" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,980</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_iN_di_msCzrCW_zUpbPPFsFzn4" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Net
    Income Noncontrolling Interests</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2024-07-01to2024-12-31" id="Fact000432" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,106</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-07-012023-12-31" id="Fact000433" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,115</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40B_eus-gaap--NetIncomeLoss_iT_mtCzrCW_zZFk8wXy5HF4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Net
    Income &#8211; Attributable to FONAR</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-01to2024-12-31" id="Fact000435" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,099</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-12-31" id="Fact000436" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,865</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Net
    Income Available to Common Stockholders</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_c20240701__20241231__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_zEYBjUkSbdN7" title="Net Income Available to Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OREVOU0VEIENPTlNPTElEQVRFRCBTVEFURU1FTlRTIE9GIE9QRVJBVElPTlMA" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2024-07-012024-12-31_custom_CommonStockholdersMember" id="Fact000438" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,775</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_c20230701__20231231__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_zzBrhpQCLCWa" title="Net Income Available to Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OREVOU0VEIENPTlNPTElEQVRFRCBTVEFURU1FTlRTIE9GIE9QRVJBVElPTlMA" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2023-07-012023-12-31_custom_CommonStockholdersMember" id="Fact000440" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,375</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Net
    Income Available to Class A Non-Voting Preferred Stockholders</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_c20240701__20241231__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockholdersMember_zjexx66bqLXl" title="Net Income Available to Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OREVOU0VEIENPTlNPTElEQVRFRCBTVEFURU1FTlRTIE9GIE9QRVJBVElPTlMA" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2024-07-012024-12-31_custom_ClassANonVotingPreferredStockholdersMember" id="Fact000442" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">241</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_c20230701__20231231__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockholdersMember_zB6NHKex0tWe" title="Net Income Available to Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OREVOU0VEIENPTlNPTElEQVRFRCBTVEFURU1FTlRTIE9GIE9QRVJBVElPTlMA" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2023-07-012023-12-31_custom_ClassANonVotingPreferredStockholdersMember" id="Fact000444" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">365</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Net
    Income Available to Class C Common Stockholders</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zgGqDmNN5pZ5" title="Net Income Available to Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OREVOU0VEIENPTlNPTElEQVRFRCBTVEFURU1FTlRTIE9GIE9QRVJBVElPTlMA" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2024-07-012024-12-31_us-gaap_CommonClassCMember" id="Fact000446" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">83</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zgCQVw0Akq4" title="Net Income Available to Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OREVOU0VEIENPTlNPTElEQVRFRCBTVEFURU1FTlRTIE9GIE9QRVJBVElPTlMA" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2023-07-012023-12-31_us-gaap_CommonClassCMember" id="Fact000448" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">125</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Basic
    Net Income Per Common Share Available to Common Stockholders</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ09OREVOU0VEIENPTlNPTElEQVRFRCBTVEFURU1FTlRTIE9GIE9QRVJBVElPTlMA" id="xdx_908_eus-gaap--EarningsPerShareBasic_pip0_c20240701__20241231__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_z28OyWeU9iTh" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2024-07-012024-12-31_custom_CommonStockholdersMember" id="Fact000449" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.76</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ09OREVOU0VEIENPTlNPTElEQVRFRCBTVEFURU1FTlRTIE9GIE9QRVJBVElPTlMA" id="xdx_909_eus-gaap--EarningsPerShareBasic_pip0_c20230701__20231231__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_zPf9E0YupUke" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-07-012023-12-31_custom_CommonStockholdersMember" id="Fact000450" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">1.14</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Diluted
    Net Income Per Common Share Available to Common Stockholders</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ09OREVOU0VEIENPTlNPTElEQVRFRCBTVEFURU1FTlRTIE9GIE9QRVJBVElPTlMA" id="xdx_909_eus-gaap--EarningsPerShareDiluted_pip0_c20240701__20241231__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_zXOTdFUEQopk" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-07-012024-12-31_custom_CommonStockholdersMember" id="Fact000451" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.74</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ09OREVOU0VEIENPTlNPTElEQVRFRCBTVEFURU1FTlRTIE9GIE9QRVJBVElPTlMA" id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pip0_c20230701__20231231__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_zVWDP5409myg" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-07-012023-12-31_custom_CommonStockholdersMember" id="Fact000452" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">1.12</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Basic
    and Diluted Income Per Share &#8211; Class C Common</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ09OREVOU0VEIENPTlNPTElEQVRFRCBTVEFURU1FTlRTIE9GIE9QRVJBVElPTlMA" id="xdx_904_eus-gaap--EarningsPerShareDiluted_pip0_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zXWvucF7lxc8" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-07-012024-12-31_us-gaap_CommonClassCMember" id="Fact000453" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.22</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ09OREVOU0VEIENPTlNPTElEQVRFRCBTVEFURU1FTlRTIE9GIE9QRVJBVElPTlMA" id="xdx_906_eus-gaap--EarningsPerShareDiluted_pip0_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zOofqMR757hj" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-07-012023-12-31_us-gaap_CommonClassCMember" id="Fact000454" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.33</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Weighted
    Average Basic Shares Outstanding &#8211; Common Stockholders</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ09OREVOU0VEIENPTlNPTElEQVRFRCBTVEFURU1FTlRTIE9GIE9QRVJBVElPTlMA" id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20240701__20241231__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_zFcCbiyptC82" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-07-012024-12-31_custom_CommonStockholdersMember" id="Fact000455" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,313</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ09OREVOU0VEIENPTlNPTElEQVRFRCBTVEFURU1FTlRTIE9GIE9QRVJBVElPTlMA" id="xdx_904_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20231231__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_zQgCkZP0tSml" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-07-012023-12-31_custom_CommonStockholdersMember" id="Fact000456" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,448</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Weighted
    Average Diluted Shares Outstanding _ Common Stockholders</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ09OREVOU0VEIENPTlNPTElEQVRFRCBTVEFURU1FTlRTIE9GIE9QRVJBVElPTlMA" id="xdx_903_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20240701__20241231__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_zvr6UUSQ7WNb" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-07-012024-12-31_custom_CommonStockholdersMember" id="Fact000457" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,441</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ09OREVOU0VEIENPTlNPTElEQVRFRCBTVEFURU1FTlRTIE9GIE9QRVJBVElPTlMA" id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20230701__20231231__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_zR4Q3pbZibP2" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-07-012023-12-31_custom_CommonStockholdersMember" id="Fact000458" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,576</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Weighted
    Average Basic and Diluted Shares Outstanding _Class C Common</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ09OREVOU0VEIENPTlNPTElEQVRFRCBTVEFURU1FTlRTIE9GIE9QRVJBVElPTlMA" id="xdx_90D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zCkUMaIhiHP2" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-07-012024-12-31_us-gaap_CommonClassCMember" id="Fact000459" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ09OREVOU0VEIENPTlNPTElEQVRFRCBTVEFURU1FTlRTIE9GIE9QRVJBVElPTlMA" id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zSRJJSQuOBlc" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-07-012023-12-31_us-gaap_CommonClassCMember" id="Fact000460" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">See
accompanying notes to the unaudited condensed consolidated financial statements.&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Page; Sequence: 8 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif"><br/>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif"><span id="Changes_in_Equity_3_months"></span>CONDENSED
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(UNAUDITED)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_302_114_pn3n3_z6JSzsYjHEwc" summary="xdx: Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_4BA_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zuCHYktxmggj" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_4BC_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zKtUB6T7wLf8" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_4BA_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zikWsmjcq0Vc" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_4B9_us-gaap--StatementEquityComponentsAxis_us-gaap--TreasuryStockCommonMember_z8UFQA8YXtze" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_4B0_us-gaap--StatementEquityComponentsAxis_us-gaap--NoncontrollingInterestMember_zsDqoeVpgaok" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_4B4_zJphnRelvij4" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td colspan="33" style="text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">For
    the Three Months Ended December 31, 2024</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Common
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"></p>
                                                                               <p style="margin-top: 0; margin-bottom: 0">&#160;<span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>
                                                                               <p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">Common Stock Outstanding (Shares)</span></p></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Paid-in
    <br/> capital in excess of par value</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Accumulated
    Deficit</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Treasury
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Treasury
    Stock (Shares)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Non
    Controlling Interests</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Total</span></td></tr>
  <tr id="xdx_432_c20241001__20241231_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zaIAMECQZIT2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 28%; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Balance
    &#8211; September 30, 2024</span></td><td style="width: 2%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-09-30_us-gaap_CommonStockMember" id="Fact000462" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--SharesOutstanding_iS_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zdZLDlBz6PQ4" title="Beginning balance, shares" style="width: 5%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-09-30_us-gaap_CommonStockMember" id="Fact000469" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,328</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000463" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">180,608</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-09-30_us-gaap_RetainedEarningsMember" id="Fact000464" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">10,489</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-09-30_us-gaap_TreasuryStockCommonMember" id="Fact000465" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,432</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--SharesOutstanding_iS_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_z2kIVBjyaM02" title="Beginning balance, shares" style="width: 5%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-09-30_us-gaap_TreasuryStockCommonMember" id="Fact000471" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">69</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-09-30_us-gaap_NoncontrollingInterestMember" id="Fact000466" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">9,861</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-09-30" id="Fact000467" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">158,827</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--NetIncomeLoss_zfumN1yOQOeb" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Net
    income</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0473">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0474">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-10-012024-12-31_us-gaap_RetainedEarningsMember" id="Fact000475" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,964</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0476">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0477">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-10-012024-12-31" id="Fact000478" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,964</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--StockRepurchasedDuringPeriodValue_iN_di_zh6Ph58KV097" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Purchase
    of Treasury stock</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0480">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0481">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0482">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2024-10-012024-12-31_us-gaap_TreasuryStockCommonMember" id="Fact000483" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">926</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--StockRepurchasedDuringPeriodShares_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zd8z8J8kiTl3" title="Purchase of Treasury stock, shares" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="From2024-10-012024-12-31_us-gaap_TreasuryStockCommonMember" id="Fact000487" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">60</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0484">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2024-10-012024-12-31" id="Fact000485" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">926</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_402_ecustom--CancellationOfTreasuryStock_zncD2iFXWx0d" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Cancellation
    of Treasury stock</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0489">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_ecustom--CancellationOfTreasuryStockShares_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z2SfuJWVZjNd" title="Cancellation of Treasury stock, shares" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="FONR:CancellationOfTreasuryStockShares" contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember" id="Fact000496" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="Shares">125</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="FONR:CancellationOfTreasuryStock" contextRef="From2024-10-012024-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000490" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,963</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0491">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:CancellationOfTreasuryStock" contextRef="From2024-10-012024-12-31_us-gaap_TreasuryStockCommonMember" id="Fact000492" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,963</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_ecustom--CancellationOfTreasuryStockShares_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_ztwOptKsNdrf" title="Cancellation of Treasury stock, shares" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="FONR:CancellationOfTreasuryStockShares" contextRef="From2024-10-012024-12-31_us-gaap_TreasuryStockCommonMember" id="Fact000498" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="Shares">125</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0493">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0494">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--SaleNonControllingInterests_zCxTJGJ1HwKk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Sale
    - Non controlling interests</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0500">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:SaleNonControllingInterests" contextRef="From2024-10-012024-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000501" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">113</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0502">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0503">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:SaleNonControllingInterests" contextRef="From2024-10-012024-12-31_us-gaap_NoncontrollingInterestMember" id="Fact000504" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:SaleNonControllingInterests" contextRef="From2024-10-012024-12-31" id="Fact000505" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">132</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_di_zXFWHlG1rNGc" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Distributions
    - Non controlling interests</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0507">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0508">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0509">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0510">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2024-10-012024-12-31_us-gaap_NoncontrollingInterestMember" id="Fact000511" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,287</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2024-10-012024-12-31" id="Fact000512" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,287</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_402_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_z6MFekRVTlEk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Income
    - Non controlling interests</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0514">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0515">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0516">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0517">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2024-10-012024-12-31_us-gaap_NoncontrollingInterestMember" id="Fact000518" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">241</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2024-10-012024-12-31" id="Fact000519" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">241</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_437_c20241001__20241231_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_zGqtLKU7f1Ia" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Balance
    &#8211; December 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-12-31_us-gaap_CommonStockMember529343781" id="Fact000521" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--SharesOutstanding_iE_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zfhfZ5rw10ye" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-12-31_us-gaap_CommonStockMember529343781" id="Fact000528" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,203</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000522" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">178,758</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-12-31_us-gaap_RetainedEarningsMember" id="Fact000523" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">8,525</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-12-31_us-gaap_TreasuryStockCommonMember" id="Fact000524" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">395</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--SharesOutstanding_iE_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zeyFZ2HWHMv" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-12-31_us-gaap_TreasuryStockCommonMember" id="Fact000530" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">4</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-12-31_us-gaap_NoncontrollingInterestMember" id="Fact000525" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">10,888</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-12-31" id="Fact000526" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">158,951</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">See
accompanying notes to the unaudited condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 9 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">CONDENSED
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(UNAUDITED)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: normal 11pt Times New Roman, Times, Serif">For
the Three Months Ended December 31, 2023</span></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Common
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Common
    Stock Outstanding (Shares)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Paid-in
    <br/> capital in excess of par value</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Accumulated
    Deficit</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Treasury
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Treasury
    Stock (Shares)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Non
    Controlling Interests</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Total</span></td></tr>
  <tr id="xdx_43A_c20231001__20231231_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zezqZ0Kb3ze" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 28%; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Balance
    &#8211; September 30, 2023</span></td><td style="width: 2%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-09-30_us-gaap_CommonStockMember" id="Fact000532" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--SharesOutstanding_iS_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zfdFBlyL4nY3" title="Beginning balance, shares" style="width: 5%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-09-30_us-gaap_CommonStockMember" id="Fact000539" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,451</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000533" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">182,613</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-09-30_us-gaap_RetainedEarningsMember" id="Fact000534" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">20,085</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-09-30_us-gaap_TreasuryStockCommonMember" id="Fact000535" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,230</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--SharesOutstanding_iS_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zCp64oAVlvrc" title="Beginning balance, shares" style="width: 5%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-09-30_us-gaap_TreasuryStockCommonMember" id="Fact000541" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">55</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-09-30_us-gaap_NoncontrollingInterestMember" id="Fact000536" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,226</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-09-30" id="Fact000537" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">154,073</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--NetIncomeLoss_znMRFxd226rb" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Net
    income</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0543">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0544">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-10-012023-12-31_us-gaap_RetainedEarningsMember" id="Fact000545" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,759</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0546">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0547">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-10-012023-12-31" id="Fact000548" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,759</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--StockRepurchasedDuringPeriodValue_iN_di_zyH93qffEYw5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Purchase
    of Treasury stock</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0550">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0551">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0552">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-10-012023-12-31_us-gaap_TreasuryStockCommonMember" id="Fact000553" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,171</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--StockRepurchasedDuringPeriodShares_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zNbenBCl3Ezf" title="Purchase of Treasury stock, shares" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="From2023-10-012023-12-31_us-gaap_TreasuryStockCommonMember" id="Fact000557" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">72</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0554">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-10-012023-12-31" id="Fact000555" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,171</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_401_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensationForfeited_iP3us-gaap--StockRepurchasedDuringPeriodShares_zeiSMsar5Au3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Cancellation
    of shares</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0559">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_iP3us-gaap--StockIssuedDuringPeriodValueShareBasedCompensationForfeited_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zX1VYWb5fO26" title="Cancellation of shares, shares" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember" id="Fact000566" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="Shares">123</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2023-10-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000560" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,006</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0561">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2023-10-012023-12-31_us-gaap_TreasuryStockCommonMember" id="Fact000562" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,006</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zNwlo2R1Vhc8" title="Cancellation of shares, shares" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" contextRef="From2023-10-012023-12-31_us-gaap_TreasuryStockCommonMember" id="Fact000568" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="Shares">123</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0563">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0564">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_di_z9qParNz0swd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Distributions
    - Non controlling interests</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0570">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0571">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0572">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0573">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-10-012023-12-31_us-gaap_NoncontrollingInterestMember" id="Fact000574" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,225</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-10-012023-12-31" id="Fact000575" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,225</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_402_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_zX0LodNpdYB" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Income
    - Non controlling interests</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0577">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0578">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0579">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0580">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-10-012023-12-31_us-gaap_NoncontrollingInterestMember" id="Fact000581" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">861</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-10-012023-12-31" id="Fact000582" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">861</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_430_c20231001__20231231_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_zYTomilSAzO2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Balance
    &#8211; December 31, 2023</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact000584" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--SharesOutstanding_iE_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zszF77B47JT6" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact000591" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,328</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000585" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">180,607</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember" id="Fact000586" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">16,326</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-12-31_us-gaap_TreasuryStockCommonMember" id="Fact000587" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">395</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--SharesOutstanding_iE_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zIFzu8sbdx0g" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_us-gaap_TreasuryStockCommonMember" id="Fact000593" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">4</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-12-31_us-gaap_NoncontrollingInterestMember" id="Fact000588" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,590</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-12-31" id="Fact000589" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">156,297</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">See
accompanying notes to the unaudited condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 10 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif"><span id="Changes_in_Equity_6_months"></span>CONDENSED
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(UNAUDITED)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="33" style="text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">For the Six Months Ended December 31, 2024</span></p>
                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Common
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Common
    Stock Outstanding (Shares)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Paid-in
    <br/> capital in excess of par value</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Accumulated
    Deficit</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Treasury
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Treasury
    Stock (Shares)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Non
    Controlling Interests</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Total</span></td></tr>
  <tr id="xdx_432_c20240701__20241231_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zCFVfD2BRZl9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 28%; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Balance
    &#8211; June 30, 2024</span></td><td style="width: 2%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember529343609" id="Fact000595" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--SharesOutstanding_iS_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zxYUyqUHjUi4" title="Beginning balance, shares" style="width: 5%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember529343609" id="Fact000602" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,328</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000596" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">180,608</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30_us-gaap_RetainedEarningsMember" id="Fact000597" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">13,624</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30_us-gaap_TreasuryStockCommonMember" id="Fact000598" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,017</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--SharesOutstanding_iS_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zzAqMpCLi6Y2" title="Beginning balance, shares" style="width: 5%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-06-30_us-gaap_TreasuryStockCommonMember" id="Fact000604" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">45</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30_us-gaap_NoncontrollingInterestMember" id="Fact000599" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">9,180</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30" id="Fact000600" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">156,788</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--NetIncomeLoss_zfwkq5Tqt0T9" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Net
    income</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0606">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0607">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-012024-12-31_us-gaap_RetainedEarningsMember" id="Fact000608" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,099</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0609">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0610">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-01to2024-12-31" id="Fact000611" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,099</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--StockRepurchasedDuringPeriodValue_iN_di_zqrPXVHoq6dg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Purchase
    of Treasury stock</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0613">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0614">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0615">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2024-07-012024-12-31_us-gaap_TreasuryStockCommonMember" id="Fact000616" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,341</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--StockRepurchasedDuringPeriodShares_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zdT1TmxaAGT9" title="Purchase of Treasury stock, shares" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="From2024-07-012024-12-31_us-gaap_TreasuryStockCommonMember" id="Fact000620" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">84</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0617">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2024-07-01to2024-12-31" id="Fact000618" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,341</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_404_ecustom--CancellationOfTreasuryStock_zSGFi29BXtsi" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Cancellation
    of Treasury stock</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0622">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_ecustom--CancellationOfTreasuryStockShares_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zNEhWvXbXkl8" title="Cancellation of Treasury stock, shares" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="FONR:CancellationOfTreasuryStockShares" contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember" id="Fact000629" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="Shares">125</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="FONR:CancellationOfTreasuryStock" contextRef="From2024-07-012024-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000623" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,963</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0624">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:CancellationOfTreasuryStock" contextRef="From2024-07-012024-12-31_us-gaap_TreasuryStockCommonMember" id="Fact000625" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,963</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_ecustom--CancellationOfTreasuryStockShares_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zE1cE0ZEwwC1" title="Cancellation of Treasury stock, shares" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="FONR:CancellationOfTreasuryStockShares" contextRef="From2024-10-012024-12-31_us-gaap_TreasuryStockCommonMember" id="Fact000631" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="Shares">125</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0626">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0627">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--SaleNonControllingInterests_zeKbaK70gKDl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Sale
    - Non controlling interests</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0633">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:SaleNonControllingInterests" contextRef="From2024-07-012024-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000634" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">113</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0635">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0636">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:SaleNonControllingInterests" contextRef="From2024-07-012024-12-31_us-gaap_NoncontrollingInterestMember" id="Fact000637" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:SaleNonControllingInterests" contextRef="From2024-07-01to2024-12-31" id="Fact000638" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">132</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_di_zWSgxwBYm3u7" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Distributions
    - Non controlling interests</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0640">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0641">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0642">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0643">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2024-07-012024-12-31_us-gaap_NoncontrollingInterestMember" id="Fact000644" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,833</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2024-07-01to2024-12-31" id="Fact000645" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,833</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_402_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_zFbHrI1pMKTc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Income
    - Non controlling interests</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0647">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0648">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0649">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0650">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2024-07-012024-12-31_us-gaap_NoncontrollingInterestMember" id="Fact000651" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,106</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2024-07-01to2024-12-31" id="Fact000652" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,106</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_430_c20240701__20241231_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_z1inZUXcmqm7" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Balance
    &#8211; December 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-12-31_us-gaap_CommonStockMember529343781" id="Fact000654" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--SharesOutstanding_iE_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zCU9VnMSG9X9" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-12-31_us-gaap_CommonStockMember529343781" id="Fact000661" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,203</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000655" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">178,758</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-12-31_us-gaap_RetainedEarningsMember" id="Fact000656" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">8,525</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-12-31_us-gaap_TreasuryStockCommonMember" id="Fact000657" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">395</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--SharesOutstanding_iE_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zyuN3VxVUU1k" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-12-31_us-gaap_TreasuryStockCommonMember" id="Fact000663" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">4</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-12-31_us-gaap_NoncontrollingInterestMember" id="Fact000658" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">10,888</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-12-31" id="Fact000659" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">158,951</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">See
accompanying notes to the unaudited condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 11 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">CONDENSED
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(UNAUDITED)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;For
the Six Months Ended December 31, 2023</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Common
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Common
    Stock Outstanding (Shares)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Paid-in
    <br/> capital in excess of par value</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Accumulated
    Deficit</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Treasury
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Treasury
    Stock (Shares)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Non
    Controlling Interests</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Total</span></td></tr>
  <tr id="xdx_43C_c20230701__20231231_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zwbxS8JrRKs" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 28%; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Balance
    &#8211; June 30, 2023</span></td><td style="width: 2%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" id="Fact000665" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--SharesOutstanding_iS_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zbFkYc93EJTd" title="Beginning balance, shares" style="width: 5%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" id="Fact000672" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,451</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000666" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">182,613</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember" id="Fact000667" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">24,191</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_TreasuryStockCommonMember" id="Fact000668" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">516</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--SharesOutstanding_iS_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zSmkJpPRu9Pg" title="Beginning balance, shares" style="width: 5%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-06-30_us-gaap_TreasuryStockCommonMember" id="Fact000674" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">11</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_NoncontrollingInterestMember" id="Fact000669" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,079</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30" id="Fact000670" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">150,828</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--NetIncomeLoss_zhWz4cpbt5F5" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Net
    income</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0676">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0677">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-12-31_us-gaap_RetainedEarningsMember" id="Fact000678" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,865</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0679">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0680">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-12-31" id="Fact000681" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,865</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--StockRepurchasedDuringPeriodValue_iN_di_zByswcC4Kqo3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Purchase
    of Treasury stock</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0683">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0684">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0685">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-07-012023-12-31_us-gaap_TreasuryStockCommonMember" id="Fact000686" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,885</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--StockRepurchasedDuringPeriodShares_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zIKfTZO3xREf" title="Purchase of Treasury stock, shares" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="From2023-07-012023-12-31_us-gaap_TreasuryStockCommonMember" id="Fact000690" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">116</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0687">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-07-012023-12-31" id="Fact000688" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,885</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40B_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensationForfeited_zAM22UK3x2gg" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Cancellation
    of shares</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0692">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zADKduLGe8V3" title="Cancellation of shares, shares" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" contextRef="From2023-07-012023-12-31_us-gaap_CommonStockMember" id="Fact000699" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="Shares">123</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2023-07-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000693" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,006</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0694">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2023-07-012023-12-31_us-gaap_TreasuryStockCommonMember" id="Fact000695" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,006</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_z9eC2IEObWI1" title="Cancellation of shares, shares" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" contextRef="From2023-07-012023-12-31_us-gaap_TreasuryStockCommonMember" id="Fact000701" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="Shares">123</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0696">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0697">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_di_zod9XtbapI25" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Distributions
    - Non controlling interests</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0703">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0704">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0705">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0706">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-07-012023-12-31_us-gaap_NoncontrollingInterestMember" id="Fact000707" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,626</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-07-012023-12-31" id="Fact000708" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,626</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_402_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_zi49qqADdBU8" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Income
    - Non controlling interests</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0710">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0711">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0712">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0713">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-07-012023-12-31_us-gaap_NoncontrollingInterestMember" id="Fact000714" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,115</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-07-012023-12-31" id="Fact000715" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,115</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_436_c20230701__20231231_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_zKkisX84mqe6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Balance
    &#8211; December 31, 2023</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact000717" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--SharesOutstanding_iE_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zzzNfYM8sgg7" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact000724" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,328</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000718" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">180,607</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember" id="Fact000719" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">16,326</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-12-31_us-gaap_TreasuryStockCommonMember" id="Fact000720" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">395</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--SharesOutstanding_iE_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zWtrYlWbetK" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_us-gaap_TreasuryStockCommonMember" id="Fact000726" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">4</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-12-31_us-gaap_NoncontrollingInterestMember" id="Fact000721" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,590</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-12-31" id="Fact000722" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">156,297</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">See
accompanying notes to the unaudited condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 12 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif"><span id="CashFlow"></span>CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(UNAUDITED)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30E_112_pn3n3_zhyuwcMkQ5Ui" summary="xdx: Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_491_20240701__20241231_zgDFP4cLmx84" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_491_20230701__20231231_zSDdHvoRrRYi" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FOR
    THE SIX MONTHS<br/> ENDED DECEMBER 31,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">2023</span></td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zJBIjY93E4B7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Cash
    Flows from Operating Activities:</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--ProfitLoss_i01_maCzpJZ_zPGpGQEJxGr6" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 40pt; width: 56%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Consolidated
    Net income</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2024-07-01to2024-12-31" id="Fact000731" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,205</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-012023-12-31" id="Fact000732" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,980</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Adjustments
    to reconcile consolidated net income to net cash provided by operating activities:</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--OtherDepreciationAndAmortization_i01_maCzpJZ_zdudmZN8E954" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Depreciation
    and amortization</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherDepreciationAndAmortization" contextRef="From2024-07-01to2024-12-31" id="Fact000737" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,298</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherDepreciationAndAmortization" contextRef="From2023-07-012023-12-31" id="Fact000738" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,415</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--NetChangeInOperatingRightOfUseAssetsAndLeaseLiabilities_i01N_di_msCzpJZ_zawAqytE8NW4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Net
    change in operating right of use assets and lease liabilities</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="FONR:NetChangeInOperatingRightOfUseAssetsAndLeaseLiabilities" contextRef="From2024-07-01to2024-12-31" id="Fact000740" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">63</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="FONR:NetChangeInOperatingRightOfUseAssetsAndLeaseLiabilities" contextRef="From2023-07-012023-12-31" id="Fact000741" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">119</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_408_ecustom--ProvisionForBadDebts_i01_maCzpJZ_zxdJFEr2wSrd" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Provision
    for credit losses</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ProvisionForBadDebts" contextRef="From2024-07-01to2024-12-31" id="Fact000743" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,279</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ProvisionForBadDebts" contextRef="From2023-07-012023-12-31" id="Fact000744" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">355</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredIncomeTaxExpenseBenefit_i01_maCzpJZ_zX6e6JgrwmYg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Deferred
    tax expense</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2024-07-01to2024-12-31" id="Fact000746" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,111</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2023-07-012023-12-31" id="Fact000747" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,284</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_ecustom--GainOnSaleOfEquipmentRelatedParty_i01N_di_msCzpJZ_zYQkcq960Pzl" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Gain
    on sale of equipment &#8211; related party</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0749">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="FONR:GainOnSaleOfEquipmentRelatedParty" contextRef="From2023-07-012023-12-31" id="Fact000750" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">577</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_408_eus-gaap--IncreaseDecreaseInOperatingAssetsAbstract_iB_zRYjx3cn5PHa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Changes
    in operating assets and liabilities, net:</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--IncreaseDecreaseInAccountsReceivable_i01N_di_msCzpJZ_zjPFAgVAZqu2" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Accounts,
    medical and management fee receivable(s)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2024-07-01to2024-12-31" id="Fact000755" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">435</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2023-07-012023-12-31" id="Fact000756" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,958</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_401_ecustom--IncreaseDecreaseInNotesReceivable_i01_maCzpJZ_zMUJ8CuWpNB7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Notes
    receivable</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0758">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:IncreaseDecreaseInNotesReceivable" contextRef="From2023-07-012023-12-31" id="Fact000759" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--IncreaseDecreaseInNotesReceivableRelatedParty_i01_maCzpJZ_zUFCkbMe7V9k" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Notes
    receivable &#8211; related party</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="FONR:IncreaseDecreaseInNotesReceivableRelatedParty" contextRef="From2024-07-01to2024-12-31" id="Fact000761" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">26</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0762">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--IncreaseDecreaseInInventories_i01N_di_msCzpJZ_z8dIhYbTSikb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 30pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Inventories</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2024-07-01to2024-12-31" id="Fact000764" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">143</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2023-07-012023-12-31" id="Fact000765" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">265</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_404_eus-gaap--IncreaseDecreaseInPrepaidExpensesOther_i01N_di_msCzpJZ_zBGX0o9So9Na" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Prepaid
    expenses and other current assets</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="From2024-07-01to2024-12-31" id="Fact000767" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">677</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="From2023-07-012023-12-31" id="Fact000768" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">217</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--IncreaseDecreaseInOtherNoncurrentAssets_i01N_di_msCzpJZ_zr7AzL2aFp1h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Other
    assets</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" contextRef="From2024-07-01to2024-12-31" id="Fact000770" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" contextRef="From2023-07-012023-12-31" id="Fact000771" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">22</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--IncreaseDecreaseInAccountsPayable_i01_maCzpJZ_z6SYdqBAsfaa" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Accounts
    payable</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2024-07-01to2024-12-31" id="Fact000773" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">903</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2023-07-012023-12-31" id="Fact000774" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">244</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_408_eus-gaap--IncreaseDecreaseInOtherCurrentLiabilities_i01_maCzpJZ_zJXlwYN8GLak" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Other
    current liabilities</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="From2024-07-01to2024-12-31" id="Fact000776" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,556</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="From2023-07-012023-12-31" id="Fact000777" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,341</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_403_eus-gaap--IncreaseDecreaseInTradingLiabilities_i01_maCzpJZ_zXaSYsIrcnFi" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Financing
    lease liabilities</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInTradingLiabilities" contextRef="From2024-07-01to2024-12-31" id="Fact000779" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">86</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInTradingLiabilities" contextRef="From2023-07-012023-12-31" id="Fact000780" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">108</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40B_ecustom--IncreaseDecreaseInCustomerDeposit_i01_maCzpJZ_zxLVV5UKTJv8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Customer
    deposits</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="FONR:IncreaseDecreaseInCustomerDeposit" contextRef="From2024-07-01to2024-12-31" id="Fact000782" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">87</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="FONR:IncreaseDecreaseInCustomerDeposit" contextRef="From2023-07-012023-12-31" id="Fact000783" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_400_eus-gaap--IncreaseDecreaseInOtherAccruedLiabilities_i01_maCzpJZ_zlB5aOShyHGe" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Other
    liabilities</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherAccruedLiabilities" contextRef="From2024-07-01to2024-12-31" id="Fact000785" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherAccruedLiabilities" contextRef="From2023-07-012023-12-31" id="Fact000786" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">19</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_408_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_mtCzpJZ_maCz018_zv1VAnjDLhI9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Net
    cash provided by operating activities</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2024-07-01to2024-12-31" id="Fact000788" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,899</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2023-07-012023-12-31" id="Fact000789" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,689</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zJ2seayGG20i" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Cash
    Flows from Investing Activities:</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msCzQZQ_zFvh0IdjtfZg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Purchases
    of property and equipment</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2024-07-01to2024-12-31" id="Fact000794" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,552</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2023-07-012023-12-31" id="Fact000795" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">192</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_409_eus-gaap--ProceedsFromSaleOfShortTermInvestments_i01_maCzQZQ_zlVXhhMFqeMk" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Proceeds
    from short term investments</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ProceedsFromSaleOfShortTermInvestments" contextRef="From2024-07-01to2024-12-31" id="Fact000797" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0798">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--PaymentsToAcquireIntangibleAssets_iN_di_msCzQZQ_zfPx8l8LWSG3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 30pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Cost
    of patents</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2024-07-01to2024-12-31" id="Fact000800" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2023-07-012023-12-31" id="Fact000801" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInInvestingActivities_iT_mtCzQZQ_maCz018_zZw1h0WMa6N9" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Net
    cash used in investing activities</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2024-07-01to2024-12-31" id="Fact000803" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,557</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2023-07-012023-12-31" id="Fact000804" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">212</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_408_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_z2SGoZp4yGHk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Cash
    Flows from Financing Activities:</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--RepaymentsOfNotesPayable_i01N_di_msCzglm_zgLNchndUh59" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Repayment
    of borrowings and capital lease obligations</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" contextRef="From2024-07-01to2024-12-31" id="Fact000809" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">58</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" contextRef="From2023-07-012023-12-31" id="Fact000810" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40D_eus-gaap--ProceedsFromMinorityShareholders_i01_maCzglm_zZYK95gEGhre" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Sale
    of noncontrolling interest</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ProceedsFromMinorityShareholders" contextRef="From2024-07-01to2024-12-31" id="Fact000812" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">132</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0813">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--PaymentsForRepurchaseOfConvertiblePreferredStock_i01N_di_msCzglm_z6ITFVK6m3ag" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Purchase
    of treasury stock</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:PaymentsForRepurchaseOfConvertiblePreferredStock" contextRef="From2024-07-01to2024-12-31" id="Fact000815" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,341</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:PaymentsForRepurchaseOfConvertiblePreferredStock" contextRef="From2023-07-012023-12-31" id="Fact000816" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,885</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_408_eus-gaap--PaymentsOfDividendsMinorityInterest_i01N_di_msCzglm_z0XtxqQIJUOf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Distributions
    to noncontrolling interests</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsMinorityInterest" contextRef="From2024-07-01to2024-12-31" id="Fact000818" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,833</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsMinorityInterest" contextRef="From2023-07-012023-12-31" id="Fact000819" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,626</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40F_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtCzglm_maCz018_zzDXvO2pdmO6" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Net
    cash used in financing activities</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2024-07-01to2024-12-31" id="Fact000821" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,100</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2023-07-012023-12-31" id="Fact000822" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,532</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40D_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_i01T_mtCz018_zzH3WiC20Jl8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Net
    (Decrease) Increase in Cash and Cash Equivalents</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2024-07-01to2024-12-31" id="Fact000824" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,758</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2023-07-012023-12-31" id="Fact000825" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,945</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_i01S_zLozqqvG4UQl" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Cash
    and Cash Equivalents - Beginning of Period</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2024-06-30" id="Fact000827" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">56,341</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2023-06-30" id="Fact000828" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">51,280</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_i01E_z8StoxLfkSi1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Cash
    and Cash Equivalents - End of Period</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2024-12-31" id="Fact000830" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">53,583</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2023-12-31" id="Fact000831" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">53,225</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">See
accompanying notes to the unaudited condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 13 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif"><span id="Notes"></span>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">DECEMBER
31, 2024 and 2023</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(UNAUDITED)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2024-12-31" escape="true" id="Fact000833" name="FONR:DescriptionOfBusinessAndBasisOfPresentationTextBlock"><p id="xdx_80C_ecustom--DescriptionOfBusinessAndBasisOfPresentationTextBlock_z8j2h5oPWmk1" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif"><b>NOTE
1 &#8211; <span id="xdx_829_zxTANboTL8r5">DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">Description
of Business</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;FONAR
Corporation (the &#8220;Company&#8221; or &#8220;FONAR&#8221;) is a Delaware corporation, which was incorporated on July 17, 1978. FONAR
is engaged in the research, development, production and marketing of medical scanning equipment, which uses principles of Magnetic Resonance
Imaging (&#8220;MRI&#8221;) for the detection and diagnosis of human diseases. In addition to deriving revenues from the direct sale
of MRI equipment, revenue is also generated from our installed-base of customers through our service and upgrade programs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR,
through its wholly-owned subsidiary Health Management Corporation of America (&#8220;HMCA&#8221;) provides comprehensive management services
to diagnostic imaging facilities. The services provided by the Company include development, administration, leasing of office space,
facilities and medical equipment, provision of supplies, staffing and supervision of non-medical personnel, legal services, accounting,
billing and collection and the development and implementation of practice growth and marketing strategies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Effective
July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business.
The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and Health
Diagnostics Management (&#8220;HDM&#8221;). Imperial Management Services, LLC contributed all of its assets (which were utilized in the
business of Health Management Corporation of America) to HDM and received a <span id="xdx_907_eus-gaap--InvestmentOwnedPercentOfNetAssets_iI_pip0_dp_c20150701__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zQBJXRA8WhL"><ix:nonFraction name="us-gaap:InvestmentOwnedPercentOfNetAssets" contextRef="AsOf2015-07-01_us-gaap_OtherInvesteesMember" id="Fact000834" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">24.2</ix:nonFraction></span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
interest in HDM. Health Management Corporation of America retained a direct ownership interest of <span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pip0_dp_c20150701__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zRAgwz5pzns6"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2015-07-01_us-gaap_OtherInvesteesMember" id="Fact000835" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">45.8</ix:nonFraction></span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
in HDM, and the original investors in HDM retained a <span id="xdx_90A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pip0_dp_c20150701__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zozjfGVU7r64"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2015-07-01_us-gaap_NoncontrollingInterestMember_us-gaap_OtherInvesteesMember" id="Fact000836" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">30.0</ix:nonFraction></span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
ownership interest in the newly expanded HDM. As of June 30, 2024, the Company had a direct ownership interest of <span id="xdx_908_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pip0_dp_c20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zplnBcIDbWsf"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2024-06-30_us-gaap_OtherInvesteesMember" id="Fact000837" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">70.8</ix:nonFraction></span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
and the investors&#8217; a <span id="xdx_906_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pip0_dp_c20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zY5juJW1dty7"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2024-06-30_us-gaap_NoncontrollingInterestMember_us-gaap_OtherInvesteesMember" id="Fact000838" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">29.2</ix:nonFraction></span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
ownership interest. During the quarter ended December 31, 2024, the Company sold non-controlling interests to a minority shareholder
for $<span id="xdx_907_eus-gaap--ProceedsFromPaymentsToMinorityShareholders_pn3n3_c20241001__20241231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_z9fo00PVoO0k"><ix:nonFraction name="us-gaap:ProceedsFromPaymentsToMinorityShareholders" contextRef="From2024-10-012024-12-31_us-gaap_OtherInvesteesMember" id="Fact000839" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">132</ix:nonFraction></span></span><span style="font: normal 11pt Times New Roman, Times, Serif">.
Currently, the Company has a direct ownership interest of <span id="xdx_903_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pip0_dp_c20241231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_z7Xw58DYnbG9"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2024-12-31_us-gaap_OtherInvesteesMember" id="Fact000840" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">70.63</ix:nonFraction></span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
and the investors&#8217; have a <span id="xdx_907_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pip0_dp_c20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zuemWa2ZyRif"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2024-12-31_us-gaap_NoncontrollingInterestMember_us-gaap_OtherInvesteesMember" id="Fact000841" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">29.37</ix:nonFraction></span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
ownership interest. The entire management of diagnostic imaging centers business segment is now being conducted by HDM, operating under
the name &#8220;Health Management Company of America&#8221;.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">Basis
of Presentation</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">These
unaudited condensed consolidated financial statements for the period ended December 31, 2024 have been prepared in accordance with generally
accepted accounting principles in the United States of America (&#8220;GAAP&#8221;) and pursuant to the rules and regulations of the
Securities and Exchange Commission pertaining to interim financial statements. Accordingly, they do not include all of the information
and footnotes required by GAAP for complete financial statements and should be read in conjunction with the audited consolidated financial
statements and notes thereto included in the Company&#8217;s Annual Report on Form 10-K for the year ended June 30, 2024, from which
the accompanying balance sheet at June 30, 2024 was derived. All intercompany balances and transactions have been eliminated in consolidation.
In the opinion of management, all adjustments considered necessary for a fair presentation of the interim financial information have
been included and are of a normal recurring nature. The preparation of the condensed consolidated financial statements in conformity
with GAAP requires the Company to make estimates and assumptions that affect the disclosure and reported amounts of assets and liabilities
at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting
period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><p id="xdx_23F_zj5Gd7kEmue2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 14 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_236_zFH5dSsJCYy" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zrYBC47dJhG6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_z0bxNBSLgwK8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zpGyqZJlKp4g" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">DECEMBER
31, 2024 and 2023</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zXIHLMvlUXr9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_z7pziQ9Trs9e" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zzqHjAxEVjE9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" escape="true" id="Fact000851" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_80C_eus-gaap--SignificantAccountingPoliciesTextBlock_zJKlTJe1YgXi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"><b>NOTE
2 - <span id="xdx_824_zyHhAaGWVple">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2024-12-31" escape="true" id="Fact000853" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p id="xdx_841_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zQxMpzIdddeb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_861_zh0MhL9MYTzf" style="font: normal 11pt Times New Roman, Times, Serif">Basis
of Presentation</span> <span style="font: normal 11pt Times New Roman, Times, Serif">(Continued)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">The
Company evaluates theses estimates and judgements on an ongoing basis. The Company bases estimates and judgements on historical experience
and on various other factors that are believed to be reasonable under the circumstances. The results of operations for any interim period
are not necessarily indicative of the results of operations for a full year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" escape="true" id="Fact000855" name="us-gaap:ConsolidationPolicyTextBlock"><p id="xdx_84A_eus-gaap--ConsolidationPolicyTextBlock_z4ZlKuNI17Si" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_86B_zc7HOogWPoOd" style="font: normal 11pt Times New Roman, Times, Serif">Principles
of Consolidation</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">The
unaudited condensed consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries
and partnerships (collectively, the &#8220;Company&#8221;). All significant intercompany accounts and transactions have been eliminated
in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" escape="true" id="Fact000857" name="us-gaap:RevenueRecognitionPolicyTextBlock"><p id="xdx_84B_eus-gaap--RevenueRecognitionPolicyTextBlock_zb1qsGCBxFXa" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_86F_z04AOfkiJI19" style="font: normal 11pt Times New Roman, Times, Serif">Revenue
Recognition</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">The
Company&#8217;s revenues generally relate to net patient fees&#160;received from various payers and patients themselves under contracts
in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our
obligations to provide diagnostic services are satisfied. The Company&#8217;s performance obligations for diagnostic services are generally
satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party
payer (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance
exchanges) and the transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated
with (managed care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party
payers for the services we provide to the related patients typically specify payments at amounts less than the Company&#8217;s standard
charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates.
Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the
frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">The
Company&#8217;s patient fee revenue, net of contractual allowances and discounts for the three and six months ended December 31, 2024
and 2023 are summarized in the following table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2024-12-31" escape="true" id="Fact000859" name="us-gaap:DisaggregationOfRevenueTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--DisaggregationOfRevenueTableTextBlock_pn3n3_zL3DJiQxVnde" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span id="xdx_8BD_zlEmX5Fwg5k5" style="font: normal 11pt Times New Roman, Times, Serif">Schedule
    of patient fee revenue - net</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">For
    the Three Months Ended<br/> December 31,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">2023</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Commercial
    Insurance/Managed Care</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--NetPatientFeeRevenue_pn3n3_c20241001__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_z18Xcauvc52g" title="Patient Fee Revenue, net of contractual allowances and discounts" style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2024-10-012024-12-31_custom_CommercialInsuranceManagedCareMember" id="Fact000861" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,174</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_ecustom--NetPatientFeeRevenue_pn3n3_c20231001__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zK8wWpjbWbjh" title="Patient Fee Revenue, net of contractual allowances and discounts" style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2023-10-012023-12-31_custom_CommercialInsuranceManagedCareMember" id="Fact000863" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,243</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Medicare/Medicaid</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_ecustom--NetPatientFeeRevenue_pn3n3_c20241001__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zZRbS1gC7hzd" title="Patient Fee Revenue, net of contractual allowances and discounts" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2024-10-012024-12-31_custom_MedicareMedicaidMember" id="Fact000865" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">301</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_ecustom--NetPatientFeeRevenue_pn3n3_c20231001__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zu8U0uK35Gs5" title="Patient Fee Revenue, net of contractual allowances and discounts" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2023-10-012023-12-31_custom_MedicareMedicaidMember" id="Fact000867" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">284</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Workers&#8217;
    Compensation/Personal Injury</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_ecustom--NetPatientFeeRevenue_pn3n3_c20241001__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_z1j0hmlMJQob" title="Patient Fee Revenue, net of contractual allowances and discounts" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2024-10-012024-12-31_custom_WorkersCompensationPersonalInjuryMember" id="Fact000869" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,683</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_ecustom--NetPatientFeeRevenue_pn3n3_c20231001__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zvblavHXJkE4" title="Patient Fee Revenue, net of contractual allowances and discounts" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2023-10-012023-12-31_custom_WorkersCompensationPersonalInjuryMember" id="Fact000871" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,907</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Other</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_ecustom--NetPatientFeeRevenue_pn3n3_c20241001__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zLfcHqiMhZg4" title="Patient Fee Revenue, net of contractual allowances and discounts" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2024-10-012024-12-31_custom_OtherRevenueSourceMember" id="Fact000873" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,786</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_ecustom--NetPatientFeeRevenue_pn3n3_c20231001__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zYdnTWS83VXh" title="Patient Fee Revenue, net of contractual allowances and discounts" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2023-10-012023-12-31_custom_OtherRevenueSourceMember" id="Fact000875" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,787</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Patient
    Fee Revenue, net of contractual allowances and discounts</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--NetPatientFeeRevenue_pn3n3_c20241001__20241231_zSf07rU5Y7ia" title="Patient Fee Revenue, net of contractual allowances and discounts" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2024-10-012024-12-31" id="Fact000877" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,944</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_ecustom--NetPatientFeeRevenue_pn3n3_c20231001__20231231_zm8zC3UOQeni" title="Patient Fee Revenue, net of contractual allowances and discounts" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2023-10-012023-12-31" id="Fact000879" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,221</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><p id="xdx_235_zvh3r9ZyqxAb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 15 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_zijOucdK9BKb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zlumj8O360yk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zQwTBlKvGcU3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zxJibOuUCaje" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">DECEMBER
31, 2024 and 2023</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zbQ78nUEDFt7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_z5VSg4MY3491" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zg7pEoHcFV4i" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zR6S7GCoyiy4" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif"><b>NOTE
2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zLORmNeSB7pi" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Revenue
    Recognition (Continued)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">For
    the Six Months Ended<br/> December 31,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">2023</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Commercial
    Insurance/ Managed Care</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--NetPatientFeeRevenue_c20240701__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" title="Patient Fee Revenue, net of contractual allowances and discounts" style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2024-07-012024-12-31_custom_CommercialInsuranceManagedCareMember" id="Fact000891" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,378</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--NetPatientFeeRevenue_c20230701__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" title="Patient Fee Revenue, net of contractual allowances and discounts" style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2023-07-012023-12-31_custom_CommercialInsuranceManagedCareMember" id="Fact000893" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,416</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Medicare/Medicaid</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_ecustom--NetPatientFeeRevenue_c20240701__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" title="Patient Fee Revenue, net of contractual allowances and discounts" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2024-07-012024-12-31_custom_MedicareMedicaidMember" id="Fact000895" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">562</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_ecustom--NetPatientFeeRevenue_c20230701__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" title="Patient Fee Revenue, net of contractual allowances and discounts" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2023-07-012023-12-31_custom_MedicareMedicaidMember" id="Fact000897" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">555</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Workers&#8217;
    Compensation/Personal Injury</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_ecustom--NetPatientFeeRevenue_c20240701__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" title="Patient Fee Revenue, net of contractual allowances and discounts" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2024-07-012024-12-31_custom_WorkersCompensationPersonalInjuryMember" id="Fact000899" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,382</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_ecustom--NetPatientFeeRevenue_c20230701__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" title="Patient Fee Revenue, net of contractual allowances and discounts" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2023-07-012023-12-31_custom_WorkersCompensationPersonalInjuryMember" id="Fact000901" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,044</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Other</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_ecustom--NetPatientFeeRevenue_c20240701__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" title="Patient Fee Revenue, net of contractual allowances and discounts" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2024-07-012024-12-31_custom_OtherRevenueSourceMember" id="Fact000903" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,109</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_ecustom--NetPatientFeeRevenue_c20230701__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" title="Patient Fee Revenue, net of contractual allowances and discounts" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2023-07-012023-12-31_custom_OtherRevenueSourceMember" id="Fact000905" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,881</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Patient
    Fee Revenue, net of contractual allowances and discounts</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_ecustom--NetPatientFeeRevenue_c20240701__20241231_pn3n3" title="Patient Fee Revenue, net of contractual allowances and discounts" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2024-07-01to2024-12-31" id="Fact000907" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15,431</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--NetPatientFeeRevenue_c20230701__20231231_pn3n3" title="Patient Fee Revenue, net of contractual allowances and discounts" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2023-07-012023-12-31" id="Fact000909" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,896</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8AF_zUozMHWSpZk9" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" escape="true" id="Fact000911" name="FONR:ManagementAndOtherFeeReceivablePolicyTextBlock"><p id="xdx_849_ecustom--ManagementAndOtherFeeReceivablePolicyTextBlock_zXjWOO9c32X9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_863_zKeWDttgnjpe" style="font: normal 11pt Times New Roman, Times, Serif">Management
and other fee receivable</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">HMCA
generates revenues from providing comprehensive management services, including development, administration, accounting, billing and collection
services, together with office space, medical equipment, supplies and non-medical personnel to its clients. Revenues are in the form
of fees which are earned under annual management contracts with HMCA clients. Management fee receivable is related to the management
fees outstanding from the related and non-related professional corporations (&#8220;PCs&#8221;) under the management agreements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" escape="true" id="Fact000913" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_840_eus-gaap--EarningsPerSharePolicyTextBlock_znCGB8Glccd5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_863_zFFWWr33Y5O5" style="font: normal 11pt Times New Roman, Times, Serif">Earnings
Per Share</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Basic
earnings per share (&#8220;EPS&#8221;) is computed based upon the weighted average number of shares of common stock and stock equivalents
outstanding, net of common stock. In accordance with ASC Topic 260-10, &#8220;Participating Securities and the Two-Class method&#8221;,
the Company used the Two-Class method for calculating basic income per share and applied the converted method in calculating diluted
income per share for the three and six months ended December 31, 2024 and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Diluted
EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average
market price of common shares outstanding during the period. For the three and six months ended December 31, 2024 and 2023, diluted EPS
for common shareholders includes <span id="xdx_90E_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20230701__20231231_z9QoejhFelni"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" contextRef="From2023-07-012023-12-31" id="Fact000914" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">128</ix:nonFraction>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">shares
upon conversion of Class C Common.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:exclude><p id="xdx_233_zGMRkWjrTC3i" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 16 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_zhWfJOmvgW17" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zlA4DcSeNd6k" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_z5KIQ7Uyo5s4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zUWoG26k098" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">DECEMBER
31, 2024 and 2023</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zrdXL3De366l" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zi64XKY4WE0e" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zo97zPcqPNpg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zYGKJx9MIUBi" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif"><b>NOTE
2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zGRiXf0OptYb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zWnJOfjQMKu7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Earnings
Per Share (Continued)</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zYMs8qG6XUBe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<ix:nonNumeric contextRef="From2024-07-01to2024-12-31" escape="true" id="Fact000928" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_zvSuADktrMr1" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details 1)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B3_zWIu7i8E4IPh" style="font: normal 11pt Times New Roman, Times, Serif">Schedule
    of earning per share</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Three
    months ended <br/> December 31, 2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Three
    months ended <br/> December 31, 2023</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Common
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Class
    C Common <br/> Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Common
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Class
    C Common <br/> Stock</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Basic</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Numerator:
    <br/> Net income available to common stockholders</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20241001__20241231_ztTa1wwlnWDd" title="Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2024-10-012024-12-31" id="Fact000930" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,964</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zOf2aCRyKGJf" title="Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember" id="Fact000932" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,840</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zMUw31DAxzei" title="Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2024-10-012024-12-31_us-gaap_CommonClassCMember" id="Fact000934" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">31</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20231001__20231231_zxID2v0G8pLh" title="Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2023-10-012023-12-31" id="Fact000936" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,759</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zjdCfLIuesc1" title="Common Stock and Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember" id="Fact000938" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,525</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zweySSu8W3Yl" title="Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2023-10-012023-12-31_us-gaap_CommonClassCMember" id="Fact000940" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">59</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Denominator:</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Weighted
    average shares outstanding</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20241001__20241231_zVkAyP0a5yFb" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-10-012024-12-31" id="Fact000941" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,686</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zobPQYC1HAV7" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember" id="Fact000942" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,303</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z3jBeGlOPqt4" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-10-012024-12-31_us-gaap_CommonClassCMember" id="Fact000943" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20231001__20231231_z6FfKz3syYVg" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-10-012023-12-31" id="Fact000944" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,437</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z0Xpm9av716" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember" id="Fact000945" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,437</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zAtOM6gjv5Z8" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-10-012023-12-31_us-gaap_CommonClassCMember" id="Fact000946" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Basic
    income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_900_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20241001__20241231_zkUoT17qDZl3" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2024-10-012024-12-31" id="Fact000947" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.31</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_900_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFfqm38RqGb7" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember" id="Fact000948" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.29</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z6n52whbB474" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2024-10-012024-12-31_us-gaap_CommonClassCMember" id="Fact000949" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.08</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20231001__20231231_zyxsQRp4L6pd" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2023-10-012023-12-31" id="Fact000950" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.58</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKO1ImWncDt8" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember" id="Fact000951" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.55</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zHRgAfVOuBdh" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2023-10-012023-12-31_us-gaap_CommonClassCMember" id="Fact000952" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.16</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Diluted</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Denominator:
    <br/>
    Weighted average shares outstanding</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zixYLlEfAWGf" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember" id="Fact000953" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,303</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_909_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zhCScoo7cZ8i" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-10-012024-12-31_us-gaap_CommonClassCMember" id="Fact000954" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zELp0cpWqRE1" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember" id="Fact000955" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,437</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zNbaLYf5rIV5" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-10-012023-12-31_us-gaap_CommonClassCMember" id="Fact000956" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Convertible
    Class C Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90B_ecustom--ConvertibleClassCStock_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zZMFXw6Dq7lh" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ConvertibleClassCStock" contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember" id="Fact000957" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">128</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_902_ecustom--ConvertibleClassCStock_pn3n3_d0_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zyO3CHookUdb" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ConvertibleClassCStock" contextRef="From2024-10-012024-12-31_us-gaap_CommonClassCMember" id="Fact000958" format="ixt:zerodash" decimals="-3" scale="3" unitRef="Shares">&#8212;</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90D_ecustom--ConvertibleClassCStock_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zUvmoPZSrzwa" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ConvertibleClassCStock" contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember" id="Fact000959" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">128</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_ecustom--ConvertibleClassCStock_pn3n3_d0_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zha7t8rJIDG3" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ConvertibleClassCStock" contextRef="From2023-10-012023-12-31_us-gaap_CommonClassCMember" id="Fact000960" format="ixt:zerodash" decimals="-3" scale="3" unitRef="Shares">&#8212;</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Total
    Denominator for diluted earnings per share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zicEmHf5MvJf" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedEarningsPerShare" contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember" id="Fact000961" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,431</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zWL9xD6Js6k9" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedEarningsPerShare" contextRef="From2024-10-012024-12-31_us-gaap_CommonClassCMember" id="Fact000962" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zocz0Ddf5Lxa" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedEarningsPerShare" contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember" id="Fact000963" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,565</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zv8RsJ5XOfq1" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedEarningsPerShare" contextRef="From2023-10-012023-12-31_us-gaap_CommonClassCMember" id="Fact000964" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Diluted
    income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_eus-gaap--EarningsPerShareDiluted_pip0_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKjdQMnTyOKd" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember" id="Fact000965" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.29</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--EarningsPerShareDiluted_pip0_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zo2e9dER4va1" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-10-012024-12-31_us-gaap_CommonClassCMember" id="Fact000966" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.08</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_eus-gaap--EarningsPerShareDiluted_pip0_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zNYREjn4QC94" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember" id="Fact000967" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.54</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--EarningsPerShareDiluted_pip0_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zdX8taCtG7x3" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-10-012023-12-31_us-gaap_CommonClassCMember" id="Fact000968" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.16</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Six
    months ended <br/> December 31, 2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Six
    months ended <br/> December 31, 2023</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Common
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Class
    C Common <br/> Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Common
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Class
    C Common <br/> Stock</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Basic</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Numerator:
    <br/> Net income available to common stockholders</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20240701__20241231_zUYItGA2tivc" title="Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2024-07-01to2024-12-31" id="Fact000970" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,099</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zCBPfN32iqRd" title="Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2024-07-012024-12-31_us-gaap_CommonStockMember" id="Fact000972" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,775</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zfGRoSD7DnI7" title="Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2024-07-012024-12-31_us-gaap_CommonClassCMember" id="Fact000974" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">83</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20231231_zAu6tNscy156" title="Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2023-07-012023-12-31" id="Fact000976" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,865</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z25N3f8IwFq3" title="Common Stock and Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2023-07-012023-12-31_us-gaap_CommonStockMember" id="Fact000978" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,375</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z39Ly1ZxxTdb" title="Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2023-07-012023-12-31_us-gaap_CommonClassCMember" id="Fact000980" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">125</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Denominator:</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Weighted
    average shares outstanding</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20240701__20241231_zYwD3YAJ5rwj" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-07-01to2024-12-31" id="Fact000981" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,696</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zwVPrZqX6W7i" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-07-012024-12-31_us-gaap_CommonStockMember" id="Fact000982" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,313</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zKmXnF1ZPk5b" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-07-012024-12-31_us-gaap_CommonClassCMember" id="Fact000983" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20231231_zMtQCmFp8RQg" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-07-012023-12-31" id="Fact000984" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,448</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsymdHwEt081" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-07-012023-12-31_us-gaap_CommonStockMember" id="Fact000985" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,448</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zUaLrSiJ4oW2" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-07-012023-12-31_us-gaap_CommonClassCMember" id="Fact000986" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Basic
    income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20240701__20241231_zwHIYbIkQc5a" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2024-07-01to2024-12-31" id="Fact000987" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.81</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zeZ8c3bHHjcb" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2024-07-012024-12-31_us-gaap_CommonStockMember" id="Fact000988" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.76</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zd1gkLEBpid5" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2024-07-012024-12-31_us-gaap_CommonClassCMember" id="Fact000989" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.22</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20231231_zewRQ7HypSj2" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2023-07-012023-12-31" id="Fact000990" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">1.22</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zmSgeA9ml2x9" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2023-07-012023-12-31_us-gaap_CommonStockMember" id="Fact000991" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">1.14</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zbz4B56NEhO8" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2023-07-012023-12-31_us-gaap_CommonClassCMember" id="Fact000992" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.33</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Diluted</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Denominator:
    <br/>
    Weighted average shares outstanding</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_909_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z6I7pQfx89Kf" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-07-012024-12-31_us-gaap_CommonStockMember" id="Fact000993" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,313</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zC6thKXWDBT" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-07-012024-12-31_us-gaap_CommonClassCMember" id="Fact000994" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zq7I6DGVsxv1" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-07-012023-12-31_us-gaap_CommonStockMember" id="Fact000995" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,448</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z7lO4NhLTXT" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-07-012023-12-31_us-gaap_CommonClassCMember" id="Fact000996" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Convertible
    Class C Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_900_ecustom--ConvertibleClassCStock_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z38YTp5LspV8" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ConvertibleClassCStock" contextRef="From2024-07-012024-12-31_us-gaap_CommonStockMember" id="Fact000997" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">128</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_ecustom--ConvertibleClassCStock_pn3n3_d0_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zl2aWvQISKl" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ConvertibleClassCStock" contextRef="From2024-07-012024-12-31_us-gaap_CommonClassCMember" id="Fact000998" format="ixt:zerodash" decimals="-3" scale="3" unitRef="Shares">&#8212;</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_907_ecustom--ConvertibleClassCStock_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zNGs04uCaZF8" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ConvertibleClassCStock" contextRef="From2023-07-012023-12-31_us-gaap_CommonStockMember" id="Fact000999" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">128</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_ecustom--ConvertibleClassCStock_pn3n3_d0_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zVWHVdr5Bdh8" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ConvertibleClassCStock" contextRef="From2023-07-012023-12-31_us-gaap_CommonClassCMember" id="Fact001000" format="ixt:zerodash" decimals="-3" scale="3" unitRef="Shares">&#8212;</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Total
    Denominator for diluted earnings per share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zYd2uol9Mkn4" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedEarningsPerShare" contextRef="From2024-07-012024-12-31_us-gaap_CommonStockMember" id="Fact001001" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,441</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zZIbJkgYMhXf" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedEarningsPerShare" contextRef="From2024-07-012024-12-31_us-gaap_CommonClassCMember" id="Fact001002" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zm6Vydg7fSyl" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedEarningsPerShare" contextRef="From2023-07-012023-12-31_us-gaap_CommonStockMember" id="Fact001003" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,576</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zvspvf0JtAzk" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedEarningsPerShare" contextRef="From2023-07-012023-12-31_us-gaap_CommonClassCMember" id="Fact001004" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Diluted
    income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_eus-gaap--EarningsPerShareDiluted_pip0_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVDisZxHxga4" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-07-012024-12-31_us-gaap_CommonStockMember" id="Fact001005" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.74</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pip0_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zPzXBe83AY8i" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-07-012024-12-31_us-gaap_CommonClassCMember" id="Fact001006" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.22</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--EarningsPerShareDiluted_pip0_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zBUHA1ZB096b" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-07-012023-12-31_us-gaap_CommonStockMember" id="Fact001007" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">1.12</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pip0_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zdQZ3ehBp5D7" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-07-012023-12-31_us-gaap_CommonClassCMember" id="Fact001008" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.33</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8AC_zzOIAfL0t6lj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<ix:exclude><!-- Field: Page; Sequence: 17 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_234_zxuzhCorA61j" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zCbiruB5g4c" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_z0ceRWg4zazg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zlwV1Z2HqJG8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">DECEMBER
31, 2024 and 2023</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zPjh6MxWTa4g" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zRLRujpfaVCa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zkyxwsryxak2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zNmxcM2n4Kr3" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif"><b>NOTE
2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zByiuX40DgVj" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" escape="true" id="Fact001019" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription"><p id="xdx_84C_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z3iwg8LUJeek" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_860_zaxSgFmUHCb4" style="font: normal 11pt Times New Roman, Times, Serif">Correction
of immaterial errors</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">In
conjunction with preparing its interim financial statements for the three and six months ended December 31, 2024, the Company determined
that its calculation of Right to Use Assets and Operating Lease Liabilities at the end of the past two annual periods and at September
30, 2024 and 2023 contained three immaterial errors. The Company evaluated the errors, both qualitatively and quantitatively, and determined
that no prior interim or annual periods were materially misstated. The Company then evaluated whether the cumulative amount of the misstatement
was material to its projected fiscal 2025 results of operations, and determined the cumulative amount was not material. Therefore, the
Condensed Consolidated Financial Statements for the six and three months ended December 31, 2024 include an out-of-period correction
of the following three items; a) a reclass of a software license of $<span id="xdx_90E_ecustom--RightToUseAssetToIntangibleAsset_pn3n3_dm_c20240701__20241231_zxhPpzIF4r77"><ix:nonFraction name="FONR:RightToUseAssetToIntangibleAsset" contextRef="From2024-07-01to2024-12-31" id="Fact001020" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">1.3</ix:nonFraction>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">million
from Right to Use Asset/Liabilities to an intangible asset, b) a decrease to ROU of $<span id="xdx_90B_eus-gaap--IncreaseDecreaseInOperatingLeaseLiability_pn3n3_dm_c20240701__20241231_zkIBhlBv2jyb"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="From2024-07-01to2024-12-31" id="Fact001021" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">1.7</ix:nonFraction>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">million
and an increase to Lease Liability of $<span id="xdx_90D_eus-gaap--OperatingLeasePayments_pn3n3_dm_c20240701__20241231_zJtdLAwjr0P7"><ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2024-07-01to2024-12-31" id="Fact001022" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">1.1</ix:nonFraction>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">million
to correct the discounting of future lease payments and c) correct the accounting for 6 lease modifications.. The correction of these
three errors resulted in an out of period charge to expenses of $<span id="xdx_90D_eus-gaap--IncomeTaxExpenseBenefitIntraperiodTaxAllocation_pn3n3_c20240701__20241231_zFYOxIgox9Gd"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefitIntraperiodTaxAllocation" contextRef="From2024-07-01to2024-12-31" id="Fact001023" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">116</ix:nonFraction>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">to pre-tax
income for the three and six months ended December 31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" escape="true" id="Fact001025" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_845_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zxNQfhqQxiw" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_865_z7SoHmRgVHk8" style="font: normal 11pt Times New Roman, Times, Serif">Recent
Accounting Standards</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">In
December 2023, The Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2023-09, &#8220;Income Taxes (Topic 740) Improvements
to Income Tax Disclosures, which requires the annual financial statements to include consistent categories and great disaggregation of
information in the rate reconciliation and income taxes paid disaggregated by jurisdiction. ASU 2023-09 is effective for the Company&#8217;s
annual reporting beginning after December 15, 2024, with early adoption permitted, and should be applied on a prospective basis, with
a retrospective option. The Company is currently evaluating the effect that the adoption of ASU 2023-09 will have on its disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">In
November 2023, FASB issued ASU 2023-07, &#8220;Segment Reporting (Topic 280)&#8221;, which is intended to improve reportable segment
disclosure requirements through enhanced disclosures about significant segment expenses. The amendments require disclosure of significant
segment expenses regularly provided to the chief operating decision maker (&#8220;CODM&#8221;) as well as other segment items, extended
certain annual disclosures to interim periods, clarify the applicability to single reportable segment entities, permit more than one
measure of profit or loss to be reported under certain conditions, and require disclosure of the title and position of the CODM. The
effective date for public entities is for fiscal years beginning after December 15, 2023 and interim periods with fiscal years beginning
after December 15, 2024. The Company is expected to adopt the new disclosures as required and are currently evaluating the impact on
the related disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><p id="xdx_238_zIgGix4o3zO8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 18 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23B_z2yF9Qa8V3bb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zlt6zcoY4Sa3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zErJjVpyCxMh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zfN7MwUD7hW5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">DECEMBER
31, 2024 and 2023</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zelG6wUTfuq9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_znH5HGZvqZCg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zDpOorx8Mbm9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zcTSHWrGn8Tc" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif"><b>NOTE
2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zRBrBVLax1Ug" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">Recent
Accounting Standards</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of December 31,
2024 that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly
affected our financial accounting measures or disclosures had they been in effect during 2024 or 2023, and it does not believe that any
of those standards will have a significant impact on our unaudited consolidated condensed financial statements at the time they become
effective.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" escape="true" id="Fact001037" name="us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"><p id="xdx_803_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zxKOpEEyGGM7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">NOTE
3 &#8211; <span id="xdx_822_zL9n8kAU2hWj">ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Receivables,
net are comprised of the following at December 31, 2024, and June 30, 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2024-12-31" escape="true" id="Fact001039" name="us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_pn3n3_z8bd1OG0LX96" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BB_zp1GhDq6yE6j" style="font: normal 11pt Times New Roman, Times, Serif">Schedule
    of financing receivable noncurrent allowance for credit loss</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_49A_20241231__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z0RBRf7wwER3" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_493_20241231__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zvXSVmvYjjFa" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_498_20241231_zSDSREaE2xR3" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">December
    31, 2024</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Gross
    Receivable</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Allowance
    for credit losses</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Net</span></td></tr>
  <tr id="xdx_401_eus-gaap--AccountsReceivableNet_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 46%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Accounts
    receivable</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2024-12-31_us-gaap_AccountsReceivableMember" id="Fact001041" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,663</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2024-12-31_us-gaap_DoubtfulMember" id="Fact001042" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">273</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2024-12-31" id="Fact001043" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,390</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--AccountsReceivableNetRelatedParty_iI_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Accounts
    receivable - related party</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:AccountsReceivableNetRelatedParty" contextRef="AsOf2024-12-31_us-gaap_AccountsReceivableMember" id="Fact001045" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">60</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1046">&#8212;</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:AccountsReceivableNetRelatedParty" contextRef="AsOf2024-12-31" id="Fact001047" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">60</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--NontradeReceivables_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Medical
    receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NontradeReceivables" contextRef="AsOf2024-12-31_us-gaap_AccountsReceivableMember" id="Fact001049" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23,496</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1050">&#8212;</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NontradeReceivables" contextRef="AsOf2024-12-31" id="Fact001051" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23,496</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Management
    and other fees receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesNonRelatedParties" contextRef="AsOf2024-12-31_us-gaap_AccountsReceivableMember" id="Fact001053" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">55,148</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesNonRelatedParties" contextRef="AsOf2024-12-31_us-gaap_DoubtfulMember" id="Fact001054" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,663</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesNonRelatedParties" contextRef="AsOf2024-12-31" id="Fact001055" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">42,485</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Management
    and other fees receivable from related medical practices (&#8220;PC&#8217;s&#8221;)</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2024-12-31_us-gaap_AccountsReceivableMember" id="Fact001057" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,666</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2024-12-31_us-gaap_DoubtfulMember" id="Fact001058" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,989</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2024-12-31" id="Fact001059" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,677</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_494_20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zB9JXYN3V1k1" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_493_20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_ziASn6lVxep1" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_49B_20240630_zWOBFj4GtxU2" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">June
    30, 2024</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Gross
    Receivable</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Allowance
    for credit losses</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Net</span></td></tr>
  <tr id="xdx_404_eus-gaap--AccountsReceivableNet_iI_pn3n3_zuWXkbN34zhl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 46%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Accounts
    receivable</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2024-06-30_us-gaap_AccountsReceivableMember" id="Fact001061" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,201</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2024-06-30_us-gaap_DoubtfulMember" id="Fact001062" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">166</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2024-06-30" id="Fact001063" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,035</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--NontradeReceivables_iI_pn3n3_zADsAvQzSfo1" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Medical
    receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NontradeReceivables" contextRef="AsOf2024-06-30_us-gaap_AccountsReceivableMember" id="Fact001065" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23,992</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1066">&#8212;</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NontradeReceivables" contextRef="AsOf2024-06-30" id="Fact001067" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23,992</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_zmX6owK18J8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Management
    and other fees receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesNonRelatedParties" contextRef="AsOf2024-06-30_us-gaap_AccountsReceivableMember" id="Fact001069" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">54,324</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesNonRelatedParties" contextRef="AsOf2024-06-30_us-gaap_DoubtfulMember" id="Fact001070" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,370</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesNonRelatedParties" contextRef="AsOf2024-06-30" id="Fact001071" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">41,954</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_ziRgeoenE1Ej" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Management
    and other fees receivable from related medical practices (&#8220;PC&#8217;s&#8221;)</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2024-06-30_us-gaap_AccountsReceivableMember" id="Fact001073" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15,975</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2024-06-30_us-gaap_DoubtfulMember" id="Fact001074" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,110</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2024-06-30" id="Fact001075" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,865</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8A5_z8u9XdpqKvl1" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">The
Company&#8217;s customers are concentrated in the healthcare industry.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><p id="xdx_230_z7u7NKXFCH2f" style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 19 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_239_zw6liv3IWCMb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zmkecchJZ0e" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_z2fWZIp7cTb9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_z8F7ICoaebT3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">DECEMBER
31, 2024 and 2023</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zXFuGp4f2jnf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zL3CbexbcjQ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zHZ2c1LbtXWh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zniPgWulzOq6" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif"><b>NOTE
3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (CONTINUED)</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_z5rgLOkJei4l" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">Accounts
Receivable</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Credit
risk with respect to the Company&#8217;s accounts receivable related to product sales and service and repair fees is limited due to the
customer advances received prior to the commencement of work performed and the billing of amounts to customers as sub-assemblies are
completed. Service and repair fees are billed on a monthly or quarterly basis and the Company does not continue providing these services
if accounts receivable become past due. The Company has established a current expected credit loss (&#8220;CECL&#8221;) to address the
risk that a portion of these fees will not be paid. The Company controls credit risk with respect to accounts receivable from service
and repair fees through its credit evaluation process, credit limits, monitoring procedures and reasonably short collection terms. The
Company performs ongoing credit authorizations before a product sales contract is entered into or service and repair fees are provided.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Long
Term-Accounts Receivable</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Long
term-accounts receivable balances at December 31, 2024 and June 30, 2024 amounted to approximately $<span id="xdx_90A_eus-gaap--IncreaseDecreaseInAccountsAndOtherReceivables_pn3n3_c20240701__20241231_zjjc5VzZsEjl"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables" contextRef="From2024-07-01to2024-12-31" id="Fact001086" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">724</ix:nonFraction>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
$<span id="xdx_902_eus-gaap--IncreaseDecreaseInAccountsAndOtherReceivables_pn3n3_c20230701__20240630_zLgzvCanbhz5"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables" contextRef="From2023-07-012024-06-30" id="Fact001087" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">830</ix:nonFraction> </span></span><span style="font: normal 11pt Times New Roman, Times, Serif">respectively.
The Company will generate revenue from long-term, non-cancellable contracts to provide service and repair services. Future revenue to
be recognized over the following four years as of December 31, 2024 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2024-12-31" escape="true" id="Fact001089" name="us-gaap:LongTermPurchaseCommitmentTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--LongTermPurchaseCommitmentTextBlock_pn3n3_znuwEuARe03l" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Future Revenue (Details 1)" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span id="xdx_8B7_zmpitxKBUFql" style="font: normal 11pt Times New Roman, Times, Serif">Schedule
    of future revenue</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 44%; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2026</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 10%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--ContractReceivableDueOneToTwoYears_iI_pn3n3_c20241231_z5Tohm8lWPjh" style="width: 43%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ContractReceivableDueOneToTwoYears" contextRef="AsOf2024-12-31" id="Fact001090" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">677</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2027</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pn3n3_c20241231_zClkZxZ6BGU1" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ContractReceivableDueTwoToThreeYears" contextRef="AsOf2024-12-31" id="Fact001091" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">242</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2028</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--ContractReceivableDueThreeToFourYears_iI_pn3n3_c20241231_zKybmD13r44i" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ContractReceivableDueThreeToFourYears" contextRef="AsOf2024-12-31" id="Fact001092" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">87</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2029</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--ContractReceivableDueFourToFiveYears_iI_pn3n3_c20241231_zgJgvGHDrpw8" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ContractReceivableDueFourToFiveYears" contextRef="AsOf2024-12-31" id="Fact001093" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_pn3n3_c20241231_zcukdl8FyWpa" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsReceivableBilledForLongTermContractsOrPrograms" contextRef="AsOf2024-12-31" id="Fact001094" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,050</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A6_zL6NKvyxND37" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">Medical
Receivables</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Medical
receivables are due under fee-for-service contracts from third party payors, such as hospitals, government sponsored healthcare programs,
patient&#8217;s legal counsel and directly from patients. Substantially all the revenue relates to patients residing in Florida. Medical
receivables are recorded at net realizable value based on the estimated amounts the Company expects to receive from patients and third-party
payors. The medical receivable is reduced by contractual adjustments based on the historical experience with each payor class at each
location.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><p id="xdx_238_zVtcUD3KUvh8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 20 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_235_zQ5VwQOagZwi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zRIcB09xPv3a" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zAtkKQpoeSK2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zQdqhbeH2Qth" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">DECEMBER
31, 2024 and 2023</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zvFZGTN7BYle" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zjdGhRlJebWe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zz1DUcLbQUO2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zyAHaq20v7T8" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif"><b>NOTE
3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (CONTINUED)</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zCwitKJSSP47" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">Management
and Other Fees Receivable</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; color: #212529"><span style="font: normal 11pt Times New Roman, Times, Serif">Management
fees receivable is related to management fees outstanding from the related and non related PCs under management agreements. The Company
has established a CECL to address the risk that a portion of the contractually obligated management fees receivable from the PCs may
not be paid. The PC&#8217;s may be limited in their ability to pay the full management fee receivable if they do not collect sufficient
expected fees from third-party payers and patients. The Company&#8217;s management fees are collateralized, individually and collectively,
by the assets of the PCs. The CECL is determined based on the difference between the management fee receivable and the current amount
of outstanding fees estimated to be collected by the PCs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">Management
and Other Fees Receivable (Continued)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">The
Company&#8217;s considerations into the estimate of the PC&#8217;s fee collection is based on a combination of factors. As each management
agreement specifies the Company&#8217;s ultimate collateral for unpaid management fees are the patient fee receivables owned by each
PC, the Company considers the historical loss rates to pools of receivables with similar risks characteristics, aging of the patient
fee receivables, and the financial condition of each PC. In addition, the Company subjectively adjusts its estimated expected credit
losses for current and forward-looking economic conditions which would include trends seen within the industry and newly enacted regulation.
The Company also incorporates qualitative factors, such as changes in the nature and volume of receivables, regulatory changes, and other
relevant factors. Specifically, insurance carriers covering automobile no-fault and workers compensation claims incur longer payment
cycles and rigorous informational requirements and certain other disallowed claims. Approximately <span id="xdx_90C_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_pip0_dp_c20241001__20241231_z5ccBn2cRVya"><ix:nonFraction name="FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" contextRef="From2024-10-012024-12-31" id="Fact001105" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">58.2</ix:nonFraction></span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
and <span id="xdx_909_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_pip0_dp_c20231001__20231231_z1YtUwiVPcDl"><ix:nonFraction name="FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" contextRef="From2023-10-012023-12-31" id="Fact001106" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">54.4</ix:nonFraction></span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
of the Company&#8217;s owned PCs&#8217; net revenues were derived from no-fault and personal injury protection claims for the three months
ending December 31, 2024 and 2023, respectively. In addition, <span id="xdx_904_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_pip0_dp_c20240701__20241231_zWKW9CZnMfpc"><ix:nonFraction name="FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" contextRef="From2024-07-01to2024-12-31" id="Fact001107" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">59.3</ix:nonFraction></span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
and <span id="xdx_904_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_pip0_dp_c20230701__20231231_zaSvVOdRtX4g"><ix:nonFraction name="FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" contextRef="From2023-07-012023-12-31" id="Fact001108" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">57.5</ix:nonFraction></span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
of the Company&#8217;s owned PC&#8217;s net revenues were derived from no-fault and personal injury protection claims for the six months
ending December 31, 2024 and 2023, respectively. Also approximately <span id="xdx_90F_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1_pip0_dp_c20241001__20241231_zsobWHLM2KKf"><ix:nonFraction name="FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1" contextRef="From2024-10-012024-12-31" id="Fact001109" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">72.5</ix:nonFraction></span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
and <span id="xdx_909_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1_pip0_dp_c20231001__20231231_z1yWlLdBUiB5"><ix:nonFraction name="FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1" contextRef="From2023-10-012023-12-31" id="Fact001110" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">71.7</ix:nonFraction></span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
of the Company&#8217;s managed PCs&#8217; net revenues were derived from no-fault and personal injury protection claims for the three
months ending December 31, 2024 and 2023, respectively. In addition <span id="xdx_90C_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1_pip0_dp_c20240701__20241231_zmeew03pjEy8"><ix:nonFraction name="FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1" contextRef="From2024-07-01to2024-12-31" id="Fact001111" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">72.2</ix:nonFraction></span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
and <span id="xdx_909_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1_pip0_dp_c20230701__20231231_zXlqGjbwFFfk"><ix:nonFraction name="FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1" contextRef="From2023-07-012023-12-31" id="Fact001112" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">71.8</ix:nonFraction></span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
of the Company&#8217;s net revenues were derived from no-fault and personal injury protection claims for the six months ending December
31, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">The
Company combines an objective and subjective loss-rate methodology to estimate expected credit losses based on the collateral owned by
each PC. This involves objectively using historical loss rates to pools of receivables with similar risk characteristics (i.e. various
insurance payors) and then subjectively adjusting for current and forward-looking economic conditions which would include trends seen
within the industry and newly enacted regulation. The Company also incorporates qualitative factors, such as changes in the nature and
volume of the receivables, regulatory changes, and other relevant factors. Additional Company managed entities also operate under a guaranty
agreement, pursuant to which management fees are payable to the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><p id="xdx_234_zUZSPE8AKi26" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 21 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23E_z2c3Y9jL0ALf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zSiEkjXSNIP9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zuh9n0XlvWCh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zabpW1a3qvZ" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">DECEMBER
31, 2024 and 2023</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zVzmlWrCGI2e" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zLoNIWurW5G8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zMnxWMglYjph" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zPwxQweBzQ8h" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span><span style="font: normal 11pt Times New Roman, Times, Serif"><b>NOTE
3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (CONTINUED)</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zC80VxvUmtX5" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Net
revenues from management and other fees charged to the related PCs accounted for approximately <span id="xdx_903_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_pip0_dp_c20241001__20241231_z66qqLsno2Of"><ix:nonFraction name="FONR:PercentageOfConsolidatedNetRevenueFromManagementFees" contextRef="From2024-10-012024-12-31" id="Fact001123" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12.0</ix:nonFraction></span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
and <span id="xdx_909_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_pip0_dp_c20231001__20231231_zfGLIrZ0eSV7"><ix:nonFraction name="FONR:PercentageOfConsolidatedNetRevenueFromManagementFees" contextRef="From2023-10-012023-12-31" id="Fact001124" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">11.8</ix:nonFraction></span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
of the consolidated net revenues for the three months ended December 31, 2024 and 2023, respectively. Net revenues from management and
other fees charges to the related PCs accounted for approximately <span id="xdx_90A_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_pip0_dp_c20240701__20241231_zPvFRPsjOa8"><ix:nonFraction name="FONR:PercentageOfConsolidatedNetRevenueFromManagementFees" contextRef="From2024-07-01to2024-12-31" id="Fact001125" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12.0</ix:nonFraction></span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
and <span id="xdx_903_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_pip0_dp_c20230701__20231231_zCC45mEQQDk7"><ix:nonFraction name="FONR:PercentageOfConsolidatedNetRevenueFromManagementFees" contextRef="From2023-07-012023-12-31" id="Fact001126" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">11.7</ix:nonFraction></span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
of the consolidated net revenues for the six months ended December 31, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" escape="true" id="Fact001128" name="FONR:LesseeOperatingLeasesAndFinanceLeaseTextBlock"><p id="xdx_805_ecustom--LesseeOperatingLeasesAndFinanceLeaseTextBlock_zamZ6oSUQyO" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">NOTE
4 &#8211; <span id="xdx_822_z1kl8VJVawgg">OPERATING AND FINANCING LEASES</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">The
Company accounts for its various operating leases in accordance with Accounting Standards Codification (ASC) 842 &#8211; &#8220;Leases&#8221;,
as updated by ASU 2016-02. At the inception of a lease, the Company recognizes right-of-use lease assets and related lease liabilities
measured at present value of future lease payments on its balance sheet. Lease expense is recognized on a straight-line basis over the
term of the lease. The Company most common initial term varies in length from 2 to 19 years. Including renewal options negotiated with
the landlord, we have a total span of 2 to 16 years at the facilities we lease. The Company reviewed its contracts with vendors and customers,
determining that its right-to-use lease assets consisted of only office space operating leases. In determining the right-to-use lease
assets and liabilities, the Company did recognize lease extension options which the Company feels would be reasonably exercised. Our
incremental borrowing rate (&#8220;IBR&#8221;) used to discount the stream of operating lease payments is closely related to the interest
rates available to the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">A
reconciliation of operating and financing lease payments undiscounted cash flows to lease liabilities recognized as of December 31, 2024
is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2024-12-31" escape="true" id="Fact001130" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_pn3n3_zytfQ93lppu7" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="text-align: center"><span id="xdx_8B7_zrgoY2NwmBF" style="font: normal 11pt Times New Roman, Times, Serif">Schedule
    of lessee operating leases liability maturity</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Twelve
    Months Ending<br/> December 31,</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Operating
    Lease<br/> Payments</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Financing
    Lease Payments</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 27%; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2025</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" title="2025" style="width: 26%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="AsOf2024-12-31_custom_OperatingLeasePaymentsMember" id="Fact001132" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,584</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" title="2025" style="width: 26%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="AsOf2024-12-31_custom_FinancingLeasePaymentsMember" id="Fact001134" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">244</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2026</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" title="2026" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="AsOf2024-12-31_custom_OperatingLeasePaymentsMember" id="Fact001136" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,388</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" title="2026" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" contextRef="AsOf2024-12-31_custom_FinancingLeasePaymentsMember" id="Fact001138" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">244</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2027</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" title="2027" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="AsOf2024-12-31_custom_OperatingLeasePaymentsMember" id="Fact001140" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,371</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" title="2027" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" contextRef="AsOf2024-12-31_custom_FinancingLeasePaymentsMember" id="Fact001142" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">61</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2028</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" title="2028" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" contextRef="AsOf2024-12-31_custom_OperatingLeasePaymentsMember" id="Fact001144" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,019</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_iI_pn3n3_d0_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_z75D5Qjhrzic" title="2028" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" contextRef="AsOf2024-12-31_custom_FinancingLeasePaymentsMember" id="Fact001146" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2029</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" title="2029" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" contextRef="AsOf2024-12-31_custom_OperatingLeasePaymentsMember" id="Fact001148" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,876</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_pn3n3_d0_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zKGemonbDrvi" title="2029" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" contextRef="AsOf2024-12-31_custom_FinancingLeasePaymentsMember" id="Fact001150" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Thereafter</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" title="Thereafter" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" contextRef="AsOf2024-12-31_custom_OperatingLeasePaymentsMember" id="Fact001152" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26,841</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_iI_pn3n3_d0_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zYdNNieE4te1" title="Thereafter" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" contextRef="AsOf2024-12-31_custom_FinancingLeasePaymentsMember" id="Fact001154" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">Present
                                            value discount</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_ecustom--PresentValueDiscount_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" title="Present value discount" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="FONR:PresentValueDiscount" contextRef="AsOf2024-12-31_custom_OperatingLeasePaymentsMember" id="Fact001156" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">14,893</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_ecustom--PresentValueDiscountFinancingLease_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" title="Present value discount" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="FONR:PresentValueDiscountFinancingLease" contextRef="AsOf2024-12-31_custom_FinancingLeasePaymentsMember" id="Fact001158" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">15</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">Total
                                            lease liability</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--OperatingLeaseLiability_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" title="Operating Lease, Liability" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2024-12-31_custom_OperatingLeasePaymentsMember" id="Fact001160" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,186</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--FinanceLeaseLiability_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" title="Finance Lease, Liability" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiability" contextRef="AsOf2024-12-31_custom_FinancingLeasePaymentsMember" id="Fact001162" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">534</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8A8_zGWSg06hXHil" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><p id="xdx_23A_zRkRIpFXeJQ8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 22 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_239_zt38dDyDA8Ta" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zV0ZWR9sfSbe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zUfWTh9U6yM2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zn70RINVTUAa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">DECEMBER
31, 2024 and 2023</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zTxLIb4QnCe9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zkP6WGj6Lnk8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zSBXm69Eewh8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zuDrecTIovH4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"><b>NOTE
4 &#8211; OPERATING AND FINANCING LEASES (CONTINUED)</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_235_z7S7XD014d29" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Weighted
Average Remaining Lease Term</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2024-12-31" escape="true" id="Fact001174" name="FONR:ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock_pn3n3_zBX9eKrkHgPh" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES (Details 1)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BC_zzStWqTbube1" style="font: normal 11pt Times New Roman, Times, Serif">Schedule
    of weighted average remaining lease term</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 70%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Operating
    leases - years</span></td><td style="width: 10%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 18%; text-align: right"><span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20241231_zu6b4AUiB196" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="AsOf2024-12-31" format="ixt-sec:duryear" id="Fact001175" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1">10.6</ix:nonNumeric></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Finance
    lease - years</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_90C_eus-gaap--FinanceLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20241231_zm6RJ9MkEECd" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="AsOf2024-12-31" format="ixt-sec:duryear" id="Fact001176" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1">2.1</ix:nonNumeric></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Weighted
    Average Discount Rate</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Operating
    leases</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_90B_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pip0_dp_c20241231_ztzDBNXnEY8" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2024-12-31" id="Fact001177" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">6.5</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Finance
    lease</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_907_eus-gaap--FinanceLeaseWeightedAverageDiscountRatePercent_iI_pip0_dp_c20241231_zZSAoawyfMod" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2024-12-31" id="Fact001178" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.6</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">%</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AB_zien8TJiwFR2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="text-decoration: underline">The
components of lease expense were as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2024-12-31" escape="true" id="Fact001180" name="us-gaap:LeaseCostTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--LeaseCostTableTextBlock_pn3n3_zSSD0KJ9T22f" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES (Details 2)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BD_zRXWrP9tobWa" style="font: normal 11pt Times New Roman, Times, Serif">Components
    of lease expense</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" id="xdx_49F_20240701__20241231_zYUEbGBhDME5" style="text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" id="xdx_49E_20230701__20231231_zweC4Lzxt2Lh" style="text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">For
    the six months ended Dec.31,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">2023</span></td></tr>
  <tr id="xdx_408_eus-gaap--OperatingLeaseCost_pn3n3_zo2KYggax5El" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Operating
    lease cost</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2024-07-01to2024-12-31" id="Fact001182" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,190</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2023-07-012023-12-31" id="Fact001183" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,865</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--FinanceLeaseCostsAbstract_iB_zKhjZXR9Yz15" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Finance
    lease cost:</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--DepreciationOfLeasedEquipment_i01_pn3n3_zP7Zw1OPGPHd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Depreciation
    of leased equipment</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:DepreciationOfLeasedEquipment" contextRef="From2024-07-01to2024-12-31" id="Fact001188" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">100</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:DepreciationOfLeasedEquipment" contextRef="From2023-07-012023-12-31" id="Fact001189" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">100</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--FinanceLeaseInterestExpense_i01_pn3n3_zVCWL9KIkLZ4" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Interest
    on lease liabilities</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FinanceLeaseInterestExpense" contextRef="From2024-07-01to2024-12-31" id="Fact001191" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FinanceLeaseInterestExpense" contextRef="From2023-07-012023-12-31" id="Fact001192" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--FinanceLeaseCost_i01_pn3n3_zBRBwGlHafN6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Total
    finance lease cost</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:FinanceLeaseCost" contextRef="From2024-07-01to2024-12-31" id="Fact001194" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">105</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:FinanceLeaseCost" contextRef="From2023-07-012023-12-31" id="Fact001195" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">114</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8A7_z4MqkZ4FCLE2" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Supplemental
cash flow information related to leases was as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2024-12-31" escape="true" id="Fact001197" name="FONR:SupplementalCashFlowInformationRelatedToLeasesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_pn3n3_zv22ZU9izFM1" summary="xdx: Disclosure -  OPERATING &amp; FINANCING LEASES (Details 3)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BF_zU6hV9BuBgL" style="font: normal 11pt Times New Roman, Times, Serif">Supplemental
    cash flow information related to leases</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" id="xdx_49F_20240701__20241231_zgIXIEmxP1s5" style="text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" id="xdx_49E_20230701__20231231_zsXLlWN0wOQ1" style="text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">For
    the six months ended Dec. 31,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Cash
    paid for amounts included in the measurement of lease liabilities:</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">2023</span></td></tr>
  <tr id="xdx_40A_ecustom--OperatingCashFlowsFromOperatingLeases_zYsccWh63qKc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Operating
    cash flows from operating leases</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:OperatingCashFlowsFromOperatingLeases" contextRef="From2024-07-01to2024-12-31" id="Fact001199" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,541</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:OperatingCashFlowsFromOperatingLeases" contextRef="From2023-07-012023-12-31" id="Fact001200" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,164</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--FinancingCashFlowsFromFinancingLeases_zbSB6ZuGtWT5" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Financing
    cash flows from financing leases</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:FinancingCashFlowsFromFinancingLeases" contextRef="From2024-07-01to2024-12-31" id="Fact001202" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">122</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:FinancingCashFlowsFromFinancingLeases" contextRef="From2023-07-012023-12-31" id="Fact001203" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">122</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract_iB_zKdnXriZjHSl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Right-of-use
    and equipment assets obtained in exchange for lease obligations:</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_ztrAUcoQpSkg" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Operating
    leases</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" contextRef="From2024-07-01to2024-12-31" id="Fact001208" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">359</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" contextRef="From2023-07-012023-12-31" id="Fact001209" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,212</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8A7_ze62rNaIXQk2" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<ix:exclude><!-- Field: Page; Sequence: 23 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_234_zu5xKWqgMfFa" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zij7jmxGeIS4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zp7Qdans64ob" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zSsSdu1tw4Xb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">DECEMBER
31, 2024 and 2023</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zZfDCse9CNV5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zYy00ENnqwd1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zYfFqinzkRp" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" escape="true" id="Fact001218" name="us-gaap:InventoryDisclosureTextBlock"><p id="xdx_80D_eus-gaap--InventoryDisclosureTextBlock_zVMGuHgV7ha1" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif"><b>NOTE
5 - <span id="xdx_824_zSDNoBjj1IV1">INVENTORIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Inventories
included in the accompanying condensed consolidated balance sheets consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2024-12-31" escape="true" id="Fact001220" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_pn3n3_zeGDeJwevqRd" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-indent: -10pt"><span id="xdx_8BA_zr6ZVnBFTz4j" style="font: normal 11pt Times New Roman, Times, Serif">Schedule
    of inventories</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_499_20241231_zKIawok9SSxd" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_491_20240630_zoNNStkb4kR3" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">December
    31,<br/> 2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">June
    30,<br/> 2024</span></td></tr>
  <tr id="xdx_40E_eus-gaap--OtherInventorySupplies_iI_maIFGAWzdt0_zU1xG5uwxAEe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Purchased
    parts, components and supplies</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherInventorySupplies" contextRef="AsOf2024-12-31" id="Fact001222" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,583</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherInventorySupplies" contextRef="AsOf2024-06-30" id="Fact001223" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,524</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--InventoryWorkInProcess_iI_maIFGAWzdt0_zFoczDa3Bvu3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Work-in-process</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InventoryWorkInProcess" contextRef="AsOf2024-12-31" id="Fact001225" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">275</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InventoryWorkInProcess" contextRef="AsOf2024-06-30" id="Fact001226" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">191</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--InventoryNet_iTI_mtIFGAWzdt0_zQ8O4Qu1uqLj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Total
    Inventories</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2024-12-31" id="Fact001228" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,858</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2024-06-30" id="Fact001229" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,715</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" escape="true" id="Fact001231" name="us-gaap:IntangibleAssetsDisclosureTextBlock"><p id="xdx_808_eus-gaap--IntangibleAssetsDisclosureTextBlock_z01m3GSJamy4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"><b>NOTE
6 &#8211; <span id="xdx_826_z054P3mriy64">OTHER INTANGIBLE ASSETS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Other
intangible assets, net of accumulated amortization, in the accompanying condensed consolidated balance sheets consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2024-12-31" escape="true" id="Fact001233" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_pn3n3_zoa8HS5I6cUk" summary="xdx: Disclosure -  OTHER INTANGIBLE ASSETS (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B9_zvCmY5nnJH53" style="font: normal 11pt Times New Roman, Times, Serif">Schedule
    of other intangible assets</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Weighted
    average useful lives</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Gross
    carrying amount &#8211; December 31, 2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Accumulated
    amortization &#8211; December 31, 2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Net
    carrying amount &#8211; December 31, 2024</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Capitalized
    software development costs</span></td><td style="width: 3%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 10%; text-align: center"><span id="xdx_90D_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zuOgvJbo0sAb" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2024-07-012024-12-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" format="ixt-sec:duryear" id="Fact001234" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">5</ix:nonNumeric>
                                            </span><span style="font: normal 11pt Times New Roman, Times, Serif">years</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zSMGe5ZhVwRb" title="Gross carrying amount intangible assets" style="width: 10%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-12-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" id="Fact001236" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,005</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zDhkRmDjIaFj" title="Accumulated amortization intangible assets" style="width: 10%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2024-12-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" id="Fact001238" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,005</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="width: 3%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zWGwYxTQxTe2" title="Net carrying amount intangible assets" style="width: 10%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1240">&#8212;</span></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Software
    License</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span id="xdx_900_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_zpMsHY9YSou7" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2024-07-012024-12-31_us-gaap_LicenseMember" format="ixt-sec:duryear" id="Fact001241" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">3</ix:nonNumeric>
                                            </span><span style="font: normal 11pt Times New Roman, Times, Serif">years</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_z7yfeQTcbjOa" title="Gross carrying amount intangible assets" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-12-31_us-gaap_LicenseMember" id="Fact001243" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,260</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_zSA5eePW4P44" title="Accumulated amortization intangible assets" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2024-12-31_us-gaap_LicenseMember" id="Fact001245" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">567</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_zoxuC3EnwFN3" title="Net carrying amount intangible assets" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2024-12-31_us-gaap_LicenseMember" id="Fact001247" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">693</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Patents
    and copy rights</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span id="xdx_90B_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zBnTAz3MBZWf" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2024-07-012024-12-31_custom_PatentsAndCopyrightsMember" format="ixt-sec:duryear" id="Fact001248" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">15</ix:nonNumeric>
                                            </span><span style="font: normal 11pt Times New Roman, Times, Serif">years</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zmRhXzD9AXKj" title="Gross carrying amount intangible assets" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-12-31_custom_PatentsAndCopyrightsMember" id="Fact001250" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,280</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zriiQuIm7zB5" title="Accumulated amortization intangible assets" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2024-12-31_custom_PatentsAndCopyrightsMember" id="Fact001252" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,180</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zskrWHIfldx" title="Net carrying amount intangible assets" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2024-12-31_custom_PatentsAndCopyrightsMember" id="Fact001254" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,100</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Non-compete</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span id="xdx_90B_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zHlh8MkVo0bg" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2024-07-012024-12-31_us-gaap_NoncompeteAgreementsMember" format="ixt-sec:duryear" id="Fact001255" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">7</ix:nonNumeric>
                                            </span><span style="font: normal 11pt Times New Roman, Times, Serif">years</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zAWGEImeexz5" title="Gross carrying amount intangible assets" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-12-31_us-gaap_NoncompeteAgreementsMember" id="Fact001257" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,150</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zgNjX0ISAODf" title="Accumulated amortization intangible assets" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2024-12-31_us-gaap_NoncompeteAgreementsMember" id="Fact001259" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,150</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_d0_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zT3sOx8MNlph" title="Net carrying amount intangible assets" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2024-12-31_us-gaap_NoncompeteAgreementsMember" id="Fact001261" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Customer
    relationships</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span id="xdx_90D_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zyOOFtJqB4Vh" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2024-07-012024-12-31_us-gaap_CustomerRelationshipsMember" format="ixt-sec:duryear" id="Fact001262" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">20</ix:nonNumeric>
                                            </span><span style="font: normal 11pt Times New Roman, Times, Serif">years</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zlWOjgwulIZ1" title="Gross carrying amount intangible assets" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-12-31_us-gaap_CustomerRelationshipsMember" id="Fact001264" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,900</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zn514S0v8gwk" title="Accumulated amortization intangible assets" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2024-12-31_us-gaap_CustomerRelationshipsMember" id="Fact001266" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,286</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zKDqHfGgrHI1" title="Net carrying amount intangible assets" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2024-12-31_us-gaap_CustomerRelationshipsMember" id="Fact001268" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,614</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20241231_zsROI8wQYTji" title="Gross carrying amount intangible assets" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-12-31" id="Fact001270" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,595</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20241231_zrPbHDgvMIea" title="Accumulated amortization intangible assets" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2024-12-31" id="Fact001272" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">18,188</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20241231_zzD7VWLzjNYj" title="Net carrying amount intangible assets" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2024-12-31" id="Fact001274" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,407</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><p id="xdx_236_zyNwWL0GnRCh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 24 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_230_ztHkcGGCnp7d" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zaJ8n3yNRmEf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_z0TiA3jpi7ya" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zDz1Ixk2mhQa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">DECEMBER
31, 2024 and 2023</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zdzbVP4SnnDf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zflRWjsanzec" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zE20wiuJfbXg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zVR9anvErTsg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"><b>NOTE
6 &#8211; OTHER INTANGIBLE ASSETS (CONTINUED)</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zlX2KSkQLrx9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Weighted
    average useful lives</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Gross
    carrying amount &#8211; June 30, 2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Accumulated
    amortization</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Net
    carrying amount</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Capitalized
    software development costs</span></td><td style="width: 3%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 10%; text-align: right"><span id="xdx_900_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_z9hyDTLaQPi4" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2023-07-012024-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" format="ixt-sec:duryear" id="Fact001285" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">5</ix:nonNumeric>
                                            </span><span style="font: normal 11pt Times New Roman, Times, Serif">years</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zyOjKKCz6YOf" title="Gross carrying amount intangible assets" style="width: 10%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" id="Fact001287" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,005</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zzVdNT1TaP5a" title="Accumulated amortization intangible assets" style="width: 10%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2024-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" id="Fact001289" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,005</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="width: 3%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zhYAuVwULF31" title="Net carrying amount intangible assets" style="width: 10%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1291">&#8212;</span></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Patents
    and copy rights</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_905_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zow9pwIMzb9g" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_PatentsAndCopyrightsMember" format="ixt-sec:duryear" id="Fact001292" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">15</ix:nonNumeric>
                                            </span><span style="font: normal 11pt Times New Roman, Times, Serif">years</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_za9fs2E2Y20i" title="Gross carrying amount intangible assets" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-06-30_custom_PatentsAndCopyrightsMember" id="Fact001294" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,260</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zZsfMtt2K1a1" title="Accumulated amortization intangible assets" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2024-06-30_custom_PatentsAndCopyrightsMember" id="Fact001296" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,104</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zVU6RAC8ljH" title="Net carrying amount intangible assets" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2024-06-30_custom_PatentsAndCopyrightsMember" id="Fact001298" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,156</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Non-compete</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_90F_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zrFG4NLr6P36" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2023-07-012024-06-30_us-gaap_NoncompeteAgreementsMember" format="ixt-sec:duryear" id="Fact001299" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">7</ix:nonNumeric>
                                            </span><span style="font: normal 11pt Times New Roman, Times, Serif">years</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zu8Wf5pVAOQ3" title="Gross carrying amount intangible assets" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-06-30_us-gaap_NoncompeteAgreementsMember" id="Fact001301" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,150</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_z9kyx76t2BFb" title="Accumulated amortization intangible assets" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2024-06-30_us-gaap_NoncompeteAgreementsMember" id="Fact001303" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,150</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_d0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zfuMXou8EK7e" title="Net carrying amount intangible assets" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2024-06-30_us-gaap_NoncompeteAgreementsMember" id="Fact001305" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Customer
    relationships</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_903_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zdz3MqKtFvid" style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2023-07-012024-06-30_us-gaap_CustomerRelationshipsMember" format="ixt-sec:duryear" id="Fact001306" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">20</ix:nonNumeric>
                                            </span><span style="font: normal 11pt Times New Roman, Times, Serif">years</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zhFVZ3Sh1nXa" title="Gross carrying amount intangible assets" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-06-30_us-gaap_CustomerRelationshipsMember" id="Fact001308" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,900</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zKDX8EhfhdTl" title="Accumulated amortization intangible assets" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2024-06-30_us-gaap_CustomerRelationshipsMember" id="Fact001310" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,186</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zNl0CxAndfNg" title="Net carrying amount intangible assets" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2024-06-30_us-gaap_CustomerRelationshipsMember" id="Fact001312" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,714</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20240630_zLHtBSUhebjg" title="Gross carrying amount intangible assets" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-06-30" id="Fact001314" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,315</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20240630_zLMYcQfE7n8a" title="Accumulated amortization intangible assets" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2024-06-30" id="Fact001316" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">17,445</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20240630_zmqzJxKLgLH7" title="Net carrying amount intangible assets" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2024-06-30" id="Fact001318" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,870</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8AB_zqwkamRw3he9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Amortization
of patents and copyrights for the three months ended December 31, 2024 and 2023 amounted to $<span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20241001__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zEOqH6prnW7c"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2024-10-012024-12-31_custom_PatentsAndCopyrightsMember" id="Fact001319" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">37</ix:nonFraction>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
$<span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20231001__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zREHpi7jeGq9"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2023-10-012023-12-31_custom_PatentsAndCopyrightsMember" id="Fact001320" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">43</ix:nonFraction></span></span><span style="font: normal 11pt Times New Roman, Times, Serif">,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Amortization
of customer relationships for the three months ended December 31, 2024 and 2023 amounted to $<span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20241001__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zbu2OoPrAAL2"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2024-10-012024-12-31_us-gaap_CustomerRelationshipsMember" id="Fact001321" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50</ix:nonFraction>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
$<span id="xdx_90E_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20231001__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z92xCaTvO523"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2023-10-012023-12-31_us-gaap_CustomerRelationshipsMember" id="Fact001322" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50</ix:nonFraction></span></span><span style="font: normal 11pt Times New Roman, Times, Serif">,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Amortization
of patents and copyrights for the six months ended December 31, 2024 and 2023 amounted to $<span id="xdx_900_eus-gaap--AmortizationOfIntangibleAssets_c20240701__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2024-07-012024-12-31_custom_PatentsAndCopyrightsMember" id="Fact001323" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">76</ix:nonFraction>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
$<span id="xdx_906_eus-gaap--AmortizationOfIntangibleAssets_c20230701__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2023-07-012023-12-31_custom_PatentsAndCopyrightsMember" id="Fact001324" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">86</ix:nonFraction></span></span><span style="font: normal 11pt Times New Roman, Times, Serif">,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Amortization
of customer relationships for the six months ended December 31, 2024 and 2023 amounted to $<span id="xdx_90B_eus-gaap--AmortizationOfIntangibleAssets_c20240701__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2024-07-012024-12-31_us-gaap_CustomerRelationshipsMember" id="Fact001325" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">100</ix:nonFraction>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
$<span id="xdx_905_eus-gaap--AmortizationOfIntangibleAssets_c20230701__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2023-07-012023-12-31_us-gaap_CustomerRelationshipsMember" id="Fact001326" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">100</ix:nonFraction></span></span><span style="font: normal 11pt Times New Roman, Times, Serif">,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Amortization
expense for reach of the next five years and thereafter as of December 31, 2024 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2024-12-31" escape="true" id="Fact001328" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_pn3n3_zAocYU0caLF3" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS (Details 1)" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 40%; margin-right: auto">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 44%; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2025</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 10%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pn3n3_c20241231_zeCa6dwE0e44" style="width: 43%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="AsOf2024-12-31" id="Fact001329" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">723</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2026</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pn3n3_c20241231_zrDJdQRdjKj1" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="AsOf2024-12-31" id="Fact001330" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">650</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2027</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pn3n3_c20241231_z8zbW0NOgyY9" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="AsOf2024-12-31" id="Fact001331" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">321</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2028</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pn3n3_c20241231_zr70CM00YPMi" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="AsOf2024-12-31" id="Fact001332" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">317</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2029</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pn3n3_c20241231_z81xc37J5ltk" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextRef="AsOf2024-12-31" id="Fact001333" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">314</ix:nonFraction></span></td><td style="text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Thereafter</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pn3n3_c20241231_zZ2j3yH5tTEa" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" contextRef="AsOf2024-12-31" id="Fact001334" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1082</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_pn3n3_c20241231_zOYqppaOdbP8" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2024-12-31" id="Fact001335" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,407</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A2_zqvS13e4NxLj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><p id="xdx_236_ztRFJfeqWno2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 25 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_zSB5u0MVXBx6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zw8TUVLHjWKb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zEfZDRF7EjZg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zVOIr7qUFuC4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">DECEMBER
31, 2024 and 2023</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zvxonqkRLvah" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zhfib2u2O4Rl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_z2bKFxSpwyWd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" escape="true" id="Fact001345" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"><p id="xdx_806_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zBottQqPbveh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"><b>NOTE
7 &#8211; <span id="xdx_823_zs7bghJuC262">OTHER CURRENT LIABILITIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Other
current liabilities in the accompanying condensed consolidated balance sheets consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2024-12-31" escape="true" id="Fact001347" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_pn3n3_z8H95YZKmxF3" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B0_zmewYkyOxNY5" style="font: normal 11pt Times New Roman, Times, Serif">Schedule
    of other current liabilities</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_490_20241231_zUHSd0BseHid" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_497_20240630_zv9akfW2dwue" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">December
    31,<br/> 2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">June
    30,<br/> 2024</span></td></tr>
  <tr id="xdx_400_eus-gaap--AccruedSalariesCurrent_iI_pn3n3_maOLCzdop_zikMYErCYEJk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Accrued
    salaries, commissions and payroll taxes</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccruedSalariesCurrent" contextRef="AsOf2024-12-31" id="Fact001349" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,541</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccruedSalariesCurrent" contextRef="AsOf2024-06-30" id="Fact001350" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,678</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pn3n3_maOLCzdop_zfgmq7aK6eA5" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Sales
    tax payable</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SalesAndExciseTaxPayableCurrent" contextRef="AsOf2024-12-31" id="Fact001352" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">183</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SalesAndExciseTaxPayableCurrent" contextRef="AsOf2024-06-30" id="Fact001353" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">197</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--AccruedPayrollTaxesCurrent_iI_pn3n3_maOLCzdop_z3ehj54qmLha" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Federal
    and state income taxes payable</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1355">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccruedPayrollTaxesCurrent" contextRef="AsOf2024-06-30" id="Fact001356" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,461</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_ecustom--SelffundedHealthInsuranceReserve_iI_pn3n3_maOLCzdop_z3fz6TGCpfxh" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Self-funded
    health insurance reserve</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:SelffundedHealthInsuranceReserve" contextRef="AsOf2024-12-31" id="Fact001358" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">168</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:SelffundedHealthInsuranceReserve" contextRef="AsOf2024-06-30" id="Fact001359" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">121</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--SoftwareLicenses_iI_pn3n3_z5pMnuieRC8a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Software
    Licenses</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:SoftwareLicenses" contextRef="AsOf2024-12-31" id="Fact001361" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">252</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1362">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pn3n3_maOLCzdop_zUCODa2QQI07" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Other
    general and administrative expenses</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherSundryLiabilitiesCurrent" contextRef="AsOf2024-12-31" id="Fact001364" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,768</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherSundryLiabilitiesCurrent" contextRef="AsOf2024-06-30" id="Fact001365" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,484</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--OtherLiabilitiesCurrent_iTI_pn3n3_mtOLCzdop_zGIZ13tmpgTf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Other
    Current Liabilities</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2024-12-31" id="Fact001367" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,912</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2024-06-30" id="Fact001368" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,941</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" escape="true" id="Fact001370" name="us-gaap:SegmentReportingDisclosureTextBlock"><p id="xdx_801_eus-gaap--SegmentReportingDisclosureTextBlock_zptfoUDKi6Ef" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif"><b>NOTE
8 - <span id="xdx_82D_zB66pAl4E1O5">SEGMENT AND RELATED INFORMATION</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">The
Company operates in two industry segments - manufacturing and the servicing of medical equipment and management of diagnostic imaging
centers. The accounting policies of the segments are the same as those described in the summary of significant accounting policies as
disclosed in the Company&#8217;s 10-K as of June 30, 2024. All inter segment sales are market-based. The Company evaluates performance
based on income or loss from operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Summarized
financial information concerning the Company&#8217;s reportable segments is shown in the following table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2024-12-31" escape="true" id="Fact001372" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_pn3n3_ziO5u5Cqwiba" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Summarized Segments - (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B9_zj6XJ57Ltw81" style="font: normal 11pt Times New Roman, Times, Serif">Schedule
    of summarized segment financial information</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Manufacturing
    and Service of MRI Equipment</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Management
    of Diagnostic Imaging Centers</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Totals</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">For
    the three months ended December 31, 2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 46%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Net
    revenues from external customers</span></td><td style="width: 5%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--Revenues_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zqoyNHe2R5Ii" title="Net revenues from external customers" style="width: 11%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-10-012024-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember" id="Fact001374" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,829</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--Revenues_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zLjcbEjDro24" title="Net revenues from external customers" style="width: 11%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-10-012024-12-31_us-gaap_HealthCareOtherMember" id="Fact001376" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23,121</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--Revenues_pn3n3_c20241001__20241231_zjsbg6sAZ4fl" title="Net revenues from external customers" style="width: 11%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-10-012024-12-31" id="Fact001378" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24,950</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Inter-segment
    net revenues</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--IntersegmentNetRevenues_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zru1txtcsWBc" title="Inter-segment net revenues" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2024-10-012024-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember" id="Fact001380" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">294</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_987_ecustom--IntersegmentNetRevenues_pn3n3_d0_c20241001__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zI9RiDiZws79" title="Inter-segment net revenues" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2024-10-012024-12-31_us-gaap_HealthCareOtherMember" id="Fact001382" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_ecustom--IntersegmentNetRevenues_pn3n3_c20241001__20241231_zodU8SHHQWs6" title="Inter-segment net revenues" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2024-10-012024-12-31" id="Fact001384" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">294</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">(Loss)
    Income from operations</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zP6rPQgqyWMk" title="(Loss) Income from operations" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2024-10-012024-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember" id="Fact001386" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,291</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zOYc445bZx9a" title="(Loss) Income from operations" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2024-10-012024-12-31_us-gaap_HealthCareOtherMember" id="Fact001388" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,726</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20241001__20241231_zL1BymUXABw5" title="(Loss) Income from operations" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2024-10-012024-12-31" id="Fact001390" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,435</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Depreciation
    and amortization</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zRca5VP2lrvj" title="Depreciation and amortization" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2024-10-012024-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember" id="Fact001392" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">54</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zpYaV7Vmcjvf" title="Depreciation and amortization" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2024-10-012024-12-31_us-gaap_HealthCareOtherMember" id="Fact001394" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,181</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20241001__20241231_z4Xfk5ehyXdj" title="Depreciation and amortization" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2024-10-012024-12-31" id="Fact001396" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,235</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Capital
    expenditures</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_z3VAJ6J87m29" title="Capital expenditures" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2024-10-012024-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember" id="Fact001398" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zi40VVKqnAwg" title="Capital expenditures" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2024-10-012024-12-31_us-gaap_HealthCareOtherMember" id="Fact001400" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">731</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20241001__20241231_z8KRIarlKWQ3" title="Capital expenditures" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2024-10-012024-12-31" id="Fact001402" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">754</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">For
    the three months ended December 31, 2023</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Net
    revenues from external customers</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--Revenues_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_z7VSkIJPQTx" title="Net revenues from external customers" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-10-012023-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember" id="Fact001404" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,861</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--Revenues_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zbzusP5xFYhf" title="Net revenues from external customers" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-10-012023-12-31_us-gaap_HealthCareOtherMember" id="Fact001406" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23,525</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--Revenues_pn3n3_c20231001__20231231_zFqsOWjpzNN5" title="Net revenues from external customers" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-10-012023-12-31" id="Fact001408" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,386</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Inter-segment
    net revenues</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--IntersegmentNetRevenues_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_z4p3S0ElHEtc" title="Inter-segment net revenues" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2023-10-012023-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember" id="Fact001410" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">254</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--IntersegmentNetRevenues_pn3n3_d0_c20231001__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zuzjTVgdI8P3" title="Inter-segment net revenues" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2023-10-012023-12-31_us-gaap_HealthCareOtherMember" id="Fact001412" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--IntersegmentNetRevenues_pn3n3_c20231001__20231231_zxTCTGpw7g5b" title="Inter-segment net revenues" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2023-10-012023-12-31" id="Fact001414" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">254</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">(Loss)
    Income from operations</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zmAl3hnryYie" title="(Loss) Income from operations" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2023-10-012023-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember" id="Fact001416" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">993</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zYaTj8A4GG44" title="(Loss) Income from operations" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2023-10-012023-12-31_us-gaap_HealthCareOtherMember" id="Fact001418" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,878</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20231001__20231231_zMhFoeeGe71c" title="(Loss) Income from operations" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2023-10-012023-12-31" id="Fact001420" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,885</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Depreciation
    and amortization</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zBMDNEytuZph" title="Depreciation and amortization" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2023-10-012023-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember" id="Fact001422" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">60</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zsmhsZdetKh9" title="Depreciation and amortization" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2023-10-012023-12-31_us-gaap_HealthCareOtherMember" id="Fact001424" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,160</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20231001__20231231_zGFMXu32QBHc" title="Depreciation and amortization" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2023-10-012023-12-31" id="Fact001426" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,220</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Capital
    expenditures</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zI0cp9rcMBMf" title="Capital expenditures" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2023-10-012023-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember" id="Fact001428" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_z9VJtVX5yjs9" title="Capital expenditures" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2023-10-012023-12-31_us-gaap_HealthCareOtherMember" id="Fact001430" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">129</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20231001__20231231_zMTjKOlL5QVl" title="Capital expenditures" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2023-10-012023-12-31" id="Fact001432" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">133</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><p id="xdx_23F_zolhUaJljoW1" style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 26 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_zHwfcLHzjqE8" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zvcJ3fXc6AN4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zd7ML8CggYpc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zjElZmD7Hfc2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">DECEMBER
31, 2024 and 2023</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_z0kP1hyNYJg9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_z9OJxYNi7ytf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_z8muSaQUmZm4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zCtGuq7J22yk" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif"><b>NOTE
8 - SEGMENT AND RELATED INFORMATION (CONTINUED)</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zdKbt63KOVCl" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Manufacturing
    and Service of MRI Equipment</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Management
    of Diagnostic Imaging Centers</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Totals</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">For
    the six months ended December 31, 2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 46%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Net
    revenues from external customers</span></td><td style="width: 5%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--Revenues_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_z6rTfOyUeHx5" title="Net revenues from external customers" style="width: 11%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-07-012024-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember" id="Fact001444" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,986</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--Revenues_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zVdQ9YdB7FE2" title="Net revenues from external customers" style="width: 11%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-07-012024-12-31_us-gaap_HealthCareOtherMember" id="Fact001446" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">45,924</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--Revenues_pn3n3_c20240701__20241231_zOAnJjpq6wRe" title="Net revenues from external customers" style="width: 11%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-07-01to2024-12-31" id="Fact001448" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">49,910</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Inter-segment
    net revenues</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--IntersegmentNetRevenues_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zvFt0W2XpZAc" title="Inter-segment net revenues" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2024-07-012024-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember" id="Fact001450" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">583</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--IntersegmentNetRevenues_pn3n3_d0_c20240701__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zSPNhFx6ooS2" title="Inter-segment net revenues" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2024-07-012024-12-31_us-gaap_HealthCareOtherMember" id="Fact001452" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_ecustom--IntersegmentNetRevenues_pn3n3_c20240701__20241231_zNovGROUlx81" title="Inter-segment net revenues" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2024-07-01to2024-12-31" id="Fact001454" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">583</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">(Loss)
    Income from operations</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zIeJiG93EX4l" title="(Loss) Income from operations" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2024-07-012024-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember" id="Fact001456" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,335</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zDgFO1C9ERce" title="(Loss) Income from operations" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2024-07-012024-12-31_us-gaap_HealthCareOtherMember" id="Fact001458" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,376</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20240701__20241231_ziaZirzu7d94" title="(Loss) Income from operations" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2024-07-01to2024-12-31" id="Fact001460" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,041</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Depreciation
    and amortization</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zDnnIO1vJht6" title="Depreciation and amortization" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2024-07-012024-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember" id="Fact001462" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">103</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zLeFMY1hgjcf" title="Depreciation and amortization" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2024-07-012024-12-31_us-gaap_HealthCareOtherMember" id="Fact001464" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,195</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20240701__20241231_zT3IGbMgMFdk" title="Depreciation and amortization" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2024-07-01to2024-12-31" id="Fact001466" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,298</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Capital
    expenditures</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zKZclh3mbo6i" title="Capital expenditures" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2024-07-012024-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember" id="Fact001468" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">95</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zoq1aTNbWS0b" title="Capital expenditures" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2024-07-012024-12-31_us-gaap_HealthCareOtherMember" id="Fact001470" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,477</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20240701__20241231_zp2UGg8VGrre" title="Capital expenditures" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2024-07-01to2024-12-31" id="Fact001472" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,572</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Manufacturing
    and Service of MRI Equipment</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Management
    of Diagnostic Imaging Centers</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Totals</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">For
    the six months ended December 31, 2023</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 46%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Net
    revenues from external customers</span></td><td style="width: 5%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--Revenues_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zWHnaVjNziBl" title="Net revenues from external customers" style="width: 11%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-07-012023-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember" id="Fact001474" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,917</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--Revenues_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zdYVE2jw5V53" title="Net revenues from external customers" style="width: 11%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-07-012023-12-31_us-gaap_HealthCareOtherMember" id="Fact001476" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">47,307</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--Revenues_pn3n3_c20230701__20231231_zFhRemx8lEgd" title="Net revenues from external customers" style="width: 11%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-07-012023-12-31" id="Fact001478" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">51,224</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Inter-segment
    net revenues</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_ecustom--IntersegmentNetRevenues_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zcQm4gard3ac" title="Inter-segment net revenues" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2023-07-012023-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember" id="Fact001480" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">508</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_ecustom--IntersegmentNetRevenues_pn3n3_d0_c20230701__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zNEjy50sfMb1" title="Inter-segment net revenues" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2023-07-012023-12-31_us-gaap_HealthCareOtherMember" id="Fact001482" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_ecustom--IntersegmentNetRevenues_pn3n3_c20230701__20231231_z6xvPabKi0af" title="Inter-segment net revenues" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2023-07-012023-12-31" id="Fact001484" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">508</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">(Loss)
    Income from operations</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zPZPA8DkH9Jf" title="(Loss) Income from operations" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2023-07-012023-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember" id="Fact001486" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,731</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_z7JferkQ3J87" title="(Loss) Income from operations" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2023-07-012023-12-31_us-gaap_HealthCareOtherMember" id="Fact001488" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,187</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20230701__20231231_z6QNhsIBfkHe" title="(Loss) Income from operations" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2023-07-012023-12-31" id="Fact001490" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,456</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Depreciation
    and amortization</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zZTChwdwzBCj" title="Depreciation and amortization" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2023-07-012023-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember" id="Fact001492" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">121</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_ztmdrKBbkba3" title="Depreciation and amortization" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2023-07-012023-12-31_us-gaap_HealthCareOtherMember" id="Fact001494" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,294</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20230701__20231231_zvduOz0Rgvt8" title="Depreciation and amortization" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2023-07-012023-12-31" id="Fact001496" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,415</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Capital
    expenditures</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zqTOG5L0kDp" title="Capital expenditures" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2023-07-012023-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember" id="Fact001498" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zQdeURN2oCxa" title="Capital expenditures" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2023-07-012023-12-31_us-gaap_HealthCareOtherMember" id="Fact001500" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">192</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20230701__20231231_zSKV4qOHnYa9" title="Capital expenditures" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2023-07-012023-12-31" id="Fact001502" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">212</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A2_zRsxJk2VGJil" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" escape="true" id="Fact001504" name="us-gaap:CashFlowSupplementalDisclosuresTextBlock"><p id="xdx_802_eus-gaap--CashFlowSupplementalDisclosuresTextBlock_zGVOuN4nhr5b" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif"><b>NOTE
9 &#8211; <span id="xdx_824_zvntBC6U1sFj">SUPPLEMENTAL CASH FLOW INFORMATION</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">During
the six months ended December 31, 2024 and December 31, 2023, the Company paid $<span id="xdx_900_eus-gaap--InterestPaidNet_pn3n3_c20240701__20241231_zuYK5TSnsG41"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2024-07-01to2024-12-31" id="Fact001505" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14</ix:nonFraction>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
$<span id="xdx_90F_eus-gaap--InterestPaidNet_pn3n3_c20230701__20231231_zujyHAOd1QS2"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2023-07-012023-12-31" id="Fact001506" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">58</ix:nonFraction> </span></span><span style="font: normal 11pt Times New Roman, Times, Serif">for
interest, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">During
the six months ended December 31, 2024 and December 31, 2023, the Company paid $<span id="xdx_906_eus-gaap--IncomeTaxesPaid_pn3n3_c20240701__20241231_z5JLBWZlqcU4"><ix:nonFraction name="us-gaap:IncomeTaxesPaid" contextRef="From2024-07-01to2024-12-31" id="Fact001507" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,473</ix:nonFraction>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
$<span id="xdx_90A_eus-gaap--IncomeTaxesPaid_pn3n3_c20230701__20231231_zAD0LgjMfELh"><ix:nonFraction name="us-gaap:IncomeTaxesPaid" contextRef="From2023-07-012023-12-31" id="Fact001508" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">150</ix:nonFraction> </span></span><span style="font: normal 11pt Times New Roman, Times, Serif">for
income taxes, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">During
the six months ended December 31, 2024 and December 31, 2023, the Company obtained right-of-use and equipment assets in exchange for
lease obligations of $<span id="xdx_90F_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_pn3n3_c20240701__20241231_zAA4TmmE9Ai2"><ix:nonFraction name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="From2024-07-01to2024-12-31" id="Fact001509" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">359</ix:nonFraction>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
$<span id="xdx_905_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_pn3n3_c20230701__20231231_zss9pIctGUkh"><ix:nonFraction name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="From2023-07-012023-12-31" id="Fact001510" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,212</ix:nonFraction></span></span><span style="font: normal 11pt Times New Roman, Times, Serif">,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">During
the three months ended December 31, 2024, the Company sold a <span id="xdx_90F_ecustom--RateOfInterestSold_pip0_dp_c20241001__20241231_zykVZPaR72ja"><ix:nonFraction name="FONR:RateOfInterestSold" contextRef="From2024-10-012024-12-31" id="Fact001511" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.197</ix:nonFraction></span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
interest in HDM to an employee. The interest was sold for $<span id="xdx_90F_eus-gaap--ConversionOfStockAmountConverted1_pn3n3_c20241001__20241231_zXd3OI3qMCse"><ix:nonFraction name="us-gaap:ConversionOfStockAmountConverted1" contextRef="From2024-10-012024-12-31" id="Fact001512" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">132,000</ix:nonFraction>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">in a
noncash transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><p id="xdx_23F_zSqrwDKih6wh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 27 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_238_z2FQRzuNCM0j" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_ziOpStJe3JIa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zO6CCfzkHS62" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zyuI8nNa0qAa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">DECEMBER
31, 2024 and 2023</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zj28wJWscgYl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zxJl25iOblZd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zGXyXiFdPsG6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" escape="true" id="Fact001522" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_805_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z1jjQi59gbN" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif"><b>NOTE
10 &#8211; <span id="xdx_827_zw6Ixi3Dvh2a">COMMITMENTS AND CONTINGENCIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">Litigation</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">The
Company is subject to legal proceedings and claims arising from the ordinary course of its business, including personal injury, customer
contract and employment claims. In the opinion of management, the aggregate liability, if any, with respect to such actions, will not
have a material adverse effect on the consolidated financial position or results of operations of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">In
the ordinary course of its business, the Company is a party to various lawsuits arising from the operations at the MRI sites and other
insurance related matters, which are generally handled by the Company&#8217;s insurance carriers. Management believes, based in part
on the advice counsel, that the ultimate resolution of these matters will not have a material adverse effect on the Company&#8217;s consolidated
financial position, results of operations or cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">There
were no material changes in litigation from that reported in our Form 10-K for the fiscal year ended June 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">Other
Matters</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">On
September 13, 2022, the Company adopted a stock repurchase plan. The plan has no expiration date and cannot determine the number of shares
which will be repurchased. On September 26, 2022, the Board of Directors has approved up to $<span id="xdx_900_esrt--StockRepurchaseProgramAuthorizedAmount1_iI_pn3n3_c20220926__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_znooPvvtoGc4"><ix:nonFraction name="srt:StockRepurchaseProgramAuthorizedAmount1" contextRef="AsOf2022-09-26_srt_BoardOfDirectorsChairmanMember" id="Fact001523" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,000</ix:nonFraction>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">to be
repurchased under the plan which will be purchased on the publicly traded open market at prevailing prices. During the six months ended
December 31, 2024 and 2023, the Company repurchased <span id="xdx_901_eus-gaap--StockRepurchasedDuringPeriodShares_pn3n3_c20240701__20241231__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_z5rV5vwLrwta"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="From2024-07-012024-12-31_srt_BoardOfDirectorsChairmanMember" id="Fact001524" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">84</ix:nonFraction>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
<span id="xdx_90F_eus-gaap--StockRepurchasedDuringPeriodShares_pn3n3_c20230701__20231231__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zVkIBmmQBGIa"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="From2023-07-012023-12-31_srt_BoardOfDirectorsChairmanMember" id="Fact001525" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">116</ix:nonFraction>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">shares
at a cost of $<span id="xdx_906_eus-gaap--StockRepurchasedDuringPeriodValue_pn3n3_c20240701__20241231__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zVfH13ldLav3"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2024-07-012024-12-31_srt_BoardOfDirectorsChairmanMember" id="Fact001526" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,342</ix:nonFraction>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
$<span id="xdx_906_eus-gaap--StockRepurchasedDuringPeriodValue_pn3n3_c20230701__20231231__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zmHrbwh6Sgl5"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-07-012023-12-31_srt_BoardOfDirectorsChairmanMember" id="Fact001527" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,885</ix:nonFraction></span></span><span style="font: normal 11pt Times New Roman, Times, Serif">,
respectively. The Company cancelled <span id="xdx_909_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_pn3n3_c20240701__20241231__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zKfq3AxUgaF8"><ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" contextRef="From2024-07-012024-12-31_srt_BoardOfDirectorsChairmanMember" id="Fact001528" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">125</ix:nonFraction>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">shares
and <span id="xdx_90F_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_pn3n3_c20230701__20231231__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zlcU11vOy63i"><ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" contextRef="From2023-07-012023-12-31_srt_BoardOfDirectorsChairmanMember" id="Fact001529" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">123</ix:nonFraction>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">shares
at a cost of $<span id="xdx_907_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_pn3n3_c20240701__20241231__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_znxDloJMbJXh"><ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" contextRef="From2024-07-012024-12-31_srt_BoardOfDirectorsChairmanMember" id="Fact001530" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,963</ix:nonFraction>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
$<span id="xdx_908_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_pn3n3_c20230701__20231231__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zdVe54008bUc"><ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" contextRef="From2023-07-012023-12-31_srt_BoardOfDirectorsChairmanMember" id="Fact001531" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,005</ix:nonFraction>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">for
the six months ended December 31, 2024 and 2023, respectively. As of December 31, 2024 the remaining balance under the repurchase plan
was $<span id="xdx_907_eus-gaap--StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_iI_pn3n3_c20241231_zZkUsNBO7Fng"><ix:nonFraction name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" contextRef="AsOf2024-12-31" id="Fact001532" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,392</ix:nonFraction></span></span><span style="font: normal 11pt Times New Roman, Times, Serif">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">The
Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third-party insurer to limit the maximum
potential liability for individual claims to $<span id="xdx_90D_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpense_iI_pn3n3_c20241231_z0A4HrGwez5b"><ix:nonFraction name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" contextRef="AsOf2024-12-31" id="Fact001533" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">150</ix:nonFraction>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">per
person and for a maximum potential claim liability based on member enrollment. With respect to this program, the Company considers historical
and projected medical utilization data when estimating its health insurance program liability and related expense. As of December 31,
2024 and June 30, 2024, the Company had approximately $<span id="xdx_90B_eus-gaap--SelfInsuranceReserve_iI_pn3n3_c20241231_zBKROCOAQFS1"><ix:nonFraction name="us-gaap:SelfInsuranceReserve" contextRef="AsOf2024-12-31" id="Fact001534" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">168</ix:nonFraction>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
$<span id="xdx_906_eus-gaap--SelfInsuranceReserve_iI_pn3n3_c20240630_zHRNR6EF4VF1"><ix:nonFraction name="us-gaap:SelfInsuranceReserve" contextRef="AsOf2024-06-30" id="Fact001535" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">86</ix:nonFraction></span></span><span style="font: normal 11pt Times New Roman, Times, Serif">,
respectively, in reserve for its self-funded health insurance programs. The reserves are included in &#8220;Other current liabilities&#8221;
in the condensed consolidated balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">The
Company regularly analyzes its reserves for incurred but not reported claims, and for reported but not paid claims related to its reinsurance
and self-funded insurance programs. The Company believes its reserves are adequate. However, significant judgment is involved in assessing
these reserves such as assessing historical paid claims, average lags between the claims&#8217; incurred date, reported dates and paid
dates, and the frequency and severity of claims. There may be differences between actual settlement amounts and recorded reserves and
any resulting adjustments are included in expense once a probable amount is known. There were no significant adjustments recorded in
the periods covered by this report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><p id="xdx_238_zf9R331kf3vb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 28 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23C_zwK5avl774kd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zmJgkRsdG3qj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zK57zI2Skxb9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zQ0apjtoJZL8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">DECEMBER
31, 2024 and 2023</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zs5Q9R9Grbw3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_z5RXk5d5OfF9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_z1Apm7R3N0x8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" escape="true" id="Fact001545" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_802_eus-gaap--IncomeTaxDisclosureTextBlock_zIAvIM0KbBci" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif"><b>NOTE
11 - <span id="xdx_82A_zaGn0S1yZ4dd">INCOME TAXES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">In
accordance with ASC 740-270, &#8220;Income Taxes &#8211; Interim Reporting&#8221;, the Company is required at the end of each interim
period to determine the best estimate of its annual effective tax rate and apply that rate to year-to-date ordinary income or loss. The
resulting tax expense (or benefit) is adjusted for the tax effect of specific events, if any, required to be discretely recognized in
the interim period as they occur. For the six months ended December 31, 2024 and 2023, the Company recorded income tax expense of $<span id="xdx_901_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_pn3n3_c20240701__20241231_zm0zu1WccEGe"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" contextRef="From2024-07-01to2024-12-31" id="Fact001546" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,011</ix:nonFraction>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">in 2024
as compared to $<span id="xdx_909_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_pn3n3_c20230701__20231231_zEWptVzY14Ae"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" contextRef="From2023-07-012023-12-31" id="Fact001547" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,036</ix:nonFraction>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">in 2023.
For the three months ended December 31, 2024 and 2023, the Company recorded income tax expense of $<span id="xdx_90E_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_pn3n3_c20241001__20241231_zxnBt1dSQfog"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" contextRef="From2024-10-012024-12-31" id="Fact001548" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">762</ix:nonFraction>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
$<span id="xdx_90A_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_pn3n3_c20231001__20231231_zYxtQAbFfyIh"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" contextRef="From2023-10-012023-12-31" id="Fact001549" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,366</ix:nonFraction></span></span><span style="font: normal 11pt Times New Roman, Times, Serif">,
respectively. The six month and three month 2024 provision is comprised of a current income tax component of $<span id="xdx_905_eus-gaap--ExtinguishmentOfDebtGainLossNetOfTax_pn3n3_c20241001__20241231_zaArqZR5zmQ4"><ix:nonFraction name="us-gaap:ExtinguishmentOfDebtGainLossNetOfTax" contextRef="From2024-10-012024-12-31" id="Fact001550" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">900</ix:nonFraction>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
a deferred income tax component of $<span id="xdx_90E_ecustom--DeferredIncomeTaxComponent_pn3n3_c20241001__20241231_zlqWZzStf8Dd"><ix:nonFraction name="FONR:DeferredIncomeTaxComponent" contextRef="From2024-10-012024-12-31" id="Fact001551" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,111</ix:nonFraction>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
a current income tax component of $<span id="xdx_90C_eus-gaap--ExtinguishmentOfDebtGainLossNetOfTax_pn3n3_c20240701__20241231_zFQftXO4HOll"><ix:nonFraction name="us-gaap:ExtinguishmentOfDebtGainLossNetOfTax" contextRef="From2024-07-01to2024-12-31" id="Fact001552" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">517</ix:nonFraction>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
a deferred income tax component of $<span id="xdx_908_ecustom--DeferredIncomeTaxComponent_pn3n3_c20240701__20241231_zsgxYyBSjbm9"><ix:nonFraction name="FONR:DeferredIncomeTaxComponent" contextRef="From2024-07-01to2024-12-31" id="Fact001553" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">245</ix:nonFraction></span></span><span style="font: normal 11pt Times New Roman, Times, Serif">,
respectively. Obligations for any liability associated with the current income tax provision has been reduced, primarily resulting from
the benefits and utilization of net operating loss carryforwards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">ASC
Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax
positions taken or expected to be taken in a corporate tax return. For those benefits to be recognized, a tax position must be more-likely-than-not
to be sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return
and the benefit recognized and measured pursuant to the interpretation are referred to as unrecognized benefits. A liability is recognized
(or amount of net operating loss carryforward or amount of tax refundable is reduced) for an unrecognized tax benefit because it represents
an enterprise&#8217;s potential future obligation to the taxing authority for a tax position that was not recognized as a result of applying
the provisions of ASC Topic 740. The Company believes there are no uncertain tax positions in prior year tax filings and therefore it
has not recorded a liability for unrecognized tax benefits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">The
Company recorded a deferred tax asset of $<span id="xdx_90C_eus-gaap--DeferredTaxAssetsNet_iI_pn3n3_c20241231_zgNN64Zs867j"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2024-12-31" id="Fact001554" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,113</ix:nonFraction></span></span>
<span style="font: normal 11pt Times New Roman, Times, Serif">and a deferred tax
liability of $<span id="xdx_907_eus-gaap--DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_iI_pn3n3_c20241231_z9VPwcNEHSbl"><ix:nonFraction name="us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" contextRef="AsOf2024-12-31" id="Fact001555" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">371</ix:nonFraction>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">as of
December 31, 2024, primarily relating to allowance for credit losses and tax credits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">The
Company files corporate income tax returns in the United States (federal) and in various state and local jurisdictions. In most instances,
the Company is no longer subject to federal, state and local income tax examinations by tax authorities for years prior to 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Future
ownership changes as determined under Section 382 of the Internal Revenue Code could further limit the utilization of net operating loss
carryforwards. As of December 31, 2024, no such changes in ownership have occurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">The
Inflation Reduction Act (&#8220;IRA&#8221;) was enacted on August 16, 2022. The IRA includes provisions imposing a <span id="xdx_908_ecustom--PercentageOfExciseTax_pip0_dp_c20240701__20241231_zAm4uPdPzHfb"><ix:nonFraction name="FONR:PercentageOfExciseTax" contextRef="From2024-07-01to2024-12-31" id="Fact001556" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1</ix:nonFraction></span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
excise tax on share repurchases that occur after December 31, 2022 and introduces a <span id="xdx_904_ecustom--CorporateAlternativeMinimumTaxPercentage_pip0_dp_c20240701__20241231_zZVa5sJmk6Ci"><ix:nonFraction name="FONR:CorporateAlternativeMinimumTaxPercentage" contextRef="From2024-07-01to2024-12-31" id="Fact001557" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">15</ix:nonFraction></span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
corporate alternative minimum tax (&#8220;CAMT&#8221;) on adjusted financial statement of income. The CAMT will be effective for tax
years beginning after December 31, 2022. Currently, the IRA did not have a material impact to the Company&#8217;s financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><p id="xdx_237_zPrLMab625rb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 29 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23E_z2rkEDeLLAk6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_z2nvluIfrNn5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_z74BlaFGY1e6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zL1ClaGqdE1c" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">DECEMBER
31, 2024 and 2023</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zgkuFOjtnEr3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zQGyuXIVHfOc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zrRvkzaG4kZ5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" escape="true" id="Fact001567" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_802_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zo7LEpQgiQQj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"><b>NOTE
12 &#8211; <span id="xdx_82E_zSiHb1g03432">RELATED PARTY TRANSACTIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Tallahassee
Magnetic Resonance Imaging, Inc. Stand Up MRI of Boca Raton, PA and Stand Up MRI &amp; Diagnostic Center, Inc. (all related medical practices)
entered into a guaranty agreement, pursuant to which they cross guaranteed all management fees which are payable to the Company, which
have arisen under each individual management agreement. During the six months ended December 31, 2024 and 2023, the net revenues received
by the Company was $<span id="xdx_90F_ecustom--NetRevenues_pn3n3_c20240701__20241231_zErcmVKPf2tg"><ix:nonFraction name="FONR:NetRevenues" contextRef="From2024-07-01to2024-12-31" id="Fact001568" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,975</ix:nonFraction></span></span><span style="font: normal 11pt Times New Roman, Times, Serif">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Bensonhurst
MRI Limited Partnership (&#8220;Bensonhurst&#8221;), in which the CEO and President of the Company holds an interest, is party to an
agreement with the Company for the service and maintenance of its Upright MRI Scanner for a price of $<span id="xdx_905_ecustom--ServiceAndMaintenancePrice_iI_pn3n3_c20241231_zwDYaqwMms79"><ix:nonFraction name="FONR:ServiceAndMaintenancePrice" contextRef="AsOf2024-12-31" id="Fact001569" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">110,000</ix:nonFraction>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">per
annum. On February 1, 2024, Bensonhurst entered into a second contract with the Company for the service and maintenance of a High-Field
MRI Scanner for a price of $<span id="xdx_90B_ecustom--ServiceAndMaintenancePrice_iI_pn3n3_c20240201_zzT091ULAfB5"><ix:nonFraction name="FONR:ServiceAndMaintenancePrice" contextRef="AsOf2024-02-01" id="Fact001570" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">70,000</ix:nonFraction> </span></span><span style="font: normal 11pt Times New Roman, Times, Serif">per
annum. For the six months ended December 31, 2024 and 2023 the Company recorded service and repair fees of $<span id="xdx_907_ecustom--ServiceAndRepairFees_pn3n3_c20240701__20241231_zjlB78Fenfjb"><ix:nonFraction name="FONR:ServiceAndRepairFees" contextRef="From2024-07-01to2024-12-31" id="Fact001571" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">90</ix:nonFraction>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
$<span id="xdx_901_ecustom--ServiceAndRepairFees_pn3n3_c20230701__20231231_zGqFM62hfyCl"><ix:nonFraction name="FONR:ServiceAndRepairFees" contextRef="From2023-07-012023-12-31" id="Fact001572" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">55</ix:nonFraction></span></span><span style="font: normal 11pt Times New Roman, Times, Serif">,
respectively from Bensonhurst. Also during the three months ended December 31, 2024 and 2023 the Company recorded service and repair
fees of $<span id="xdx_90C_ecustom--ServiceAndRepairFees_pn3n3_c20241001__20241231_zJqoN3Rob3Gi"><ix:nonFraction name="FONR:ServiceAndRepairFees" contextRef="From2024-10-012024-12-31" id="Fact001573" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">45</ix:nonFraction></span></span> <span style="font: normal 11pt Times New Roman, Times, Serif">and
$<span id="xdx_90A_ecustom--ServiceAndRepairFees_pn3n3_c20231001__20231231_zwjbBAN0jRB3"><ix:nonFraction name="FONR:ServiceAndRepairFees" contextRef="From2023-10-012023-12-31" id="Fact001574" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28</ix:nonFraction></span></span><span style="font: normal 11pt Times New Roman, Times, Serif">,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Radian
Healthcare Management, LLC (&#8220;Radian&#8221;), which is owned by the son-in-law of the CEO and President of the Company provided
the Company with personnel recruitment of new employees at a fee of approximately $<span id="xdx_90E_ecustom--EmployeesFee_pn3n3_c20241001__20241231_zidyaf4biOXf"><ix:nonFraction name="FONR:EmployeesFee" contextRef="From2024-10-012024-12-31" id="Fact001575" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">68</ix:nonFraction>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
$<span id="xdx_90F_ecustom--EmployeesFee_pn3n3_c20231001__20231231_zqdyow07D3K"><ix:nonFraction name="FONR:EmployeesFee" contextRef="From2023-10-012023-12-31" id="Fact001576" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">0</ix:nonFraction> </span></span><span style="font: normal 11pt Times New Roman, Times, Serif">for
the six months ended December 31, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">On
December 31, 2023, the Company entered into an agreement with Magnetic Resonance Management, LLC (&#8220;MRM&#8221;) for the sale of
a MRI scanner. MRM is owned by the CEO and President of the Company. The sales price of the equipment was $<span id="xdx_907_eus-gaap--ConvertibleNotesPayable_iI_pn3n3_c20231231__us-gaap--TypeOfArrangementAxis__custom--MagneticResonanceManagementMember_zT6yk4qzBl04"><ix:nonFraction name="us-gaap:ConvertibleNotesPayable" contextRef="AsOf2023-12-31_custom_MagneticResonanceManagementMember" id="Fact001577" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">577</ix:nonFraction>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">which
is payable based upon a promissory note dated December 1, 2023. The note bears interest at a rate of <span id="xdx_90C_eus-gaap--DerivativeFixedInterestRate_iI_pip0_dp_c20231231__us-gaap--TypeOfArrangementAxis__custom--MagneticResonanceManagementMember_zujBx1q0ELBj"><ix:nonFraction name="us-gaap:DerivativeFixedInterestRate" contextRef="AsOf2023-12-31_custom_MagneticResonanceManagementMember" id="Fact001578" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">9</ix:nonFraction></span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
and is payable in full at the maturity of the note in December 2028. During the six months ending December 31, 2024 the Company recorded
$<span id="xdx_908_eus-gaap--InvestmentIncomeNet_pn3n3_c20240701__20241231__us-gaap--TypeOfArrangementAxis__custom--MagneticResonanceManagementMember_zWA4op3gh335"><ix:nonFraction name="us-gaap:InvestmentIncomeNet" contextRef="From2024-07-012024-12-31_custom_MagneticResonanceManagementMember" id="Fact001579" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26</ix:nonFraction>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">in investment
income on this promissory note. Also during the three months ending December 31, 2024, the Company recorded $<span id="xdx_908_eus-gaap--InvestmentIncomeNet_pn3n3_c20241001__20241231__us-gaap--TypeOfArrangementAxis__custom--MagneticResonanceManagementMember_z6Pg8Kzv6k31"><ix:nonFraction name="us-gaap:InvestmentIncomeNet" contextRef="From2024-10-012024-12-31_custom_MagneticResonanceManagementMember" id="Fact001580" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13</ix:nonFraction>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">in investment
income on this promissory note. The MRI scanner had zero basis, which resulted in a gain of $<span id="xdx_907_eus-gaap--DeferredGainOnSaleOfProperty_iI_pn3n3_c20240630__us-gaap--TypeOfArrangementAxis__custom--MagneticResonanceManagementMember_zpUuRMy9QPfb"><ix:nonFraction name="us-gaap:DeferredGainOnSaleOfProperty" contextRef="AsOf2024-06-30_custom_MagneticResonanceManagementMember" id="Fact001581" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">577</ix:nonFraction></span></span><span style="font: normal 11pt Times New Roman, Times, Serif">,
which was recorded during the year ended June 30, 2024. The Company has the option but not the obligation to re-take possession of the
scanner in lieu of payment upon maturity of the note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" escape="true" id="Fact001583" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_800_eus-gaap--SubsequentEventsTextBlock_zfPruQxUqIX2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"><b>NOTE
13 &#8211; <span id="xdx_82D_z7iW2NUdCF1">SUBSEQUENT EVENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">The
Company has evaluated events that occurred subsequent to December 31, 2024 and through the date the condensed consolidated financial
statements were issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">In
the subsequent period up to the date of filing, the Company repurchased <span id="xdx_905_ecustom--StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchaseds_iI_pn3n3_c20241231_zJPtizoyNA9b"><ix:nonFraction name="FONR:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchaseds" contextRef="AsOf2024-12-31" id="Fact001584" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">7</ix:nonFraction>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">shares
of common stock at a cost of $<span id="xdx_900_ecustom--StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount_iI_pn3n3_c20241231_zO0ilU4ztNwb"><ix:nonFraction name="FONR:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount" contextRef="AsOf2024-12-31" id="Fact001585" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">108</ix:nonFraction>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">which
was authorized under the stock repurchase plan adopted in September 2022.</span></p>

</ix:nonNumeric><p id="xdx_810_zEfj9Zz1VfM8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 30 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"><span id="MDA"></span>Item
2. &#8211; MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">The
following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited
condensed consolidated financial statements and notes thereto included in Part I, item 1 of the Quarterly Report on Form 10-Q and with
our audited consolidated financial statements and notes thereto for the year ended June 30, 2024 included in our Annual Report on Form
10-K for the fiscal year ended June 30, 2024 filed with the U.S. Securities and Exchange Commission (SEC) on September 27, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Forward
Looking Statements</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Certain
statements made in this Quarterly Report on Form 10-Q are &#8220;forward-looking statements&#8221; (within the meaning of the Private
Securities Litigation Reform Act of 1995) regarding the plans and objectives of management for future operations. These statements involve
known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially
different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking
statements are based on current expectations that involve numerous risks and uncertainties. Our plans and objectives are based, in part,
on assumptions involving the expansion of business. These assumptions involve judgments with respect to future economic, competitive
and market conditions and future business decisions, all of which are difficult or impossible to predict accurately. Many of these assumptions
involve factors which are beyond our control. Although we believe that our assumptions underlying these forward-looking statements are
reasonable, any of the assumptions could prove inaccurate. Therefore, there can be no assurance that the forward-looking statements included
in this Quarterly Report will be accurate. In light of the significant uncertainties inherent in these forward-looking statements, the
inclusion of such information should not be considered a representation by us or any other person that our objectives will be achieved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">For
the six-month period ended December 31, 2024, we reported a net income of $6.3 million on revenues of $50 million as compared to net
income of $10.0 million on revenues of $51.2 million for the six-month period ended December 31, 2023. Operating income decreased from
$11.5 million for the six-month period ended December 31, 2023 to $7.1 million for the six month period ended December 31, 2024. We have
taken a significant reserve against accounts receivable that are attributable to American Transit Insurance Company, a New York based
motor vehicle insurer who has recently indicated that they are approaching insolvency. We are monitoring the situation for new developments.
We may need to take additional reserves in the future if this carrier is placed into receivership by the New York Department of Financial
Services. Revenues from product sales and service and repair fees increased from $3.9 million for the first six months of fiscal 2024
as compared to $4.0 million for the first six months of fiscal 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">For
the-three month period ending December 31, 2024, we reported a net income of $2.3 million on revenues of $25.0 million as compared to
net income of $4.6 million on revenues of $25.4 million for the three-month period ended December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">The
revenue decrease, from $51.2 million for the first six months of fiscal 2024 to $50.0 million for the first six months of fiscal 2025,
was primarily due to decreases in patient fee revenue of $1.5 million, from $16.9 million for the first six months of fiscal 2024 to
$15.4 million for the first six months of fiscal 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></p>

<!-- Field: Page; Sequence: 31 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 40pt; margin-top: 0; margin-bottom: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">The
revenue decrease from $25.4 million for the three-month period ended December 31, 2023 to $25.0 million for the three-month period ended
December 31, 2024, was primarily due to decreases in patient revenue of $300, from $8.2 million for the three-month period ended December
31, 2023 to $7.9 million for the three-month period ended December 31, 2024. Revenues from product sales and service and repair fees
decreased slightly from $1.9 million for the three-month period ended December 31, 2023 to $1.8 million for the three-month period ended
December 31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">During
the first half of fiscal 2025, the aggregate number of scans performed by the sites we own decreased to 26,961 scans from 28,214 scans
in the first half of fiscal 2024. This decrease was due to increase competition in certain areas along with hurricane related closures.
During the first half of fiscal 2025, the aggregate number of scans performed by the sites we manage increased to 79,207 scans from 73,776
scans in the first half of fiscal 2024. This increase was due to improvements in our information technology systems, increased shift
coverage, and increased capacity from our recent equipment expansions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">The
combination of our revenues decreasing along with our costs and expenses increasing caused our operating income to decrease to $7.0 million
for the six months ended December 31, 2024 as compared to $11.5 million for the six months ended December 31, 2023. In terms of percentages,
costs and expenses increased 7.5% to $42.8 million for the first six months of fiscal 2025 as compared to $39.8 million for the first
six months of fiscal 2024, while revenues decreased 2.6% to $50.0 million for the first six months of fiscal 2025 as compared to $51.2
million for the first six months of fiscal 2024. The decrease in revenue can be attributable to a decrease in patient fee revenues of
$1.5 million from the six-month period ending December 31, 2024 as compared to $16.9 million from the six-month period ending December
31, 2023. The increase in costs and expenses can be attributable to additional reserves of $923 which was mainly due to increase reserves
for the outstanding balance of American Transit Insurance along a new outside billing for the collection of our commercial insurance
which commenced on January 1, 2024. The costs of the new billing contract in the six-month period ended was $421.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;The
combination of our revenues decreasing along with our costs and expenses increasing caused our operating income to decrease to $2.6 million
for the three-month period ended December 31, 2024 as compared to $4.9 million for the three months ended December 31, 2023. In terms
of percentages, costs and expenses increased 9.3% to $22.4 million for the three months ended December 31, 2024 as compared to $20.5
million for the three months ended December 31, 2023, while revenues decreased 1.7% to $25.0 million for the three months end December
31, 2024 as compared to $25.4 million for the three months ended December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR&#8217;s
wholly-owned subsidiary, Health Management Corporation of America (&#8220;HMCA&#8221;), has the controlling interest in Health Diagnostics
Management, LLC (&#8220;HDM&#8221;). HMCA presently has a direct ownership interest of 70.6% in HDM, and the investors in HDM have a
29.4% ownership interest. During the quarter ended December 31, 2024, the Company sold non-controlling interests to a minority shareholder
for $132,000. The management of the diagnostic imaging centers business segment is being conducted by HDM, operating under the name &#8220;Health
Management Company of America&#8221;. For the sake of simplicity, HMCA, and HDM are referred to as &#8220;HMCA&#8221;, unless otherwise
indicated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Critical
Accounting Estimates</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">There
have been no material changes in our Critical Accounting Estimates from the information provided in the &#8220;Critical Accounting Estimates&#8221;
section of &#8220;Item 7 &#8211; Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in
our Annual Report on Form 10-K for the fiscal year ended June 30, 2024.<br/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></p>

<!-- Field: Page; Sequence: 32 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Results
                                            of Operations</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">We
operate in two industry segments: the manufacture and servicing of medical (MRI) equipment, which is conducted by FONAR and diagnostic
facilities management services, which is conducted through HMCA.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Consolidated</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">For
the first six months of fiscal 2025, our consolidated net revenues decreased by 2.6% to $50.0 million from $51.2 million for the first
six months of fiscal 2024, and total costs and expenses increased by 7.8% to $42.9 million from the first six months of fiscal 2025 as
compared to $39.8 million for the first six months of fiscal 2024, respectively. As a result, our operating income decreased to $7.0
million in the first six months of fiscal 2025 as compared to $11.5 million in the first six months of fiscal 2024. A decrease in selling,
general and other administrative costs in particular resulted in cost and expenses increase at a much lower percentage as compared to
the increase in net revenues.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Selling,
general and administrative expenses increased to $12.1 million in the first six months of fiscal 2025 from $10.5 million in the first
three months of fiscal 2024. This increase in selling, general and administrative expenses was due to additional reserves taken in the
current period of $923 mainly for the uncertainty of the collection of American Transit Insurance coupled with the new outside billing
contract that accounts for $421.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Research
and development expenses decreased by 22.7% to $683,000 for the first six months of fiscal 2025 from $883,000 for the first six months
of fiscal 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Interest
expense in the first six months of fiscal 2025 decreased by 63.2% to $14,000 from $38,000 in the first six months of fiscal 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">The
results of operations for the first six months of fiscal 2025 reflect a decrease in revenues from management, patient and other fees,
as compared to the first six months of fiscal 2024 ($45.9 million for the first six months of fiscal 2025 as compared to $47.3 million
for the first six months of fiscal 2024), coupled with an increase in the total cost and expenses ($42.9 million for the first six months
of fiscal 2025 as compared to $39.8 million for the first six months of fiscal 2024). Revenues were 8.0% from the MRI equipment segment
and 92.0% from HMCA, for the first six months of fiscal 2025, as compared to 7.6% from the MRI equipment segment and 92.4% from HMCA
for the first six months of fiscal 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">We
are committed to improving our operating results and dealing with the challenges posed by legislative and regulatory requirements. Nevertheless,
factors beyond our control, such as the timing and rate of market growth, economic conditions, the availability of credit and payor reimbursement
rates, or unexpected expenditures and the timing of such expenditures, make it difficult to forecast future operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Medicare
reimbursement rates for MRI scans continue to see year over year reductions. This also results in a reduction in the reimbursement rates
by commercial insurers and government programs which tie their reimbursement rates to the Medicare rates. The patient volume of the scanning
centers we manage or own has enabled us to maintain healthy operating results in spite of these reductions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></p>

<!-- Field: Page; Sequence: 33 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Our
                                            Upright&#174; MRI (also referred to as the Stand-Up&#174; MRI), together with our works-in-progress,
                                            are intended to significantly improve our competitive position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">The
Upright&#174; MRI scanner, which operates at 6000 gauss (.6 Tesla) field strength, allows patients to be scanned while standing, sitting,
reclining and in multiple flexion and extension positions. It is common in visualizing the spine that abnormalities are visualized in
some positions and not others. This enables surgical corrections that heretofore would not have been addressable for lack of visualizing
the symptom causing the pathology and therefore, in general enables the treating physician to achieve a better outcome for his patient.
A floor-recessed elevator brings the patient to the height appropriate for the targeted image region. A custom-built multi-position adjustable
bed will allow patients to sit or lie on their backs, sides or stomachs at any angle. This allows the MRI technologist to ask the patient
to position himself/herself in the exact position that generates pain so that images of the patient in the position that explicitly generates
the patient&#8217;s pain can be nailed down. Full-range-of-motion studies of the joints in virtually any direction are possible, a particularly
promising feature for sports injuries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">Medical
Equipment - Manufacturing and Service of MRI Equipment</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Revenues
from MRI product sales decreased to $145,000 for the first six months of fiscal 2025 from $219,000 for the first six months of fiscal
2024. Costs related to product sales increased from $405,000 for the six month period ended December 31, 2023 to $442,000 for the six
month period ended December 31, 2024 Revenues from MRI product sales decreased to $25 for the three months ending December 31, 2024 from
$55 for the three months ending December 31, 2023. Costs related to product sales decreased from $302 for the three months ending December
31, 2023 as compared to $221 for the three months ended December 31, 2024, Economic uncertainty and lower reimbursement rates for MRI
scans, have depressed the market for our MRI scanner products, notwithstanding our scanners&#8217; unique technological capabilities
(e.g., multi-positional scanning). Due to the low sales volumes of our MRI product, period to period comparisons are not necessarily
indicative of any trends.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Service
revenues increased to $3.8 million for the six-month period ended December 31, 2024 from $3.7 million for the six-month period ended
December 31, 2023. Service revenues remained constant at $1.8 million for the three month periods ending December 31, 2024 and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Costs
relating to providing service were $2.1 million in the first six months of fiscal 2025 as compared to $1.7 million in the first six months
of fiscal 2024. Costs relating to providing service were $1.1 million for the three month period ended December 31, 2024 as compared
to $796 for the three months ended December 31, 2023. The increase is attributable to spending on our subsidiary dedicated to the maintenance
and repair of non-FONAR MRI equipment, and various costs related to the marketing and distribution of SwiftMR&#8482; software. Because
of our ability to monitor the performance of customers&#8217; scanners from our facilities in Melville, New York on a daily basis and
to detect and repair any irregularities before more serious and costly problems develop, we have been able to contain our costs of providing
service.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">There
were approximately $314,000 in foreign revenues for the first six months of fiscal 2025 as compared to $263,000 for the first six months
of fiscal 2024. We do not regard this as a material trend, but as part of a normal although sometimes volatile variation resulting from
low volumes of foreign sales.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></p>

<!-- Field: Page; Sequence: 34 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Revenues
for the medical equipment segment increased to $4.0 million for the first six months of fiscal 2025 from $3.9 million for the first six
months of fiscal 2024. Operating losses for our medical equipment segment increased to an operating loss of $2.3 million, for the first
six months of fiscal 2025 as compared to an operating loss of $1.7 million for the first six months of fiscal 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Revenues
for the medical equipment segment decreased to $1.8 million for the three months ending December 31, 2024 from $1.9 million for the three
months ending December 31, 2023. Operating losses for our medical equipment segment increased to an operating loss of $1.3 million, for
the three months ending December 31, 2024 as compared to an operating loss of $993 for the three months ending December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Management
of Diagnostic Imaging Centers</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">HMCA
revenues decreased in the first six months of fiscal 2025 by 2.9% to $45.9 million from $47.3 million for the first six months of fiscal
2024. The percentage of our revenues derived from our diagnostic facilities management segment relative to the percentage of our total
revenues decreased slightly to 92.0% for the first three months of fiscal 2025, from 92.4% for the first three months of fiscal 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">HMCA
revenues decreased in the three months ending December 31, 2024 by 1.8% to $23.1 million from $23.5 million for the three months ending
December 31, 2023. The percentage of our revenues derived from our diagnostic facilities management segment relative to the percentage
of our total revenues remained constant to 92.7% for the three months ending December 31, 2024 and 2023.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">We
completed the installation of a new scanner in the Naples, Florida location at the end of the first quarter of fiscal 2025. We now manage
or own a total of 43 MRI scanners. Twenty-five (25) MRI scanners are located in New York and eighteen (18) are located in Florida. HMCA
experienced an operating income of $9.5 million for the first six months of fiscal 2025 compared to operating income of $13.2 million
for the first six months of fiscal 2024. The decrease in operating revenue is a combination of increased expenses and reduced patient
fee revenue at the HMCA-owned Florida sites. Expenses increased in the form of staffing costs, equipment repair costs, and helium replacement
costs. Although scan volume was up in the aggregate, a decrease in patient fee revenue at the HMCA-owned Florida sites also contributed
to the reduction on operating income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">The
ability of HMCA to maintain its profitability is principally due to HMCA&#8217;s success in marketing the scanning services of the facilities
managed or owned by HMCA, notwithstanding the decrease in reimbursement rates paid for MRI scans by insurers, Medicare and other government
programs. The reductions in reimbursement rates are not unique to HMCA or HMCA&#8217;s clients but are being experienced by the industry
in general.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">HMCA&#8217;s
cost of revenues for the first six months of fiscal 2025 increased to $27.6 million as compared to $26.4 million for the first six months
of fiscal 2024. HMCA&#8217;s cost of revenues for the three months ending December 31, 2024 increased to $14.0 million from $13.4 million
for the three months ending December 31, 2023. This increase is the result of increased expenses from scanning volume at our HMCA-managed
sites, where revenues are fixed pursuant to the management agreements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></p>

<!-- Field: Page; Sequence: 35 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">Liquidity
and Capital Resources</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Cash
and cash equivalents, and short term investments decreased from $56.5 million at June 30, 2024 to $53.7 million at December 31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Cash
provided by operating activities for the first six months of fiscal 2025 was $3.9 million. Cash provided by operating activities was
attributable principally to net income of $6.2 million, adjusted for depreciation and amortization of $2.3 million, provision for credit
losses of $1.3 million, and deferred income tax of $1.1 million, offset primarily by an increase in accounts, management fee receivables
and medical receivables of $435,000, and a decrease in other current liabilities of $4.6 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 34.05pt; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Cash
used in investing activities for the first six months of fiscal 2025 was $2.6 million. Cash used in investing activities during the first
six months of fiscal 2025 consisted of patent costs of $20,000, the purchase of property and equipment of $2.6 million, offset set by
proceeds from short-term investments of $15,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Cash
used in financing activities for the first six months of fiscal 2025 was $4.1 million. The principal uses of cash in financing activities
during the first six months of fiscal 2025 were the repayment of principal on long-term debt and capital lease obligations of $58,000,
the purchase of treasury stock of $1.3 million, distributions to non-controlling interests of $2.8 million offset by the sale of non-controlling
interest of $132,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Total
liabilities decreased by 14.7% to $49.0 million at December 31, 2024 from $57.5 million at June 30, 2024. &#8220;Other&#8221; current
liabilities decreased by 50.7% to $3.9 million at December 31, 2024 from $7.9 million at June 30, 2024. The current portion of our service
contract liabilities decreased by 10.4% to $3.5 million at December 31, 2024 as compared to $3.9 million at June 30, 2024. The long-term
portion of operating lease liability decreased from $37.5 million at June 30, 2024 to $34.9 million at December 31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">As
of December 31, 2024, the total of $3.9 million in &#8220;other&#8221; current liabilities included accrued salaries and payroll taxes
of $1.5 million, sales taxes payable of $183,000, software license of $252,000 and other general and administrative expenses of $1.7
million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Our
working capital increased to $125.4 million at December 31, 2024 from $122.5 million at June 30, 2024. This resulted from a decrease
in current assets ($140.3 million at June 30, 2024 as compared to $137.6million at December 31, 2024), and a decrease in current liabilities
from $17.9 million at June 30, 2024 to $12.2 million at December 31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">The
ultimate realization of deferred tax assets is dependent on the generation of future taxable income during the periods in which those
temporary differences become deductible or when such net operating losses can be utilized. The Company considers projected future taxable
income, the regulatory environment of the industry, and tax planning strategies in making this assessment. At the present, the Company
believes that it is more likely than not that the benefits from certain deferred tax asset carryforwards, will not all be fully realized.
In recognition of this inherent risk, a valuation allowance was established for separate state net operating losses that are not expected
to be fully utilized. A valuation allowance will be maintained until sufficient positive evidence exists to support the reversal of any
portion or all of the valuation allowance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></p>

<!-- Field: Page; Sequence: 36 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">The
                                            Company&#8217;s effective income tax rate is based on expected income, statutory rates and
                                            tax planning opportunities available in the various jurisdictions in which it operates. For
                                            interim financial reporting, the Company estimates the annual income tax rate based on projected
                                            taxable income for the full year and records a quarterly income tax provision or benefit
                                            in accordance with the anticipated annual rate. The Company refines the estimates of the
                                            year&#8217;s taxable income on a periodic basis as new information becomes available, including
                                            actual year-to-date financial results. This continual estimation process often results in
                                            a change to the expected effective income tax rate for the year. When this occurs, the Company
                                            adjusts the income tax provision during the quarter in which the change in estimate occurs
                                            so that the year-to-date provision reflects the expected income tax rate. Significant judgment
                                            is required in determining the effective tax rate and in evaluating tax positions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
is committed to making the following significant capital expenditures for the remainder of the 2025 fiscal year. The Company is in the
process of placing an additional scanner in a current location in New York and anticipates it to be completed by the fourth quarter of
fiscal 2025. The estimated costs to complete this project have been estimated to be $2.0 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Critical
to our business plan are the improvement and expansion of the MRI facilities managed or owned by HMCA, and increasing the number of scans
performed at those facilities. In addition, our business plan calls for a continuing commitment to providing our customers with enhanced
equipment service and maintenance capabilities and delivering state-of-the-art, innovative and high quality equipment and upgrades at
competitive prices.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
entered into an agreement with AIRS Medical to install its SwiftMR&#8482; product on all FONAR Upright&#174; scanners operating at the
facilities HMCA owns or manages. FONAR will also make the AIRS SwiftMR&#8482; product available to the installed base of FONAR scanners
operating in the United States. Management believes this product improves the quality of the images produced by FONAR equipment, and
provides operational efficiencies that result in additional scan volume in the scanners operated by HMCA facilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Management
is seeking to promote wider market recognition of FONAR&#8217;s scanner products, and to increase demand for Upright&#174; scanning at
the facilities HMCA owns or manages. Given the liquidity and credit constraints in the markets, and the high level of competition in
the marketplace, the sale of medical equipment has and may continue to suffer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">The
Company believes that its business plan has been responsible for its profitability in the past ten consecutive fiscal years and first
six months of fiscal 2025, and that its capital resources will be adequate to support operations through a year from the date of filing.
The future effects on our business of healthcare legislation, the 2.3% excise tax on sales of medical equipment, reimbursement rates,
public health conditions and the general economic and business climate are not known at the present time. Nevertheless, there is a possibility
of adverse consequences to our business operations from these causes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"><span id="QualitativeDisclosures"></span>Item
3. Quantitative and Qualitative Disclosures About Market Risk</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">The
Company maintains its funds in liquid accounts. None of our investments are in fixed rate instruments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">All
of our revenue, expense and capital purchasing activities are transacted in United States dollars.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></p>

<!-- Field: Page; Sequence: 37 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"><span id="ControlsAndProcedures"></span>Item
                                            4. Controls and Procedures</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Disclosure
Controls and Procedures</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">We
carried out an evaluation as of the end of the period covered by this Quarterly Report on Form 10-Q, under the supervision and with the
participation of our management, including our chief executive officer and chief financial officer, of the effectiveness of the design
and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act
of 1934, as amended (the &#8216;&#8216;Exchange Act&#8217;&#8217;). Disclosure controls and procedures include, without limitation, controls
and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under
the Exchange Act is accumulated and communicated to the issuer&#8217;s management, including its principal executive and principal financial
officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Based upon
our evaluation, our chief executive officer and chief financial officer have concluded that the Company&#8217;s disclosure controls and
procedures were effective as of September 30, 2024, in ensuring that material information that we are required to disclose in reports
that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the same time periods specified
in the Securities and Exchange Commission rules and forms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Changes
in Internal Control over Financial Reporting</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">There
were no changes in our system of internal control over financial reporting during our most recently completed fiscal quarter that have
materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"><span id="RiskFactors"></span><span id="LegalProceedings"></span><span id="PartII"></span>PART
II &#8211; OTHER INFORMATION</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Item
    1 &#8211; Legal Proceedings: There were no material changes in litigation from that reported in our Form 10-K for the fiscal year
    ended June 30, 2024. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Item
1A &#8211; Risk Factors: An investment in the securities of the Company is subject to various risks, the most significant of which are
summarized below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">1.
Reduced Reimbursement Rates. Most of our revenues are derived from our scanning center business conducted by HMCA. Our scanning center
clients and the Florida facilities owned by HMCA are experiencing lower reimbursement rates from Medicare, other government programs
and private insurance companies. To the extent possible, we counter these reductions by increasing scanning volume and controlling operating
expenses. Inflation in the cost of both materials and labor have limited our ability to control our costs, negatively impacting our ability
to maintain profitability in this business segment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">2.
Inflation. Inflation has drastically increased our costs for both materials and labor. Diagnostic imaging facilities require significant
amounts of capital to operate, particularly in the context of opening new diagnostic imaging centers. These increased costs make it more
difficult to achieve organic growth and extend the time that a new center takes to achieve profitability. Continued costs increases,
coupled with reduced reimbursement rates may threaten the profitability of our current operations and cause the cost of expansion to
become prohibitively high.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 38 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">3.
                                            Cybersecurity threats. The healthcare industry has increasingly become a target for threat
                                            actors. Our organization relies on information technology systems and computer networks to
                                            operate. Our partners, vendors, and business associates are equally reliant on their own
                                            computer systems to provide the services that we depend on to perform core functions. Data
                                            incidents in the form of breaches, ransomware attacks, denial-of-service attacks, and a variety
                                            of other hazards could materially disrupt our operations, or the operations of our partners.
                                            In addition, the costs to respond to such incidents related to rebuilding internal systems,
                                            restoring data, responding to regulatory investigations and/or litigation could be significant.
                                            Our cybersecurity liability insurance may be inadequate to cover these losses. The cost of
                                            maintaining and improving our security technologies to protect ourselves from these threats
                                            is increasing. Risks outside of our control, such as cybersecurity attacks to our partners,
                                            vendors and business associates could threaten our ability to operate in the short term and
                                            reduce operating margins.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">4.
Dependence on Referrals. HMCA derives substantially all of its revenue, directly or indirectly, from fees charged for the diagnostic
imaging services performed at the facilities. We depend on referrals of patients from unaffiliated physicians and other third parties
to the facilities we manage or own for the services we perform. If these physicians and other third parties were to reduce the number
of patients they refer or discontinue referring patients, scan volumes could decrease, which would reduce our net revenue and operating
margins.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">5.
Pressure to Control Healthcare Costs. One of the principal objectives of health maintenance organizations and preferred provider organizations
is to control the cost of healthcare services. Healthcare providers participating in managed care plans may be required to refer diagnostic
imaging tests to certain providers depending on the plan in which a covered patient is enrolled. In addition, managed care contracting
has become very competitive. The expansion of health maintenance organizations, preferred provider organizations and other managed care
organizations in New York or Florida could have a negative impact on the utilization and pricing of services performed at the facilities
HMCA manages or owns to the extent these organizations exert control over patients&#8217; access to diagnostic imaging services, selections
of the provider of such services and reimbursement rates for those services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">6.
Scanning Facility Competition. The market for diagnostic imaging services is highly competitive. The facilities we manage or own compete
for patients on the basis of reputation, location and the quality of diagnostic imaging services. Groups of radiologists, established
hospitals, clinics and other independent organizations that own and operate imaging equipment are the principal competitors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">7.
Eligibility Changes to Insurance Programs. Due to potential decreased availability of healthcare through private employers, the number
of patients who are uninsured or participate in governmental programs may increase. Healthcare reform legislation will continue to increase
the participation of individuals in the Medicaid program in states that elect to participate in the expanded Medicaid coverage. A shift
in payor mix from managed care and other private payors to government payors or an increase in the number of uninsured patients may result
in a reduction in the rates of reimbursement or an increase in uncollectible receivables or uncompensated care, with a corresponding
decrease in net revenue. Policies now being offered under various insurance plans are expected to reduce demand for MRI scans as they
become less affordable. Changes in the eligibility requirements for governmental programs such as the Medicaid program and state decisions
on whether to participate in the expansion of such programs also could increase the number of patients who participate in such programs
and the number of uninsured patients. Even for those patients who remain in private insurance plans, changes to those plans could increase
patient financial responsibility, resulting in a greater risk of uncollectible receivables. These factors and events could have a material
adverse effect on our business, financial condition, and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 39 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">8.
                                            Federal and state privacy and information security laws. We must comply with numerous federal
                                            and state laws and regulations governing the collection, dissemination, access, use, security
                                            and privacy of PHI, including HIPAA and its implementing privacy and security regulations,
                                            as amended by the federal HITECH Act. If we fail to comply with applicable privacy and security
                                            laws, regulations and standards, properly maintain the integrity of our data, or protect
                                            our proprietary rights to our systems, our business, reputation, results of operations, financial
                                            position and cash flows could be materially and adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">9.
Current and future changes in Florida Insurance Law. On March 24, 2023, Florida enacted House Bill 837. Dubbed the Tort Reform Act, the
bill made sweeping changes to Florida&#8217;s negligence laws that negatively impact our Florida diagnostic imaging facilities (both
those we own and those we manage) with more unpaid bills, higher administrative costs, and lower reimbursement rates. The full extent
of those reductions are unclear at this time. Florida legislators continue to propose significant changes to the current structure of
Florida&#8217;s insurance industry, which may impact our future operations in Florida.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">10.
Demand for MRI Scanners. The reduced reimbursement rates have a negative effect on our sales of MRI scanners. With lower revenue projections,
prospective customers would demand lower prices for scanners. Although the reduced reimbursements may not affect foreign demand, a lower
number of sales in the aggregate could reduce economies of scale and consequently, profit margins.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">11.
Manufacturing Competition. Many if not most of our competing scanner manufacturers have significantly greater financial resources, production
capacity, and other resources than we do. Such competitors would include General Electric, Siemens, Hitachi and Phillips. Although FONAR
is the only company which can manufacture and sell the unique Stand-Up&#174; (Upright&#174;) MRI scanner, potential customers must be
convinced that the purchase of a FONAR scanner is their best choice. We believe that with time, that objective will be reached, particularly
with customers scanning patients having neck, back, knee and various orthopedic issues who would benefit from being scanned in weight-bearing
positions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">12.
Other changes in Domestic and Worldwide Economic Conditions. We are subject to risk arising from adverse changes in general domestic
and global economic and other conditions, including recessions or economic slowdowns, disruptions of credit markets and military conflicts.
Turbulence and uncertainty in the United States and international markets and economies may adversely affect our workforce, liquidity,
financial condition, revenues, profitability and business operations generally.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"><span id="UseOfProceeds"></span>Item
2 &#8211; Unregistered Sales of Equity Securities and Use of Proceeds: None</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: normal 11pt Times New Roman, Times, Serif; background-color: white">In
September 2022, our Board of Directors authorized a program to repurchase up to $9 million of our common stock. Under this program, we
may purchase stock in the open market or through privately negotiated transactions in accordance with applicable securities laws, including
pursuant to pre-arranged stock trading plans. The timing and actual amount of the stock repurchases will depend on several factors including
price, capital availability, regulatory requirements, and other market conditions. We are not obligated to repurchase a specific number
of shares under this program and it may be modified, suspended or discontinued at any time. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 40 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 36pt"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: normal 11pt Times New Roman, Times, Serif">The
                                            following table summarizes the number of shares repurchased during the three months ended
                                            December 31, 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Fiscal
    Month</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">Total</span></p>
                                                                               <p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">Number of Shares Purchased</span></p></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Average
    Price Paid per Share</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Total
    Number of Shares Purchased as Part of Publicly Announced Programs</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Maximum
    Dollar Value that May Still Be Purchased Under the Program (In Thousands)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding: 0pt 0pt 0pt 10pt; text-indent: 10pt; width: 26%; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">October
                                            1, 2024 &#8211; October 31, 2024</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 13%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">32,217</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 13%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">15.62</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 13%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">32,217</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 13%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">3,815</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding: 0pt 0pt 0pt 10pt; text-indent: 10pt; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">November
                                            1, 2024 &#8211; November 30, 2024</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">27,498</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">15.39</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">27,498</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">3,392</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding: 0pt 0pt 0pt 10pt; text-indent: 10pt; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">December
                                            1, 2024 &#8211; December 31, 2024</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">0</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">0.00</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">0</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">3,392</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding: 0pt 0pt 0pt 10pt; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Total</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">59,715</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">15.52</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">59,715</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"><span id="Defaults"></span>Item
3 - Defaults Upon Senior Securities: None</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"><span id="MineSafety"></span>Item
4 - Mine Safety Disclosure: Not Applicable</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"><span id="MoreInformation"></span>Item
5 - Other Information</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Rule
10b5-1 Trading Plan</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">During
the fiscal quarter ended December 31, 2024, none of our directors or executive officers <span id="xdx_904_eecd--Rule10b51ArrAdoptedFlag_dbF_c20240701__20241231_zBJ28FHFiTaa"><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" format="ixt:booleanfalse" id="Fact001586" name="ecd:Rule10b51ArrAdoptedFlag">adopted</ix:nonNumeric>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">or <span id="xdx_909_eecd--Rule10b51ArrTrmntdFlag_dbF_c20240701__20241231_zLaGYytQGdgh"><ix:nonNumeric contextRef="From2024-07-01to2024-12-31" format="ixt:booleanfalse" id="Fact001587" name="ecd:Rule10b51ArrTrmntdFlag">terminated</ix:nonNumeric>
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">any
contract, instruction or written plan for the purchase or sale of Company securities that was intended to satisfy the affirmative defense
conditions of Rule 10b5-1(c) or any &#8220;non-Rule 10b5-1 trading arrangement&#8221;.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"><span id="Exhibits"></span>Item
6 - Exhibits and Reports on Form 8-K:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font: normal 11pt Times New Roman, Times, Serif">a)</span></td>
    <td style="white-space: nowrap; width: 89%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font: normal 11pt Times New Roman, Times, Serif"><a href="fonar_exhibit-31.htm">Exhibit
    31.1 Certification. See Exhibits</a></span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font: normal 11pt Times New Roman, Times, Serif">b)</span></td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font: normal 11pt Times New Roman, Times, Serif"><a href="fonar_exhibit-32.htm">Exhibit
    32.1 Certification. See Exhibits</a></span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font: normal 11pt Times New Roman, Times, Serif">c)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font: normal 11pt Times New Roman, Times, Serif"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/355019/000173112224001767/fonar_8-k.htm" style="-sec-extract: exhibit">Report on Form 8-K filed on November 12, 2024, Item 2.02: Results of Operations and Financial Condition for the quarter ended September 30, 2024.</a></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 41 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"><span id="Signatures"></span>SIGNATURES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 50%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 50%"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
    CORPORATION</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">(Registrant)</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">By: /s/ Timothy
    Damadian</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">Timothy Damadian</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">Chairman of
    the Board of Directors, President,</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">Principal
    Executive Officer and Treasurer</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">/s/ Luciano
    Bonanni</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">Luciano Bonanni</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">Executive
    Vice President, Chief Operating Officer,</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">Acting Principal
    Financial Officer</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">Dated: February
    19, 2025</span></td>
    <td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Page
42</span></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; font-size: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- 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 -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>fonar_exhibit-31.htm
<DESCRIPTION>SECTION 302 CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">Exhibit
31.1</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="text-align: justify"></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">CERTIFICATION</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD></TR>
  </TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="text-align: justify"></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="text-align: justify"></TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">Timothy
Damadian and Luciano Bonanni each certify that:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="text-align: justify"></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">1.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">I
    have reviewed this report on Form 10-Q of Fonar Corporation;</FONT></TD></TR>
  </TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="text-align: justify"></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">2.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">Based
    on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
    to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to
    the period covered by this report;</FONT></TD></TR>
  </TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="text-align: justify"></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">3.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">Based
    on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
    respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in
    this report;</FONT></TD></TR>
  </TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="text-align: justify"></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">4.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">I
    am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
    15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13(a)-15(f) and 15d-15(f) for the registrant
    and have:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">a)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">designed
    such disclosure controls and procedures or caused such disclosure controls over procedures to be designed under my supervision to
    ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
    within those entities, particularly during the period in which this report is being prepared;</FONT></TD></TR>
  </TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="text-align: justify"></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">b)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">designed
    such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my
    supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
    for external purposes in accordance with generally accepted accounting principles;</FONT></TD></TR>
  </TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="text-align: justify"></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">c)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">evaluated
    the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report my conclusions about
    the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report; and</FONT></TD></TR>
  </TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="text-align: justify"></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">d)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">disclosed
    in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s
    most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected,
    or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">5.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">I
    have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors
    and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">(a)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">all
    significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
    reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information;
    and</FONT></TD></TR>
  </TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="text-align: justify"></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">(b)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">Any
    fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
    internal control over financial reporting.</FONT></TD></TR>
  </TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="text-align: justify"></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">February
    19, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; width: 50%; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">/s/
    Timothy Damadian</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">________________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">Timothy
    Damadian</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">Principal
    Executive Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">/s/
    Luciano Bonanni</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">________________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><P STYLE="margin-bottom: 0; font: 10pt Arial, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">Luciano
                                            Bonanni</FONT></P>
    <P STYLE="margin-bottom: 0"></P></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">Acting
    Principal Financial Officer&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>3
<FILENAME>fonar_exhibit-32.htm
<DESCRIPTION>SECTION 906 CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">Exhibit
32.1</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">CERTIFICATION
PURSUANT TO</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">18
U.S.C. SECTION 1350,</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">AS
ADOPTED PURSUANT TO</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">In
connection with the Quarterly Report of FONAR Corporation and Subsidiaries (the &ldquo;Company&rdquo;) on Form 10-Q for the fiscal quarter
ended December 31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the &ldquo;Report&rdquo;), I, Timothy
Damadian, Principal Executive Officer, and I, Luciano Bonanni, Acting Principal Financial Officer of the Company, certify, pursuant to
18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">The
Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">The
information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the
Company.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">/s/Timothy
    Damadian</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">________________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">Timothy
    Damadian</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">Principal
    Executive Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">/s/
    Luciano Bonanni</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">________________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><P STYLE="margin-bottom: 0; font: 10pt Arial, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">Luciano
                                            Bonanni&nbsp;</FONT></P>
    <P STYLE="margin-bottom: 0; font: 10pt Arial, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">Acting
    Principal Financial Officer&nbsp;</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">February
19, 2025</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">A
signed original of this written statement required by Section 906 has been provided to Fonar Corporation and will be retained by Fonar
Corporation and furnished to the Securities and Exchange Commission or its staff upon request.</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>fonar_logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fonar_logo.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" !# ;H# 2(  A$! Q$!_\0
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M1?R76I:O?2WE]<2MEI)9'+LQ/N2:SJ_%L=Q%FF)Q<ZL*LHQ;T2>RZ?\ !/\
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MA^$LYI9EEM)0PN(TY8JRA4BE=);)27O+S4NQW5% (/0T5]B?@!Q/[0GBW5_
M7P/\9>.?#LJ)J.C^&;Z]L7DCW*LL4#NA([C('%?C"O\ P7#_ ."@( SXXT(\
M?] !/\:_8K]KC_DV+XC?]B5JF/\ P$DK^;A<XY'TK\^XUQ^-P5>C&A4<4TV[
M.W4_JKZ.?"O#?$.6YA/,\)3KN$Z:BYQ4K)J3:5^Y]>M_P7$_X* GIXYT,?\
M< 3_ !I#_P %PO\ @H&>GCO1!_W (_\ &OD2C-?$?VYG'_01+[S^DO\ B&?A
M]_T*J'_@M'UW_P /P_\ @H(1@^/-$_\ !!'_ (T?\/PO^"@?_0^:)_X((_\
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M#_HH6N_^$O=?_$U];]=X<_GI?^2GX5_JQXO_ /0+C?\ P&L>N_\ #OS]C/\
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M]#%?DT/B1_==?^#+T?Y'],OP_P#E\)Z0H_Z!<'_HM:W:PO !SX5TG_L%P?\
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MOV.[_P#8C_:,O?A&=4>_TNYLH]2T"]D #RVDC.H#X_B5XW4_[H/>O#:^O/\
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M,D[;K]6>!Q+XB<'<'XR&%S?%>RG./,ERS=U=J]XQ:W3/S8HK]*/^(<#XE_\
M1U&A?^$Q-_\ 'Z/^(<#XE_\ 1U&A?^$Q-_\ 'Z[?]5,]?_+G\8_YGSO_ !'+
MPN_Z&*_\ J__ "!^:]%?I1_Q#@?$O_HZC0O_  F)O_C]'_$.!\2_^CJ-"_\
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H45WY3AZ%+FY();;)(\GB+.LXS>E2>/Q-2MRMVYYRG:]KVYF[7\C_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>fonr-20241231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 9a45o7xRiXhun8uGbHdcOaKOaaP9wZ93mekhsGR2benqjyAh5umR2i9HQ4umIbcB -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:FONR="http://fonar.com/20241231" elementFormDefault="qualified" targetNamespace="http://fonar.com/20241231">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://fonar.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheets" id="CondensedConsolidatedBalanceSheets">
          <link:definition>00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical" id="CondensedConsolidatedBalanceSheetsParenthetical">
          <link:definition>00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfOperations" id="CondensedConsolidatedStatementsOfOperations">
          <link:definition>00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity" id="CondensedConsolidatedStatementsOfChangesInEquity">
          <link:definition>00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows" id="CondensedConsolidatedStatementsOfCashFlows">
          <link:definition>00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation" id="DescriptionOfBusinessAndBasisOfPresentation">
          <link:definition>995612 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
          <link:definition>995613 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable">
          <link:definition>995614 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OperatingAndFinancingLeases" id="OperatingAndFinancingLeases">
          <link:definition>995615 - Disclosure - OPERATING AND FINANCING LEASES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/Inventories" id="Inventories">
          <link:definition>995616 - Disclosure - INVENTORIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssets" id="OtherIntangibleAssets">
          <link:definition>995617 - Disclosure - OTHER INTANGIBLE ASSETS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherCurrentLiabilities" id="OtherCurrentLiabilities">
          <link:definition>995618 - Disclosure - OTHER CURRENT LIABILITIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SegmentAndRelatedInformation" id="SegmentAndRelatedInformation">
          <link:definition>995619 - Disclosure - SEGMENT AND RELATED INFORMATION</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SupplementalCashFlowInformation" id="SupplementalCashFlowInformation">
          <link:definition>995620 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
          <link:definition>995621 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/IncomeTaxes" id="IncomeTaxes">
          <link:definition>995622 - Disclosure - INCOME TAXES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
          <link:definition>995623 - Disclosure - RELATED PARTY TRANSACTIONS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SubsequentEvents" id="SubsequentEvents">
          <link:definition>995624 - Disclosure - SUBSEQUENT EVENTS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
          <link:definition>995625 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
          <link:definition>995626 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables">
          <link:definition>995627 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OperatingAndFinancingLeasesTables" id="OperatingAndFinancingLeasesTables">
          <link:definition>995628 - Disclosure - OPERATING AND FINANCING LEASES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/InventoriesTables" id="InventoriesTables">
          <link:definition>995629 - Disclosure - INVENTORIES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssetsTables" id="OtherIntangibleAssetsTables">
          <link:definition>995630 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherCurrentLiabilitiesTables" id="OtherCurrentLiabilitiesTables">
          <link:definition>995631 - Disclosure - OTHER CURRENT LIABILITIES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SegmentAndRelatedInformationTables" id="SegmentAndRelatedInformationTables">
          <link:definition>995632 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" id="DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative">
          <link:definition>995633 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details" id="SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details">
          <link:definition>995634 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details1" id="SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details1">
          <link:definition>995635 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
          <link:definition>995636 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails">
          <link:definition>995637 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-FutureRevenueDetails1" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-FutureRevenueDetails1">
          <link:definition>995638 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Future Revenue (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative">
          <link:definition>995639 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" id="OperatingFinancingLeases-LeasePaymentsDetails">
          <link:definition>995640 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OperatingFinancingLeasesDetails1" id="OperatingFinancingLeasesDetails1">
          <link:definition>995641 - Disclosure - OPERATING &amp; FINANCING LEASES (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OperatingFinancingLeasesDetails2" id="OperatingFinancingLeasesDetails2">
          <link:definition>995642 - Disclosure - OPERATING &amp; FINANCING LEASES (Details 2)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OperatingFinancingLeasesDetails3" id="OperatingFinancingLeasesDetails3">
          <link:definition>995643 - Disclosure -  OPERATING &amp; FINANCING LEASES (Details 3)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/Inventories-InventoriesDetails" id="Inventories-InventoriesDetails">
          <link:definition>995644 - Disclosure - INVENTORIES - Inventories (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssetsDetails" id="OtherIntangibleAssetsDetails">
          <link:definition>995645 - Disclosure -  OTHER INTANGIBLE ASSETS (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssetsDetails1" id="OtherIntangibleAssetsDetails1">
          <link:definition>995646 - Disclosure - OTHER INTANGIBLE ASSETS (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" id="OtherIntangibleAssetsDetailsNarrative">
          <link:definition>995647 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" id="OtherCurrentLiabilities-OtherCurrentLiabilities-Details">
          <link:definition>995648 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details" id="SegmentAndRelatedInformation-SummarizedSegments-Details">
          <link:definition>995649 - Disclosure - SEGMENT AND RELATED INFORMATION - Summarized Segments - (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" id="SupplementalCashFlowInformationDetailsNarrative">
          <link:definition>995650 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
          <link:definition>995651 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
          <link:definition>995652 - Disclosure - INCOME TAXES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative" id="RelatedPartyTransactionsDetailsNarrative">
          <link:definition>995653 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
          <link:definition>995654 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="fonr-20241231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="fonr-20241231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="fonr-20241231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="fonr-20241231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
    <element id="FONR_ClassANonVotingPreferredStockMember" name="ClassANonVotingPreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CommonStockholdersMember" name="CommonStockholdersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ClassANonVotingPreferredStockholdersMember" name="ClassANonVotingPreferredStockholdersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CommercialInsuranceManagedCareMember" name="CommercialInsuranceManagedCareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MedicareMedicaidMember" name="MedicareMedicaidMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_WorkersCompensationPersonalInjuryMember" name="WorkersCompensationPersonalInjuryMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OtherRevenueSourceMember" name="OtherRevenueSourceMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OperatingLeasePaymentsMember" name="OperatingLeasePaymentsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_FinancingLeasePaymentsMember" name="FinancingLeasePaymentsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PatentsAndCopyrightsMember" name="PatentsAndCopyrightsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManufacturingAndServiceOfMRIEquipmentMember" name="ManufacturingAndServiceOfMRIEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MagneticResonanceManagementMember" name="MagneticResonanceManagementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountReceivableRelatedParties" name="AccountReceivableRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MedicalReceivable" name="MedicalReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" name="ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountsReceivableNetLongTerm" name="AccountsReceivableNetLongTerm" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NoteReceivableRelatedParty" name="NoteReceivableRelatedParty" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_UnearnedRevenueOnServiceContractsRelatedParty" name="UnearnedRevenueOnServiceContractsRelatedParty" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CustomerDeposits" name="CustomerDeposits" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountsPayableRelatedPartyNoncurrent" name="AccountsPayableRelatedPartyNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" name="ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts" name="RelatedPartyReceivableAllowancesForDoubtfulAccounts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" name="PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ProductSalesNet" name="ProductSalesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ServiceAndRepairFeesNet" name="ServiceAndRepairFeesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ServiceAndRepairFeesRelatedPartiesNet" name="ServiceAndRepairFeesRelatedPartiesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFeesNet" name="ManagementAndOtherFeesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" name="ManagementAndOtherFeesRelatedMedicalPracticesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToProductSales" name="CostsRelatedToProductSales" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToServiceAndRepairFees" name="CostsRelatedToServiceAndRepairFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" name="CostsRelatedToServiceAndRepairFeesRelatedParties" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToManagementAndOtherFees" name="CostsRelatedToManagementAndOtherFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" name="CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_InvestmentIncomeRelatedParty" name="InvestmentIncomeRelatedParty" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OtherIncomeRelatedParty" name="OtherIncomeRelatedParty" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ConsolidatedNetIncome" name="ConsolidatedNetIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CancellationOfTreasuryStock" name="CancellationOfTreasuryStock" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CancellationOfTreasuryStockShares" name="CancellationOfTreasuryStockShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_SaleNonControllingInterests" name="SaleNonControllingInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NetChangeInOperatingRightOfUseAssetsAndLeaseLiabilities" name="NetChangeInOperatingRightOfUseAssetsAndLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ProvisionForBadDebts" name="ProvisionForBadDebts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_GainOnSaleOfEquipmentRelatedParty" name="GainOnSaleOfEquipmentRelatedParty" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncreaseDecreaseInNotesReceivable" name="IncreaseDecreaseInNotesReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncreaseDecreaseInNotesReceivableRelatedParty" name="IncreaseDecreaseInNotesReceivableRelatedParty" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncreaseDecreaseInCustomerDeposit" name="IncreaseDecreaseInCustomerDeposit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract" name="DisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DescriptionOfBusinessAndBasisOfPresentationTextBlock" name="DescriptionOfBusinessAndBasisOfPresentationTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DisclosureOperatingAndFinancingLeasesAbstract" name="DisclosureOperatingAndFinancingLeasesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_LesseeOperatingLeasesAndFinanceLeaseTextBlock" name="LesseeOperatingLeasesAndFinanceLeaseTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFeeReceivablePolicyTextBlock" name="ManagementAndOtherFeeReceivablePolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" name="ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" name="SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NetPatientFeeRevenue" name="NetPatientFeeRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NetIncomeLossAvailableToCommonStockholderBasic" name="NetIncomeLossAvailableToCommonStockholderBasic" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ConvertibleClassCStock" name="ConvertibleClassCStock" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_WeightedAverageNumberOfDilutedEarningsPerShare" name="WeightedAverageNumberOfDilutedEarningsPerShare" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_RightToUseAssetToIntangibleAsset" name="RightToUseAssetToIntangibleAsset" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountsReceivableNetRelatedParty" name="AccountsReceivableNetRelatedParty" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFeesNonRelatedParties" name="ManagementAndOtherFeesNonRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" name="PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1" name="PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" name="PercentageOfConsolidatedNetRevenueFromManagementFees" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PresentValueDiscount" name="PresentValueDiscount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PresentValueDiscountFinancingLease" name="PresentValueDiscountFinancingLease" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_FinanceLeaseCostsAbstract" name="FinanceLeaseCostsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DepreciationOfLeasedEquipment" name="DepreciationOfLeasedEquipment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_FinanceLeaseCost" name="FinanceLeaseCost" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OperatingCashFlowsFromOperatingLeases" name="OperatingCashFlowsFromOperatingLeases" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_FinancingCashFlowsFromFinancingLeases" name="FinancingCashFlowsFromFinancingLeases" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" name="RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" name="RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_SelffundedHealthInsuranceReserve" name="SelffundedHealthInsuranceReserve" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_SoftwareLicenses" name="SoftwareLicenses" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IntersegmentNetRevenues" name="IntersegmentNetRevenues" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_RateOfInterestSold" name="RateOfInterestSold" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DeferredIncomeTaxComponent" name="DeferredIncomeTaxComponent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PercentageOfExciseTax" name="PercentageOfExciseTax" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CorporateAlternativeMinimumTaxPercentage" name="CorporateAlternativeMinimumTaxPercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NetRevenues" name="NetRevenues" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ServiceAndMaintenancePrice" name="ServiceAndMaintenancePrice" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ServiceAndRepairFees" name="ServiceAndRepairFees" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_EmployeesFee" name="EmployeesFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchaseds" name="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchaseds" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount" name="StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>fonr-20241231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://fonar.com/role/Cover" xlink:href="fonr-20241231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheets" xlink:href="fonr-20241231.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="fonr-20241231.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfOperations" xlink:href="fonr-20241231.xsd#CondensedConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity" xlink:href="fonr-20241231.xsd#CondensedConsolidatedStatementsOfChangesInEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:href="fonr-20241231.xsd#CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:href="fonr-20241231.xsd#DescriptionOfBusinessAndBasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="fonr-20241231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:href="fonr-20241231.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingAndFinancingLeases" xlink:href="fonr-20241231.xsd#OperatingAndFinancingLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories" xlink:href="fonr-20241231.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets" xlink:href="fonr-20241231.xsd#OtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities" xlink:href="fonr-20241231.xsd#OtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation" xlink:href="fonr-20241231.xsd#SegmentAndRelatedInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformation" xlink:href="fonr-20241231.xsd#SupplementalCashFlowInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingencies" xlink:href="fonr-20241231.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes" xlink:href="fonr-20241231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/RelatedPartyTransactions" xlink:href="fonr-20241231.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEvents" xlink:href="fonr-20241231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="fonr-20241231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="fonr-20241231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:href="fonr-20241231.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingAndFinancingLeasesTables" xlink:href="fonr-20241231.xsd#OperatingAndFinancingLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/InventoriesTables" xlink:href="fonr-20241231.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:href="fonr-20241231.xsd#OtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:href="fonr-20241231.xsd#OtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:href="fonr-20241231.xsd#SegmentAndRelatedInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:href="fonr-20241231.xsd#DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details" xlink:href="fonr-20241231.xsd#SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details1" xlink:href="fonr-20241231.xsd#SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details1" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="fonr-20241231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:href="fonr-20241231.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-FutureRevenueDetails1" xlink:href="fonr-20241231.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-FutureRevenueDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:href="fonr-20241231.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:href="fonr-20241231.xsd#OperatingFinancingLeases-LeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeasesDetails1" xlink:href="fonr-20241231.xsd#OperatingFinancingLeasesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeasesDetails2" xlink:href="fonr-20241231.xsd#OperatingFinancingLeasesDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeasesDetails3" xlink:href="fonr-20241231.xsd#OperatingFinancingLeasesDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories-InventoriesDetails" xlink:href="fonr-20241231.xsd#Inventories-InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsDetails" xlink:href="fonr-20241231.xsd#OtherIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsDetails1" xlink:href="fonr-20241231.xsd#OtherIntangibleAssetsDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:href="fonr-20241231.xsd#OtherIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:href="fonr-20241231.xsd#OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details" xlink:href="fonr-20241231.xsd#SegmentAndRelatedInformation-SummarizedSegments-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:href="fonr-20241231.xsd#SupplementalCashFlowInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="fonr-20241231.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:href="fonr-20241231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="fonr-20241231.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:href="fonr-20241231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="loc_us-gaapAccountsAndOtherReceivablesNetCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsAndOtherReceivablesNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_AccountReceivableRelatedParties" xlink:label="loc_FONRAccountReceivableRelatedParties" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRAccountReceivableRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRMedicalReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedFeesAndOtherRevenueReceivable" xlink:label="loc_us-gaapAccruedFeesAndOtherRevenueReceivable" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccruedFeesAndOtherRevenueReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="loc_FONRAccountsReceivableNetLongTerm" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_FONRAccountsReceivableNetLongTerm" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_NoteReceivableRelatedParty" xlink:label="loc_FONRNoteReceivableRelatedParty" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_FONRNoteReceivableRelatedParty" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAsset" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_UnearnedRevenueOnServiceContractsRelatedParty" xlink:label="loc_FONRUnearnedRevenueOnServiceContractsRelatedParty" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_FONRUnearnedRevenueOnServiceContractsRelatedParty" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityCurrent" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapFinanceLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_CustomerDeposits" xlink:label="loc_FONRCustomerDeposits" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_FONRCustomerDeposits" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaapDeferredRevenueNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapDeferredRevenueNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_AccountsPayableRelatedPartyNoncurrent" xlink:label="loc_FONRAccountsPayableRelatedPartyNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_FONRAccountsPayableRelatedPartyNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityNoncurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapFinanceLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapLongTermDebtNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOtherLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:label="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ProductSalesNet" xlink:label="loc_FONRProductSalesNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRProductSalesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ServiceAndRepairFeesNet" xlink:label="loc_FONRServiceAndRepairFeesNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRServiceAndRepairFeesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="loc_FONRServiceAndRepairFeesRelatedPartiesNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRServiceAndRepairFeesRelatedPartiesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ManagementAndOtherFeesNet" xlink:label="loc_FONRManagementAndOtherFeesNet" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRManagementAndOtherFeesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="loc_us-gaapOtherCostOfOperatingRevenue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapOtherCostOfOperatingRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_CostsRelatedToProductSales" xlink:label="loc_FONRCostsRelatedToProductSales" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToProductSales" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_CostsRelatedToServiceAndRepairFees" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFees" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_CostsRelatedToManagementAndOtherFees" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFees" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="loc_us-gaapCostsAndExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="loc_us-gaapInterestExpenseNonoperating" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapInterestExpenseNonoperating" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_InvestmentIncomeRelatedParty" xlink:label="loc_FONRInvestmentIncomeRelatedParty" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_FONRInvestmentIncomeRelatedParty" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapInvestmentIncomeNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_OtherIncomeRelatedParty" xlink:label="loc_FONROtherIncomeRelatedParty" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_FONROtherIncomeRelatedParty" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ConsolidatedNetIncome" xlink:label="loc_FONRConsolidatedNetIncome" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_FONRConsolidatedNetIncome" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_FONRConsolidatedNetIncome" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_FONRConsolidatedNetIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity" xlink:title="00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="loc_us-gaapOtherDepreciationAndAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOtherDepreciationAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_NetChangeInOperatingRightOfUseAssetsAndLeaseLiabilities" xlink:label="loc_FONRNetChangeInOperatingRightOfUseAssetsAndLeaseLiabilities" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRNetChangeInOperatingRightOfUseAssetsAndLeaseLiabilities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ProvisionForBadDebts" xlink:label="loc_FONRProvisionForBadDebts" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRProvisionForBadDebts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_GainOnSaleOfEquipmentRelatedParty" xlink:label="loc_FONRGainOnSaleOfEquipmentRelatedParty" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRGainOnSaleOfEquipmentRelatedParty" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_IncreaseDecreaseInNotesReceivable" xlink:label="loc_FONRIncreaseDecreaseInNotesReceivable" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRIncreaseDecreaseInNotesReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_IncreaseDecreaseInNotesReceivableRelatedParty" xlink:label="loc_FONRIncreaseDecreaseInNotesReceivableRelatedParty" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRIncreaseDecreaseInNotesReceivableRelatedParty" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInTradingLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInTradingLiabilities" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInTradingLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_IncreaseDecreaseInCustomerDeposit" xlink:label="loc_FONRIncreaseDecreaseInCustomerDeposit" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRIncreaseDecreaseInCustomerDeposit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccruedLiabilities" />
      <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:label="loc_us-gaapProceedsFromSaleOfShortTermInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleOfShortTermInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromMinorityShareholders" xlink:label="loc_us-gaapProceedsFromMinorityShareholders" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromMinorityShareholders" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" xlink:label="loc_us-gaapPaymentsForRepurchaseOfConvertiblePreferredStock" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsForRepurchaseOfConvertiblePreferredStock" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="loc_us-gaapPaymentsOfDividendsMinorityInterest" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfDividendsMinorityInterest" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:title="995612 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="995613 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:title="995614 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingAndFinancingLeases" xlink:title="995615 - Disclosure - OPERATING AND FINANCING LEASES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories" xlink:title="995616 - Disclosure - INVENTORIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets" xlink:title="995617 - Disclosure - OTHER INTANGIBLE ASSETS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities" xlink:title="995618 - Disclosure - OTHER CURRENT LIABILITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation" xlink:title="995619 - Disclosure - SEGMENT AND RELATED INFORMATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformation" xlink:title="995620 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingencies" xlink:title="995621 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes" xlink:title="995622 - Disclosure - INCOME TAXES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/RelatedPartyTransactions" xlink:title="995623 - Disclosure - RELATED PARTY TRANSACTIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEvents" xlink:title="995624 - Disclosure - SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="995625 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="995626 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:title="995627 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingAndFinancingLeasesTables" xlink:title="995628 - Disclosure - OPERATING AND FINANCING LEASES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/InventoriesTables" xlink:title="995629 - Disclosure - INVENTORIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:title="995630 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:title="995631 - Disclosure - OTHER CURRENT LIABILITIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:title="995632 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:title="995633 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details" xlink:title="995634 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details1" xlink:title="995635 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="995636 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:title="995637 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-FutureRevenueDetails1" xlink:title="995638 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Future Revenue (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:title="995639 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:title="995640 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeasesDetails1" xlink:title="995641 - Disclosure - OPERATING &amp; FINANCING LEASES (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeasesDetails2" xlink:title="995642 - Disclosure - OPERATING &amp; FINANCING LEASES (Details 2)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeasesDetails3" xlink:title="995643 - Disclosure -  OPERATING &amp; FINANCING LEASES (Details 3)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories-InventoriesDetails" xlink:title="995644 - Disclosure - INVENTORIES - Inventories (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherInventorySupplies" xlink:label="loc_us-gaapOtherInventorySupplies" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapOtherInventorySupplies" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsDetails" xlink:title="995645 - Disclosure -  OTHER INTANGIBLE ASSETS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsDetails1" xlink:title="995646 - Disclosure - OTHER INTANGIBLE ASSETS (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:title="995647 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:title="995648 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaapAccruedSalariesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedSalariesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="loc_us-gaapSalesAndExciseTaxPayableCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapSalesAndExciseTaxPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedPayrollTaxesCurrent" xlink:label="loc_us-gaapAccruedPayrollTaxesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedPayrollTaxesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_SelffundedHealthInsuranceReserve" xlink:label="loc_FONRSelffundedHealthInsuranceReserve" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_FONRSelffundedHealthInsuranceReserve" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherSundryLiabilitiesCurrent" xlink:label="loc_us-gaapOtherSundryLiabilitiesCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapOtherSundryLiabilitiesCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details" xlink:title="995649 - Disclosure - SEGMENT AND RELATED INFORMATION - Summarized Segments - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:title="995650 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="995651 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:title="995652 - Disclosure - INCOME TAXES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="995653 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:title="995654 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>fonr-20241231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://fonar.com/role/Cover" xlink:href="fonr-20241231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheets" xlink:href="fonr-20241231.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="fonr-20241231.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfOperations" xlink:href="fonr-20241231.xsd#CondensedConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity" xlink:href="fonr-20241231.xsd#CondensedConsolidatedStatementsOfChangesInEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:href="fonr-20241231.xsd#CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:href="fonr-20241231.xsd#DescriptionOfBusinessAndBasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="fonr-20241231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:href="fonr-20241231.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingAndFinancingLeases" xlink:href="fonr-20241231.xsd#OperatingAndFinancingLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories" xlink:href="fonr-20241231.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets" xlink:href="fonr-20241231.xsd#OtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities" xlink:href="fonr-20241231.xsd#OtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation" xlink:href="fonr-20241231.xsd#SegmentAndRelatedInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformation" xlink:href="fonr-20241231.xsd#SupplementalCashFlowInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingencies" xlink:href="fonr-20241231.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes" xlink:href="fonr-20241231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/RelatedPartyTransactions" xlink:href="fonr-20241231.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEvents" xlink:href="fonr-20241231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="fonr-20241231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="fonr-20241231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:href="fonr-20241231.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingAndFinancingLeasesTables" xlink:href="fonr-20241231.xsd#OperatingAndFinancingLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/InventoriesTables" xlink:href="fonr-20241231.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:href="fonr-20241231.xsd#OtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:href="fonr-20241231.xsd#OtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:href="fonr-20241231.xsd#SegmentAndRelatedInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:href="fonr-20241231.xsd#DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details" xlink:href="fonr-20241231.xsd#SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details1" xlink:href="fonr-20241231.xsd#SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details1" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="fonr-20241231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:href="fonr-20241231.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-FutureRevenueDetails1" xlink:href="fonr-20241231.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-FutureRevenueDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:href="fonr-20241231.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:href="fonr-20241231.xsd#OperatingFinancingLeases-LeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeasesDetails1" xlink:href="fonr-20241231.xsd#OperatingFinancingLeasesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeasesDetails2" xlink:href="fonr-20241231.xsd#OperatingFinancingLeasesDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeasesDetails3" xlink:href="fonr-20241231.xsd#OperatingFinancingLeasesDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories-InventoriesDetails" xlink:href="fonr-20241231.xsd#Inventories-InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsDetails" xlink:href="fonr-20241231.xsd#OtherIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsDetails1" xlink:href="fonr-20241231.xsd#OtherIntangibleAssetsDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:href="fonr-20241231.xsd#OtherIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:href="fonr-20241231.xsd#OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details" xlink:href="fonr-20241231.xsd#SegmentAndRelatedInformation-SummarizedSegments-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:href="fonr-20241231.xsd#SupplementalCashFlowInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="fonr-20241231.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:href="fonr-20241231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="fonr-20241231.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:href="fonr-20241231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosureWithAdditionalMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosureWithAdditionalMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpTable" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsToCompensation" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsToCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TabularListsByExecutiveCategory" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TabularListsByExecutiveCategory" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TabularListMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TabularListMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpExecutiveCategoriesOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#IndividualsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTypeOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TradingArrangmentsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ForgoneRecoveries" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ForgoneRecoveries" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/OutstandingRecoveries" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#OutstandingRecoveries" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardsCloseToMnpiDisc" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardsCloseToMnpiDisc" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangementsByInd" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangemenstByInd" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/Defaults" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#Defaults" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredClassAMember" xlink:label="loc_us-gaapPreferredClassAMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredClassAMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_60" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_60" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_60" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_60" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_60" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_60" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_60" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_60" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_60" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_60" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_60" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_60" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_60" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_60" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_60" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_60" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_60" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_60" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_60" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_60" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_60" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_60" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_60" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_60" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_60" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_60" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_60" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_60" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_60" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_60" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_60" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_60" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_60" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_60" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_60" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_60" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_60" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_60" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_60" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_60" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_60" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_60" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_60" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_60" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_60" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_60" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_60" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_60" xlink:type="arc" order="57" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsCurrentAbstract_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapShortTermInvestments_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="loc_us-gaapAccountsAndOtherReceivablesNetCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapAccountsAndOtherReceivablesNetCurrent_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_AccountReceivableRelatedParties" xlink:label="loc_FONRAccountReceivableRelatedParties_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRAccountReceivableRelatedParties_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRMedicalReceivable_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedFeesAndOtherRevenueReceivable" xlink:label="loc_us-gaapAccruedFeesAndOtherRevenueReceivable_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapAccruedFeesAndOtherRevenueReceivable_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess_130" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_130" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapAssetsCurrent_130" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="loc_FONRAccountsReceivableNetLongTerm_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRAccountsReceivableNetLongTerm_130" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome_130" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_130" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_NoteReceivableRelatedParty" xlink:label="loc_FONRNoteReceivableRelatedParty_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRNoteReceivableRelatedParty_130" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset_130" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAsset_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAsset_130" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapGoodwill_130" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_130" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapOtherAssets_130" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapAssets_130" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapLongTermDebtCurrent_130" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapAccountsPayableCurrent_130" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapOtherLiabilitiesCurrent_130" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapDeferredRevenueCurrent_130" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_UnearnedRevenueOnServiceContractsRelatedParty" xlink:label="loc_FONRUnearnedRevenueOnServiceContractsRelatedParty_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_FONRUnearnedRevenueOnServiceContractsRelatedParty_130" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent_130" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapFinanceLeaseLiabilityCurrent_130" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_CustomerDeposits" xlink:label="loc_FONRCustomerDeposits_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_FONRCustomerDeposits_130" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapLiabilitiesCurrent_130" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaapDeferredRevenueNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapDeferredRevenueNoncurrent_130" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_130" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_AccountsPayableRelatedPartyNoncurrent" xlink:label="loc_FONRAccountsPayableRelatedPartyNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_FONRAccountsPayableRelatedPartyNoncurrent_130" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent_130" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapFinanceLeaseLiabilityNoncurrent_130" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapLongTermDebtNoncurrent_130" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapOtherLiabilities_130" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapLiabilitiesNoncurrent_130" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapLiabilities_130" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_130" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_130" xlink:to="loc_us-gaapPreferredStockValue_130" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_130" xlink:to="loc_us-gaapCommonStockValue_130" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_130" xlink:to="loc_us-gaapAdditionalPaidInCapital_130" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_130" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_130" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_130" xlink:to="loc_us-gaapTreasuryStockValue_130" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_130" xlink:to="loc_us-gaapStockholdersEquity_130" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_130" xlink:to="loc_us-gaapMinorityInterest_130" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_130" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_130" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_130" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_130" xlink:type="arc" order="50" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" xlink:label="loc_FONRManagementAndOtherReceivableAllowancesForDoubtfulAccounts_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRManagementAndOtherReceivableAllowancesForDoubtfulAccounts_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts" xlink:label="loc_FONRRelatedPartyReceivableAllowancesForDoubtfulAccounts_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRRelatedPartyReceivableAllowancesForDoubtfulAccounts_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_90" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_90" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="loc_us-gaapTreasuryStockCommonShares_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockCommonShares_90" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_CommonStockholdersMember" xlink:label="loc_FONRCommonStockholdersMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRCommonStockholdersMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ClassANonVotingPreferredStockholdersMember" xlink:label="loc_FONRClassANonVotingPreferredStockholdersMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockholdersMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaapRevenuesAbstract_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenuesAbstract_170" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:label="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_170" xlink:to="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts_170" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ProductSalesNet" xlink:label="loc_FONRProductSalesNet_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_170" xlink:to="loc_FONRProductSalesNet_170" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ServiceAndRepairFeesNet" xlink:label="loc_FONRServiceAndRepairFeesNet_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_170" xlink:to="loc_FONRServiceAndRepairFeesNet_170" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="loc_FONRServiceAndRepairFeesRelatedPartiesNet_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_170" xlink:to="loc_FONRServiceAndRepairFeesRelatedPartiesNet_170" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ManagementAndOtherFeesNet" xlink:label="loc_FONRManagementAndOtherFeesNet_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_170" xlink:to="loc_FONRManagementAndOtherFeesNet_170" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_170" xlink:to="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet_170" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues_170" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="loc_us-gaapCostsAndExpensesAbstract_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostsAndExpensesAbstract_170" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="loc_us-gaapOtherCostOfOperatingRevenue_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_170" xlink:to="loc_us-gaapOtherCostOfOperatingRevenue_170" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_CostsRelatedToProductSales" xlink:label="loc_FONRCostsRelatedToProductSales_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_170" xlink:to="loc_FONRCostsRelatedToProductSales_170" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_CostsRelatedToServiceAndRepairFees" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFees_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_170" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFees_170" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_170" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties_170" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_CostsRelatedToManagementAndOtherFees" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFees_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_170" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFees_170" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_170" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_170" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_170" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_170" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_170" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense_170" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_170" xlink:to="loc_us-gaapCostsAndExpenses_170" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_170" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract_170" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="loc_us-gaapInterestExpenseNonoperating_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestExpenseNonoperating_170" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_InvestmentIncomeRelatedParty" xlink:label="loc_FONRInvestmentIncomeRelatedParty_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRInvestmentIncomeRelatedParty_170" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentIncomeNet_170" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_OtherIncomeRelatedParty" xlink:label="loc_FONROtherIncomeRelatedParty_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONROtherIncomeRelatedParty_170" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense_170" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_170" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_170" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ConsolidatedNetIncome" xlink:label="loc_FONRConsolidatedNetIncome_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRConsolidatedNetIncome_170" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_170" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_170" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic_170" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic_170" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted_170" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_170" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_170" xlink:type="arc" order="34" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity" xlink:title="00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember" xlink:label="loc_us-gaapTreasuryStockCommonMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapTreasuryStockCommonMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapNoncontrollingInterestMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensationForfeited_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensationForfeited_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_CancellationOfTreasuryStock" xlink:label="loc_FONRCancellationOfTreasuryStock_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRCancellationOfTreasuryStock_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_CancellationOfTreasuryStockShares" xlink:label="loc_FONRCancellationOfTreasuryStockShares_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRCancellationOfTreasuryStockShares_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_SaleNonControllingInterests" xlink:label="loc_FONRSaleNonControllingInterests_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRSaleNonControllingInterests_70" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_70" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_70" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:title="995612 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="995613 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:title="995614 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingAndFinancingLeases" xlink:title="995615 - Disclosure - OPERATING AND FINANCING LEASES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories" xlink:title="995616 - Disclosure - INVENTORIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets" xlink:title="995617 - Disclosure - OTHER INTANGIBLE ASSETS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities" xlink:title="995618 - Disclosure - OTHER CURRENT LIABILITIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation" xlink:title="995619 - Disclosure - SEGMENT AND RELATED INFORMATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformation" xlink:title="995620 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingencies" xlink:title="995621 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes" xlink:title="995622 - Disclosure - INCOME TAXES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/RelatedPartyTransactions" xlink:title="995623 - Disclosure - RELATED PARTY TRANSACTIONS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEvents" xlink:title="995624 - Disclosure - SUBSEQUENT EVENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="995625 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="995626 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:title="995627 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingAndFinancingLeasesTables" xlink:title="995628 - Disclosure - OPERATING AND FINANCING LEASES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/InventoriesTables" xlink:title="995629 - Disclosure - INVENTORIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:title="995630 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:title="995631 - Disclosure - OTHER CURRENT LIABILITIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:title="995632 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:title="995633 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherInvesteesMember" xlink:label="loc_us-gaapOtherInvesteesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_us-gaapOtherInvesteesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapNoncontrollingInterestMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentOwnedPercentOfNetAssets" xlink:label="loc_us-gaapInvestmentOwnedPercentOfNetAssets_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentOwnedPercentOfNetAssets_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:label="loc_us-gaapProceedsFromPaymentsToMinorityShareholders_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromPaymentsToMinorityShareholders_80" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details" xlink:title="995634 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaapDisaggregationOfRevenueLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaapDisaggregationOfRevenueTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_us-gaapDisaggregationOfRevenueTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_CommercialInsuranceManagedCareMember" xlink:label="loc_FONRCommercialInsuranceManagedCareMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRCommercialInsuranceManagedCareMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_MedicareMedicaidMember" xlink:label="loc_FONRMedicareMedicaidMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRMedicareMedicaidMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_WorkersCompensationPersonalInjuryMember" xlink:label="loc_FONRWorkersCompensationPersonalInjuryMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRWorkersCompensationPersonalInjuryMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_OtherRevenueSourceMember" xlink:label="loc_FONROtherRevenueSourceMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONROtherRevenueSourceMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_NetPatientFeeRevenue" xlink:label="loc_FONRNetPatientFeeRevenue_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_FONRNetPatientFeeRevenue_210" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details1" xlink:title="995635 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_NetIncomeLossAvailableToCommonStockholderBasic" xlink:label="loc_FONRNetIncomeLossAvailableToCommonStockholderBasic_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRNetIncomeLossAvailableToCommonStockholderBasic_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ConvertibleClassCStock" xlink:label="loc_FONRConvertibleClassCStock_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRConvertibleClassCStock_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_WeightedAverageNumberOfDilutedEarningsPerShare" xlink:label="loc_FONRWeightedAverageNumberOfDilutedEarningsPerShare_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRWeightedAverageNumberOfDilutedEarningsPerShare_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted_130" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="995636 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:title="995637 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaapReceivableTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="loc_us-gaapReceivableTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaapReceivableTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="loc_us-gaapReceivableTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapAccountsReceivableMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DoubtfulMember" xlink:label="loc_us-gaapDoubtfulMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapDoubtfulMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaapAccountsReceivableNet_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_us-gaapAccountsReceivableNet_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_AccountsReceivableNetRelatedParty" xlink:label="loc_FONRAccountsReceivableNetRelatedParty_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRAccountsReceivableNetRelatedParty_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NontradeReceivables" xlink:label="loc_us-gaapNontradeReceivables_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_us-gaapNontradeReceivables_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ManagementAndOtherFeesNonRelatedParties" xlink:label="loc_FONRManagementAndOtherFeesNonRelatedParties_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRManagementAndOtherFeesNonRelatedParties_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_70" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-FutureRevenueDetails1" xlink:title="995638 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Future Revenue (Details 1)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:title="995639 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:title="995640 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_OperatingLeasePaymentsMember" xlink:label="loc_FONROperatingLeasePaymentsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_FONROperatingLeasePaymentsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_FinancingLeasePaymentsMember" xlink:label="loc_FONRFinancingLeasePaymentsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_FONRFinancingLeasePaymentsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearTwo_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearTwo_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearThree_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearThree_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFour_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFour_30" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFive_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFive_30" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_30" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueAfterYearFive_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueAfterYearFive_30" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_PresentValueDiscount" xlink:label="loc_FONRPresentValueDiscount_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPresentValueDiscount_30" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_PresentValueDiscountFinancingLease" xlink:label="loc_FONRPresentValueDiscountFinancingLease_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPresentValueDiscountFinancingLease_30" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseLiability_30" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaapFinanceLeaseLiability_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiability_30" xlink:type="arc" order="15" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeasesDetails1" xlink:title="995641 - Disclosure - OPERATING &amp; FINANCING LEASES (Details 1)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeasesDetails2" xlink:title="995642 - Disclosure - OPERATING &amp; FINANCING LEASES (Details 2)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeasesDetails3" xlink:title="995643 - Disclosure -  OPERATING &amp; FINANCING LEASES (Details 3)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories-InventoriesDetails" xlink:title="995644 - Disclosure - INVENTORIES - Inventories (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsDetails" xlink:title="995645 - Disclosure -  OTHER INTANGIBLE ASSETS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LicenseMember" xlink:label="loc_us-gaapLicenseMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapLicenseMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="loc_FONRPatentsAndCopyrightsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRPatentsAndCopyrightsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_210" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross_210" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_210" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet_210" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsDetails1" xlink:title="995646 - Disclosure - OTHER INTANGIBLE ASSETS (Details 1)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:title="995647 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="loc_FONRPatentsAndCopyrightsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRPatentsAndCopyrightsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets_90" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:title="995648 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details" xlink:title="995649 - Disclosure - SEGMENT AND RELATED INFORMATION - Summarized Segments - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:label="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:label="loc_us-gaapScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ManufacturingAndServiceOfMRIEquipmentMember" xlink:label="loc_FONRManufacturingAndServiceOfMRIEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_FONRManufacturingAndServiceOfMRIEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HealthCareOtherMember" xlink:label="loc_us-gaapHealthCareOtherMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapHealthCareOtherMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapRevenues_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_IntersegmentNetRevenues" xlink:label="loc_FONRIntersegmentNetRevenues_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_FONRIntersegmentNetRevenues_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaapPaymentsToAcquireProductiveAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapPaymentsToAcquireProductiveAssets_130" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:title="995650 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="995651 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="loc_srtBoardOfDirectorsChairmanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtBoardOfDirectorsChairmanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramAuthorizedAmount1" xlink:label="loc_srtStockRepurchaseProgramAuthorizedAmount1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_srtStockRepurchaseProgramAuthorizedAmount1_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:label="loc_us-gaapStockRedeemedOrCalledDuringPeriodShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRedeemedOrCalledDuringPeriodShares_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:label="loc_us-gaapStockRedeemedOrCalledDuringPeriodValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRedeemedOrCalledDuringPeriodValue_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:label="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:label="loc_us-gaapLiabilityForClaimsAndClaimsAdjustmentExpense_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilityForClaimsAndClaimsAdjustmentExpense_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SelfInsuranceReserve" xlink:label="loc_us-gaapSelfInsuranceReserve_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSelfInsuranceReserve_60" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:title="995652 - Disclosure - INCOME TAXES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="995653 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_MagneticResonanceManagementMember" xlink:label="loc_FONRMagneticResonanceManagementMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_FONRMagneticResonanceManagementMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_NetRevenues" xlink:label="loc_FONRNetRevenues_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_FONRNetRevenues_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ServiceAndMaintenancePrice" xlink:label="loc_FONRServiceAndMaintenancePrice_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_FONRServiceAndMaintenancePrice_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ServiceAndRepairFees" xlink:label="loc_FONRServiceAndRepairFees_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_FONRServiceAndRepairFees_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_EmployeesFee" xlink:label="loc_FONREmployeesFee_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_FONREmployeesFee_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_us-gaapConvertibleNotesPayable_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapConvertibleNotesPayable_110" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFixedInterestRate" xlink:label="loc_us-gaapDerivativeFixedInterestRate_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDerivativeFixedInterestRate_110" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapInvestmentIncomeNet_110" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredGainOnSaleOfProperty" xlink:label="loc_us-gaapDeferredGainOnSaleOfProperty_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDeferredGainOnSaleOfProperty_110" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:title="995654 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>fonr-20241231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassBMember_lbl" xml:lang="en-US">Common Class B [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassCMember" xlink:label="us-gaap_CommonClassCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassCMember" xlink:to="us-gaap_CommonClassCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassCMember_lbl" xml:lang="en-US">Common Class C [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredClassAMember" xlink:label="us-gaap_PreferredClassAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredClassAMember" xlink:to="us-gaap_PreferredClassAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredClassAMember_lbl" xml:lang="en-US">Preferred Class A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="FONR_ClassANonVotingPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassANonVotingPreferredStockMember" xlink:to="FONR_ClassANonVotingPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ClassANonVotingPreferredStockMember_lbl" xml:lang="en-US">Class A Non Voting Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_CommonStockholdersMember" xlink:label="FONR_CommonStockholdersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CommonStockholdersMember" xlink:to="FONR_CommonStockholdersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CommonStockholdersMember_lbl" xml:lang="en-US">Common Stockholders [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ClassANonVotingPreferredStockholdersMember" xlink:label="FONR_ClassANonVotingPreferredStockholdersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassANonVotingPreferredStockholdersMember" xlink:to="FONR_ClassANonVotingPreferredStockholdersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ClassANonVotingPreferredStockholdersMember_lbl" xml:lang="en-US">Class A Non Voting Preferred Stockholders [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember" xlink:label="us-gaap_TreasuryStockCommonMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockCommonMember" xlink:to="us-gaap_TreasuryStockCommonMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockCommonMember_lbl" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="us-gaap_NoncontrollingInterestMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestMember" xlink:to="us-gaap_NoncontrollingInterestMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncontrollingInterestMember_lbl" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xml:lang="en-US">Investment, Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherInvesteesMember" xlink:label="us-gaap_OtherInvesteesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInvesteesMember" xlink:to="us-gaap_OtherInvesteesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherInvesteesMember_lbl" xml:lang="en-US">Nonconsolidated Investees, Other [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="us-gaap_HealthCareOrganizationRevenueSourcesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:to="us-gaap_HealthCareOrganizationRevenueSourcesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_HealthCareOrganizationRevenueSourcesAxis_lbl" xml:lang="en-US">Health Care Organization, Revenue Sources [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_CommercialInsuranceManagedCareMember" xlink:label="FONR_CommercialInsuranceManagedCareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CommercialInsuranceManagedCareMember" xlink:to="FONR_CommercialInsuranceManagedCareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CommercialInsuranceManagedCareMember_lbl" xml:lang="en-US">Commercial Insurance Managed Care [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_MedicareMedicaidMember" xlink:label="FONR_MedicareMedicaidMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicareMedicaidMember" xlink:to="FONR_MedicareMedicaidMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MedicareMedicaidMember_lbl" xml:lang="en-US">Medicare Medicaid [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_WorkersCompensationPersonalInjuryMember" xlink:label="FONR_WorkersCompensationPersonalInjuryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_WorkersCompensationPersonalInjuryMember" xlink:to="FONR_WorkersCompensationPersonalInjuryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_WorkersCompensationPersonalInjuryMember_lbl" xml:lang="en-US">Workers Compensation Personal Injury [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_OtherRevenueSourceMember" xlink:label="FONR_OtherRevenueSourceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OtherRevenueSourceMember" xlink:to="FONR_OtherRevenueSourceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OtherRevenueSourceMember_lbl" xml:lang="en-US">Other Revenue Source [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_lbl" xml:lang="en-US">Receivable Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableMember_lbl" xml:lang="en-US">Accounts Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DoubtfulMember" xlink:label="us-gaap_DoubtfulMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DoubtfulMember" xlink:to="us-gaap_DoubtfulMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DoubtfulMember_lbl" xml:lang="en-US">Doubtful [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_OperatingLeasePaymentsMember" xlink:label="FONR_OperatingLeasePaymentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OperatingLeasePaymentsMember" xlink:to="FONR_OperatingLeasePaymentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OperatingLeasePaymentsMember_lbl" xml:lang="en-US">Operating Lease Payments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_FinancingLeasePaymentsMember" xlink:label="FONR_FinancingLeasePaymentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_FinancingLeasePaymentsMember" xlink:to="FONR_FinancingLeasePaymentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_FinancingLeasePaymentsMember_lbl" xml:lang="en-US">Financing Lease Payments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xml:lang="en-US">Software and Software Development Costs [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LicenseMember" xlink:label="us-gaap_LicenseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LicenseMember" xlink:to="us-gaap_LicenseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LicenseMember_lbl" xml:lang="en-US">License [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="FONR_PatentsAndCopyrightsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PatentsAndCopyrightsMember" xlink:to="FONR_PatentsAndCopyrightsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PatentsAndCopyrightsMember_lbl" xml:lang="en-US">Patents And Copyrights [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="us-gaap_NoncompeteAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncompeteAgreementsMember" xlink:to="us-gaap_NoncompeteAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncompeteAgreementsMember_lbl" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerRelationshipsMember" xlink:to="us-gaap_CustomerRelationshipsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerRelationshipsMember_lbl" xml:lang="en-US">Customer Relationships [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ManufacturingAndServiceOfMRIEquipmentMember" xlink:label="FONR_ManufacturingAndServiceOfMRIEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManufacturingAndServiceOfMRIEquipmentMember" xlink:to="FONR_ManufacturingAndServiceOfMRIEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManufacturingAndServiceOfMRIEquipmentMember_lbl" xml:lang="en-US">Manufacturing And Service Of M R I Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HealthCareOtherMember" xlink:label="us-gaap_HealthCareOtherMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HealthCareOtherMember" xlink:to="us-gaap_HealthCareOtherMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_HealthCareOtherMember_lbl" xml:lang="en-US">Health Care, Other [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title and Position [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="srt_BoardOfDirectorsChairmanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_BoardOfDirectorsChairmanMember" xlink:to="srt_BoardOfDirectorsChairmanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_BoardOfDirectorsChairmanMember_lbl" xml:lang="en-US">Board of Directors Chairman [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_MagneticResonanceManagementMember" xlink:label="FONR_MagneticResonanceManagementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MagneticResonanceManagementMember" xlink:to="FONR_MagneticResonanceManagementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MagneticResonanceManagementMember_lbl" xml:lang="en-US">Magnetic Resonance Management [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current Assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermInvestments_lbl" xml:lang="en-US">Short-term investments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:to="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl" xml:lang="en-US">Accounts receivable &#8211; net of allowance for credit losses of $273 and $166 at December 31, 2024 and June 30, 2024, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_AccountReceivableRelatedParties" xlink:label="FONR_AccountReceivableRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountReceivableRelatedParties" xlink:to="FONR_AccountReceivableRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountReceivableRelatedParties_lbl" xml:lang="en-US">Accounts receivable _ related party</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_MedicalReceivable" xlink:label="FONR_MedicalReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicalReceivable" xlink:to="FONR_MedicalReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MedicalReceivable_lbl" xml:lang="en-US">Medical receivable &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedFeesAndOtherRevenueReceivable" xlink:label="us-gaap_AccruedFeesAndOtherRevenueReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedFeesAndOtherRevenueReceivable" xlink:to="us-gaap_AccruedFeesAndOtherRevenueReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedFeesAndOtherRevenueReceivable_lbl" xml:lang="en-US">Management and other fees receivable &#8211; net of allowance for credit losses of $12,663 and $12,370 at December 31, 2024 and June 30, 2024, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:to="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_lbl" xml:lang="en-US">Management and other fees receivable &#8211; related medical practices &#8211; net of allowance for credit losses of $6,989 and $6,110 at December 31, 2024 and June 30, 2024, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="us-gaap_InventoryFinishedGoodsAndWorkInProcess" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:to="us-gaap_InventoryFinishedGoodsAndWorkInProcess_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoodsAndWorkInProcess_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="FONR_AccountsReceivableNetLongTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableNetLongTerm" xlink:to="FONR_AccountsReceivableNetLongTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountsReceivableNetLongTerm_lbl" xml:lang="en-US">Accounts receivable &#8211; long term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xml:lang="en-US">Deferred income tax asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_NoteReceivableRelatedParty" xlink:label="FONR_NoteReceivableRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NoteReceivableRelatedParty" xlink:to="FONR_NoteReceivableRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NoteReceivableRelatedParty_lbl" xml:lang="en-US">Note receivable &#8211; related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Right-of-use-asset &#8211; operating leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="us-gaap_FinanceLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset_lbl" xml:lang="en-US">Right-of-use-asset &#8211; financing lease</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Other intangible assets &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssets" xlink:label="us-gaap_OtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssets" xlink:to="us-gaap_OtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current Liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xml:lang="en-US">Current portion of long-term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xml:lang="en-US">Unearned revenue on service contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_UnearnedRevenueOnServiceContractsRelatedParty" xlink:label="FONR_UnearnedRevenueOnServiceContractsRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_UnearnedRevenueOnServiceContractsRelatedParty" xlink:to="FONR_UnearnedRevenueOnServiceContractsRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_UnearnedRevenueOnServiceContractsRelatedParty_lbl" xml:lang="en-US">Unearned revenue on service contracts &#8211; related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Operating lease liabilities _ current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent_lbl" xml:lang="en-US">Financing lease liability _ current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_CustomerDeposits" xlink:label="FONR_CustomerDeposits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CustomerDeposits" xlink:to="FONR_CustomerDeposits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CustomerDeposits_lbl" xml:lang="en-US">Customer deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xml:lang="en-US">Long-Term Liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueNoncurrent" xlink:to="us-gaap_DeferredRevenueNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredRevenueNoncurrent_lbl" xml:lang="en-US">Unearned revenue on service contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:to="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_lbl" xml:lang="en-US">Deferred income tax liability</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_AccountsPayableRelatedPartyNoncurrent" xlink:label="FONR_AccountsPayableRelatedPartyNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsPayableRelatedPartyNoncurrent" xlink:to="FONR_AccountsPayableRelatedPartyNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountsPayableRelatedPartyNoncurrent_lbl" xml:lang="en-US">Due to related party medical practices</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Operating lease liabilities &#8211; net of current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Financing lease liability &#8211; net of current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xml:lang="en-US">Long-term debt, less current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_OtherLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilities_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Total Long-Term Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">EQUITY:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Paid-in capital in excess of par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValue" xlink:label="us-gaap_TreasuryStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_TreasuryStockValue_lbl" xml:lang="en-US">Treasury stock, at cost &#8211; 4 shares of common stock at December 31, 2024 and 45 shares of common stock at June 30, 2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total FONAR Corporation&#8217;s Stockholders&#8217; Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterest_lbl" xml:lang="en-US">Noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Total Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total Liabilities and Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:label="us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:to="us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_lbl" xml:lang="en-US">Allowance for Doubtful Accounts, Premiums and Other Receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" xlink:label="FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" xlink:to="FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts_lbl" xml:lang="en-US">[custom:ManagementAndOtherReceivableAllowancesForDoubtfulAccounts-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts" xlink:label="FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts" xlink:to="FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts_lbl" xml:lang="en-US">[custom:RelatedPartyReceivableAllowancesForDoubtfulAccounts-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="us-gaap_TreasuryStockCommonShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockCommonShares" xlink:to="us-gaap_TreasuryStockCommonShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockCommonShares_lbl" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesAbstract_lbl" xml:lang="en-US">REVENUES</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:label="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:to="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts_lbl" xml:lang="en-US">Patient fee revenue &#8211; net of contractual allowances and discounts</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ProductSalesNet" xlink:label="FONR_ProductSalesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ProductSalesNet" xlink:to="FONR_ProductSalesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ProductSalesNet_lbl" xml:lang="en-US">Product sales</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ServiceAndRepairFeesNet" xlink:label="FONR_ServiceAndRepairFeesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ServiceAndRepairFeesNet" xlink:to="FONR_ServiceAndRepairFeesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ServiceAndRepairFeesNet_lbl" xml:lang="en-US">Service and repair fees</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="FONR_ServiceAndRepairFeesRelatedPartiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:to="FONR_ServiceAndRepairFeesRelatedPartiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ServiceAndRepairFeesRelatedPartiesNet_lbl" xml:lang="en-US">Service and repair fees _ related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ManagementAndOtherFeesNet" xlink:label="FONR_ManagementAndOtherFeesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesNet" xlink:to="FONR_ManagementAndOtherFeesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFeesNet_lbl" xml:lang="en-US">Management and other fees</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:to="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet_lbl" xml:lang="en-US">Management and other fees _ related medical practices</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Total Revenues &#8211; Net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="us-gaap_CostsAndExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_CostsAndExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpensesAbstract_lbl" xml:lang="en-US">COSTS AND EXPENSES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="us-gaap_OtherCostOfOperatingRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCostOfOperatingRevenue" xlink:to="us-gaap_OtherCostOfOperatingRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCostOfOperatingRevenue_lbl" xml:lang="en-US">Costs related to patient fee revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_CostsRelatedToProductSales" xlink:label="FONR_CostsRelatedToProductSales" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToProductSales" xlink:to="FONR_CostsRelatedToProductSales_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToProductSales_lbl" xml:lang="en-US">Costs related to product sales</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_CostsRelatedToServiceAndRepairFees" xlink:label="FONR_CostsRelatedToServiceAndRepairFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToServiceAndRepairFees" xlink:to="FONR_CostsRelatedToServiceAndRepairFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToServiceAndRepairFees_lbl" xml:lang="en-US">Costs related to service and repair fees</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:to="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties_lbl" xml:lang="en-US">Costs related to service and repair fees _ related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_CostsRelatedToManagementAndOtherFees" xlink:label="FONR_CostsRelatedToManagementAndOtherFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToManagementAndOtherFees" xlink:to="FONR_CostsRelatedToManagementAndOtherFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToManagementAndOtherFees_lbl" xml:lang="en-US">Costs related to management and other fees</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:to="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_lbl" xml:lang="en-US">Costs related to management and other fees &#8211; related medical practices</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling, general and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CostsAndExpenses_lbl" xml:lang="en-US">Total Costs and Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_lbl" xml:lang="en-US">INCOME FROM OPERATIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other income and (expenses)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="us-gaap_InterestExpenseNonoperating" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseNonoperating" xlink:to="us-gaap_InterestExpenseNonoperating_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpenseNonoperating_lbl" xml:lang="en-US">Interest Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_InvestmentIncomeRelatedParty" xlink:label="FONR_InvestmentIncomeRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_InvestmentIncomeRelatedParty" xlink:to="FONR_InvestmentIncomeRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_InvestmentIncomeRelatedParty_lbl" xml:lang="en-US">Investment income &#8211; related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeNet" xlink:label="us-gaap_InvestmentIncomeNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeNet" xlink:to="us-gaap_InvestmentIncomeNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeNet_lbl" xml:lang="en-US">Investment income</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_OtherIncomeRelatedParty" xlink:label="FONR_OtherIncomeRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OtherIncomeRelatedParty" xlink:to="FONR_OtherIncomeRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OtherIncomeRelatedParty_lbl" xml:lang="en-US">Other income &#8211; related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Income Before Provision for Income Taxes and Noncontrolling Interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Provision for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ConsolidatedNetIncome" xlink:label="FONR_ConsolidatedNetIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ConsolidatedNetIncome" xlink:to="FONR_ConsolidatedNetIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="FONR_ConsolidatedNetIncome_lbl" xml:lang="en-US">Consolidated Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Net Income Noncontrolling Interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net Income &#8211; Attributable to FONAR</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US">Net Income Available to Common Stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Earnings Per Share, Basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Balance &#8211; June 30, 2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Beginning balance, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue_lbl" xml:lang="en-US">Purchase of Treasury stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xml:lang="en-US">Purchase of Treasury stock, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_lbl" xml:lang="en-US">Cancellation of shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_lbl" xml:lang="en-US">Cancellation of shares, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_CancellationOfTreasuryStock" xlink:label="FONR_CancellationOfTreasuryStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CancellationOfTreasuryStock" xlink:to="FONR_CancellationOfTreasuryStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CancellationOfTreasuryStock_lbl" xml:lang="en-US">Cancellation of Treasury stock</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_CancellationOfTreasuryStockShares" xlink:label="FONR_CancellationOfTreasuryStockShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CancellationOfTreasuryStockShares" xlink:to="FONR_CancellationOfTreasuryStockShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CancellationOfTreasuryStockShares_lbl" xml:lang="en-US">Cancellation of Treasury stock, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_SaleNonControllingInterests" xlink:label="FONR_SaleNonControllingInterests" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SaleNonControllingInterests" xlink:to="FONR_SaleNonControllingInterests_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_SaleNonControllingInterests_lbl" xml:lang="en-US">Sale - Non controlling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" xml:lang="en-US">Distributions - Non controlling interests</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Income - Non controlling interests</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xml:lang="en-US">Balance &#8211; December 31, 2023</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Ending balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Operating Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Consolidated Net income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile consolidated net income to net cash provided by operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="us-gaap_OtherDepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherDepreciationAndAmortization" xlink:to="us-gaap_OtherDepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherDepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_NetChangeInOperatingRightOfUseAssetsAndLeaseLiabilities" xlink:label="FONR_NetChangeInOperatingRightOfUseAssetsAndLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetChangeInOperatingRightOfUseAssetsAndLeaseLiabilities" xlink:to="FONR_NetChangeInOperatingRightOfUseAssetsAndLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="FONR_NetChangeInOperatingRightOfUseAssetsAndLeaseLiabilities_lbl" xml:lang="en-US">Net change in operating right of use assets and lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ProvisionForBadDebts" xlink:label="FONR_ProvisionForBadDebts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ProvisionForBadDebts" xlink:to="FONR_ProvisionForBadDebts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ProvisionForBadDebts_lbl" xml:lang="en-US">Provision for credit losses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred tax expense</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_GainOnSaleOfEquipmentRelatedParty" xlink:label="FONR_GainOnSaleOfEquipmentRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_GainOnSaleOfEquipmentRelatedParty" xlink:to="FONR_GainOnSaleOfEquipmentRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="FONR_GainOnSaleOfEquipmentRelatedParty_lbl" xml:lang="en-US">Gain on sale of equipment &#8211; related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities, net:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts, medical and management fee receivable(s)</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_IncreaseDecreaseInNotesReceivable" xlink:label="FONR_IncreaseDecreaseInNotesReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInNotesReceivable" xlink:to="FONR_IncreaseDecreaseInNotesReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncreaseDecreaseInNotesReceivable_lbl" xml:lang="en-US">Notes receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_IncreaseDecreaseInNotesReceivableRelatedParty" xlink:label="FONR_IncreaseDecreaseInNotesReceivableRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInNotesReceivableRelatedParty" xlink:to="FONR_IncreaseDecreaseInNotesReceivableRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncreaseDecreaseInNotesReceivableRelatedParty_lbl" xml:lang="en-US">Notes receivable &#8211; related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInTradingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInTradingLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInTradingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInTradingLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInTradingLiabilities_lbl" xml:lang="en-US">Financing lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_IncreaseDecreaseInCustomerDeposit" xlink:label="FONR_IncreaseDecreaseInCustomerDeposit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInCustomerDeposit" xlink:to="FONR_IncreaseDecreaseInCustomerDeposit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_IncreaseDecreaseInCustomerDeposit_lbl" xml:lang="en-US">Customer deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash provided by operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Investing Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchases of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:label="us-gaap_ProceedsFromSaleOfShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:to="us-gaap_ProceedsFromSaleOfShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfShortTermInvestments_lbl" xml:lang="en-US">Proceeds from short term investments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US">Cost of patents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Financing Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xml:lang="en-US">Repayment of borrowings and capital lease obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromMinorityShareholders" xlink:label="us-gaap_ProceedsFromMinorityShareholders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromMinorityShareholders" xlink:to="us-gaap_ProceedsFromMinorityShareholders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromMinorityShareholders_lbl" xml:lang="en-US">Sale of noncontrolling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" xlink:label="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" xlink:to="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock_lbl" xml:lang="en-US">Purchase of treasury stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xml:lang="en-US">Distributions to noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash used in financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xml:lang="en-US">Net (Decrease) Increase in Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash and Cash Equivalents - Beginning of Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xml:lang="en-US">Cash and Cash Equivalents - End of Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable" xlink:label="ecd_PvpTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTable" xlink:to="ecd_PvpTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTable_lbl" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis" xlink:label="ecd_ExecutiveCategoryAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ExecutiveCategoryAxis" xlink:to="ecd_ExecutiveCategoryAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ExecutiveCategoryAxis_lbl" xml:lang="en-US">Executive Category [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="ecd_IndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_IndividualAxis" xlink:to="ecd_IndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_IndividualAxis_lbl" xml:lang="en-US">Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis" xlink:label="ecd_AdjToCompAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAxis" xlink:to="ecd_AdjToCompAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAxis_lbl" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis" xlink:label="ecd_MeasureAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MeasureAxis" xlink:to="ecd_MeasureAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MeasureAxis_lbl" xml:lang="en-US">Measure [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock" xlink:label="ecd_PvpTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTableTextBlock" xlink:to="ecd_PvpTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTableTextBlock_lbl" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName" xlink:label="ecd_CoSelectedMeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureName" xlink:to="ecd_CoSelectedMeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureName_lbl" xml:lang="en-US">Company Selected Measure Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="ecd_PeerGroupIssuersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupIssuersFnTextBlock" xlink:to="ecd_PeerGroupIssuersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupIssuersFnTextBlock_lbl" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="ecd_ChangedPeerGroupFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ChangedPeerGroupFnTextBlock" xlink:to="ecd_ChangedPeerGroupFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ChangedPeerGroupFnTextBlock_lbl" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt" xlink:label="ecd_PeoTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoTotalCompAmt" xlink:to="ecd_PeoTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoTotalCompAmt_lbl" xml:lang="en-US">PEO Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="ecd_PeoActuallyPaidCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoActuallyPaidCompAmt" xlink:to="ecd_PeoActuallyPaidCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoActuallyPaidCompAmt_lbl" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="ecd_AdjToPeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToPeoCompFnTextBlock" xlink:to="ecd_AdjToPeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToPeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock" xlink:label="ecd_TabularListTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TabularListTableTextBlock" xlink:to="ecd_TabularListTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TabularListTableTextBlock_lbl" xml:lang="en-US">Tabular List, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt" xlink:label="ecd_TotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnAmt" xlink:to="ecd_TotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnAmt_lbl" xml:lang="en-US">Total Shareholder Return Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_3_lbl" xml:lang="en-US">Net Income (Loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt" xlink:label="ecd_CoSelectedMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureAmt" xlink:to="ecd_CoSelectedMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureAmt_lbl" xml:lang="en-US">Company Selected Measure Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt" xlink:label="ecd_OtherPerfMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OtherPerfMeasureAmt" xlink:to="ecd_OtherPerfMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OtherPerfMeasureAmt_lbl" xml:lang="en-US">Other Performance Measure, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt" xlink:label="ecd_AdjToCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAmt" xlink:to="ecd_AdjToCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAmt_lbl" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName" xlink:label="ecd_PeoName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoName" xlink:to="ecd_PeoName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoName_lbl" xml:lang="en-US">PEO Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName" xlink:label="ecd_MeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MeasureName" xlink:to="ecd_MeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MeasureName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xml:lang="en-US">Non-GAAP Measure Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="ecd_Additional402vDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Additional402vDisclosureTextBlock" xlink:to="ecd_Additional402vDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Additional402vDisclosureTextBlock_lbl" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="ecd_PnsnBnftsAdjFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PnsnBnftsAdjFnTextBlock" xlink:to="ecd_PnsnBnftsAdjFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PnsnBnftsAdjFnTextBlock_lbl" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable" xlink:label="ecd_ErrCompRecoveryTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompRecoveryTable" xlink:to="ecd_ErrCompRecoveryTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompRecoveryTable_lbl" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis" xlink:label="ecd_RestatementDateAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDateAxis" xlink:to="ecd_RestatementDateAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDateAxis_lbl" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate" xlink:label="ecd_RestatementDeterminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDeterminationDate" xlink:to="ecd_RestatementDeterminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDeterminationDate_lbl" xml:lang="en-US">Restatement Determination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt" xlink:label="ecd_AggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompAmt" xlink:to="ecd_AggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompAmt_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="ecd_ErrCompAnalysisTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompAnalysisTextBlock" xlink:to="ecd_ErrCompAnalysisTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompAnalysisTextBlock_lbl" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="ecd_OutstandingAggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingAggtErrCompAmt" xlink:to="ecd_OutstandingAggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingAggtErrCompAmt_lbl" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName" xlink:label="ecd_ForgoneRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_ForgoneRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName" xlink:label="ecd_OutstandingRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_OutstandingRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="ecd_OutstandingRecoveryCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryCompAmt" xlink:to="ecd_OutstandingRecoveryCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryCompAmt_lbl" xml:lang="en-US">Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xml:lang="en-US">Restatement does not require Recovery</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable" xlink:label="ecd_AwardsCloseToMnpiDiscTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTable" xlink:to="ecd_AwardsCloseToMnpiDiscTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTable_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="ecd_AwardTmgMnpiDiscTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiDiscTextBlock" xlink:to="ecd_AwardTmgMnpiDiscTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiDiscTextBlock_lbl" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="ecd_AwardTmgMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMethodTextBlock" xlink:to="ecd_AwardTmgMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMethodTextBlock_lbl" xml:lang="en-US">Award Timing Method</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="ecd_AwardTmgPredtrmndFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgPredtrmndFlag" xlink:to="ecd_AwardTmgPredtrmndFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgPredtrmndFlag_lbl" xml:lang="en-US">Award Timing Predetermined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xml:lang="en-US">Award Timing MNPI Considered</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="ecd_MnpiDiscTimedForCompValFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MnpiDiscTimedForCompValFlag" xlink:to="ecd_MnpiDiscTimedForCompValFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MnpiDiscTimedForCompValFlag_lbl" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="ecd_AwardsCloseToMnpiDiscIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="ecd_AwardUndrlygSecuritiesAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardUndrlygSecuritiesAmt" xlink:to="ecd_AwardUndrlygSecuritiesAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardUndrlygSecuritiesAmt_lbl" xml:lang="en-US">Underlying Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice" xlink:label="ecd_AwardExrcPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardExrcPrice" xlink:to="ecd_AwardExrcPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardExrcPrice_lbl" xml:lang="en-US">Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue" xlink:label="ecd_AwardGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardGrantDateFairValue" xlink:to="ecd_AwardGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardGrantDateFairValue_lbl" xml:lang="en-US">Fair Value as of Grant Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="ecd_UndrlygSecurityMktPriceChngPct" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_UndrlygSecurityMktPriceChngPct" xlink:to="ecd_UndrlygSecurityMktPriceChngPct_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_UndrlygSecurityMktPriceChngPct_lbl" xml:lang="en-US">Underlying Security Market Price Change</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable" xlink:label="ecd_TradingArrByIndTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TradingArrByIndTable" xlink:to="ecd_TradingArrByIndTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TradingArrByIndTable_lbl" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis" xlink:label="ecd_TradingArrAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TradingArrAxis" xlink:to="ecd_TradingArrAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TradingArrAxis_lbl" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName" xlink:label="ecd_TrdArrIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_TrdArrIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle" xlink:label="ecd_TrdArrIndTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndTitle" xlink:to="ecd_TrdArrIndTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndTitle_lbl" xml:lang="en-US">Title</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="ecd_Rule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrAdoptedFlag" xlink:to="ecd_Rule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="ecd_NonRule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrAdoptedFlag" xlink:to="ecd_NonRule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate" xlink:label="ecd_TrdArrAdoptionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrAdoptionDate" xlink:to="ecd_TrdArrAdoptionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrAdoptionDate_lbl" xml:lang="en-US">Adoption Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="ecd_Rule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrTrmntdFlag" xlink:to="ecd_Rule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="ecd_NonRule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrTrmntdFlag" xlink:to="ecd_NonRule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate" xlink:label="ecd_TrdArrTerminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrTerminationDate" xlink:to="ecd_TrdArrTerminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrTerminationDate_lbl" xml:lang="en-US">Termination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate" xlink:label="ecd_TrdArrExpirationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrExpirationDate" xlink:to="ecd_TrdArrExpirationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrExpirationDate_lbl" xml:lang="en-US">Expiration Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration" xlink:label="ecd_TrdArrDuration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrDuration" xlink:to="ecd_TrdArrDuration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrDuration_lbl" xml:lang="en-US">Arrangement Duration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="ecd_InsiderTradingPoliciesProcLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTradingPoliciesProcLineItems" xlink:to="ecd_InsiderTradingPoliciesProcLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTradingPoliciesProcLineItems_lbl" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_DisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract" xlink:label="FONR_DisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract" xlink:to="FONR_DisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract_lbl" xml:lang="en-US">Description Of Business And Basis Of Presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_DescriptionOfBusinessAndBasisOfPresentationTextBlock" xlink:label="FONR_DescriptionOfBusinessAndBasisOfPresentationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DescriptionOfBusinessAndBasisOfPresentationTextBlock" xlink:to="FONR_DescriptionOfBusinessAndBasisOfPresentationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DescriptionOfBusinessAndBasisOfPresentationTextBlock_lbl" xml:lang="en-US">DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesAbstract" xlink:label="us-gaap_ReceivablesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="us-gaap_ReceivablesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesAbstract_lbl" xml:lang="en-US">Receivables [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:to="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_lbl" xml:lang="en-US">ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_DisclosureOperatingAndFinancingLeasesAbstract" xlink:label="FONR_DisclosureOperatingAndFinancingLeasesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DisclosureOperatingAndFinancingLeasesAbstract" xlink:to="FONR_DisclosureOperatingAndFinancingLeasesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DisclosureOperatingAndFinancingLeasesAbstract_lbl" xml:lang="en-US">Operating And Financing Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_LesseeOperatingLeasesAndFinanceLeaseTextBlock" xlink:label="FONR_LesseeOperatingLeasesAndFinanceLeaseTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_LesseeOperatingLeasesAndFinanceLeaseTextBlock" xlink:to="FONR_LesseeOperatingLeasesAndFinanceLeaseTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_LesseeOperatingLeasesAndFinanceLeaseTextBlock_lbl" xml:lang="en-US">OPERATING AND FINANCING LEASES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">INVENTORIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">OTHER INTANGIBLE ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xml:lang="en-US">OTHER CURRENT LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">SEGMENT AND RELATED INFORMATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_SupplementalCashFlowElementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract_lbl" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:label="us-gaap_CashFlowSupplementalDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="us-gaap_CashFlowSupplementalDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowSupplementalDisclosuresTextBlock_lbl" xml:lang="en-US">SUPPLEMENTAL CASH FLOW INFORMATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">RELATED PARTY TRANSACTIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ManagementAndOtherFeeReceivablePolicyTextBlock" xlink:label="FONR_ManagementAndOtherFeeReceivablePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeeReceivablePolicyTextBlock" xlink:to="FONR_ManagementAndOtherFeeReceivablePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFeeReceivablePolicyTextBlock_lbl" xml:lang="en-US">Management and other fee receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Earnings Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xml:lang="en-US">Correction of immaterial errors</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Standards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xml:lang="en-US">Schedule of patient fee revenue - net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Schedule of earning per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_lbl" xml:lang="en-US">Schedule of financing receivable noncurrent allowance for credit loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermPurchaseCommitmentTextBlock" xlink:label="us-gaap_LongTermPurchaseCommitmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermPurchaseCommitmentTextBlock" xlink:to="us-gaap_LongTermPurchaseCommitmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermPurchaseCommitmentTextBlock_lbl" xml:lang="en-US">Schedule of future revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">Schedule of lessee operating leases liability maturity</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" xlink:label="FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" xlink:to="FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock_lbl" xml:lang="en-US">Schedule of weighted average remaining lease term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xml:lang="en-US">Components of lease expense</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:label="FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:to="FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_lbl" xml:lang="en-US">Supplemental cash flow information related to leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Schedule of inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl" xml:lang="en-US">Schedule of other intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xml:lang="en-US">Schedule of summarized segment financial information</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentOwnedPercentOfNetAssets" xlink:label="us-gaap_InvestmentOwnedPercentOfNetAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedPercentOfNetAssets" xlink:to="us-gaap_InvestmentOwnedPercentOfNetAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentOwnedPercentOfNetAssets_lbl" xml:lang="en-US">Investment Owned, Net Assets, Percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:label="us-gaap_ProceedsFromPaymentsToMinorityShareholders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:to="us-gaap_ProceedsFromPaymentsToMinorityShareholders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromPaymentsToMinorityShareholders_lbl" xml:lang="en-US">Proceeds from (Payments to) Noncontrolling Interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTable_lbl" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_NetPatientFeeRevenue" xlink:label="FONR_NetPatientFeeRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetPatientFeeRevenue" xlink:to="FONR_NetPatientFeeRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NetPatientFeeRevenue_lbl" xml:lang="en-US">Patient Fee Revenue, net of contractual allowances and discounts</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_NetIncomeLossAvailableToCommonStockholderBasic" xlink:label="FONR_NetIncomeLossAvailableToCommonStockholderBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetIncomeLossAvailableToCommonStockholderBasic" xlink:to="FONR_NetIncomeLossAvailableToCommonStockholderBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NetIncomeLossAvailableToCommonStockholderBasic_lbl" xml:lang="en-US">Basic Numerator: Net income available to common stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ConvertibleClassCStock" xlink:label="FONR_ConvertibleClassCStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ConvertibleClassCStock" xlink:to="FONR_ConvertibleClassCStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ConvertibleClassCStock_lbl" xml:lang="en-US">[custom:ConvertibleClassCStock]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_WeightedAverageNumberOfDilutedEarningsPerShare" xlink:label="FONR_WeightedAverageNumberOfDilutedEarningsPerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_WeightedAverageNumberOfDilutedEarningsPerShare" xlink:to="FONR_WeightedAverageNumberOfDilutedEarningsPerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_WeightedAverageNumberOfDilutedEarningsPerShare_lbl" xml:lang="en-US">[custom:WeightedAverageNumberOfDilutedEarningsPerShare]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_lbl" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_RightToUseAssetToIntangibleAsset" xlink:label="FONR_RightToUseAssetToIntangibleAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RightToUseAssetToIntangibleAsset" xlink:to="FONR_RightToUseAssetToIntangibleAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_RightToUseAssetToIntangibleAsset_lbl" xml:lang="en-US">[custom:RightToUseAssetToIntangibleAsset]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US">Operating Lease, Payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefitIntraperiodTaxAllocation" xlink:label="us-gaap_IncomeTaxExpenseBenefitIntraperiodTaxAllocation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefitIntraperiodTaxAllocation" xlink:to="us-gaap_IncomeTaxExpenseBenefitIntraperiodTaxAllocation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefitIntraperiodTaxAllocation_lbl" xml:lang="en-US">Income Tax Expense (Benefit), Intraperiod Tax Allocation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_lbl" xml:lang="en-US">Accounts and Financing Receivables [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="us-gaap_AccountsNotesAndLoansReceivableLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_AccountsNotesAndLoansReceivableLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsNotesAndLoansReceivableLineItems_lbl" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNet" xlink:label="us-gaap_AccountsReceivableNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNet" xlink:to="us-gaap_AccountsReceivableNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNet_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_AccountsReceivableNetRelatedParty" xlink:label="FONR_AccountsReceivableNetRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableNetRelatedParty" xlink:to="FONR_AccountsReceivableNetRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountsReceivableNetRelatedParty_lbl" xml:lang="en-US">Accounts receivable - related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NontradeReceivables" xlink:label="us-gaap_NontradeReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NontradeReceivables" xlink:to="us-gaap_NontradeReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NontradeReceivables_lbl" xml:lang="en-US">Medical receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ManagementAndOtherFeesNonRelatedParties" xlink:label="FONR_ManagementAndOtherFeesNonRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesNonRelatedParties" xlink:to="FONR_ManagementAndOtherFeesNonRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFeesNonRelatedParties_lbl" xml:lang="en-US">Management and other fees receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:to="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_2_lbl" xml:lang="en-US">Management and other fees receivable from related medical practices (&#8220;PC&#8217;s&#8221;)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractReceivableDueOneToTwoYears" xlink:label="us-gaap_ContractReceivableDueOneToTwoYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractReceivableDueOneToTwoYears" xlink:to="us-gaap_ContractReceivableDueOneToTwoYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractReceivableDueOneToTwoYears_lbl" xml:lang="en-US">Construction Contractor, Receivable, Excluding Contract Retainage, Year Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractReceivableDueTwoToThreeYears" xlink:label="us-gaap_ContractReceivableDueTwoToThreeYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractReceivableDueTwoToThreeYears" xlink:to="us-gaap_ContractReceivableDueTwoToThreeYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractReceivableDueTwoToThreeYears_lbl" xml:lang="en-US">Construction Contractor, Receivable, Excluding Contract Retainage, Year Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractReceivableDueThreeToFourYears" xlink:label="us-gaap_ContractReceivableDueThreeToFourYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractReceivableDueThreeToFourYears" xlink:to="us-gaap_ContractReceivableDueThreeToFourYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractReceivableDueThreeToFourYears_lbl" xml:lang="en-US">Construction Contractor, Receivable, Excluding Contract Retainage, Year Four</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractReceivableDueFourToFiveYears" xlink:label="us-gaap_ContractReceivableDueFourToFiveYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractReceivableDueFourToFiveYears" xlink:to="us-gaap_ContractReceivableDueFourToFiveYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractReceivableDueFourToFiveYears_lbl" xml:lang="en-US">Construction Contractor, Receivable, Excluding Contract Retainage, Year Five</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:label="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:to="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_lbl" xml:lang="en-US">Construction Contractor, Receivable, Excluding Contract Retainage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_lbl" xml:lang="en-US">Increase (Decrease) in Accounts and Other Receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:label="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:to="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_lbl" xml:lang="en-US">[custom:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1" xlink:label="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1" xlink:to="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1_lbl" xml:lang="en-US">[custom:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" xlink:label="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" xlink:to="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees_lbl" xml:lang="en-US">[custom:PercentageOfConsolidatedNetRevenueFromManagementFees]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">2027</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">2027</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US">2028</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US">2028</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xml:lang="en-US">2029</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_lbl" xml:lang="en-US">2029</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_PresentValueDiscount" xlink:label="FONR_PresentValueDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PresentValueDiscount" xlink:to="FONR_PresentValueDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PresentValueDiscount_lbl" xml:lang="en-US">Present value discount</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_PresentValueDiscountFinancingLease" xlink:label="FONR_PresentValueDiscountFinancingLease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PresentValueDiscountFinancingLease" xlink:to="FONR_PresentValueDiscountFinancingLease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_PresentValueDiscountFinancingLease_lbl" xml:lang="en-US">Present value discount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Operating Lease, Liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiability" xlink:label="us-gaap_FinanceLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiability" xlink:to="us-gaap_FinanceLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiability_lbl" xml:lang="en-US">Finance Lease, Liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DisclosureOperatingAndFinancingLeasesAbstract" xlink:to="FONR_DisclosureOperatingAndFinancingLeasesAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_DisclosureOperatingAndFinancingLeasesAbstract_2_lbl" xml:lang="en-US">Operating Financing Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseCost_lbl" xml:lang="en-US">Operating lease cost</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_FinanceLeaseCostsAbstract" xlink:label="FONR_FinanceLeaseCostsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_FinanceLeaseCostsAbstract" xlink:to="FONR_FinanceLeaseCostsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_FinanceLeaseCostsAbstract_lbl" xml:lang="en-US">Finance lease cost:</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_DepreciationOfLeasedEquipment" xlink:label="FONR_DepreciationOfLeasedEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DepreciationOfLeasedEquipment" xlink:to="FONR_DepreciationOfLeasedEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DepreciationOfLeasedEquipment_lbl" xml:lang="en-US">Depreciation of leased equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseInterestExpense" xlink:label="us-gaap_FinanceLeaseInterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseInterestExpense" xlink:to="us-gaap_FinanceLeaseInterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseInterestExpense_lbl" xml:lang="en-US">Interest on lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_FinanceLeaseCost" xlink:label="FONR_FinanceLeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_FinanceLeaseCost" xlink:to="FONR_FinanceLeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_FinanceLeaseCost_lbl" xml:lang="en-US">Total finance lease cost</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_OperatingCashFlowsFromOperatingLeases" xlink:label="FONR_OperatingCashFlowsFromOperatingLeases" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OperatingCashFlowsFromOperatingLeases" xlink:to="FONR_OperatingCashFlowsFromOperatingLeases_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OperatingCashFlowsFromOperatingLeases_lbl" xml:lang="en-US">Operating cash flows from operating leases</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_FinancingCashFlowsFromFinancingLeases" xlink:label="FONR_FinancingCashFlowsFromFinancingLeases" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_FinancingCashFlowsFromFinancingLeases" xlink:to="FONR_FinancingCashFlowsFromFinancingLeases_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_FinancingCashFlowsFromFinancingLeases_lbl" xml:lang="en-US">Financing cash flows from financing leases</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" xlink:label="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" xlink:to="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract_lbl" xml:lang="en-US">Right-of-use and equipment assets obtained in exchange for lease obligations:</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" xlink:label="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" xlink:to="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_lbl" xml:lang="en-US">Operating leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherInventorySupplies" xlink:label="us-gaap_OtherInventorySupplies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInventorySupplies" xlink:to="us-gaap_OtherInventorySupplies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherInventorySupplies_lbl" xml:lang="en-US">Purchased parts, components and supplies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcess" xlink:label="us-gaap_InventoryWorkInProcess" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcess" xlink:to="us-gaap_InventoryWorkInProcess_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWorkInProcess_lbl" xml:lang="en-US">Work-in-process</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Total Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xml:lang="en-US">Intangible Asset, Finite-Lived [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_lbl" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US">Gross carrying amount intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Accumulated amortization intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Net carrying amount intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_2_lbl" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization of Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="us-gaap_AccruedSalariesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedSalariesCurrent" xlink:to="us-gaap_AccruedSalariesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedSalariesCurrent_lbl" xml:lang="en-US">Accrued salaries, commissions and payroll taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesAndExciseTaxPayableCurrent" xlink:to="us-gaap_SalesAndExciseTaxPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrent_lbl" xml:lang="en-US">Sales tax payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedPayrollTaxesCurrent" xlink:label="us-gaap_AccruedPayrollTaxesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedPayrollTaxesCurrent" xlink:to="us-gaap_AccruedPayrollTaxesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedPayrollTaxesCurrent_lbl" xml:lang="en-US">Federal and state income taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_SelffundedHealthInsuranceReserve" xlink:label="FONR_SelffundedHealthInsuranceReserve" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SelffundedHealthInsuranceReserve" xlink:to="FONR_SelffundedHealthInsuranceReserve_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_SelffundedHealthInsuranceReserve_lbl" xml:lang="en-US">Self-funded health insurance reserve</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_SoftwareLicenses" xlink:label="FONR_SoftwareLicenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SoftwareLicenses" xlink:to="FONR_SoftwareLicenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_SoftwareLicenses_lbl" xml:lang="en-US">Software Licenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherSundryLiabilitiesCurrent" xlink:label="us-gaap_OtherSundryLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="us-gaap_OtherSundryLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherSundryLiabilitiesCurrent_lbl" xml:lang="en-US">Other general and administrative expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherLiabilitiesCurrent_2_lbl" xml:lang="en-US">Other Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:label="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_lbl" xml:lang="en-US">Segment Reporting, Revenue from External Customer, Product and Service [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:label="us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_lbl" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_2_lbl" xml:lang="en-US">Net revenues from external customers</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_IntersegmentNetRevenues" xlink:label="FONR_IntersegmentNetRevenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IntersegmentNetRevenues" xlink:to="FONR_IntersegmentNetRevenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IntersegmentNetRevenues_lbl" xml:lang="en-US">Inter-segment net revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="us-gaap_IncomeLossFromContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperations" xlink:to="us-gaap_IncomeLossFromContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperations_lbl" xml:lang="en-US">(Loss) Income from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xml:lang="en-US">Capital expenditures</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaid" xlink:label="us-gaap_IncomeTaxesPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaid_lbl" xml:lang="en-US">Income Taxes Paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_RateOfInterestSold" xlink:label="FONR_RateOfInterestSold" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RateOfInterestSold" xlink:to="FONR_RateOfInterestSold_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_RateOfInterestSold_lbl" xml:lang="en-US">[custom:RateOfInterestSold]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="us-gaap_ConversionOfStockAmountConverted1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockAmountConverted1" xlink:to="us-gaap_ConversionOfStockAmountConverted1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockAmountConverted1_lbl" xml:lang="en-US">Conversion of Stock, Amount Converted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramAuthorizedAmount1" xlink:label="srt_StockRepurchaseProgramAuthorizedAmount1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StockRepurchaseProgramAuthorizedAmount1" xlink:to="srt_StockRepurchaseProgramAuthorizedAmount1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StockRepurchaseProgramAuthorizedAmount1_lbl" xml:lang="en-US">Share Repurchase Program, Authorized, Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_2_lbl" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue_2_lbl" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodShares_lbl" xml:lang="en-US">Stock Redeemed or Called During Period, Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodValue_lbl" xml:lang="en-US">Stock Redeemed or Called During Period, Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:label="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_lbl" xml:lang="en-US">Share Repurchase Program, Remaining Authorized, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:label="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:to="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_lbl" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SelfInsuranceReserve" xlink:label="us-gaap_SelfInsuranceReserve" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SelfInsuranceReserve" xlink:to="us-gaap_SelfInsuranceReserve_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SelfInsuranceReserve_lbl" xml:lang="en-US">Self Insurance Reserve</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_lbl" xml:lang="en-US">Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" xlink:label="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" xlink:to="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax_lbl" xml:lang="en-US">Extinguishment of Debt, Gain (Loss), Net of Tax</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_DeferredIncomeTaxComponent" xlink:label="FONR_DeferredIncomeTaxComponent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DeferredIncomeTaxComponent" xlink:to="FONR_DeferredIncomeTaxComponent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DeferredIncomeTaxComponent_lbl" xml:lang="en-US">[custom:DeferredIncomeTaxComponent]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:label="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:to="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_lbl" xml:lang="en-US">Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Policyholders' Surplus</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_PercentageOfExciseTax" xlink:label="FONR_PercentageOfExciseTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PercentageOfExciseTax" xlink:to="FONR_PercentageOfExciseTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PercentageOfExciseTax_lbl" xml:lang="en-US">[custom:PercentageOfExciseTax]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_CorporateAlternativeMinimumTaxPercentage" xlink:label="FONR_CorporateAlternativeMinimumTaxPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CorporateAlternativeMinimumTaxPercentage" xlink:to="FONR_CorporateAlternativeMinimumTaxPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CorporateAlternativeMinimumTaxPercentage_lbl" xml:lang="en-US">[custom:CorporateAlternativeMinimumTaxPercentage]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_NetRevenues" xlink:label="FONR_NetRevenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetRevenues" xlink:to="FONR_NetRevenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NetRevenues_lbl" xml:lang="en-US">[custom:NetRevenues]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ServiceAndMaintenancePrice" xlink:label="FONR_ServiceAndMaintenancePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ServiceAndMaintenancePrice" xlink:to="FONR_ServiceAndMaintenancePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ServiceAndMaintenancePrice_lbl" xml:lang="en-US">[custom:ServiceAndMaintenancePrice-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ServiceAndRepairFees" xlink:label="FONR_ServiceAndRepairFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ServiceAndRepairFees" xlink:to="FONR_ServiceAndRepairFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ServiceAndRepairFees_lbl" xml:lang="en-US">[custom:ServiceAndRepairFees]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_EmployeesFee" xlink:label="FONR_EmployeesFee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EmployeesFee" xlink:to="FONR_EmployeesFee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_EmployeesFee_lbl" xml:lang="en-US">[custom:EmployeesFee]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="us-gaap_ConvertibleNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayable" xlink:to="us-gaap_ConvertibleNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleNotesPayable_lbl" xml:lang="en-US">Convertible Notes Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFixedInterestRate" xlink:label="us-gaap_DerivativeFixedInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeFixedInterestRate" xlink:to="us-gaap_DerivativeFixedInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeFixedInterestRate_lbl" xml:lang="en-US">Derivative, Fixed Interest Rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeNet" xlink:to="us-gaap_InvestmentIncomeNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InvestmentIncomeNet_2_lbl" xml:lang="en-US">Investment Income, Net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredGainOnSaleOfProperty" xlink:label="us-gaap_DeferredGainOnSaleOfProperty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredGainOnSaleOfProperty" xlink:to="us-gaap_DeferredGainOnSaleOfProperty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredGainOnSaleOfProperty_lbl" xml:lang="en-US">Deferred Gain on Sale of Property</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchaseds" xlink:label="FONR_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchaseds" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchaseds" xlink:to="FONR_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchaseds_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchaseds_lbl" xml:lang="en-US">[custom:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchaseds-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount" xlink:label="FONR_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount" xlink:to="FONR_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount_lbl" xml:lang="en-US">[custom:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount-0]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueNoncurrent" xlink:to="us-gaap_DeferredRevenueNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueNoncurrent_2_lbl" xml:lang="en-US">Deferred Revenue, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Liabilities, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockValue_2_lbl" xml:lang="en-US">Treasury Stock, Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Equity, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4_lbl" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpenses_2_lbl" xml:lang="en-US">Costs and Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Interest Expense, Interest Income, Income Taxes, Noncontrolling Interests, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseNonoperating" xlink:to="us-gaap_InterestExpenseNonoperating_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseNonoperating_2_lbl" xml:lang="en-US">Interest Expense, Nonoperating</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ConsolidatedNetIncome" xlink:to="FONR_ConsolidatedNetIncome_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ConsolidatedNetIncome_2_lbl" xml:lang="en-US">ConsolidatedNetIncome</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_2_lbl" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetChangeInOperatingRightOfUseAssetsAndLeaseLiabilities" xlink:to="FONR_NetChangeInOperatingRightOfUseAssetsAndLeaseLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NetChangeInOperatingRightOfUseAssetsAndLeaseLiabilities_2_lbl" xml:lang="en-US">NetChangeInOperatingRightOfUseAssetsAndLeaseLiabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_GainOnSaleOfEquipmentRelatedParty" xlink:to="FONR_GainOnSaleOfEquipmentRelatedParty_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_GainOnSaleOfEquipmentRelatedParty_2_lbl" xml:lang="en-US">GainOnSaleOfEquipmentRelatedParty</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expenses, Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Current Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInCustomerDeposit" xlink:to="FONR_IncreaseDecreaseInCustomerDeposit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncreaseDecreaseInCustomerDeposit_2_lbl" xml:lang="en-US">IncreaseDecreaseInCustomerDeposit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfNotesPayable_2_lbl" xml:lang="en-US">Repayments of Notes Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" xlink:to="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock_2_lbl" xml:lang="en-US">Payments for Repurchase of Convertible Preferred Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="us-gaap_PaymentsOfDividendsMinorityInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest_2_lbl" xml:lang="en-US">Payments of Ordinary Dividends, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryIndName_2_lbl" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryIndName_2_lbl" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndName_2_lbl" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PresentValueDiscountFinancingLease" xlink:to="FONR_PresentValueDiscountFinancingLease_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PresentValueDiscountFinancingLease_2_lbl" xml:lang="en-US">PresentValueDiscountFinancingLease</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_2_lbl" xml:lang="en-US">Inventory, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_2_lbl" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>fonr-20241231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://fonar.com/role/Cover" xlink:href="fonr-20241231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheets" xlink:href="fonr-20241231.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="fonr-20241231.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfOperations" xlink:href="fonr-20241231.xsd#CondensedConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity" xlink:href="fonr-20241231.xsd#CondensedConsolidatedStatementsOfChangesInEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:href="fonr-20241231.xsd#CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:href="fonr-20241231.xsd#DescriptionOfBusinessAndBasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="fonr-20241231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:href="fonr-20241231.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingAndFinancingLeases" xlink:href="fonr-20241231.xsd#OperatingAndFinancingLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories" xlink:href="fonr-20241231.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets" xlink:href="fonr-20241231.xsd#OtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities" xlink:href="fonr-20241231.xsd#OtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation" xlink:href="fonr-20241231.xsd#SegmentAndRelatedInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformation" xlink:href="fonr-20241231.xsd#SupplementalCashFlowInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingencies" xlink:href="fonr-20241231.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes" xlink:href="fonr-20241231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/RelatedPartyTransactions" xlink:href="fonr-20241231.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEvents" xlink:href="fonr-20241231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="fonr-20241231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="fonr-20241231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:href="fonr-20241231.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingAndFinancingLeasesTables" xlink:href="fonr-20241231.xsd#OperatingAndFinancingLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/InventoriesTables" xlink:href="fonr-20241231.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:href="fonr-20241231.xsd#OtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:href="fonr-20241231.xsd#OtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:href="fonr-20241231.xsd#SegmentAndRelatedInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:href="fonr-20241231.xsd#DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details" xlink:href="fonr-20241231.xsd#SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details1" xlink:href="fonr-20241231.xsd#SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details1" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="fonr-20241231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:href="fonr-20241231.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-FutureRevenueDetails1" xlink:href="fonr-20241231.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-FutureRevenueDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:href="fonr-20241231.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:href="fonr-20241231.xsd#OperatingFinancingLeases-LeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeasesDetails1" xlink:href="fonr-20241231.xsd#OperatingFinancingLeasesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeasesDetails2" xlink:href="fonr-20241231.xsd#OperatingFinancingLeasesDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeasesDetails3" xlink:href="fonr-20241231.xsd#OperatingFinancingLeasesDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories-InventoriesDetails" xlink:href="fonr-20241231.xsd#Inventories-InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsDetails" xlink:href="fonr-20241231.xsd#OtherIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsDetails1" xlink:href="fonr-20241231.xsd#OtherIntangibleAssetsDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:href="fonr-20241231.xsd#OtherIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:href="fonr-20241231.xsd#OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details" xlink:href="fonr-20241231.xsd#SegmentAndRelatedInformation-SummarizedSegments-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:href="fonr-20241231.xsd#SupplementalCashFlowInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="fonr-20241231.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:href="fonr-20241231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="fonr-20241231.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:href="fonr-20241231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredClassAMember" xlink:label="loc_us-gaapPreferredClassAMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="loc_us-gaapAccountsAndOtherReceivablesNetCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsAndOtherReceivablesNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_AccountReceivableRelatedParties" xlink:label="loc_FONRAccountReceivableRelatedParties" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRAccountReceivableRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRMedicalReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedFeesAndOtherRevenueReceivable" xlink:label="loc_us-gaapAccruedFeesAndOtherRevenueReceivable" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccruedFeesAndOtherRevenueReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="loc_FONRAccountsReceivableNetLongTerm" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRAccountsReceivableNetLongTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_NoteReceivableRelatedParty" xlink:label="loc_FONRNoteReceivableRelatedParty" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRNoteReceivableRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAsset" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_UnearnedRevenueOnServiceContractsRelatedParty" xlink:label="loc_FONRUnearnedRevenueOnServiceContractsRelatedParty" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_FONRUnearnedRevenueOnServiceContractsRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityCurrent" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapFinanceLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_CustomerDeposits" xlink:label="loc_FONRCustomerDeposits" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_FONRCustomerDeposits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaapDeferredRevenueNoncurrent" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapDeferredRevenueNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_AccountsPayableRelatedPartyNoncurrent" xlink:label="loc_FONRAccountsPayableRelatedPartyNoncurrent" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_FONRAccountsPayableRelatedPartyNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityNoncurrent" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapFinanceLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLongTermDebtNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOtherLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" xlink:label="loc_FONRManagementAndOtherReceivableAllowancesForDoubtfulAccounts" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRManagementAndOtherReceivableAllowancesForDoubtfulAccounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts" xlink:label="loc_FONRRelatedPartyReceivableAllowancesForDoubtfulAccounts" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRRelatedPartyReceivableAllowancesForDoubtfulAccounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="loc_us-gaapTreasuryStockCommonShares" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockCommonShares" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_CommonStockholdersMember" xlink:label="loc_FONRCommonStockholdersMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRCommonStockholdersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ClassANonVotingPreferredStockholdersMember" xlink:label="loc_FONRClassANonVotingPreferredStockholdersMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockholdersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaapRevenuesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenuesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:label="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ProductSalesNet" xlink:label="loc_FONRProductSalesNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRProductSalesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ServiceAndRepairFeesNet" xlink:label="loc_FONRServiceAndRepairFeesNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRServiceAndRepairFeesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="loc_FONRServiceAndRepairFeesRelatedPartiesNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRServiceAndRepairFeesRelatedPartiesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ManagementAndOtherFeesNet" xlink:label="loc_FONRManagementAndOtherFeesNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRManagementAndOtherFeesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="loc_us-gaapCostsAndExpensesAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostsAndExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="loc_us-gaapOtherCostOfOperatingRevenue" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapOtherCostOfOperatingRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_CostsRelatedToProductSales" xlink:label="loc_FONRCostsRelatedToProductSales" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToProductSales" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_CostsRelatedToServiceAndRepairFees" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFees" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_CostsRelatedToManagementAndOtherFees" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFees" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapCostsAndExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="loc_us-gaapInterestExpenseNonoperating" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestExpenseNonoperating" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_InvestmentIncomeRelatedParty" xlink:label="loc_FONRInvestmentIncomeRelatedParty" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRInvestmentIncomeRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentIncomeNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_OtherIncomeRelatedParty" xlink:label="loc_FONROtherIncomeRelatedParty" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONROtherIncomeRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ConsolidatedNetIncome" xlink:label="loc_FONRConsolidatedNetIncome" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRConsolidatedNetIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity" xlink:title="00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember" xlink:label="loc_us-gaapTreasuryStockCommonMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapTreasuryStockCommonMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapNoncontrollingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensationForfeited" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_CancellationOfTreasuryStock" xlink:label="loc_FONRCancellationOfTreasuryStock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRCancellationOfTreasuryStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_CancellationOfTreasuryStockShares" xlink:label="loc_FONRCancellationOfTreasuryStockShares" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRCancellationOfTreasuryStockShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_SaleNonControllingInterests" xlink:label="loc_FONRSaleNonControllingInterests" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRSaleNonControllingInterests" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="loc_us-gaapOtherDepreciationAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapOtherDepreciationAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_NetChangeInOperatingRightOfUseAssetsAndLeaseLiabilities" xlink:label="loc_FONRNetChangeInOperatingRightOfUseAssetsAndLeaseLiabilities" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_FONRNetChangeInOperatingRightOfUseAssetsAndLeaseLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ProvisionForBadDebts" xlink:label="loc_FONRProvisionForBadDebts" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_FONRProvisionForBadDebts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_GainOnSaleOfEquipmentRelatedParty" xlink:label="loc_FONRGainOnSaleOfEquipmentRelatedParty" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_FONRGainOnSaleOfEquipmentRelatedParty" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_IncreaseDecreaseInNotesReceivable" xlink:label="loc_FONRIncreaseDecreaseInNotesReceivable" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_FONRIncreaseDecreaseInNotesReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_IncreaseDecreaseInNotesReceivableRelatedParty" xlink:label="loc_FONRIncreaseDecreaseInNotesReceivableRelatedParty" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_FONRIncreaseDecreaseInNotesReceivableRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInTradingLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInTradingLiabilities" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInTradingLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_IncreaseDecreaseInCustomerDeposit" xlink:label="loc_FONRIncreaseDecreaseInCustomerDeposit" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_FONRIncreaseDecreaseInCustomerDeposit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccruedLiabilities" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:label="loc_us-gaapProceedsFromSaleOfShortTermInvestments" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromSaleOfShortTermInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromMinorityShareholders" xlink:label="loc_us-gaapProceedsFromMinorityShareholders" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromMinorityShareholders" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" xlink:label="loc_us-gaapPaymentsForRepurchaseOfConvertiblePreferredStock" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsForRepurchaseOfConvertiblePreferredStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="loc_us-gaapPaymentsOfDividendsMinorityInterest" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfDividendsMinorityInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:title="995410 - Disclosure - Pay vs Performance Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems" xlink:label="loc_ecdPayVsPerformanceDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable" xlink:label="loc_ecdPvpTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis" xlink:label="loc_ecdExecutiveCategoryAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdExecutiveCategoryAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllExecutiveCategoriesMember" xlink:label="loc_ecdAllExecutiveCategoriesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdExecutiveCategoryAxis" xlink:to="loc_ecdAllExecutiveCategoriesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis" xlink:label="loc_ecdAdjToCompAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdAdjToCompAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember" xlink:label="loc_ecdAllAdjToCompMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAdjToCompAxis" xlink:to="loc_ecdAllAdjToCompMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis" xlink:label="loc_ecdMeasureAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdMeasureAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock" xlink:label="loc_ecdPvpTableTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName" xlink:label="loc_ecdCoSelectedMeasureName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdCoSelectedMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="loc_ecdNamedExecutiveOfficersFnTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNamedExecutiveOfficersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="loc_ecdPeerGroupIssuersFnTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeerGroupIssuersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="loc_ecdChangedPeerGroupFnTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdChangedPeerGroupFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt" xlink:label="loc_ecdPeoTotalCompAmt" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="loc_ecdPeoActuallyPaidCompAmt" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoActuallyPaidCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="loc_ecdAdjToPeoCompFnTextBlock" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToPeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="loc_ecdNonPeoNeoAvgTotalCompAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdNonPeoNeoAvgTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="loc_ecdAdjToNonPeoNeoCompFnTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdAdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:presentationArc order="2140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" />
      <link:presentationArc order="2150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" />
      <link:presentationArc order="2160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock" xlink:label="loc_ecdTabularListTableTextBlock" />
      <link:presentationArc order="2170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdTabularListTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt" xlink:label="loc_ecdTotalShareholderRtnAmt" />
      <link:presentationArc order="2180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="loc_ecdPeerGroupTotalShareholderRtnAmt" />
      <link:presentationArc order="2190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdPeerGroupTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="2200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt" xlink:label="loc_ecdCoSelectedMeasureAmt" />
      <link:presentationArc order="2210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdCoSelectedMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt" xlink:label="loc_ecdOtherPerfMeasureAmt" />
      <link:presentationArc order="2220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdOtherPerfMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt" xlink:label="loc_ecdAdjToCompAmt" />
      <link:presentationArc order="2230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdAdjToCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName" xlink:label="loc_ecdPeoName" />
      <link:presentationArc order="2240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdPeoName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName" xlink:label="loc_ecdMeasureName" />
      <link:presentationArc order="2250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="loc_ecdNonGaapMeasureDescriptionTextBlock" />
      <link:presentationArc order="2260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdMeasureName" xlink:to="loc_ecdNonGaapMeasureDescriptionTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="loc_ecdAdditional402vDisclosureTextBlock" />
      <link:presentationArc order="2270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdAdditional402vDisclosureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="loc_ecdPnsnBnftsAdjFnTextBlock" />
      <link:presentationArc order="2280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPnsnBnftsAdjFnTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:title="995440 - Disclosure - Recovery of Erroneously Awarded Compensation">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems" xlink:label="loc_ecdRecoveryOfErrCompDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable" xlink:label="loc_ecdErrCompRecoveryTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdErrCompRecoveryTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis" xlink:label="loc_ecdRestatementDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdRestatementDateAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate" xlink:label="loc_ecdRestatementDeterminationDate" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdRestatementDeterminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt" xlink:label="loc_ecdAggtErrCompAmt" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="loc_ecdErrCompAnalysisTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdErrCompAnalysisTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="loc_ecdOutstandingAggtErrCompAmt" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdOutstandingAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="loc_ecdAggtErrCompNotYetDeterminedTextBlock" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdAggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName" xlink:label="loc_ecdForgoneRecoveryIndName" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName" xlink:label="loc_ecdOutstandingRecoveryIndName" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="loc_ecdOutstandingRecoveryCompAmt" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:title="995443 - Disclosure - Award Timing Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems" xlink:label="loc_ecdAwardTmgDiscLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable" xlink:label="loc_ecdAwardsCloseToMnpiDiscTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardsCloseToMnpiDiscTable" xlink:to="loc_ecdIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="loc_ecdAwardTmgMnpiDiscTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiDiscTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="loc_ecdAwardTmgMethodTextBlock" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="loc_ecdAwardTmgPredtrmndFlag" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgPredtrmndFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="loc_ecdAwardTmgMnpiCnsdrdFlag" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiCnsdrdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="loc_ecdMnpiDiscTimedForCompValFlag" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdMnpiDiscTimedForCompValFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="loc_ecdAwardsCloseToMnpiDiscIndName" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="loc_ecdAwardUndrlygSecuritiesAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardUndrlygSecuritiesAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice" xlink:label="loc_ecdAwardExrcPrice" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardExrcPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue" xlink:label="loc_ecdAwardGrantDateFairValue" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="loc_ecdUndrlygSecurityMktPriceChngPct" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdUndrlygSecurityMktPriceChngPct" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:title="995445 - Disclosure - Insider Trading Arrangements">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems" xlink:label="loc_ecdInsiderTradingArrLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable" xlink:label="loc_ecdTradingArrByIndTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTradingArrByIndTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis" xlink:label="loc_ecdTradingArrAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrByIndTable" xlink:to="loc_ecdTradingArrAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllTradingArrangementsMember" xlink:label="loc_ecdAllTradingArrangementsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrAxis" xlink:to="loc_ecdAllTradingArrangementsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrByIndTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="loc_ecdMtrlTermsOfTrdArrTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdMtrlTermsOfTrdArrTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName" xlink:label="loc_ecdTrdArrIndName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle" xlink:label="loc_ecdTrdArrIndTitle" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="loc_ecdRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="loc_ecdNonRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate" xlink:label="loc_ecdTrdArrAdoptionDate" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrAdoptionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="loc_ecdRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="loc_ecdNonRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate" xlink:label="loc_ecdTrdArrTerminationDate" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrTerminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate" xlink:label="loc_ecdTrdArrExpirationDate" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrExpirationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration" xlink:label="loc_ecdTrdArrDuration" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrDuration" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:title="995447 - Disclosure - Insider Trading Policies and Procedures">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="loc_ecdInsiderTradingPoliciesProcLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:title="995612 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION">
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_DisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract" xlink:label="loc_FONRDisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_DescriptionOfBusinessAndBasisOfPresentationTextBlock" xlink:label="loc_FONRDescriptionOfBusinessAndBasisOfPresentationTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract" xlink:to="loc_FONRDescriptionOfBusinessAndBasisOfPresentationTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="995613 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:title="995614 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="loc_us-gaapLoansNotesTradeAndOtherReceivablesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapLoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingAndFinancingLeases" xlink:title="995615 - Disclosure - OPERATING AND FINANCING LEASES">
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_DisclosureOperatingAndFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingAndFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_LesseeOperatingLeasesAndFinanceLeaseTextBlock" xlink:label="loc_FONRLesseeOperatingLeasesAndFinanceLeaseTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingAndFinancingLeasesAbstract" xlink:to="loc_FONRLesseeOperatingLeasesAndFinanceLeaseTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories" xlink:title="995616 - Disclosure - INVENTORIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaapInventoryDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets" xlink:title="995617 - Disclosure - OTHER INTANGIBLE ASSETS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaapIntangibleAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapIntangibleAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities" xlink:title="995618 - Disclosure - OTHER CURRENT LIABILITIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="loc_us-gaapAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation" xlink:title="995619 - Disclosure - SEGMENT AND RELATED INFORMATION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaapSegmentReportingDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapSegmentReportingDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformation" xlink:title="995620 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="loc_us-gaapSupplementalCashFlowElementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:label="loc_us-gaapCashFlowSupplementalDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapCashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingencies" xlink:title="995621 - Disclosure - COMMITMENTS AND CONTINGENCIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes" xlink:title="995622 - Disclosure - INCOME TAXES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/RelatedPartyTransactions" xlink:title="995623 - Disclosure - RELATED PARTY TRANSACTIONS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEvents" xlink:title="995624 - Disclosure - SUBSEQUENT EVENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="995625 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ManagementAndOtherFeeReceivablePolicyTextBlock" xlink:label="loc_FONRManagementAndOtherFeeReceivablePolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_FONRManagementAndOtherFeeReceivablePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="995626 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaapDisaggregationOfRevenueTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDisaggregationOfRevenueTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:title="995627 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermPurchaseCommitmentTextBlock" xlink:label="loc_us-gaapLongTermPurchaseCommitmentTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapLongTermPurchaseCommitmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingAndFinancingLeasesTables" xlink:title="995628 - Disclosure - OPERATING AND FINANCING LEASES (Tables)">
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_DisclosureOperatingAndFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingAndFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingAndFinancingLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" xlink:label="loc_FONRScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingAndFinancingLeasesAbstract" xlink:to="loc_FONRScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaapLeaseCostTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingAndFinancingLeasesAbstract" xlink:to="loc_us-gaapLeaseCostTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:label="loc_FONRSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingAndFinancingLeasesAbstract" xlink:to="loc_FONRSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/InventoriesTables" xlink:title="995629 - Disclosure - INVENTORIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:title="995630 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="loc_us-gaapScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="loc_us-gaapScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:title="995631 - Disclosure - OTHER CURRENT LIABILITIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:title="995632 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:title="995633 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_DisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract" xlink:label="loc_FONRDisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherInvesteesMember" xlink:label="loc_us-gaapOtherInvesteesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_us-gaapOtherInvesteesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapNoncontrollingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentOwnedPercentOfNetAssets" xlink:label="loc_us-gaapInvestmentOwnedPercentOfNetAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentOwnedPercentOfNetAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:label="loc_us-gaapProceedsFromPaymentsToMinorityShareholders" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromPaymentsToMinorityShareholders" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details" xlink:title="995634 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaapDisaggregationOfRevenueTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDisaggregationOfRevenueTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaapDisaggregationOfRevenueLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_us-gaapDisaggregationOfRevenueLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_CommercialInsuranceManagedCareMember" xlink:label="loc_FONRCommercialInsuranceManagedCareMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRCommercialInsuranceManagedCareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_MedicareMedicaidMember" xlink:label="loc_FONRMedicareMedicaidMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRMedicareMedicaidMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_WorkersCompensationPersonalInjuryMember" xlink:label="loc_FONRWorkersCompensationPersonalInjuryMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRWorkersCompensationPersonalInjuryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_OtherRevenueSourceMember" xlink:label="loc_FONROtherRevenueSourceMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONROtherRevenueSourceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_NetPatientFeeRevenue" xlink:label="loc_FONRNetPatientFeeRevenue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_FONRNetPatientFeeRevenue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details1" xlink:title="995635 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_NetIncomeLossAvailableToCommonStockholderBasic" xlink:label="loc_FONRNetIncomeLossAvailableToCommonStockholderBasic" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRNetIncomeLossAvailableToCommonStockholderBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ConvertibleClassCStock" xlink:label="loc_FONRConvertibleClassCStock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRConvertibleClassCStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_WeightedAverageNumberOfDilutedEarningsPerShare" xlink:label="loc_FONRWeightedAverageNumberOfDilutedEarningsPerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRWeightedAverageNumberOfDilutedEarningsPerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="995636 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_RightToUseAssetToIntangibleAsset" xlink:label="loc_FONRRightToUseAssetToIntangibleAsset" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_FONRRightToUseAssetToIntangibleAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaapOperatingLeasePayments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapOperatingLeasePayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefitIntraperiodTaxAllocation" xlink:label="loc_us-gaapIncomeTaxExpenseBenefitIntraperiodTaxAllocation" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefitIntraperiodTaxAllocation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:title="995637 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaapReceivableTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="loc_us-gaapReceivableTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapAccountsReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DoubtfulMember" xlink:label="loc_us-gaapDoubtfulMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapDoubtfulMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaapAccountsReceivableNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_us-gaapAccountsReceivableNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_AccountsReceivableNetRelatedParty" xlink:label="loc_FONRAccountsReceivableNetRelatedParty" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRAccountsReceivableNetRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NontradeReceivables" xlink:label="loc_us-gaapNontradeReceivables" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_us-gaapNontradeReceivables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ManagementAndOtherFeesNonRelatedParties" xlink:label="loc_FONRManagementAndOtherFeesNonRelatedParties" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRManagementAndOtherFeesNonRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-FutureRevenueDetails1" xlink:title="995638 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Future Revenue (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractReceivableDueOneToTwoYears" xlink:label="loc_us-gaapContractReceivableDueOneToTwoYears" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapContractReceivableDueOneToTwoYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractReceivableDueTwoToThreeYears" xlink:label="loc_us-gaapContractReceivableDueTwoToThreeYears" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapContractReceivableDueTwoToThreeYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractReceivableDueThreeToFourYears" xlink:label="loc_us-gaapContractReceivableDueThreeToFourYears" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapContractReceivableDueThreeToFourYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractReceivableDueFourToFiveYears" xlink:label="loc_us-gaapContractReceivableDueFourToFiveYears" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapContractReceivableDueFourToFiveYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:label="loc_us-gaapAccountsReceivableBilledForLongTermContractsOrPrograms" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapAccountsReceivableBilledForLongTermContractsOrPrograms" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:title="995639 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsAndOtherReceivables" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsAndOtherReceivables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:label="loc_FONRPercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRPercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1" xlink:label="loc_FONRPercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRPercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" xlink:label="loc_FONRPercentageOfConsolidatedNetRevenueFromManagementFees" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRPercentageOfConsolidatedNetRevenueFromManagementFees" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:title="995640 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_DisclosureOperatingAndFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingAndFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingAndFinancingLeasesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_OperatingLeasePaymentsMember" xlink:label="loc_FONROperatingLeasePaymentsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_FONROperatingLeasePaymentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_FinancingLeasePaymentsMember" xlink:label="loc_FONRFinancingLeasePaymentsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_FONRFinancingLeasePaymentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearTwo" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearThree" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFour" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFive" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_PresentValueDiscount" xlink:label="loc_FONRPresentValueDiscount" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPresentValueDiscount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_PresentValueDiscountFinancingLease" xlink:label="loc_FONRPresentValueDiscountFinancingLease" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPresentValueDiscountFinancingLease" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaapFinanceLeaseLiability" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiability" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeasesDetails1" xlink:title="995641 - Disclosure - OPERATING &amp; FINANCING LEASES (Details 1)">
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_DisclosureOperatingAndFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingAndFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingAndFinancingLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapFinanceLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingAndFinancingLeasesAbstract" xlink:to="loc_us-gaapFinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingAndFinancingLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapFinanceLeaseWeightedAverageDiscountRatePercent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingAndFinancingLeasesAbstract" xlink:to="loc_us-gaapFinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeasesDetails2" xlink:title="995642 - Disclosure - OPERATING &amp; FINANCING LEASES (Details 2)">
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_DisclosureOperatingAndFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingAndFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaapOperatingLeaseCost" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingAndFinancingLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_FinanceLeaseCostsAbstract" xlink:label="loc_FONRFinanceLeaseCostsAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingAndFinancingLeasesAbstract" xlink:to="loc_FONRFinanceLeaseCostsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_DepreciationOfLeasedEquipment" xlink:label="loc_FONRDepreciationOfLeasedEquipment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRFinanceLeaseCostsAbstract" xlink:to="loc_FONRDepreciationOfLeasedEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseInterestExpense" xlink:label="loc_us-gaapFinanceLeaseInterestExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRFinanceLeaseCostsAbstract" xlink:to="loc_us-gaapFinanceLeaseInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_FinanceLeaseCost" xlink:label="loc_FONRFinanceLeaseCost" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRFinanceLeaseCostsAbstract" xlink:to="loc_FONRFinanceLeaseCost" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeasesDetails3" xlink:title="995643 - Disclosure -  OPERATING &amp; FINANCING LEASES (Details 3)">
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_DisclosureOperatingAndFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingAndFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_OperatingCashFlowsFromOperatingLeases" xlink:label="loc_FONROperatingCashFlowsFromOperatingLeases" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingAndFinancingLeasesAbstract" xlink:to="loc_FONROperatingCashFlowsFromOperatingLeases" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_FinancingCashFlowsFromFinancingLeases" xlink:label="loc_FONRFinancingCashFlowsFromFinancingLeases" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingAndFinancingLeasesAbstract" xlink:to="loc_FONRFinancingCashFlowsFromFinancingLeases" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" xlink:label="loc_FONRRightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingAndFinancingLeasesAbstract" xlink:to="loc_FONRRightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" xlink:label="loc_FONRRightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingAndFinancingLeasesAbstract" xlink:to="loc_FONRRightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories-InventoriesDetails" xlink:title="995644 - Disclosure - INVENTORIES - Inventories (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherInventorySupplies" xlink:label="loc_us-gaapOtherInventorySupplies" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapOtherInventorySupplies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsDetails" xlink:title="995645 - Disclosure -  OTHER INTANGIBLE ASSETS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LicenseMember" xlink:label="loc_us-gaapLicenseMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapLicenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="loc_FONRPatentsAndCopyrightsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRPatentsAndCopyrightsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsDetails1" xlink:title="995646 - Disclosure - OTHER INTANGIBLE ASSETS (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:title="995647 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="loc_FONRPatentsAndCopyrightsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRPatentsAndCopyrightsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:title="995648 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaapAccruedSalariesCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedSalariesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="loc_us-gaapSalesAndExciseTaxPayableCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapSalesAndExciseTaxPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedPayrollTaxesCurrent" xlink:label="loc_us-gaapAccruedPayrollTaxesCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedPayrollTaxesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_SelffundedHealthInsuranceReserve" xlink:label="loc_FONRSelffundedHealthInsuranceReserve" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_FONRSelffundedHealthInsuranceReserve" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_SoftwareLicenses" xlink:label="loc_FONRSoftwareLicenses" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_FONRSoftwareLicenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherSundryLiabilitiesCurrent" xlink:label="loc_us-gaapOtherSundryLiabilitiesCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherSundryLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details" xlink:title="995649 - Disclosure - SEGMENT AND RELATED INFORMATION - Summarized Segments - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:label="loc_us-gaapScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:label="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="loc_srtProductOrServiceAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ManufacturingAndServiceOfMRIEquipmentMember" xlink:label="loc_FONRManufacturingAndServiceOfMRIEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_FONRManufacturingAndServiceOfMRIEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HealthCareOtherMember" xlink:label="loc_us-gaapHealthCareOtherMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapHealthCareOtherMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_IntersegmentNetRevenues" xlink:label="loc_FONRIntersegmentNetRevenues" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_FONRIntersegmentNetRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaapPaymentsToAcquireProductiveAssets" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapPaymentsToAcquireProductiveAssets" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:title="995650 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="loc_us-gaapSupplementalCashFlowElementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaapIncomeTaxesPaid" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapIncomeTaxesPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="loc_us-gaapRightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapRightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_RateOfInterestSold" xlink:label="loc_FONRRateOfInterestSold" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_FONRRateOfInterestSold" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="loc_us-gaapConversionOfStockAmountConverted1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapConversionOfStockAmountConverted1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="995651 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="loc_srtBoardOfDirectorsChairmanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtBoardOfDirectorsChairmanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramAuthorizedAmount1" xlink:label="loc_srtStockRepurchaseProgramAuthorizedAmount1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_srtStockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:label="loc_us-gaapStockRedeemedOrCalledDuringPeriodShares" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRedeemedOrCalledDuringPeriodShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:label="loc_us-gaapStockRedeemedOrCalledDuringPeriodValue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRedeemedOrCalledDuringPeriodValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:label="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:label="loc_us-gaapLiabilityForClaimsAndClaimsAdjustmentExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilityForClaimsAndClaimsAdjustmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SelfInsuranceReserve" xlink:label="loc_us-gaapSelfInsuranceReserve" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSelfInsuranceReserve" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:title="995652 - Disclosure - INCOME TAXES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:label="loc_us-gaapIncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" xlink:label="loc_us-gaapExtinguishmentOfDebtGainLossNetOfTax" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapExtinguishmentOfDebtGainLossNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_DeferredIncomeTaxComponent" xlink:label="loc_FONRDeferredIncomeTaxComponent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FONRDeferredIncomeTaxComponent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:label="loc_us-gaapDeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_PercentageOfExciseTax" xlink:label="loc_FONRPercentageOfExciseTax" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FONRPercentageOfExciseTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_CorporateAlternativeMinimumTaxPercentage" xlink:label="loc_FONRCorporateAlternativeMinimumTaxPercentage" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FONRCorporateAlternativeMinimumTaxPercentage" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="995653 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_MagneticResonanceManagementMember" xlink:label="loc_FONRMagneticResonanceManagementMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_FONRMagneticResonanceManagementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_NetRevenues" xlink:label="loc_FONRNetRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_FONRNetRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ServiceAndMaintenancePrice" xlink:label="loc_FONRServiceAndMaintenancePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_FONRServiceAndMaintenancePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_ServiceAndRepairFees" xlink:label="loc_FONRServiceAndRepairFees" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_FONRServiceAndRepairFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_EmployeesFee" xlink:label="loc_FONREmployeesFee" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_FONREmployeesFee" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_us-gaapConvertibleNotesPayable" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapConvertibleNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFixedInterestRate" xlink:label="loc_us-gaapDerivativeFixedInterestRate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDerivativeFixedInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapInvestmentIncomeNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredGainOnSaleOfProperty" xlink:label="loc_us-gaapDeferredGainOnSaleOfProperty" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDeferredGainOnSaleOfProperty" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:title="995654 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchaseds" xlink:label="loc_FONRStockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchaseds" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_FONRStockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchaseds" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20241231.xsd#FONR_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount" xlink:label="loc_FONRStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_FONRStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800500432816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Feb. 03, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-10248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">FONAR
CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000355019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">11-2464137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">110
    Marcus Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Melville<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">11747<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">631<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">694-2929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
Stock, $.0001 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">FONR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassAMember', window );">Preferred Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">313,438<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,203,465<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800498263264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 53,583<span></span>
</td>
<td class="nump">$ 56,341<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">121<span></span>
</td>
<td class="nump">136<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsAndOtherReceivablesNetCurrent', window );">Accounts receivable &#8211; net of allowance for credit losses of $273 and $166 at December 31, 2024 and June 30, 2024, respectively</a></td>
<td class="nump">3,390<span></span>
</td>
<td class="nump">4,035<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountReceivableRelatedParties', window );">Accounts receivable _ related party</a></td>
<td class="nump">60<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_MedicalReceivable', window );">Medical receivable &#8211; net</a></td>
<td class="nump">23,496<span></span>
</td>
<td class="nump">23,992<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedFeesAndOtherRevenueReceivable', window );">Management and other fees receivable &#8211; net of allowance for credit losses of $12,663 and $12,370 at December 31, 2024 and June 30, 2024, respectively</a></td>
<td class="nump">42,485<span></span>
</td>
<td class="nump">41,954<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances', window );">Management and other fees receivable &#8211; related medical practices &#8211; net of allowance for credit losses of $6,989 and $6,110 at December 31, 2024 and June 30, 2024, respectively</a></td>
<td class="nump">9,677<span></span>
</td>
<td class="nump">9,865<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsAndWorkInProcess', window );">Inventories</a></td>
<td class="nump">2,858<span></span>
</td>
<td class="nump">2,715<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,962<span></span>
</td>
<td class="nump">1,286<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">137,632<span></span>
</td>
<td class="nump">140,324<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsReceivableNetLongTerm', window );">Accounts receivable &#8211; long term</a></td>
<td class="nump">724<span></span>
</td>
<td class="nump">830<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">Deferred income tax asset</a></td>
<td class="nump">6,113<span></span>
</td>
<td class="nump">7,223<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment &#8211; net</a></td>
<td class="nump">19,270<span></span>
</td>
<td class="nump">18,709<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NoteReceivableRelatedParty', window );">Note receivable &#8211; related party</a></td>
<td class="nump">607<span></span>
</td>
<td class="nump">581<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use-asset &#8211; operating leases</a></td>
<td class="nump">34,946<span></span>
</td>
<td class="nump">38,428<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Right-of-use-asset &#8211; financing lease</a></td>
<td class="nump">496<span></span>
</td>
<td class="nump">531<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">4,269<span></span>
</td>
<td class="nump">4,269<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets &#8211; net</a></td>
<td class="nump">3,407<span></span>
</td>
<td class="nump">2,870<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other assets</a></td>
<td class="nump">493<span></span>
</td>
<td class="nump">481<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">207,957<span></span>
</td>
<td class="nump">214,246<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">953<span></span>
</td>
<td class="nump">1,856<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">3,912<span></span>
</td>
<td class="nump">7,941<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Unearned revenue on service contracts</a></td>
<td class="nump">3,413<span></span>
</td>
<td class="nump">3,870<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_UnearnedRevenueOnServiceContractsRelatedParty', window );">Unearned revenue on service contracts &#8211; related party</a></td>
<td class="nump">55<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities _ current portion</a></td>
<td class="nump">3,259<span></span>
</td>
<td class="nump">3,474<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Financing lease liability _ current portion</a></td>
<td class="nump">244<span></span>
</td>
<td class="nump">226<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CustomerDeposits', window );">Customer deposits</a></td>
<td class="nump">357<span></span>
</td>
<td class="nump">443<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">12,242<span></span>
</td>
<td class="nump">17,857<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-Term Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Unearned revenue on service contracts</a></td>
<td class="nump">1,050<span></span>
</td>
<td class="nump">1,175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent', window );">Deferred income tax liability</a></td>
<td class="nump">371<span></span>
</td>
<td class="nump">371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsPayableRelatedPartyNoncurrent', window );">Due to related party medical practices</a></td>
<td class="nump">93<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities &#8211; net of current portion</a></td>
<td class="nump">34,927<span></span>
</td>
<td class="nump">37,468<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Financing lease liability &#8211; net of current portion</a></td>
<td class="nump">290<span></span>
</td>
<td class="nump">395<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, less current portion</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Other liabilities</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total Long-Term Liabilities</a></td>
<td class="nump">36,764<span></span>
</td>
<td class="nump">39,601<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">49,006<span></span>
</td>
<td class="nump">57,458<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>EQUITY:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Paid-in capital in excess of par value</a></td>
<td class="nump">178,758<span></span>
</td>
<td class="nump">180,608<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(8,525)<span></span>
</td>
<td class="num">(13,624)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost &#8211; 4 shares of common stock at December 31, 2024 and 45 shares of common stock at June 30, 2024</a></td>
<td class="num">(395)<span></span>
</td>
<td class="num">(1,017)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total FONAR Corporation&#8217;s Stockholders&#8217; Equity</a></td>
<td class="nump">169,839<span></span>
</td>
<td class="nump">165,968<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="num">(10,888)<span></span>
</td>
<td class="num">(9,180)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total Equity</a></td>
<td class="nump">158,951<span></span>
</td>
<td class="nump">156,788<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Equity</a></td>
<td class="nump">207,957<span></span>
</td>
<td class="nump">214,246<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember', window );">Class A Non Voting Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>EQUITY:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>EQUITY:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>EQUITY:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock value</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>EQUITY:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>EQUITY:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountReceivableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountReceivableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsPayableRelatedPartyNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsPayableRelatedPartyNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableNetLongTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableNetLongTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CustomerDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CustomerDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_MedicalReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_MedicalReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NoteReceivableRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NoteReceivableRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_UnearnedRevenueOnServiceContractsRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_UnearnedRevenueOnServiceContractsRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsAndOtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsAndOtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedFeesAndOtherRevenueReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, the amount of fees and other revenue, excluding investment income receivable, earned but not yet received, which were recognized in conformity with revenue recognition criteria based on estimates or specific contractual terms.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedFeesAndOtherRevenueReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other liabilities expected to be paid after one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsAndWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation reserves of merchandise or goods held by the entity that are readily available for sale and items held by the entity which are partially complete or in the process of being readied for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsAndWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-24<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-23<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-5<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 43: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 44: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 45: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 46: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-15<br><br>Reference 47: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-16<br><br>Reference 48: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4I<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800498210832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables', window );">Allowance for Doubtful Accounts, Premiums and Other Receivables</a></td>
<td class="nump">$ 273<span></span>
</td>
<td class="nump">$ 166<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts', window );">[custom:ManagementAndOtherReceivableAllowancesForDoubtfulAccounts-0]</a></td>
<td class="nump">12,663<span></span>
</td>
<td class="nump">12,370<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts', window );">[custom:RelatedPartyReceivableAllowancesForDoubtfulAccounts-0]</a></td>
<td class="nump">$ 6,989<span></span>
</td>
<td class="nump">$ 6,110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury Stock, Common, Shares</a></td>
<td class="nump">4,000<span></span>
</td>
<td class="nump">45,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember', window );">Class A Non Voting Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">453,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">313,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">567,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">6,207,000<span></span>
</td>
<td class="nump">6,373,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">6,203,000<span></span>
</td>
<td class="nump">6,328,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">227,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">567,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The valuation allowance as of the balance sheet date to reduce the gross amount of receivables to estimated net realizable value, which would be presented in parentheses on the face of the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800506496032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts', window );">Patient fee revenue &#8211; net of contractual allowances and discounts</a></td>
<td class="nump">$ 7,944<span></span>
</td>
<td class="nump">$ 8,221<span></span>
</td>
<td class="nump">$ 15,431<span></span>
</td>
<td class="nump">$ 16,896<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ProductSalesNet', window );">Product sales</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="nump">145<span></span>
</td>
<td class="nump">219<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ServiceAndRepairFeesNet', window );">Service and repair fees</a></td>
<td class="nump">1,759<span></span>
</td>
<td class="nump">1,778<span></span>
</td>
<td class="nump">3,751<span></span>
</td>
<td class="nump">3,643<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ServiceAndRepairFeesRelatedPartiesNet', window );">Service and repair fees _ related parties</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAndOtherFeesNet', window );">Management and other fees</a></td>
<td class="nump">12,189<span></span>
</td>
<td class="nump">12,316<span></span>
</td>
<td class="nump">24,518<span></span>
</td>
<td class="nump">24,436<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet', window );">Management and other fees _ related medical practices</a></td>
<td class="nump">2,988<span></span>
</td>
<td class="nump">2,988<span></span>
</td>
<td class="nump">5,975<span></span>
</td>
<td class="nump">5,975<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues &#8211; Net</a></td>
<td class="nump">24,950<span></span>
</td>
<td class="nump">25,386<span></span>
</td>
<td class="nump">49,910<span></span>
</td>
<td class="nump">51,224<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>COSTS AND EXPENSES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCostOfOperatingRevenue', window );">Costs related to patient fee revenue</a></td>
<td class="nump">4,623<span></span>
</td>
<td class="nump">4,602<span></span>
</td>
<td class="nump">9,269<span></span>
</td>
<td class="nump">9,029<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToProductSales', window );">Costs related to product sales</a></td>
<td class="nump">221<span></span>
</td>
<td class="nump">302<span></span>
</td>
<td class="nump">442<span></span>
</td>
<td class="nump">405<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToServiceAndRepairFees', window );">Costs related to service and repair fees</a></td>
<td class="nump">938<span></span>
</td>
<td class="nump">784<span></span>
</td>
<td class="nump">2,029<span></span>
</td>
<td class="nump">1,633<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToServiceAndRepairFeesRelatedParties', window );">Costs related to service and repair fees _ related parties</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">96<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToManagementAndOtherFees', window );">Costs related to management and other fees</a></td>
<td class="nump">7,801<span></span>
</td>
<td class="nump">7,208<span></span>
</td>
<td class="nump">15,111<span></span>
</td>
<td class="nump">14,231<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices', window );">Costs related to management and other fees &#8211; related medical practices</a></td>
<td class="nump">1,601<span></span>
</td>
<td class="nump">1,590<span></span>
</td>
<td class="nump">3,174<span></span>
</td>
<td class="nump">3,109<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">376<span></span>
</td>
<td class="nump">416<span></span>
</td>
<td class="nump">683<span></span>
</td>
<td class="nump">883<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">6,927<span></span>
</td>
<td class="nump">5,587<span></span>
</td>
<td class="nump">12,065<span></span>
</td>
<td class="nump">10,453<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total Costs and Expenses</a></td>
<td class="nump">22,515<span></span>
</td>
<td class="nump">20,501<span></span>
</td>
<td class="nump">42,869<span></span>
</td>
<td class="nump">39,768<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet', window );">INCOME FROM OPERATIONS</a></td>
<td class="nump">2,435<span></span>
</td>
<td class="nump">4,885<span></span>
</td>
<td class="nump">7,041<span></span>
</td>
<td class="nump">11,456<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other income and (expenses)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest Expense</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="num">(58)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_InvestmentIncomeRelatedParty', window );">Investment income &#8211; related party</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Investment income</a></td>
<td class="nump">524<span></span>
</td>
<td class="nump">534<span></span>
</td>
<td class="nump">1,163<span></span>
</td>
<td class="nump">1,040<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_OtherIncomeRelatedParty', window );">Other income &#8211; related party</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">577<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">577<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income</a></td>
<td class="nump">1<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income Before Provision for Income Taxes and Noncontrolling Interests</a></td>
<td class="nump">2,967<span></span>
</td>
<td class="nump">5,986<span></span>
</td>
<td class="nump">8,216<span></span>
</td>
<td class="nump">13,016<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">(762)<span></span>
</td>
<td class="num">(1,366)<span></span>
</td>
<td class="num">(2,011)<span></span>
</td>
<td class="num">(3,036)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ConsolidatedNetIncome', window );">Consolidated Net Income</a></td>
<td class="nump">2,205<span></span>
</td>
<td class="nump">4,620<span></span>
</td>
<td class="nump">6,205<span></span>
</td>
<td class="nump">9,980<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net Income Noncontrolling Interests</a></td>
<td class="num">(241)<span></span>
</td>
<td class="num">(861)<span></span>
</td>
<td class="num">(1,106)<span></span>
</td>
<td class="num">(2,115)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income &#8211; Attributable to FONAR</a></td>
<td class="nump">$ 1,964<span></span>
</td>
<td class="nump">$ 3,759<span></span>
</td>
<td class="nump">$ 5,099<span></span>
</td>
<td class="nump">$ 7,865<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Number of Shares Outstanding, Basic</a></td>
<td class="nump">6,686<span></span>
</td>
<td class="nump">6,437<span></span>
</td>
<td class="nump">6,696<span></span>
</td>
<td class="nump">6,448<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_CommonStockholdersMember', window );">Common Stockholders [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other income and (expenses)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net Income Available to Common Stockholders</a></td>
<td class="nump">$ 1,840<span></span>
</td>
<td class="nump">$ 3,525<span></span>
</td>
<td class="nump">$ 4,775<span></span>
</td>
<td class="nump">$ 7,375<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings Per Share, Basic</a></td>
<td class="nump">$ 0.29<span></span>
</td>
<td class="nump">$ 0.55<span></span>
</td>
<td class="nump">$ 0.76<span></span>
</td>
<td class="nump">$ 1.14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings Per Share, Diluted</a></td>
<td class="nump">$ 0.29<span></span>
</td>
<td class="nump">$ 0.54<span></span>
</td>
<td class="nump">$ 0.74<span></span>
</td>
<td class="nump">$ 1.12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Number of Shares Outstanding, Basic</a></td>
<td class="nump">6,303<span></span>
</td>
<td class="nump">6,437<span></span>
</td>
<td class="nump">6,313<span></span>
</td>
<td class="nump">6,448<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Number of Shares Outstanding, Diluted</a></td>
<td class="nump">6,431<span></span>
</td>
<td class="nump">6,565<span></span>
</td>
<td class="nump">6,441<span></span>
</td>
<td class="nump">6,576<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockholdersMember', window );">Class A Non Voting Preferred Stockholders [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other income and (expenses)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net Income Available to Common Stockholders</a></td>
<td class="nump">$ 93<span></span>
</td>
<td class="nump">$ 175<span></span>
</td>
<td class="nump">$ 241<span></span>
</td>
<td class="nump">$ 365<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other income and (expenses)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net Income Available to Common Stockholders</a></td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 59<span></span>
</td>
<td class="nump">$ 83<span></span>
</td>
<td class="nump">$ 125<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings Per Share, Diluted</a></td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="nump">$ 0.16<span></span>
</td>
<td class="nump">$ 0.22<span></span>
</td>
<td class="nump">$ 0.33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Number of Shares Outstanding, Basic</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Number of Shares Outstanding, Diluted</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ConsolidatedNetIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ConsolidatedNetIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToManagementAndOtherFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToManagementAndOtherFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToProductSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToProductSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToServiceAndRepairFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToServiceAndRepairFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToServiceAndRepairFeesRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToServiceAndRepairFeesRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_InvestmentIncomeRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_InvestmentIncomeRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherFeesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherFeesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_OtherIncomeRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_OtherIncomeRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ProductSalesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ProductSalesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ServiceAndRepairFeesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ServiceAndRepairFeesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ServiceAndRepairFeesRelatedPartiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ServiceAndRepairFeesRelatedPartiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, nonoperating income (expense) and income (loss) from equity method investments, before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCostOfOperatingRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other costs incurred during the reporting period related to other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCostOfOperatingRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_CommonStockholdersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_CommonStockholdersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockholdersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockholdersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800498722992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Treasury Stock, Common [Member]</div></th>
<th class="th"><div>Noncontrolling Interest [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance &#8211; June 30, 2023 at Jun. 30, 2023</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 182,613<span></span>
</td>
<td class="num">$ (24,191)<span></span>
</td>
<td class="num">$ (516)<span></span>
</td>
<td class="num">$ (7,079)<span></span>
</td>
<td class="nump">$ 150,828<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Jun. 30, 2023</a></td>
<td class="nump">6,451<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">7,865<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">7,865<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Purchase of Treasury stock</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (1,885)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,885)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Purchase of Treasury stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited', window );">Cancellation of shares</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(2,006)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 2,006<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Cancellation of shares, shares</a></td>
<td class="num">(123)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(123)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions - Non controlling interests</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,626)<span></span>
</td>
<td class="num">(2,626)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Income - Non controlling interests</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,115<span></span>
</td>
<td class="nump">2,115<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance &#8211; December 31, 2023 at Dec. 31, 2023</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">180,607<span></span>
</td>
<td class="num">(16,326)<span></span>
</td>
<td class="num">$ (395)<span></span>
</td>
<td class="num">(7,590)<span></span>
</td>
<td class="nump">156,297<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Dec. 31, 2023</a></td>
<td class="nump">6,328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance &#8211; June 30, 2023 at Sep. 30, 2023</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">182,613<span></span>
</td>
<td class="num">(20,085)<span></span>
</td>
<td class="num">$ (1,230)<span></span>
</td>
<td class="num">(7,226)<span></span>
</td>
<td class="nump">154,073<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Sep. 30, 2023</a></td>
<td class="nump">6,451<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,759<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,759<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Purchase of Treasury stock</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (1,171)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,171)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Purchase of Treasury stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited', window );">Cancellation of shares</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(2,006)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 2,006<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Cancellation of shares, shares</a></td>
<td class="num">(123)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(123)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions - Non controlling interests</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,225)<span></span>
</td>
<td class="num">(1,225)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Income - Non controlling interests</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">861<span></span>
</td>
<td class="nump">861<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance &#8211; December 31, 2023 at Dec. 31, 2023</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">180,607<span></span>
</td>
<td class="num">(16,326)<span></span>
</td>
<td class="num">$ (395)<span></span>
</td>
<td class="num">(7,590)<span></span>
</td>
<td class="nump">156,297<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Dec. 31, 2023</a></td>
<td class="nump">6,328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance &#8211; June 30, 2023 at Jun. 30, 2024</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">180,608<span></span>
</td>
<td class="num">(13,624)<span></span>
</td>
<td class="num">$ (1,017)<span></span>
</td>
<td class="num">(9,180)<span></span>
</td>
<td class="nump">156,788<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Jun. 30, 2024</a></td>
<td class="nump">6,328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,099<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,099<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Purchase of Treasury stock</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (1,341)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,341)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Purchase of Treasury stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CancellationOfTreasuryStock', window );">Cancellation of Treasury stock</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(1,963)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,963<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_SaleNonControllingInterests', window );">Sale - Non controlling interests</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">132<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions - Non controlling interests</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,833)<span></span>
</td>
<td class="num">(2,833)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Income - Non controlling interests</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,106<span></span>
</td>
<td class="nump">1,106<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance &#8211; December 31, 2023 at Dec. 31, 2024</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">178,758<span></span>
</td>
<td class="num">(8,525)<span></span>
</td>
<td class="num">$ (395)<span></span>
</td>
<td class="num">(10,888)<span></span>
</td>
<td class="nump">158,951<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Dec. 31, 2024</a></td>
<td class="nump">6,203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance &#8211; June 30, 2023 at Sep. 30, 2024</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">180,608<span></span>
</td>
<td class="num">(10,489)<span></span>
</td>
<td class="num">$ (1,432)<span></span>
</td>
<td class="num">(9,861)<span></span>
</td>
<td class="nump">158,827<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Sep. 30, 2024</a></td>
<td class="nump">6,328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,964<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,964<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Purchase of Treasury stock</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (926)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(926)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Purchase of Treasury stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CancellationOfTreasuryStock', window );">Cancellation of Treasury stock</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(1,963)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,963<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CancellationOfTreasuryStockShares', window );">Cancellation of Treasury stock, shares</a></td>
<td class="num">(125)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(125)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_SaleNonControllingInterests', window );">Sale - Non controlling interests</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">132<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions - Non controlling interests</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,287)<span></span>
</td>
<td class="num">(1,287)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Income - Non controlling interests</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">241<span></span>
</td>
<td class="nump">241<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance &#8211; December 31, 2023 at Dec. 31, 2024</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 178,758<span></span>
</td>
<td class="num">$ (8,525)<span></span>
</td>
<td class="num">$ (395)<span></span>
</td>
<td class="num">$ (10,888)<span></span>
</td>
<td class="nump">$ 158,951<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Dec. 31, 2024</a></td>
<td class="nump">6,203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CancellationOfTreasuryStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CancellationOfTreasuryStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CancellationOfTreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CancellationOfTreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_SaleNonControllingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_SaleNonControllingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-24<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-23<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-5<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 43: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 44: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 45: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 46: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-15<br><br>Reference 47: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-16<br><br>Reference 48: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4I<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800498622496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows from Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Consolidated Net income</a></td>
<td class="nump">$ 6,205<span></span>
</td>
<td class="nump">$ 9,980<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile consolidated net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">2,298<span></span>
</td>
<td class="nump">2,415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetChangeInOperatingRightOfUseAssetsAndLeaseLiabilities', window );">Net change in operating right of use assets and lease liabilities</a></td>
<td class="num">(63)<span></span>
</td>
<td class="num">(119)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ProvisionForBadDebts', window );">Provision for credit losses</a></td>
<td class="nump">1,279<span></span>
</td>
<td class="nump">355<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred tax expense</a></td>
<td class="nump">1,111<span></span>
</td>
<td class="nump">2,284<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_GainOnSaleOfEquipmentRelatedParty', window );">Gain on sale of equipment &#8211; related party</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(577)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract', window );"><strong>Changes in operating assets and liabilities, net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts, medical and management fee receivable(s)</a></td>
<td class="num">(435)<span></span>
</td>
<td class="num">(4,958)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IncreaseDecreaseInNotesReceivable', window );">Notes receivable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IncreaseDecreaseInNotesReceivableRelatedParty', window );">Notes receivable &#8211; related party</a></td>
<td class="num">(26)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(143)<span></span>
</td>
<td class="num">(265)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(677)<span></span>
</td>
<td class="nump">217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="num">(11)<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(903)<span></span>
</td>
<td class="num">(244)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities', window );">Other current liabilities</a></td>
<td class="num">(4,556)<span></span>
</td>
<td class="num">(2,341)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTradingLiabilities', window );">Financing lease liabilities</a></td>
<td class="num">(86)<span></span>
</td>
<td class="num">(108)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IncreaseDecreaseInCustomerDeposit', window );">Customer deposits</a></td>
<td class="num">(87)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities', window );">Other liabilities</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">3,899<span></span>
</td>
<td class="nump">6,689<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows from Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(2,552)<span></span>
</td>
<td class="num">(192)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfShortTermInvestments', window );">Proceeds from short term investments</a></td>
<td class="nump">15<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Cost of patents</a></td>
<td class="num">(20)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(2,557)<span></span>
</td>
<td class="num">(212)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows from Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of borrowings and capital lease obligations</a></td>
<td class="num">(58)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromMinorityShareholders', window );">Sale of noncontrolling interest</a></td>
<td class="nump">132<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock', window );">Purchase of treasury stock</a></td>
<td class="num">(1,341)<span></span>
</td>
<td class="num">(1,885)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsMinorityInterest', window );">Distributions to noncontrolling interests</a></td>
<td class="num">(2,833)<span></span>
</td>
<td class="num">(2,626)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(4,100)<span></span>
</td>
<td class="num">(4,532)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net (Decrease) Increase in Cash and Cash Equivalents</a></td>
<td class="num">(2,758)<span></span>
</td>
<td class="nump">1,945<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and Cash Equivalents - Beginning of Period</a></td>
<td class="nump">56,341<span></span>
</td>
<td class="nump">51,280<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and Cash Equivalents - End of Period</a></td>
<td class="nump">$ 53,583<span></span>
</td>
<td class="nump">$ 53,225<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_GainOnSaleOfEquipmentRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_GainOnSaleOfEquipmentRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncreaseDecreaseInCustomerDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncreaseDecreaseInCustomerDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncreaseDecreaseInNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncreaseDecreaseInNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncreaseDecreaseInNotesReceivableRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncreaseDecreaseInNotesReceivableRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NetChangeInOperatingRightOfUseAssetsAndLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NetChangeInOperatingRightOfUseAssetsAndLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ProvisionForBadDebts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ProvisionForBadDebts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in other expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpensesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTradingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of trading liabilities from the reporting entity's trading activities. This include liabilities resulting from sales of assets that the reporting entity does not own and revaluation losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTradingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire preferred stock originally issued and identified as a security that can be exchanged for another type of financial security. This repurchased stock is held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsMinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsMinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800503286048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="nump">$ 1,964<span></span>
</td>
<td class="nump">$ 3,759<span></span>
</td>
<td class="nump">$ 5,099<span></span>
</td>
<td class="nump">$ 7,865<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800506184064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800506244208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract', window );"><strong>Description Of Business And Basis Of Presentation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DescriptionOfBusinessAndBasisOfPresentationTextBlock', window );">DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</a></td>
<td class="text"><p id="xdx_80C_ecustom--DescriptionOfBusinessAndBasisOfPresentationTextBlock_z8j2h5oPWmk1" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif"><b>NOTE
1 &#8211; <span id="xdx_829_zxTANboTL8r5">DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">Description
of Business</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;FONAR
Corporation (the &#8220;Company&#8221; or &#8220;FONAR&#8221;) is a Delaware corporation, which was incorporated on July 17, 1978. FONAR
is engaged in the research, development, production and marketing of medical scanning equipment, which uses principles of Magnetic Resonance
Imaging (&#8220;MRI&#8221;) for the detection and diagnosis of human diseases. In addition to deriving revenues from the direct sale
of MRI equipment, revenue is also generated from our installed-base of customers through our service and upgrade programs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR,
through its wholly-owned subsidiary Health Management Corporation of America (&#8220;HMCA&#8221;) provides comprehensive management services
to diagnostic imaging facilities. The services provided by the Company include development, administration, leasing of office space,
facilities and medical equipment, provision of supplies, staffing and supervision of non-medical personnel, legal services, accounting,
billing and collection and the development and implementation of practice growth and marketing strategies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Effective
July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business.
The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and Health
Diagnostics Management (&#8220;HDM&#8221;). Imperial Management Services, LLC contributed all of its assets (which were utilized in the
business of Health Management Corporation of America) to HDM and received a <span id="xdx_907_eus-gaap--InvestmentOwnedPercentOfNetAssets_iI_pip0_dp_c20150701__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zQBJXRA8WhL">24.2</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
interest in HDM. Health Management Corporation of America retained a direct ownership interest of <span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pip0_dp_c20150701__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zRAgwz5pzns6">45.8</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
in HDM, and the original investors in HDM retained a <span id="xdx_90A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pip0_dp_c20150701__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zozjfGVU7r64">30.0</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
ownership interest in the newly expanded HDM. As of June 30, 2024, the Company had a direct ownership interest of <span id="xdx_908_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pip0_dp_c20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zplnBcIDbWsf">70.8</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
and the investors&#8217; a <span id="xdx_906_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pip0_dp_c20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zY5juJW1dty7">29.2</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
ownership interest. During the quarter ended December 31, 2024, the Company sold non-controlling interests to a minority shareholder
for $<span id="xdx_907_eus-gaap--ProceedsFromPaymentsToMinorityShareholders_pn3n3_c20241001__20241231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_z9fo00PVoO0k">132</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">.
Currently, the Company has a direct ownership interest of <span id="xdx_903_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pip0_dp_c20241231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_z7Xw58DYnbG9">70.63</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
and the investors&#8217; have a <span id="xdx_907_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pip0_dp_c20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zuemWa2ZyRif">29.37</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
ownership interest. The entire management of diagnostic imaging centers business segment is now being conducted by HDM, operating under
the name &#8220;Health Management Company of America&#8221;.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">Basis
of Presentation</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">These
unaudited condensed consolidated financial statements for the period ended December 31, 2024 have been prepared in accordance with generally
accepted accounting principles in the United States of America (&#8220;GAAP&#8221;) and pursuant to the rules and regulations of the
Securities and Exchange Commission pertaining to interim financial statements. Accordingly, they do not include all of the information
and footnotes required by GAAP for complete financial statements and should be read in conjunction with the audited consolidated financial
statements and notes thereto included in the Company&#8217;s Annual Report on Form 10-K for the year ended June 30, 2024, from which
the accompanying balance sheet at June 30, 2024 was derived. All intercompany balances and transactions have been eliminated in consolidation.
In the opinion of management, all adjustments considered necessary for a fair presentation of the interim financial information have
been included and are of a normal recurring nature. The preparation of the condensed consolidated financial statements in conformity
with GAAP requires the Company to make estimates and assumptions that affect the disclosure and reported amounts of assets and liabilities
at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting
period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>



















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DescriptionOfBusinessAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DescriptionOfBusinessAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800503401296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--SignificantAccountingPoliciesTextBlock_zJKlTJe1YgXi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"><b>NOTE
2 - <span id="xdx_824_zyHhAaGWVple">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_841_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zQxMpzIdddeb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_861_zh0MhL9MYTzf" style="font: normal 11pt Times New Roman, Times, Serif">Basis
of Presentation</span> <span style="font: normal 11pt Times New Roman, Times, Serif">(Continued)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">The
Company evaluates theses estimates and judgements on an ongoing basis. The Company bases estimates and judgements on historical experience
and on various other factors that are believed to be reasonable under the circumstances. The results of operations for any interim period
are not necessarily indicative of the results of operations for a full year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_84A_eus-gaap--ConsolidationPolicyTextBlock_z4ZlKuNI17Si" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_86B_zc7HOogWPoOd" style="font: normal 11pt Times New Roman, Times, Serif">Principles
of Consolidation</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">The
unaudited condensed consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries
and partnerships (collectively, the &#8220;Company&#8221;). All significant intercompany accounts and transactions have been eliminated
in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_84B_eus-gaap--RevenueRecognitionPolicyTextBlock_zb1qsGCBxFXa" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_86F_z04AOfkiJI19" style="font: normal 11pt Times New Roman, Times, Serif">Revenue
Recognition</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">The
Company&#8217;s revenues generally relate to net patient fees&#160;received from various payers and patients themselves under contracts
in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our
obligations to provide diagnostic services are satisfied. The Company&#8217;s performance obligations for diagnostic services are generally
satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party
payer (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance
exchanges) and the transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated
with (managed care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party
payers for the services we provide to the related patients typically specify payments at amounts less than the Company&#8217;s standard
charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates.
Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the
frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">The
Company&#8217;s patient fee revenue, net of contractual allowances and discounts for the three and six months ended December 31, 2024
and 2023 are summarized in the following table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--DisaggregationOfRevenueTableTextBlock_pn3n3_zL3DJiQxVnde" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span id="xdx_8BD_zlEmX5Fwg5k5" style="font: normal 11pt Times New Roman, Times, Serif">Schedule
    of patient fee revenue - net</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">For
    the Three Months Ended<br/> December 31,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">2023</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Commercial
    Insurance/Managed Care</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--NetPatientFeeRevenue_pn3n3_c20241001__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_z18Xcauvc52g" style="width: 12%; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">1,174</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_ecustom--NetPatientFeeRevenue_pn3n3_c20231001__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zK8wWpjbWbjh" style="width: 12%; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">1,243</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Medicare/Medicaid</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_ecustom--NetPatientFeeRevenue_pn3n3_c20241001__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zZRbS1gC7hzd" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">301</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_ecustom--NetPatientFeeRevenue_pn3n3_c20231001__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zu8U0uK35Gs5" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">284</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Workers&#8217;
    Compensation/Personal Injury</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_ecustom--NetPatientFeeRevenue_pn3n3_c20241001__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_z1j0hmlMJQob" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">4,683</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_ecustom--NetPatientFeeRevenue_pn3n3_c20231001__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zvblavHXJkE4" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">4,907</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Other</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_ecustom--NetPatientFeeRevenue_pn3n3_c20241001__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zLfcHqiMhZg4" style="border-bottom: Black 1pt solid; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">1,786</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_ecustom--NetPatientFeeRevenue_pn3n3_c20231001__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zYdnTWS83VXh" style="border-bottom: Black 1pt solid; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">1,787</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Patient
    Fee Revenue, net of contractual allowances and discounts</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--NetPatientFeeRevenue_pn3n3_c20241001__20241231_zSf07rU5Y7ia" style="border-bottom: Black 2.5pt double; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">7,944</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_ecustom--NetPatientFeeRevenue_pn3n3_c20231001__20231231_zm8zC3UOQeni" style="border-bottom: Black 2.5pt double; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">8,221</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>























<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Revenue
    Recognition (Continued)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">For
    the Six Months Ended<br/> December 31,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">2023</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Commercial
    Insurance/ Managed Care</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--NetPatientFeeRevenue_c20240701__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" style="width: 12%; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">2,378</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--NetPatientFeeRevenue_c20230701__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" style="width: 12%; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">2,416</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Medicare/Medicaid</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_ecustom--NetPatientFeeRevenue_c20240701__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">562</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_ecustom--NetPatientFeeRevenue_c20230701__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">555</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Workers&#8217;
    Compensation/Personal Injury</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_ecustom--NetPatientFeeRevenue_c20240701__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">9,382</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_ecustom--NetPatientFeeRevenue_c20230701__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">10,044</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Other</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_ecustom--NetPatientFeeRevenue_c20240701__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">3,109</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_ecustom--NetPatientFeeRevenue_c20230701__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">3,881</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Patient
    Fee Revenue, net of contractual allowances and discounts</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_ecustom--NetPatientFeeRevenue_c20240701__20241231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">15,431</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--NetPatientFeeRevenue_c20230701__20231231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">16,896</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p id="xdx_8AF_zUozMHWSpZk9" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_849_ecustom--ManagementAndOtherFeeReceivablePolicyTextBlock_zXjWOO9c32X9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_863_zKeWDttgnjpe" style="font: normal 11pt Times New Roman, Times, Serif">Management
and other fee receivable</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">HMCA
generates revenues from providing comprehensive management services, including development, administration, accounting, billing and collection
services, together with office space, medical equipment, supplies and non-medical personnel to its clients. Revenues are in the form
of fees which are earned under annual management contracts with HMCA clients. Management fee receivable is related to the management
fees outstanding from the related and non-related professional corporations (&#8220;PCs&#8221;) under the management agreements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_840_eus-gaap--EarningsPerSharePolicyTextBlock_znCGB8Glccd5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_863_zFFWWr33Y5O5" style="font: normal 11pt Times New Roman, Times, Serif">Earnings
Per Share</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Basic
earnings per share (&#8220;EPS&#8221;) is computed based upon the weighted average number of shares of common stock and stock equivalents
outstanding, net of common stock. In accordance with ASC Topic 260-10, &#8220;Participating Securities and the Two-Class method&#8221;,
the Company used the Two-Class method for calculating basic income per share and applied the converted method in calculating diluted
income per share for the three and six months ended December 31, 2024 and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Diluted
EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average
market price of common shares outstanding during the period. For the three and six months ended December 31, 2024 and 2023, diluted EPS
for common shareholders includes <span id="xdx_90E_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20230701__20231231_z9QoejhFelni">128
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">shares
upon conversion of Class C Common.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>



























<table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_zvSuADktrMr1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details 1)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B3_zWIu7i8E4IPh" style="font: normal 11pt Times New Roman, Times, Serif">Schedule
    of earning per share</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Three
    months ended <br/> December 31, 2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Three
    months ended <br/> December 31, 2023</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Common
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Class
    C Common <br/> Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Common
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Class
    C Common <br/> Stock</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Basic</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Numerator:
    <br/> Net income available to common stockholders</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20241001__20241231_ztTa1wwlnWDd" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Times New Roman, Times, Serif">1,964</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zOf2aCRyKGJf" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Times New Roman, Times, Serif">1,840</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zMUw31DAxzei" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Times New Roman, Times, Serif">31</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20231001__20231231_zxID2v0G8pLh" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Times New Roman, Times, Serif">3,759</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zjdCfLIuesc1" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Common Stock and Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Times New Roman, Times, Serif">3,525</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zweySSu8W3Yl" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Times New Roman, Times, Serif">59</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Denominator:</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Weighted
    average shares outstanding</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20241001__20241231_zVkAyP0a5yFb" style="font: normal 11pt Times New Roman, Times, Serif">6,686</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zobPQYC1HAV7" style="font: normal 11pt Times New Roman, Times, Serif">6,303</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z3jBeGlOPqt4" style="font: normal 11pt Times New Roman, Times, Serif">383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20231001__20231231_z6FfKz3syYVg" style="font: normal 11pt Times New Roman, Times, Serif">6,437</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z0Xpm9av716" style="font: normal 11pt Times New Roman, Times, Serif">6,437</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zAtOM6gjv5Z8" style="font: normal 11pt Times New Roman, Times, Serif">383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Basic
    income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_900_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20241001__20241231_zkUoT17qDZl3" style="font: normal 11pt Times New Roman, Times, Serif">0.31</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_900_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFfqm38RqGb7" style="font: normal 11pt Times New Roman, Times, Serif">0.29</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z6n52whbB474" style="font: normal 11pt Times New Roman, Times, Serif">0.08</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20231001__20231231_zyxsQRp4L6pd" style="font: normal 11pt Times New Roman, Times, Serif">0.58</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKO1ImWncDt8" style="font: normal 11pt Times New Roman, Times, Serif">0.55</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zHRgAfVOuBdh" style="font: normal 11pt Times New Roman, Times, Serif">0.16</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Diluted</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Denominator:
    <br/>
    Weighted average shares outstanding</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zixYLlEfAWGf" style="font: normal 11pt Times New Roman, Times, Serif">6,303</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_909_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zhCScoo7cZ8i" style="font: normal 11pt Times New Roman, Times, Serif">383</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zELp0cpWqRE1" style="font: normal 11pt Times New Roman, Times, Serif">6,437</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zNbaLYf5rIV5" style="font: normal 11pt Times New Roman, Times, Serif">383</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Convertible
    Class C Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90B_ecustom--ConvertibleClassCStock_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zZMFXw6Dq7lh" style="font: normal 11pt Times New Roman, Times, Serif">128</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_902_ecustom--ConvertibleClassCStock_pn3n3_d0_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zyO3CHookUdb" style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90D_ecustom--ConvertibleClassCStock_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zUvmoPZSrzwa" style="font: normal 11pt Times New Roman, Times, Serif">128</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_ecustom--ConvertibleClassCStock_pn3n3_d0_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zha7t8rJIDG3" style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Total
    Denominator for diluted earnings per share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zicEmHf5MvJf" style="font: normal 11pt Times New Roman, Times, Serif">6,431</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zWL9xD6Js6k9" style="font: normal 11pt Times New Roman, Times, Serif">383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zocz0Ddf5Lxa" style="font: normal 11pt Times New Roman, Times, Serif">6,565</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zv8RsJ5XOfq1" style="font: normal 11pt Times New Roman, Times, Serif">383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Diluted
    income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_eus-gaap--EarningsPerShareDiluted_pip0_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKjdQMnTyOKd" style="font: normal 11pt Times New Roman, Times, Serif">0.29</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--EarningsPerShareDiluted_pip0_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zo2e9dER4va1" style="font: normal 11pt Times New Roman, Times, Serif">0.08</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_eus-gaap--EarningsPerShareDiluted_pip0_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zNYREjn4QC94" style="font: normal 11pt Times New Roman, Times, Serif">0.54</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--EarningsPerShareDiluted_pip0_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zdX8taCtG7x3" style="font: normal 11pt Times New Roman, Times, Serif">0.16</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Six
    months ended <br/> December 31, 2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Six
    months ended <br/> December 31, 2023</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Common
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Class
    C Common <br/> Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Common
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Class
    C Common <br/> Stock</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Basic</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Numerator:
    <br/> Net income available to common stockholders</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20240701__20241231_zUYItGA2tivc" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Times New Roman, Times, Serif">5,099</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zCBPfN32iqRd" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Times New Roman, Times, Serif">4,775</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zfGRoSD7DnI7" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Times New Roman, Times, Serif">83</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20231231_zAu6tNscy156" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Times New Roman, Times, Serif">7,865</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z25N3f8IwFq3" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Common Stock and Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Times New Roman, Times, Serif">7,375</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z39Ly1ZxxTdb" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Times New Roman, Times, Serif">125</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Denominator:</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Weighted
    average shares outstanding</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20240701__20241231_zYwD3YAJ5rwj" style="font: normal 11pt Times New Roman, Times, Serif">6,696</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zwVPrZqX6W7i" style="font: normal 11pt Times New Roman, Times, Serif">6,313</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zKmXnF1ZPk5b" style="font: normal 11pt Times New Roman, Times, Serif">383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20231231_zMtQCmFp8RQg" style="font: normal 11pt Times New Roman, Times, Serif">6,448</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsymdHwEt081" style="font: normal 11pt Times New Roman, Times, Serif">6,448</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zUaLrSiJ4oW2" style="font: normal 11pt Times New Roman, Times, Serif">383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Basic
    income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20240701__20241231_zwHIYbIkQc5a" style="font: normal 11pt Times New Roman, Times, Serif">0.81</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zeZ8c3bHHjcb" style="font: normal 11pt Times New Roman, Times, Serif">0.76</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zd1gkLEBpid5" style="font: normal 11pt Times New Roman, Times, Serif">0.22</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20231231_zewRQ7HypSj2" style="font: normal 11pt Times New Roman, Times, Serif">1.22</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zmSgeA9ml2x9" style="font: normal 11pt Times New Roman, Times, Serif">1.14</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zbz4B56NEhO8" style="font: normal 11pt Times New Roman, Times, Serif">0.33</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Diluted</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Denominator:
    <br/>
    Weighted average shares outstanding</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_909_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z6I7pQfx89Kf" style="font: normal 11pt Times New Roman, Times, Serif">6,313</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zC6thKXWDBT" style="font: normal 11pt Times New Roman, Times, Serif">383</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zq7I6DGVsxv1" style="font: normal 11pt Times New Roman, Times, Serif">6,448</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z7lO4NhLTXT" style="font: normal 11pt Times New Roman, Times, Serif">383</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Convertible
    Class C Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_900_ecustom--ConvertibleClassCStock_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z38YTp5LspV8" style="font: normal 11pt Times New Roman, Times, Serif">128</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_ecustom--ConvertibleClassCStock_pn3n3_d0_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zl2aWvQISKl" style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_907_ecustom--ConvertibleClassCStock_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zNGs04uCaZF8" style="font: normal 11pt Times New Roman, Times, Serif">128</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_ecustom--ConvertibleClassCStock_pn3n3_d0_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zVWHVdr5Bdh8" style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Total
    Denominator for diluted earnings per share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zYd2uol9Mkn4" style="font: normal 11pt Times New Roman, Times, Serif">6,441</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zZIbJkgYMhXf" style="font: normal 11pt Times New Roman, Times, Serif">383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zm6Vydg7fSyl" style="font: normal 11pt Times New Roman, Times, Serif">6,576</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zvspvf0JtAzk" style="font: normal 11pt Times New Roman, Times, Serif">383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Diluted
    income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_eus-gaap--EarningsPerShareDiluted_pip0_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVDisZxHxga4" style="font: normal 11pt Times New Roman, Times, Serif">0.74</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pip0_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zPzXBe83AY8i" style="font: normal 11pt Times New Roman, Times, Serif">0.22</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--EarningsPerShareDiluted_pip0_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zBUHA1ZB096b" style="font: normal 11pt Times New Roman, Times, Serif">1.12</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pip0_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zdQZ3ehBp5D7" style="font: normal 11pt Times New Roman, Times, Serif">0.33</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p id="xdx_8AC_zzOIAfL0t6lj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>





















<p id="xdx_84C_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z3iwg8LUJeek" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_860_zaxSgFmUHCb4" style="font: normal 11pt Times New Roman, Times, Serif">Correction
of immaterial errors</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">In
conjunction with preparing its interim financial statements for the three and six months ended December 31, 2024, the Company determined
that its calculation of Right to Use Assets and Operating Lease Liabilities at the end of the past two annual periods and at September
30, 2024 and 2023 contained three immaterial errors. The Company evaluated the errors, both qualitatively and quantitatively, and determined
that no prior interim or annual periods were materially misstated. The Company then evaluated whether the cumulative amount of the misstatement
was material to its projected fiscal 2025 results of operations, and determined the cumulative amount was not material. Therefore, the
Condensed Consolidated Financial Statements for the six and three months ended December 31, 2024 include an out-of-period correction
of the following three items; a) a reclass of a software license of $<span id="xdx_90E_ecustom--RightToUseAssetToIntangibleAsset_pn3n3_dm_c20240701__20241231_zxhPpzIF4r77">1.3
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">million
from Right to Use Asset/Liabilities to an intangible asset, b) a decrease to ROU of $<span id="xdx_90B_eus-gaap--IncreaseDecreaseInOperatingLeaseLiability_pn3n3_dm_c20240701__20241231_zkIBhlBv2jyb">1.7
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">million
and an increase to Lease Liability of $<span id="xdx_90D_eus-gaap--OperatingLeasePayments_pn3n3_dm_c20240701__20241231_zJtdLAwjr0P7">1.1
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">million
to correct the discounting of future lease payments and c) correct the accounting for 6 lease modifications.. The correction of these
three errors resulted in an out of period charge to expenses of $<span id="xdx_90D_eus-gaap--IncomeTaxExpenseBenefitIntraperiodTaxAllocation_pn3n3_c20240701__20241231_zFYOxIgox9Gd">116
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">to pre-tax
income for the three and six months ended December 31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_845_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zxNQfhqQxiw" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_865_z7SoHmRgVHk8" style="font: normal 11pt Times New Roman, Times, Serif">Recent
Accounting Standards</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">In
December 2023, The Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2023-09, &#8220;Income Taxes (Topic 740) Improvements
to Income Tax Disclosures, which requires the annual financial statements to include consistent categories and great disaggregation of
information in the rate reconciliation and income taxes paid disaggregated by jurisdiction. ASU 2023-09 is effective for the Company&#8217;s
annual reporting beginning after December 15, 2024, with early adoption permitted, and should be applied on a prospective basis, with
a retrospective option. The Company is currently evaluating the effect that the adoption of ASU 2023-09 will have on its disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">In
November 2023, FASB issued ASU 2023-07, &#8220;Segment Reporting (Topic 280)&#8221;, which is intended to improve reportable segment
disclosure requirements through enhanced disclosures about significant segment expenses. The amendments require disclosure of significant
segment expenses regularly provided to the chief operating decision maker (&#8220;CODM&#8221;) as well as other segment items, extended
certain annual disclosures to interim periods, clarify the applicability to single reportable segment entities, permit more than one
measure of profit or loss to be reported under certain conditions, and require disclosure of the title and position of the CODM. The
effective date for public entities is for fiscal years beginning after December 15, 2023 and interim periods with fiscal years beginning
after December 15, 2024. The Company is expected to adopt the new disclosures as required and are currently evaluating the impact on
the related disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>























<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">Recent
Accounting Standards</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of December 31,
2024 that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly
affected our financial accounting measures or disclosures had they been in effect during 2024 or 2023, and it does not believe that any
of those standards will have a significant impact on our unaudited consolidated condensed financial statements at the time they become
effective.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800510268912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock', window );">ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</a></td>
<td class="text"><p id="xdx_803_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zxKOpEEyGGM7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">NOTE
3 &#8211; <span id="xdx_822_zL9n8kAU2hWj">ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Receivables,
net are comprised of the following at December 31, 2024, and June 30, 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_pn3n3_z8bd1OG0LX96" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BB_zp1GhDq6yE6j" style="font: normal 11pt Times New Roman, Times, Serif">Schedule
    of financing receivable noncurrent allowance for credit loss</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_49A_20241231__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z0RBRf7wwER3" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_493_20241231__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zvXSVmvYjjFa" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_498_20241231_zSDSREaE2xR3" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">December
    31, 2024</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Gross
    Receivable</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Allowance
    for credit losses</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Net</span></td></tr>
  <tr id="xdx_401_eus-gaap--AccountsReceivableNet_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 46%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Accounts
    receivable</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">3,663</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">273</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">3,390</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--AccountsReceivableNetRelatedParty_iI_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Accounts
    receivable - related party</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">60</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1046">&#8212;</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">60</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--NontradeReceivables_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Medical
    receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">23,496</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1050">&#8212;</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">23,496</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Management
    and other fees receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">55,148</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">12,663</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">42,485</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Management
    and other fees receivable from related medical practices (&#8220;PC&#8217;s&#8221;)</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">16,666</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">6,989</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">9,677</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_494_20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zB9JXYN3V1k1" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_493_20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_ziASn6lVxep1" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_49B_20240630_zWOBFj4GtxU2" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">June
    30, 2024</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Gross
    Receivable</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Allowance
    for credit losses</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Net</span></td></tr>
  <tr id="xdx_404_eus-gaap--AccountsReceivableNet_iI_pn3n3_zuWXkbN34zhl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 46%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Accounts
    receivable</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">4,201</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">166</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">4,035</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--NontradeReceivables_iI_pn3n3_zADsAvQzSfo1" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Medical
    receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">23,992</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1066">&#8212;</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">23,992</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_zmX6owK18J8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Management
    and other fees receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">54,324</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">12,370</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">41,954</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_ziRgeoenE1Ej" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Management
    and other fees receivable from related medical practices (&#8220;PC&#8217;s&#8221;)</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">15,975</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">6,110</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">9,865</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p id="xdx_8A5_z8u9XdpqKvl1" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">The
Company&#8217;s customers are concentrated in the healthcare industry.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>























<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">Accounts
Receivable</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Credit
risk with respect to the Company&#8217;s accounts receivable related to product sales and service and repair fees is limited due to the
customer advances received prior to the commencement of work performed and the billing of amounts to customers as sub-assemblies are
completed. Service and repair fees are billed on a monthly or quarterly basis and the Company does not continue providing these services
if accounts receivable become past due. The Company has established a current expected credit loss (&#8220;CECL&#8221;) to address the
risk that a portion of these fees will not be paid. The Company controls credit risk with respect to accounts receivable from service
and repair fees through its credit evaluation process, credit limits, monitoring procedures and reasonably short collection terms. The
Company performs ongoing credit authorizations before a product sales contract is entered into or service and repair fees are provided.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Long
Term-Accounts Receivable</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Long
term-accounts receivable balances at December 31, 2024 and June 30, 2024 amounted to approximately $<span id="xdx_90A_eus-gaap--IncreaseDecreaseInAccountsAndOtherReceivables_pn3n3_c20240701__20241231_zjjc5VzZsEjl">724
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
$<span id="xdx_902_eus-gaap--IncreaseDecreaseInAccountsAndOtherReceivables_pn3n3_c20230701__20240630_zLgzvCanbhz5">830 </span></span><span style="font: normal 11pt Times New Roman, Times, Serif">respectively.
The Company will generate revenue from long-term, non-cancellable contracts to provide service and repair services. Future revenue to
be recognized over the following four years as of December 31, 2024 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--LongTermPurchaseCommitmentTextBlock_pn3n3_znuwEuARe03l" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Future Revenue (Details 1)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span id="xdx_8B7_zmpitxKBUFql" style="font: normal 11pt Times New Roman, Times, Serif">Schedule
    of future revenue</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 44%; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2026</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 10%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--ContractReceivableDueOneToTwoYears_iI_pn3n3_c20241231_z5Tohm8lWPjh" style="width: 43%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">677</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2027</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pn3n3_c20241231_zClkZxZ6BGU1" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">242</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2028</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--ContractReceivableDueThreeToFourYears_iI_pn3n3_c20241231_zKybmD13r44i" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">87</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2029</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--ContractReceivableDueFourToFiveYears_iI_pn3n3_c20241231_zgJgvGHDrpw8" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">44</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_pn3n3_c20241231_zcukdl8FyWpa" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">1,050</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A6_zL6NKvyxND37" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">Medical
Receivables</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Medical
receivables are due under fee-for-service contracts from third party payors, such as hospitals, government sponsored healthcare programs,
patient&#8217;s legal counsel and directly from patients. Substantially all the revenue relates to patients residing in Florida. Medical
receivables are recorded at net realizable value based on the estimated amounts the Company expects to receive from patients and third-party
payors. The medical receivable is reduced by contractual adjustments based on the historical experience with each payor class at each
location.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>























<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">Management
and Other Fees Receivable</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; color: #212529"><span style="font: normal 11pt Times New Roman, Times, Serif">Management
fees receivable is related to management fees outstanding from the related and non related PCs under management agreements. The Company
has established a CECL to address the risk that a portion of the contractually obligated management fees receivable from the PCs may
not be paid. The PC&#8217;s may be limited in their ability to pay the full management fee receivable if they do not collect sufficient
expected fees from third-party payers and patients. The Company&#8217;s management fees are collateralized, individually and collectively,
by the assets of the PCs. The CECL is determined based on the difference between the management fee receivable and the current amount
of outstanding fees estimated to be collected by the PCs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">Management
and Other Fees Receivable (Continued)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">The
Company&#8217;s considerations into the estimate of the PC&#8217;s fee collection is based on a combination of factors. As each management
agreement specifies the Company&#8217;s ultimate collateral for unpaid management fees are the patient fee receivables owned by each
PC, the Company considers the historical loss rates to pools of receivables with similar risks characteristics, aging of the patient
fee receivables, and the financial condition of each PC. In addition, the Company subjectively adjusts its estimated expected credit
losses for current and forward-looking economic conditions which would include trends seen within the industry and newly enacted regulation.
The Company also incorporates qualitative factors, such as changes in the nature and volume of receivables, regulatory changes, and other
relevant factors. Specifically, insurance carriers covering automobile no-fault and workers compensation claims incur longer payment
cycles and rigorous informational requirements and certain other disallowed claims. Approximately <span id="xdx_90C_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_pip0_dp_c20241001__20241231_z5ccBn2cRVya">58.2</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
and <span id="xdx_909_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_pip0_dp_c20231001__20231231_z1YtUwiVPcDl">54.4</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
of the Company&#8217;s owned PCs&#8217; net revenues were derived from no-fault and personal injury protection claims for the three months
ending December 31, 2024 and 2023, respectively. In addition, <span id="xdx_904_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_pip0_dp_c20240701__20241231_zWKW9CZnMfpc">59.3</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
and <span id="xdx_904_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_pip0_dp_c20230701__20231231_zaSvVOdRtX4g">57.5</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
of the Company&#8217;s owned PC&#8217;s net revenues were derived from no-fault and personal injury protection claims for the six months
ending December 31, 2024 and 2023, respectively. Also approximately <span id="xdx_90F_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1_pip0_dp_c20241001__20241231_zsobWHLM2KKf">72.5</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
and <span id="xdx_909_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1_pip0_dp_c20231001__20231231_z1yWlLdBUiB5">71.7</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
of the Company&#8217;s managed PCs&#8217; net revenues were derived from no-fault and personal injury protection claims for the three
months ending December 31, 2024 and 2023, respectively. In addition <span id="xdx_90C_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1_pip0_dp_c20240701__20241231_zmeew03pjEy8">72.2</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
and <span id="xdx_909_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1_pip0_dp_c20230701__20231231_zXlqGjbwFFfk">71.8</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
of the Company&#8217;s net revenues were derived from no-fault and personal injury protection claims for the six months ending December
31, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">The
Company combines an objective and subjective loss-rate methodology to estimate expected credit losses based on the collateral owned by
each PC. This involves objectively using historical loss rates to pools of receivables with similar risk characteristics (i.e. various
insurance payors) and then subjectively adjusting for current and forward-looking economic conditions which would include trends seen
within the industry and newly enacted regulation. The Company also incorporates qualitative factors, such as changes in the nature and
volume of the receivables, regulatory changes, and other relevant factors. Additional Company managed entities also operate under a guaranty
agreement, pursuant to which management fees are payable to the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>























<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Net
revenues from management and other fees charged to the related PCs accounted for approximately <span id="xdx_903_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_pip0_dp_c20241001__20241231_z66qqLsno2Of">12.0</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
and <span id="xdx_909_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_pip0_dp_c20231001__20231231_zfGLIrZ0eSV7">11.8</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
of the consolidated net revenues for the three months ended December 31, 2024 and 2023, respectively. Net revenues from management and
other fees charges to the related PCs accounted for approximately <span id="xdx_90A_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_pip0_dp_c20240701__20241231_zPvFRPsjOa8">12.0</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
and <span id="xdx_903_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_pip0_dp_c20230701__20231231_zCC45mEQQDk7">11.7</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
of the consolidated net revenues for the six months ended December 31, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due to entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/310-10/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800499684432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING AND FINANCING LEASES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureOperatingAndFinancingLeasesAbstract', window );"><strong>Operating And Financing Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_LesseeOperatingLeasesAndFinanceLeaseTextBlock', window );">OPERATING AND FINANCING LEASES</a></td>
<td class="text"><p id="xdx_805_ecustom--LesseeOperatingLeasesAndFinanceLeaseTextBlock_zamZ6oSUQyO" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">NOTE
4 &#8211; <span id="xdx_822_z1kl8VJVawgg">OPERATING AND FINANCING LEASES</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">The
Company accounts for its various operating leases in accordance with Accounting Standards Codification (ASC) 842 &#8211; &#8220;Leases&#8221;,
as updated by ASU 2016-02. At the inception of a lease, the Company recognizes right-of-use lease assets and related lease liabilities
measured at present value of future lease payments on its balance sheet. Lease expense is recognized on a straight-line basis over the
term of the lease. The Company most common initial term varies in length from 2 to 19 years. Including renewal options negotiated with
the landlord, we have a total span of 2 to 16 years at the facilities we lease. The Company reviewed its contracts with vendors and customers,
determining that its right-to-use lease assets consisted of only office space operating leases. In determining the right-to-use lease
assets and liabilities, the Company did recognize lease extension options which the Company feels would be reasonably exercised. Our
incremental borrowing rate (&#8220;IBR&#8221;) used to discount the stream of operating lease payments is closely related to the interest
rates available to the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">A
reconciliation of operating and financing lease payments undiscounted cash flows to lease liabilities recognized as of December 31, 2024
is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_pn3n3_zytfQ93lppu7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="text-align: center"><span id="xdx_8B7_zrgoY2NwmBF" style="font: normal 11pt Times New Roman, Times, Serif">Schedule
    of lessee operating leases liability maturity</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Twelve
    Months Ending<br/> December 31,</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Operating
    Lease<br/> Payments</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Financing
    Lease Payments</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 27%; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2025</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="width: 26%; text-align: right" title="2025"><span style="font: normal 11pt Times New Roman, Times, Serif">5,584</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="width: 26%; text-align: right" title="2025"><span style="font: normal 11pt Times New Roman, Times, Serif">244</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2026</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="text-align: right" title="2026"><span style="font: normal 11pt Times New Roman, Times, Serif">5,388</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="text-align: right" title="2026"><span style="font: normal 11pt Times New Roman, Times, Serif">244</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2027</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="text-align: right" title="2027"><span style="font: normal 11pt Times New Roman, Times, Serif">5,371</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="text-align: right" title="2027"><span style="font: normal 11pt Times New Roman, Times, Serif">61</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2028</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="text-align: right" title="2028"><span style="font: normal 11pt Times New Roman, Times, Serif">5,019</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_iI_pn3n3_d0_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_z75D5Qjhrzic" style="text-align: right" title="2028"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2029</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="text-align: right" title="2029"><span style="font: normal 11pt Times New Roman, Times, Serif">4,876</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_pn3n3_d0_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zKGemonbDrvi" style="text-align: right" title="2029"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Thereafter</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="text-align: right" title="Thereafter"><span style="font: normal 11pt Times New Roman, Times, Serif">26,841</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_iI_pn3n3_d0_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zYdNNieE4te1" style="text-align: right" title="Thereafter"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">Present
                                            value discount</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_ecustom--PresentValueDiscount_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Present value discount"><span style="font: normal 11pt Times New Roman, Times, Serif">(14,893</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_ecustom--PresentValueDiscountFinancingLease_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Present value discount"><span style="font: normal 11pt Times New Roman, Times, Serif">(15</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">Total
                                            lease liability</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--OperatingLeaseLiability_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating Lease, Liability"><span style="font: normal 11pt Times New Roman, Times, Serif">38,186</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--FinanceLeaseLiability_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Finance Lease, Liability"><span style="font: normal 11pt Times New Roman, Times, Serif">534</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p id="xdx_8A8_zGWSg06hXHil" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>























<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Weighted
Average Remaining Lease Term</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock_pn3n3_zBX9eKrkHgPh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES (Details 1)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BC_zzStWqTbube1" style="font: normal 11pt Times New Roman, Times, Serif">Schedule
    of weighted average remaining lease term</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 70%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Operating
    leases - years</span></td><td style="width: 10%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 18%; text-align: right"><span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20241231_zu6b4AUiB196" style="font: normal 11pt Times New Roman, Times, Serif">10.6</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Finance
    lease - years</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_90C_eus-gaap--FinanceLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20241231_zm6RJ9MkEECd" style="font: normal 11pt Times New Roman, Times, Serif">2.1</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Weighted
    Average Discount Rate</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Operating
    leases</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_90B_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pip0_dp_c20241231_ztzDBNXnEY8" style="font: normal 11pt Times New Roman, Times, Serif">6.5</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Finance
    lease</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_907_eus-gaap--FinanceLeaseWeightedAverageDiscountRatePercent_iI_pip0_dp_c20241231_zZSAoawyfMod" style="font: normal 11pt Times New Roman, Times, Serif">3.6</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">%</span></td></tr>
  </table>

<p id="xdx_8AB_zien8TJiwFR2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="text-decoration: underline">The
components of lease expense were as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--LeaseCostTableTextBlock_pn3n3_zSSD0KJ9T22f" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES (Details 2)">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BD_zRXWrP9tobWa" style="font: normal 11pt Times New Roman, Times, Serif">Components
    of lease expense</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" id="xdx_49F_20240701__20241231_zYUEbGBhDME5" style="text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" id="xdx_49E_20230701__20231231_zweC4Lzxt2Lh" style="text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">For
    the six months ended Dec.31,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">2023</span></td></tr>
  <tr id="xdx_408_eus-gaap--OperatingLeaseCost_pn3n3_zo2KYggax5El" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Operating
    lease cost</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">3,190</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">2,865</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--FinanceLeaseCostsAbstract_iB_zKhjZXR9Yz15" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Finance
    lease cost:</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--DepreciationOfLeasedEquipment_i01_pn3n3_zP7Zw1OPGPHd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Depreciation
    of leased equipment</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">100</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">100</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--FinanceLeaseInterestExpense_i01_pn3n3_zVCWL9KIkLZ4" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Interest
    on lease liabilities</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">5</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">14</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--FinanceLeaseCost_i01_pn3n3_zBRBwGlHafN6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Total
    finance lease cost</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">105</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">114</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p id="xdx_8A7_z4MqkZ4FCLE2" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Supplemental
cash flow information related to leases was as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_pn3n3_zv22ZU9izFM1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure -  OPERATING &amp; FINANCING LEASES (Details 3)">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BF_zU6hV9BuBgL" style="font: normal 11pt Times New Roman, Times, Serif">Supplemental
    cash flow information related to leases</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" id="xdx_49F_20240701__20241231_zgIXIEmxP1s5" style="text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" id="xdx_49E_20230701__20231231_zsXLlWN0wOQ1" style="text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">For
    the six months ended Dec. 31,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Cash
    paid for amounts included in the measurement of lease liabilities:</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">2023</span></td></tr>
  <tr id="xdx_40A_ecustom--OperatingCashFlowsFromOperatingLeases_zYsccWh63qKc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Operating
    cash flows from operating leases</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">2,541</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">3,164</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--FinancingCashFlowsFromFinancingLeases_zbSB6ZuGtWT5" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Financing
    cash flows from financing leases</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">122</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">122</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract_iB_zKdnXriZjHSl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Right-of-use
    and equipment assets obtained in exchange for lease obligations:</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_ztrAUcoQpSkg" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Operating
    leases</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">359</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">1,212</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p id="xdx_8A7_ze62rNaIXQk2" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureOperatingAndFinancingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureOperatingAndFinancingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_LesseeOperatingLeasesAndFinanceLeaseTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_LesseeOperatingLeasesAndFinanceLeaseTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800499976816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORIES</a></td>
<td class="text"><p id="xdx_80D_eus-gaap--InventoryDisclosureTextBlock_zVMGuHgV7ha1" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif"><b>NOTE
5 - <span id="xdx_824_zSDNoBjj1IV1">INVENTORIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Inventories
included in the accompanying condensed consolidated balance sheets consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_pn3n3_zeGDeJwevqRd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-indent: -10pt"><span id="xdx_8BA_zr6ZVnBFTz4j" style="font: normal 11pt Times New Roman, Times, Serif">Schedule
    of inventories</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_499_20241231_zKIawok9SSxd" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_491_20240630_zoNNStkb4kR3" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">December
    31,<br/> 2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">June
    30,<br/> 2024</span></td></tr>
  <tr id="xdx_40E_eus-gaap--OtherInventorySupplies_iI_maIFGAWzdt0_zU1xG5uwxAEe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Purchased
    parts, components and supplies</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">2,583</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">2,524</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--InventoryWorkInProcess_iI_maIFGAWzdt0_zFoczDa3Bvu3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Work-in-process</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">275</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">191</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--InventoryNet_iTI_mtIFGAWzdt0_zQ8O4Qu1uqLj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Total
    Inventories</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">2,858</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">2,715</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/330/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800506344016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">OTHER INTANGIBLE ASSETS</a></td>
<td class="text"><p id="xdx_808_eus-gaap--IntangibleAssetsDisclosureTextBlock_z01m3GSJamy4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"><b>NOTE
6 &#8211; <span id="xdx_826_z054P3mriy64">OTHER INTANGIBLE ASSETS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Other
intangible assets, net of accumulated amortization, in the accompanying condensed consolidated balance sheets consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_pn3n3_zoa8HS5I6cUk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure -  OTHER INTANGIBLE ASSETS (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B9_zvCmY5nnJH53" style="font: normal 11pt Times New Roman, Times, Serif">Schedule
    of other intangible assets</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Weighted
    average useful lives</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Gross
    carrying amount &#8211; December 31, 2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Accumulated
    amortization &#8211; December 31, 2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Net
    carrying amount &#8211; December 31, 2024</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Capitalized
    software development costs</span></td><td style="width: 3%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 10%; text-align: center"><span id="xdx_90D_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zuOgvJbo0sAb" style="font: normal 11pt Times New Roman, Times, Serif">5
                                            </span><span style="font: normal 11pt Times New Roman, Times, Serif">years</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zSMGe5ZhVwRb" style="width: 10%; text-align: right" title="Gross carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">7,005</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zDhkRmDjIaFj" style="width: 10%; text-align: right" title="Accumulated amortization intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">(7,005</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="width: 3%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zWGwYxTQxTe2" style="width: 10%; text-align: right" title="Net carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1240">&#8212;</span></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Software
    License</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span id="xdx_900_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_zpMsHY9YSou7" style="font: normal 11pt Times New Roman, Times, Serif">3
                                            </span><span style="font: normal 11pt Times New Roman, Times, Serif">years</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_z7yfeQTcbjOa" style="text-align: right" title="Gross carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">1,260</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_zSA5eePW4P44" style="text-align: right" title="Accumulated amortization intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">(567</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_zoxuC3EnwFN3" style="text-align: right" title="Net carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">693</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Patents
    and copy rights</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span id="xdx_90B_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zBnTAz3MBZWf" style="font: normal 11pt Times New Roman, Times, Serif">15
                                            </span><span style="font: normal 11pt Times New Roman, Times, Serif">years</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zmRhXzD9AXKj" style="text-align: right" title="Gross carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">5,280</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zriiQuIm7zB5" style="text-align: right" title="Accumulated amortization intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">(4,180</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zskrWHIfldx" style="text-align: right" title="Net carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">1,100</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Non-compete</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span id="xdx_90B_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zHlh8MkVo0bg" style="font: normal 11pt Times New Roman, Times, Serif">7
                                            </span><span style="font: normal 11pt Times New Roman, Times, Serif">years</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zAWGEImeexz5" style="text-align: right" title="Gross carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">4,150</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zgNjX0ISAODf" style="text-align: right" title="Accumulated amortization intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">(4,150</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_d0_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zT3sOx8MNlph" style="text-align: right" title="Net carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Customer
    relationships</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span id="xdx_90D_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zyOOFtJqB4Vh" style="font: normal 11pt Times New Roman, Times, Serif">20
                                            </span><span style="font: normal 11pt Times New Roman, Times, Serif">years</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zlWOjgwulIZ1" style="border-bottom: Black 1pt solid; text-align: right" title="Gross carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">3,900</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zn514S0v8gwk" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated amortization intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">(2,286</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zKDqHfGgrHI1" style="border-bottom: Black 1pt solid; text-align: right" title="Net carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">1,614</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20241231_zsROI8wQYTji" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">21,595</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20241231_zrPbHDgvMIea" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated amortization intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">(18,188</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20241231_zzD7VWLzjNYj" style="border-bottom: Black 2.5pt double; text-align: right" title="Net carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">3,407</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>























<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Weighted
    average useful lives</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Gross
    carrying amount &#8211; June 30, 2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Accumulated
    amortization</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Net
    carrying amount</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Capitalized
    software development costs</span></td><td style="width: 3%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 10%; text-align: right"><span id="xdx_900_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_z9hyDTLaQPi4" style="font: normal 11pt Times New Roman, Times, Serif">5
                                            </span><span style="font: normal 11pt Times New Roman, Times, Serif">years</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zyOjKKCz6YOf" style="width: 10%; text-align: right" title="Gross carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">7,005</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zzVdNT1TaP5a" style="width: 10%; text-align: right" title="Accumulated amortization intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">(7,005</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="width: 3%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zhYAuVwULF31" style="width: 10%; text-align: right" title="Net carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1291">&#8212;</span></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Patents
    and copy rights</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_905_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zow9pwIMzb9g" style="font: normal 11pt Times New Roman, Times, Serif">15
                                            </span><span style="font: normal 11pt Times New Roman, Times, Serif">years</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_za9fs2E2Y20i" style="text-align: right" title="Gross carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">5,260</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zZsfMtt2K1a1" style="text-align: right" title="Accumulated amortization intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">(4,104</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zVU6RAC8ljH" style="text-align: right" title="Net carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">1,156</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Non-compete</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_90F_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zrFG4NLr6P36" style="font: normal 11pt Times New Roman, Times, Serif">7
                                            </span><span style="font: normal 11pt Times New Roman, Times, Serif">years</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zu8Wf5pVAOQ3" style="text-align: right" title="Gross carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">4,150</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_z9kyx76t2BFb" style="text-align: right" title="Accumulated amortization intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">(4,150</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_d0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zfuMXou8EK7e" style="text-align: right" title="Net carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Customer
    relationships</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_903_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zdz3MqKtFvid" style="font: normal 11pt Times New Roman, Times, Serif">20
                                            </span><span style="font: normal 11pt Times New Roman, Times, Serif">years</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zhFVZ3Sh1nXa" style="border-bottom: Black 1pt solid; text-align: right" title="Gross carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">3,900</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zKDX8EhfhdTl" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated amortization intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">(2,186</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zNl0CxAndfNg" style="border-bottom: Black 1pt solid; text-align: right" title="Net carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">1,714</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20240630_zLHtBSUhebjg" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">20,315</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20240630_zLMYcQfE7n8a" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated amortization intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">(17,445</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20240630_zmqzJxKLgLH7" style="border-bottom: Black 2.5pt double; text-align: right" title="Net carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">2,870</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p id="xdx_8AB_zqwkamRw3he9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Amortization
of patents and copyrights for the three months ended December 31, 2024 and 2023 amounted to $<span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20241001__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zEOqH6prnW7c">37
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
$<span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20231001__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zREHpi7jeGq9">43</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Amortization
of customer relationships for the three months ended December 31, 2024 and 2023 amounted to $<span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20241001__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zbu2OoPrAAL2">50
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
$<span id="xdx_90E_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20231001__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z92xCaTvO523">50</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Amortization
of patents and copyrights for the six months ended December 31, 2024 and 2023 amounted to $<span id="xdx_900_eus-gaap--AmortizationOfIntangibleAssets_c20240701__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3">76
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
$<span id="xdx_906_eus-gaap--AmortizationOfIntangibleAssets_c20230701__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3">86</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Amortization
of customer relationships for the six months ended December 31, 2024 and 2023 amounted to $<span id="xdx_90B_eus-gaap--AmortizationOfIntangibleAssets_c20240701__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3">100
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
$<span id="xdx_905_eus-gaap--AmortizationOfIntangibleAssets_c20230701__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3">100</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Amortization
expense for reach of the next five years and thereafter as of December 31, 2024 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_pn3n3_zAocYU0caLF3" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 40%; margin-right: auto" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS (Details 1)">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 44%; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2025</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 10%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pn3n3_c20241231_zeCa6dwE0e44" style="width: 43%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">723</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2026</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pn3n3_c20241231_zrDJdQRdjKj1" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">650</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2027</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pn3n3_c20241231_z8zbW0NOgyY9" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">321</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2028</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pn3n3_c20241231_zr70CM00YPMi" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">317</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2029</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pn3n3_c20241231_z81xc37J5ltk" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">314</span></td><td style="text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Thereafter</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pn3n3_c20241231_zZ2j3yH5tTEa" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">1082</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_pn3n3_c20241231_zOYqppaOdbP8" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">3,407</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A2_zqvS13e4NxLj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>



















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/985-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800655675984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CURRENT LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">OTHER CURRENT LIABILITIES</a></td>
<td class="text"><p id="xdx_806_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zBottQqPbveh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"><b>NOTE
7 &#8211; <span id="xdx_823_zs7bghJuC262">OTHER CURRENT LIABILITIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Other
current liabilities in the accompanying condensed consolidated balance sheets consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_pn3n3_z8H95YZKmxF3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B0_zmewYkyOxNY5" style="font: normal 11pt Times New Roman, Times, Serif">Schedule
    of other current liabilities</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_490_20241231_zUHSd0BseHid" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_497_20240630_zv9akfW2dwue" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">December
    31,<br/> 2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">June
    30,<br/> 2024</span></td></tr>
  <tr id="xdx_400_eus-gaap--AccruedSalariesCurrent_iI_pn3n3_maOLCzdop_zikMYErCYEJk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Accrued
    salaries, commissions and payroll taxes</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">1,541</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">4,678</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pn3n3_maOLCzdop_zfgmq7aK6eA5" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Sales
    tax payable</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">183</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">197</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--AccruedPayrollTaxesCurrent_iI_pn3n3_maOLCzdop_z3ehj54qmLha" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Federal
    and state income taxes payable</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1355">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">1,461</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_ecustom--SelffundedHealthInsuranceReserve_iI_pn3n3_maOLCzdop_z3fz6TGCpfxh" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Self-funded
    health insurance reserve</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">168</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">121</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--SoftwareLicenses_iI_pn3n3_z5pMnuieRC8a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Software
    Licenses</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">252</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1362">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pn3n3_maOLCzdop_zUCODa2QQI07" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Other
    general and administrative expenses</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">1,768</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">1,484</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--OtherLiabilitiesCurrent_iTI_pn3n3_mtOLCzdop_zGIZ13tmpgTf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Other
    Current Liabilities</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">3,912</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">7,941</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800503170048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND RELATED INFORMATION<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT AND RELATED INFORMATION</a></td>
<td class="text"><p id="xdx_801_eus-gaap--SegmentReportingDisclosureTextBlock_zptfoUDKi6Ef" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif"><b>NOTE
8 - <span id="xdx_82D_zB66pAl4E1O5">SEGMENT AND RELATED INFORMATION</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">The
Company operates in two industry segments - manufacturing and the servicing of medical equipment and management of diagnostic imaging
centers. The accounting policies of the segments are the same as those described in the summary of significant accounting policies as
disclosed in the Company&#8217;s 10-K as of June 30, 2024. All inter segment sales are market-based. The Company evaluates performance
based on income or loss from operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Summarized
financial information concerning the Company&#8217;s reportable segments is shown in the following table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_pn3n3_ziO5u5Cqwiba" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Summarized Segments - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B9_zj6XJ57Ltw81" style="font: normal 11pt Times New Roman, Times, Serif">Schedule
    of summarized segment financial information</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Manufacturing
    and Service of MRI Equipment</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Management
    of Diagnostic Imaging Centers</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Totals</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">For
    the three months ended December 31, 2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 46%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Net
    revenues from external customers</span></td><td style="width: 5%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--Revenues_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zqoyNHe2R5Ii" style="width: 11%; text-align: right" title="Net revenues from external customers"><span style="font: normal 11pt Times New Roman, Times, Serif">1,829</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--Revenues_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zLjcbEjDro24" style="width: 11%; text-align: right" title="Net revenues from external customers"><span style="font: normal 11pt Times New Roman, Times, Serif">23,121</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--Revenues_pn3n3_c20241001__20241231_zjsbg6sAZ4fl" style="width: 11%; text-align: right" title="Net revenues from external customers"><span style="font: normal 11pt Times New Roman, Times, Serif">24,950</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Inter-segment
    net revenues</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--IntersegmentNetRevenues_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zru1txtcsWBc" style="text-align: right" title="Inter-segment net revenues"><span style="font: normal 11pt Times New Roman, Times, Serif">294</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_987_ecustom--IntersegmentNetRevenues_pn3n3_d0_c20241001__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zI9RiDiZws79" style="text-align: right" title="Inter-segment net revenues"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_ecustom--IntersegmentNetRevenues_pn3n3_c20241001__20241231_zodU8SHHQWs6" style="text-align: right" title="Inter-segment net revenues"><span style="font: normal 11pt Times New Roman, Times, Serif">294</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">(Loss)
    Income from operations</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zP6rPQgqyWMk" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Times New Roman, Times, Serif">(1,291</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zOYc445bZx9a" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Times New Roman, Times, Serif">3,726</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20241001__20241231_zL1BymUXABw5" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Times New Roman, Times, Serif">2,435</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Depreciation
    and amortization</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zRca5VP2lrvj" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Times New Roman, Times, Serif">54</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zpYaV7Vmcjvf" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Times New Roman, Times, Serif">1,181</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20241001__20241231_z4Xfk5ehyXdj" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Times New Roman, Times, Serif">1,235</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Capital
    expenditures</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_z3VAJ6J87m29" style="text-align: right" title="Capital expenditures"><span style="font: normal 11pt Times New Roman, Times, Serif">23</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zi40VVKqnAwg" style="text-align: right" title="Capital expenditures"><span style="font: normal 11pt Times New Roman, Times, Serif">731</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20241001__20241231_z8KRIarlKWQ3" style="text-align: right" title="Capital expenditures"><span style="font: normal 11pt Times New Roman, Times, Serif">754</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">For
    the three months ended December 31, 2023</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Net
    revenues from external customers</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--Revenues_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_z7VSkIJPQTx" style="text-align: right" title="Net revenues from external customers"><span style="font: normal 11pt Times New Roman, Times, Serif">1,861</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--Revenues_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zbzusP5xFYhf" style="text-align: right" title="Net revenues from external customers"><span style="font: normal 11pt Times New Roman, Times, Serif">23,525</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--Revenues_pn3n3_c20231001__20231231_zFqsOWjpzNN5" style="text-align: right" title="Net revenues from external customers"><span style="font: normal 11pt Times New Roman, Times, Serif">25,386</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Inter-segment
    net revenues</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--IntersegmentNetRevenues_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_z4p3S0ElHEtc" style="text-align: right" title="Inter-segment net revenues"><span style="font: normal 11pt Times New Roman, Times, Serif">254</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--IntersegmentNetRevenues_pn3n3_d0_c20231001__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zuzjTVgdI8P3" style="text-align: right" title="Inter-segment net revenues"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--IntersegmentNetRevenues_pn3n3_c20231001__20231231_zxTCTGpw7g5b" style="text-align: right" title="Inter-segment net revenues"><span style="font: normal 11pt Times New Roman, Times, Serif">254</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">(Loss)
    Income from operations</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zmAl3hnryYie" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Times New Roman, Times, Serif">(993</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zYaTj8A4GG44" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Times New Roman, Times, Serif">5,878</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20231001__20231231_zMhFoeeGe71c" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Times New Roman, Times, Serif">4,885</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Depreciation
    and amortization</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zBMDNEytuZph" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Times New Roman, Times, Serif">60</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zsmhsZdetKh9" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Times New Roman, Times, Serif">1,160</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20231001__20231231_zGFMXu32QBHc" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Times New Roman, Times, Serif">1,220</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Capital
    expenditures</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zI0cp9rcMBMf" style="text-align: right" title="Capital expenditures"><span style="font: normal 11pt Times New Roman, Times, Serif">4</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_z9VJtVX5yjs9" style="text-align: right" title="Capital expenditures"><span style="font: normal 11pt Times New Roman, Times, Serif">129</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20231001__20231231_zMTjKOlL5QVl" style="text-align: right" title="Capital expenditures"><span style="font: normal 11pt Times New Roman, Times, Serif">133</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>























<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Manufacturing
    and Service of MRI Equipment</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Management
    of Diagnostic Imaging Centers</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Totals</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">For
    the six months ended December 31, 2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 46%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Net
    revenues from external customers</span></td><td style="width: 5%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--Revenues_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_z6rTfOyUeHx5" style="width: 11%; text-align: right" title="Net revenues from external customers"><span style="font: normal 11pt Times New Roman, Times, Serif">3,986</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--Revenues_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zVdQ9YdB7FE2" style="width: 11%; text-align: right" title="Net revenues from external customers"><span style="font: normal 11pt Times New Roman, Times, Serif">45,924</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--Revenues_pn3n3_c20240701__20241231_zOAnJjpq6wRe" style="width: 11%; text-align: right" title="Net revenues from external customers"><span style="font: normal 11pt Times New Roman, Times, Serif">49,910</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Inter-segment
    net revenues</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--IntersegmentNetRevenues_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zvFt0W2XpZAc" style="text-align: right" title="Inter-segment net revenues"><span style="font: normal 11pt Times New Roman, Times, Serif">583</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--IntersegmentNetRevenues_pn3n3_d0_c20240701__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zSPNhFx6ooS2" style="text-align: right" title="Inter-segment net revenues"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_ecustom--IntersegmentNetRevenues_pn3n3_c20240701__20241231_zNovGROUlx81" style="text-align: right" title="Inter-segment net revenues"><span style="font: normal 11pt Times New Roman, Times, Serif">583</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">(Loss)
    Income from operations</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zIeJiG93EX4l" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Times New Roman, Times, Serif">(2,335</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zDgFO1C9ERce" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Times New Roman, Times, Serif">9,376</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20240701__20241231_ziaZirzu7d94" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Times New Roman, Times, Serif">7,041</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Depreciation
    and amortization</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zDnnIO1vJht6" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Times New Roman, Times, Serif">103</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zLeFMY1hgjcf" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Times New Roman, Times, Serif">2,195</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20240701__20241231_zT3IGbMgMFdk" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Times New Roman, Times, Serif">2,298</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Capital
    expenditures</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zKZclh3mbo6i" style="text-align: right" title="Capital expenditures"><span style="font: normal 11pt Times New Roman, Times, Serif">95</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zoq1aTNbWS0b" style="text-align: right" title="Capital expenditures"><span style="font: normal 11pt Times New Roman, Times, Serif">2,477</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20240701__20241231_zp2UGg8VGrre" style="text-align: right" title="Capital expenditures"><span style="font: normal 11pt Times New Roman, Times, Serif">2,572</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Manufacturing
    and Service of MRI Equipment</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Management
    of Diagnostic Imaging Centers</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Totals</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">For
    the six months ended December 31, 2023</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 46%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Net
    revenues from external customers</span></td><td style="width: 5%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--Revenues_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zWHnaVjNziBl" style="width: 11%; text-align: right" title="Net revenues from external customers"><span style="font: normal 11pt Times New Roman, Times, Serif">3,917</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--Revenues_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zdYVE2jw5V53" style="width: 11%; text-align: right" title="Net revenues from external customers"><span style="font: normal 11pt Times New Roman, Times, Serif">47,307</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--Revenues_pn3n3_c20230701__20231231_zFhRemx8lEgd" style="width: 11%; text-align: right" title="Net revenues from external customers"><span style="font: normal 11pt Times New Roman, Times, Serif">51,224</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Inter-segment
    net revenues</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_ecustom--IntersegmentNetRevenues_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zcQm4gard3ac" style="text-align: right" title="Inter-segment net revenues"><span style="font: normal 11pt Times New Roman, Times, Serif">508</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_ecustom--IntersegmentNetRevenues_pn3n3_d0_c20230701__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zNEjy50sfMb1" style="text-align: right" title="Inter-segment net revenues"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_ecustom--IntersegmentNetRevenues_pn3n3_c20230701__20231231_z6xvPabKi0af" style="text-align: right" title="Inter-segment net revenues"><span style="font: normal 11pt Times New Roman, Times, Serif">508</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">(Loss)
    Income from operations</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zPZPA8DkH9Jf" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Times New Roman, Times, Serif">(1,731</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_z7JferkQ3J87" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Times New Roman, Times, Serif">13,187</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20230701__20231231_z6QNhsIBfkHe" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Times New Roman, Times, Serif">11,456</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Depreciation
    and amortization</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zZTChwdwzBCj" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Times New Roman, Times, Serif">121</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_ztmdrKBbkba3" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Times New Roman, Times, Serif">2,294</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20230701__20231231_zvduOz0Rgvt8" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Times New Roman, Times, Serif">2,415</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Capital
    expenditures</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zqTOG5L0kDp" style="text-align: right" title="Capital expenditures"><span style="font: normal 11pt Times New Roman, Times, Serif">20</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zQdeURN2oCxa" style="text-align: right" title="Capital expenditures"><span style="font: normal 11pt Times New Roman, Times, Serif">192</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20230701__20231231_zSKV4qOHnYa9" style="text-align: right" title="Capital expenditures"><span style="font: normal 11pt Times New Roman, Times, Serif">212</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A2_zRsxJk2VGJil" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800506109648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW INFORMATION<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">SUPPLEMENTAL CASH FLOW INFORMATION</a></td>
<td class="text"><p id="xdx_802_eus-gaap--CashFlowSupplementalDisclosuresTextBlock_zGVOuN4nhr5b" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif"><b>NOTE
9 &#8211; <span id="xdx_824_zvntBC6U1sFj">SUPPLEMENTAL CASH FLOW INFORMATION</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">During
the six months ended December 31, 2024 and December 31, 2023, the Company paid $<span id="xdx_900_eus-gaap--InterestPaidNet_pn3n3_c20240701__20241231_zuYK5TSnsG41">14
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
$<span id="xdx_90F_eus-gaap--InterestPaidNet_pn3n3_c20230701__20231231_zujyHAOd1QS2">58 </span></span><span style="font: normal 11pt Times New Roman, Times, Serif">for
interest, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">During
the six months ended December 31, 2024 and December 31, 2023, the Company paid $<span id="xdx_906_eus-gaap--IncomeTaxesPaid_pn3n3_c20240701__20241231_z5JLBWZlqcU4">2,473
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
$<span id="xdx_90A_eus-gaap--IncomeTaxesPaid_pn3n3_c20230701__20231231_zAD0LgjMfELh">150 </span></span><span style="font: normal 11pt Times New Roman, Times, Serif">for
income taxes, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">During
the six months ended December 31, 2024 and December 31, 2023, the Company obtained right-of-use and equipment assets in exchange for
lease obligations of $<span id="xdx_90F_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_pn3n3_c20240701__20241231_zAA4TmmE9Ai2">359
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
$<span id="xdx_905_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_pn3n3_c20230701__20231231_zss9pIctGUkh">1,212</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">During
the three months ended December 31, 2024, the Company sold a <span id="xdx_90F_ecustom--RateOfInterestSold_pip0_dp_c20241001__20241231_zykVZPaR72ja">0.197</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
interest in HDM to an employee. The interest was sold for $<span id="xdx_90F_eus-gaap--ConversionOfStockAmountConverted1_pn3n3_c20241001__20241231_zXd3OI3qMCse">132,000
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">in a
noncash transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>



















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/230/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800506010688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p id="xdx_805_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z1jjQi59gbN" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif"><b>NOTE
10 &#8211; <span id="xdx_827_zw6Ixi3Dvh2a">COMMITMENTS AND CONTINGENCIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">Litigation</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">The
Company is subject to legal proceedings and claims arising from the ordinary course of its business, including personal injury, customer
contract and employment claims. In the opinion of management, the aggregate liability, if any, with respect to such actions, will not
have a material adverse effect on the consolidated financial position or results of operations of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">In
the ordinary course of its business, the Company is a party to various lawsuits arising from the operations at the MRI sites and other
insurance related matters, which are generally handled by the Company&#8217;s insurance carriers. Management believes, based in part
on the advice counsel, that the ultimate resolution of these matters will not have a material adverse effect on the Company&#8217;s consolidated
financial position, results of operations or cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">There
were no material changes in litigation from that reported in our Form 10-K for the fiscal year ended June 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">Other
Matters</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">On
September 13, 2022, the Company adopted a stock repurchase plan. The plan has no expiration date and cannot determine the number of shares
which will be repurchased. On September 26, 2022, the Board of Directors has approved up to $<span id="xdx_900_esrt--StockRepurchaseProgramAuthorizedAmount1_iI_pn3n3_c20220926__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_znooPvvtoGc4">9,000
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">to be
repurchased under the plan which will be purchased on the publicly traded open market at prevailing prices. During the six months ended
December 31, 2024 and 2023, the Company repurchased <span id="xdx_901_eus-gaap--StockRepurchasedDuringPeriodShares_pn3n3_c20240701__20241231__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_z5rV5vwLrwta">84
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
<span id="xdx_90F_eus-gaap--StockRepurchasedDuringPeriodShares_pn3n3_c20230701__20231231__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zVkIBmmQBGIa">116
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">shares
at a cost of $<span id="xdx_906_eus-gaap--StockRepurchasedDuringPeriodValue_pn3n3_c20240701__20241231__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zVfH13ldLav3">1,342
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
$<span id="xdx_906_eus-gaap--StockRepurchasedDuringPeriodValue_pn3n3_c20230701__20231231__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zmHrbwh6Sgl5">1,885</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">,
respectively. The Company cancelled <span id="xdx_909_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_pn3n3_c20240701__20241231__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zKfq3AxUgaF8">125
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">shares
and <span id="xdx_90F_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_pn3n3_c20230701__20231231__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zlcU11vOy63i">123
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">shares
at a cost of $<span id="xdx_907_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_pn3n3_c20240701__20241231__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_znxDloJMbJXh">1,963
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
$<span id="xdx_908_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_pn3n3_c20230701__20231231__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zdVe54008bUc">2,005
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">for
the six months ended December 31, 2024 and 2023, respectively. As of December 31, 2024 the remaining balance under the repurchase plan
was $<span id="xdx_907_eus-gaap--StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_iI_pn3n3_c20241231_zZkUsNBO7Fng">3,392</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">The
Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third-party insurer to limit the maximum
potential liability for individual claims to $<span id="xdx_90D_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpense_iI_pn3n3_c20241231_z0A4HrGwez5b">150
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">per
person and for a maximum potential claim liability based on member enrollment. With respect to this program, the Company considers historical
and projected medical utilization data when estimating its health insurance program liability and related expense. As of December 31,
2024 and June 30, 2024, the Company had approximately $<span id="xdx_90B_eus-gaap--SelfInsuranceReserve_iI_pn3n3_c20241231_zBKROCOAQFS1">168
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
$<span id="xdx_906_eus-gaap--SelfInsuranceReserve_iI_pn3n3_c20240630_zHRNR6EF4VF1">86</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">,
respectively, in reserve for its self-funded health insurance programs. The reserves are included in &#8220;Other current liabilities&#8221;
in the condensed consolidated balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">The
Company regularly analyzes its reserves for incurred but not reported claims, and for reported but not paid claims related to its reinsurance
and self-funded insurance programs. The Company believes its reserves are adequate. However, significant judgment is involved in assessing
these reserves such as assessing historical paid claims, average lags between the claims&#8217; incurred date, reported dates and paid
dates, and the frequency and severity of claims. There may be differences between actual settlement amounts and recorded reserves and
any resulting adjustments are included in expense once a probable amount is known. There were no significant adjustments recorded in
the periods covered by this report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>



















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800505702080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><p id="xdx_802_eus-gaap--IncomeTaxDisclosureTextBlock_zIAvIM0KbBci" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif"><b>NOTE
11 - <span id="xdx_82A_zaGn0S1yZ4dd">INCOME TAXES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">In
accordance with ASC 740-270, &#8220;Income Taxes &#8211; Interim Reporting&#8221;, the Company is required at the end of each interim
period to determine the best estimate of its annual effective tax rate and apply that rate to year-to-date ordinary income or loss. The
resulting tax expense (or benefit) is adjusted for the tax effect of specific events, if any, required to be discretely recognized in
the interim period as they occur. For the six months ended December 31, 2024 and 2023, the Company recorded income tax expense of $<span id="xdx_901_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_pn3n3_c20240701__20241231_zm0zu1WccEGe">2,011
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">in 2024
as compared to $<span id="xdx_909_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_pn3n3_c20230701__20231231_zEWptVzY14Ae">3,036
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">in 2023.
For the three months ended December 31, 2024 and 2023, the Company recorded income tax expense of $<span id="xdx_90E_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_pn3n3_c20241001__20241231_zxnBt1dSQfog">762
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
$<span id="xdx_90A_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_pn3n3_c20231001__20231231_zYxtQAbFfyIh">1,366</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">,
respectively. The six month and three month 2024 provision is comprised of a current income tax component of $<span id="xdx_905_eus-gaap--ExtinguishmentOfDebtGainLossNetOfTax_pn3n3_c20241001__20241231_zaArqZR5zmQ4">900
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
a deferred income tax component of $<span id="xdx_90E_ecustom--DeferredIncomeTaxComponent_pn3n3_c20241001__20241231_zlqWZzStf8Dd">1,111
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
a current income tax component of $<span id="xdx_90C_eus-gaap--ExtinguishmentOfDebtGainLossNetOfTax_pn3n3_c20240701__20241231_zFQftXO4HOll">517
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
a deferred income tax component of $<span id="xdx_908_ecustom--DeferredIncomeTaxComponent_pn3n3_c20240701__20241231_zsgxYyBSjbm9">245</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">,
respectively. Obligations for any liability associated with the current income tax provision has been reduced, primarily resulting from
the benefits and utilization of net operating loss carryforwards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">ASC
Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax
positions taken or expected to be taken in a corporate tax return. For those benefits to be recognized, a tax position must be more-likely-than-not
to be sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return
and the benefit recognized and measured pursuant to the interpretation are referred to as unrecognized benefits. A liability is recognized
(or amount of net operating loss carryforward or amount of tax refundable is reduced) for an unrecognized tax benefit because it represents
an enterprise&#8217;s potential future obligation to the taxing authority for a tax position that was not recognized as a result of applying
the provisions of ASC Topic 740. The Company believes there are no uncertain tax positions in prior year tax filings and therefore it
has not recorded a liability for unrecognized tax benefits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">The
Company recorded a deferred tax asset of $<span id="xdx_90C_eus-gaap--DeferredTaxAssetsNet_iI_pn3n3_c20241231_zgNN64Zs867j">6,113</span></span>
<span style="font: normal 11pt Times New Roman, Times, Serif">and a deferred tax
liability of $<span id="xdx_907_eus-gaap--DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_iI_pn3n3_c20241231_z9VPwcNEHSbl">371
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">as of
December 31, 2024, primarily relating to allowance for credit losses and tax credits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">The
Company files corporate income tax returns in the United States (federal) and in various state and local jurisdictions. In most instances,
the Company is no longer subject to federal, state and local income tax examinations by tax authorities for years prior to 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Future
ownership changes as determined under Section 382 of the Internal Revenue Code could further limit the utilization of net operating loss
carryforwards. As of December 31, 2024, no such changes in ownership have occurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">The
Inflation Reduction Act (&#8220;IRA&#8221;) was enacted on August 16, 2022. The IRA includes provisions imposing a <span id="xdx_908_ecustom--PercentageOfExciseTax_pip0_dp_c20240701__20241231_zAm4uPdPzHfb">1</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
excise tax on share repurchases that occur after December 31, 2022 and introduces a <span id="xdx_904_ecustom--CorporateAlternativeMinimumTaxPercentage_pip0_dp_c20240701__20241231_zZVa5sJmk6Ci">15</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
corporate alternative minimum tax (&#8220;CAMT&#8221;) on adjusted financial statement of income. The CAMT will be effective for tax
years beginning after December 31, 2022. Currently, the IRA did not have a material impact to the Company&#8217;s financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>



















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800499955824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY TRANSACTIONS</a></td>
<td class="text"><p id="xdx_802_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zo7LEpQgiQQj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"><b>NOTE
12 &#8211; <span id="xdx_82E_zSiHb1g03432">RELATED PARTY TRANSACTIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Tallahassee
Magnetic Resonance Imaging, Inc. Stand Up MRI of Boca Raton, PA and Stand Up MRI &amp; Diagnostic Center, Inc. (all related medical practices)
entered into a guaranty agreement, pursuant to which they cross guaranteed all management fees which are payable to the Company, which
have arisen under each individual management agreement. During the six months ended December 31, 2024 and 2023, the net revenues received
by the Company was $<span id="xdx_90F_ecustom--NetRevenues_pn3n3_c20240701__20241231_zErcmVKPf2tg">5,975</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Bensonhurst
MRI Limited Partnership (&#8220;Bensonhurst&#8221;), in which the CEO and President of the Company holds an interest, is party to an
agreement with the Company for the service and maintenance of its Upright MRI Scanner for a price of $<span id="xdx_905_ecustom--ServiceAndMaintenancePrice_iI_pn3n3_c20241231_zwDYaqwMms79">110,000
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">per
annum. On February 1, 2024, Bensonhurst entered into a second contract with the Company for the service and maintenance of a High-Field
MRI Scanner for a price of $<span id="xdx_90B_ecustom--ServiceAndMaintenancePrice_iI_pn3n3_c20240201_zzT091ULAfB5">70,000 </span></span><span style="font: normal 11pt Times New Roman, Times, Serif">per
annum. For the six months ended December 31, 2024 and 2023 the Company recorded service and repair fees of $<span id="xdx_907_ecustom--ServiceAndRepairFees_pn3n3_c20240701__20241231_zjlB78Fenfjb">90
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
$<span id="xdx_901_ecustom--ServiceAndRepairFees_pn3n3_c20230701__20231231_zGqFM62hfyCl">55</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">,
respectively from Bensonhurst. Also during the three months ended December 31, 2024 and 2023 the Company recorded service and repair
fees of $<span id="xdx_90C_ecustom--ServiceAndRepairFees_pn3n3_c20241001__20241231_zJqoN3Rob3Gi">45</span></span> <span style="font: normal 11pt Times New Roman, Times, Serif">and
$<span id="xdx_90A_ecustom--ServiceAndRepairFees_pn3n3_c20231001__20231231_zwjbBAN0jRB3">28</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Radian
Healthcare Management, LLC (&#8220;Radian&#8221;), which is owned by the son-in-law of the CEO and President of the Company provided
the Company with personnel recruitment of new employees at a fee of approximately $<span id="xdx_90E_ecustom--EmployeesFee_pn3n3_c20241001__20241231_zidyaf4biOXf">68
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">and
$<span id="xdx_90F_ecustom--EmployeesFee_pn3n3_c20231001__20231231_zqdyow07D3K">0 </span></span><span style="font: normal 11pt Times New Roman, Times, Serif">for
the six months ended December 31, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">On
December 31, 2023, the Company entered into an agreement with Magnetic Resonance Management, LLC (&#8220;MRM&#8221;) for the sale of
a MRI scanner. MRM is owned by the CEO and President of the Company. The sales price of the equipment was $<span id="xdx_907_eus-gaap--ConvertibleNotesPayable_iI_pn3n3_c20231231__us-gaap--TypeOfArrangementAxis__custom--MagneticResonanceManagementMember_zT6yk4qzBl04">577
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">which
is payable based upon a promissory note dated December 1, 2023. The note bears interest at a rate of <span id="xdx_90C_eus-gaap--DerivativeFixedInterestRate_iI_pip0_dp_c20231231__us-gaap--TypeOfArrangementAxis__custom--MagneticResonanceManagementMember_zujBx1q0ELBj">9</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">%
and is payable in full at the maturity of the note in December 2028. During the six months ending December 31, 2024 the Company recorded
$<span id="xdx_908_eus-gaap--InvestmentIncomeNet_pn3n3_c20240701__20241231__us-gaap--TypeOfArrangementAxis__custom--MagneticResonanceManagementMember_zWA4op3gh335">26
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">in investment
income on this promissory note. Also during the three months ending December 31, 2024, the Company recorded $<span id="xdx_908_eus-gaap--InvestmentIncomeNet_pn3n3_c20241001__20241231__us-gaap--TypeOfArrangementAxis__custom--MagneticResonanceManagementMember_z6Pg8Kzv6k31">13
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">in investment
income on this promissory note. The MRI scanner had zero basis, which resulted in a gain of $<span id="xdx_907_eus-gaap--DeferredGainOnSaleOfProperty_iI_pn3n3_c20240630__us-gaap--TypeOfArrangementAxis__custom--MagneticResonanceManagementMember_zpUuRMy9QPfb">577</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">,
which was recorded during the year ended June 30, 2024. The Company has the option but not the obligation to re-take possession of the
scanner in lieu of payment upon maturity of the note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800499794752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p id="xdx_800_eus-gaap--SubsequentEventsTextBlock_zfPruQxUqIX2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"><b>NOTE
13 &#8211; <span id="xdx_82D_z7iW2NUdCF1">SUBSEQUENT EVENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">The
Company has evaluated events that occurred subsequent to December 31, 2024 and through the date the condensed consolidated financial
statements were issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">In
the subsequent period up to the date of filing, the Company repurchased <span id="xdx_905_ecustom--StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchaseds_iI_pn3n3_c20241231_zJPtizoyNA9b">7
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">shares
of common stock at a cost of $<span id="xdx_900_ecustom--StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount_iI_pn3n3_c20241231_zO0ilU4ztNwb">108
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">which
was authorized under the stock repurchase plan adopted in September 2022.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800510348240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p id="xdx_841_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zQxMpzIdddeb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_861_zh0MhL9MYTzf" style="font: normal 11pt Times New Roman, Times, Serif">Basis
of Presentation</span> <span style="font: normal 11pt Times New Roman, Times, Serif">(Continued)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">The
Company evaluates theses estimates and judgements on an ongoing basis. The Company bases estimates and judgements on historical experience
and on various other factors that are believed to be reasonable under the circumstances. The results of operations for any interim period
are not necessarily indicative of the results of operations for a full year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--ConsolidationPolicyTextBlock_z4ZlKuNI17Si" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_86B_zc7HOogWPoOd" style="font: normal 11pt Times New Roman, Times, Serif">Principles
of Consolidation</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">The
unaudited condensed consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries
and partnerships (collectively, the &#8220;Company&#8221;). All significant intercompany accounts and transactions have been eliminated
in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--RevenueRecognitionPolicyTextBlock_zb1qsGCBxFXa" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_86F_z04AOfkiJI19" style="font: normal 11pt Times New Roman, Times, Serif">Revenue
Recognition</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">The
Company&#8217;s revenues generally relate to net patient fees&#160;received from various payers and patients themselves under contracts
in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our
obligations to provide diagnostic services are satisfied. The Company&#8217;s performance obligations for diagnostic services are generally
satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party
payer (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance
exchanges) and the transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated
with (managed care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party
payers for the services we provide to the related patients typically specify payments at amounts less than the Company&#8217;s standard
charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates.
Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the
frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">The
Company&#8217;s patient fee revenue, net of contractual allowances and discounts for the three and six months ended December 31, 2024
and 2023 are summarized in the following table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--DisaggregationOfRevenueTableTextBlock_pn3n3_zL3DJiQxVnde" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span id="xdx_8BD_zlEmX5Fwg5k5" style="font: normal 11pt Times New Roman, Times, Serif">Schedule
    of patient fee revenue - net</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">For
    the Three Months Ended<br/> December 31,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">2023</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Commercial
    Insurance/Managed Care</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--NetPatientFeeRevenue_pn3n3_c20241001__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_z18Xcauvc52g" style="width: 12%; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">1,174</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_ecustom--NetPatientFeeRevenue_pn3n3_c20231001__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zK8wWpjbWbjh" style="width: 12%; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">1,243</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Medicare/Medicaid</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_ecustom--NetPatientFeeRevenue_pn3n3_c20241001__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zZRbS1gC7hzd" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">301</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_ecustom--NetPatientFeeRevenue_pn3n3_c20231001__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zu8U0uK35Gs5" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">284</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Workers&#8217;
    Compensation/Personal Injury</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_ecustom--NetPatientFeeRevenue_pn3n3_c20241001__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_z1j0hmlMJQob" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">4,683</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_ecustom--NetPatientFeeRevenue_pn3n3_c20231001__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zvblavHXJkE4" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">4,907</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Other</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_ecustom--NetPatientFeeRevenue_pn3n3_c20241001__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zLfcHqiMhZg4" style="border-bottom: Black 1pt solid; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">1,786</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_ecustom--NetPatientFeeRevenue_pn3n3_c20231001__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zYdnTWS83VXh" style="border-bottom: Black 1pt solid; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">1,787</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Patient
    Fee Revenue, net of contractual allowances and discounts</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--NetPatientFeeRevenue_pn3n3_c20241001__20241231_zSf07rU5Y7ia" style="border-bottom: Black 2.5pt double; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">7,944</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_ecustom--NetPatientFeeRevenue_pn3n3_c20231001__20231231_zm8zC3UOQeni" style="border-bottom: Black 2.5pt double; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">8,221</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>























<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Revenue
    Recognition (Continued)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">For
    the Six Months Ended<br/> December 31,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">2023</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Commercial
    Insurance/ Managed Care</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--NetPatientFeeRevenue_c20240701__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" style="width: 12%; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">2,378</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--NetPatientFeeRevenue_c20230701__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" style="width: 12%; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">2,416</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Medicare/Medicaid</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_ecustom--NetPatientFeeRevenue_c20240701__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">562</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_ecustom--NetPatientFeeRevenue_c20230701__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">555</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Workers&#8217;
    Compensation/Personal Injury</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_ecustom--NetPatientFeeRevenue_c20240701__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">9,382</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_ecustom--NetPatientFeeRevenue_c20230701__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">10,044</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Other</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_ecustom--NetPatientFeeRevenue_c20240701__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">3,109</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_ecustom--NetPatientFeeRevenue_c20230701__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">3,881</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Patient
    Fee Revenue, net of contractual allowances and discounts</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_ecustom--NetPatientFeeRevenue_c20240701__20241231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">15,431</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--NetPatientFeeRevenue_c20230701__20231231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">16,896</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p id="xdx_8AF_zUozMHWSpZk9" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAndOtherFeeReceivablePolicyTextBlock', window );">Management and other fee receivable</a></td>
<td class="text"><p id="xdx_849_ecustom--ManagementAndOtherFeeReceivablePolicyTextBlock_zXjWOO9c32X9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_863_zKeWDttgnjpe" style="font: normal 11pt Times New Roman, Times, Serif">Management
and other fee receivable</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">HMCA
generates revenues from providing comprehensive management services, including development, administration, accounting, billing and collection
services, together with office space, medical equipment, supplies and non-medical personnel to its clients. Revenues are in the form
of fees which are earned under annual management contracts with HMCA clients. Management fee receivable is related to the management
fees outstanding from the related and non-related professional corporations (&#8220;PCs&#8221;) under the management agreements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><p id="xdx_840_eus-gaap--EarningsPerSharePolicyTextBlock_znCGB8Glccd5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_863_zFFWWr33Y5O5" style="font: normal 11pt Times New Roman, Times, Serif">Earnings
Per Share</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Basic
earnings per share (&#8220;EPS&#8221;) is computed based upon the weighted average number of shares of common stock and stock equivalents
outstanding, net of common stock. In accordance with ASC Topic 260-10, &#8220;Participating Securities and the Two-Class method&#8221;,
the Company used the Two-Class method for calculating basic income per share and applied the converted method in calculating diluted
income per share for the three and six months ended December 31, 2024 and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Diluted
EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average
market price of common shares outstanding during the period. For the three and six months ended December 31, 2024 and 2023, diluted EPS
for common shareholders includes <span id="xdx_90E_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20230701__20231231_z9QoejhFelni">128
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">shares
upon conversion of Class C Common.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>



























<table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_zvSuADktrMr1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details 1)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B3_zWIu7i8E4IPh" style="font: normal 11pt Times New Roman, Times, Serif">Schedule
    of earning per share</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Three
    months ended <br/> December 31, 2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Three
    months ended <br/> December 31, 2023</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Common
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Class
    C Common <br/> Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Common
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Class
    C Common <br/> Stock</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Basic</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Numerator:
    <br/> Net income available to common stockholders</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20241001__20241231_ztTa1wwlnWDd" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Times New Roman, Times, Serif">1,964</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zOf2aCRyKGJf" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Times New Roman, Times, Serif">1,840</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zMUw31DAxzei" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Times New Roman, Times, Serif">31</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20231001__20231231_zxID2v0G8pLh" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Times New Roman, Times, Serif">3,759</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zjdCfLIuesc1" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Common Stock and Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Times New Roman, Times, Serif">3,525</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zweySSu8W3Yl" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Times New Roman, Times, Serif">59</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Denominator:</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Weighted
    average shares outstanding</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20241001__20241231_zVkAyP0a5yFb" style="font: normal 11pt Times New Roman, Times, Serif">6,686</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zobPQYC1HAV7" style="font: normal 11pt Times New Roman, Times, Serif">6,303</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z3jBeGlOPqt4" style="font: normal 11pt Times New Roman, Times, Serif">383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20231001__20231231_z6FfKz3syYVg" style="font: normal 11pt Times New Roman, Times, Serif">6,437</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z0Xpm9av716" style="font: normal 11pt Times New Roman, Times, Serif">6,437</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zAtOM6gjv5Z8" style="font: normal 11pt Times New Roman, Times, Serif">383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Basic
    income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_900_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20241001__20241231_zkUoT17qDZl3" style="font: normal 11pt Times New Roman, Times, Serif">0.31</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_900_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFfqm38RqGb7" style="font: normal 11pt Times New Roman, Times, Serif">0.29</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z6n52whbB474" style="font: normal 11pt Times New Roman, Times, Serif">0.08</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20231001__20231231_zyxsQRp4L6pd" style="font: normal 11pt Times New Roman, Times, Serif">0.58</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKO1ImWncDt8" style="font: normal 11pt Times New Roman, Times, Serif">0.55</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zHRgAfVOuBdh" style="font: normal 11pt Times New Roman, Times, Serif">0.16</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Diluted</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Denominator:
    <br/>
    Weighted average shares outstanding</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zixYLlEfAWGf" style="font: normal 11pt Times New Roman, Times, Serif">6,303</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_909_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zhCScoo7cZ8i" style="font: normal 11pt Times New Roman, Times, Serif">383</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zELp0cpWqRE1" style="font: normal 11pt Times New Roman, Times, Serif">6,437</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zNbaLYf5rIV5" style="font: normal 11pt Times New Roman, Times, Serif">383</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Convertible
    Class C Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90B_ecustom--ConvertibleClassCStock_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zZMFXw6Dq7lh" style="font: normal 11pt Times New Roman, Times, Serif">128</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_902_ecustom--ConvertibleClassCStock_pn3n3_d0_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zyO3CHookUdb" style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90D_ecustom--ConvertibleClassCStock_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zUvmoPZSrzwa" style="font: normal 11pt Times New Roman, Times, Serif">128</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_ecustom--ConvertibleClassCStock_pn3n3_d0_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zha7t8rJIDG3" style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Total
    Denominator for diluted earnings per share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zicEmHf5MvJf" style="font: normal 11pt Times New Roman, Times, Serif">6,431</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zWL9xD6Js6k9" style="font: normal 11pt Times New Roman, Times, Serif">383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zocz0Ddf5Lxa" style="font: normal 11pt Times New Roman, Times, Serif">6,565</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zv8RsJ5XOfq1" style="font: normal 11pt Times New Roman, Times, Serif">383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Diluted
    income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_eus-gaap--EarningsPerShareDiluted_pip0_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKjdQMnTyOKd" style="font: normal 11pt Times New Roman, Times, Serif">0.29</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--EarningsPerShareDiluted_pip0_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zo2e9dER4va1" style="font: normal 11pt Times New Roman, Times, Serif">0.08</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_eus-gaap--EarningsPerShareDiluted_pip0_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zNYREjn4QC94" style="font: normal 11pt Times New Roman, Times, Serif">0.54</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--EarningsPerShareDiluted_pip0_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zdX8taCtG7x3" style="font: normal 11pt Times New Roman, Times, Serif">0.16</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Six
    months ended <br/> December 31, 2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Six
    months ended <br/> December 31, 2023</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Common
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Class
    C Common <br/> Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Common
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Class
    C Common <br/> Stock</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Basic</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Numerator:
    <br/> Net income available to common stockholders</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20240701__20241231_zUYItGA2tivc" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Times New Roman, Times, Serif">5,099</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zCBPfN32iqRd" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Times New Roman, Times, Serif">4,775</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zfGRoSD7DnI7" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Times New Roman, Times, Serif">83</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20231231_zAu6tNscy156" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Times New Roman, Times, Serif">7,865</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z25N3f8IwFq3" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Common Stock and Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Times New Roman, Times, Serif">7,375</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z39Ly1ZxxTdb" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Times New Roman, Times, Serif">125</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Denominator:</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Weighted
    average shares outstanding</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20240701__20241231_zYwD3YAJ5rwj" style="font: normal 11pt Times New Roman, Times, Serif">6,696</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zwVPrZqX6W7i" style="font: normal 11pt Times New Roman, Times, Serif">6,313</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zKmXnF1ZPk5b" style="font: normal 11pt Times New Roman, Times, Serif">383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20231231_zMtQCmFp8RQg" style="font: normal 11pt Times New Roman, Times, Serif">6,448</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsymdHwEt081" style="font: normal 11pt Times New Roman, Times, Serif">6,448</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zUaLrSiJ4oW2" style="font: normal 11pt Times New Roman, Times, Serif">383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Basic
    income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20240701__20241231_zwHIYbIkQc5a" style="font: normal 11pt Times New Roman, Times, Serif">0.81</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zeZ8c3bHHjcb" style="font: normal 11pt Times New Roman, Times, Serif">0.76</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zd1gkLEBpid5" style="font: normal 11pt Times New Roman, Times, Serif">0.22</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20231231_zewRQ7HypSj2" style="font: normal 11pt Times New Roman, Times, Serif">1.22</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zmSgeA9ml2x9" style="font: normal 11pt Times New Roman, Times, Serif">1.14</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zbz4B56NEhO8" style="font: normal 11pt Times New Roman, Times, Serif">0.33</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Diluted</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Denominator:
    <br/>
    Weighted average shares outstanding</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_909_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z6I7pQfx89Kf" style="font: normal 11pt Times New Roman, Times, Serif">6,313</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zC6thKXWDBT" style="font: normal 11pt Times New Roman, Times, Serif">383</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zq7I6DGVsxv1" style="font: normal 11pt Times New Roman, Times, Serif">6,448</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z7lO4NhLTXT" style="font: normal 11pt Times New Roman, Times, Serif">383</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Convertible
    Class C Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_900_ecustom--ConvertibleClassCStock_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z38YTp5LspV8" style="font: normal 11pt Times New Roman, Times, Serif">128</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_ecustom--ConvertibleClassCStock_pn3n3_d0_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zl2aWvQISKl" style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_907_ecustom--ConvertibleClassCStock_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zNGs04uCaZF8" style="font: normal 11pt Times New Roman, Times, Serif">128</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_ecustom--ConvertibleClassCStock_pn3n3_d0_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zVWHVdr5Bdh8" style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Total
    Denominator for diluted earnings per share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zYd2uol9Mkn4" style="font: normal 11pt Times New Roman, Times, Serif">6,441</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zZIbJkgYMhXf" style="font: normal 11pt Times New Roman, Times, Serif">383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zm6Vydg7fSyl" style="font: normal 11pt Times New Roman, Times, Serif">6,576</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zvspvf0JtAzk" style="font: normal 11pt Times New Roman, Times, Serif">383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Diluted
    income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_eus-gaap--EarningsPerShareDiluted_pip0_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVDisZxHxga4" style="font: normal 11pt Times New Roman, Times, Serif">0.74</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pip0_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zPzXBe83AY8i" style="font: normal 11pt Times New Roman, Times, Serif">0.22</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--EarningsPerShareDiluted_pip0_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zBUHA1ZB096b" style="font: normal 11pt Times New Roman, Times, Serif">1.12</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pip0_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zdQZ3ehBp5D7" style="font: normal 11pt Times New Roman, Times, Serif">0.33</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p id="xdx_8AC_zzOIAfL0t6lj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>





















<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Correction of immaterial errors</a></td>
<td class="text"><p id="xdx_84C_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z3iwg8LUJeek" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_860_zaxSgFmUHCb4" style="font: normal 11pt Times New Roman, Times, Serif">Correction
of immaterial errors</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">In
conjunction with preparing its interim financial statements for the three and six months ended December 31, 2024, the Company determined
that its calculation of Right to Use Assets and Operating Lease Liabilities at the end of the past two annual periods and at September
30, 2024 and 2023 contained three immaterial errors. The Company evaluated the errors, both qualitatively and quantitatively, and determined
that no prior interim or annual periods were materially misstated. The Company then evaluated whether the cumulative amount of the misstatement
was material to its projected fiscal 2025 results of operations, and determined the cumulative amount was not material. Therefore, the
Condensed Consolidated Financial Statements for the six and three months ended December 31, 2024 include an out-of-period correction
of the following three items; a) a reclass of a software license of $<span id="xdx_90E_ecustom--RightToUseAssetToIntangibleAsset_pn3n3_dm_c20240701__20241231_zxhPpzIF4r77">1.3
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">million
from Right to Use Asset/Liabilities to an intangible asset, b) a decrease to ROU of $<span id="xdx_90B_eus-gaap--IncreaseDecreaseInOperatingLeaseLiability_pn3n3_dm_c20240701__20241231_zkIBhlBv2jyb">1.7
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">million
and an increase to Lease Liability of $<span id="xdx_90D_eus-gaap--OperatingLeasePayments_pn3n3_dm_c20240701__20241231_zJtdLAwjr0P7">1.1
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">million
to correct the discounting of future lease payments and c) correct the accounting for 6 lease modifications.. The correction of these
three errors resulted in an out of period charge to expenses of $<span id="xdx_90D_eus-gaap--IncomeTaxExpenseBenefitIntraperiodTaxAllocation_pn3n3_c20240701__20241231_zFYOxIgox9Gd">116
</span></span><span style="font: normal 11pt Times New Roman, Times, Serif">to pre-tax
income for the three and six months ended December 31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Standards</a></td>
<td class="text"><p id="xdx_845_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zxNQfhqQxiw" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_865_z7SoHmRgVHk8" style="font: normal 11pt Times New Roman, Times, Serif">Recent
Accounting Standards</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">In
December 2023, The Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2023-09, &#8220;Income Taxes (Topic 740) Improvements
to Income Tax Disclosures, which requires the annual financial statements to include consistent categories and great disaggregation of
information in the rate reconciliation and income taxes paid disaggregated by jurisdiction. ASU 2023-09 is effective for the Company&#8217;s
annual reporting beginning after December 15, 2024, with early adoption permitted, and should be applied on a prospective basis, with
a retrospective option. The Company is currently evaluating the effect that the adoption of ASU 2023-09 will have on its disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">In
November 2023, FASB issued ASU 2023-07, &#8220;Segment Reporting (Topic 280)&#8221;, which is intended to improve reportable segment
disclosure requirements through enhanced disclosures about significant segment expenses. The amendments require disclosure of significant
segment expenses regularly provided to the chief operating decision maker (&#8220;CODM&#8221;) as well as other segment items, extended
certain annual disclosures to interim periods, clarify the applicability to single reportable segment entities, permit more than one
measure of profit or loss to be reported under certain conditions, and require disclosure of the title and position of the CODM. The
effective date for public entities is for fiscal years beginning after December 15, 2023 and interim periods with fiscal years beginning
after December 15, 2024. The Company is expected to adopt the new disclosures as required and are currently evaluating the impact on
the related disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>























<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">Recent
Accounting Standards</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of December 31,
2024 that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly
affected our financial accounting measures or disclosures had they been in effect during 2024 or 2023, and it does not believe that any
of those standards will have a significant impact on our unaudited consolidated condensed financial statements at the time they become
effective.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherFeeReceivablePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherFeeReceivablePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483504/205-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800655675728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of patient fee revenue - net</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--DisaggregationOfRevenueTableTextBlock_pn3n3_zL3DJiQxVnde" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span id="xdx_8BD_zlEmX5Fwg5k5" style="font: normal 11pt Times New Roman, Times, Serif">Schedule
    of patient fee revenue - net</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">For
    the Three Months Ended<br/> December 31,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">2023</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Commercial
    Insurance/Managed Care</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--NetPatientFeeRevenue_pn3n3_c20241001__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_z18Xcauvc52g" style="width: 12%; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">1,174</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_ecustom--NetPatientFeeRevenue_pn3n3_c20231001__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zK8wWpjbWbjh" style="width: 12%; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">1,243</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Medicare/Medicaid</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_ecustom--NetPatientFeeRevenue_pn3n3_c20241001__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zZRbS1gC7hzd" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">301</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_ecustom--NetPatientFeeRevenue_pn3n3_c20231001__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zu8U0uK35Gs5" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">284</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Workers&#8217;
    Compensation/Personal Injury</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_ecustom--NetPatientFeeRevenue_pn3n3_c20241001__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_z1j0hmlMJQob" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">4,683</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_ecustom--NetPatientFeeRevenue_pn3n3_c20231001__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zvblavHXJkE4" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">4,907</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Other</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_ecustom--NetPatientFeeRevenue_pn3n3_c20241001__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zLfcHqiMhZg4" style="border-bottom: Black 1pt solid; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">1,786</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_ecustom--NetPatientFeeRevenue_pn3n3_c20231001__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zYdnTWS83VXh" style="border-bottom: Black 1pt solid; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">1,787</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Patient
    Fee Revenue, net of contractual allowances and discounts</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--NetPatientFeeRevenue_pn3n3_c20241001__20241231_zSf07rU5Y7ia" style="border-bottom: Black 2.5pt double; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">7,944</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_ecustom--NetPatientFeeRevenue_pn3n3_c20231001__20231231_zm8zC3UOQeni" style="border-bottom: Black 2.5pt double; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">8,221</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>























<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Revenue
    Recognition (Continued)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">For
    the Six Months Ended<br/> December 31,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">2023</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Commercial
    Insurance/ Managed Care</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--NetPatientFeeRevenue_c20240701__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" style="width: 12%; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">2,378</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--NetPatientFeeRevenue_c20230701__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" style="width: 12%; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">2,416</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Medicare/Medicaid</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_ecustom--NetPatientFeeRevenue_c20240701__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">562</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_ecustom--NetPatientFeeRevenue_c20230701__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">555</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Workers&#8217;
    Compensation/Personal Injury</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_ecustom--NetPatientFeeRevenue_c20240701__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">9,382</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_ecustom--NetPatientFeeRevenue_c20230701__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">10,044</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Other</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_ecustom--NetPatientFeeRevenue_c20240701__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">3,109</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_ecustom--NetPatientFeeRevenue_c20230701__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">3,881</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Patient
    Fee Revenue, net of contractual allowances and discounts</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_ecustom--NetPatientFeeRevenue_c20240701__20241231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">15,431</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--NetPatientFeeRevenue_c20230701__20231231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"><span style="font: normal 11pt Times New Roman, Times, Serif">16,896</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of earning per share</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_zvSuADktrMr1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details 1)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B3_zWIu7i8E4IPh" style="font: normal 11pt Times New Roman, Times, Serif">Schedule
    of earning per share</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Three
    months ended <br/> December 31, 2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Three
    months ended <br/> December 31, 2023</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Common
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Class
    C Common <br/> Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Common
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Class
    C Common <br/> Stock</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Basic</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Numerator:
    <br/> Net income available to common stockholders</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20241001__20241231_ztTa1wwlnWDd" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Times New Roman, Times, Serif">1,964</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zOf2aCRyKGJf" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Times New Roman, Times, Serif">1,840</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zMUw31DAxzei" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Times New Roman, Times, Serif">31</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20231001__20231231_zxID2v0G8pLh" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Times New Roman, Times, Serif">3,759</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zjdCfLIuesc1" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Common Stock and Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Times New Roman, Times, Serif">3,525</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zweySSu8W3Yl" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Times New Roman, Times, Serif">59</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Denominator:</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Weighted
    average shares outstanding</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20241001__20241231_zVkAyP0a5yFb" style="font: normal 11pt Times New Roman, Times, Serif">6,686</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zobPQYC1HAV7" style="font: normal 11pt Times New Roman, Times, Serif">6,303</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z3jBeGlOPqt4" style="font: normal 11pt Times New Roman, Times, Serif">383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20231001__20231231_z6FfKz3syYVg" style="font: normal 11pt Times New Roman, Times, Serif">6,437</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z0Xpm9av716" style="font: normal 11pt Times New Roman, Times, Serif">6,437</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zAtOM6gjv5Z8" style="font: normal 11pt Times New Roman, Times, Serif">383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Basic
    income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_900_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20241001__20241231_zkUoT17qDZl3" style="font: normal 11pt Times New Roman, Times, Serif">0.31</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_900_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFfqm38RqGb7" style="font: normal 11pt Times New Roman, Times, Serif">0.29</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z6n52whbB474" style="font: normal 11pt Times New Roman, Times, Serif">0.08</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20231001__20231231_zyxsQRp4L6pd" style="font: normal 11pt Times New Roman, Times, Serif">0.58</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKO1ImWncDt8" style="font: normal 11pt Times New Roman, Times, Serif">0.55</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zHRgAfVOuBdh" style="font: normal 11pt Times New Roman, Times, Serif">0.16</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Diluted</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Denominator:
    <br/>
    Weighted average shares outstanding</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zixYLlEfAWGf" style="font: normal 11pt Times New Roman, Times, Serif">6,303</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_909_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zhCScoo7cZ8i" style="font: normal 11pt Times New Roman, Times, Serif">383</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zELp0cpWqRE1" style="font: normal 11pt Times New Roman, Times, Serif">6,437</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zNbaLYf5rIV5" style="font: normal 11pt Times New Roman, Times, Serif">383</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Convertible
    Class C Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90B_ecustom--ConvertibleClassCStock_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zZMFXw6Dq7lh" style="font: normal 11pt Times New Roman, Times, Serif">128</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_902_ecustom--ConvertibleClassCStock_pn3n3_d0_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zyO3CHookUdb" style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90D_ecustom--ConvertibleClassCStock_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zUvmoPZSrzwa" style="font: normal 11pt Times New Roman, Times, Serif">128</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_ecustom--ConvertibleClassCStock_pn3n3_d0_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zha7t8rJIDG3" style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Total
    Denominator for diluted earnings per share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zicEmHf5MvJf" style="font: normal 11pt Times New Roman, Times, Serif">6,431</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zWL9xD6Js6k9" style="font: normal 11pt Times New Roman, Times, Serif">383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zocz0Ddf5Lxa" style="font: normal 11pt Times New Roman, Times, Serif">6,565</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zv8RsJ5XOfq1" style="font: normal 11pt Times New Roman, Times, Serif">383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Diluted
    income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_eus-gaap--EarningsPerShareDiluted_pip0_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKjdQMnTyOKd" style="font: normal 11pt Times New Roman, Times, Serif">0.29</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--EarningsPerShareDiluted_pip0_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zo2e9dER4va1" style="font: normal 11pt Times New Roman, Times, Serif">0.08</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_eus-gaap--EarningsPerShareDiluted_pip0_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zNYREjn4QC94" style="font: normal 11pt Times New Roman, Times, Serif">0.54</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--EarningsPerShareDiluted_pip0_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zdX8taCtG7x3" style="font: normal 11pt Times New Roman, Times, Serif">0.16</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Six
    months ended <br/> December 31, 2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Six
    months ended <br/> December 31, 2023</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Common
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Class
    C Common <br/> Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Common
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Class
    C Common <br/> Stock</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Basic</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Numerator:
    <br/> Net income available to common stockholders</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20240701__20241231_zUYItGA2tivc" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Times New Roman, Times, Serif">5,099</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zCBPfN32iqRd" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Times New Roman, Times, Serif">4,775</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zfGRoSD7DnI7" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Times New Roman, Times, Serif">83</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20231231_zAu6tNscy156" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Times New Roman, Times, Serif">7,865</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z25N3f8IwFq3" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Common Stock and Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Times New Roman, Times, Serif">7,375</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z39Ly1ZxxTdb" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Times New Roman, Times, Serif">125</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Denominator:</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Weighted
    average shares outstanding</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20240701__20241231_zYwD3YAJ5rwj" style="font: normal 11pt Times New Roman, Times, Serif">6,696</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zwVPrZqX6W7i" style="font: normal 11pt Times New Roman, Times, Serif">6,313</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zKmXnF1ZPk5b" style="font: normal 11pt Times New Roman, Times, Serif">383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20231231_zMtQCmFp8RQg" style="font: normal 11pt Times New Roman, Times, Serif">6,448</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsymdHwEt081" style="font: normal 11pt Times New Roman, Times, Serif">6,448</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zUaLrSiJ4oW2" style="font: normal 11pt Times New Roman, Times, Serif">383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Basic
    income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20240701__20241231_zwHIYbIkQc5a" style="font: normal 11pt Times New Roman, Times, Serif">0.81</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zeZ8c3bHHjcb" style="font: normal 11pt Times New Roman, Times, Serif">0.76</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zd1gkLEBpid5" style="font: normal 11pt Times New Roman, Times, Serif">0.22</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20231231_zewRQ7HypSj2" style="font: normal 11pt Times New Roman, Times, Serif">1.22</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zmSgeA9ml2x9" style="font: normal 11pt Times New Roman, Times, Serif">1.14</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zbz4B56NEhO8" style="font: normal 11pt Times New Roman, Times, Serif">0.33</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Diluted</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Denominator:
    <br/>
    Weighted average shares outstanding</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_909_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z6I7pQfx89Kf" style="font: normal 11pt Times New Roman, Times, Serif">6,313</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zC6thKXWDBT" style="font: normal 11pt Times New Roman, Times, Serif">383</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zq7I6DGVsxv1" style="font: normal 11pt Times New Roman, Times, Serif">6,448</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z7lO4NhLTXT" style="font: normal 11pt Times New Roman, Times, Serif">383</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Convertible
    Class C Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_900_ecustom--ConvertibleClassCStock_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z38YTp5LspV8" style="font: normal 11pt Times New Roman, Times, Serif">128</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_ecustom--ConvertibleClassCStock_pn3n3_d0_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zl2aWvQISKl" style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_907_ecustom--ConvertibleClassCStock_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zNGs04uCaZF8" style="font: normal 11pt Times New Roman, Times, Serif">128</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_ecustom--ConvertibleClassCStock_pn3n3_d0_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zVWHVdr5Bdh8" style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Total
    Denominator for diluted earnings per share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zYd2uol9Mkn4" style="font: normal 11pt Times New Roman, Times, Serif">6,441</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zZIbJkgYMhXf" style="font: normal 11pt Times New Roman, Times, Serif">383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zm6Vydg7fSyl" style="font: normal 11pt Times New Roman, Times, Serif">6,576</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zvspvf0JtAzk" style="font: normal 11pt Times New Roman, Times, Serif">383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Diluted
    income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_eus-gaap--EarningsPerShareDiluted_pip0_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVDisZxHxga4" style="font: normal 11pt Times New Roman, Times, Serif">0.74</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pip0_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zPzXBe83AY8i" style="font: normal 11pt Times New Roman, Times, Serif">0.22</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--EarningsPerShareDiluted_pip0_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zBUHA1ZB096b" style="font: normal 11pt Times New Roman, Times, Serif">1.12</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pip0_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zdQZ3ehBp5D7" style="font: normal 11pt Times New Roman, Times, Serif">0.33</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800499680496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock', window );">Schedule of financing receivable noncurrent allowance for credit loss</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_pn3n3_z8bd1OG0LX96" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BB_zp1GhDq6yE6j" style="font: normal 11pt Times New Roman, Times, Serif">Schedule
    of financing receivable noncurrent allowance for credit loss</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_49A_20241231__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z0RBRf7wwER3" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_493_20241231__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zvXSVmvYjjFa" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_498_20241231_zSDSREaE2xR3" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">December
    31, 2024</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Gross
    Receivable</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Allowance
    for credit losses</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Net</span></td></tr>
  <tr id="xdx_401_eus-gaap--AccountsReceivableNet_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 46%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Accounts
    receivable</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">3,663</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">273</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">3,390</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--AccountsReceivableNetRelatedParty_iI_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Accounts
    receivable - related party</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">60</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1046">&#8212;</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">60</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--NontradeReceivables_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Medical
    receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">23,496</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1050">&#8212;</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">23,496</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Management
    and other fees receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">55,148</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">12,663</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">42,485</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Management
    and other fees receivable from related medical practices (&#8220;PC&#8217;s&#8221;)</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">16,666</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">6,989</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">9,677</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_494_20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zB9JXYN3V1k1" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_493_20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_ziASn6lVxep1" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_49B_20240630_zWOBFj4GtxU2" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">June
    30, 2024</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Gross
    Receivable</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Allowance
    for credit losses</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Net</span></td></tr>
  <tr id="xdx_404_eus-gaap--AccountsReceivableNet_iI_pn3n3_zuWXkbN34zhl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 46%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Accounts
    receivable</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">4,201</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">166</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">4,035</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--NontradeReceivables_iI_pn3n3_zADsAvQzSfo1" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Medical
    receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">23,992</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1066">&#8212;</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">23,992</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_zmX6owK18J8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Management
    and other fees receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">54,324</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">12,370</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">41,954</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_ziRgeoenE1Ej" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Management
    and other fees receivable from related medical practices (&#8220;PC&#8217;s&#8221;)</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">15,975</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">6,110</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">9,865</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentTextBlock', window );">Schedule of future revenue</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--LongTermPurchaseCommitmentTextBlock_pn3n3_znuwEuARe03l" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Future Revenue (Details 1)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span id="xdx_8B7_zmpitxKBUFql" style="font: normal 11pt Times New Roman, Times, Serif">Schedule
    of future revenue</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 44%; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2026</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 10%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--ContractReceivableDueOneToTwoYears_iI_pn3n3_c20241231_z5Tohm8lWPjh" style="width: 43%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">677</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2027</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pn3n3_c20241231_zClkZxZ6BGU1" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">242</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2028</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--ContractReceivableDueThreeToFourYears_iI_pn3n3_c20241231_zKybmD13r44i" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">87</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2029</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--ContractReceivableDueFourToFiveYears_iI_pn3n3_c20241231_zgJgvGHDrpw8" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">44</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_pn3n3_c20241231_zcukdl8FyWpa" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">1,050</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of key provisions of an arrangement under which the entity has agreed to purchase goods or services over a period of time greater than one year or the normal operating cycle, if longer, including the item for which expenditures will be made, minimum quantities, milestones, time period and committed amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss of financing receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-11B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800610831856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING AND FINANCING LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureOperatingAndFinancingLeasesAbstract', window );"><strong>Operating And Financing Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of lessee operating leases liability maturity</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_pn3n3_zytfQ93lppu7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="text-align: center"><span id="xdx_8B7_zrgoY2NwmBF" style="font: normal 11pt Times New Roman, Times, Serif">Schedule
    of lessee operating leases liability maturity</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Twelve
    Months Ending<br/> December 31,</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Operating
    Lease<br/> Payments</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Financing
    Lease Payments</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 27%; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2025</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="width: 26%; text-align: right" title="2025"><span style="font: normal 11pt Times New Roman, Times, Serif">5,584</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="width: 26%; text-align: right" title="2025"><span style="font: normal 11pt Times New Roman, Times, Serif">244</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2026</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="text-align: right" title="2026"><span style="font: normal 11pt Times New Roman, Times, Serif">5,388</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="text-align: right" title="2026"><span style="font: normal 11pt Times New Roman, Times, Serif">244</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2027</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="text-align: right" title="2027"><span style="font: normal 11pt Times New Roman, Times, Serif">5,371</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="text-align: right" title="2027"><span style="font: normal 11pt Times New Roman, Times, Serif">61</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2028</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="text-align: right" title="2028"><span style="font: normal 11pt Times New Roman, Times, Serif">5,019</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_iI_pn3n3_d0_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_z75D5Qjhrzic" style="text-align: right" title="2028"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2029</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="text-align: right" title="2029"><span style="font: normal 11pt Times New Roman, Times, Serif">4,876</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_pn3n3_d0_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zKGemonbDrvi" style="text-align: right" title="2029"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Thereafter</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="text-align: right" title="Thereafter"><span style="font: normal 11pt Times New Roman, Times, Serif">26,841</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_iI_pn3n3_d0_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zYdNNieE4te1" style="text-align: right" title="Thereafter"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">Present
                                            value discount</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_ecustom--PresentValueDiscount_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Present value discount"><span style="font: normal 11pt Times New Roman, Times, Serif">(14,893</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_ecustom--PresentValueDiscountFinancingLease_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Present value discount"><span style="font: normal 11pt Times New Roman, Times, Serif">(15</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">Total
                                            lease liability</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--OperatingLeaseLiability_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating Lease, Liability"><span style="font: normal 11pt Times New Roman, Times, Serif">38,186</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--FinanceLeaseLiability_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Finance Lease, Liability"><span style="font: normal 11pt Times New Roman, Times, Serif">534</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock', window );">Schedule of weighted average remaining lease term</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock_pn3n3_zBX9eKrkHgPh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES (Details 1)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BC_zzStWqTbube1" style="font: normal 11pt Times New Roman, Times, Serif">Schedule
    of weighted average remaining lease term</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 70%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Operating
    leases - years</span></td><td style="width: 10%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 18%; text-align: right"><span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20241231_zu6b4AUiB196" style="font: normal 11pt Times New Roman, Times, Serif">10.6</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Finance
    lease - years</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_90C_eus-gaap--FinanceLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20241231_zm6RJ9MkEECd" style="font: normal 11pt Times New Roman, Times, Serif">2.1</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Weighted
    Average Discount Rate</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Operating
    leases</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_90B_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pip0_dp_c20241231_ztzDBNXnEY8" style="font: normal 11pt Times New Roman, Times, Serif">6.5</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Finance
    lease</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_907_eus-gaap--FinanceLeaseWeightedAverageDiscountRatePercent_iI_pip0_dp_c20241231_zZSAoawyfMod" style="font: normal 11pt Times New Roman, Times, Serif">3.6</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">%</span></td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Components of lease expense</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--LeaseCostTableTextBlock_pn3n3_zSSD0KJ9T22f" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES (Details 2)">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BD_zRXWrP9tobWa" style="font: normal 11pt Times New Roman, Times, Serif">Components
    of lease expense</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" id="xdx_49F_20240701__20241231_zYUEbGBhDME5" style="text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" id="xdx_49E_20230701__20231231_zweC4Lzxt2Lh" style="text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">For
    the six months ended Dec.31,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">2023</span></td></tr>
  <tr id="xdx_408_eus-gaap--OperatingLeaseCost_pn3n3_zo2KYggax5El" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Operating
    lease cost</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">3,190</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">2,865</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--FinanceLeaseCostsAbstract_iB_zKhjZXR9Yz15" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Finance
    lease cost:</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--DepreciationOfLeasedEquipment_i01_pn3n3_zP7Zw1OPGPHd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Depreciation
    of leased equipment</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">100</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">100</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--FinanceLeaseInterestExpense_i01_pn3n3_zVCWL9KIkLZ4" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Interest
    on lease liabilities</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">5</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">14</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--FinanceLeaseCost_i01_pn3n3_zBRBwGlHafN6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Total
    finance lease cost</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">105</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">114</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock', window );">Supplemental cash flow information related to leases</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_pn3n3_zv22ZU9izFM1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure -  OPERATING &amp; FINANCING LEASES (Details 3)">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BF_zU6hV9BuBgL" style="font: normal 11pt Times New Roman, Times, Serif">Supplemental
    cash flow information related to leases</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" id="xdx_49F_20240701__20241231_zgIXIEmxP1s5" style="text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" id="xdx_49E_20230701__20231231_zsXLlWN0wOQ1" style="text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">For
    the six months ended Dec. 31,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Cash
    paid for amounts included in the measurement of lease liabilities:</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">2023</span></td></tr>
  <tr id="xdx_40A_ecustom--OperatingCashFlowsFromOperatingLeases_zYsccWh63qKc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Operating
    cash flows from operating leases</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">2,541</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">3,164</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--FinancingCashFlowsFromFinancingLeases_zbSB6ZuGtWT5" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Financing
    cash flows from financing leases</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">122</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">122</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract_iB_zKdnXriZjHSl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Right-of-use
    and equipment assets obtained in exchange for lease obligations:</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_ztrAUcoQpSkg" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Operating
    leases</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">359</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">1,212</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureOperatingAndFinancingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureOperatingAndFinancingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800505681504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of inventories</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_pn3n3_zeGDeJwevqRd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-indent: -10pt"><span id="xdx_8BA_zr6ZVnBFTz4j" style="font: normal 11pt Times New Roman, Times, Serif">Schedule
    of inventories</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_499_20241231_zKIawok9SSxd" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_491_20240630_zoNNStkb4kR3" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">December
    31,<br/> 2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">June
    30,<br/> 2024</span></td></tr>
  <tr id="xdx_40E_eus-gaap--OtherInventorySupplies_iI_maIFGAWzdt0_zU1xG5uwxAEe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Purchased
    parts, components and supplies</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">2,583</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">2,524</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--InventoryWorkInProcess_iI_maIFGAWzdt0_zFoczDa3Bvu3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Work-in-process</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">275</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">191</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--InventoryNet_iTI_mtIFGAWzdt0_zQ8O4Qu1uqLj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Total
    Inventories</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">2,858</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">2,715</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800506011840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of other intangible assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_pn3n3_zoa8HS5I6cUk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure -  OTHER INTANGIBLE ASSETS (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B9_zvCmY5nnJH53" style="font: normal 11pt Times New Roman, Times, Serif">Schedule
    of other intangible assets</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Weighted
    average useful lives</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Gross
    carrying amount &#8211; December 31, 2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Accumulated
    amortization &#8211; December 31, 2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Net
    carrying amount &#8211; December 31, 2024</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Capitalized
    software development costs</span></td><td style="width: 3%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 10%; text-align: center"><span id="xdx_90D_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zuOgvJbo0sAb" style="font: normal 11pt Times New Roman, Times, Serif">5
                                            </span><span style="font: normal 11pt Times New Roman, Times, Serif">years</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zSMGe5ZhVwRb" style="width: 10%; text-align: right" title="Gross carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">7,005</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zDhkRmDjIaFj" style="width: 10%; text-align: right" title="Accumulated amortization intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">(7,005</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="width: 3%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zWGwYxTQxTe2" style="width: 10%; text-align: right" title="Net carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1240">&#8212;</span></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Software
    License</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span id="xdx_900_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_zpMsHY9YSou7" style="font: normal 11pt Times New Roman, Times, Serif">3
                                            </span><span style="font: normal 11pt Times New Roman, Times, Serif">years</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_z7yfeQTcbjOa" style="text-align: right" title="Gross carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">1,260</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_zSA5eePW4P44" style="text-align: right" title="Accumulated amortization intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">(567</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_zoxuC3EnwFN3" style="text-align: right" title="Net carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">693</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Patents
    and copy rights</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span id="xdx_90B_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zBnTAz3MBZWf" style="font: normal 11pt Times New Roman, Times, Serif">15
                                            </span><span style="font: normal 11pt Times New Roman, Times, Serif">years</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zmRhXzD9AXKj" style="text-align: right" title="Gross carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">5,280</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zriiQuIm7zB5" style="text-align: right" title="Accumulated amortization intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">(4,180</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zskrWHIfldx" style="text-align: right" title="Net carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">1,100</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Non-compete</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span id="xdx_90B_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zHlh8MkVo0bg" style="font: normal 11pt Times New Roman, Times, Serif">7
                                            </span><span style="font: normal 11pt Times New Roman, Times, Serif">years</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zAWGEImeexz5" style="text-align: right" title="Gross carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">4,150</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zgNjX0ISAODf" style="text-align: right" title="Accumulated amortization intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">(4,150</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_d0_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zT3sOx8MNlph" style="text-align: right" title="Net carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Customer
    relationships</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span id="xdx_90D_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zyOOFtJqB4Vh" style="font: normal 11pt Times New Roman, Times, Serif">20
                                            </span><span style="font: normal 11pt Times New Roman, Times, Serif">years</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zlWOjgwulIZ1" style="border-bottom: Black 1pt solid; text-align: right" title="Gross carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">3,900</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zn514S0v8gwk" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated amortization intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">(2,286</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zKDqHfGgrHI1" style="border-bottom: Black 1pt solid; text-align: right" title="Net carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">1,614</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20241231_zsROI8wQYTji" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">21,595</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20241231_zrPbHDgvMIea" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated amortization intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">(18,188</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20241231_zzD7VWLzjNYj" style="border-bottom: Black 2.5pt double; text-align: right" title="Net carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">3,407</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>























<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Weighted
    average useful lives</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Gross
    carrying amount &#8211; June 30, 2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Accumulated
    amortization</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Net
    carrying amount</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Capitalized
    software development costs</span></td><td style="width: 3%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 10%; text-align: right"><span id="xdx_900_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_z9hyDTLaQPi4" style="font: normal 11pt Times New Roman, Times, Serif">5
                                            </span><span style="font: normal 11pt Times New Roman, Times, Serif">years</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zyOjKKCz6YOf" style="width: 10%; text-align: right" title="Gross carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">7,005</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zzVdNT1TaP5a" style="width: 10%; text-align: right" title="Accumulated amortization intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">(7,005</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="width: 3%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zhYAuVwULF31" style="width: 10%; text-align: right" title="Net carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1291">&#8212;</span></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Patents
    and copy rights</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_905_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zow9pwIMzb9g" style="font: normal 11pt Times New Roman, Times, Serif">15
                                            </span><span style="font: normal 11pt Times New Roman, Times, Serif">years</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_za9fs2E2Y20i" style="text-align: right" title="Gross carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">5,260</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zZsfMtt2K1a1" style="text-align: right" title="Accumulated amortization intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">(4,104</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zVU6RAC8ljH" style="text-align: right" title="Net carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">1,156</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Non-compete</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_90F_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zrFG4NLr6P36" style="font: normal 11pt Times New Roman, Times, Serif">7
                                            </span><span style="font: normal 11pt Times New Roman, Times, Serif">years</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zu8Wf5pVAOQ3" style="text-align: right" title="Gross carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">4,150</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_z9kyx76t2BFb" style="text-align: right" title="Accumulated amortization intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">(4,150</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_d0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zfuMXou8EK7e" style="text-align: right" title="Net carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Customer
    relationships</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_903_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zdz3MqKtFvid" style="font: normal 11pt Times New Roman, Times, Serif">20
                                            </span><span style="font: normal 11pt Times New Roman, Times, Serif">years</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zhFVZ3Sh1nXa" style="border-bottom: Black 1pt solid; text-align: right" title="Gross carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">3,900</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zKDX8EhfhdTl" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated amortization intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">(2,186</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zNl0CxAndfNg" style="border-bottom: Black 1pt solid; text-align: right" title="Net carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">1,714</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20240630_zLHtBSUhebjg" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">20,315</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20240630_zLMYcQfE7n8a" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated amortization intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">(17,445</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20240630_zmqzJxKLgLH7" style="border-bottom: Black 2.5pt double; text-align: right" title="Net carrying amount intangible assets"><span style="font: normal 11pt Times New Roman, Times, Serif">2,870</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_pn3n3_zAocYU0caLF3" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 40%; margin-right: auto" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS (Details 1)">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 44%; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2025</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 10%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pn3n3_c20241231_zeCa6dwE0e44" style="width: 43%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">723</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2026</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pn3n3_c20241231_zrDJdQRdjKj1" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">650</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2027</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pn3n3_c20241231_z8zbW0NOgyY9" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">321</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2028</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pn3n3_c20241231_zr70CM00YPMi" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">317</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">2029</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pn3n3_c20241231_z81xc37J5ltk" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">314</span></td><td style="text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Thereafter</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pn3n3_c20241231_zZ2j3yH5tTEa" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">1082</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_pn3n3_c20241231_zOYqppaOdbP8" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">3,407</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800506111664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CURRENT LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of other current liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_pn3n3_z8H95YZKmxF3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B0_zmewYkyOxNY5" style="font: normal 11pt Times New Roman, Times, Serif">Schedule
    of other current liabilities</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_490_20241231_zUHSd0BseHid" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_497_20240630_zv9akfW2dwue" style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">December
    31,<br/> 2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">June
    30,<br/> 2024</span></td></tr>
  <tr id="xdx_400_eus-gaap--AccruedSalariesCurrent_iI_pn3n3_maOLCzdop_zikMYErCYEJk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Accrued
    salaries, commissions and payroll taxes</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">1,541</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">4,678</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pn3n3_maOLCzdop_zfgmq7aK6eA5" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Sales
    tax payable</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">183</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">197</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--AccruedPayrollTaxesCurrent_iI_pn3n3_maOLCzdop_z3ehj54qmLha" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Federal
    and state income taxes payable</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1355">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">1,461</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_ecustom--SelffundedHealthInsuranceReserve_iI_pn3n3_maOLCzdop_z3fz6TGCpfxh" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Self-funded
    health insurance reserve</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">168</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">121</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--SoftwareLicenses_iI_pn3n3_z5pMnuieRC8a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Software
    Licenses</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">252</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1362">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pn3n3_maOLCzdop_zUCODa2QQI07" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Other
    general and administrative expenses</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">1,768</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">1,484</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--OtherLiabilitiesCurrent_iTI_pn3n3_mtOLCzdop_zGIZ13tmpgTf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Other
    Current Liabilities</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">3,912</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">7,941</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800503167968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND RELATED INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of summarized segment financial information</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_pn3n3_ziO5u5Cqwiba" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Summarized Segments - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B9_zj6XJ57Ltw81" style="font: normal 11pt Times New Roman, Times, Serif">Schedule
    of summarized segment financial information</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Manufacturing
    and Service of MRI Equipment</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Management
    of Diagnostic Imaging Centers</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Totals</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">For
    the three months ended December 31, 2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 46%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Net
    revenues from external customers</span></td><td style="width: 5%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--Revenues_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zqoyNHe2R5Ii" style="width: 11%; text-align: right" title="Net revenues from external customers"><span style="font: normal 11pt Times New Roman, Times, Serif">1,829</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--Revenues_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zLjcbEjDro24" style="width: 11%; text-align: right" title="Net revenues from external customers"><span style="font: normal 11pt Times New Roman, Times, Serif">23,121</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--Revenues_pn3n3_c20241001__20241231_zjsbg6sAZ4fl" style="width: 11%; text-align: right" title="Net revenues from external customers"><span style="font: normal 11pt Times New Roman, Times, Serif">24,950</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Inter-segment
    net revenues</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--IntersegmentNetRevenues_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zru1txtcsWBc" style="text-align: right" title="Inter-segment net revenues"><span style="font: normal 11pt Times New Roman, Times, Serif">294</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_987_ecustom--IntersegmentNetRevenues_pn3n3_d0_c20241001__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zI9RiDiZws79" style="text-align: right" title="Inter-segment net revenues"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_ecustom--IntersegmentNetRevenues_pn3n3_c20241001__20241231_zodU8SHHQWs6" style="text-align: right" title="Inter-segment net revenues"><span style="font: normal 11pt Times New Roman, Times, Serif">294</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">(Loss)
    Income from operations</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zP6rPQgqyWMk" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Times New Roman, Times, Serif">(1,291</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zOYc445bZx9a" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Times New Roman, Times, Serif">3,726</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20241001__20241231_zL1BymUXABw5" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Times New Roman, Times, Serif">2,435</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Depreciation
    and amortization</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zRca5VP2lrvj" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Times New Roman, Times, Serif">54</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zpYaV7Vmcjvf" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Times New Roman, Times, Serif">1,181</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20241001__20241231_z4Xfk5ehyXdj" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Times New Roman, Times, Serif">1,235</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Capital
    expenditures</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_z3VAJ6J87m29" style="text-align: right" title="Capital expenditures"><span style="font: normal 11pt Times New Roman, Times, Serif">23</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zi40VVKqnAwg" style="text-align: right" title="Capital expenditures"><span style="font: normal 11pt Times New Roman, Times, Serif">731</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20241001__20241231_z8KRIarlKWQ3" style="text-align: right" title="Capital expenditures"><span style="font: normal 11pt Times New Roman, Times, Serif">754</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">For
    the three months ended December 31, 2023</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Net
    revenues from external customers</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--Revenues_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_z7VSkIJPQTx" style="text-align: right" title="Net revenues from external customers"><span style="font: normal 11pt Times New Roman, Times, Serif">1,861</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--Revenues_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zbzusP5xFYhf" style="text-align: right" title="Net revenues from external customers"><span style="font: normal 11pt Times New Roman, Times, Serif">23,525</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--Revenues_pn3n3_c20231001__20231231_zFqsOWjpzNN5" style="text-align: right" title="Net revenues from external customers"><span style="font: normal 11pt Times New Roman, Times, Serif">25,386</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Inter-segment
    net revenues</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--IntersegmentNetRevenues_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_z4p3S0ElHEtc" style="text-align: right" title="Inter-segment net revenues"><span style="font: normal 11pt Times New Roman, Times, Serif">254</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--IntersegmentNetRevenues_pn3n3_d0_c20231001__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zuzjTVgdI8P3" style="text-align: right" title="Inter-segment net revenues"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--IntersegmentNetRevenues_pn3n3_c20231001__20231231_zxTCTGpw7g5b" style="text-align: right" title="Inter-segment net revenues"><span style="font: normal 11pt Times New Roman, Times, Serif">254</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">(Loss)
    Income from operations</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zmAl3hnryYie" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Times New Roman, Times, Serif">(993</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zYaTj8A4GG44" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Times New Roman, Times, Serif">5,878</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20231001__20231231_zMhFoeeGe71c" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Times New Roman, Times, Serif">4,885</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Depreciation
    and amortization</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zBMDNEytuZph" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Times New Roman, Times, Serif">60</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zsmhsZdetKh9" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Times New Roman, Times, Serif">1,160</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20231001__20231231_zGFMXu32QBHc" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Times New Roman, Times, Serif">1,220</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Capital
    expenditures</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zI0cp9rcMBMf" style="text-align: right" title="Capital expenditures"><span style="font: normal 11pt Times New Roman, Times, Serif">4</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_z9VJtVX5yjs9" style="text-align: right" title="Capital expenditures"><span style="font: normal 11pt Times New Roman, Times, Serif">129</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20231001__20231231_zMTjKOlL5QVl" style="text-align: right" title="Capital expenditures"><span style="font: normal 11pt Times New Roman, Times, Serif">133</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>























<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Manufacturing
    and Service of MRI Equipment</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Management
    of Diagnostic Imaging Centers</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Totals</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">For
    the six months ended December 31, 2024</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 46%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Net
    revenues from external customers</span></td><td style="width: 5%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--Revenues_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_z6rTfOyUeHx5" style="width: 11%; text-align: right" title="Net revenues from external customers"><span style="font: normal 11pt Times New Roman, Times, Serif">3,986</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--Revenues_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zVdQ9YdB7FE2" style="width: 11%; text-align: right" title="Net revenues from external customers"><span style="font: normal 11pt Times New Roman, Times, Serif">45,924</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--Revenues_pn3n3_c20240701__20241231_zOAnJjpq6wRe" style="width: 11%; text-align: right" title="Net revenues from external customers"><span style="font: normal 11pt Times New Roman, Times, Serif">49,910</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Inter-segment
    net revenues</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--IntersegmentNetRevenues_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zvFt0W2XpZAc" style="text-align: right" title="Inter-segment net revenues"><span style="font: normal 11pt Times New Roman, Times, Serif">583</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--IntersegmentNetRevenues_pn3n3_d0_c20240701__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zSPNhFx6ooS2" style="text-align: right" title="Inter-segment net revenues"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_ecustom--IntersegmentNetRevenues_pn3n3_c20240701__20241231_zNovGROUlx81" style="text-align: right" title="Inter-segment net revenues"><span style="font: normal 11pt Times New Roman, Times, Serif">583</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">(Loss)
    Income from operations</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zIeJiG93EX4l" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Times New Roman, Times, Serif">(2,335</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zDgFO1C9ERce" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Times New Roman, Times, Serif">9,376</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20240701__20241231_ziaZirzu7d94" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Times New Roman, Times, Serif">7,041</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Depreciation
    and amortization</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zDnnIO1vJht6" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Times New Roman, Times, Serif">103</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zLeFMY1hgjcf" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Times New Roman, Times, Serif">2,195</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20240701__20241231_zT3IGbMgMFdk" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Times New Roman, Times, Serif">2,298</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Capital
    expenditures</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zKZclh3mbo6i" style="text-align: right" title="Capital expenditures"><span style="font: normal 11pt Times New Roman, Times, Serif">95</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zoq1aTNbWS0b" style="text-align: right" title="Capital expenditures"><span style="font: normal 11pt Times New Roman, Times, Serif">2,477</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20240701__20241231_zp2UGg8VGrre" style="text-align: right" title="Capital expenditures"><span style="font: normal 11pt Times New Roman, Times, Serif">2,572</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Manufacturing
    and Service of MRI Equipment</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Management
    of Diagnostic Imaging Centers</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">Totals</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">For
    the six months ended December 31, 2023</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 46%; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Net
    revenues from external customers</span></td><td style="width: 5%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--Revenues_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zWHnaVjNziBl" style="width: 11%; text-align: right" title="Net revenues from external customers"><span style="font: normal 11pt Times New Roman, Times, Serif">3,917</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--Revenues_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zdYVE2jw5V53" style="width: 11%; text-align: right" title="Net revenues from external customers"><span style="font: normal 11pt Times New Roman, Times, Serif">47,307</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--Revenues_pn3n3_c20230701__20231231_zFhRemx8lEgd" style="width: 11%; text-align: right" title="Net revenues from external customers"><span style="font: normal 11pt Times New Roman, Times, Serif">51,224</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Inter-segment
    net revenues</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_ecustom--IntersegmentNetRevenues_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zcQm4gard3ac" style="text-align: right" title="Inter-segment net revenues"><span style="font: normal 11pt Times New Roman, Times, Serif">508</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_ecustom--IntersegmentNetRevenues_pn3n3_d0_c20230701__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zNEjy50sfMb1" style="text-align: right" title="Inter-segment net revenues"><span style="font: normal 11pt Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_ecustom--IntersegmentNetRevenues_pn3n3_c20230701__20231231_z6xvPabKi0af" style="text-align: right" title="Inter-segment net revenues"><span style="font: normal 11pt Times New Roman, Times, Serif">508</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">(Loss)
    Income from operations</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zPZPA8DkH9Jf" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Times New Roman, Times, Serif">(1,731</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">)</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_z7JferkQ3J87" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Times New Roman, Times, Serif">13,187</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20230701__20231231_z6QNhsIBfkHe" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Times New Roman, Times, Serif">11,456</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Depreciation
    and amortization</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zZTChwdwzBCj" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Times New Roman, Times, Serif">121</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_ztmdrKBbkba3" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Times New Roman, Times, Serif">2,294</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20230701__20231231_zvduOz0Rgvt8" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Times New Roman, Times, Serif">2,415</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font: normal 11pt Times New Roman, Times, Serif">Capital
    expenditures</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zqTOG5L0kDp" style="text-align: right" title="Capital expenditures"><span style="font: normal 11pt Times New Roman, Times, Serif">20</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zQdeURN2oCxa" style="text-align: right" title="Capital expenditures"><span style="font: normal 11pt Times New Roman, Times, Serif">192</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td><td><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20230701__20231231_zSKV4qOHnYa9" style="text-align: right" title="Capital expenditures"><span style="font: normal 11pt Times New Roman, Times, Serif">212</span></td><td style="text-align: left"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800498236496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative) - Nonconsolidated Investees, Other [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jul. 01, 2015</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Investment Owned, Net Assets, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity Method Investment, Ownership Percentage</a></td>
<td class="nump">70.63%<span></span>
</td>
<td class="nump">70.80%<span></span>
</td>
<td class="nump">45.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsToMinorityShareholders', window );">Proceeds from (Payments to) Noncontrolling Interests</a></td>
<td class="nump">$ 132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=us-gaap_OtherInvesteesMember', window );">Noncontrolling Interest [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity Method Investment, Ownership Percentage</a></td>
<td class="nump">29.37%<span></span>
</td>
<td class="nump">29.20%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedPercentOfNetAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of investment owned to net assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column D))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedPercentOfNetAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from (to) a noncontrolling interest. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=us-gaap_OtherInvesteesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=us-gaap_OtherInvesteesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800500040560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetPatientFeeRevenue', window );">Patient Fee Revenue, net of contractual allowances and discounts</a></td>
<td class="nump">$ 7,944<span></span>
</td>
<td class="nump">$ 8,221<span></span>
</td>
<td class="nump">$ 15,431<span></span>
</td>
<td class="nump">$ 16,896<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_CommercialInsuranceManagedCareMember', window );">Commercial Insurance Managed Care [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetPatientFeeRevenue', window );">Patient Fee Revenue, net of contractual allowances and discounts</a></td>
<td class="nump">1,174<span></span>
</td>
<td class="nump">1,243<span></span>
</td>
<td class="nump">2,378<span></span>
</td>
<td class="nump">2,416<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_MedicareMedicaidMember', window );">Medicare Medicaid [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetPatientFeeRevenue', window );">Patient Fee Revenue, net of contractual allowances and discounts</a></td>
<td class="nump">301<span></span>
</td>
<td class="nump">284<span></span>
</td>
<td class="nump">562<span></span>
</td>
<td class="nump">555<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_WorkersCompensationPersonalInjuryMember', window );">Workers Compensation Personal Injury [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetPatientFeeRevenue', window );">Patient Fee Revenue, net of contractual allowances and discounts</a></td>
<td class="nump">4,683<span></span>
</td>
<td class="nump">4,907<span></span>
</td>
<td class="nump">9,382<span></span>
</td>
<td class="nump">10,044<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_OtherRevenueSourceMember', window );">Other Revenue Source [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetPatientFeeRevenue', window );">Patient Fee Revenue, net of contractual allowances and discounts</a></td>
<td class="nump">$ 1,786<span></span>
</td>
<td class="nump">$ 1,787<span></span>
</td>
<td class="nump">$ 3,109<span></span>
</td>
<td class="nump">$ 3,881<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NetPatientFeeRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NetPatientFeeRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_CommercialInsuranceManagedCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_CommercialInsuranceManagedCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_MedicareMedicaidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_MedicareMedicaidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_WorkersCompensationPersonalInjuryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_WorkersCompensationPersonalInjuryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_OtherRevenueSourceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_OtherRevenueSourceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800492938544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details 1) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetIncomeLossAvailableToCommonStockholderBasic', window );">Basic Numerator: Net income available to common stockholders</a></td>
<td class="nump">$ 1,964<span></span>
</td>
<td class="nump">$ 3,759<span></span>
</td>
<td class="nump">$ 5,099<span></span>
</td>
<td class="nump">$ 7,865<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Number of Shares Outstanding, Basic</a></td>
<td class="nump">6,686<span></span>
</td>
<td class="nump">6,437<span></span>
</td>
<td class="nump">6,696<span></span>
</td>
<td class="nump">6,448<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Income (Loss) from Continuing Operations, Per Basic Share</a></td>
<td class="nump">$ 0.31<span></span>
</td>
<td class="nump">$ 0.58<span></span>
</td>
<td class="nump">$ 0.81<span></span>
</td>
<td class="nump">$ 1.22<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetIncomeLossAvailableToCommonStockholderBasic', window );">Basic Numerator: Net income available to common stockholders</a></td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 59<span></span>
</td>
<td class="nump">$ 83<span></span>
</td>
<td class="nump">$ 125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Number of Shares Outstanding, Basic</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Income (Loss) from Continuing Operations, Per Basic Share</a></td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="nump">$ 0.16<span></span>
</td>
<td class="nump">$ 0.22<span></span>
</td>
<td class="nump">$ 0.33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Number of Shares Outstanding, Diluted</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ConvertibleClassCStock', window );">[custom:ConvertibleClassCStock]</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_WeightedAverageNumberOfDilutedEarningsPerShare', window );">[custom:WeightedAverageNumberOfDilutedEarningsPerShare]</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings Per Share, Diluted</a></td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="nump">$ 0.16<span></span>
</td>
<td class="nump">$ 0.22<span></span>
</td>
<td class="nump">$ 0.33<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetIncomeLossAvailableToCommonStockholderBasic', window );">Basic Numerator: Net income available to common stockholders</a></td>
<td class="nump">$ 1,840<span></span>
</td>
<td class="nump">$ 3,525<span></span>
</td>
<td class="nump">$ 4,775<span></span>
</td>
<td class="nump">$ 7,375<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Number of Shares Outstanding, Basic</a></td>
<td class="nump">6,303<span></span>
</td>
<td class="nump">6,437<span></span>
</td>
<td class="nump">6,313<span></span>
</td>
<td class="nump">6,448<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Income (Loss) from Continuing Operations, Per Basic Share</a></td>
<td class="nump">$ 0.29<span></span>
</td>
<td class="nump">$ 0.55<span></span>
</td>
<td class="nump">$ 0.76<span></span>
</td>
<td class="nump">$ 1.14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Number of Shares Outstanding, Diluted</a></td>
<td class="nump">6,303<span></span>
</td>
<td class="nump">6,437<span></span>
</td>
<td class="nump">6,313<span></span>
</td>
<td class="nump">6,448<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ConvertibleClassCStock', window );">[custom:ConvertibleClassCStock]</a></td>
<td class="nump">128<span></span>
</td>
<td class="nump">128<span></span>
</td>
<td class="nump">128<span></span>
</td>
<td class="nump">128<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_WeightedAverageNumberOfDilutedEarningsPerShare', window );">[custom:WeightedAverageNumberOfDilutedEarningsPerShare]</a></td>
<td class="nump">6,431<span></span>
</td>
<td class="nump">6,565<span></span>
</td>
<td class="nump">6,441<span></span>
</td>
<td class="nump">6,576<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings Per Share, Diluted</a></td>
<td class="nump">$ 0.29<span></span>
</td>
<td class="nump">$ 0.54<span></span>
</td>
<td class="nump">$ 0.74<span></span>
</td>
<td class="nump">$ 1.12<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ConvertibleClassCStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ConvertibleClassCStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NetIncomeLossAvailableToCommonStockholderBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NetIncomeLossAvailableToCommonStockholderBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_WeightedAverageNumberOfDilutedEarningsPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_WeightedAverageNumberOfDilutedEarningsPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 17: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800498255952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock', window );">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_RightToUseAssetToIntangibleAsset', window );">[custom:RightToUseAssetToIntangibleAsset]</a></td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Increase (Decrease) in Operating Lease Liability</a></td>
<td class="nump">1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating Lease, Payments</a></td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitIntraperiodTaxAllocation', window );">Income Tax Expense (Benefit), Intraperiod Tax Allocation</a></td>
<td class="nump">$ 116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_RightToUseAssetToIntangibleAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_RightToUseAssetToIntangibleAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitIntraperiodTaxAllocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income tax expense (benefit) for continuing operations, discontinued operations, other comprehensive income, and items charged (credited) directly to shareholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitIntraperiodTaxAllocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-42<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800499165424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable</a></td>
<td class="nump">$ 3,390<span></span>
</td>
<td class="nump">$ 4,035<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsReceivableNetRelatedParty', window );">Accounts receivable - related party</a></td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NontradeReceivables', window );">Medical receivable</a></td>
<td class="nump">23,496<span></span>
</td>
<td class="nump">23,992<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAndOtherFeesNonRelatedParties', window );">Management and other fees receivable</a></td>
<td class="nump">42,485<span></span>
</td>
<td class="nump">41,954<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances', window );">Management and other fees receivable from related medical practices (&#8220;PC&#8217;s&#8221;)</a></td>
<td class="nump">9,677<span></span>
</td>
<td class="nump">9,865<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable</a></td>
<td class="nump">3,663<span></span>
</td>
<td class="nump">4,201<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsReceivableNetRelatedParty', window );">Accounts receivable - related party</a></td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NontradeReceivables', window );">Medical receivable</a></td>
<td class="nump">23,496<span></span>
</td>
<td class="nump">23,992<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAndOtherFeesNonRelatedParties', window );">Management and other fees receivable</a></td>
<td class="nump">55,148<span></span>
</td>
<td class="nump">54,324<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances', window );">Management and other fees receivable from related medical practices (&#8220;PC&#8217;s&#8221;)</a></td>
<td class="nump">16,666<span></span>
</td>
<td class="nump">15,975<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_DoubtfulMember', window );">Doubtful [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable</a></td>
<td class="nump">273<span></span>
</td>
<td class="nump">166<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsReceivableNetRelatedParty', window );">Accounts receivable - related party</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NontradeReceivables', window );">Medical receivable</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAndOtherFeesNonRelatedParties', window );">Management and other fees receivable</a></td>
<td class="nump">12,663<span></span>
</td>
<td class="nump">12,370<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances', window );">Management and other fees receivable from related medical practices (&#8220;PC&#8217;s&#8221;)</a></td>
<td class="nump">$ 6,989<span></span>
</td>
<td class="nump">$ 6,110<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableNetRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableNetRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherFeesNonRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherFeesNonRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 40<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481628/310-20-40-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477802/946-310-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479196/954-310-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NontradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amounts due as of the balance sheet date of the sum of amounts receivable other than from customers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NontradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_DoubtfulMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_DoubtfulMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800505934096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Future Revenue (Details 1)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractReceivableDueOneToTwoYears', window );">Construction Contractor, Receivable, Excluding Contract Retainage, Year Two</a></td>
<td class="nump">$ 677<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractReceivableDueTwoToThreeYears', window );">Construction Contractor, Receivable, Excluding Contract Retainage, Year Three</a></td>
<td class="nump">242<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractReceivableDueThreeToFourYears', window );">Construction Contractor, Receivable, Excluding Contract Retainage, Year Four</a></td>
<td class="nump">87<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractReceivableDueFourToFiveYears', window );">Construction Contractor, Receivable, Excluding Contract Retainage, Year Five</a></td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms', window );">Construction Contractor, Receivable, Excluding Contract Retainage</a></td>
<td class="nump">$ 1,050<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount billed to customers under long-term contracts or programs but not paid. Excludes amounts due that have been withheld because of retainage provisions in a contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 910<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482546/910-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractReceivableDueFourToFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 910<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482546/910-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractReceivableDueFourToFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractReceivableDueOneToTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 910<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482546/910-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractReceivableDueOneToTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractReceivableDueThreeToFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 910<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482546/910-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractReceivableDueThreeToFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractReceivableDueTwoToThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 910<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482546/910-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractReceivableDueTwoToThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800506354928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables', window );">Increase (Decrease) in Accounts and Other Receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 830<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims', window );">[custom:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims]</a></td>
<td class="nump">58.20%<span></span>
</td>
<td class="nump">54.40%<span></span>
</td>
<td class="nump">59.30%<span></span>
</td>
<td class="nump">57.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1', window );">[custom:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1]</a></td>
<td class="nump">72.50%<span></span>
</td>
<td class="nump">71.70%<span></span>
</td>
<td class="nump">72.20%<span></span>
</td>
<td class="nump">71.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PercentageOfConsolidatedNetRevenueFromManagementFees', window );">[custom:PercentageOfConsolidatedNetRevenueFromManagementFees]</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">11.80%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">11.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PercentageOfConsolidatedNetRevenueFromManagementFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PercentageOfConsolidatedNetRevenueFromManagementFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800500778784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OPERATING &amp; FINANCING LEASES - Lease Payments (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=FONR_OperatingLeasePaymentsMember', window );">Operating Lease Payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 5,584<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2026</a></td>
<td class="nump">5,388<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2027</a></td>
<td class="nump">5,371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2028</a></td>
<td class="nump">5,019<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2029</a></td>
<td class="nump">4,876<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">26,841<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PresentValueDiscount', window );">Present value discount</a></td>
<td class="num">(14,893)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating Lease, Liability</a></td>
<td class="nump">38,186<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=FONR_FinancingLeasePaymentsMember', window );">Financing Lease Payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2025</a></td>
<td class="nump">244<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2026</a></td>
<td class="nump">244<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2027</a></td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2028</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2029</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PresentValueDiscountFinancingLease', window );">Present value discount</a></td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance Lease, Liability</a></td>
<td class="nump">$ 534<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PresentValueDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PresentValueDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PresentValueDiscountFinancingLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PresentValueDiscountFinancingLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=FONR_OperatingLeasePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=FONR_OperatingLeasePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=FONR_FinancingLeasePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=FONR_FinancingLeasePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800503286048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OPERATING &amp; FINANCING LEASES (Details 1)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureOperatingAndFinancingLeasesAbstract', window );"><strong>Operating And Financing Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">10 years 7 months 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">2 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="nump">6.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="nump">3.60%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureOperatingAndFinancingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureOperatingAndFinancingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800506223472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING &amp; FINANCING LEASES (Details 2) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureOperatingAndFinancingLeasesAbstract', window );"><strong>Operating And Financing Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 3,190<span></span>
</td>
<td class="nump">$ 2,865<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_FinanceLeaseCostsAbstract', window );"><strong>Finance lease cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DepreciationOfLeasedEquipment', window );">Depreciation of leased equipment</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_FinanceLeaseCost', window );">Total finance lease cost</a></td>
<td class="nump">$ 105<span></span>
</td>
<td class="nump">$ 114<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DepreciationOfLeasedEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DepreciationOfLeasedEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureOperatingAndFinancingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureOperatingAndFinancingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_FinanceLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_FinanceLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_FinanceLeaseCostsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_FinanceLeaseCostsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800506323952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING &amp; FINANCING LEASES (Details 3) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureOperatingAndFinancingLeasesAbstract', window );"><strong>Operating And Financing Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_OperatingCashFlowsFromOperatingLeases', window );">Operating cash flows from operating leases</a></td>
<td class="nump">$ 2,541<span></span>
</td>
<td class="nump">$ 3,164<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_FinancingCashFlowsFromFinancingLeases', window );">Financing cash flows from financing leases</a></td>
<td class="nump">122<span></span>
</td>
<td class="nump">122<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract', window );"><strong>Right-of-use and equipment assets obtained in exchange for lease obligations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases', window );">Operating leases</a></td>
<td class="nump">$ 359<span></span>
</td>
<td class="nump">$ 1,212<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureOperatingAndFinancingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureOperatingAndFinancingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_FinancingCashFlowsFromFinancingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_FinancingCashFlowsFromFinancingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_OperatingCashFlowsFromOperatingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_OperatingCashFlowsFromOperatingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800608364192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVENTORIES - Inventories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInventorySupplies', window );">Purchased parts, components and supplies</a></td>
<td class="nump">$ 2,583<span></span>
</td>
<td class="nump">$ 2,524<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work-in-process</a></td>
<td class="nump">275<span></span>
</td>
<td class="nump">191<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total Inventories</a></td>
<td class="nump">$ 2,858<span></span>
</td>
<td class="nump">$ 2,715<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInventorySupplies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of other supplies used within the manufacturing or production process expected to be consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInventorySupplies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800500356576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying amount intangible assets</a></td>
<td class="nump">$ 21,595<span></span>
</td>
<td class="nump">$ 20,315<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization intangible assets</a></td>
<td class="num">(18,188)<span></span>
</td>
<td class="num">(17,445)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net carrying amount intangible assets</a></td>
<td class="nump">$ 3,407<span></span>
</td>
<td class="nump">$ 2,870<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Software and Software Development Costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying amount intangible assets</a></td>
<td class="nump">$ 7,005<span></span>
</td>
<td class="nump">$ 7,005<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization intangible assets</a></td>
<td class="num">(7,005)<span></span>
</td>
<td class="num">(7,005)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net carrying amount intangible assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicenseMember', window );">License [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying amount intangible assets</a></td>
<td class="nump">$ 1,260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization intangible assets</a></td>
<td class="num">(567)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net carrying amount intangible assets</a></td>
<td class="nump">$ 693<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember', window );">Patents And Copyrights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying amount intangible assets</a></td>
<td class="nump">$ 5,280<span></span>
</td>
<td class="nump">$ 5,260<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization intangible assets</a></td>
<td class="num">(4,180)<span></span>
</td>
<td class="num">(4,104)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net carrying amount intangible assets</a></td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="nump">$ 1,156<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying amount intangible assets</a></td>
<td class="nump">$ 4,150<span></span>
</td>
<td class="nump">$ 4,150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization intangible assets</a></td>
<td class="num">(4,150)<span></span>
</td>
<td class="num">(4,150)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net carrying amount intangible assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">20 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying amount intangible assets</a></td>
<td class="nump">$ 3,900<span></span>
</td>
<td class="nump">$ 3,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization intangible assets</a></td>
<td class="num">(2,286)<span></span>
</td>
<td class="num">(2,186)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net carrying amount intangible assets</a></td>
<td class="nump">$ 1,614<span></span>
</td>
<td class="nump">$ 1,714<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478859/928-340-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800498606624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS (Details 1) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Finite-Lived Intangible Asset, Expected Amortization, Year One</a></td>
<td class="nump">$ 723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Finite-Lived Intangible Asset, Expected Amortization, Year Two</a></td>
<td class="nump">650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Finite-Lived Intangible Asset, Expected Amortization, Year Three</a></td>
<td class="nump">321<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Finite-Lived Intangible Asset, Expected Amortization, Year Four</a></td>
<td class="nump">317<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Finite-Lived Intangible Asset, Expected Amortization, Year Five</a></td>
<td class="nump">314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</a></td>
<td class="nump">1,082<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">$ 3,407<span></span>
</td>
<td class="nump">$ 2,870<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800500260112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember', window );">Patents And Copyrights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">$ 37<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="nump">$ 76<span></span>
</td>
<td class="nump">$ 86<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">$ 50<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800498652352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Accrued salaries, commissions and payroll taxes</a></td>
<td class="nump">$ 1,541<span></span>
</td>
<td class="nump">$ 4,678<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalesAndExciseTaxPayableCurrent', window );">Sales tax payable</a></td>
<td class="nump">183<span></span>
</td>
<td class="nump">197<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedPayrollTaxesCurrent', window );">Federal and state income taxes payable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,461<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_SelffundedHealthInsuranceReserve', window );">Self-funded health insurance reserve</a></td>
<td class="nump">168<span></span>
</td>
<td class="nump">121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_SoftwareLicenses', window );">Software Licenses</a></td>
<td class="nump">252<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesCurrent', window );">Other general and administrative expenses</a></td>
<td class="nump">1,768<span></span>
</td>
<td class="nump">1,484<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other Current Liabilities</a></td>
<td class="nump">$ 3,912<span></span>
</td>
<td class="nump">$ 7,941<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_SelffundedHealthInsuranceReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_SelffundedHealthInsuranceReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_SoftwareLicenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_SoftwareLicenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedPayrollTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedPayrollTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481573/470-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesAndExciseTaxPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesAndExciseTaxPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800498283216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND RELATED INFORMATION - Summarized Segments - (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenues from external customers</a></td>
<td class="nump">$ 24,950<span></span>
</td>
<td class="nump">$ 25,386<span></span>
</td>
<td class="nump">$ 49,910<span></span>
</td>
<td class="nump">$ 51,224<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IntersegmentNetRevenues', window );">Inter-segment net revenues</a></td>
<td class="nump">294<span></span>
</td>
<td class="nump">254<span></span>
</td>
<td class="nump">583<span></span>
</td>
<td class="nump">508<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">(Loss) Income from operations</a></td>
<td class="nump">2,435<span></span>
</td>
<td class="nump">4,885<span></span>
</td>
<td class="nump">7,041<span></span>
</td>
<td class="nump">11,456<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,235<span></span>
</td>
<td class="nump">1,220<span></span>
</td>
<td class="nump">2,298<span></span>
</td>
<td class="nump">2,415<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">754<span></span>
</td>
<td class="nump">133<span></span>
</td>
<td class="nump">2,572<span></span>
</td>
<td class="nump">212<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=FONR_ManufacturingAndServiceOfMRIEquipmentMember', window );">Manufacturing And Service Of M R I Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenues from external customers</a></td>
<td class="nump">1,829<span></span>
</td>
<td class="nump">1,861<span></span>
</td>
<td class="nump">3,986<span></span>
</td>
<td class="nump">3,917<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IntersegmentNetRevenues', window );">Inter-segment net revenues</a></td>
<td class="nump">294<span></span>
</td>
<td class="nump">254<span></span>
</td>
<td class="nump">583<span></span>
</td>
<td class="nump">508<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">(Loss) Income from operations</a></td>
<td class="num">(1,291)<span></span>
</td>
<td class="num">(993)<span></span>
</td>
<td class="num">(2,335)<span></span>
</td>
<td class="num">(1,731)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">54<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="nump">103<span></span>
</td>
<td class="nump">121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">95<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember', window );">Health Care, Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenues from external customers</a></td>
<td class="nump">23,121<span></span>
</td>
<td class="nump">23,525<span></span>
</td>
<td class="nump">45,924<span></span>
</td>
<td class="nump">47,307<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IntersegmentNetRevenues', window );">Inter-segment net revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">(Loss) Income from operations</a></td>
<td class="nump">3,726<span></span>
</td>
<td class="nump">5,878<span></span>
</td>
<td class="nump">9,376<span></span>
</td>
<td class="nump">13,187<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,181<span></span>
</td>
<td class="nump">1,160<span></span>
</td>
<td class="nump">2,195<span></span>
</td>
<td class="nump">2,294<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">$ 731<span></span>
</td>
<td class="nump">$ 129<span></span>
</td>
<td class="nump">$ 2,477<span></span>
</td>
<td class="nump">$ 192<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IntersegmentNetRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IntersegmentNetRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480060/805-50-25-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=FONR_ManufacturingAndServiceOfMRIEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=FONR_ManufacturingAndServiceOfMRIEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800506351056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest Paid, Excluding Capitalized Interest, Operating Activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 58<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income Taxes Paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,473<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 359<span></span>
</td>
<td class="nump">$ 1,212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_RateOfInterestSold', window );">[custom:RateOfInterestSold]</a></td>
<td class="nump">0.197%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountConverted1', window );">Conversion of Stock, Amount Converted</a></td>
<td class="nump">$ 132,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_RateOfInterestSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_RateOfInterestSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-23<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800499981728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Sep. 26, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Stock Repurchased During Period, Value</a></td>
<td class="nump">$ 926<span></span>
</td>
<td class="nump">$ 1,171<span></span>
</td>
<td class="nump">$ 1,341<span></span>
</td>
<td class="nump">$ 1,885<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Share Repurchase Program, Remaining Authorized, Amount</a></td>
<td class="nump">3,392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Liability for Claims and Claims Adjustment Expense</a></td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self Insurance Reserve</a></td>
<td class="nump">$ 168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember', window );">Board of Directors Chairman [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StockRepurchaseProgramAuthorizedAmount1', window );">Share Repurchase Program, Authorized, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock Repurchased During Period, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84<span></span>
</td>
<td class="nump">116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Stock Repurchased During Period, Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,342<span></span>
</td>
<td class="nump">$ 1,885<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares', window );">Stock Redeemed or Called During Period, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="nump">123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue', window );">Stock Redeemed or Called During Period, Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,963<span></span>
</td>
<td class="nump">$ 2,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480046/944-40-55-7<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 9E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480046/944-40-55-9E<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480081/944-40-50-3<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(13)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of stock bought back by the entity at the exercise price or redemption price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRedeemedOrCalledDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock bought back by the entity at the exercise price or redemption price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRedeemedOrCalledDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800499588560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability', window );">Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability</a></td>
<td class="nump">$ 762<span></span>
</td>
<td class="nump">$ 1,366<span></span>
</td>
<td class="nump">$ 2,011<span></span>
</td>
<td class="nump">$ 3,036<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax', window );">Extinguishment of Debt, Gain (Loss), Net of Tax</a></td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DeferredIncomeTaxComponent', window );">[custom:DeferredIncomeTaxComponent]</a></td>
<td class="nump">1,111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred Tax Assets, Net of Valuation Allowance</a></td>
<td class="nump">6,113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus', window );">Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Policyholders' Surplus</a></td>
<td class="nump">$ 371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PercentageOfExciseTax', window );">[custom:PercentageOfExciseTax]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CorporateAlternativeMinimumTaxPercentage', window );">[custom:CorporateAlternativeMinimumTaxPercentage]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CorporateAlternativeMinimumTaxPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CorporateAlternativeMinimumTaxPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DeferredIncomeTaxComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DeferredIncomeTaxComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PercentageOfExciseTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PercentageOfExciseTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability not recognized because of the exceptions to comprehensive recognition of deferred taxes related to a policyholders' surplus.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 740<br> -Topic 944<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478822/944-740-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the reacquisition price and the net carrying amount of the extinguished debt recognized currently as a component of income in the period of extinguishment, net of tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtGainLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income tax expense (benefit) from continuing operations attributable to an adjustment of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800499982816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Feb. 01, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetRevenues', window );">[custom:NetRevenues]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ServiceAndMaintenancePrice', window );">[custom:ServiceAndMaintenancePrice-0]</a></td>
<td class="nump">$ 110,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ServiceAndRepairFees', window );">[custom:ServiceAndRepairFees]</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_EmployeesFee', window );">[custom:EmployeesFee]</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Investment Income, Net</a></td>
<td class="nump">524<span></span>
</td>
<td class="nump">534<span></span>
</td>
<td class="nump">1,163<span></span>
</td>
<td class="nump">1,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=FONR_MagneticResonanceManagementMember', window );">Magnetic Resonance Management [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Derivative, Fixed Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Investment Income, Net</a></td>
<td class="nump">$ 13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredGainOnSaleOfProperty', window );">Deferred Gain on Sale of Property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_EmployeesFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_EmployeesFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NetRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NetRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ServiceAndMaintenancePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ServiceAndMaintenancePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ServiceAndRepairFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ServiceAndRepairFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredGainOnSaleOfProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain on the sale of property that does not qualify for gain recognition as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredGainOnSaleOfProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fixed interest rate related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=FONR_MagneticResonanceManagementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=FONR_MagneticResonanceManagementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45800505952912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details Narrative)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchaseds', window );">[custom:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchaseds-0] | shares</a></td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount', window );">[custom:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount-0] | $</a></td>
<td class="nump">$ 108<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchaseds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchaseds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>62
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M0=5 Y3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%
M  @ %VY36MW\N?A(!@  120  !@   !X;"]W;W)K<VAE971S+W-H965T,2YX
M;6RUFF%SJD84AK_?7[%C.YUV)D9V5XVY-<X8DK29WB1>3=NY[?3#"JLR%UB[
MK";Y]ST@2FZR'"TC^9"(<M[LPX'E >D_*?TU64AIR',4QLE%8V',\F.KE7@+
M&8GD5"UE#)_,E(Z$@44];R5++86?%45ABSE.MQ6)(&X,^ME[(SWHJY4)@UB.
M-$E6423TRZ4,U=-%@S:V;XR#^<*D;[0&_:68RXDTOR]'&I9:NQ0_B&2<!"HF
M6LXN&D/ZT>6]M"!;XX] /B6O7I,49:K4UW3AUK]H..F(9"@]DT8(^+.6K@S#
M- G&\6\>VMC]S[3P]>MM^DT&#S!3D4A7A7\&OEE<-'H-XLN96(5FK)Y^E3E0
M)\WS5)ADO\G39MUVNT&\56)4E!?#"*(@WOP5S_F&>%7 :4D!RPO8FP):]A]X
M7L ST,W(,JPK8<2@K]43T>G:D):^R+9-5@TT09RV<6(T?!I G1FX:BTU:9)D
M(;1,^BT#F>DG+2^OO]S4LY+Z+KE3L5DDY#KVI?]M?0O&LAL0VP[HDJ&!5]([
M)9R>$.:PMF4\+EY^(Z>GQ.%9>0<9#M]M'Y[E\;+A*&\%>ZTACR]+:=L\>#EU
MFI]M$&A5>NA^3);"DQ<-.#83J=>R,?CA.]IU?D:0VCND-CJF(?#X&=--*.8V
M)KQ^)L+$MBE<M*PB5&<'U3FL3Y]70ANIPQ<REDNEC8T/CS)Z9<5#JRKB=7=X
MW0-W0RU@"LUFP'(^/*NT?VA91<"S'>#988 CJ0/EI],)@0G->LCM2=I.(*4S
M"%I?D;.WX^P=QGD3))X(M[@W\+9U]L73/C,;'UI3D>]\QW?^O_B^2*'+Z?"L
M]U/XA@^MJLA'G>*$Z:"C<E=:OP7$]M8]<<VFTVURQ\:)5U8%?64&%!W9=6P"
M\P*<H23WJV@JM14/#W&:%(["GA4/K:R*QPH\=@C>6,Z#Q,"L:LB]B.P=Q(-N
M'NZ'XP_NPWCT,!X^WC[<6V'1C*JPA<50W$-R6!=V7 T[[2W(VC/Y3;Y8<?$H
M!WYXI^/0<RMG'69#"[6AN)ODG(_BF=SZ !O, D]D9TMD#\8C*6VR=K=-^9F5
MMP[IH87U4-Q5<M[;V%,:;"!#/2$3 W,149JX:@4-A[XKW[YG[Y&J:RMR'2)$
M"Q.BN+[DR$/?A_3D9/N"?(+UR$-LY\0C*74^$/BY$QI.5.1*PY6EE;P.0Z*%
M(E'<;-Z2N^D2=/E1/<56:CSN3H;K( SMI'4X$BTDB>)>\Y9TMT./M%H'L6=O
M,IYY_\4*6H<LT<*6**XX;T%'*C$P/_\5+,N/63R1TK.V?::J0YM8H4ULCS9E
MG%J*4K ] 5U.K;<#ZI D5D@2P_WFD\HL?J%B3)+VA'3/VTUVSJPG5+RT*E]A
M20R7F\? @/ZI&:'LQ^E/9"*]E89.6B'Q)%=%D8H_3(SROIZ0[T]!(RA9@CRO
M16B_X,8#JZ(7SL1PT8%+;3^(YV3R$DU5:"7& T ,QU:N.AR)%8[$<*'9]I!<
M/WL+$<]EJ?CN";H?3JZ&UMM;>&%5PL**V$%6M+U2V]PHR5H)YQ'[E>B>Q"_6
M>Z,N7E65LU A=I *W<9&ZLW]\/0J5&S!K9QX8AEG'>+#"O%A!XE/>B4*3@LJ
M,%?:/@7A.4//DQ ! ?XFS,I:A_JP0GW80>HSB408DLM5 A\G]CT6SRF[BXF7
M5<4KA(<=)#S7D=3S](C\!1+, IP@6HK8WE,\L/1N)EY7$907OL-Q7=GV<2&A
MCPC>GIA2/+RN*E[A/1Q7ELW9G+BA@$NO2_+WG4S=YQ\KX9$,)N>NPX=XX4/\
MH+M&.7XN,Y/LRS/RL#)@[W$J#=;M<"2=R;?#)JV=I:5?UJX'M-WMM]8VO%??
M=N'*\DU;7;RM1[*8'*<.)^*%$_&#[AM5:NN17"??#NUW;>4]UJ&\I+.%$W'<
M8$9:SB1H@9\W=X@W]TABDT/5H4F\T"1^D"95:NZ1Q"??#MWWS:6\S7LES2T$
MB>-B\QH-[^N1Y";GJ4.5>*%*_"!5JM37(UE0OAUZ[_K:90YO=SMO&MMZ]:!&
M:D#9\RL)\=+;M)MG-G;O[IZ1&69/AK2*U3</V-R)5* 2$LH9E#JG9W",Z<TS
M*YL%HY;98Q]398R*LI<+*7RITQ7@\YE29KN0_H/=DT.#_P!02P,$%     @
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MQNQZ!N(J5:F<";5CA)>AB7/%?-:'/B06,A):K-?8QV[N.ZR?I;D"TL9ZT'B
ML$:_ @CYU!9V36'LQO ?4DZ?TRP#S3)YQ0B/^G;MD.KN!375B)MJ-PTDTKR*
M\\>T3N*6$[M6'C$Y1IF1PH 4"0-+62.:=L1-N]9F.]"(B2H6]0L9)&1;7F1K
M;[T/SNP8(R:>B!=$OA$Y0 ZKIM'"6Z(Q1NA>N_^K-'Y(L[12W0Q\!."DX<%G
M  -IZSJM.4C<''QQ>JEVV?6AFFI1:V2W&^ZI>(!3W"0=ZR]*2":P3)%F(=ES
MK[V,?]9< 8TSD1;Y1HI#W/-M*:2Q1]S8N^GTE9E.)-!0DV(TPOVN#9 *(MNA
M"M&P(V[8?<U%7.2*Q(50O?M*(#7W=7:I+0U*9%[5VQO8:@AS1B\$2=G+FX8<
M<4-N+ZOW;S8( +3^UM-MT>&'#D2#D;C!>--M.K;3"?V]2;+UP@7=,[E(B6\L
M5$"*!99- =7TI&YZ?NPV'1OK?^YG.P7XR/I; TB(6!8QU0RE;H9.FC-WM8ZG
M8BG+U'(B:C*2&J@"A!BS; BH!BD]9%]XY2XR%-CT$<+Z5082"T+?4K#IUB&S
MFZE7-4ON:Y;LHBH=E*I#:>NZK:E*W51]=76EP &UY_=W;9 4#BQ')533E;KI
M"NV)-\L6M!8X8P[Z1^X[A+JV:M)2-VDO5% KV2WQYN$<:+0)5*,#=LMT3=;(
MI6[DNNIY[Q!QGP();C>)48( L8!QRW:3:A)3-XGMY?T5KI@8)L:="D"(1K:4
MUXRE;L9>=7K=(^5,6>YEL@E-(_*F"+?44Z:IRO;9D^YH+!F Q?Y>'I"AECL/
M3).3N<G9D@FL^:"= $-YP/N4A\0B[MGN*VJ.LGTXNLM&$XPL\CPCG*:8'S#?
MLLR8YB=S\_/RGU\_W?\;!"8;%)A#:>OZN763UPW,VSB='J<Y2N)E6L^*>BE^
M)/5B5"5$%7?T%&<K<+O' !8&86#<7H#D0H][MBG2U&0[]Z2KQ:K%T%3,TB0%
M]\S,Q.!QZ)/^=@,2PY3;#NF9!B9S _.^4'5Z5?Q$JKE-OAW5MYT26>I#0H;*
M>5RT-ZD4_1=UQU)+VN]/,=\QI'/S"HR'B=CC[8*^#@<@A3ULJZ.:Q<S-XG;M
M?[RY/O^")K)0E3ZN2WT3C.!]B>YJ/^8RFXJB7+^)+K^O+'T0,R&+>132_E8+
ME/,C&XV9IC%ST_A:YDU;*;.L1G*:*Z2)TO*8A E2%=(P-!8,(!>I)6.Q52.7
MN9';AMX13).;V \CWWB4 Y+C06@)IJ\9Z[L9:W"AR7:[P3Z 6^C@$I)S'%SZ
M&KO^C@UK%JM">8Y4%J"_9--AWA8OO7R3R>@_GYL%_%_0?J?V0T$RE+9N+#34
M??<C7 Y@^H,^NS64MJZ?NC'PW?=<]02W)=?*1]^\?6H\!.02Z=JG@>[O /HA
M">A4=?#$#*2MZ_C6TV#^JQ/0V4@<[.= VKI^ZG["=_<3^R>@B7 C 5TB7?LT
MX7TWX2=M0[)']CGU'#PK VGK>JT; 3]\=?:]XB#;X>= VKI^ZB;"=S<1D^UV
MTYYZ0(O03SV72/?Q1]U <'<#L3:NQ?('9_*Y-1TZ*4-IZ_JM^Q".7YM\?- >
M8RAM73]UC\'=!P?[)1\WCP2,YUE=(EWC=&/ =SS7O9U\$W?R#7J",)2VKM^Z
MX>#LU<DW:'\QE+:NG[J_X.[CACV3KU7"7<GG$FF-&V_]JJ3^2<_GN'A,\Q)E
M8J;&>&\#I:)H?R737E1RV?S0Y$%6E5PT+^<B5IOH6D!]/I.R>KFH?[NR^:W2
MV?\ 4$L#!!0    ( !=N4UIYX2@TT@0  !H9   8    >&PO=V]R:W-H965T
M<R]S:&5E=#,N>&ULM9E=3^,X%(;_BI4=K4!B2.RT:6':2J5E-:P&J"@P%Z.]
M<!.71B1QQW;HL+]^G0^2E#BFZ71O:)+ZO#G/B8_]D@XVE#WS%2$"_ J#B ^-
ME1#K<]/D[HJ$F)_2-8GD-TO*0BSD*7LR^9H1[*5!86 BRW+,$/N1,1JDUV9L
M-*"Q"/R(S!C@<1AB]GI! KH9&M!XNW#G/ZU$<L$<#=;XB<R)>%C/F#PS"Q7/
M#TG$?1H!1I9#8PS/)\A) M(1CS[9\,HQ2% 6E#XG)U?>T+"2C$A 7)%(8/GQ
M0B8D"!(EF<?/7-0H[ID$5H_?U/]*X27, G,RH<%WWQ.KH=$W@$>6. [$'=U\
M)3E0-]%S:<#3OV"3C[4,X,9<T# /EAF$?I1]XE]Y(2H!L-,0@/( M&N G0?8
M*6B668HUQ0*/!HQN $M&2[7D(*U-&BUI_"AYC'/!Y+>^C!.CR>W-]/)F?CD%
M\FA^^^UJ.KZ7)Q?C;^.;R268?[V\O)^#HX<(QYXOB'<,CF:8D4BLB/!='!R#
MS^!A/@5'GX[!)^!'X'Y%8XXCCP],(?-+[F*Z>2X762ZH(9<I<4^!#4\ LE!'
M$3[1A_\=1S+<4H6;LBI%:5!1&I3JV0UZXT#.<1RY!,AN 5,:+\0R#L#8=6D<
M"7X"9HR$?AQR(''!K:P( W?$)?X+7@1$R9_=T$EOF#38RPCU[('Y4H6LCX&.
M4XS9(K$+$EM+\B.;2.?7.)*M*9M0C",O3;C,MZ#ELCW>8-]8/UO_J'"RNW:J
MJ2+'>0^D&F7W+#52IT#J[(1T1P(LIZ6<D^+U]V ZM;H[9_VS=RR*01 VH'0+
ME*X6Y5XNOSQFKV NJ/M\ B8T#&ET N8KV6C*:=2M5;1C6=:[5!6#NM516[DZ
M1:Z.-M=)@#D'8W C5^!'*OSH*>F")6&,>%G^X,<U"1>$*6NL%4]VK'.^QBX9
M&G)+XH2]$&/TYQ_0L;ZH5H,#B6W5H5?4H:>MPSMHN19@!N0J,1?); 2/.(@)
MF,D%(7V(JE)H]=N6(A/K59ZU=2J?-50_['X!V6\'F<U(,([%BC+_7^*IP+2:
M;<'ZBDEL-\[BLP+L;"^PVUAP(1=S.:U59%K1MF1G-3(;-I-!J]S/K39LVG;4
M2[4E.I3:-GC%R,#_N27U-VA=CDRM_ZXI&WH2EJX$ZFW)?EVI%VW-AFJSM^OT
MFF=O:52@WJGLV9EZU=9T=<?2!%;:%:CW*]FFODM/:G5:HQQ(;9NZ=#90;VVJ
MU/LTI%:]=2VZK79)6'HB^($IVJ+<K1T/ZH1RM>J$[2=>K[$?2YL#]3Y'A78"
MKCB/&[AZM4P<9/7J[E0UT.YI-L#2M$"]:U&G_-$"4C<:,F];D;=BH(WZS7F7
MG@3J34F>=^:P+_1KQ$&=R*'4MO_)+@T+TAN6WUPC].IM:Y&K[;I&H-*=(+T[
MV6.-T"NV)H.UB8M0\Y:-*F])]'YDKW[3:[9FJ]L1V&EX9X)*+X+T7F2K(2?:
MAM0KM<8YD-HV=VE5T.Y699^&/*B!R=5V;LC2FJ VUF2WACRH'4'U%S0Z#XU*
M.X+:VY&/&_*@A@35#8G=5VSN9N7%=?*KP35F3W[$04"6,M Z[<D:L>Q%?'8B
MZ#I]E[V@0M P/5P1[!&6#)#?+RD5;R?)Z_'BYY#1?U!+ P04    "  7;E-:
MIG-F%N@)  !*.@  &    'AL+W=O<FMS:&5E=',O<VAE970T+GAM;+5;:V_C
M-A;]*X1;%"TP,Q8?>J6)@4328 -L["#.3!=8+!:*S<3"R)(KT<GTWR_UB&61
M5XPSU7Y)+/OP4N?R\O)<BCI_R8MOY89S@;YOTZR\F&R$V)U-I^5JP[=Q^2G?
M\4S^\I@7VUC(R^)I6NX*'J_K1MMT2BS+F6[C))O,SNOO;HO9>;X7:9+QVP*5
M^^TV+OZZXFG^<C'!D]<O[I*GC:B^F,[.=_$37W+Q97=;R*OIP<HZV?*L3/(,
M%?SQ8G*)SR+F5PUJQ->$OY1'GU%%Y2'/OU47U^N+B57=$4_Y2E0F8OGOF0<\
M32M+\C[^;(U.#GU6#8\_OUK_7).79![BD@=Y^D>R%IN+B3=!:_X8[U-QE[_\
M@[>$[,K>*D_+^B]Z:;'6!*WVI<BW;6-Y!]LD:_['WUM''#60=N &I&U U 9L
MH %M&]!3>V!M W9J#W;;H*8^;;C7C@MC$<_.B_P%%15:6JL^U-ZO6TM_)5D5
M*$M1R%\3V4[,@L4\C.;+*$3RTW+QS^OP\EY>+._EOYMH?K]$B\]H<1O=7=Y?
M2P#ZB+XL0_3KS[^A<A,7O$1)ANXW^;Z,LW7Y ?W<NSZ?"GF+54?357L[5\WM
MD(';H>@FS\2F1%&VYFN@?6AN[QC:3Z5K#OXAK_ZY(D:#(5]]0A1_0,0B#+B?
MX/3F%*+S]WJ/?KCWGC/H(5AH;<\>L'<7?8WF7Z(E-*Y-2PJWK-+=6;F+5_QB
M(O-9R8MG/IG]\A-VK-\AIXYI+!S36#22L9[[V<']S&1]=AN+A&<"/7(N<_0S
MS_8<_?*31S#^'65R3<D?T4I&?R&3[SY.49S*52#.5G*2RLF(UDFYRO>9 &=E
MT[%3=URM+<\SUV<RXIZ/1T4'>83@/BC40=AF5$%% ,KQ?.> ZOG'/OC'-ONG
MR-?[E4!EG'*09=.<'?5*;(6C#K$52*A#,%,P$= 3]F%VSH&=8V2WE-&4K'@]
ME@7?Q4E1!0+(T]'OT+5]A2D$<CV%JPZBKJT.)@!R&(79N@>V[H^P1?^55VDL
M^!KMXD).!Y"_J]V0.D"!#B$J=QWB6PIS'7(4+3W>WH&W9^1]$V=2GVVK:5Y1
MS\6&#X^SIP\AP9XZT!"*8D=AJZ,(L['BDPA",3HP;_T#9__'.!^-]I:ODY5,
M:KLJN\G  /WAZW?G>PJ%X!10J(-LWU4G^1N@GB^PU0DRR^B-^UQ(GG=-?B\/
M"7[.!2BG+&!$?%L)U ""V=13@P" ,=_':M@#,!L3P@:H'VE1;-07P6(I!>?E
M/$31OVXK50HJC=;(2%)C5&OAJ-:BL:SUAX-TPT&,D1CDI2@/,U#D,N5J @0<
M(*)'D4.H&I(0RB)J1.HHGSB^&I  RB(#"R[NY"XVRCG  6\IC-9@;YZI$BD
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M>"MA]A=(']".:I4"8#3R@%!559G13)]YIU&)6:-JS$&.P(8F43=V(1!5]3@
MPE)JJT0!E,6&N'8"E)@%:"_+G#[ 1J/P%$1@GM'EI.VJJ^Y8O45O]-9W82==
MB5FZ'KL0=!8@*M4X,?9P.L-P+$.1\:;[CNJD*S%+U^LFRJ[X8UYP=%ODSTG]
M6%Q>HO:W^_A[^U1EGF?U,Y>\5G_H->O"6@?8/?4=5>(!*-O7=NH E)P46MH!
M]GZIA8<6_4[L$K/8[3NEG9:B<@K(6]>9'UV'J+P!%*:.1AR $4LK "$8M89V
MJFFG;:E9VP9Y5N9ILJX3SYR+-B+ )Z*0M+54C0>@F$/4-09 .9JM"$#YOC>0
M?&DG:ZE9UG8TWQ7N5%><'XFJ2P,(Y3FJL(=0&%MJO(-=8CRP_T$[D4O-.Z%'
M'GA=?"Z%*)*'O8@?4EYM!'Q>S"_O0#<TIGO/.GU'78(!%-6>V84 RK9\M;P!
M4*[G##GAZ.&_65'^41^ZD6%_^2P+W"<9#/OM@UQ2\D>T;,Z"+/:B%#(KUG7P
M55PF*] AN@YT'#7!!1"*477-!6UI>V*@+38@/6DG/>E;^Z3;K4R!2Y&OOFWR
M=,V+$OW[AE=.^0](W&CNW6<DQK06CFHM&LM:?V Z94SM,6M2:M39[QZ7,:V%
MHUJ+QK+6'Y=.Q5.SBC]*HY?/<9*^YDY@(H'CY.B9U&/JHTX 16WUG$<(H)BK
M/>$%4"X=>L1+.RE.S5(\BHM,YL@2W<HPK7.G*5TVMOSCTO&3^APD %':T140
MI6ZU1@ *?\(#3W=IIZNI65=#K,,DW0OPH-]5:^TMWA#*5FM7$*5MA0,HR9L,
M\.[$,C6+Y='636"'6$I:U2$ "E@W(5OJYD<$VAI:-UFGH9E90[_3(88888 L
MU@Z;!1#*5G?#0]"6MHT*VG('R@K626QFEMA!&I<ENJST-?J:BTI;WQ;\D1>%
M=-/) L/<R7L7LE&MA:-:B\:RUA^NKAY@HVYZLU$WO4>U%HYJ+1K+6G]<NA*%
MF4N4ORDP6NO'R[VOYE< @U7=$ (@K?*- ! =JM+8T1GADXJ2)J$$YG0Q:CTR
MJK5P5&O16-;Z8]+5(VS4>H2-6H^,:BT<U5HTEK7^N'3U"/N_UB,,J#0T[:%C
MM%T= *,=6@ P>.A<#^L*$?;^0L0DMZ#R03VB$X H[:@&B"+J 3<0-72\BW6E
M"#.7(F-)<@:<7%&'+C@%%)X"BMX ]9W1U2=LU/K$%!]ZO0"XXP10> HH>@/4
MN&-Z]&[<EA=/]4N)):I?A6G>?#I\>WCQ\;)^W4_Y_@J?!1CX/L1G4?-:8V>^
M><OR)BZ>DJQ$*7^47<F"4V:[HGEQL;D0^:Y^,^\A%R+?UA\W/);II@+(WQ_S
M7+Q>5!T<7A^=_0]02P,$%     @ %VY36K!@/H/6"0  ?54  !@   !X;"]W
M;W)K<VAE971S+W-H965T-2YX;6RMG&MSHS@6AO\*Y9F:FJEJMT'BYIXD56DC
MF&QMI[/M9+>VMO8#L4E"M6VR0#HS_WZ%0XPE'1^"<[XDOAR]1^B5A'@L.'DN
MRN_50Y;5UI_KU:8Z'3W4]>.GR:1:/&3KM/I8/&8;^<U=4:[36KXM[R?58YFE
MRVVA]6K";-N?K--\,SH[V7YV59Z=%$_U*M]D5Z55/:W7:?G7YVQ5/)^.G-'K
M!]_R^X>Z^6!R=O*8WF?SK+YYO"KEN\E.99FOLTV5%QNKS.Y.1^?.I\3UFP+;
MB'_FV7.U]]IJ#N6V*+XW;RZ6IR.[J5&VRA9U(Y'*?S^R6;9:-4JR'O]K14>[
MG$W!_=>OZO'VX.7!W*95-BM6_\J7]</I*!Q9R^PN?5K5WXKG/[+V@+Q&;U&L
MJNU?Z[F-M4?6XJFJBW5;6-9@G6]>_J=_M@VQ5X"Q P586X!I!;A_H !O"W ]
M0W"@@-L6</4,AZKDM04\O0 _4,!O"_A: >=0@: M$&S->FG=K3516J=G)V7Q
M;)5-M%1K7FS]W9:6CN2;IBO.ZU)^F\MR]=GLZV4D+N<BLN2K^=>_7T3GU_+-
M_%K^^R(NK^?6U]B:_7%^F8BY=7%IB7_<7%S_V_KUYO+\)KJ0H;]98^MF'EF_
M_OR;53VD9599^<:Z?BB>JG2SK#Y8/ROO3R:UK'63>[)H:_CYI8;L4 V+]5KV
MV7E=++Y;__F2K6^S\K^ S R7.5\N\Z;SIROK*LV78UFI6?J8U_(](AKAHM^R
M6H[V;&F)M-SDF_L*TQ*XUK6<2:JG\J^7(_U@M<>-",:XX&6Q612;NBQ6\IM[
MZV)39]*=&E-,>JI8R.92BTUD?]MU.K;K=&RKPP_H?$Y7Z6:16;_\%#+'^=WZ
MV],FL[C]P6(VXU9:-Q]\W'T =9D7?7^KW\RV/\Z<D\F/_=X 1(3,=[@:%IEA
M8^8Z4TU- &&>XZM!,1 4V,%4C4J BGEVR,)=F-*D?->D'&_2[#[?-%U03LS;
MQOWP.AK?TIPOVNY>G7S7TUL4K4!SROQ4/::+['0DSXE55O[(1F>__.3X]N_0
MN*(4$V;U':WR,66^A$A,,=K=&>VB1E_*Y4DN!_8Z@XQ$R\(ULZ"YE$@G<@UG
M@M#WM,%%E"PFTDEZ*JW8YNUL\U#;KI[*Q8-<,EG%G;6;Z:MFIH=L1+4&V$BD
M$Q'I",^<(9TPU/I#3)0M\0P?U6R*D?[.2/]((U]G7,A05'/@]#.C%(LHQ80/
M3,3Z69(R84(DIO2$8-<3 K0GS)K3[&J5;B^I9&\X[#ZJ,V X!V:';BXYM24-
M4381&(/53!83)4O>KZ-X&.X\#(_P$!O)(3"I,&U5.4.3#AVAE&+B+=6/*3,F
M1&**O=.=O5/4WBBOZC*_?6KLK>2%JKPDLO:OB?+VF@AT&I4>,&J)="(B'4&D
M$T^!V<AGV@21]$4IOCIVARULU-F+[1)XJ*6XZ !/J80B*B%!)12W0ON.R8MT
M;8V6]$6IMN[1*&<0&8BRQ1966-SIZ(#\\./N ]!FIQ</M"'*4B6T?3O03J9
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M>9BM_^R$YQ]\YQSI1A[@"/1%*&G"A$I--;O#0KP'"PW9% =[;M[$9(PCD[V
MR V(DUW?#74( *0<.R[7?\^'Y*;F[P)0[;PP9 ?8->\(#,<)S)LWQ<'M:G(%
M +GA51@\EDCO?H*.8*I[1'K[$Y6::GC';#C.;'#DAA<>LJZ@8C3<1!WRLDP'
MW%3I8BJAI*_>JGT=H>''$AK03JIM,U1"$960X.;&FO%4_P$QIDJ7<&#?T/30
M+3&\XRL<YRO' 3=<="AP(U6+2-4$-R&0K^\K)\V84*FI#PKHX(R+PYGAP T7
M'/+\ &A+B0G<J/*)5J@'N%&E2PB$5$\[A./B" ?W%!OH+G0GDW[--L/3#QW
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M<62_IE7C@OWP(?83$6/Q-G!J 7M5I)E<PFQL8F@_ 3A15RDM* ]Z_E>_?=[
M!35B/S6.A+([V!5,374&.-@1M\H6^(7VT17TB/WTF!<Z;+!CLPGA>;T<*'(7
M&X9AI3VYQ(*Z5"E($_??5.4%,1VJ<B\9O[G*WTG;_N?+@HZ)GXY_P+3X;+=$
MD%]3(4$!N"";&B.ZXAKV3AE1BVG"Y_:SCS.8Q+6W+7_W<0GAFI&"%#Q-_#P]
MV6[M4Y%&(M52)(D)(T^A\B$1G6BKA!R0<H_RO_;M!4\*:B=^:G_IO<8J+<']
M:_F,8!B)?CF-<?'W[JBV-<<EUNO5[#C(SB=P/]&/N=*23]<V->RG4W<<W&E3
MI? 3W"/EP=DIUMG9$NYC+ZB>'-BBEGO7+.\"_MY%'#O4=M J=URG6$AJFA<I
MR)GXR=G@/AJSR.0&.X8));LR%MB^9LK77EP"5V^@/FIH@[C8NENMVZI8T&_7
M94[!UL3/UK50T0FZ8'.>IB804 -W3'(1.PVH$G?8<>2^0RS =><*I&!F<H"9
M/19<FHVW%WNW<M81DK!7R7V7&,9E[S=WS@IATS*W1Z@*V:UK=KZ6/\V/:8?V
M<++T_"(X'66'K86:[.SW.Y40% 6$, .5K<]=2 N9':=F-UJL[(GD5&C8.=G+
M!:,QDT8 ?I\)H5]NS OR0^W!_U!+ P04    "  7;E-:U:2!OHH"  ##!P
M&    'AL+W=O<FMS:&5E=',O<VAE970W+GAM;*U5;4_;,!#^*U:&)B9MY+U
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M-ATPF<T;Z7<> ?J91*9B(CM6[P-<Z)3F=>2A4D"L70WI4TW'J"D0M[9IOE.
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M930"#2W ^X5S=?Q#"-KO'=_^'U!+ P04    "  7;E-:,=K*&3T+  !Y(
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M\U%=SCR[Y$FCR&X/S&K[MH=A,:7P6*H1E71I.M0@U> V$EEU/6+P;K0()M&
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MBQ0M;Z#UI3%^-V #[1OW\O]02P,$%     @ %VY36M-MD\:K @  MP4  !D
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MA\&"1DA>"PS(Q?<NI3)CN40=N%)_KR4&O;@3S&N=%=1@>5 Q;4T'G!(E"66
MR9SF1E4)@L-'2#KIH->L23]XHKX_X?*DTBI#8R Y3Z'[N1L\*,M$L)>M1PS2
M@5_/NRD<JEFTUTPEZK4?&2[+6MJFK]K3=BI=-,WX-[P9:3=,K[DT('!%T/CT
MG-ZI;L9$8UA5^=9<*DN-[K<%35;4+H#\*Z7LSG 7M+-Z\@=02P,$%     @
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MJ'=,WJ$;1V\F5E7>19?*DB?[84&7(&H70-]72MG]Q&W07JOC_P!02P,$%
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MVM%7I9@V/BGX"HJ@V@LK82;/5X)<$HL%;331"-CJC)(YI'*V@.](/L++.!F
M-9:. JTXLA/\:P/@847[&]#)J>2; .QMHDAQ5G'K-^3'"M$PM6.*KUU-F[Z.
MSO9X[L.;F\_7#):*&%6#5S:1&D4#/P0L5\$O8  0")Q"$E8H*509="FU805V
M*@BEF[YM(0-_.')LJRWCUDJH&;&;+EPL%4J*E8!NXN,<XL&AI($7H$O::FH-
M]B?O&\.!J*30$+I&U;Y)!'P":(V]72S9M\7RN>G]V"9?QW;X6F0M7'4%6Z!)
MPEF4EA7)&K]@RM:$#+@M!>&#'.WJL D5G+2B,M9'1) *C/H6FT[>_\K0O8.Y
M"Q <%&T$MTP01;-?:BW8?!()=L3N0CAO&C#N='(O*B_*5%@VG0>AV6X^\=Q4
M="1GJ,3LD6RH+0P%4I7B.O@2G@"H(V_$4R6CVXQ0BM3 -4&>"YR*)B?"";H.
MQP(H5R!]7!(S*00H%;V#<IBMV=;0V4'?T'/#;4Y:+J5%X S<(DMX!7Y:P?"Z
MHD)XQSX,)Y-)@L=4)#W=K 9,$;S@Q:X16[$F'ZHZ53)#BH.-"%Z:GA! ^XCY
M"A%".UAQ< MQF466(M:7M:4E;7;RB96Q?X;@).A^T:6V P:T\##?#4+?WL.]
M!$+)='J0-+CA7([$=)Y0>,>FP_G>+,C0\^'A/ALF#;5A0%*;&+)6=49UJ*A8
MI[/]3J.FY?S5 SX<S)L#9D!U/T'Z)2\YR-YR<->FLU R7\N36BMH_"044ZX"
M;VR#]BP?DS5B_X[-A_,/,S;:Z6&DP^.'"!+$L7B_J(.-A> *[+\E)23.TO(R
M-H60]]5[3 V.(6%!?PK\"@K(-JV +Z3-WT?.#5K(-'1)B4DDV(AY3I9UF53&
M@]^HTKL6%"I7ZERN9%X3!<0F&C)VNC])0"%)[(H!.9+FK3ZVU1>V];2F;<Z6
M$4ZAK5&*V'7$_GS6ZV"^:WW>33LB.YD344 $E27!+2$W($VS +4!# #$.&!;
M)?_MRIZCCE 8P@5&ILA1\WD5Z:WAI+UM,6 2W [$2[F1=+FTPV^[YA<\CS3P
M%-H"BA:8'APVF7MX\*PN:!!AS3@7PP*3OR51(J&W6UWHA7&FB51-S6,V.0K4
MBXG&6FIRK<L82\/WZ1&:;#L^Y.1WOCM(M*D?[@)N-[4QV-2*6T7X<;7YEWH(
MC.\LBDD6CH:BVH<&V'63F'/#+L&Z#ZUDQ64WWK7!0>+$(SHX0F;T\7H-J-;J
MML_OVDKH@5K_J7',B/ULUA"Q0U#+4LL%<@W8?:GS99@4)/7*E5&K"#1W#O,0
MLBV)/;_3&<<YMQ7H)73?.V" PS"'8&#"5)L*OQ:BB4H0:.: +9@4F^$6,5K&
MN8FT)F$9@0W=V<(M7$5BFCMRC'(>N=V.L6$P0'T3."R7&$60+&@CG2F828DF
MG/!>Q6F)EQB$FML.&B"&19'WT$2NQPRAL80\Y_D7#-7-#>E9IC85!^+(:#9"
MV%*>*M&<07 _:K/6K9WM -./35]]9XZ,@RR(3)J<ABAXWHZ'TC7PC5ZZ.XU[
M5U_< Y;A@N_"\.?C+;A[V_T/X2Q>G;?B\1\0-]PNB?V56&#K9/0#[I V7NKC
M CP?+M*I\;ATA$>4//B/!/!]8<"WS8(.Z/ZS<OH?4$L#!!0    ( !=N4UJB
M C4EA@<  +P1   9    >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;+58VW+;
M.!)]YU>@--FII$JV;KYDXTN5XR2U?L@D97MVMVIK'R"R*2$A 0T 6M9\_9YN
M4!1]B3,O^Q!' KL;?3NGFSI=._\]+(FBNJ\K&\X&RQA7[T:CD"^IUF'?K<CB
M2>E\K2.^^L4HK#SI0I3J:C0=CX]&M39V<'XJ9U_]^:EK8F4L??4J-'6M_>8]
M56Y]-I@,M@?79K&,?# Z/UWI!=U0_'WUU>/;J+-2F)IL,,XJ3^79X&+R[OT!
MRXO /PVM0^^SXDCFSGWG+U?%V6#,#E%%>60+&O_=T255%1N"&W^T-@?=E:S8
M_[RU_DEB1RQS'>C25?\R15R>#=X.5$&E;JIX[=;_H#:>0[:7NRK(7[5.LK/9
M0.5-B*YNE>%!;6SZ7]^W>>@IO!W_0&':*DS%[W21>/E!1WU^ZMU:>9:&-?X@
MH8HVG#.6BW(3/9X:Z,7SJ]\NOWS^J&XO_OWQYG0489'/1WFK_3YI3W^@?:0^
M.QN707VT!14/]4?PI'-GNG7G_?1%@Q\HWU>SR5!-Q].#%^S-NO!F8N_P1^'9
MW-6D;O6]^F!"7KG0>%+_N9B'Z-$0_WTNY&1Q]KQ%!LF[L-(YG0V @D#^C@;G
MO_XR.1J?O.#O0>?OP4O6?UJ.E[5_^W+[,9M,U)[JVU%7-M-Y[GRA;4[HK[A4
M%S>7ZOA@O#<]'@_5K[^\G4[')[M<49"SR>0$NI&\J=4UK9R/QBY$>'(R5'%)
MZM+5*VTWR@0 ](_&>"J4CO*(;*%<J4CG2V62D6R%OZY0T0$W.$$[D\C.*42%
M?P8H(]8R,2AM;:,K165)@EP5443/ AJF]6I5;:",V^0,-C>D_5YT>X48\86Q
M8!G<+5$YKU#\L*]NEY2A;@ M@A&;= ^&"Z1>0V9.EDH3WW!$NO@&_"$B4)^X
M*<+B#OL85I2;TN2*[LC&,%2FA&>;X2X3\&E.JD#?>80+=SWE;F'-GWAF;,8F
MV\RH-C,Z\$4;Y?*\\?OJ4WMQ,/>J3D C!IH"3*B>D^^@(CG!A]G#NO"%OI#K
M) O]<!'"*S4=CB>3S%@QDN'ZG#5;YU^IV7 \.VH?S_:SK3]QZ8G^3QX='TTS
MJ&:OU&0X.SI20Z[6*K5 M9'Z[?(AE_2\23>OO+LS,C5,"LB;0-*-&I3J/<K5
MOYXEG.5#<>#OX[$XH)G<R?N'OCX2G@PGR%\2_[GIP\GQ7S<]/3A\$OR7>646
MFL=9D*[DC%9&STUEX@;=$UQN-+>L@)SS_HQ3N_0L4? Y$4_7HLFI&.(9,.B-
M].H6(Z5W=99@*N (DO4FXM(_Q1?VUV)_P*8 ++(*0TWEVOL-O%QK7P!XH)SL
MUJT &!"/8N[,O0'R4906%V*+JQF6KBH2S%5-FCF[YB!TC%!I .\M)$N W"+F
M2H6(P$6J;XUM]"W 4Z0@6[E@4A:C_H[X88V;,(\=:M,Y.A]U=1[<)R3##$2Q
M\7:+31=Z:4F:.Y /H2P);V]3-?B$16KG::\RWU'3/5"8W;,N9DD[0 2K%/QH
MT SP2H,E4Y;G&[;&Z=4-;O:P2<CK!P-*0HUSXF+&-=>S?^M?BG$7698@U875
M)ZU>-@NU:GQH-'(*8QV5H:PQ>0L2X:4M=3E$T&J-[=G:9@V-T6MA&21;F8P9
M6=>N287[28NI!\(IH+*QA9Y7E.Q*C[]I@?/0&Q;?!CRG7#>HJ\0N,Q[TCK2
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MSCX=GDVXRH07ITM_?9AJ1Y<1_YC1[0\-"]#WF2::]0L;:.Z3)_\ 4$L#!!0
M   ( !=N4UI#3LB*V0(  !4&   9    >&PO=V]R:W-H965T<R]S:&5E=#(Q
M+GAM;(U52U/;,!"^^U?LF XG)GZ$1PI)9@BD4PY02H >.CTH]B;68$E&DF/H
MK^]*3DPZA4POUFJU^^U^*^UZV"C]9 I$"R^BE&84%M96IU%DL@(%,SU5H:23
MA=*"6=KJ960JC2SW3J*,TC@^C@3C,AP/O>Y6CX>JMB67>*O!U$(P_3K!4C6C
M, DWBCN^+*Q31.-AQ98X0_M0W6K:11U*S@5*PY4$C8M1>)Z<3@Z=O3=XY-B8
M+1D<D[E23VYSE8_"V"6$)6;6(3!:5GB!9>F *(WG-6;8A72.V_(&_8OG3ESF
MS."%*G_PW!:C<!!"C@M6E_9.-5]QS>?(X66J-/X+36N;?@XAJXU58NU,&0@N
MVY6]K.NPY3"(/W!(UPZIS[L-Y+.\9):-AUHUH)TUH3G!4_7>E!R7[E)F5M,I
M)S\[GCU,9M/O#].;>Y@^TG<VC"S!NL,H6T-,6HCT XACN%;2%@:F,L?\;_^(
MTNER2C<Y3=*=@)>8]:"?'$ :IX<[\/H=Q[['._J(8STW^%RCM#!=T=? S_.Y
ML9I>Q*_WZ+9H_??17)><FHIE. JI#0SJ%8;C_;WD.#[;D>MAE^OA+O3_NX_=
M$#??[J=!TH?]O4&:)&?P#R3<%QA<*%$Q^0H%,X K5M;,8DZ2KX\MF 659;76
MI#1O];,*Z'90S%%W-P1,YN2A5;TL:$7("<H+F:(7(0U!D&14R7,?9,$EDQEG
M96 L*80/V:!&X,;4F/?@2@;.?RMPA9JK'.K*I= %40L"(_[+ Z_;<-)8U3HC
M9A3L)# %HWL*R#930M DH*;*GH 8,M(8ZU ^01(/@J;@61$T5!%6VT)I_IL
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ML!0O;DVN4ZW<Z>N+"E C@(O4HWG':(;/H)F*&U-6&R<^E)G*#O=? ,D-W<-
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M+H#W*V.J\ <1-->1W_X/4$L#!!0    ( !=N4UKLLLJ7E 0  "\,   9
M>&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;+U7ZV_;-A#_KK_BX Y%"VC1^^$\
M##A.TQE8$B-.%@S#/C 2;7.52)>DXO2_WY&272=UW'38]H7'U]W][D6=CE="
M?E(+2C4\UA57)[V%ULM#SU/%@M9$'8@EY7@R$[(F&I=R[JFEI*2T3'7EA;Z?
M>C5AO#<XMGL3.3@6C:X8IQ,)JJEK(K^<TDJL3GI!;[UQS>8+;3:\P?&2S.F4
MZMOE1.+*VT@I64VY8H*#I+.3WC X/$W,?7OA-T97:FL.QI)[(3Z9Q;@\Z?D&
M$*UHH8T$@N2!CFA5&4$(XW,GL[=1:1BWYVOIY]9VM.6>*#H2U1TK]>*DE_>@
MI#/25/I:K'ZAG3T68"$J94=8M7>3L =%H[2H.V9$4#/>4O+8^6&+(?=?8 @[
MAM#B;A59E&=$D\&Q%"N0YC9*,Q-KJN5&<(R;H$RUQ%.&?'HPO;VX&%[_#E?G
M,!U_O!R?CT?#RQL8CD97MY<WX\N/,+GZ=3P:?YC"NQMR7U'U_MC3J-BP>T6G
MY+15$KZ@)(4+P?5"P0=>TO(IOX> -ZC#->K3<*_ ,UH<0!2X$/IAO$=>M/%"
M9.4E+\@;%H5HN&9\#A-1L8)1!7\,[Y66F#5_[C*XE1?MEF<JZ5 M24%/>E@J
MBLH'VAN\?1.D_M$>M/$&;;Q/^F"*E5DV%04Q@R71C'(-,TJQ1AXH;RC\#)SJ
M7:#WBMT->JW+V:?+P0)Q](+"S4+BV7:P'1,A$Z;(&8FZIK)@I'+&7#62\()Z
M%X1C[9<P(I+"3Q"X019;&L:1<T%+5N"!UTY8"9$?0)C'SAV6.I7J[9L\#+(C
M(QI?*45,H7L3/!"<5##F?S7R"\1NFD<X]OW,N4*4$J5G>6K'S)FT1CGG"/RZ
M-<HU-AGG%FB(R8 &A9$*WR\#60'A)91,V911"#9S^[$!G;MA&#B=$*2%F'-F
MWYYW(V&RJZ'E>UC[:LH>?\A3\,Q5H1MEN:5QD.YP59*&D"3)#[FJ[T9Y"('O
M^G'<^2IR [^/8YX'_X:O@L2-H\!,4C?OI["G'))-.22O+@=*)#=5O$3D:H'^
MV%4&>\5]OPR^T>'8M'?J-IC4!!.^W7)NA$;?F-@*[DRU*#[!J")*.:-N$[Y[
MPSDEBA7.98/I0;20AXXIE7[:EDP>^TBM=R,W2_J6)F&"-.D[9Y0+_("T;'?V
M:X6@R -*FM/6$ 7XV58:8V;L2[%N4APC/X((*RC%R&7=B.L."^.%J*EU1M%:
M846A3O_ 0O$/PKXE?FY)TI'$$DS=,U8U!LH3@,_5&H581(A6,_P*.=8O,(+6
M2T&8@TWP\&A[WKI\6S!@&X/Y:!6N ZF^1M(J"SJU29I8M6M\^RQ]9F*\M@V+
M_&E>/-_XK[(B<?V^P12[668\C1:9ARI/$TLCNQF$R3]*B[Y-BV 3GSCOQM>E
M1=ZF19:VK@L-DC4)6M=%T8MI\43M_Y<6\28M$/=KTR*+MTT,PLZVG:^>M]7$
M82#GME558%_.MI_;[&ZZX6';!'Z]WK;2%T3.&5=0T1FR(@Q\\63;GK8++9:V
M);P7&AM,.UU@1T^EN8#G,R'T>F$4;/X1!G\#4$L#!!0    ( !=N4UJGW3?'
MC0,  "H)   9    >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;+U6;8_:.!#^
MGE]AI:>JE7*;]P#+BY1E:;NG0E<L[7TXW0>3#! UL:GM+.V_O[$#*50L0KK3
M?8D]XYEGGAE[8@]V7'R5&P!%OE<EDT-[H]3VUG5EMH&*RAN^!88K*RXJJE 4
M:U=N!=#<.%6E&WA>XE:T8/9H8'2/8C3@M2H+!H^"R+JJJ/AQ!R7?#6W?/BCF
MQ7JCM,(=#;9T#4^@/F\?!4INBY(7%3!9<$8$K(9VZM_>Q=K>&'PI8">/YD1G
MLN3\JQ8>\J'M:4)00J8T L7A&<90EAH(:7S;8]IM2.UX/#^@OS.Y8RY+*F',
MRS^+7&V&=M<F.:QH7:HYWWV ?3Z&8,9+:;YDM[?U;)+54O%J[XP,JH(U(_V^
MK\,U#L'>(3"\FT"&Y3U5=#00?$>$MD8T/3&I&F\D5S"]*4]*X&J!?FJ4CL>?
M/L\63V0^&4\>OJ1W'R<.F4[N'\;IQR,=26?W9)K.TO>3Z62V,.*GQ8?)G+R;
M3(Z=R9L%798@WPY<A?1T$#?;4[EKJ 0O4$G(E#.UD63"<LA/_5U,J\TM..1V
M%UP$O(?LAH2^0P(OB"[@A6VM0H,7OX WAPR*9Y,>^2M=2B7P3/U]+M$&)SR/
MH_OL5FYI!D,;&TF"> 9[]/J5GWC]"RRCEF5T"7WTA'V;UR40OB*K@E&6%6R-
M_7/@3AAG62T$,$5HB4V)%D"PO4DF("\4*;F4YY*Z&/9\4@<NUK_A8N$^0K4$
M81WVTGHOM/[G?I#TX&S]XHQ;-0-EI5G&:Z:D=13[-Q(Z21+B&'1"(X4][ZSE
M[TBYI IRLJ5"_4#;Q,//ZU?=P _Z1K2F&#*CY6F ('2B7G)BVJBL*67XS\._
MF[(HRPE7&Q!D!4CW!"".'3_JXL0/]ERCP(FZ\77^*\&KEGK5$"1;?6J+#"W?
M:%:!UW\<&WJ=OC0*O_]6!TPPH*:>.+UN#\>>DW0ZUA\U ROT_MM]B)S \TW,
MQ$A>&+]8SUXO^+6>J+JZGI$3!E%3S["C-S'RG5X<_0_UC)U>)S;U]'W/U+.;
MQ.1"P\=MP\?7-WRM:@'(\1E8#>>Z^"+6%5U\$L#"4V#.")X,G'9($ 5ZTB5=
MH^B1*+(67&&9L *.%WMG$W:/[J\*Q-K<TI*8H])<9:VV?0BDS?WWT[QY14RI
M6!=,DA)6Z.K==#!?T=S,C:#XUMR&2Z[P;C73#3YF0&@#7%]QK@Z"#M ^CT;_
M %!+ P04    "  7;E-:_'C3@5L$  !("P  &0   'AL+W=O<FMS:&5E=',O
M<VAE970R-2YX;6R55EMOHSH0?O>O&+$7;:5L B00FDTBI;<]E79[HK;G[+,#
M0V(M8!:;IOWW9PR$I&V*>E[ 8WN^N8]GNI7%;[5!U/"8)IF:61NM\\E@H,(-
MIESU98X9G<2R2+DFLE@/5%X@CRJF-!FXMNT/4BXR:SZM]I;%?"I+G8@,EP6H
M,DUY\72&B=S.+,?:;=R*]4:;C<%\FO,UWJ'^)U\61 U:E$BDF"DA,R@PGED+
M9W(V-O>K"_\*W*J#-1A+5E+^-L1U-+-LHQ F&&J#P.GW@.>8) :(U/C38%JM
M2,-XN-ZA7U6VDRTKKO!<)K]$I#<S*[ @PIB7B;Z5V[^PL<<S>*%,5/6%;7W7
M\RP(2Z5EVC"3!JG(ZC]_;/QPP!#8;S"X#8-;Z5T+JK2\X)K/IX7<0F%N$YI9
M5*96W*2<R$Q0[G1!IX+X]/SOY>7MXO[ZYCLL;B[@ZOIF<7-NJ!^7B[O+._AR
MSU<)JI/I0),PPS((&^"S&MA] ]B'GS+3&P676831<_X!*=EJZNXT/7,[ 2\P
M[,/0Z8%KNZ,.O&%K^;#"\]ZR/,>":Y&M89%%<"4RGH6&^H$49'7,X!IO>!S/
M5,]$Y3S$F47EH;!X0&O^^8/CV]\ZM!VUVHZZT.=W5(U1F2#(&"@@"FG5&I!4
M*D,B^$HD0C]1@NBRH,4Q*SKE'+=B)YS]+^'L?HO) [)]'ICKK=M9Y>B]XQMZ
MR9^HYK5B%&8//H+7\X(1_=W1R&SYM#$,@ATY-N38 =\Q5$"4[9S"YP^!Z[C?
MS-8IC'K!V&^W[C=(O2O66(#K]X*1TYXLC;F99@\\*1$BH4)99AJ^. 1P.H03
M6GEPPNZEY@FKC#ZP^2,,@YX3^$;AX0@Z NZU ??>'?!MU5LP OY SELC=4/3
M;UOO YF3'HOU^T2P]XI@^^ U4?\*3\@+!8[=]UD=2FR<LSMR^P[[U:"S18-^
ML7/O+=?X&M;O>_#I!=ZP[\.G#L?ZK6/]3JO/99K+S*1874L&&Q_ID5-XS(6=
M8,?+92^!O93 Z"EA>H.@Q".D=6&@:9!@VAMU-Y.S(]/BAB^] J%4VB1:SSFU
M34'T M][X2-S9<(ND'0)!3?/7JM!!/BG%+FI+6)V;+O^LNN,(HM*,WHBGV>U
MH$!XX(R:E(]K2?!,&<<V->HXG2D_;B,S[L[',L\3-!KR!$*N-A#3S  BJV>/
M>@Q(N,E2+9N^<RQDG5+>Z' 'HMD[17?'TCQ5[)R06,Y%!(0#/#4IKP@U3$IS
M3V1@^%."*XM*^CXE#Z(P@6-)T6JI("YD^KHCFQ3QJ,%5*>./V+[3OF2-V\>O
M975<M_ZR:D[[*N.O):4OSP[SB--38,IHI:E5U/;@8[CA&56X,;BV1*X2L:Y\
MJ":O2YVT\TZ-J!YUX:-9-#B8;E(LUM4,IZ#J'_6@T^ZV8^*BGH[VU^L9\R<O
MUB*CQPIC8K7[8VJ013VWU826>34KK:2FR:M:;FC4Q<)<H/-82KTCC(!V>)[_
M!U!+ P04    "  7;E-:;!LXDG<"  !.!0  &0   'AL+W=O<FMS:&5E=',O
M<VAE970R-BYX;6Q]5%UOVC 4?<^OL+)IVB3:?$%A'40J;:<QJ1TJ7?LP[<$D
M%V+5L3/;*>V_W[434BH!+[&O?<_QN<X]'F^D>M(%@"$O)1=ZXA?&5.=!H+,"
M2JI/904"=U92E=1@J-:!KA30W(%*'L1A>!:4E D_';NUN4K'LC:<"9@KHNNR
MI.IU"EQN)G[D;Q?NV+HP=B%(QQ5=PP+,[VJN, HZEIR5(#23@BA83?R+Z'S:
MM_DNX8'!1N_,B:UD*>63#6;YQ ^M(."0&<M <7B&2^#<$J&,?RVGWQUI@;OS
M+?MW5SO6LJ0:+B5_9+DI)O[()SFL:,W-G=S\@+:>@>7+)-?N2S9-;A+[)*NU
MD64+1@4E$\U(7]I[V &,P@. N 7$3G=SD%-Y10U-QTINB++9R&8GKE2'1G%,
MV)^R, IW&>),.KM]N+Z]_W4WNUZ0S_=TR4%_&0<&F>U^D+4LTX8E/L!R1FZD
M,(4FUR*'_#T^0$6=K'@K:QH?);R"[)0D48_$8=P_PI=T92:.;W"H3/$,PDCU
M2JZ8SKC4M0+RYV*IC<*^^+NOXH8PV4]HO7*N*YK!Q$<S:%#/X*>?/D1GX;<C
M<ON=W/XQ]G2!WLMK#D2N"&NE,]#[9!XEVB]SR^Z]9_?PTJ%<@O+LQ?^L!7A)
MV//FM<H*[/O<JZ@RND<R6592($H3*G*T<U5QA)./).X-1DDSQGWO$>UXPL1)
MI60&6I-X."#1U\B[EX9R;_9VL$.,!B,W#J,!V7>#P4Z/EZ#6SLD:Q=3"-.W>
MK7:/Q47CD;?TYJ6YH6K-A"8<5@@-3X?8-:IQ;Q,863G'+*5!_[EI@0\>*)N
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M2X,=IYYBQC#GU@#/,RG-;F$=['\:HW]02P,$%     @ %VY36A]XC'3\ P
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MHV+%/Q?#BU:>C^'!M/,&T\Z,-]LE$KF5R*O#FX+<(%J9VP!F\RF9?-V6&PN
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MFP@[/EW>S^<7MW^!FRNPG'V\GEW-_(OK.W#A^S?WUW>SZX]@<?-IYL_")?@
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M\RX[>GM$4<D+0_&-K9X+KG0MMLU$/WXHC(,>7W&N#H8IR.5S&OP&4$L#!!0
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MVG%!LQ(L*\@24OSC+Z4.1P#)TPRP2H!5!W3. .P28#\U0Z<$=)Z:H5L"NG6
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M:HKP?#>8#R1+LQW8A$FUG\M.%VH'#5P_H.[/&).O [VI*_;D@W]02P,$%
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M$YCBA*IGOKR#-4_-^ LYE>D5+3/;AF.A,)&*1VNQSB B++OCU;H.6P*W^H;
M6PN\?Q7X:X&?@F:9I5@]K'#0%GR)A+'6WLP@K4VJUC2$F;<X5$*O$JU3P>/H
MKO^,!@^C[L/MX.J^C[K#87\T1*<]4)A0B=PS=(Y>ACUT>G*&3A!A:#3GB<1L
M(MNVTAD8/W:XCG:51?/>B-:#\ +Y;@5YCE<MD%^7RS\F3,N=(KFMN7-X+X?W
M4G^U-_S=<CY9$DJ1ID$#IC";D3$%U)42E$0](D/*92( ?>N.I1+ZF_M>!)U%
M\8NCF'UX*6,<0L?2&TV"6( 5O'_GUIT/127X3\[^*HB?%\0O\Q[<$$84G-_K
MG;5?D KJKV*]^_12-^)"D5_8[,0*^@I8H$<&1:7)XM73>.9$600-SV_;BVWB
MTIP.)*[FQ-5C$8^6O(@XBU?=(J[7G!WBTIP.)*[EQ+6C$<\%%+[EVAZS[[D[
MS*59'<A<SYGKQV*^X8DH0J[O([N-'>32I Y$;N3(C:,A:TT1<J, N;J#7)K4
M@<C-'+EY!&0\52#*P9M[X*[3]';(2W,[D+R5D[=*R??^717TH#O T_XJI,F$
ML!G:_.K.BOA:>X>T7W5V/^9](Z_9^'.P97G;6YV(Z0(_83$C3"(*4RUS+AKZ
M%!!99Y5-%(_3YF3,E6YUTN%<-Z,@C(%>GW*N-A/3[^3M;? ;4$L#!!0    (
M !=N4UH5S< ^-0,  )\-   9    >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM
M;+5776_:,!3]*U9639VT-D#"QQ@@ 4E7I+9#I=T>ICT8<B%6$SNS#;3[];.=
M-(629MV6O8#MG'.N[SVQ8_>VC-^)$$"B^SBBHF^%4B9=VQ:+$&(L3ED"5#U9
M,AYCJ;I\98N$ PX,*8[L1JW6LF-,J#7HF;$I'_386D:$PI0CL8YCS!]&$+%M
MWZI;CP/79!5*/6 />@E>P0SD;3+EJF?G*@&)@0K"*.*P[%O#>M?O:+P!?"&P
M%3MMI#.9,W:G.Y.@;]7TA"""A=0*6/UM8 Q1I(74-'YDFE8>4A-WVX_J9R9W
ME<L<"QBSZ"L)9-BW.A8*8(G7D;QFVW/(\FEJO06+A/E%VQ3;^F"AQ5I(%F=D
M-8.8T/0?WV=UV"$HG6)"(R,TGA/<%PA.1G!>&\'-".YK(S0S@DG=3G,WA?.P
MQ(,>9UO$-5JIZ8:IOF&K>A&JWY.9Y.HI43PY^'QS[E^CR=7-\.K39'3AH^%L
MYM_,T+$'$I-(H"O,.=9FOD,GZ';FH>.C=^@($8IN0K86F :B9TLU$ZUG+[*H
MHS1JXX6H#KID5(8"^32 H(#OE?-;)7Q;52 O0^.Q#*-&J: 'BU/DU-^C1JWA
M%LQG_'JZ4Y3.OT7W_SKZ7C&<_)UPC)[S@MX42Z!2H"$-T)@E#UPO-H&^74(\
M!_Z]R.Y20;W7=46"%]"WU&8F@&_ &KQ]4V_5/A;5NDHQKTHQOR*Q/5?<W!77
MJ#=?<.6,4"+AY$(MQ0!-J,1T1>81H*$0H-VY4'@TD1"+0H?<*AVJ4LRK4LRO
M2&S/H6;N4+-TW0QCQB7YB<T7D"T/32KR)95L&4G]4=\,G';/WNQ6^Q#B.OL0
M[Q#2;NU#_$-(YPFREV\KS[=5FN_8?)Z HVN(3-(B)$GY/E$J^*=O895B7I5B
M?D5B>ZZT<U?:_W.?:%?I4)5B7I5B?D5B>PYU<H<ZU>\3G8/EVZP]VR=^#_$.
M(?7:,XQ?CDDSMG=.G&H'6)FCOD +MJ8R/6CDH_EM8F@.T<_&1_7NN%XP[JG;
M1WI9>))/KRZ7F*\(%2B"I0I5.VVKA<#3ZT#:D2PQY]TYDVI[,LU0W:" :X!Z
MOF1,/G9T@/Q.-O@%4$L#!!0    ( !=N4UH=05IX.@,  'T)   9    >&PO
M=V]R:W-H965T<R]S:&5E=#0U+GAM;*V646_:,!#'OXJ53=,FK0T)(4 'D5K:
M:4S=6D&[/4Q[,,E!K#EQ9CNE_?8[)VE$P41]V O8R=WY]S^??9ELA?RC4@!-
M'C.>JZF3:EV<N:Z*4\BH.A4%Y/AF+61&-4[EQE6%!)I43AEW_5XO=#/*<B>:
M5,]N9301I>8LAUM)5)EE5#Y= !?;J>,YSP\6;)-J\\"-)@7=P!+T?7$K<>:V
M41*60:Z8R(F$]=0Y]\YF8V-?&?Q@L%4[8V*4K(3X8R;S9.KT#!!PB+6)0/'O
M 6; N0F$&'^;F$Z[I''<'3]'_UQI1RTKJF F^$^6Z'3JC!R2P)J67"_$]@LT
M>@8F7BRXJG[)MK'M.20NE199XXP$&<OK?_K8Y&''P0N../B-@_]:AW[CT*^$
MUF25K$NJ:3218DNDL<9H9E#EIO)&-2PWN[C4$M\R]-/1S=V7JP69W2\65]_O
MR/7\_&)^/;^;7RW)";G1*4@R*Z6$7)-K1E>,,\U X;OWEZ IX^H#CN^7E^3]
MVP_D+6$YN4M%J6B>J(FKD<^LXL8-RT7-XA]AN83XE/2]C\3O^8'%?=;M_K7,
MT;UG<W<Q*VUJ_#8U?A5O<"3>+7VB*XYJ40TYCV-94J[(K_.5TA*K[[=-8!VQ
M;X]H3N29*F@,4P>/G +Y $[T[HT7]C[9Y/ZG8"_$]UOQ_:[H4:47$J(HIQ*W
M_".)198Q94YOG9&"/DG!.='T$:R;72\05@N8R^0A\@:!-W$?=C4>&@7A<-0:
MO6 /6O:@DWU)S:XAEV$T6VBCJT,$NW2C_AZ<Q68\M+,-6K9!)]MG2$!27F50
M::H!SPQF%NHT=@%WQK57 [%5U>!05!!Z=E5AJRKLSCCP]<FZS!.LF!0HURG*
M4J6D>0RDP;%I"@]9PM'>)EAL_".XPQ9WV(TKUGI+)>"=%F-#LI?O\&!=?^#O
ML74N\ZH]><$_:OE'G?SUQ;R!O"TEFF!O8.9B,EV1P&-Q5-?H,)_#@Z1;C()1
M8,_ZN*4>OX+:TDYLE..#>Z$_]O;3?V@T' ?[M>'N-$?S8?*-R@T6)^&P1K?>
MZ1 /A*R;?3W1HJCZY4IH[+[5$&L:CZTQP/=K(?3SQ+3@]HLK^@=02P,$%
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MBA4 4 0K2R2$:IO-?>6-X27=AO>U9J"B:7^#:]NO2J\*PO(NP - Q+1M62Y
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MUV"V<L'\R^K^9N5[J_F-MP8?7<0ACAE804JA'#2?P"_@Z]H%'S]\ BR"%#&
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M;-^#.^^C:/6>BM;_)1P^ %!+ P04    "  7;E-:EXJ[',     3 @  "P
M %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=
MOZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'
MTD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[P
MS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T
M>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    ( !=N4UHWC\FY<00
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M.=K<TTH7]3&?M7^@IY]02P$"% ,4    "  7;E-:!T%-8H$   "Q    $
M            @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( !=N
M4UIJN."<\    "L"   1              "  :\   !D;V-0<F]P<R]C;W)E
M+GAM;%!+ 0(4 Q0    ( !=N4UJ97)PC$ 8  )PG   3              "
M <X!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ %VY36MW\N?A(
M!@  120  !@              ("!#P@  'AL+W=O<FMS:&5E=',O<VAE970Q
M+GAM;%!+ 0(4 Q0    ( !=N4UIWNQF3KPD  +<T   8              "
M@8T.  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    "  7;E-:
M>>$H--($   :&0  &               @(%R&   >&PO=V]R:W-H965T<R]S
M:&5E=#,N>&UL4$L! A0#%     @ %VY36J9S9A;H"0  2CH  !@
M     ("!>AT  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    (
M !=N4UJP8#Z#U@D  'U5   8              " @9@G  !X;"]W;W)K<VAE
M971S+W-H965T-2YX;6Q02P$"% ,4    "  7;E-:*?<>72T'  #@'@  &
M            @(&D,0  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#
M%     @ %VY36M6D@;Z* @  PP<  !@              ("!!SD  'AL+W=O
M<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( !=N4UH+,E4;+0(  %4%
M   8              " @<<[  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q0
M2P$"% ,4    "  7;E-:U:$Y$@P(  #-$P  &               @($J/@
M>&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ %VY36F5T7H)E
M#P  ^R@  !D              ("!;$8  'AL+W=O<FMS:&5E=',O<VAE970Q
M,"YX;6Q02P$"% ,4    "  7;E-:,=K*&3T+  !Y(   &0
M@($(5@  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( !=N
M4UI'3$3F;@8  .\.   9              " @7QA  !X;"]W;W)K<VAE971S
M+W-H965T,3(N>&UL4$L! A0#%     @ %VY36M-MD\:K @  MP4  !D
M         ("!(6@  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4
M    "  7;E-:O,2[L6X$  #*"P  &0              @($#:P  >&PO=V]R
M:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( !=N4UHM^@K5-P,  ,(&
M   9              " @:AO  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL
M4$L! A0#%     @ %VY36J)*JT#T!   '@T  !D              ("!%G,
M 'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    "  7;E-:K4<1
M310#  !B!P  &0              @(%!>   >&PO=V]R:W-H965T<R]S:&5E
M=#$W+GAM;%!+ 0(4 Q0    ( !=N4UH13X8I?0<  &41   9
M  " @8Q[  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @
M%VY36J("-26&!P  O!$  !D              ("!0(,  'AL+W=O<FMS:&5E
M=',O<VAE970Q.2YX;6Q02P$"% ,4    "  7;E-:15&B/\L%  !;#@  &0
M            @(']B@  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4
M Q0    ( !=N4UI#3LB*V0(  !4&   9              " @?^0  !X;"]W
M;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ %VY36KV:W<#W#P
MFBP  !D              ("!#Y0  'AL+W=O<FMS:&5E=',O<VAE970R,BYX
M;6Q02P$"% ,4    "  7;E-:[++*EY0$   O#   &0              @($]
MI   >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( !=N4UJG
MW3?'C0,  "H)   9              " @0BI  !X;"]W;W)K<VAE971S+W-H
M965T,C0N>&UL4$L! A0#%     @ %VY36OQXTX%;!   2 L  !D
M     ("!S*P  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4
M"  7;E-:;!LXDG<"  !.!0  &0              @(%>L0  >&PO=V]R:W-H
M965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( !=N4UK F6E&U ,  (<)   9
M              " @0RT  !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L!
M A0#%     @ %VY36N*@L*O^ @  0 8  !D              ("!%[@  'AL
M+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4    "  7;E-:'WB,=/P#
M  #>"@  &0              @(%,NP  >&PO=V]R:W-H965T<R]S:&5E=#(Y
M+GAM;%!+ 0(4 Q0    ( !=N4UH!US[;/ ,  "H*   9              "
M@7^_  !X;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @ %VY3
M6E;Q+K.'!   DAD  !D              ("!\L(  'AL+W=O<FMS:&5E=',O
M<VAE970S,2YX;6Q02P$"% ,4    "  7;E-:\^O\MF\%  !W&@  &0
M        @(&PQP  >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0
M   ( !=N4UKG(.K.: ,  ,,)   9              " @5;-  !X;"]W;W)K
M<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @ %VY36@+Q?,Q6!   JQ0
M !D              ("!]=   'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q0
M2P$"% ,4    "  7;E-:B=R.T*0"  !:!P  &0              @(&"U0
M>&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( !=N4UH3JX.Z
MN@,  "(.   9              " @5W8  !X;"]W;W)K<VAE971S+W-H965T
M,S8N>&UL4$L! A0#%     @ %VY36O@^<[0Y P  GPL  !D
M ("!3MP  'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4    "  7
M;E-:8)%%0F@"  !;!@  &0              @(&^WP  >&PO=V]R:W-H965T
M<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    ( !=N4UHGXILLYP(  )4(   9
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M970T,RYX;6Q02P$"% ,4    "  7;E-:%<W /C4#  "?#0  &0
M    @(%-]   >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    (
M !=N4UH=05IX.@,  'T)   9              " @;GW  !X;"]W;W)K<VAE
M971S+W-H965T-#4N>&UL4$L! A0#%     @ %VY36DK<)+=Z!0  ]QL  !D
M             ("!*OL  'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"
M% ,4    "  7;E-:]2!AX8H#  "/"P  &0              @(';  $ >&PO
M=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( !=N4UJPT9]*BP0
M 'L9   9              " @9P$ 0!X;"]W;W)K<VAE971S+W-H965T-#@N
M>&UL4$L! A0#%     @ %VY36K0ED8HN!   BA   !D              ("!
M7@D! 'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q02P$"% ,4    "  7;E-:
M-A.X*^T$  ""'0  &0              @('##0$ >&PO=V]R:W-H965T<R]S
M:&5E=#4P+GAM;%!+ 0(4 Q0    ( !=N4UHEY/1G90(  "<%   9
M      " @><2 0!X;"]W;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%
M  @ %VY36C2XHIM( P  ,A0   T              ( !@Q4! 'AL+W-T>6QE
M<RYX;6Q02P$"% ,4    "  7;E-:EXJ[',     3 @  "P
M@ 'V& $ 7W)E;',O+G)E;'-02P$"% ,4    "  7;E-:-X_)N7$$  !E(@
M#P              @ '?&0$ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @
M%VY36J&7ZI3) 0  H!X  !H              ( !?1X! 'AL+U]R96QS+W=O
M<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ %VY36BBT:!/# 0  B1X  !,
M             ( !?B ! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     #L
,.P 4$   <B(!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>156</ContextCount>
  <ElementCount>296</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>31</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CondensedConsolidatedStatementsOfOperations</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>995612 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>995613 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>995614 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>995615 - Disclosure - OPERATING AND FINANCING LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingAndFinancingLeases</Role>
      <ShortName>OPERATING AND FINANCING LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>995616 - Disclosure - INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Inventories</Role>
      <ShortName>INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>995617 - Disclosure - OTHER INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssets</Role>
      <ShortName>OTHER INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>995618 - Disclosure - OTHER CURRENT LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherCurrentLiabilities</Role>
      <ShortName>OTHER CURRENT LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>995619 - Disclosure - SEGMENT AND RELATED INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SegmentAndRelatedInformation</Role>
      <ShortName>SEGMENT AND RELATED INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>995620 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SupplementalCashFlowInformation</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>995621 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CommitmentsAndContingencies</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>995622 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/IncomeTaxes</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>995623 - Disclosure - RELATED PARTY TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/RelatedPartyTransactions</Role>
      <ShortName>RELATED PARTY TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>995624 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SubsequentEvents</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>995625 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>995626 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>995627 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>995628 - Disclosure - OPERATING AND FINANCING LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingAndFinancingLeasesTables</Role>
      <ShortName>OPERATING AND FINANCING LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/OperatingAndFinancingLeases</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>995629 - Disclosure - INVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/InventoriesTables</Role>
      <ShortName>INVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Inventories</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>995630 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssetsTables</Role>
      <ShortName>OTHER INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/OtherIntangibleAssets</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>995631 - Disclosure - OTHER CURRENT LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherCurrentLiabilitiesTables</Role>
      <ShortName>OTHER CURRENT LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/OtherCurrentLiabilities</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>995632 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SegmentAndRelatedInformationTables</Role>
      <ShortName>SEGMENT AND RELATED INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/SegmentAndRelatedInformation</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>995633 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>995634 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>995635 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details1</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>995636 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>995637 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>995638 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Future Revenue (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-FutureRevenueDetails1</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Future Revenue (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>995639 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>995640 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails</Role>
      <ShortName>OPERATING &amp; FINANCING LEASES - Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>995641 - Disclosure - OPERATING &amp; FINANCING LEASES (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingFinancingLeasesDetails1</Role>
      <ShortName>OPERATING &amp; FINANCING LEASES (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>995642 - Disclosure - OPERATING &amp; FINANCING LEASES (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingFinancingLeasesDetails2</Role>
      <ShortName>OPERATING &amp; FINANCING LEASES (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>995643 - Disclosure -  OPERATING &amp; FINANCING LEASES (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingFinancingLeasesDetails3</Role>
      <ShortName>OPERATING &amp; FINANCING LEASES (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>995644 - Disclosure - INVENTORIES - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Inventories-InventoriesDetails</Role>
      <ShortName>INVENTORIES - Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>995645 - Disclosure -  OTHER INTANGIBLE ASSETS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssetsDetails</Role>
      <ShortName>OTHER INTANGIBLE ASSETS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/OtherIntangibleAssetsTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>995646 - Disclosure - OTHER INTANGIBLE ASSETS (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssetsDetails1</Role>
      <ShortName>OTHER INTANGIBLE ASSETS (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/OtherIntangibleAssetsTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>995647 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative</Role>
      <ShortName>OTHER INTANGIBLE ASSETS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/OtherIntangibleAssetsTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>995648 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details</Role>
      <ShortName>OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>995649 - Disclosure - SEGMENT AND RELATED INFORMATION - Summarized Segments - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details</Role>
      <ShortName>SEGMENT AND RELATED INFORMATION - Summarized Segments - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>995650 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/SupplementalCashFlowInformation</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>995651 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>995652 - Disclosure - INCOME TAXES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>INCOME TAXES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/IncomeTaxes</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>995653 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative</Role>
      <ShortName>RELATED PARTY TRANSACTIONS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/RelatedPartyTransactions</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>995654 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>SUBSEQUENT EVENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/SubsequentEvents</ParentRole>
      <Position>51</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" isDefinitelyFs="true" isUsgaap="true" original="fonar_10-q.htm">fonar_10-q.htm</File>
    <File>fonr-20241231.xsd</File>
    <File>fonr-20241231_cal.xml</File>
    <File>fonr-20241231_def.xml</File>
    <File>fonr-20241231_lab.xml</File>
    <File>fonr-20241231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>fonar_logo.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2024</BaseTaxonomy>
    <BaseTaxonomy items="696">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="32">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>68
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "fonar_10-q.htm": {
   "nsprefix": "FONR",
   "nsuri": "http://fonar.com/20241231",
   "dts": {
    "inline": {
     "local": [
      "fonar_10-q.htm"
     ]
    },
    "schema": {
     "local": [
      "fonr-20241231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "fonr-20241231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "fonr-20241231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "fonr-20241231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "fonr-20241231_pre.xml"
     ]
    }
   },
   "keyStandard": 228,
   "keyCustom": 68,
   "axisStandard": 10,
   "axisCustom": 0,
   "memberStandard": 18,
   "memberCustom": 12,
   "hidden": {
    "total": 109,
    "http://fonar.com/20241231": 23,
    "http://fasb.org/us-gaap/2024": 81,
    "http://xbrl.sec.gov/dei/2024": 5
   },
   "contextCount": 156,
   "entityCount": 1,
   "segmentCount": 31,
   "elementCount": 505,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 696,
    "http://xbrl.sec.gov/dei/2024": 32,
    "http://xbrl.sec.gov/ecd/2024": 2,
    "http://fasb.org/srt/2024": 1
   },
   "report": {
    "R1": {
     "role": "http://fonar.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
     "longName": "00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "longName": "00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations",
     "longName": "00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "From2024-10-012024-12-31",
      "name": "FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-10-012024-12-31",
      "name": "FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity",
     "longName": "00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30_us-gaap_CommonStockMember",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30_us-gaap_CommonStockMember",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows",
     "longName": "00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "From2024-10-012024-12-31",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R8": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation",
     "longName": "995612 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION",
     "shortName": "DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "FONR:DescriptionOfBusinessAndBasisOfPresentationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "FONR:DescriptionOfBusinessAndBasisOfPresentationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPolicies",
     "longName": "995613 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable",
     "longName": "995614 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://fonar.com/role/OperatingAndFinancingLeases",
     "longName": "995615 - Disclosure - OPERATING AND FINANCING LEASES",
     "shortName": "OPERATING AND FINANCING LEASES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "FONR:LesseeOperatingLeasesAndFinanceLeaseTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "FONR:LesseeOperatingLeasesAndFinanceLeaseTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://fonar.com/role/Inventories",
     "longName": "995616 - Disclosure - INVENTORIES",
     "shortName": "INVENTORIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://fonar.com/role/OtherIntangibleAssets",
     "longName": "995617 - Disclosure - OTHER INTANGIBLE ASSETS",
     "shortName": "OTHER INTANGIBLE ASSETS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://fonar.com/role/OtherCurrentLiabilities",
     "longName": "995618 - Disclosure - OTHER CURRENT LIABILITIES",
     "shortName": "OTHER CURRENT LIABILITIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://fonar.com/role/SegmentAndRelatedInformation",
     "longName": "995619 - Disclosure - SEGMENT AND RELATED INFORMATION",
     "shortName": "SEGMENT AND RELATED INFORMATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://fonar.com/role/SupplementalCashFlowInformation",
     "longName": "995620 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION",
     "shortName": "SUPPLEMENTAL CASH FLOW INFORMATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://fonar.com/role/CommitmentsAndContingencies",
     "longName": "995621 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://fonar.com/role/IncomeTaxes",
     "longName": "995622 - Disclosure - INCOME TAXES",
     "shortName": "INCOME TAXES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://fonar.com/role/RelatedPartyTransactions",
     "longName": "995623 - Disclosure - RELATED PARTY TRANSACTIONS",
     "shortName": "RELATED PARTY TRANSACTIONS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://fonar.com/role/SubsequentEvents",
     "longName": "995624 - Disclosure - SUBSEQUENT EVENTS",
     "shortName": "SUBSEQUENT EVENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "longName": "995625 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "22",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables",
     "longName": "995626 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "23",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:RevenueRecognitionPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:RevenueRecognitionPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables",
     "longName": "995627 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "24",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://fonar.com/role/OperatingAndFinancingLeasesTables",
     "longName": "995628 - Disclosure - OPERATING AND FINANCING LEASES (Tables)",
     "shortName": "OPERATING AND FINANCING LEASES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "25",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "FONR:LesseeOperatingLeasesAndFinanceLeaseTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "FONR:LesseeOperatingLeasesAndFinanceLeaseTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://fonar.com/role/InventoriesTables",
     "longName": "995629 - Disclosure - INVENTORIES (Tables)",
     "shortName": "INVENTORIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://fonar.com/role/OtherIntangibleAssetsTables",
     "longName": "995630 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)",
     "shortName": "OTHER INTANGIBLE ASSETS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://fonar.com/role/OtherCurrentLiabilitiesTables",
     "longName": "995631 - Disclosure - OTHER CURRENT LIABILITIES (Tables)",
     "shortName": "OTHER CURRENT LIABILITIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://fonar.com/role/SegmentAndRelatedInformationTables",
     "longName": "995632 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)",
     "shortName": "SEGMENT AND RELATED INFORMATION (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative",
     "longName": "995633 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)",
     "shortName": "DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "30",
     "firstAnchor": {
      "contextRef": "AsOf2015-07-01_us-gaap_OtherInvesteesMember",
      "name": "us-gaap:InvestmentOwnedPercentOfNetAssets",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "FONR:DescriptionOfBusinessAndBasisOfPresentationTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2015-07-01_us-gaap_OtherInvesteesMember",
      "name": "us-gaap:InvestmentOwnedPercentOfNetAssets",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "FONR:DescriptionOfBusinessAndBasisOfPresentationTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details",
     "longName": "995634 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "31",
     "firstAnchor": {
      "contextRef": "From2024-10-012024-12-31",
      "name": "FONR:NetPatientFeeRevenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "us-gaap:RevenueRecognitionPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-10-012024-12-31",
      "name": "FONR:NetPatientFeeRevenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "us-gaap:RevenueRecognitionPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details1",
     "longName": "995635 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details 1)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "32",
     "firstAnchor": {
      "contextRef": "From2024-10-012024-12-31",
      "name": "FONR:NetIncomeLossAvailableToCommonStockholderBasic",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-10-012024-12-31",
      "name": "FONR:NetIncomeLossAvailableToCommonStockholderBasic",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
     "longName": "995636 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "33",
     "firstAnchor": {
      "contextRef": "From2023-07-012023-12-31",
      "name": "us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-012023-12-31",
      "name": "us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails",
     "longName": "995637 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:AccountsReceivableNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:AccountsReceivableNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-FutureRevenueDetails1",
     "longName": "995638 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Future Revenue (Details 1)",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Future Revenue (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:ContractReceivableDueOneToTwoYears",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LongTermPurchaseCommitmentTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:ContractReceivableDueOneToTwoYears",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LongTermPurchaseCommitmentTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative",
     "longName": "995639 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails",
     "longName": "995640 - Disclosure - OPERATING & FINANCING LEASES - Lease Payments (Details)",
     "shortName": "OPERATING & FINANCING LEASES - Lease Payments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31_custom_OperatingLeasePaymentsMember",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "FONR:LesseeOperatingLeasesAndFinanceLeaseTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-31_custom_OperatingLeasePaymentsMember",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "FONR:LesseeOperatingLeasesAndFinanceLeaseTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://fonar.com/role/OperatingFinancingLeasesDetails1",
     "longName": "995641 - Disclosure - OPERATING & FINANCING LEASES (Details 1)",
     "shortName": "OPERATING & FINANCING LEASES (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock",
       "FONR:LesseeOperatingLeasesAndFinanceLeaseTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock",
       "FONR:LesseeOperatingLeasesAndFinanceLeaseTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://fonar.com/role/OperatingFinancingLeasesDetails2",
     "longName": "995642 - Disclosure - OPERATING & FINANCING LEASES (Details 2)",
     "shortName": "OPERATING & FINANCING LEASES (Details 2)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "FONR:LesseeOperatingLeasesAndFinanceLeaseTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "FONR:LesseeOperatingLeasesAndFinanceLeaseTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://fonar.com/role/OperatingFinancingLeasesDetails3",
     "longName": "995643 - Disclosure -  OPERATING & FINANCING LEASES (Details 3)",
     "shortName": "OPERATING & FINANCING LEASES (Details 3)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "FONR:OperatingCashFlowsFromOperatingLeases",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:SupplementalCashFlowInformationRelatedToLeasesTableTextBlock",
       "FONR:LesseeOperatingLeasesAndFinanceLeaseTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "FONR:OperatingCashFlowsFromOperatingLeases",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:SupplementalCashFlowInformationRelatedToLeasesTableTextBlock",
       "FONR:LesseeOperatingLeasesAndFinanceLeaseTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://fonar.com/role/Inventories-InventoriesDetails",
     "longName": "995644 - Disclosure - INVENTORIES - Inventories (Details)",
     "shortName": "INVENTORIES - Inventories (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:OtherInventorySupplies",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:OtherInventorySupplies",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://fonar.com/role/OtherIntangibleAssetsDetails",
     "longName": "995645 - Disclosure -  OTHER INTANGIBLE ASSETS (Details)",
     "shortName": "OTHER INTANGIBLE ASSETS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://fonar.com/role/OtherIntangibleAssetsDetails1",
     "longName": "995646 - Disclosure - OTHER INTANGIBLE ASSETS (Details 1)",
     "shortName": "OTHER INTANGIBLE ASSETS (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative",
     "longName": "995647 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)",
     "shortName": "OTHER INTANGIBLE ASSETS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "From2024-10-012024-12-31_custom_PatentsAndCopyrightsMember",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-10-012024-12-31_custom_PatentsAndCopyrightsMember",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details",
     "longName": "995648 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)",
     "shortName": "OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:AccruedSalariesCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:AccruedSalariesCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details",
     "longName": "995649 - Disclosure - SEGMENT AND RELATED INFORMATION - Summarized Segments - (Details)",
     "shortName": "SEGMENT AND RELATED INFORMATION - Summarized Segments - (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "From2024-10-012024-12-31",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-10-012024-12-31",
      "name": "FONR:IntersegmentNetRevenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "unique": true
     }
    },
    "R47": {
     "role": "http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative",
     "longName": "995650 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)",
     "shortName": "SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:InterestPaidNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "us-gaap:InterestPaidNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative",
     "longName": "995651 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "From2024-10-012024-12-31",
      "name": "us-gaap:StockRepurchasedDuringPeriodValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:SelfInsuranceReserve",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "unique": true
     }
    },
    "R49": {
     "role": "http://fonar.com/role/IncomeTaxesDetailsNarrative",
     "longName": "995652 - Disclosure - INCOME TAXES (Details Narrative)",
     "shortName": "INCOME TAXES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "From2024-10-012024-12-31",
      "name": "us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-10-012024-12-31",
      "name": "us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative",
     "longName": "995653 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)",
     "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "FONR:NetRevenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-12-31",
      "name": "FONR:NetRevenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://fonar.com/role/SubsequentEventsDetailsNarrative",
     "longName": "995654 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)",
     "shortName": "SUBSEQUENT EVENTS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "FONR:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchaseds",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "FONR:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchaseds",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "FONR_AccountReceivableRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "AccountReceivableRelatedParties",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable _ related party"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsAndOtherReceivablesNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsAndOtherReceivablesNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable \u2013 net of allowance for credit losses of $273 and $166 at December 31, 2024 and June 30, 2024, respectively",
        "documentation": "Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r200",
      "r658"
     ]
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivable Type [Axis]",
        "documentation": "Information by type of receivable."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r50"
     ]
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "OTHER CURRENT LIABILITIES",
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r273"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r516"
     ]
    },
    "FONR_AccountsPayableRelatedPartyNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "AccountsPayableRelatedPartyNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Due to related party medical practices"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableBilledForLongTermContractsOrPrograms",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-FutureRevenueDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Construction Contractor, Receivable, Excluding Contract Retainage",
        "documentation": "Amount billed to customers under long-term contracts or programs but not paid. Excludes amounts due that have been withheld because of retainage provisions in a contract."
       }
      }
     },
     "auth_ref": [
      "r707"
     ]
    },
    "us-gaap_AccountsReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableMember",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable [Member]",
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold."
       }
      }
     },
     "auth_ref": [
      "r480"
     ]
    },
    "us-gaap_AccountsReceivableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableNet",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business."
       }
      }
     },
     "auth_ref": [
      "r429",
      "r479",
      "r526",
      "r713",
      "r714"
     ]
    },
    "FONR_AccountsReceivableNetLongTerm": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "AccountsReceivableNetLongTerm",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable \u2013 long term"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_AccountsReceivableNetRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "AccountsReceivableNetRelatedParty",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable - related party"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedFeesAndOtherRevenueReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedFeesAndOtherRevenueReceivable",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees receivable \u2013 net of allowance for credit losses of $12,663 and $12,370 at December 31, 2024 and June 30, 2024, respectively",
        "documentation": "For an unclassified balance sheet, the amount of fees and other revenue, excluding investment income receivable, earned but not yet received, which were recognized in conformity with revenue recognition criteria based on estimates or specific contractual terms."
       }
      }
     },
     "auth_ref": [
      "r631"
     ]
    },
    "us-gaap_AccruedPayrollTaxesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedPayrollTaxesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Federal and state income taxes payable",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "us-gaap_AccruedSalariesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedSalariesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued salaries, commissions and payroll taxes",
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r487"
     ]
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life",
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r215",
      "r483"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r581"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Paid-in capital in excess of par value",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r516",
      "r750"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r399",
      "r644",
      "r645",
      "r646",
      "r647",
      "r698",
      "r751"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r587"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r587"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r587"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r587"
     ]
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile consolidated net income to net cash provided by operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r552",
      "r563",
      "r573",
      "r598"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r555",
      "r566",
      "r576",
      "r601"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r587"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r594"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r556",
      "r567",
      "r577",
      "r594",
      "r602",
      "r606",
      "r614"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "auth_ref": [
      "r612"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Allowance for Doubtful Accounts, Premiums and Other Receivables",
        "documentation": "The valuation allowance as of the balance sheet date to reduce the gross amount of receivables to estimated net realizable value, which would be presented in parentheses on the face of the balance sheet."
       }
      }
     },
     "auth_ref": [
      "r657"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of Intangible Assets",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r212",
      "r218",
      "r502"
     ]
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r559"
     ]
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r299"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r93",
      "r118",
      "r141",
      "r171",
      "r179",
      "r189",
      "r192",
      "r204",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r301",
      "r305",
      "r319",
      "r358",
      "r434",
      "r496",
      "r497",
      "r516",
      "r533",
      "r681",
      "r682",
      "r705"
     ]
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Current Assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r125",
      "r141",
      "r204",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r301",
      "r305",
      "r319",
      "r516",
      "r681",
      "r682",
      "r705"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Assets:"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r559"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r609"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r610"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "auth_ref": [
      "r605"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r605"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r605"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r605"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r605"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r605"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r608"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r607"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r606"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r606"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Presentation",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "srt_BoardOfDirectorsChairmanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "BoardOfDirectorsChairmanMember",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Board of Directors Chairman [Member]",
        "documentation": "Leader of board of directors."
       }
      }
     },
     "auth_ref": [
      "r656"
     ]
    },
    "FONR_CancellationOfTreasuryStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "CancellationOfTreasuryStock",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cancellation of Treasury stock"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_CancellationOfTreasuryStockShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "CancellationOfTreasuryStockShares",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cancellation of Treasury stock, shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r699",
      "r700"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash and Cash Equivalents - Beginning of Period",
        "periodEndLabel": "Cash and Cash Equivalents - End of Period",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r69",
      "r139"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net (Decrease) Increase in Cash and Cash Equivalents",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r69"
     ]
    },
    "us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashFlowSupplementalDisclosuresTextBlock",
     "presentation": [
      "http://fonar.com/role/SupplementalCashFlowInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUPPLEMENTAL CASH FLOW INFORMATION",
        "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r585"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ClassANonVotingPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "ClassANonVotingPreferredStockMember",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A Non Voting Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ClassANonVotingPreferredStockholdersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "ClassANonVotingPreferredStockholdersMember",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A Non Voting Preferred Stockholders [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r121",
      "r122",
      "r123",
      "r141",
      "r160",
      "r161",
      "r166",
      "r168",
      "r173",
      "r174",
      "r204",
      "r231",
      "r233",
      "r234",
      "r235",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r319",
      "r388",
      "r389",
      "r390",
      "r391",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r421",
      "r443",
      "r463",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r622",
      "r641",
      "r648"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r586"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r586"
     ]
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r299"
     ]
    },
    "FONR_CommercialInsuranceManagedCareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "CommercialInsuranceManagedCareMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commercial Insurance Managed Care [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "COMMITMENTS AND CONTINGENCIES",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r229",
      "r230",
      "r481",
      "r677",
      "r678"
     ]
    },
    "us-gaap_CommonClassBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonClassBMember",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Class B [Member]",
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r751"
     ]
    },
    "us-gaap_CommonClassCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonClassCMember",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Class C [Member]",
        "documentation": "Classification of common stock that has different rights than provided to Class A or B shares, representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r523",
      "r524",
      "r525",
      "r527",
      "r528",
      "r529",
      "r530",
      "r644",
      "r645",
      "r647",
      "r698",
      "r747",
      "r751"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r421"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r43",
      "r421",
      "r440",
      "r751",
      "r752"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock value",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r361",
      "r516"
     ]
    },
    "FONR_CommonStockholdersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "CommonStockholdersMember",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stockholders [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r590"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r592"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r589"
     ]
    },
    "FONR_ConsolidatedNetIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "ConsolidatedNetIncome",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Consolidated Net Income",
        "label": "ConsolidatedNetIncome"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principles of Consolidation",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r488"
     ]
    },
    "us-gaap_ContractReceivableDueFourToFiveYears": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractReceivableDueFourToFiveYears",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-FutureRevenueDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Construction Contractor, Receivable, Excluding Contract Retainage, Year Five",
        "documentation": "Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r708"
     ]
    },
    "us-gaap_ContractReceivableDueOneToTwoYears": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractReceivableDueOneToTwoYears",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-FutureRevenueDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Construction Contractor, Receivable, Excluding Contract Retainage, Year Two",
        "documentation": "Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r708"
     ]
    },
    "us-gaap_ContractReceivableDueThreeToFourYears": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractReceivableDueThreeToFourYears",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-FutureRevenueDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Construction Contractor, Receivable, Excluding Contract Retainage, Year Four",
        "documentation": "Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r708"
     ]
    },
    "us-gaap_ContractReceivableDueTwoToThreeYears": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractReceivableDueTwoToThreeYears",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-FutureRevenueDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Construction Contractor, Receivable, Excluding Contract Retainage, Year Three",
        "documentation": "Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r708"
     ]
    },
    "us-gaap_ConversionOfStockAmountConverted1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConversionOfStockAmountConverted1",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Stock, Amount Converted",
        "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r13",
      "r14"
     ]
    },
    "FONR_ConvertibleClassCStock": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "ConvertibleClassCStock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ConvertibleClassCStock]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertibleNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleNotesPayable",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Notes Payable",
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r82",
      "r711"
     ]
    },
    "FONR_CorporateAlternativeMinimumTaxPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "CorporateAlternativeMinimumTaxPercentage",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:CorporateAlternativeMinimumTaxPercentage]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostsAndExpenses",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Costs and Expenses",
        "label": "Costs and Expenses",
        "documentation": "Total costs of sales and operating expenses for the period."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostsAndExpensesAbstract",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "COSTS AND EXPENSES"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_CostsRelatedToManagementAndOtherFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "CostsRelatedToManagementAndOtherFees",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to management and other fees"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to management and other fees \u2013 related medical practices"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_CostsRelatedToProductSales": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "CostsRelatedToProductSales",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to product sales"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_CostsRelatedToServiceAndRepairFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "CostsRelatedToServiceAndRepairFees",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to service and repair fees"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_CostsRelatedToServiceAndRepairFeesRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "CostsRelatedToServiceAndRepairFeesRelatedParties",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to service and repair fees _ related parties"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_CustomerDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "CustomerDeposits",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer deposits"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CustomerRelationshipsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CustomerRelationshipsMember",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsDetails",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Relationships [Member]",
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r675",
      "r676"
     ]
    },
    "us-gaap_DeferredGainOnSaleOfProperty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredGainOnSaleOfProperty",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Gain on Sale of Property",
        "documentation": "Amount of gain on the sale of property that does not qualify for gain recognition as of the balance sheet date."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_DeferredIncomeTaxComponent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "DeferredIncomeTaxComponent",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:DeferredIncomeTaxComponent]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax expense",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r100",
      "r643"
     ]
    },
    "us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred income tax liability",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other liabilities expected to be paid after one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredRevenueCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredRevenueCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unearned revenue on service contracts",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r629"
     ]
    },
    "us-gaap_DeferredRevenueNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredRevenueNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Unearned revenue on service contracts",
        "label": "Deferred Revenue, Noncurrent",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r630"
     ]
    },
    "us-gaap_DeferredTaxAssetsDeferredIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsDeferredIncome",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred income tax asset",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income."
       }
      }
     },
     "auth_ref": [
      "r689"
     ]
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r686"
     ]
    },
    "us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Policyholders' Surplus",
        "documentation": "Amount of deferred tax liability not recognized because of the exceptions to comprehensive recognition of deferred taxes related to a policyholders' surplus."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r171",
      "r183",
      "r192",
      "r496",
      "r497"
     ]
    },
    "FONR_DepreciationOfLeasedEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "DepreciationOfLeasedEquipment",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeasesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation of leased equipment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeFixedInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeFixedInterestRate",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative, Fixed Interest Rate",
        "documentation": "Fixed interest rate related to the interest rate derivative."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_DescriptionOfBusinessAndBasisOfPresentationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "DescriptionOfBusinessAndBasisOfPresentationTextBlock",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueLineItems",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r246",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueTable",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Table]",
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r246",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of patient fee revenue - net",
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r684"
     ]
    },
    "FONR_DisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "DisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Description Of Business And Basis Of Presentation"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_DisclosureOperatingAndFinancingLeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "DisclosureOperatingAndFinancingLeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating And Financing Leases",
        "verboseLabel": "Operating Financing Leases"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r547"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r545",
      "r547",
      "r559"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r546"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r534"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r547"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r547"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r580"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r537"
     ]
    },
    "us-gaap_DoubtfulMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DoubtfulMember",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Doubtful [Member]",
        "documentation": "A category of financing receivables that have all the weaknesses inherent in those classified as substandard, with the added characteristic that the weaknesses make collection or liquidation in full, on the basis of currently existing facts, conditions, and values, highly questionable and improbable."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r96",
      "r97",
      "r662"
     ]
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r132",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r157",
      "r160",
      "r166",
      "r167",
      "r168",
      "r170",
      "r295",
      "r298",
      "r314",
      "r315",
      "r354",
      "r371",
      "r490"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r132",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r160",
      "r166",
      "r167",
      "r168",
      "r170",
      "r295",
      "r298",
      "r314",
      "r315",
      "r354",
      "r371",
      "r490"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r16",
      "r169"
     ]
    },
    "FONR_EmployeesFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "EmployeesFee",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:EmployeesFee]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r540"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r536"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r536"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r621"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r536"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r618"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r559"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r536"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r536"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r536"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r536"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r619"
     ]
    },
    "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from External Customer [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r110",
      "r128",
      "r129",
      "r130",
      "r143",
      "r144",
      "r145",
      "r147",
      "r152",
      "r154",
      "r156",
      "r172",
      "r205",
      "r206",
      "r225",
      "r245",
      "r284",
      "r285",
      "r292",
      "r293",
      "r294",
      "r296",
      "r297",
      "r298",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r327",
      "r329",
      "r342",
      "r370",
      "r382",
      "r383",
      "r384",
      "r399",
      "r463"
     ]
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "EquityMethodInvesteeNameDomain",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of investment including named security. Excludes entity that is consolidated."
       }
      }
     },
     "auth_ref": [
      "r201",
      "r202",
      "r203",
      "r291",
      "r623",
      "r624",
      "r625",
      "r691",
      "r692",
      "r693",
      "r694"
     ]
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investment, Ownership Percentage",
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting."
       }
      }
     },
     "auth_ref": [
      "r201"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r552",
      "r563",
      "r573",
      "r598"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r549",
      "r560",
      "r570",
      "r595"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r594"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ExtinguishmentOfDebtGainLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ExtinguishmentOfDebtGainLossNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extinguishment of Debt, Gain (Loss), Net of Tax",
        "documentation": "The difference between the reacquisition price and the net carrying amount of the extinguished debt recognized currently as a component of income in the period of extinguishment, net of tax."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "FONR_FinanceLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "FinanceLeaseCost",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeasesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total finance lease cost"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_FinanceLeaseCostsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "FinanceLeaseCostsAbstract",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeasesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance lease cost:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseInterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeasesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest on lease liabilities",
        "documentation": "Amount of interest expense on finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r332",
      "r334",
      "r515"
     ]
    },
    "us-gaap_FinanceLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease."
       }
      }
     },
     "auth_ref": [
      "r331",
      "r340"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing lease liability _ current portion",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r331"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing lease liability \u2013 net of current portion",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r331"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Thereafter",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r340"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2025",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r340"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2029",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r340"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2028",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r340"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2027",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r340"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2026",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r340"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use-asset \u2013 financing lease",
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r330"
     ]
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeasesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for finance lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r339",
      "r515"
     ]
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeasesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r338",
      "r515"
     ]
    },
    "FONR_FinancingCashFlowsFromFinancingLeases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "FinancingCashFlowsFromFinancingLeases",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeasesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing cash flows from financing leases"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_FinancingLeasePaymentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "FinancingLeasePaymentsMember",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing Lease Payments [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated amortization intangible assets",
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r208",
      "r217",
      "r502"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r673",
      "r753"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r483",
      "r502"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r483",
      "r502"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r483",
      "r502"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r483",
      "r502"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r483",
      "r502"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsDetails",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r211",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r220",
      "r221",
      "r351",
      "r352",
      "r483"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsGross",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross carrying amount intangible assets",
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r208",
      "r217",
      "r352",
      "r502"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsDetails",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r211",
      "r217",
      "r220",
      "r221",
      "r223",
      "r351",
      "r483",
      "r502"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsDetails",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r211",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r220",
      "r221",
      "r483"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net carrying amount intangible assets",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r351",
      "r672"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r556",
      "r567",
      "r577",
      "r602"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r556",
      "r567",
      "r577",
      "r602"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r556",
      "r567",
      "r577",
      "r602"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r556",
      "r567",
      "r577",
      "r602"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r556",
      "r567",
      "r577",
      "r602"
     ]
    },
    "FONR_GainOnSaleOfEquipmentRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "GainOnSaleOfEquipmentRelatedParty",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gain on sale of equipment \u2013 related party",
        "label": "GainOnSaleOfEquipmentRelatedParty"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill",
        "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r209",
      "r353",
      "r497",
      "r501",
      "r513",
      "r516",
      "r664",
      "r665"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_HealthCareOrganizationRevenueSourcesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "HealthCareOrganizationRevenueSourcesAxis",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Health Care Organization, Revenue Sources [Axis]",
        "documentation": "Information by major payor source of revenue for health care organizations."
       }
      }
     },
     "auth_ref": [
      "r684"
     ]
    },
    "us-gaap_HealthCareOrganizationRevenueSourcesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "HealthCareOrganizationRevenueSourcesDomain",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Major payor source of revenue for health care organizations."
       }
      }
     },
     "auth_ref": [
      "r684"
     ]
    },
    "us-gaap_HealthCareOtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "HealthCareOtherMember",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Health Care, Other [Member]",
        "documentation": "Service provided for maintenance, diagnosis and treatment of physical and mental health, classified as other."
       }
      }
     },
     "auth_ref": [
      "r685"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperations",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "(Loss) Income from operations",
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r55",
      "r72",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r164",
      "r168",
      "r298"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations": {
       "parentTag": "FONR_ConsolidatedNetIncome",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income Before Provision for Income Taxes and Noncontrolling Interests",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r87",
      "r92",
      "r355",
      "r366",
      "r492",
      "r496",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "INCOME FROM OPERATIONS",
        "label": "Income (Loss) from Continuing Operations before Interest Expense, Interest Income, Income Taxes, Noncontrolling Interests, Net",
        "documentation": "Amount of income (loss) from continuing operations, nonoperating income (expense) and income (loss) from equity method investments, before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of interest income (expense)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Continuing Operations, Per Basic Share",
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r88",
      "r132",
      "r146",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r160",
      "r166",
      "r167",
      "r295",
      "r298",
      "r315",
      "r354",
      "r715"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r226",
      "r227",
      "r228",
      "r316",
      "r317",
      "r318",
      "r380",
      "r381",
      "r448",
      "r483",
      "r514",
      "r717"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r227",
      "r228",
      "r316",
      "r317",
      "r318",
      "r380",
      "r381",
      "r448",
      "r483",
      "r514",
      "r717"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "INCOME TAXES",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r275",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r286",
      "r288",
      "r289",
      "r290",
      "r393",
      "r510"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations": {
       "parentTag": "FONR_ConsolidatedNetIncome",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Provision for income taxes",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r101",
      "r155",
      "r156",
      "r171",
      "r184",
      "r192",
      "r276",
      "r277",
      "r287",
      "r372",
      "r510"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability",
        "documentation": "Amount of income tax expense (benefit) from continuing operations attributable to an adjustment of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity."
       }
      }
     },
     "auth_ref": [
      "r283"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefitIntraperiodTaxAllocation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefitIntraperiodTaxAllocation",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Expense (Benefit), Intraperiod Tax Allocation",
        "documentation": "Amount of income tax expense (benefit) for continuing operations, discontinued operations, other comprehensive income, and items charged (credited) directly to shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r287",
      "r690"
     ]
    },
    "us-gaap_IncomeTaxesPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxesPaid",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes Paid",
        "documentation": "Amount, before refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r71",
      "r640",
      "r687",
      "r688"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsAndOtherReceivables",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Accounts and Other Receivables",
        "documentation": "The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts, medical and management fee receivable(s)",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "FONR_IncreaseDecreaseInCustomerDeposit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "IncreaseDecreaseInCustomerDeposit",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Customer deposits",
        "label": "IncreaseDecreaseInCustomerDeposit"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Inventories",
        "label": "Increase (Decrease) in Inventories",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "FONR_IncreaseDecreaseInNotesReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "IncreaseDecreaseInNotesReceivable",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes receivable"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_IncreaseDecreaseInNotesReceivableRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "IncreaseDecreaseInNotesReceivableRelatedParty",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes receivable \u2013 related party"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingAssetsAbstract",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in operating assets and liabilities, net:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Lease Liability",
        "documentation": "Amount of increase (decrease) in obligation for operating lease."
       }
      }
     },
     "auth_ref": [
      "r626",
      "r639"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other liabilities",
        "label": "Increase (Decrease) in Other Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in other expenses incurred but not yet paid."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherCurrentLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other current liabilities",
        "label": "Increase (Decrease) in Other Current Liabilities",
        "documentation": "Amount of increase (decrease) in current liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r639"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other assets",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r639"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpensesOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInPrepaidExpensesOther",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses and other current assets",
        "label": "Increase (Decrease) in Prepaid Expenses, Other",
        "documentation": "Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "us-gaap_IncreaseDecreaseInTradingLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInTradingLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing lease liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of trading liabilities from the reporting entity's trading activities. This include liabilities resulting from sales of assets that the reporting entity does not own and revaluation losses."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncrementalCommonSharesAttributableToConversionOfPreferredStock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r163",
      "r168"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r556",
      "r567",
      "r577",
      "r594",
      "r602",
      "r606",
      "r614"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "auth_ref": [
      "r612"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r548",
      "r617"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r548",
      "r617"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r548",
      "r617"
     ]
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "OTHER INTANGIBLE ASSETS",
        "documentation": "The entire disclosure for all or part of the information related to intangible assets."
       }
      }
     },
     "auth_ref": [
      "r210",
      "r222",
      "r224",
      "r482",
      "r483"
     ]
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/OtherIntangibleAssetsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other intangible assets \u2013 net",
        "verboseLabel": "Intangible Assets, Net (Excluding Goodwill)",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r211",
      "r672",
      "r674"
     ]
    },
    "us-gaap_InterestExpenseNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpenseNonoperating",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest Expense",
        "label": "Interest Expense, Nonoperating",
        "documentation": "Amount of interest expense classified as nonoperating."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r638"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r137",
      "r138"
     ]
    },
    "FONR_IntersegmentNetRevenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "IntersegmentNetRevenues",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inter-segment net revenues"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/Inventories"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "INVENTORIES",
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory."
       }
      }
     },
     "auth_ref": [
      "r207"
     ]
    },
    "us-gaap_InventoryFinishedGoodsAndWorkInProcess": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryFinishedGoodsAndWorkInProcess",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventories",
        "documentation": "Amount before valuation reserves of merchandise or goods held by the entity that are readily available for sale and items held by the entity which are partially complete or in the process of being readied for sale."
       }
      }
     },
     "auth_ref": [
      "r634"
     ]
    },
    "us-gaap_InventoryNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryNet",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/Inventories-InventoriesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fonar.com/role/Inventories-InventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Inventories",
        "label": "Inventory, Net",
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r486",
      "r516"
     ]
    },
    "us-gaap_InventoryWorkInProcess": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryWorkInProcess",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/Inventories-InventoriesDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/Inventories-InventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Work-in-process",
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r632"
     ]
    },
    "us-gaap_InvestmentIncomeNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentIncomeNet",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment income",
        "verboseLabel": "Investment Income, Net",
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r61",
      "r62"
     ]
    },
    "FONR_InvestmentIncomeRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "InvestmentIncomeRelatedParty",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment income \u2013 related party"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentOwnedPercentOfNetAssets": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentOwnedPercentOfNetAssets",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Owned, Net Assets, Percentage",
        "documentation": "Percentage of investment owned to net assets."
       }
      }
     },
     "auth_ref": [
      "r411",
      "r412",
      "r413",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r525",
      "r748"
     ]
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://fonar.com/role/OperatingAndFinancingLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of lease expense",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r702"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://fonar.com/role/OperatingAndFinancingLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of lessee operating leases liability maturity",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r703"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Thereafter",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r340"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2025",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r340"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2029",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r340"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2028",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r340"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2027",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r340"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2026",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r340"
     ]
    },
    "FONR_LesseeOperatingLeasesAndFinanceLeaseTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "LesseeOperatingLeasesAndFinanceLeaseTextBlock",
     "presentation": [
      "http://fonar.com/role/OperatingAndFinancingLeases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "OPERATING AND FINANCING LEASES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r141",
      "r204",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r302",
      "r305",
      "r306",
      "r319",
      "r420",
      "r491",
      "r533",
      "r681",
      "r705",
      "r706"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities and Equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r84",
      "r364",
      "r516",
      "r642",
      "r660",
      "r701"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "EQUITY:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Current Liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r114",
      "r141",
      "r204",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r302",
      "r305",
      "r306",
      "r319",
      "r516",
      "r681",
      "r705",
      "r706"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Long-Term Liabilities",
        "label": "Liabilities, Noncurrent",
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r38",
      "r39",
      "r40",
      "r41",
      "r141",
      "r204",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r302",
      "r305",
      "r306",
      "r319",
      "r681",
      "r705",
      "r706"
     ]
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesNoncurrentAbstract",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpense",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Claims and Claims Adjustment Expense",
        "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date."
       }
      }
     },
     "auth_ref": [
      "r519",
      "r521",
      "r710",
      "r718"
     ]
    },
    "us-gaap_LicenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LicenseMember",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "License [Member]",
        "documentation": "Right to use intangible asset. Intangible asset includes, but is not limited to, patent, copyright, technology, manufacturing process, software or trademark."
       }
      }
     },
     "auth_ref": [
      "r685"
     ]
    },
    "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE",
        "documentation": "The entire disclosure for claims held for amounts due to entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses."
       }
      }
     },
     "auth_ref": [
      "r326",
      "r655"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current portion of long-term debt",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-term debt, less current portion",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "us-gaap_LongTermPurchaseCommitmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermPurchaseCommitmentTextBlock",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of future revenue",
        "documentation": "Tabular disclosure of key provisions of an arrangement under which the entity has agreed to purchase goods or services over a period of time greater than one year or the normal operating cycle, if longer, including the item for which expenditures will be made, minimum quantities, milestones, time period and committed amount."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_MagneticResonanceManagementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "MagneticResonanceManagementMember",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Magnetic Resonance Management [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManagementAndOtherFeeReceivablePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "ManagementAndOtherFeeReceivablePolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fee receivable"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManagementAndOtherFeesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "ManagementAndOtherFeesNet",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManagementAndOtherFeesNonRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "ManagementAndOtherFeesNonRelatedParties",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees receivable"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "ManagementAndOtherFeesRelatedMedicalPracticesNet",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees _ related medical practices"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "ManagementAndOtherReceivableAllowancesForDoubtfulAccounts",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ManagementAndOtherReceivableAllowancesForDoubtfulAccounts-0]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees receivable \u2013 related medical practices \u2013 net of allowance for credit losses of $6,989 and $6,110 at December 31, 2024 and June 30, 2024, respectively",
        "verboseLabel": "Management and other fees receivable from related medical practices (\u201cPC\u2019s\u201d)"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManufacturingAndServiceOfMRIEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "ManufacturingAndServiceOfMRIEquipmentMember",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Manufacturing And Service Of M R I Equipment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r586"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name"
       }
      }
     },
     "auth_ref": [
      "r586"
     ]
    },
    "FONR_MedicalReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "MedicalReceivable",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medical receivable \u2013 net"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_MedicareMedicaidMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "MedicareMedicaidMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medicare Medicaid [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MinorityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MinorityInterest",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling interests",
        "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r83",
      "r141",
      "r204",
      "r231",
      "r233",
      "r234",
      "r235",
      "r238",
      "r239",
      "r319",
      "r363",
      "r423"
     ]
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Distributions - Non controlling interests",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders."
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r605"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r613"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r587"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Financing Activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Investing Activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r70",
      "r72"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Operating Activities:"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_NetChangeInOperatingRightOfUseAssetsAndLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "NetChangeInOperatingRightOfUseAssetsAndLeaseLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Net change in operating right of use assets and lease liabilities",
        "label": "NetChangeInOperatingRightOfUseAssetsAndLeaseLiabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Income \u2013 Attributable to FONAR",
        "label": "Net income",
        "verboseLabel": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r72",
      "r89",
      "r112",
      "r126",
      "r127",
      "r130",
      "r141",
      "r146",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r155",
      "r156",
      "r164",
      "r204",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r295",
      "r298",
      "r315",
      "r319",
      "r369",
      "r442",
      "r461",
      "r462",
      "r531",
      "r681"
     ]
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Net Income Noncontrolling Interests",
        "label": "Income - Non controlling interests",
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r78",
      "r126",
      "r127",
      "r152",
      "r155",
      "r156",
      "r368",
      "r637"
     ]
    },
    "FONR_NetIncomeLossAvailableToCommonStockholderBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "NetIncomeLossAvailableToCommonStockholderBasic",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic Numerator: Net income available to common stockholders"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income Available to Common Stockholders",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r148",
      "r149",
      "r150",
      "r151",
      "r157",
      "r158",
      "r165",
      "r168",
      "r298"
     ]
    },
    "FONR_NetPatientFeeRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "NetPatientFeeRevenue",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Patient Fee Revenue, net of contractual allowances and discounts"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_NetRevenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "NetRevenues",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:NetRevenues]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recent Accounting Standards",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r586"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r584"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r583"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r613"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r613"
     ]
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoncompeteAgreementsMember",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncompete Agreements [Member]",
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r675",
      "r676"
     ]
    },
    "us-gaap_NoncontrollingInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoncontrollingInterestMember",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity",
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Member]",
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r245",
      "r644",
      "r645",
      "r646",
      "r647",
      "r751"
     ]
    },
    "us-gaap_NontradeReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NontradeReceivables",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medical receivable",
        "documentation": "Carrying amounts due as of the balance sheet date of the sum of amounts receivable other than from customers."
       }
      }
     },
     "auth_ref": [
      "r631"
     ]
    },
    "FONR_NoteReceivableRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "NoteReceivableRelatedParty",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note receivable \u2013 related party"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_OperatingCashFlowsFromOperatingLeases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "OperatingCashFlowsFromOperatingLeases",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeasesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating cash flows from operating leases"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeasesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r335",
      "r515"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r331"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liabilities _ current portion",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r331"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liabilities \u2013 net of current portion",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r331"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r333",
      "r336"
     ]
    },
    "FONR_OperatingLeasePaymentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "OperatingLeasePaymentsMember",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease Payments [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use-asset \u2013 operating leases",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r330"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeasesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r339",
      "r515"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeasesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r338",
      "r515"
     ]
    },
    "us-gaap_OtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssets",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other assets",
        "documentation": "Amount of assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r117",
      "r357",
      "r497",
      "r533"
     ]
    },
    "us-gaap_OtherCostOfOperatingRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherCostOfOperatingRevenue",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to patient fee revenue",
        "documentation": "Other costs incurred during the reporting period related to other revenue generating activities."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "us-gaap_OtherDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherDepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation and amortization",
        "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r21",
      "r58"
     ]
    },
    "FONR_OtherIncomeRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "OtherIncomeRelatedParty",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other income \u2013 related party"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherInventorySupplies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherInventorySupplies",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/Inventories-InventoriesDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/Inventories-InventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchased parts, components and supplies",
        "documentation": "Amount before valuation and LIFO reserves of other supplies used within the manufacturing or production process expected to be consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r633"
     ]
    },
    "us-gaap_OtherInvesteesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherInvesteesMember",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonconsolidated Investees, Other [Member]",
        "documentation": "Investment in group of nonconsolidated investees classified as other."
       }
      }
     },
     "auth_ref": [
      "r659"
     ]
    },
    "us-gaap_OtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other liabilities",
        "documentation": "Amount of liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r359",
      "r416",
      "r417",
      "r533",
      "r712",
      "r749"
     ]
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      },
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other current liabilities",
        "totalLabel": "Other Current Liabilities",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r516"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other income",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other income and (expenses)"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r586"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r547"
     ]
    },
    "FONR_OtherRevenueSourceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "OtherRevenueSourceMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Revenue Source [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherSundryLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherSundryLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other general and administrative expenses",
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r36"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r554",
      "r565",
      "r575",
      "r600"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r557",
      "r568",
      "r578",
      "r603"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r557",
      "r568",
      "r578",
      "r603"
     ]
    },
    "FONR_PatentsAndCopyrightsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "PatentsAndCopyrightsMember",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsDetails",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Patents And Copyrights [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "PatientFeeRevenueNetOfContractualAllowancesAndDiscounts",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Patient fee revenue \u2013 net of contractual allowances and discounts"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "auth_ref": [
      "r582"
     ]
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PayablesAndAccrualsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForRepurchaseOfConvertiblePreferredStock",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of treasury stock",
        "label": "Payments for Repurchase of Convertible Preferred Stock",
        "documentation": "The cash outflow to reacquire preferred stock originally issued and identified as a security that can be exchanged for another type of financial security. This repurchased stock is held in treasury."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "us-gaap_PaymentsOfDividendsMinorityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfDividendsMinorityInterest",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Distributions to noncontrolling interests",
        "label": "Payments of Ordinary Dividends, Noncontrolling Interest",
        "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireIntangibleAssets",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cost of patents",
        "label": "Payments to Acquire Intangible Assets",
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireProductiveAssets",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital expenditures",
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r695",
      "r696",
      "r697"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r585"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r585"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r584"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r587"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r583"
     ]
    },
    "FONR_PercentageOfConsolidatedNetRevenueFromManagementFees": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "PercentageOfConsolidatedNetRevenueFromManagementFees",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:PercentageOfConsolidatedNetRevenueFromManagementFees]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_PercentageOfExciseTax": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "PercentageOfExciseTax",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:PercentageOfExciseTax]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r584"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r541"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r543"
     ]
    },
    "us-gaap_PreferredClassAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredClassAMember",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Class A [Member]",
        "documentation": "Outstanding nonredeemable preferred class A stock or outstanding convertible preferred class A stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockMember",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock [Member]",
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company."
       }
      }
     },
     "auth_ref": [
      "r523",
      "r524",
      "r527",
      "r528",
      "r529",
      "r530",
      "r747",
      "r751"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r240"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r421"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r421",
      "r440",
      "r751",
      "r752"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock value",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r360",
      "r516"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses and other current assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r636"
     ]
    },
    "FONR_PresentValueDiscount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "PresentValueDiscount",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Present value discount"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_PresentValueDiscountFinancingLease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "PresentValueDiscountFinancingLease",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Present value discount",
        "label": "PresentValueDiscountFinancingLease"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Correction of immaterial errors",
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error."
       }
      }
     },
     "auth_ref": [
      "r628"
     ]
    },
    "us-gaap_ProceedsFromMinorityShareholders": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromMinorityShareholders",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of noncontrolling interest",
        "documentation": "Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_ProceedsFromPaymentsToMinorityShareholders": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromPaymentsToMinorityShareholders",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from (Payments to) Noncontrolling Interests",
        "documentation": "Amount of cash inflow (outflow) from (to) a noncontrolling interest. Excludes dividends paid to the noncontrolling interest."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleOfShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromSaleOfShortTermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from short term investments",
        "documentation": "The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "documentation": "Information by product and service, or group of similar products and similar services."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r104",
      "r105",
      "r106",
      "r107",
      "r108",
      "r109",
      "r195",
      "r350",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r485",
      "r503",
      "r517",
      "r518",
      "r520",
      "r521",
      "r522",
      "r627",
      "r679",
      "r680",
      "r684",
      "r716",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746"
     ]
    },
    "FONR_ProductSalesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "ProductSalesNet",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product sales"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r104",
      "r105",
      "r106",
      "r107",
      "r108",
      "r109",
      "r195",
      "r350",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r485",
      "r503",
      "r517",
      "r518",
      "r520",
      "r521",
      "r522",
      "r627",
      "r679",
      "r680",
      "r684",
      "r716",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746"
     ]
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Net income",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r126",
      "r127",
      "r135",
      "r141",
      "r146",
      "r152",
      "r155",
      "r156",
      "r204",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r295",
      "r298",
      "r300",
      "r303",
      "r304",
      "r315",
      "r319",
      "r355",
      "r367",
      "r398",
      "r442",
      "r461",
      "r462",
      "r511",
      "r512",
      "r532",
      "r637",
      "r681"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment \u2013 net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r341",
      "r356",
      "r365",
      "r516"
     ]
    },
    "FONR_ProvisionForBadDebts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "ProvisionForBadDebts",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Provision for credit losses"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r582"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r582"
     ]
    },
    "FONR_RateOfInterestSold": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "RateOfInterestSold",
     "presentation": [
      "http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:RateOfInterestSold]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReceivableTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReceivableTypeDomain",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r50"
     ]
    },
    "us-gaap_ReceivablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReceivablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "auth_ref": [
      "r549",
      "r560",
      "r570",
      "r595"
     ]
    },
    "FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "RelatedPartyReceivableAllowancesForDoubtfulAccounts",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:RelatedPartyReceivableAllowancesForDoubtfulAccounts-0]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RELATED PARTY TRANSACTIONS",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r394",
      "r395",
      "r396",
      "r446",
      "r447",
      "r448",
      "r466",
      "r467"
     ]
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfNotesPayable",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayment of borrowings and capital lease obligations",
        "label": "Repayments of Notes Payable",
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r274",
      "r483",
      "r496",
      "r709"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r550",
      "r561",
      "r571",
      "r596"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r551",
      "r562",
      "r572",
      "r597"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r558",
      "r569",
      "r579",
      "r604"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated deficit",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r76",
      "r362",
      "r385",
      "r386",
      "r392",
      "r422",
      "r516"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r143",
      "r144",
      "r145",
      "r147",
      "r152",
      "r154",
      "r156",
      "r205",
      "r206",
      "r225",
      "r284",
      "r285",
      "r292",
      "r293",
      "r294",
      "r296",
      "r297",
      "r298",
      "r307",
      "r309",
      "r310",
      "r312",
      "r313",
      "r327",
      "r329",
      "r382",
      "r384",
      "r399",
      "r751"
     ]
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRecognitionPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Recognition",
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources."
       }
      }
     },
     "auth_ref": [
      "r444",
      "r484",
      "r489"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Revenues \u2013 Net",
        "label": "Net revenues from external customers",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r91",
      "r131",
      "r141",
      "r171",
      "r180",
      "r181",
      "r188",
      "r192",
      "r195",
      "r197",
      "r198",
      "r204",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r319",
      "r355",
      "r496",
      "r681"
     ]
    },
    "us-gaap_RevenuesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenuesAbstract",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "REVENUES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r337",
      "r515"
     ]
    },
    "FONR_RightToUseAssetToIntangibleAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "RightToUseAssetToIntangibleAsset",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:RightToUseAssetToIntangibleAsset]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeasesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating leases"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeasesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use and equipment assets obtained in exchange for lease obligations:"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r613"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r613"
     ]
    },
    "FONR_SaleNonControllingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "SaleNonControllingInterests",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale - Non controlling interests"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SalesAndExciseTaxPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SalesAndExciseTaxPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales tax payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts and Financing Receivables [Table]",
        "documentation": "Disclosure of information about accounts and financing receivables. Includes, but is not limited to, amount of receivable and allowance for credit loss."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r50",
      "r200",
      "r658"
     ]
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of other current liabilities",
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r299"
     ]
    },
    "us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of financing receivable noncurrent allowance for credit loss",
        "documentation": "Tabular disclosure of allowance for credit loss of financing receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r661"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of earning per share",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r649"
     ]
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, Revenue from External Customer, Product and Service [Table]",
        "documentation": "Disclosure of information about revenue from external customer by product and service when not provided as part of reportable operating segment information."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "documentation": "Information by name of investment including named security. Excludes entity that is consolidated."
       }
      }
     },
     "auth_ref": [
      "r201",
      "r202",
      "r203",
      "r291",
      "r623",
      "r624",
      "r625",
      "r691",
      "r692",
      "r693",
      "r694"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsDetails",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Asset, Finite-Lived [Table]",
        "documentation": "Disclosure of information about finite-lived intangible asset. Excludes indefinite-lived intangible asset."
       }
      }
     },
     "auth_ref": [
      "r211",
      "r217",
      "r220",
      "r221",
      "r223",
      "r351",
      "r483",
      "r502"
     ]
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of other intangible assets",
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class."
       }
      }
     },
     "auth_ref": [
      "r663",
      "r666"
     ]
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "presentation": [
      "http://fonar.com/role/InventoriesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of inventories",
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r51",
      "r52",
      "r53"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of summarized segment financial information",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r18",
      "r19"
     ]
    },
    "FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock",
     "presentation": [
      "http://fonar.com/role/OperatingAndFinancingLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of weighted average remaining lease term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r502",
      "r673"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r535"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r539"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r538"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r544"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEGMENT AND RELATED INFORMATION",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r171",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r185",
      "r186",
      "r187",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r198",
      "r493",
      "r494",
      "r495",
      "r496",
      "r498",
      "r499",
      "r500"
     ]
    },
    "us-gaap_SelfInsuranceReserve": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SelfInsuranceReserve",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Self Insurance Reserve",
        "documentation": "Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "FONR_SelffundedHealthInsuranceReserve": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "SelffundedHealthInsuranceReserve",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Self-funded health insurance reserve"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Selling, general and administrative expenses",
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc."
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "FONR_ServiceAndMaintenancePrice": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "ServiceAndMaintenancePrice",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ServiceAndMaintenancePrice-0]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ServiceAndRepairFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "ServiceAndRepairFees",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ServiceAndRepairFees]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ServiceAndRepairFeesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "ServiceAndRepairFeesNet",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Service and repair fees"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ServiceAndRepairFeesRelatedPartiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "ServiceAndRepairFeesRelatedPartiesNet",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Service and repair fees _ related parties"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272"
     ]
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance, shares",
        "periodEndLabel": "Ending balance, shares",
        "label": "Shares, Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-term investments",
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r86",
      "r635"
     ]
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r140"
     ]
    },
    "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SoftwareAndSoftwareDevelopmentCostsMember",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Software and Software Development Costs [Member]",
        "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_SoftwareLicenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "SoftwareLicenses",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Software Licenses"
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r542"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r121",
      "r122",
      "r123",
      "r141",
      "r160",
      "r161",
      "r166",
      "r168",
      "r173",
      "r174",
      "r204",
      "r231",
      "r233",
      "r234",
      "r235",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r319",
      "r388",
      "r389",
      "r390",
      "r391",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r421",
      "r443",
      "r463",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r622",
      "r641",
      "r648"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r43",
      "r47",
      "r48",
      "r110",
      "r128",
      "r129",
      "r130",
      "r143",
      "r144",
      "r145",
      "r147",
      "r152",
      "r154",
      "r156",
      "r172",
      "r205",
      "r206",
      "r225",
      "r245",
      "r284",
      "r285",
      "r292",
      "r293",
      "r294",
      "r296",
      "r297",
      "r298",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r327",
      "r329",
      "r342",
      "r370",
      "r382",
      "r383",
      "r384",
      "r399",
      "r463"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative",
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r172",
      "r329",
      "r350",
      "r387",
      "r410",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r421",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r430",
      "r431",
      "r432",
      "r433",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r441",
      "r444",
      "r445",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r463",
      "r526"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative",
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r172",
      "r199",
      "r329",
      "r350",
      "r387",
      "r410",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r421",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r430",
      "r431",
      "r432",
      "r433",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r441",
      "r444",
      "r445",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r463",
      "r526"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r553",
      "r564",
      "r574",
      "r599"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationForfeited",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cancellation of shares, shares",
        "documentation": "Number of shares (or other type of equity) forfeited during the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensationForfeited",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cancellation of shares",
        "documentation": "Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "us-gaap_StockRedeemedOrCalledDuringPeriodShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockRedeemedOrCalledDuringPeriodShares",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Redeemed or Called During Period, Shares",
        "documentation": "Number of stock bought back by the entity at the exercise price or redemption price."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_StockRedeemedOrCalledDuringPeriodValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockRedeemedOrCalledDuringPeriodValue",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Redeemed or Called During Period, Value",
        "documentation": "Equity impact of the value of stock bought back by the entity at the exercise price or redemption price."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "srt_StockRepurchaseProgramAuthorizedAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Repurchase Program, Authorized, Amount",
        "documentation": "Amount authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership."
       }
      }
     },
     "auth_ref": [
      "r683"
     ]
    },
    "FONR_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchaseds": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchaseds",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchaseds-0]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount-0]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Repurchase Program, Remaining Authorized, Amount",
        "documentation": "Amount remaining authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockRepurchasedDuringPeriodShares",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase of Treasury stock, shares",
        "verboseLabel": "Stock Repurchased During Period, Shares",
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r42",
      "r43",
      "r76",
      "r391",
      "r463",
      "r476"
     ]
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockRepurchasedDuringPeriodValue",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of Treasury stock",
        "label": "Stock Repurchased During Period, Value",
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r42",
      "r43",
      "r76",
      "r399",
      "r463",
      "r476",
      "r532"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total FONAR Corporation\u2019s Stockholders\u2019 Equity",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r47",
      "r48",
      "r74",
      "r423",
      "r440",
      "r464",
      "r465",
      "r516",
      "r533",
      "r642",
      "r660",
      "r701",
      "r751"
     ]
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Equity",
        "periodStartLabel": "Balance \u2013 June 30, 2023",
        "periodEndLabel": "Balance \u2013 December 31, 2023",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r29",
      "r32",
      "r110",
      "r111",
      "r129",
      "r143",
      "r144",
      "r145",
      "r147",
      "r152",
      "r154",
      "r205",
      "r206",
      "r225",
      "r245",
      "r284",
      "r285",
      "r292",
      "r293",
      "r294",
      "r296",
      "r297",
      "r298",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r320",
      "r321",
      "r325",
      "r328",
      "r342",
      "r383",
      "r384",
      "r397",
      "r423",
      "r440",
      "r464",
      "r465",
      "r478",
      "r532",
      "r642",
      "r660",
      "r701",
      "r751"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://fonar.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUBSEQUENT EVENTS",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r348",
      "r349"
     ]
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalCashFlowElementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "SupplementalCashFlowInformationRelatedToLeasesTableTextBlock",
     "presentation": [
      "http://fonar.com/role/OperatingAndFinancingLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental cash flow information related to leases"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r593"
     ]
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Axis]",
        "documentation": "Information by title and position of individual or group within organization."
       }
      }
     },
     "auth_ref": [
      "r656",
      "r704"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title and position of individual or group within organization."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r585"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r592"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r612"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r614"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r615"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r616"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r616"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r614"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title"
       }
      }
     },
     "auth_ref": [
      "r614"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r615"
     ]
    },
    "us-gaap_TreasuryStockCommonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockCommonMember",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury Stock, Common [Member]",
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "us-gaap_TreasuryStockCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockCommonShares",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury Stock, Common, Shares",
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "us-gaap_TreasuryStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockValue",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Treasury stock, at cost \u2013 4 shares of common stock at December 31, 2024 and 45 shares of common stock at June 30, 2024",
        "label": "Treasury Stock, Value",
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r25",
      "r43",
      "r47"
     ]
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r299"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r611"
     ]
    },
    "FONR_UnearnedRevenueOnServiceContractsRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "UnearnedRevenueOnServiceContractsRelatedParty",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unearned revenue on service contracts \u2013 related party"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_WeightedAverageNumberOfDilutedEarningsPerShare": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "WeightedAverageNumberOfDilutedEarningsPerShare",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:WeightedAverageNumberOfDilutedEarningsPerShare]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r159",
      "r168"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r157",
      "r168"
     ]
    },
    "FONR_WorkersCompensationPersonalInjuryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20241231",
     "localname": "WorkersCompensationPersonalInjuryMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Workers Compensation Personal Injury [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r620"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "740",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478822/944-740-50-1"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481573/470-10-45-10"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-2"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481549/505-30-45-1"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-15"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-16"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-18"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4I"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/230/tableOfContent"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-11B"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-29"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-29"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-29"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column A",
   "Publisher": "SEC"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 11",
   "Section": "L",
   "Publisher": "SEC"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-5"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-2"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-11"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-42"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/330/tableOfContent"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480265/350-10-S45-1"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-4"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483384/720-30-45-1"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478758/740-323-25-1"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/850/tableOfContent"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(5)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-3"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479196/954-310-45-1"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/985-20/tableOfContent"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-8"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-7"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r626": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r627": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r628": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483504/205-10-50-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r634": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r638": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r639": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r640": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r641": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r643": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r645": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r646": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r647": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r648": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r649": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r650": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r651": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r652": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r653": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r654": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r655": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/310-10/tableOfContent"
  },
  "r656": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r657": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4"
  },
  "r658": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "40",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481628/310-20-40-7"
  },
  "r659": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r660": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r661": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r662": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r663": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-20/tableOfContent"
  },
  "r664": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r666": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r667": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r668": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r669": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r670": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r671": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r672": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r673": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r674": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r675": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r676": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r677": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r678": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r679": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r680": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r681": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r682": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r683": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r684": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r685": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r686": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r687": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22"
  },
  "r688": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r689": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r690": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r691": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r692": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r693": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r694": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r695": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480060/805-50-25-1"
  },
  "r696": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480027/805-50-30-1"
  },
  "r697": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480027/805-50-30-2"
  },
  "r698": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r699": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r700": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r701": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r702": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r703": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r704": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r705": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r706": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r707": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r708": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r709": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r710": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(13)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r711": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r712": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r713": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r714": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r715": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r716": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r717": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r718": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(cc)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-3"
  },
  "r719": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r720": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r721": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r722": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r723": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r724": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r725": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r726": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r727": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r728": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r729": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r730": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r731": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r732": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r733": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r734": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r735": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r736": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r737": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r738": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r739": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r740": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r741": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r742": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r743": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r744": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r745": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r746": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r747": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r748": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r749": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r750": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r751": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r752": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r753": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>69
<FILENAME>0000355019-25-000009-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000355019-25-000009-xbrl.zip
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M2>D4V&Z JKD(J[DH=1T(!!*52\<BER((I^"#+T1MV!$E:V@H6A=M^ 'C59%
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M:>+AA_U?#CY>B[_JJ#:*&1A.,P8X "B<F/^U1^-*L^R,-*NY%V-!5A.-JM%
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MI*GBP(1C='^;'+; L2SJ$1G<T@$.W)>E%[KS"<*G*2?X]N\3$I_\0(YJ@KJ
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M%\V)[[!&/F*'D3%7$L+4@#%AMIYHT#W8@R17[%ZR310#Z]W7*8F&!E?-A"C
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M2L4S^%NC>ELNYIHE./LF_'%7JC0;3/6*J=9*-F6.CA*?<WU]"'7"&0H4F':
M0-&@;M&')OP(7@C>)0"?,P"&_3TCVG=\.;:I^K':)OHCQ,S"ZH_3"D.=\B'L
MDW-JLGD<$6'3,[&1\3#YT/SUGNHD'L"YW\B(=!P)?3[\SNAP<JM9Q [L9#5M
M5W;<$Q-5HY[]52^G3W<UL8.V4OR$E#+<8:5,D+N[VS/3H#1&G_YWGE[>B"C@
MR#)2UED=#ZAY4V(:Y4?FKEIIWC2P<<F4H.U29(JE0NDN7ZHS A>S/_]\[_J-
M(0[F\F:9U\$KT(; S+5-"T4>6DJ^-;Y[KHE2J?!X_3#- S\2,-5+#Z7*O<>
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MOZH7\LV'TM5]_9Z[:JKU9KF4O8;_?M<??N8?2BJ\]BYW?B3"<?4R+K,%II:
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M^FEYWA$2E5YC#H>HU)Y'G4([L>?$(Y72K+]IDPOFG'A.&.7 X^; !>8*9!H
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M(FHP]EM79A9\WD0G@IC&'C43[1F!R"Y6:3;!V%"% :\!L6RH*-X#'ZB(]ZA
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M=%&HGU=:3*W.5/[<U=I/T3[3]\)0,:!YB,&;L7639Z01-#.*H<%?P0^"#P'
MYXR!:OZ=X<UO_(CXP>[JA;MR#1(HXH 22NZO1")]$D%7Q02_JJ@QY)JTI _F
M!CYBH#$5Z)J(GPJ#N.BX(5Z(]V/O"6 FM?=68=K*LC#?W:LV0P1?$1:ADE*(
M6/1;,XBP>45G0(8"1PLQ3"V/99@4,PYF&%=4EOENQD))XRE? %VHS "*J@E4
M5_WUFQ',D@-DHY%AUC2TQ6?,J\P;6M=+,6?#5Q $8VC(Z#J, 2N#GB1(.D60
M#9^=WJ!:B@0W5#=]@J]NZ7'7B%G&F3%+T>3PD@+5]?H.A!+.Y7).+I<+J0.A
MU9F^=S]:N4NU>:7M>I:*Y>LF<R=A>*%>?0F7Q@@P'+MP]?",0"5/PL_-V,[^
MR>YR,-8KT][AM0/-M7"G;.:48TF716<"*<8DS;^$2.25%ZWCX.-UE3&9U94Q
M+5=ES*(V#:0]H%M]>1+R7.6R+3H5,470ET:C544Q>Y1"HN*7#04JNV6[X*P!
M($6>UZ1R1>V#3_NP0>%^QE]Q\H*MR"7C&?+-6)2S#XVS]U>*M<C:) 7WF4#K
MB9.I>"(?!:V][#).V?KPV9JT^C;0\L)T@GA\ 67KD/S[RB[]^Q65[ZWAR^7X
MMFGD;_M'[.<3BEEVRWY\V]]/1,%L4)?HR&T'>75ZQE]Y[A+SD8VS6>+]>=2
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MX97DLEE,1%LHIE(J__I:*(O%N]S1S&LR<;!AO&0!]ATM1K$>N<DRE-!5Q";
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MY4LHZEA1L=@QW]'5"#%XDCTKF3<G_"_([HIJ_P%_S?KU#T;2&)XI YE_1Y9
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M?K?N;FX*S2?4-M.JG==KU5JI4&\SA5*I<5=OU^KGS"W4UB6W<0JRDV9G$<#
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M E8YP0*)/$[]#AS^M0LRL!R[Q7$R1K<;*.+:& A0H=BOU%"FW\[+SKC-J_(
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MN0?N2::^0V *8OG-(!5$?/' ?(HC*O@I@Y$RE$98+&A*[Y!2>I1 E$"40)1
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MRI47]:TE<R'/T[TO2]K?CXN//A]XC,VN3%YRL(#C::0U_(1S<^EHL2\HCN6
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MC2VT8,TN_)C['B\X7T,V(&-]9:B(CA.L_33MXTRK6U9/ S%3FYOFV[)FT%3
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MSX,JS6P^0JERFQXCAY$8'JD5E-;#R1L!LR+.+AWGXFH;X:E\P6M0E,V\V%?
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M8;6^$-LR@:H(O-;WRT"XV)KY'2 6NGA//1.*)X+B*;ZOAA=')W/4,U]"PT.
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MDGF+9.NW6V:,'K#7C5M^,"58J4AJ4*)=<9*D_O?_I!F:_KU4=Y*$%TC$:^Q
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MCBW(XV*%W=,S#([FVM*GY8N+4@3T5C+C>[Q%P+W3P/=8UJ 814-M<:V"C(H
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M!:@40(6@RRNW T$WEZ\NOVE]18C1$*,A1OW7C9P@]N&L\#[52)D*L*P7%8R
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M-C<*>('L:9]D7ZH47;J_8CR$7S-4\.-/[">=V5#Q2X#R_W+]&Z28;O+WE*Y
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MW*CM<3_9Z$F)XV": ).3J NGH^GTALD4Y&OHL!GL:/<."CU(T@K=GEFF! &
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M=![?PC* [.(20#U"&H(\W=!Q%?#?72"@48__8 S!CSAS)K'AB7\I*:@ ^=V
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M%0(A6&IA3 F$MJJQ./^YAL3<!%7NT;\'3OC %D["]DK=X2-67(LYOG[ HX/
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M^FO$2"G4GT<JCAI?FZ(VOX8^EBIYZZ.6(B1KJ.MX/D(?8.,E48^CWOLS7RP
M #9=J4I])K]7K80,PR%N#1ZY")-:NM#&6CTH.&C:_ *&<!#YH+@JB3Y.N@2A
ML5)4J])N:2EAH+=+!('OD8*A#741X/AB&24XA!G</MH$6',B'Q54]%"SI@\+
M$Y20NO >6+[U[(10'<;+/%9J8SXAVFVH*F;6O5:GRAZ0C%TV,M39KDK+/R8&
M'MC$!=.T;0\*-B7+J<ITS6PEL1?ZJ+U(W!@U>", 9X6%+=A>)XW$3YL6)BZ
MH'N&OI=JTI<EE8!D7MU)=_K4E4X?6:O$-(;:Y7.9=/F<R?IR4?KN>-K85A9]
MEE:6[/\U@XU%1_GXK*[D?V=BO[!*[']Z8K^P2NS_*S)2J]3^<N\'"/;"78?<
M,L"S-NW_I:R(!;_NES5N<&=KY"92M^,S!*@M]K2@+SS,\&^.HNO%T%(%1>])
MK0%O7Q3$C%].+@^^)@E!A6TAY9WBH<=1$D]78X,[+K4]*AXQ+VD(1PXE$,7
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M2PKT/:=,H0/FIVSBV%9"U?E6A1)DC1P\4=!T8$0@1;()X<]"CN0.,U'LXNV
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MAV>YW?_2K;S1]*T^_+,3==W__7]02P,$%     @ %VY36D'X3A9K"   DET
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MP6Y0OJR.K_;HG>K'[B7K]"[V?P%02P,$%     @ %VY36@D&GD3/!   #2,
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MBX.+$WYQL+-S\G!R<>\>\#M>'F[>W3]VC?RGZ=[];&S[N3G8.;C_/Q^L&D"
M$[93SK;G!+!78 ^;P!Y6 X  @#W[_QW>'N"_CCU[V?;M9^> A\$#/U!\$!X^
M&QL\Z/WPB.&[(?!]8)_ _D/'SU]F%S1UY#CA<_C"\[@,3JDKWVN%S+I()Y7N
M/@KEXCXB?%1$5/J4S.DSLLHJJFH7U36N7M/1U;NN;V!^R\+2RMK&UNF>\WT7
M5S=W7S__QP&!3X+"7H1'1+Y\%16?\#;Q7=+[#\F?,K.R<W(_?_GZH^AG<4EI
MV:_RNOJ&QJ;FWRVMW3V]??T#@T/#Q,FIZ9G9N?F%1?+Z!F63ND7;WMGU:P_
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MM*^[6= (C_I9>K7J7[@6?-F]N,VK=VIL5G6$N9)[..QCI^W,D_&'I3C%2NI
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MVD@L8(:4_B83>OX0G"_.'ZXC[>D,]\/2]]>R@$_])=,A81=Q\R\9, :<A$N
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MN+YTCD.T5[6CB)@(8;7&IV<ZM%H>M8_9YXV?]_#K;(^2HV1"QVMHL"#2,\T
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M/MD9G_+TRDNU CB'Q0Z""::P7A2T#CY<!*#PFG@1PB ,#"GL(?;\8J-GZG!
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M,]RE/4C')/#[M] /I\$57/#X/U!+ P04    "  7;E-:,(J!<M@4  #8"0$
M%0   &9O;G(M,C R-#$R,S%?8V%L+GAM;-5=X7/B.++__JKN?_#+JWHU5W5,
M)LG,WLWLSKLB8#*N(L!ALGO[Z<HQ EQC;%8V2=B__DFR#09;4AML2S-5NPE$
M+7?W3RUUM]K2+_]\6_O&"\*1%P9?KV[>?[@R4."&<R]8?KUZLCM=NV=95T84
M.\'<\<, ?;T*PJM__M]?_LL@_W[Y[T['&'C(GW\Q^J';L8)%^+,Q<M;HB_&
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M%5V'+ !4R606,&>*HR.8-^D*#7$#%*^4D_Q^046(5-=$1P"(EZL?VDS,XZ4
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M,V_?#]WPC4=2'T: G9@5.RYEM;Z%8$$]-W3034!M31]^R(/%RW1]6+(%^A8
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MCY8#X" QQN(=?L'N<L7P=9_9:6*)AQ'7PFB1"_VB&$.%FK&?Q!+B@-0:,ZP
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M5\J0B1YCVP#+]<CSY=3Y<NI\.76^G#I?3ITOI\Z74^?+J9HOIQJPCUMW"JC
M/&[C";YR^VJK[Y94@E5^TW2Z?35C*1@MCD676%"E]1X_6L>BTD2J%DC#!MKL
M(;P741H[3R<.T=PY%/J[Q-TR%Y V.=KV'B83'BCU;M"]'MP-9HG?:-Q^)_U
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M"EXY5?H5T[[U%4BC[5A?W;>LN=>IH\N!CO95<V5]*( 9:WNTR(@B?_0/%+?
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M&A% ])#ATF20(:B6]<*%AUV0))\/>9SB7-T0#:3<<D$*L<^%G@@@+LAP*;C
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MF@$3LS5.6L=LB0TPW)X(?'S,KFTA9HS?3<C,>6>XIF[;\WNL$2!1VY+;XRR
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MN<<A[_YVWE!=D+I*0?> )=_$F*M]BBVX=4.?QWV\H7=:$_3)W8^H -3H>ZP
M^HS;TZP!KP2:;-Q33+WGBJ!)T7U,56!FWV%ET*=/GF0,=E70I%:>8.D=5P1-
MON4CZ@&S^AZK@397XR1CP*N!.GOC!$OON1JH$SD>4PVHSCNK!I9Y2Z=;A%LA
M;'*:3C7W3JN&3:+3:?6#9T:UJR5GW1XDS)HM7L/D$,7ITP]9%GV)DT3&!!L]
M.,G$)J$V[>?(+Q";2?RZL8!J$]]X#WE=JJVV0[=5RZL&):?KWU8.]%:XM1I@
MPH\53&&MI+L^DFW%]6G_A M#<L#10Y $;!_>_$"(.C6,2MCM!@L=X/[6"9DD
M'$+IX$D6W9@PRBMIOA=[%^<Y.P7 -V/O@S?ZR@05P2N$[91!@O-9&M$8&^=X
M$[RN@S>V;4[/+Z.6TXV3=B[T=DOJ5<!0SP[GD(-<B_&+<8V)>V=952O6)?4W
MC/E6 4RJX"&(:8!+ IE$&@RCC!"%OC>., F2\AQ)$108Q2D-:;B,7Z=BF.(,
MWP-.MMM#&N'HKSA(BN=EFA\(RQUPCW-,A-&CI8ZS<W:V\)N3<R8%[S0:@U((
M2U3MLM1#SUR14JG21*14/1>/LFWQ)2!T4!JR,:?T-*<HXXXG"G@M+P8"0'@@
M1R64>R6&:CGOS1$_7/= F4C>;MJ$,_H6R:#C_)"C";YPUE&EX)U+8U *)V:9
M#GK":=-&!=$N3F-V>KV(7S#"Y2R3EG/G+JH1A21QW.T<C_'0F FFO(0J*71S
MNOQ.)SQ)MDB+N'C[6QSA9;K-R(Y/ ]SC%YP>,$L0LG@M,$F#9'[("]KU(?GG
MMS7)HD-8L,[Y VVX:&2S/'1VTG?Y.9]VAL\E/\IVPA>!B7+G]$[L<3WQG!SW
M>,^FM]*G"U39+Q/7U&] ]2LN4/4&'DJK5X Y2#?V@]T83M<=8<]EQ3O:[6[E
MFFP,3 4ZU@,AEXVV1EB?V#LC 2J$TO*LGSGN)N@*2( DVQY.*J'RL^/ZLX=U
MK#O30)!GG,S+L$AA#+]L=W2C%'4V+#2 ;4:'"CGOA+  )\T(>EF)H[1#%.^M
MSY)/>]UD.<\9-\]H&$H/M$VMDO9DJ3J/B5G1;<(*6T?ZZ]$F+>]\&PUUR+ZO
MF<XWJ-3OI9"D.MX)V$W'3/].,/N#]@0M#OW9J;HDX1AGNC2TT8.V*6($9FT*
M;CZ]T='QSLCZON)-5IWRKD8/\8M^'X2%GDLN6KO1):)1"4PXM$4ZY-X\V,<L
M^P^?0HOBXD! M,)ERO!U$$>Z;% #*;?MJQ3B8'-75P0,5>2XE&G;F1C;?E=O
MSZH8$_^SW*;'A2Y0F]5PQD@'8_*O;./Y^B?S0MN3Z$BY[Z<)$,5.62,"B$<R
M7"*/>#^+BW$N>6<%S_*YVOZ8EY%1FMMSW W51UETR;83N-Z;EYAN#@R+C_=!
MF3>9VBPW%J)5)U'RHILH>7"YW>DNUU;E2PX*S/=+\K#]D"7#H*B4<I>W6 FQ
MS3TLB'BGDQ[7D"(_EU-@WXL*_B?@Z5":#G=ROK'VH<C"7V<\MT/Y<X$CU?VR
M%GHN0YVU&]V 9E3RSK.Q2(7^?J/'=D!SS0M4ZJ)&^3P<S$G1X1_]5\L]^H]?
M.)9[O*_2'-/QRQ,)=K-#\9P1UMDL00[9-TK3!?\FN,(8.$+-.P?'8Q76+)_9
M5J%6'57ZE(J-A9J6GM9C!@Y&5P="F^DU)G$6<?C2"0.S%KSC/",P"^7(5#OE
M&*%2&97:%ZC4!UB$/P7)0;XQP:0$:!'.'NOH@N/JWOLBE8,1QCL<K<@\2!)=
M391_'K.VTQTVXUR24-.D"HV>EGA5%"W5$1TLE0;&AQ@85.U%G+%?JE(&1513
M"#5HOA^:=N%.92FH>#KHM=WC71"G%&W;^6IEY-WN4QCT0.8C'-?T$498@T;Z
MZ2[8=^D;HR,[]TYJ1#/A=IV1>1+$.[;MLOHC^L<A+]BJFOZZX7$F7+)^BG-=
MGH_1!\/L":"'7&Y,\#G:4I<OS%=_MG909<@[C]FY*\/!.;VHTVBL =N+LQ(Y
M,#S3@),=BD.-++H_S3&XTRV/5B3^C%.\C0O97JJ6\:OM%=YB0G!$%?GJAFEU
M[/2O\;) >^*/)%WA/=$[P-21,SFF7F.NXS'ZNGK5-Q>H?1MJ7W?1#>+9%M6O
MY$:^YF_]YG2K<<>?BGAEBX2'.'^NO]!C\0/M5;&]C'>8_D!A*\K 3M7I68<1
MSO2.-5CH@:'^"+!#.O=52W8^%A>(J:-R^VJ9-(D^H5;.M%1<UXBF#L_K^R9E
M2Y\Z:6=+QV;(S1*R6M0[@^SPJ9:4U8K^EY:'<5US[X-<U.WF9378_F9E4<X[
MARS B;N0.RU@-S4;C3)L]JK<GCQ+DNP+Z\5"(E/33M]EQ3T.LZ>T78)<;7],
M2?.;3&F=)7'X]IPE$2;YPX'LDX-J1>',[_1$[_-]/D4].?T+(5:XLWFIK;GM
MW 5]+6K?V^SRH-6Y^VXDU[Y /0#_+ZH@G*FSL<:T#-(B>&)'INL\6+)V42'H
MK(NA!=KT+J12WCEJA*;J4TAUCNY.**@PS\@^HZ,T/$OX>5%VA.$V3N/=8<=R
MHS509,[9ZSHCS%AW&@[9*L*@U4BT*J;9FO'?EVU3/,RSA,+(REPT,T+8YEY^
M%F>61G>4'8K'&_I7'H1\-L(NJ\CI7N0GI<BI/Y0\G\BIWN*]7IW=-7%O:$<?
M=0SPM8_NO\M\/\5SD**^$I0L(B?X4C>&Q"*G?87;K=&G_SC]7=2GLP^F%I[!
MJ7/4OYO373VNZ)\9,FKXR:*ARYP!+EN&.4-&W1WJ2)ZK.*O\3Y3%MT&<%CAE
MDSMK$H?2#K9.VF'&51/D3JY5E2@,*ACQJ9BA5KS\[OQ4N<?[(";76)%D52KG
M@1XB3 DQ6B%HE!"0F<G0JIR+!(O=/LG>Z NNA6L/)<^=%;H,5E/8W8<P"EF"
M2%6X75$('6M^1HQ=FG&7%>SD]YMF[*J4=G\24 E9//\GB'KGC!T^^5D_+HVX
M.%H#N2K@"I/XA?=8K^-7?H,4/P#+CL,JY]4U&F[738S0^ZL>2G$PK#)C%%<<
M:HT+Q'6:3""(:7F[A>L%ESMZRL5O95X600S>H3P=2''[4RU;937CZ[8 *GFY
ML,2VK:Q2=E_):KLF+->:<JN@7L7'\J@.O&QU4R8/J*(;02K7%OGFHRQ%3(NM
M(=9ZYQIK2,\GW!UVCYBLMN69K_8XP2;[C#N'&>6CDB,MNAN_G,3U=J1SE#GO
MW#V=#\K1TU'&SSC<GGI$Q_X+6AGS3/P1#ALX;V$),MWMX8]CNH5= \G/V Z7
M&]%TUW%U!0"=S9?C$FX2K/;957)>/[+ZZX+[K(;OZ>DSVET!X_WV%]WG'7'G
M2T?4-W_K3FJU5L*6X]3?7RD,J!C,&)7]]$J%#@$;)?_505\B4D% I:''IZT7
MD K!\.EA?G";S^SITVX(#O(#>>.]*F4R#%$*T(?6@!M^[UJTSAEG3&AQSBUE
M#$*U,WGQVT%QJE*4 O3E->"$XV#\\06:%06)'P\%F\%'18;6@<>X(N)?IE6&
MZ#5+7I^E7;B;C&^120MJGAI[JF>+[8IMBN5??@^XJ(]R2$6/QBBJK J$Z1MN
MINS]MTSLIC.K*FW2 53!K:%J&C:^[ZL4]U1(\RPORKO)]\*EM2H90(6@A"8N
ME5+!\G/[O4O4?*W-9[S-"*XK;P6W_F>IWLG,OG@M2) 1&A<"\L;W!<K#B^IT
MHT\\@(@$XC,HTAY4%QKQFXRDN0[0(\?6KM%6Z"[:7^IUPVZV_@M5@Y$;UQ?/
M6D%Z7YA"S.H<ZG+^*L5!T<N,4GE!1U.:737PX6MT53@N.HU^'2AVG-_+XV.+
M1>#P2DHA"XV:4((H.#*H$8[)C>.X/*J#@FF>)7$4%)C=/E3"$Q;PI%( 2L$"
MG&07GBCM:]3.%[-7AR(O:%]7T60*0K]\\O[=S=BD^2AI*.K(>OKHMW&:$3[J
M+Z/@%0[97!J_Q_@JSLLQ.C^;IQCZ_[4<-\K*ZE2V 52ML[DDW$PL;YPN4/VF
MLKGKO4LS?8*J]_D(IC2>S/EE0LNTN4EH<*$1&_[VKBV*Y4>DIM@!P)J3P)?<
M73W%G@\&=+?RL9FB/=L&>H\3UMJL@\%F13L-**5J#W18?D9-?QU1'F#J0+-,
M9V'(]M?D]SC$\8OJ6(*-'H!2FP17TE\M@_#7M?HW[-:TV@)J38 I1+;_.BUH
MHR6?']4J@"XV&4[+\NJH@BFG-6&GXYK)8'Z(VJ[ 9)J@2TX+V+((*QO-C/A%
M>>P<3'%R-.T&"_4F-DM5T 6J1VQ9HF7:@-8*\KI=3MU,:$[H&95 EZ(*Z]A&
MT.(<G_NJ6.T!-.PXLE8&79 FS*,J9&4'>1Y*B%[.^;9Q3*[P/LMC<9N]40-
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MV^K,)@.F8A/?:G;# =,+W$"]FP^8<,H*36U$@)B9JS:W*;$0T52YX0T*<.X
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M?W3XA'15D_BR)G7B[W*6RC'[PUD5\AJ3P"7NH2&N BAF+_9B7C*+H;SMW?"
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MW#(%XDF5_*Y+",/%U\5PF&M!Z< ]"$.UQUF(<UD5M.OP63DH\%TX\LHTQ+F
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M:L,] TUX+0[>BSQ,Z2)E/#58--$9)S9\^V\-$/JT7I:XOTI?Q&6CA7@O^JO
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MMR)A]! 8>CV@&IB'^HW.1HRIC2(HO,P("3^&--F)5W< C&@K@+FHW]YJP05
MY[9G(^$/. EF9$%; <Q"_=9("Q8 .K<^%NB2^U'$KFLK<ZN)SE,H!$:[_J!-
MJSXOU:U]A/NKF)VO_#U_Y=T$M+0L&._Z8R#M\-9HVC+LXJ# ).)2&*<696$P
M\/5',%H ;]"U[6T/#9@L$]897C;FN45=&HQ]_:&#P,VF25-$X(4DN<$(PE]:
M"4Q#_2%]%6C0Z(TQ 1U%@T]#ZBKPJY!-, %%F4+506$E?:.(OZZ:PL9VP]L=
M_^G>6Z\)@V!%C#39M@'FK9%3LSUOU3!JW9AQKLKG2,S N8#L>6P\45BV 2:R
MD6.W/9'5,$(G\I@(V9H^64TP:8V<S^L@38T'.E6E':HU9;H6P-0U<JBO@SHS
M/BU3*)D N$4[LT<8V -7!A/7B'W GCA+5-"'G4A'4W7$*2J#.6O$QE#'8-.B
MTO8X<YX2WPG'7A1#/%V:XF!>&C%!5!A+)LWQ9SSE85A5%LQ!(Z:(6N8S3 /H
M81ZU8,)8"4Q)(V8)>TJ **!?'CU[A43"S2GV.E\,GL8'Q4@D%[J$.&[NM@H.
M?.7PD9<$L]3DU3H) QKW/=ZT)783/-;#A+6T(!CJ)J^%::'6Z(=A*=4Z"<Y+
M@+%M\H:3%EN91NV['=7A/<=_!$/9Y"4>+90%/5I&T1@H52D\JH%<1J1J<%H'
MPJ1H\)%UA$R0>Q*M0D^8FTUQ4H!Z8$8:.=0:PJ/ >K<^'[L>E\/QO__N_<NI
M&QF]5\9J8#H:.<M6&R!@--J>X(,HN O6<<06&W,$FZHPF)%FG.S5XFGUFDMX
MP+A(.0Q#O@/07J;\OG29DK\&R0X6^QY=]U@+-" TB?Q]K__%84RX/=XD":+T
MZ>46>ME!GNFZI$^)HO,N!ZO9BL\W_?Y!(,U-2WE)_#!^&Q;RCERI.FU?P>0W
MI[,$>O?LO^J[$]*"^.#KND\.;*GT+5_$O,XK@$" WZX#_AZN ^:'$8E)N/4"
M 1$?4^9IHUP#]\)0Q8D; D+;AX+-)LYT4)MI"F5PKPN!0*1*X5%0/@C 3AO[
MR(M,@6C*TK@7A!10EC8F2C5;1GT1_SH+5]-P&87#*/:V J9'$C]3U\  K";N
M%2$C&S;JMVV$3V(VB .>00PR 6F*XUX0,G)@5!1ONI_0^._D.(42TY" U<2]
M062DPT;]EIEY8.K2@!QV%FS#IK9.J\KBWB<RHJ]7\8H<M@5%[A.RI-GKP6Q'
M&*QIN!+[$^6$9M4 [F4E6U8A8. .+2'A9X_Z L'I^F>Z)0/^OFNX'SM?K#C3
MMX)[T\ERGUP5I YPR0Y?O[&3K;?V5IFT2^?UC@1D[<61%9_FEG"O3=7 *10L
M7%[9!.([02;@:+OC61Z9P.*!QKUAIU*Q*=QK6!=1I63<#D:\0P!HUZ,KCWL7
MJR;RS(!<T1Y)H@STC%<JCWM!JSEV<<^"^<6$DH@=B.9$O']VM-CKYUF;^KBW
MM6IBT!ZPCOBLA9=YZ;'=PD;OM_Y0]%N+FKVT:LOI?U.AMT+BL=XGK2C:BD&%
M?SH:,%A8GWH,=AZ70>.*UI7'=R5I,<_;431:M.V'OD[GJ+G?F%VD+>8!?G.1
M8ES:2(<C^X"B9V?E"L7PX89W;KD&M88 5 %>W..Y<R+BY@.S^F'(\WR)UZ'N
M]J<RV8M10HF3)H'+7XCFN_=[NG6\0,U?,U]#[@9R9J7L-Z-_R^F.LY7SV-L-
MWA1U<=S(!JL=@$[?MAU;!WD@[EUE8=S(!FOL.^'+/4@S"XD;A]O ??"=C1[W
M0E'DJ 9+U*5Z8O5V-OH&0>2& -"+99&C%RK,,V5-D6#_F7XYR0.<:U1UD ,8
M+&G0:][V+:[#VN-M";?Q\-W#9\=7#P5M!>30!2 1 )TQ!H5TLP\9&::*R"$-
M%]M#L,>(5#*MFT5? SD8X1(^KM>7(M3Y%+BAO]\LR"H)T]?OE/&ZZN*X(0E6
M].GTQ1A$P]=P-0N]E6[8Y,K@!@I8(5W2# />C^RT+V[8/#A>R)-4ZG"6%<;U
MWUL!KM:U9>3/Q]C^\==8](/!<["921]C9I5,=7!=\5 >8)IWQ'\W"B*/@;8,
M'1%(G#.,R9QX/Q2=>%GU7E:_=]9 *QZ:@O@E8HK>&G7Y5E*+'3]\QP,P--X\
M>4E\ [P9\7Q6,:D2;;OQ3E*HW7C%,OA Z[J*%&(L!YYD[C X\C0UNH2[VJ&G
M4>#M!<_:NO;;]=WK]TT#3&UQZ"])N(VFZV7HLCYAL.WHRN,ZN*R61K/:;6<]
M%5)H[3>%(K@N+<N-B$2Y*S+3'.5?\MVX@9VL#*[OJQH]9^JU';2:^.3VNZ<?
M;OG2[])=3#2N+V5A7-^7%>H&A=M/ZF;%@*X\KN?+B@2SVBCK@)!#FT1#5@[7
MT55ARI&IB3CM+,-M$ -GG7Q97%=6Y4FGK"[NG&."7U,<UWEUR8R#3L)A^PM(
MW*,HBNMZJC#M*)1% 7[XNO-"$.[%DKA^J JPRU5%0?T^2071X7TJ@^N JH!T
M4;U.>CMFU/=6'HEF(3U:7_+>CC^9O!V'!GI.X/9X*\1E!1$<'WE-2N3H/""*
MBNV8+C-!W+P0QFT_H!IPM#0_5+2TG!DZ@5"T/%7)Y9K0.!/-8*FSJ ZDK 5#
MTF6<:;!I?0I<T\ )OUW1;3KWY=*%3]=W2<1TBZ)^X-XYD1=-U[/<=\J3X1]O
MWQ<GP_OA8C ?S9:CZ:0W?>C=?5J,)L/%HM>?W/?N^HO1@O]U-A\NAI-EGY>J
M-"TR)4+1*6_??[@5'?-A.IG_XR2)A5K]IRCF:0HDO94W>F&;E0:D2CVX +HQ
M*+2JU!36%%H##^<CM3H$W1BUBV2[=7@VT(6W"<2-\B#NKU8\74YNLI(-V-*%
MZ\6GQ\?^_.]\6"Y&'R>CA]&@/UGV^H/!]--D.9I\[,VFX]%@-%Q<OH&I="6Q
MI)9FP![N@&GJ(-WOT_&D&ZR'&VO ^E@C% #\^0BTU*L;PRX3,9J3%?%>N'_Z
MD;A,>/_T!S:!/#J!D[K_V2_B=:0'0G)U9,/R^U(>A'3\+7KSX6 X^MR_&P__
M3^]Q>,]&YSCW-[&N/O8G_8_#QR$?MNS7Z?+GX;SW,!SF*^,,WI/2@%$K+8PS
M7,?4"7BZ#=8'V?Z/''C,20A[S21KKV)SR(-90UYA%%\$%_:@GNX(MTH$&R;V
M@Q<XP8K]/"9.)%] 2\&.T]EPWA<+)1]\#Z-)?S+@OXV'_47%1=.XO=7(#-[.
M@MJH<_LZ9OLK<OIL]JG#QXGXW;1OM6RC&QM6"[;R&]1*>&&/IE'PPMJAH6+[
M^<>2\6SRF:U;TSG:_O(@\/XDEGFITE;"6;(D(@%6)GTMY 4(0$UA(8* @#U"
MQ-(X8BT%&X]O&-D@EX75__&V9&A.-W:CR;(_^3@2F[_%8KA$&C<?*76_>+[/
M)J2B,C8CR;(9K+&ED@PTQ "5D4=:)3)+8P\,4B>&X" ).3)C+\U.JEBP_BP?
MA(-/\SD_;XU'_;O1>+1$6[YFSC[=H0<N.YV&/&#7/.BTE9 R3V5'ZTPT(19Q
M<^0<#A6Y/YUXR;@$C,:ZOX,\< 'T%S-?-0(T]HA>D$UF<)D3WXD)F\;$6Y J
MO\6/)3/H\./1@#(?COO+X3U;:1^F\\?J7HK+K8:I5G.RHZ$X/QA'MKH&DMVS
M((_5R@FJC#P 3105[9UP/-"'5++;^<*,Z?@#)WI^\.D7_:AZ7WJ%=/%I-AL+
MRV1_W!OT%S_W'L;37SHPL"2Z#=,_ )9/6&V< 7>0)R_CB1*(JP'> O;0LR"Q
M, QM4<(>BP.ZW7IQJEG@#JAPDY! X>1[?UL<AX/IX^-HR<=AZHD?3(5K;SC!
M\^MI5+(Y/UHV@S0H(4)"AJ9E.\@#M!+%Q9%:"3KL\3H*V(]DZ;S*QV<I:F8T
M82-TV%OV_QO/#)I);&<&U53",M641 +9:'2UT,V@1FI*IA@S"-A#)#NGS9PP
MWB]#)XCX2S$TD(Z74M#*X80VZ\^7?^\MY_W)HC_@VTFDT:-2!N+T-M7$&4<J
MN:R&E54CZ-YN&(6%H58!)^R1MTB>(O);PMH:<F^)=,25XE$6G^X6P[]]XB:2
M(??8(0VTHNR0PYJJ!I)%I" /Q ZBKH)^!-/34;1^F'3''QJ0N$I-?.7[4G@(
M/+ZR]X=#P__^%FI978LL?K<@V#[]7\!H@]:_ME!+.UQJO5-2[<P<1$PT5^ )
M)D]?"^T^257.(""@,S4G;#)/Q)MD;-*TH@M0%7R=M"N<@>&XE#A%F)TT_/@4
MBFGFAK=BVPB0I?JSFUBS5$6[C@RTH1,&3,-H1D+Q.@UXF!DK NFK/R]*U4$&
MA *=LEGHT9 )Z5&7]2_?B:+C^X]]]Y])%*<O*Q]O(FEB-JQ; I):?]*5JJ16
M!0N=Y0GYDE,VI '[,7V#/K+<?-JW!&2Y_A0O55FN"M9UG U%UDKIR; 4^FQS
M,DR;?3L77J %P][9;$*RR5[?S?9IQH=#LOK ZM=V*K1"!7VB7:R>B9OX9+HN
M;@#XZ7;%=G/WGI_P>_9 5BLW>'5'R0NAPYY]Z[EZJ9Z=2\'V=5_ 1)[#K_4F
MYJG;#D)&>#RF4<09%5Z7)3U>I\J)/*'!*@M3M9X%:O@(NA\+>FNS 6C1%X@Q
M#38\C=HL"5?/3D1.X2.@:[J RM@3O\VM7# 6V+.[YH:D>LHN7\W0WL2]; *^
M\BNYEP\LR674PPV!_:,3BT=MH/-MI<:N]B[O)4HW:BD^+0"_$&_SS&;]_@N3
M;D/FA+]H?1"2SR%&9GF#%[2'-JO6<E/[8B#QUTTB%H@(O&525D#SU]0W3K50
M-#46];<MCKNRW*)H'(X7-8GFT:EG1-8 )_:F*)=*0;T)*EUDRR540#YR?BV9
M%4ZS^U&X0=7SI:D%]%!CVXP+MN!@#RII]@7E\/I0NM&FR,& /-1^3\D8\CWN
M7$8F]D&#*B,3W-A7D*SA A#1]ZH'V>F:;0B\F!VB7D@)B8<DYBAL^37;?PEF
MAJ\[$D1@?T^]7\&V&M799^K$O1/+03D3B'I!*%VM5.8#05X2OI;$(*>9JIBY
M(I/Q+'F%_;Q?I=6K2_I1!XC80U67XD,]7DM7+0V)/I!'[5>0\>/8U8J2Y?BZ
MVV?_:#54+1O$OAMCF1GD,MRP1Z=%-O5[$CN>'TV<D%MV7F3YD#^4;GQ:ORO0
M^T/VG=[Q0PUY?J[[K8'+!SP30UC:5,_6'SIXH1SR0\BUORF@4+/>9^TO(FBL
M>0.H*/U8_>Q/RT0I<-6#GQ/_]+ISK01$89P#G_UV I[]DH]4^RWA#CX2/U.7
MV\C2,.;R7PGAKQ K'FQG35[6XC60>+&2N5-T>TRK1+JGW/<GY])4!YFMBXDH
M\6I2N,['Y:O,D9E9.!7L^.2]:I:4ET:S\0#PE<Z6.J7QK7R'J2)5;4"W.QJ(
M.^;R&;(XP\BK7<,T"-,DYT='NHUV+I9RNCO<V)(7[Q@ANLY6O((F5PA[)N,A
MFC2(F>Z^.#O&A"$:FV8T?2WL.[C:KE:\7@30'WUR.ZVCTR\!<6<D7/&?UQ,2
MG^>#ESO(#56Q#1_*\X8D6S\(!72^Y'L@+G48/7N[3')GHSG^6C2![2P"$V@-
M"SJ1XCE>XD8/3.>9LQ>W#I?TT0LHC[X4UV&>J<_@U8Q FS:P9TXPE?; 8%L<
M8?<Q;V;L2^Q[XH)_,3'#368BE%D@)1FPP-<U;WK95WOLL[WLN[W<AUF)@WGR
M[4YG0W<ZU7KH:W5C1UKK1<XN6"$5\@%LDN::W: ,TAEAI#5OO;0@[F?B^/'S
M@"$P#3=.D$5U9)(N:,+6>,.9'-["U1()5[$9&V7-?)H.\S9M=(-3VUY<@=^:
M+  *?R._O<?VTY[CCP*V(^$O *:WG5TNE?)\S^O"JF*?.NS[93[@WP:>IA)O
MB0OI878QW7.UG*@*8R?2NHP%/00-X?X+#7]EYQ)N'B)!E*;*8[^STP+K"_],
MPKV6"'!M['1*ES%C"5)#5&7/ N=$UG*C+@XDXT_=),,$0T/H3TA<.@TKD)<7
M138L0H\0>:AU.E^)!:.8K^5@M;B5F2TNR3]\TSM\JL>^U1,?RUDJ>K=OMHK?
M7YQ457O$6QQ4%WS'G;(DO+GT02Y]/-/ FTN_DRY]?K:EP2*FJU]-?GQ)46P7
ME(WS7JDINN/PV)T&/"\MV[)Q&8'S5KE*QX8(:,XJ:X$>@I07R319R<IVC 95
MURH.$HDFW9BBA&0#V!QU7A;;[*7N2=(92J9H<X?V]#DWGIZO_\(.8N)V'LU-
ME:EC7J3Q5!_GK1KI? 11%:4ZLI(44D1-$MZ)6-?CI^UHFL11[ 0N.V>I^,S:
ML6P&V[H/#D2I! \ZJ:>.R -HTF=*$R9EEKZ(!MQZ(T06BJAIM6X(>WMG$>U7
M"2)T:A4=,LN67.J7UB-6W1#VHGCIF#5!U-"*R;H6DR/F.2G2=5HL!4K?J+PP
M]HLHL"50KVI3_C8MVT5KM<KM9MD(MO<-QD<U:-"GN*)@F;P:RX^J O9K)/#0
M9;W*U^$:@MRDO^C9D9JNT+]Y@ Z;Q/"0DS(]HXB5L1_'H?>4Q(?3"Y_2(^'@
MG+'ODC!D2ZAB!3MMK2YK^-I>+:D)R886R#E?!);T4Y3FQ%K20I(LQ9)HKH9]
MB+-[90\* _KR)WJ3$Y%[DOYW%"BR=!M&(*P)[ -;M<%F P\ZH>?R':ZSJ-E3
ME<<^@%E3I5<<G9?4!+!T7K.<@'<D(&LO9O-"Z.S$NW_LW_J^^+BG>PS1NB'L
MXUR505<%*NQ]:SW/--T<GBXI-Z>YL=7\$TXW/2Y8CTO6.XC6.\F&?:?K^M]X
M.H ZH3&)QM0)HGS:]\([7AK/:]4&N^$0K/*$DZ6B^-%89P(S687,)SE+YW?E
M 0_00C=HO;";%ZB':X\?^ 75]VZ?TYW)HX^ON*S5K[Y/6"."'GYV+I0IH$->
MNANTUM'A"]S*U<6.^Y#M]_31'^H:V-8-7?=3##25VN@GK7N:/,7KQ#>Q42R'
M;9RPX$"N(CKRY:XQD5K\E#UI8F'I:_BX"MZ<&8?'I#YSG\+H*OUFEBE\YH12
MXQVO"*B'/3%590.H7D<&SH1G[7)<DCO]J(>-M##VY'7AJ-$ T-2-9:D=9G)\
M'XUW$$]*@[CL"ZW=$3-JI?%C"5&31*GM99DLF:EMQ@T&WHI)26)N(?S"+\-K
M2;RTY8Y85ZL37 ^T.?)W!W_C.(5;J:=0\H6$3S0BHNQU&V[3YW^R>[:Z>ZJE
MQYL;,-:FPASS;Z'?8[U6^^Q +$RK.&>%3\@T($NZ_$+_3AQ=LCQ(7>3-+MS<
M"@<"?3<E%95)R41E7R!56"O5QMX77TB< HV.4L?E7-('FH25N"M5Q]XL7TJ>
M H]NLL?%9,)Z+Y4&7JDV]H;Z0NX4:*!35]X#W7F^3]P'&AX<T@=]HFDX"^DF
M=" .*MOVL+?3<'HO0^SK"%: !.&67NFN?;?;F5#=:]WDEJ/<#MWC0#O(,&79
MS-5L?2O!TY UY)17?+J>K2)AT,P.G"%_DY;?+YO0M9/X?,B>ISEC<U!,5AS>
M@>]XTMF;?Z/>3US!1KE^I:^F"]RVT =NKV+#W8#6K?4"ML^(J.^YW%IW$II+
M>UK ^<(-(!O>U!5LQ*LKUXU-VC&D^1@^(6*;HYNS$&=U6.CWWY5>[)X-YWUQ
MT>E_.]O=?_0>1I/^9,!_'P_["Y$'3[3=.S1^85RG\0'1HXKY()%42_"#H: V
MWA+?57X@U(*CMT1XS1*CP%4/_KA+\9!I</])MBR(7Q_NJ*UT191H]4"/051(
M9PI&-%3K!CV ;@?CJME,]_)+3/I$T=HJV,<O4)\ZRP\-0*"A+?7YV@8"7U\%
M^]AC#3X$ 713]9A$$2&*>YC'37%")FRKO?Q"_!?R2(/X6;.\5&^Q\\G"+M:P
M(Z2G/9/40+9]2]AS*)CEJB#5'+S3S>F ^]N67^CEL\"Q(>SIO?;17X"H\X/>
M2"FX 6QC5FU#7$WA5SZR>4Q$36,[;0K;$]W,Z,[#=!WC6T^L11/=3Z-FK]/O
M;)3SZ)EZ!GG:TM6D;*L*TE4,<3VK\!:P'\:J=8 K6/S*QW<NANC"\2U: O:(
M/Z/WB*H@7<?XUK(*;P'(YH_H;-J"\KL8W_UU3,+Z!GFA.;"-!KUS7(17Y\<[
MD&7+9J#L=M\$9V*U]?&O"B]*$?[L^ GAD0 \W%$5/B0M"J4,T3JF%KY1-Y/L
MD^>.%PN@BQ6AL"-:LJ"JX(^-FI-Q G*I7IHY]1;?'-7U!*G2&=IRI8+ST5%K
MDH:-3D0X:JY/?W]K'=1XZ>WGWWL4X_F0+CST,"<\FN#PC_S:DRRH7#HY0%K"
M\K#7%0)9%;M.S9.74&[;#IJWO2[&JP&'SK>VHQ[V:'.VZ&01]14'N;0E-$]Z
M*Z-< QXZZYK.:L6Y;3MH#O<61KD=WUW:;[V7[;?>5]]OO7_;;UT^%0]H!)YL
MT[)?UYXIKW^CD;_D^#E3+]*4O][MBT&Q1@FX)PRGE2=0FJ[%YUW^>/IN*U]U
MA++Z.JA["C..%*Q(!W<*HR F#,XX>Z #MBTH54+= X 9@FC2ZN0$G),0(]BL
M1X!*Q8YOES[(MDL?BMLEB_W2A]_E?LET%VK@1,\//OTB'D\^WQNHKK0#ZU[M
M1LE"QQ;FIJ(,!26T$Y:Q[M>PH0("U!!)XC%"NDXB<MQ5B$<(H^D3FW8"XHZ"
MX>OJV0DVA">OXB)-GWQO(R V31!U-7Z])J Z4>A>/_".4L)FWKH_<KV&HB;0
MZ,:V:!2\L'9HZ)'H)O>S)A')]\5-T6CR>3A93N<CD7,DUPCV0W('4?8G<<VY
MW+25D&Q(/"_94:Y%LMOY\G3V!YN+HCSR#5< '47CD59Q]&/T4;)?:/CK*)B%
M=$4B;>H+>7GL2ZGVQ.@U[PXQVC=KSDMAWP"]@ 3YJS1V(58QC1T?,W-_-M;/
MGM;6+4,_E,_F(J/H:++L3SZ.1-;1Q6*X7&"O0A\I=;]XOL]V&R7U+-8ERV:P
MGT!E&RLO)F.>:J\H+OC54W,;W4A(4XEAY1.H9JWQ4V]I9!R;DW'!:G>#6_L>
M738V Y3%3^:ED?-N_^C\DX8#WXDB?7(OJT:^?H++.J,G!M-(>Y)UXFR-[Y9:
M-]0-NBMT<SC?<L6Q'S==T'7\A6'#EJ?#C_?DA?A4V#"$0\?TOJ9%$]B'F8H=
MO+@<VV*&?N89>RONP#0Q62B&G2RE'K:DNC=UY<>)29HN?D!W^Y ;!?5YY705
ML/-87 B_2;V.#(T)Y<GS=B0F_4U(B#X58%9)5P<[.4$]@\:,"CIQ@R2*Z9:_
MR>"G1O1G;V=D3EL)^]YY/=0!<$'GKK_Z+?%"XFHT+L3:?HK(.O''WEIC'+BL
M560#N,VIN?1"T>5HHG<)C? ?0ZJSG)MK=GC;:>(6"DN7^>NO5LDV$6_,]K<T
MC+U_">0K,:IL"]M$WPS'!NBZS+K6O6*JU^&CQP5LRGTQG?.H2&_C_K%T.\3@
M44%[@OCWY%/131VY^2(+8+9*GGQ1N\B;J3J<+O5 V^496J(&)--NE>:P=V#M
M=X@.YEBVE=Z8D;5:@]@[-:2^T+6,O);R&Y-W5FH/>Y^'TQ>ZEKG55GQ3RK=*
M[6'GX4;J"AU+^F<A/CP%8/5&L7T@[7>*;J:#E)QDAZ\K/W&]8'/ 2!=,":F-
MG:2[#JYM<*HYXUUGS >Z5^*__Y.U&0'[L???DSGA+43S+43S+43S+43S+43S
M+43S+42ST1=@,4+%NAI7>26A8F@11QV/L+R*B*/<27NZ+BJKB2DRU+OBJ"$0
M(IWP4P^2D&-QR&K-KZ.K_JZY%/AG^=%S\&D^'TZ6O?&H?S<:CY;I3771?B_[
M0"_W!?9OR'<&9\Z>;V?X5-E?K<+$\76Y.[):VDI808!,#N(N'-_A"0$RK'7A
M??+RR$,00$<I7D^G./I4R>02V@Q?5UY$ELYKIJ&1(&-%[&V*/55 +- YR[H4
MDXZAX3,YX>-)6@?;1UMY4&D0:.C.QX+XZW7"U[.?B>/'SZ. +2\\R]V<019*
M/2.\GKD:]N;0@@.80LW2D-W$RJ[[J-(6E8MA^QUM85;HB3X%B1W3@G6 <)_;
M+AEG(4,U; >@_40$PJ$;;%GS= %#C;GM*C($XN;*TJ0LR$9D'@M<<13G9\(U
M#;>BX9M%LMVR_>:_V,8S+:8]+/U8/"PMAA\?^3&I/[GOS8?C_G)XWQM-'J;S
MQ_YR-)WP$L</] Y?P#\L99+,R8Z?=H.-^:2DKH'MDQL&C*']+YY+<KS.R0L)
M$L*S30Y95PD#QS_88Z*[_2RD;K(29K4%6X39F@%WW]7ZN6Y8CTV]0>G4JQ4+
M?/^?K3HE6U*YWUS09$?Z1I/CK-"Q+@"K(4]C%,:YCL-^.W4:]LL_,OVF8::=
MPHW(BLI+_HXH5F+0C.\01EQ>:J5G\"2YK#@RA4I85>C+=&C&E??H!,F:K2))
MF.:-S;XZ73_.1\=TL%K?GE4+:%8T/;;EHVH%7-#/1:GM8L!P$*<$DW=/41S-
M?&9#D5Z%CO"1S<F:C<>I!+(CX.)-58&8HNH-&<[$(R=1NC&>D%@#."^N+(UM
MVZ\-?:V6'1D5(YZ=A8QI)%X9&%"F>Y"P23;+(TX#;:)A<UUL\W_=0PF.%SJU
M^4>BV,\^$9@'P,P)L-K8GH6ZZ;7!K.:H^]9=_\*NMJ19SI=LL?=>C($L@*K8
MGI"ZNP48+>P@%Y&\7B398LIE[\?D( #<J_CANY*]]M-L-AYRDVU_W!OT%S_W
M'L;37\Y,MIVY8B'3?YC^ 1#: JN-=F]*O" W<SS7D&^^4!!Y,VM#2?D.E$QG
M])4UW02(R  NFFF'E"N(O;>]B RITNADB =SINM/43H52Y_).7\5Y^"PVVN.
M@I<TBKWGO8#D&L!LZBDJ)R8BN%3," OJRX:=>$!)4A![FUJ%$94N'1EV[.C#
M]K&1"/E=Q'3U*]LB)SQG,?]S3-Q;]> "5,7>0%XPA,# 8.\5!W2[]>+M\:X$
M/\IN2+ ZO<NEW2?>%O>)@^GCXVC)]XD+X=L?3"?\"=/A9# :=N@6KDYMBUNX
MELT@>?Q9-Q&=UN2J+Y3KAI.M$E-%QWM!,WR/^5&BTJ%3P\NX<SYN:<]2@3_&
M]CHO^<3%5U+7>_'<Q/'5;F=%T6N 72T]BL>X),LO7OR<O]JUI*FA1N='MFX$
MW[NL[6PZKDRJ-?+$AX'$.^J$[G1][X5DQ5J,!L^.%VZ=0.G/9)5,=3#]SA4[
M98XV&"+-;- -9(G]YISLDI"=UB)NI=R$SK:?Q,]4A%.F6U'9UIS5!E?&-B@I
M%] <299(H!^G"O*Z]R+4849"C[J+9P:+=I=@KHMN>#*29J',5^!_T:GYV?$3
M[6;=6!7= E4'VV<P=&6 NOP)$W<:#AS?KS1*S0V@&ZLLR8-"TGT*80//6!_=
M>%4;@9T<@H4U?4[X/HW'!1X7]U,9]89'/@%9M8E]HZSJ+%L!.'3NCVZ&!Y%+
MQ-L*DU#Z@_O/)!)FHBSQI9IMNU:P[Z.!^:T"#CJC_)8OX(;S\;Z-K#3V$VGP
M$:A1%ML/D'/L0NS^[XMV_]%D,'T<]I;]_^Z2F?^HE8U17UL).=8@&[]W)"!K
M+Y9%'I[&^G1]GQV(6$7AR07XO.O_$K*A - %5#$.-8.-/MD.7[GO)/&BYX/$
M3_%'MOKS0-8)87]@HJM[!JPVMHG!GFX;5!H*:SATG:/P [K=T8!(+]#S&KH*
MV,=^"P9,JG1DW!1'MOXM,GEI[/.\_;C0:=TE2H[S[(3&<[*BF^!DVIVN/P7A
M\6^R2C/J>ZO],_49_-$B"7=^HC'?-/Q9;)O!19VD.1X:FG5G)%QQ=#?\ N\A
M(9=BPE64Q3[\6\ZU6HT;0GE PQUEVR72]T6X/3\-/'J!MTVV//_942(%\/#J
MV =U2RYL<<$^(&8I8&9.&.^7[ 0;,;WX%AAR6OQ0/"T>,K[,^O/EWWO+>7^R
MZ _X)8(.G1U5"IL/D.::V*E?!M1G8M,4WS[#.=B00XB5>*M=_L]Y9<!Y7^K[
M5C>B;Z#]0IG\I3Y \./8:M"E9#63A5G6^95N=*/F!F,I%+E.\/!?IEBRMJ?K
MG*3Z-R@4Q7]GG4"! OK[$V5-';ERILP9U@UUHP-H.W,Q):VMBDVEI]D$)/96
M<Q(Q"8(5>70")Q7"D)3&6 _;DU.Q-YXGJ0&BT]!QRYQRHTJ:C:8 ;V+[D&>C
M@60;RK3-:0ZIP'UTO( =JSCWLY#]24&#K@*V$;UI6LQ@-<[2G.P<+WP@ZLS.
MTJ+8QO7VF"D#U! GP^W.IWOVG0?I\^"\S'D1;%-ZTQS( $$WN&<W%_F++A,:
M\]O?>[T!0%D!V\C=)'TFW3M"YCT)O1>AX(/W*I[Z$5>+^45CG>]#4PG;$-X"
MJ0#0T(D=L7Z7QB.DUFA#CA!)86PK>@M$:D"ZZML$![<:#UZ8!ORIF>EZ%M(=
MFXDT 3_Z6M@GLE;&M1DV;.?+(GF*R&\)#^!\X=I#G"[?EU,XW2V&?_O$L^X/
M/XL+^IWQM13U@V1I4M6H];P@C9F>)/P@/UVG-QM.@=-+>D=RUUB4)XL+&\6^
M>6?@ZNPX40M^31T&JP;$6_$*:@_[P'\YIQ:P64VFV;_P_WEB+;&__']02P$"
M% ,4    "  7;E-:PP)+P7%U 0 92A, #@              @ $     9F]N
M87)?,3 M<2YH=&U02P$"% ,4    "  7;E-:0?A.%FL(  "270  %
M        @ &==0$ 9F]N87)?97AH:6)I="TS,2YH=&U02P$"% ,4    "  7
M;E-:"0:>1,\$   -(P  %               @ $Z?@$ 9F]N87)?97AH:6)I
M="TS,BYH=&U02P$"% ,4    "  7;E-:C5V:</<U  !H.   #@
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M+3(P,C0Q,C,Q7VQA8BYX;6Q02P$"% ,4    "  7;E-:Z6Z#&%9#  "B+@0
M%0              @ &H9@( 9F]N<BTR,#(T,3(S,5]P<F4N>&UL4$L%!@
0   )  D 1P(  #&J @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>fonar_10-q_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:FONR="http://fonar.com/20241231"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="fonr-20241231.xsd" xlink:type="simple"/>
    <context id="From2024-07-01to2024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-02-03_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-03</instant>
        </period>
    </context>
    <context id="AsOf2025-02-03_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-03</instant>
        </period>
    </context>
    <context id="AsOf2025-02-03_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-03</instant>
        </period>
    </context>
    <context id="AsOf2025-02-03_us-gaap_PreferredClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-03</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_ClassANonVotingPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_ClassANonVotingPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2024-10-012024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-10-012023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-10-012024-12-31_custom_CommonStockholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:CommonStockholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-10-012023-12-31_custom_CommonStockholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:CommonStockholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-10-012024-12-31_custom_ClassANonVotingPreferredStockholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-10-012023-12-31_custom_ClassANonVotingPreferredStockholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-10-012024-12-31_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-10-012023-12-31_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-12-31_custom_CommonStockholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:CommonStockholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-12-31_custom_CommonStockholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:CommonStockholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-12-31_custom_ClassANonVotingPreferredStockholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-12-31_custom_ClassANonVotingPreferredStockholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-12-31_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-12-31_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_CommonStockMember529343609">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2024-10-012024-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-10-012024-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-10-012024-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-10-012024-12-31_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-10-012024-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-10-012023-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-10-012023-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-10-012023-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-10-012023-12-31_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-10-012023-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-12-31_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-12-31_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_CommonStockMember529343781">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2015-07-01_us-gaap_OtherInvesteesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-07-01</instant>
        </period>
    </context>
    <context id="AsOf2015-07-01_us-gaap_NoncontrollingInterestMember_us-gaap_OtherInvesteesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-07-01</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_OtherInvesteesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_NoncontrollingInterestMember_us-gaap_OtherInvesteesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2024-10-012024-12-31_us-gaap_OtherInvesteesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_OtherInvesteesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_NoncontrollingInterestMember_us-gaap_OtherInvesteesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-10-012024-12-31_custom_CommercialInsuranceManagedCareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-10-012023-12-31_custom_CommercialInsuranceManagedCareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-10-012024-12-31_custom_MedicareMedicaidMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-10-012023-12-31_custom_MedicareMedicaidMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-10-012024-12-31_custom_WorkersCompensationPersonalInjuryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-10-012023-12-31_custom_WorkersCompensationPersonalInjuryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-10-012024-12-31_custom_OtherRevenueSourceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-10-012023-12-31_custom_OtherRevenueSourceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-12-31_custom_CommercialInsuranceManagedCareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-12-31_custom_CommercialInsuranceManagedCareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-12-31_custom_MedicareMedicaidMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-12-31_custom_MedicareMedicaidMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-12-31_custom_WorkersCompensationPersonalInjuryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-12-31_custom_WorkersCompensationPersonalInjuryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-12-31_custom_OtherRevenueSourceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-12-31_custom_OtherRevenueSourceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_DoubtfulMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:DoubtfulMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_DoubtfulMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:DoubtfulMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_OperatingLeasePaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:OperatingLeasePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_FinancingLeasePaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:FinancingLeasePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-07-012024-12-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-07-012024-12-31_us-gaap_LicenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_LicenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-07-012024-12-31_custom_PatentsAndCopyrightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_PatentsAndCopyrightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-07-012024-12-31_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-07-012024-12-31_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_PatentsAndCopyrightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_PatentsAndCopyrightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2024-10-012024-12-31_custom_PatentsAndCopyrightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-10-012023-12-31_custom_PatentsAndCopyrightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-10-012024-12-31_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-10-012023-12-31_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-12-31_custom_PatentsAndCopyrightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-12-31_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-10-012024-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">FONR:ManufacturingAndServiceOfMRIEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-10-012024-12-31_us-gaap_HealthCareOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-10-012023-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">FONR:ManufacturingAndServiceOfMRIEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-10-012023-12-31_us-gaap_HealthCareOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">FONR:ManufacturingAndServiceOfMRIEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-12-31_us-gaap_HealthCareOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">FONR:ManufacturingAndServiceOfMRIEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-12-31_us-gaap_HealthCareOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-09-26_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-26</instant>
        </period>
    </context>
    <context id="From2024-07-012024-12-31_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-12-31_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-02-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2024-02-01</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_MagneticResonanceManagementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">FONR:MagneticResonanceManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-07-012024-12-31_custom_MagneticResonanceManagementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">FONR:MagneticResonanceManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-10-012024-12-31_custom_MagneticResonanceManagementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">FONR:MagneticResonanceManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_MagneticResonanceManagementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">FONR:MagneticResonanceManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2024-07-01to2024-12-31" id="Fact000003">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2024-07-01to2024-12-31" id="Fact000004">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus contextRef="From2024-07-01to2024-12-31" id="Fact000005">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="From2024-07-01to2024-12-31" id="Fact000006">2025</dei:DocumentFiscalYearFocus>
    <dei:EntityCentralIndexKey contextRef="From2024-07-01to2024-12-31" id="Fact000007">0000355019</dei:EntityCentralIndexKey>
    <FONR:AccountReceivableRelatedParties
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl0056"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:UnearnedRevenueOnServiceContractsRelatedParty
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl0126"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:OtherIncomeRelatedParty
      contextRef="From2024-10-012024-12-31"
      id="xdx2ixbrl0303"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2023-10-012023-12-31"
      id="xdx2ixbrl0307"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:OtherIncomeRelatedParty
      contextRef="From2024-07-01to2024-12-31"
      id="xdx2ixbrl0417"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2024-07-01to2024-12-31"
      id="xdx2ixbrl0420"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0473"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-10-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0474"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-10-012024-12-31_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0476"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-10-012024-12-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0477"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0480"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2024-10-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0481"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2024-10-012024-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0482"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2024-10-012024-12-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0484"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:CancellationOfTreasuryStock
      contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0489"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:CancellationOfTreasuryStock
      contextRef="From2024-10-012024-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0491"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:CancellationOfTreasuryStock
      contextRef="From2024-10-012024-12-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0493"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:CancellationOfTreasuryStock
      contextRef="From2024-10-012024-12-31"
      id="xdx2ixbrl0494"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:SaleNonControllingInterests
      contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0500"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:SaleNonControllingInterests
      contextRef="From2024-10-012024-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0502"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:SaleNonControllingInterests
      contextRef="From2024-10-012024-12-31_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0503"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0507"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2024-10-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0508"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2024-10-012024-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0509"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2024-10-012024-12-31_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0510"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0514"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2024-10-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0515"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2024-10-012024-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0516"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2024-10-012024-12-31_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0517"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0543"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-10-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0544"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-10-012023-12-31_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0546"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-10-012023-12-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0547"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0550"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-10-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0551"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-10-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0552"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-10-012023-12-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0554"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0559"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2023-10-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0561"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2023-10-012023-12-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0563"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2023-10-012023-12-31"
      id="xdx2ixbrl0564"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0570"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-10-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0571"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-10-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0572"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-10-012023-12-31_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0573"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0577"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-10-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0578"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-10-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0579"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-10-012023-12-31_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0580"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-012024-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0606"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0607"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-012024-12-31_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0609"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-012024-12-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0610"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2024-07-012024-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0613"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2024-07-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0614"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2024-07-012024-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0615"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2024-07-012024-12-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0617"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:CancellationOfTreasuryStock
      contextRef="From2024-07-012024-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0622"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:CancellationOfTreasuryStock
      contextRef="From2024-07-012024-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0624"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:CancellationOfTreasuryStock
      contextRef="From2024-07-012024-12-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0626"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:CancellationOfTreasuryStock
      contextRef="From2024-07-01to2024-12-31"
      id="xdx2ixbrl0627"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:SaleNonControllingInterests
      contextRef="From2024-07-012024-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0633"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:SaleNonControllingInterests
      contextRef="From2024-07-012024-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0635"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:SaleNonControllingInterests
      contextRef="From2024-07-012024-12-31_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0636"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2024-07-012024-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0640"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2024-07-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0641"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2024-07-012024-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0642"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2024-07-012024-12-31_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0643"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2024-07-012024-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0647"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2024-07-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0648"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2024-07-012024-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0649"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2024-07-012024-12-31_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0650"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0676"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0677"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-12-31_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0679"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-12-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0680"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-07-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0683"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-07-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0684"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-07-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0685"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-07-012023-12-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0687"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2023-07-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0692"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2023-07-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0694"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2023-07-012023-12-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0696"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2023-07-012023-12-31"
      id="xdx2ixbrl0697"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-07-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0703"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-07-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0704"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-07-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0705"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-07-012023-12-31_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0706"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-07-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0710"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-07-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0711"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-07-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0712"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-07-012023-12-31_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0713"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:GainOnSaleOfEquipmentRelatedParty
      contextRef="From2024-07-01to2024-12-31"
      id="xdx2ixbrl0749"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:IncreaseDecreaseInNotesReceivable
      contextRef="From2024-07-01to2024-12-31"
      id="xdx2ixbrl0758"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:IncreaseDecreaseInNotesReceivableRelatedParty
      contextRef="From2023-07-012023-12-31"
      id="xdx2ixbrl0762"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="From2023-07-012023-12-31"
      id="xdx2ixbrl0798"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="From2023-07-012023-12-31"
      id="xdx2ixbrl0813"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:AccountsReceivableNetRelatedParty
      contextRef="AsOf2024-12-31_us-gaap_DoubtfulMember"
      id="xdx2ixbrl1046"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NontradeReceivables
      contextRef="AsOf2024-12-31_us-gaap_DoubtfulMember"
      id="xdx2ixbrl1050"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NontradeReceivables
      contextRef="AsOf2024-06-30_us-gaap_DoubtfulMember"
      id="xdx2ixbrl1066"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2024-12-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"
      id="xdx2ixbrl1240"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2024-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"
      id="xdx2ixbrl1291"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccruedPayrollTaxesCurrent
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl1355"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:SoftwareLicenses
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl1362"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2024-07-01to2024-12-31" id="Fact000013">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="From2024-07-01to2024-12-31" id="Fact000014">true</dei:DocumentQuarterlyReport>
    <dei:DocumentTransitionReport contextRef="From2024-07-01to2024-12-31" id="Fact000015">false</dei:DocumentTransitionReport>
    <dei:DocumentPeriodEndDate contextRef="From2024-07-01to2024-12-31" id="Fact000016">2024-12-31</dei:DocumentPeriodEndDate>
    <dei:EntityFileNumber contextRef="From2024-07-01to2024-12-31" id="Fact000017">0-10248</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2024-07-01to2024-12-31" id="Fact000018">FONAR CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2024-07-01to2024-12-31" id="Fact000019">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2024-07-01to2024-12-31" id="Fact000020">11-2464137</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2024-07-01to2024-12-31" id="Fact000021">110     Marcus Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2024-07-01to2024-12-31" id="Fact000022">Melville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2024-07-01to2024-12-31" id="Fact000023">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2024-07-01to2024-12-31" id="Fact000024">11747</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2024-07-01to2024-12-31" id="Fact000025">631</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2024-07-01to2024-12-31" id="Fact000026">694-2929</dei:LocalPhoneNumber>
    <dei:EntityCurrentReportingStatus contextRef="From2024-07-01to2024-12-31" id="Fact000027">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2024-07-01to2024-12-31" id="Fact000028">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2024-07-01to2024-12-31" id="Fact000029">Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2024-07-01to2024-12-31" id="Fact000030">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2024-07-01to2024-12-31" id="Fact000031">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="From2024-07-01to2024-12-31" id="Fact000032">false</dei:EntityShellCompany>
    <dei:Security12bTitle contextRef="From2024-07-01to2024-12-31" id="Fact000033">Common Stock, $.0001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2024-07-01to2024-12-31" id="Fact000034">FONR</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2024-07-01to2024-12-31" id="Fact000035">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2025-02-03_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000036"
      unitRef="Shares">6203465</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2025-02-03_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact000037"
      unitRef="Shares">146</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2025-02-03_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000038"
      unitRef="Shares">382513</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2025-02-03_us-gaap_PreferredClassAMember"
      decimals="INF"
      id="Fact000039"
      unitRef="Shares">313438</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000044"
      unitRef="USD">53583000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000045"
      unitRef="USD">56341000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:ShortTermInvestments
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000047"
      unitRef="USD">121000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000048"
      unitRef="USD">136000</us-gaap:ShortTermInvestments>
    <us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000052"
      unitRef="USD">273000</us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables>
    <us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000053"
      unitRef="USD">166000</us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000050"
      unitRef="USD">3390000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000051"
      unitRef="USD">4035000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <FONR:AccountReceivableRelatedParties
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000055"
      unitRef="USD">60000</FONR:AccountReceivableRelatedParties>
    <FONR:MedicalReceivable
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000058"
      unitRef="USD">23496000</FONR:MedicalReceivable>
    <FONR:MedicalReceivable
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000059"
      unitRef="USD">23992000</FONR:MedicalReceivable>
    <FONR:ManagementAndOtherReceivableAllowancesForDoubtfulAccounts
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000063"
      unitRef="USD">12663000</FONR:ManagementAndOtherReceivableAllowancesForDoubtfulAccounts>
    <FONR:ManagementAndOtherReceivableAllowancesForDoubtfulAccounts
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000064"
      unitRef="USD">12370000</FONR:ManagementAndOtherReceivableAllowancesForDoubtfulAccounts>
    <us-gaap:AccruedFeesAndOtherRevenueReceivable
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000061"
      unitRef="USD">42485000</us-gaap:AccruedFeesAndOtherRevenueReceivable>
    <us-gaap:AccruedFeesAndOtherRevenueReceivable
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000062"
      unitRef="USD">41954000</us-gaap:AccruedFeesAndOtherRevenueReceivable>
    <FONR:RelatedPartyReceivableAllowancesForDoubtfulAccounts
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000068"
      unitRef="USD">6989000</FONR:RelatedPartyReceivableAllowancesForDoubtfulAccounts>
    <FONR:RelatedPartyReceivableAllowancesForDoubtfulAccounts
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000069"
      unitRef="USD">6110000</FONR:RelatedPartyReceivableAllowancesForDoubtfulAccounts>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000066"
      unitRef="USD">9677000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000067"
      unitRef="USD">9865000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <us-gaap:InventoryFinishedGoodsAndWorkInProcess
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000071"
      unitRef="USD">2858000</us-gaap:InventoryFinishedGoodsAndWorkInProcess>
    <us-gaap:InventoryFinishedGoodsAndWorkInProcess
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000072"
      unitRef="USD">2715000</us-gaap:InventoryFinishedGoodsAndWorkInProcess>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000074"
      unitRef="USD">1962000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000075"
      unitRef="USD">1286000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000077"
      unitRef="USD">137632000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000078"
      unitRef="USD">140324000</us-gaap:AssetsCurrent>
    <FONR:AccountsReceivableNetLongTerm
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000080"
      unitRef="USD">724000</FONR:AccountsReceivableNetLongTerm>
    <FONR:AccountsReceivableNetLongTerm
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000081"
      unitRef="USD">830000</FONR:AccountsReceivableNetLongTerm>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000083"
      unitRef="USD">6113000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000084"
      unitRef="USD">7223000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000086"
      unitRef="USD">19270000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000087"
      unitRef="USD">18709000</us-gaap:PropertyPlantAndEquipmentNet>
    <FONR:NoteReceivableRelatedParty
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000089"
      unitRef="USD">607000</FONR:NoteReceivableRelatedParty>
    <FONR:NoteReceivableRelatedParty
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000090"
      unitRef="USD">581000</FONR:NoteReceivableRelatedParty>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000092"
      unitRef="USD">34946000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000093"
      unitRef="USD">38428000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000095"
      unitRef="USD">496000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000096"
      unitRef="USD">531000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000098"
      unitRef="USD">4269000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000099"
      unitRef="USD">4269000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000101"
      unitRef="USD">3407000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000102"
      unitRef="USD">2870000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssets
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000104"
      unitRef="USD">493000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000105"
      unitRef="USD">481000</us-gaap:OtherAssets>
    <us-gaap:Assets
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000107"
      unitRef="USD">207957000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000108"
      unitRef="USD">214246000</us-gaap:Assets>
    <us-gaap:LongTermDebtCurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000113"
      unitRef="USD">49000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000114"
      unitRef="USD">47000</us-gaap:LongTermDebtCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000116"
      unitRef="USD">953000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000117"
      unitRef="USD">1856000</us-gaap:AccountsPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000119"
      unitRef="USD">3912000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000120"
      unitRef="USD">7941000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000122"
      unitRef="USD">3413000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000123"
      unitRef="USD">3870000</us-gaap:DeferredRevenueCurrent>
    <FONR:UnearnedRevenueOnServiceContractsRelatedParty
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000125"
      unitRef="USD">55000</FONR:UnearnedRevenueOnServiceContractsRelatedParty>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000128"
      unitRef="USD">3259000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000129"
      unitRef="USD">3474000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000131"
      unitRef="USD">244000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000132"
      unitRef="USD">226000</us-gaap:FinanceLeaseLiabilityCurrent>
    <FONR:CustomerDeposits
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000134"
      unitRef="USD">357000</FONR:CustomerDeposits>
    <FONR:CustomerDeposits
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000135"
      unitRef="USD">443000</FONR:CustomerDeposits>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000137"
      unitRef="USD">12242000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000138"
      unitRef="USD">17857000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000143"
      unitRef="USD">1050000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000144"
      unitRef="USD">1175000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000146"
      unitRef="USD">371000</us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000147"
      unitRef="USD">371000</us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent>
    <FONR:AccountsPayableRelatedPartyNoncurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000149"
      unitRef="USD">93000</FONR:AccountsPayableRelatedPartyNoncurrent>
    <FONR:AccountsPayableRelatedPartyNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000150"
      unitRef="USD">93000</FONR:AccountsPayableRelatedPartyNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000152"
      unitRef="USD">34927000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000153"
      unitRef="USD">37468000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000155"
      unitRef="USD">290000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000156"
      unitRef="USD">395000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000158"
      unitRef="USD">7000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000159"
      unitRef="USD">67000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OtherLiabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000161"
      unitRef="USD">26000</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000162"
      unitRef="USD">32000</us-gaap:OtherLiabilities>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000164"
      unitRef="USD">36764000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000165"
      unitRef="USD">39601000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000167"
      unitRef="USD">49006000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000168"
      unitRef="USD">57458000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      id="Fact000172"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="-3"
      id="Fact000173"
      unitRef="Shares">453000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="-3"
      id="Fact000174"
      unitRef="Shares">313000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2024-12-31_custom_ClassANonVotingPreferredStockMember"
      decimals="-3"
      id="Fact000176"
      unitRef="USD">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2024-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="-3"
      id="Fact000178"
      unitRef="USD">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000179"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-06-30_us-gaap_PreferredStockMember"
      decimals="-3"
      id="Fact000180"
      unitRef="Shares">567000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-06-30_us-gaap_PreferredStockMember"
      decimals="-3"
      id="Fact000181"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2024-12-31_us-gaap_PreferredStockMember"
      decimals="-3"
      id="Fact000183"
      unitRef="USD">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2024-06-30_us-gaap_PreferredStockMember"
      decimals="-3"
      id="Fact000185"
      unitRef="USD">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000186"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000187"
      unitRef="Shares">8500000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000188"
      unitRef="Shares">6207000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000189"
      unitRef="Shares">6373000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000190"
      unitRef="Shares">6203000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000191"
      unitRef="Shares">6328000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000193"
      unitRef="USD">1000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000195"
      unitRef="USD">1000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact000196"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember"
      decimals="-3"
      id="Fact000197"
      unitRef="Shares">227000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember"
      decimals="0"
      id="Fact000198"
      unitRef="Shares">146</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-12-31_us-gaap_CommonClassBMember"
      decimals="-3"
      id="Fact000200"
      unitRef="USD">0</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember"
      decimals="-3"
      id="Fact000202"
      unitRef="USD">0</us-gaap:CommonStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000203"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-06-30_us-gaap_CommonClassCMember"
      decimals="-3"
      id="Fact000204"
      unitRef="Shares">567000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-06-30_us-gaap_CommonClassCMember"
      decimals="-3"
      id="Fact000205"
      unitRef="Shares">383000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-12-31_us-gaap_CommonClassCMember"
      decimals="-3"
      id="Fact000207"
      unitRef="USD">0</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-06-30_us-gaap_CommonClassCMember"
      decimals="-3"
      id="Fact000209"
      unitRef="USD">0</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000211"
      unitRef="USD">178758000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000212"
      unitRef="USD">180608000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000214"
      unitRef="USD">-8525000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000215"
      unitRef="USD">-13624000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockCommonShares
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000219"
      unitRef="Shares">4000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000220"
      unitRef="Shares">45000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockValue
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000217"
      unitRef="USD">395000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000218"
      unitRef="USD">1017000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000222"
      unitRef="USD">169839000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000223"
      unitRef="USD">165968000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000225"
      unitRef="USD">-10888000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000226"
      unitRef="USD">-9180000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000228"
      unitRef="USD">158951000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000229"
      unitRef="USD">156788000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000231"
      unitRef="USD">207957000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000232"
      unitRef="USD">214246000</us-gaap:LiabilitiesAndStockholdersEquity>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact000237"
      unitRef="USD">7944000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact000238"
      unitRef="USD">8221000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts>
    <FONR:ProductSalesNet
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact000240"
      unitRef="USD">25000</FONR:ProductSalesNet>
    <FONR:ProductSalesNet
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact000241"
      unitRef="USD">55000</FONR:ProductSalesNet>
    <FONR:ServiceAndRepairFeesNet
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact000243"
      unitRef="USD">1759000</FONR:ServiceAndRepairFeesNet>
    <FONR:ServiceAndRepairFeesNet
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact000244"
      unitRef="USD">1778000</FONR:ServiceAndRepairFeesNet>
    <FONR:ServiceAndRepairFeesRelatedPartiesNet
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact000246"
      unitRef="USD">45000</FONR:ServiceAndRepairFeesRelatedPartiesNet>
    <FONR:ServiceAndRepairFeesRelatedPartiesNet
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact000247"
      unitRef="USD">28000</FONR:ServiceAndRepairFeesRelatedPartiesNet>
    <FONR:ManagementAndOtherFeesNet
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact000249"
      unitRef="USD">12189000</FONR:ManagementAndOtherFeesNet>
    <FONR:ManagementAndOtherFeesNet
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact000250"
      unitRef="USD">12316000</FONR:ManagementAndOtherFeesNet>
    <FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact000252"
      unitRef="USD">2988000</FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet>
    <FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact000253"
      unitRef="USD">2988000</FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet>
    <us-gaap:Revenues
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact000255"
      unitRef="USD">24950000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact000256"
      unitRef="USD">25386000</us-gaap:Revenues>
    <us-gaap:OtherCostOfOperatingRevenue
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact000261"
      unitRef="USD">4623000</us-gaap:OtherCostOfOperatingRevenue>
    <us-gaap:OtherCostOfOperatingRevenue
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact000262"
      unitRef="USD">4602000</us-gaap:OtherCostOfOperatingRevenue>
    <FONR:CostsRelatedToProductSales
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact000264"
      unitRef="USD">221000</FONR:CostsRelatedToProductSales>
    <FONR:CostsRelatedToProductSales
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact000265"
      unitRef="USD">302000</FONR:CostsRelatedToProductSales>
    <FONR:CostsRelatedToServiceAndRepairFees
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact000267"
      unitRef="USD">938000</FONR:CostsRelatedToServiceAndRepairFees>
    <FONR:CostsRelatedToServiceAndRepairFees
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact000268"
      unitRef="USD">784000</FONR:CostsRelatedToServiceAndRepairFees>
    <FONR:CostsRelatedToServiceAndRepairFeesRelatedParties
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact000270"
      unitRef="USD">28000</FONR:CostsRelatedToServiceAndRepairFeesRelatedParties>
    <FONR:CostsRelatedToServiceAndRepairFeesRelatedParties
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact000271"
      unitRef="USD">12000</FONR:CostsRelatedToServiceAndRepairFeesRelatedParties>
    <FONR:CostsRelatedToManagementAndOtherFees
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact000273"
      unitRef="USD">7801000</FONR:CostsRelatedToManagementAndOtherFees>
    <FONR:CostsRelatedToManagementAndOtherFees
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact000274"
      unitRef="USD">7208000</FONR:CostsRelatedToManagementAndOtherFees>
    <FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact000276"
      unitRef="USD">1601000</FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices>
    <FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact000277"
      unitRef="USD">1590000</FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact000279"
      unitRef="USD">376000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact000280"
      unitRef="USD">416000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact000282"
      unitRef="USD">6927000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact000283"
      unitRef="USD">5587000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:CostsAndExpenses
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact000285"
      unitRef="USD">22515000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact000286"
      unitRef="USD">20501000</us-gaap:CostsAndExpenses>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact000288"
      unitRef="USD">2435000</us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact000289"
      unitRef="USD">4885000</us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact000294"
      unitRef="USD">6000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact000295"
      unitRef="USD">10000</us-gaap:InterestExpenseNonoperating>
    <FONR:InvestmentIncomeRelatedParty
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact000297"
      unitRef="USD">13000</FONR:InvestmentIncomeRelatedParty>
    <FONR:InvestmentIncomeRelatedParty
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact000298"
      unitRef="USD">0</FONR:InvestmentIncomeRelatedParty>
    <us-gaap:InvestmentIncomeNet
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact000300"
      unitRef="USD">524000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact000301"
      unitRef="USD">534000</us-gaap:InvestmentIncomeNet>
    <FONR:OtherIncomeRelatedParty
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact000304"
      unitRef="USD">577000</FONR:OtherIncomeRelatedParty>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact000306"
      unitRef="USD">1000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact000309"
      unitRef="USD">2967000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact000310"
      unitRef="USD">5986000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact000312"
      unitRef="USD">762000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact000313"
      unitRef="USD">1366000</us-gaap:IncomeTaxExpenseBenefit>
    <FONR:ConsolidatedNetIncome
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact000315"
      unitRef="USD">2205000</FONR:ConsolidatedNetIncome>
    <FONR:ConsolidatedNetIncome
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact000316"
      unitRef="USD">4620000</FONR:ConsolidatedNetIncome>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact000318"
      unitRef="USD">241000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact000319"
      unitRef="USD">861000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact000321"
      unitRef="USD">1964000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact000322"
      unitRef="USD">3759000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2024-10-012024-12-31_custom_CommonStockholdersMember"
      decimals="-3"
      id="Fact000324"
      unitRef="USD">1840000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2023-10-012023-12-31_custom_CommonStockholdersMember"
      decimals="-3"
      id="Fact000326"
      unitRef="USD">3525000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2024-10-012024-12-31_custom_ClassANonVotingPreferredStockholdersMember"
      decimals="-3"
      id="Fact000328"
      unitRef="USD">93000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2023-10-012023-12-31_custom_ClassANonVotingPreferredStockholdersMember"
      decimals="-3"
      id="Fact000330"
      unitRef="USD">175000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2024-10-012024-12-31_us-gaap_CommonClassCMember"
      decimals="-3"
      id="Fact000332"
      unitRef="USD">31000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2023-10-012023-12-31_us-gaap_CommonClassCMember"
      decimals="-3"
      id="Fact000334"
      unitRef="USD">59000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-10-012024-12-31_custom_CommonStockholdersMember"
      decimals="INF"
      id="Fact000335"
      unitRef="USDPShares">0.29</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-10-012023-12-31_custom_CommonStockholdersMember"
      decimals="INF"
      id="Fact000336"
      unitRef="USDPShares">0.55</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-10-012024-12-31_custom_CommonStockholdersMember"
      decimals="INF"
      id="Fact000337"
      unitRef="USDPShares">0.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-10-012023-12-31_custom_CommonStockholdersMember"
      decimals="INF"
      id="Fact000338"
      unitRef="USDPShares">0.54</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-10-012024-12-31_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000339"
      unitRef="USDPShares">0.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-10-012023-12-31_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000340"
      unitRef="USDPShares">0.16</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-10-012024-12-31_custom_CommonStockholdersMember"
      decimals="-3"
      id="Fact000341"
      unitRef="Shares">6303000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-10-012023-12-31_custom_CommonStockholdersMember"
      decimals="-3"
      id="Fact000342"
      unitRef="Shares">6437000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-10-012024-12-31_custom_CommonStockholdersMember"
      decimals="-3"
      id="Fact000343"
      unitRef="Shares">6431000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-10-012023-12-31_custom_CommonStockholdersMember"
      decimals="-3"
      id="Fact000344"
      unitRef="Shares">6565000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-10-012024-12-31_us-gaap_CommonClassCMember"
      decimals="-3"
      id="Fact000345"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-10-012023-12-31_us-gaap_CommonClassCMember"
      decimals="-3"
      id="Fact000346"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000351"
      unitRef="USD">15431000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000352"
      unitRef="USD">16896000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts>
    <FONR:ProductSalesNet
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000354"
      unitRef="USD">145000</FONR:ProductSalesNet>
    <FONR:ProductSalesNet
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000355"
      unitRef="USD">219000</FONR:ProductSalesNet>
    <FONR:ServiceAndRepairFeesNet
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000357"
      unitRef="USD">3751000</FONR:ServiceAndRepairFeesNet>
    <FONR:ServiceAndRepairFeesNet
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000358"
      unitRef="USD">3643000</FONR:ServiceAndRepairFeesNet>
    <FONR:ServiceAndRepairFeesRelatedPartiesNet
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000360"
      unitRef="USD">90000</FONR:ServiceAndRepairFeesRelatedPartiesNet>
    <FONR:ServiceAndRepairFeesRelatedPartiesNet
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000361"
      unitRef="USD">55000</FONR:ServiceAndRepairFeesRelatedPartiesNet>
    <FONR:ManagementAndOtherFeesNet
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000363"
      unitRef="USD">24518000</FONR:ManagementAndOtherFeesNet>
    <FONR:ManagementAndOtherFeesNet
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000364"
      unitRef="USD">24436000</FONR:ManagementAndOtherFeesNet>
    <FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000366"
      unitRef="USD">5975000</FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet>
    <FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000367"
      unitRef="USD">5975000</FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet>
    <us-gaap:Revenues
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000369"
      unitRef="USD">49910000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000370"
      unitRef="USD">51224000</us-gaap:Revenues>
    <us-gaap:OtherCostOfOperatingRevenue
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000375"
      unitRef="USD">9269000</us-gaap:OtherCostOfOperatingRevenue>
    <us-gaap:OtherCostOfOperatingRevenue
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000376"
      unitRef="USD">9029000</us-gaap:OtherCostOfOperatingRevenue>
    <FONR:CostsRelatedToProductSales
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000378"
      unitRef="USD">442000</FONR:CostsRelatedToProductSales>
    <FONR:CostsRelatedToProductSales
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000379"
      unitRef="USD">405000</FONR:CostsRelatedToProductSales>
    <FONR:CostsRelatedToServiceAndRepairFees
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000381"
      unitRef="USD">2029000</FONR:CostsRelatedToServiceAndRepairFees>
    <FONR:CostsRelatedToServiceAndRepairFees
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000382"
      unitRef="USD">1633000</FONR:CostsRelatedToServiceAndRepairFees>
    <FONR:CostsRelatedToServiceAndRepairFeesRelatedParties
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000384"
      unitRef="USD">96000</FONR:CostsRelatedToServiceAndRepairFeesRelatedParties>
    <FONR:CostsRelatedToServiceAndRepairFeesRelatedParties
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000385"
      unitRef="USD">25000</FONR:CostsRelatedToServiceAndRepairFeesRelatedParties>
    <FONR:CostsRelatedToManagementAndOtherFees
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000387"
      unitRef="USD">15111000</FONR:CostsRelatedToManagementAndOtherFees>
    <FONR:CostsRelatedToManagementAndOtherFees
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000388"
      unitRef="USD">14231000</FONR:CostsRelatedToManagementAndOtherFees>
    <FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000390"
      unitRef="USD">3174000</FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices>
    <FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000391"
      unitRef="USD">3109000</FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000393"
      unitRef="USD">683000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000394"
      unitRef="USD">883000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000396"
      unitRef="USD">12065000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000397"
      unitRef="USD">10453000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:CostsAndExpenses
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000399"
      unitRef="USD">42869000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000400"
      unitRef="USD">39768000</us-gaap:CostsAndExpenses>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000402"
      unitRef="USD">7041000</us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000403"
      unitRef="USD">11456000</us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000408"
      unitRef="USD">14000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000409"
      unitRef="USD">58000</us-gaap:InterestExpenseNonoperating>
    <FONR:InvestmentIncomeRelatedParty
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000411"
      unitRef="USD">26000</FONR:InvestmentIncomeRelatedParty>
    <FONR:InvestmentIncomeRelatedParty
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000412"
      unitRef="USD">0</FONR:InvestmentIncomeRelatedParty>
    <us-gaap:InvestmentIncomeNet
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000414"
      unitRef="USD">1163000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000415"
      unitRef="USD">1040000</us-gaap:InvestmentIncomeNet>
    <FONR:OtherIncomeRelatedParty
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000418"
      unitRef="USD">577000</FONR:OtherIncomeRelatedParty>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000421"
      unitRef="USD">1000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000423"
      unitRef="USD">8216000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000424"
      unitRef="USD">13016000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000426"
      unitRef="USD">2011000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000427"
      unitRef="USD">3036000</us-gaap:IncomeTaxExpenseBenefit>
    <FONR:ConsolidatedNetIncome
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000429"
      unitRef="USD">6205000</FONR:ConsolidatedNetIncome>
    <FONR:ConsolidatedNetIncome
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000430"
      unitRef="USD">9980000</FONR:ConsolidatedNetIncome>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000432"
      unitRef="USD">1106000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000433"
      unitRef="USD">2115000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000435"
      unitRef="USD">5099000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000436"
      unitRef="USD">7865000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2024-07-012024-12-31_custom_CommonStockholdersMember"
      decimals="-3"
      id="Fact000438"
      unitRef="USD">4775000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2023-07-012023-12-31_custom_CommonStockholdersMember"
      decimals="-3"
      id="Fact000440"
      unitRef="USD">7375000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2024-07-012024-12-31_custom_ClassANonVotingPreferredStockholdersMember"
      decimals="-3"
      id="Fact000442"
      unitRef="USD">241000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2023-07-012023-12-31_custom_ClassANonVotingPreferredStockholdersMember"
      decimals="-3"
      id="Fact000444"
      unitRef="USD">365000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2024-07-012024-12-31_us-gaap_CommonClassCMember"
      decimals="-3"
      id="Fact000446"
      unitRef="USD">83000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2023-07-012023-12-31_us-gaap_CommonClassCMember"
      decimals="-3"
      id="Fact000448"
      unitRef="USD">125000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-07-012024-12-31_custom_CommonStockholdersMember"
      decimals="INF"
      id="Fact000449"
      unitRef="USDPShares">0.76</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-07-012023-12-31_custom_CommonStockholdersMember"
      decimals="INF"
      id="Fact000450"
      unitRef="USDPShares">1.14</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-07-012024-12-31_custom_CommonStockholdersMember"
      decimals="INF"
      id="Fact000451"
      unitRef="USDPShares">0.74</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-07-012023-12-31_custom_CommonStockholdersMember"
      decimals="INF"
      id="Fact000452"
      unitRef="USDPShares">1.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-07-012024-12-31_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000453"
      unitRef="USDPShares">0.22</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-07-012023-12-31_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000454"
      unitRef="USDPShares">0.33</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-07-012024-12-31_custom_CommonStockholdersMember"
      decimals="-3"
      id="Fact000455"
      unitRef="Shares">6313000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-07-012023-12-31_custom_CommonStockholdersMember"
      decimals="-3"
      id="Fact000456"
      unitRef="Shares">6448000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-07-012024-12-31_custom_CommonStockholdersMember"
      decimals="-3"
      id="Fact000457"
      unitRef="Shares">6441000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-07-012023-12-31_custom_CommonStockholdersMember"
      decimals="-3"
      id="Fact000458"
      unitRef="Shares">6576000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-07-012024-12-31_us-gaap_CommonClassCMember"
      decimals="-3"
      id="Fact000459"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-07-012023-12-31_us-gaap_CommonClassCMember"
      decimals="-3"
      id="Fact000460"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000462"
      unitRef="USD">1000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000469"
      unitRef="Shares">6328000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000463"
      unitRef="USD">180608000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-09-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000464"
      unitRef="USD">-10489000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-09-30_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      id="Fact000465"
      unitRef="USD">-1432000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-09-30_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      id="Fact000471"
      unitRef="Shares">69000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-09-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact000466"
      unitRef="USD">-9861000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000467"
      unitRef="USD">158827000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-10-012024-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000475"
      unitRef="USD">1964000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact000478"
      unitRef="USD">1964000</us-gaap:NetIncomeLoss>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2024-10-012024-12-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      id="Fact000483"
      unitRef="USD">926000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="From2024-10-012024-12-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      id="Fact000487"
      unitRef="Shares">60000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact000485"
      unitRef="USD">926000</us-gaap:StockRepurchasedDuringPeriodValue>
    <FONR:CancellationOfTreasuryStockShares
      contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000496"
      unitRef="Shares">-125000</FONR:CancellationOfTreasuryStockShares>
    <FONR:CancellationOfTreasuryStock
      contextRef="From2024-10-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000490"
      unitRef="USD">-1963000</FONR:CancellationOfTreasuryStock>
    <FONR:CancellationOfTreasuryStock
      contextRef="From2024-10-012024-12-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      id="Fact000492"
      unitRef="USD">1963000</FONR:CancellationOfTreasuryStock>
    <FONR:CancellationOfTreasuryStockShares
      contextRef="From2024-10-012024-12-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      id="Fact000498"
      unitRef="Shares">-125000</FONR:CancellationOfTreasuryStockShares>
    <FONR:SaleNonControllingInterests
      contextRef="From2024-10-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000501"
      unitRef="USD">113000</FONR:SaleNonControllingInterests>
    <FONR:SaleNonControllingInterests
      contextRef="From2024-10-012024-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact000504"
      unitRef="USD">19000</FONR:SaleNonControllingInterests>
    <FONR:SaleNonControllingInterests
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact000505"
      unitRef="USD">132000</FONR:SaleNonControllingInterests>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2024-10-012024-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact000511"
      unitRef="USD">1287000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact000512"
      unitRef="USD">1287000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2024-10-012024-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact000518"
      unitRef="USD">241000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact000519"
      unitRef="USD">241000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember529343781"
      decimals="-3"
      id="Fact000521"
      unitRef="USD">1000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember529343781"
      decimals="-3"
      id="Fact000528"
      unitRef="Shares">6203000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000522"
      unitRef="USD">178758000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000523"
      unitRef="USD">-8525000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      id="Fact000524"
      unitRef="USD">-395000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      id="Fact000530"
      unitRef="Shares">4000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact000525"
      unitRef="USD">-10888000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000526"
      unitRef="USD">158951000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000532"
      unitRef="USD">1000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000539"
      unitRef="Shares">6451000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000533"
      unitRef="USD">182613000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-09-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000534"
      unitRef="USD">-20085000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-09-30_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      id="Fact000535"
      unitRef="USD">-1230000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-09-30_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      id="Fact000541"
      unitRef="Shares">55000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-09-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact000536"
      unitRef="USD">-7226000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-09-30"
      decimals="-3"
      id="Fact000537"
      unitRef="USD">154073000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-10-012023-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000545"
      unitRef="USD">3759000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact000548"
      unitRef="USD">3759000</us-gaap:NetIncomeLoss>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-10-012023-12-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      id="Fact000553"
      unitRef="USD">1171000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="From2023-10-012023-12-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      id="Fact000557"
      unitRef="Shares">72000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact000555"
      unitRef="USD">1171000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000566"
      unitRef="Shares">-123000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2023-10-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000560"
      unitRef="USD">-2006000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2023-10-012023-12-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      id="Fact000562"
      unitRef="USD">2006000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="From2023-10-012023-12-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      id="Fact000568"
      unitRef="Shares">-123000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-10-012023-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact000574"
      unitRef="USD">1225000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact000575"
      unitRef="USD">1225000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-10-012023-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact000581"
      unitRef="USD">861000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact000582"
      unitRef="USD">861000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000584"
      unitRef="USD">1000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000591"
      unitRef="Shares">6328000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000585"
      unitRef="USD">180607000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000586"
      unitRef="USD">-16326000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-12-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      id="Fact000587"
      unitRef="USD">-395000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      id="Fact000593"
      unitRef="Shares">4000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact000588"
      unitRef="USD">-7590000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000589"
      unitRef="USD">156297000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember529343609"
      decimals="-3"
      id="Fact000595"
      unitRef="USD">1000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember529343609"
      decimals="-3"
      id="Fact000602"
      unitRef="Shares">6328000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000596"
      unitRef="USD">180608000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000597"
      unitRef="USD">-13624000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      id="Fact000598"
      unitRef="USD">-1017000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-06-30_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      id="Fact000604"
      unitRef="Shares">45000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact000599"
      unitRef="USD">-9180000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000600"
      unitRef="USD">156788000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-012024-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000608"
      unitRef="USD">5099000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000611"
      unitRef="USD">5099000</us-gaap:NetIncomeLoss>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2024-07-012024-12-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      id="Fact000616"
      unitRef="USD">1341000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="From2024-07-012024-12-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      id="Fact000620"
      unitRef="Shares">84000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000618"
      unitRef="USD">1341000</us-gaap:StockRepurchasedDuringPeriodValue>
    <FONR:CancellationOfTreasuryStockShares
      contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000629"
      unitRef="Shares">-125000</FONR:CancellationOfTreasuryStockShares>
    <FONR:CancellationOfTreasuryStock
      contextRef="From2024-07-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000623"
      unitRef="USD">-1963000</FONR:CancellationOfTreasuryStock>
    <FONR:CancellationOfTreasuryStock
      contextRef="From2024-07-012024-12-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      id="Fact000625"
      unitRef="USD">1963000</FONR:CancellationOfTreasuryStock>
    <FONR:CancellationOfTreasuryStockShares
      contextRef="From2024-10-012024-12-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      id="Fact000631"
      unitRef="Shares">-125000</FONR:CancellationOfTreasuryStockShares>
    <FONR:SaleNonControllingInterests
      contextRef="From2024-07-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000634"
      unitRef="USD">113000</FONR:SaleNonControllingInterests>
    <FONR:SaleNonControllingInterests
      contextRef="From2024-07-012024-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact000637"
      unitRef="USD">19000</FONR:SaleNonControllingInterests>
    <FONR:SaleNonControllingInterests
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000638"
      unitRef="USD">132000</FONR:SaleNonControllingInterests>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2024-07-012024-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact000644"
      unitRef="USD">2833000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000645"
      unitRef="USD">2833000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2024-07-012024-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact000651"
      unitRef="USD">1106000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000652"
      unitRef="USD">1106000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember529343781"
      decimals="-3"
      id="Fact000654"
      unitRef="USD">1000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember529343781"
      decimals="-3"
      id="Fact000661"
      unitRef="Shares">6203000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000655"
      unitRef="USD">178758000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000656"
      unitRef="USD">-8525000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      id="Fact000657"
      unitRef="USD">-395000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      id="Fact000663"
      unitRef="Shares">4000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact000658"
      unitRef="USD">-10888000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000659"
      unitRef="USD">158951000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000665"
      unitRef="USD">1000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000672"
      unitRef="Shares">6451000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000666"
      unitRef="USD">182613000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000667"
      unitRef="USD">-24191000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      id="Fact000668"
      unitRef="USD">-516000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      id="Fact000674"
      unitRef="Shares">11000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact000669"
      unitRef="USD">-7079000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000670"
      unitRef="USD">150828000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000678"
      unitRef="USD">7865000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000681"
      unitRef="USD">7865000</us-gaap:NetIncomeLoss>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-07-012023-12-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      id="Fact000686"
      unitRef="USD">1885000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="From2023-07-012023-12-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      id="Fact000690"
      unitRef="Shares">116000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000688"
      unitRef="USD">1885000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="From2023-07-012023-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000699"
      unitRef="Shares">-123000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2023-07-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000693"
      unitRef="USD">-2006000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2023-07-012023-12-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      id="Fact000695"
      unitRef="USD">2006000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="From2023-07-012023-12-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      id="Fact000701"
      unitRef="Shares">-123000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-07-012023-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact000707"
      unitRef="USD">2626000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000708"
      unitRef="USD">2626000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-07-012023-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact000714"
      unitRef="USD">2115000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000715"
      unitRef="USD">2115000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000717"
      unitRef="USD">1000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000724"
      unitRef="Shares">6328000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000718"
      unitRef="USD">180607000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000719"
      unitRef="USD">-16326000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-12-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      id="Fact000720"
      unitRef="USD">-395000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      id="Fact000726"
      unitRef="Shares">4000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact000721"
      unitRef="USD">-7590000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000722"
      unitRef="USD">156297000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000731"
      unitRef="USD">6205000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000732"
      unitRef="USD">9980000</us-gaap:ProfitLoss>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000737"
      unitRef="USD">2298000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000738"
      unitRef="USD">2415000</us-gaap:OtherDepreciationAndAmortization>
    <FONR:NetChangeInOperatingRightOfUseAssetsAndLeaseLiabilities
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000740"
      unitRef="USD">63000</FONR:NetChangeInOperatingRightOfUseAssetsAndLeaseLiabilities>
    <FONR:NetChangeInOperatingRightOfUseAssetsAndLeaseLiabilities
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000741"
      unitRef="USD">119000</FONR:NetChangeInOperatingRightOfUseAssetsAndLeaseLiabilities>
    <FONR:ProvisionForBadDebts
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000743"
      unitRef="USD">1279000</FONR:ProvisionForBadDebts>
    <FONR:ProvisionForBadDebts
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000744"
      unitRef="USD">355000</FONR:ProvisionForBadDebts>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000746"
      unitRef="USD">1111000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000747"
      unitRef="USD">2284000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <FONR:GainOnSaleOfEquipmentRelatedParty
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000750"
      unitRef="USD">577000</FONR:GainOnSaleOfEquipmentRelatedParty>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000755"
      unitRef="USD">435000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000756"
      unitRef="USD">4958000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <FONR:IncreaseDecreaseInNotesReceivable
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000759"
      unitRef="USD">50000</FONR:IncreaseDecreaseInNotesReceivable>
    <FONR:IncreaseDecreaseInNotesReceivableRelatedParty
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000761"
      unitRef="USD">-26000</FONR:IncreaseDecreaseInNotesReceivableRelatedParty>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000764"
      unitRef="USD">143000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000765"
      unitRef="USD">265000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000767"
      unitRef="USD">677000</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000768"
      unitRef="USD">-217000</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000770"
      unitRef="USD">11000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000771"
      unitRef="USD">-22000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000773"
      unitRef="USD">-903000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000774"
      unitRef="USD">-244000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000776"
      unitRef="USD">-4556000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000777"
      unitRef="USD">-2341000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInTradingLiabilities
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000779"
      unitRef="USD">-86000</us-gaap:IncreaseDecreaseInTradingLiabilities>
    <us-gaap:IncreaseDecreaseInTradingLiabilities
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000780"
      unitRef="USD">-108000</us-gaap:IncreaseDecreaseInTradingLiabilities>
    <FONR:IncreaseDecreaseInCustomerDeposit
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000782"
      unitRef="USD">-87000</FONR:IncreaseDecreaseInCustomerDeposit>
    <FONR:IncreaseDecreaseInCustomerDeposit
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000783"
      unitRef="USD">-3000</FONR:IncreaseDecreaseInCustomerDeposit>
    <us-gaap:IncreaseDecreaseInOtherAccruedLiabilities
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000785"
      unitRef="USD">-7000</us-gaap:IncreaseDecreaseInOtherAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccruedLiabilities
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000786"
      unitRef="USD">-19000</us-gaap:IncreaseDecreaseInOtherAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000788"
      unitRef="USD">3899000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000789"
      unitRef="USD">6689000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000794"
      unitRef="USD">2552000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000795"
      unitRef="USD">192000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000797"
      unitRef="USD">15000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000800"
      unitRef="USD">20000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000801"
      unitRef="USD">20000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000803"
      unitRef="USD">-2557000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000804"
      unitRef="USD">-212000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000809"
      unitRef="USD">58000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000810"
      unitRef="USD">21000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000812"
      unitRef="USD">132000</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:PaymentsForRepurchaseOfConvertiblePreferredStock
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000815"
      unitRef="USD">1341000</us-gaap:PaymentsForRepurchaseOfConvertiblePreferredStock>
    <us-gaap:PaymentsForRepurchaseOfConvertiblePreferredStock
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000816"
      unitRef="USD">1885000</us-gaap:PaymentsForRepurchaseOfConvertiblePreferredStock>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000818"
      unitRef="USD">2833000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000819"
      unitRef="USD">2626000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000821"
      unitRef="USD">-4100000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000822"
      unitRef="USD">-4532000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000824"
      unitRef="USD">-2758000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000825"
      unitRef="USD">1945000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000827"
      unitRef="USD">56341000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000828"
      unitRef="USD">51280000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000830"
      unitRef="USD">53583000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000831"
      unitRef="USD">53225000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <FONR:DescriptionOfBusinessAndBasisOfPresentationTextBlock contextRef="From2024-07-01to2024-12-31" id="Fact000833">&lt;p id="xdx_80C_ecustom--DescriptionOfBusinessAndBasisOfPresentationTextBlock_z8j2h5oPWmk1" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE
1 &#x2013; &lt;span id="xdx_829_zxTANboTL8r5"&gt;DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Description
of Business&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;FONAR
Corporation (the &#x201c;Company&#x201d; or &#x201c;FONAR&#x201d;) is a Delaware corporation, which was incorporated on July 17, 1978. FONAR
is engaged in the research, development, production and marketing of medical scanning equipment, which uses principles of Magnetic Resonance
Imaging (&#x201c;MRI&#x201d;) for the detection and diagnosis of human diseases. In addition to deriving revenues from the direct sale
of MRI equipment, revenue is also generated from our installed-base of customers through our service and upgrade programs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;FONAR,
through its wholly-owned subsidiary Health Management Corporation of America (&#x201c;HMCA&#x201d;) provides comprehensive management services
to diagnostic imaging facilities. The services provided by the Company include development, administration, leasing of office space,
facilities and medical equipment, provision of supplies, staffing and supervision of non-medical personnel, legal services, accounting,
billing and collection and the development and implementation of practice growth and marketing strategies.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Effective
July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business.
The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and Health
Diagnostics Management (&#x201c;HDM&#x201d;). Imperial Management Services, LLC contributed all of its assets (which were utilized in the
business of Health Management Corporation of America) to HDM and received a &lt;span id="xdx_907_eus-gaap--InvestmentOwnedPercentOfNetAssets_iI_pip0_dp_c20150701__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zQBJXRA8WhL"&gt;24.2&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;%
interest in HDM. Health Management Corporation of America retained a direct ownership interest of &lt;span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pip0_dp_c20150701__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zRAgwz5pzns6"&gt;45.8&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;%
in HDM, and the original investors in HDM retained a &lt;span id="xdx_90A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pip0_dp_c20150701__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zozjfGVU7r64"&gt;30.0&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;%
ownership interest in the newly expanded HDM. As of June 30, 2024, the Company had a direct ownership interest of &lt;span id="xdx_908_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pip0_dp_c20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zplnBcIDbWsf"&gt;70.8&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;%
and the investors&#x2019; a &lt;span id="xdx_906_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pip0_dp_c20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zY5juJW1dty7"&gt;29.2&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;%
ownership interest. During the quarter ended December 31, 2024, the Company sold non-controlling interests to a minority shareholder
for $&lt;span id="xdx_907_eus-gaap--ProceedsFromPaymentsToMinorityShareholders_pn3n3_c20241001__20241231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_z9fo00PVoO0k"&gt;132&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;.
Currently, the Company has a direct ownership interest of &lt;span id="xdx_903_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pip0_dp_c20241231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_z7Xw58DYnbG9"&gt;70.63&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;%
and the investors&#x2019; have a &lt;span id="xdx_907_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pip0_dp_c20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zuemWa2ZyRif"&gt;29.37&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;%
ownership interest. The entire management of diagnostic imaging centers business segment is now being conducted by HDM, operating under
the name &#x201c;Health Management Company of America&#x201d;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Basis
of Presentation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;These
unaudited condensed consolidated financial statements for the period ended December 31, 2024 have been prepared in accordance with generally
accepted accounting principles in the United States of America (&#x201c;GAAP&#x201d;) and pursuant to the rules and regulations of the
Securities and Exchange Commission pertaining to interim financial statements. Accordingly, they do not include all of the information
and footnotes required by GAAP for complete financial statements and should be read in conjunction with the audited consolidated financial
statements and notes thereto included in the Company&#x2019;s Annual Report on Form 10-K for the year ended June 30, 2024, from which
the accompanying balance sheet at June 30, 2024 was derived. All intercompany balances and transactions have been eliminated in consolidation.
In the opinion of management, all adjustments considered necessary for a fair presentation of the interim financial information have
been included and are of a normal recurring nature. The preparation of the condensed consolidated financial statements in conformity
with GAAP requires the Company to make estimates and assumptions that affect the disclosure and reported amounts of assets and liabilities
at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting
period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



















</FONR:DescriptionOfBusinessAndBasisOfPresentationTextBlock>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="AsOf2015-07-01_us-gaap_OtherInvesteesMember"
      decimals="INF"
      id="Fact000834"
      unitRef="Pure">0.242</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2015-07-01_us-gaap_OtherInvesteesMember"
      decimals="INF"
      id="Fact000835"
      unitRef="Pure">0.458</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2015-07-01_us-gaap_NoncontrollingInterestMember_us-gaap_OtherInvesteesMember"
      decimals="INF"
      id="Fact000836"
      unitRef="Pure">0.300</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2024-06-30_us-gaap_OtherInvesteesMember"
      decimals="INF"
      id="Fact000837"
      unitRef="Pure">0.708</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2024-06-30_us-gaap_NoncontrollingInterestMember_us-gaap_OtherInvesteesMember"
      decimals="INF"
      id="Fact000838"
      unitRef="Pure">0.292</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:ProceedsFromPaymentsToMinorityShareholders
      contextRef="From2024-10-012024-12-31_us-gaap_OtherInvesteesMember"
      decimals="-3"
      id="Fact000839"
      unitRef="USD">132000</us-gaap:ProceedsFromPaymentsToMinorityShareholders>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2024-12-31_us-gaap_OtherInvesteesMember"
      decimals="INF"
      id="Fact000840"
      unitRef="Pure">0.7063</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2024-12-31_us-gaap_NoncontrollingInterestMember_us-gaap_OtherInvesteesMember"
      decimals="INF"
      id="Fact000841"
      unitRef="Pure">0.2937</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2024-07-01to2024-12-31" id="Fact000851">&lt;p id="xdx_80C_eus-gaap--SignificantAccountingPoliciesTextBlock_zJKlTJe1YgXi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE
2 - &lt;span id="xdx_824_zyHhAaGWVple"&gt;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zQxMpzIdddeb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span id="xdx_861_zh0MhL9MYTzf" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Basis
of Presentation&lt;/span&gt; &lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(Continued)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;The
Company evaluates theses estimates and judgements on an ongoing basis. The Company bases estimates and judgements on historical experience
and on various other factors that are believed to be reasonable under the circumstances. The results of operations for any interim period
are not necessarily indicative of the results of operations for a full year.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--ConsolidationPolicyTextBlock_z4ZlKuNI17Si" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span id="xdx_86B_zc7HOogWPoOd" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Principles
of Consolidation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;The
unaudited condensed consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries
and partnerships (collectively, the &#x201c;Company&#x201d;). All significant intercompany accounts and transactions have been eliminated
in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--RevenueRecognitionPolicyTextBlock_zb1qsGCBxFXa" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span id="xdx_86F_z04AOfkiJI19" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Revenue
Recognition&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;The
Company&#x2019;s revenues generally relate to net patient fees&#160;received from various payers and patients themselves under contracts
in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our
obligations to provide diagnostic services are satisfied. The Company&#x2019;s performance obligations for diagnostic services are generally
satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party
payer (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance
exchanges) and the transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated
with (managed care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party
payers for the services we provide to the related patients typically specify payments at amounts less than the Company&#x2019;s standard
charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates.
Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the
frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;The
Company&#x2019;s patient fee revenue, net of contractual allowances and discounts for the three and six months ended December 31, 2024
and 2023 are summarized in the following table:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--DisaggregationOfRevenueTableTextBlock_pn3n3_zL3DJiQxVnde" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span id="xdx_8BD_zlEmX5Fwg5k5" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Schedule
    of patient fee revenue - net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;For
    the Three Months Ended&lt;br/&gt; December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Commercial
    Insurance/Managed Care&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NetPatientFeeRevenue_pn3n3_c20241001__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_z18Xcauvc52g" style="width: 12%; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,174&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--NetPatientFeeRevenue_pn3n3_c20231001__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zK8wWpjbWbjh" style="width: 12%; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,243&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Medicare/Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--NetPatientFeeRevenue_pn3n3_c20241001__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zZRbS1gC7hzd" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;301&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--NetPatientFeeRevenue_pn3n3_c20231001__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zu8U0uK35Gs5" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;284&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Workers&#x2019;
    Compensation/Personal Injury&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetPatientFeeRevenue_pn3n3_c20241001__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_z1j0hmlMJQob" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;4,683&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetPatientFeeRevenue_pn3n3_c20231001__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zvblavHXJkE4" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;4,907&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--NetPatientFeeRevenue_pn3n3_c20241001__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zLfcHqiMhZg4" style="border-bottom: Black 1pt solid; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,786&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--NetPatientFeeRevenue_pn3n3_c20231001__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zYdnTWS83VXh" style="border-bottom: Black 1pt solid; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,787&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Patient
    Fee Revenue, net of contractual allowances and discounts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetPatientFeeRevenue_pn3n3_c20241001__20241231_zSf07rU5Y7ia" style="border-bottom: Black 2.5pt double; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;7,944&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--NetPatientFeeRevenue_pn3n3_c20231001__20231231_zm8zC3UOQeni" style="border-bottom: Black 2.5pt double; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;8,221&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;























&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Revenue
    Recognition (Continued)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;For
    the Six Months Ended&lt;br/&gt; December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Commercial
    Insurance/ Managed Care&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--NetPatientFeeRevenue_c20240701__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" style="width: 12%; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2,378&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NetPatientFeeRevenue_c20230701__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" style="width: 12%; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2,416&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Medicare/Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--NetPatientFeeRevenue_c20240701__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;562&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--NetPatientFeeRevenue_c20230701__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;555&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Workers&#x2019;
    Compensation/Personal Injury&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--NetPatientFeeRevenue_c20240701__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;9,382&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--NetPatientFeeRevenue_c20230701__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;10,044&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--NetPatientFeeRevenue_c20240701__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;3,109&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetPatientFeeRevenue_c20230701__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;3,881&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Patient
    Fee Revenue, net of contractual allowances and discounts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--NetPatientFeeRevenue_c20240701__20241231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;15,431&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--NetPatientFeeRevenue_c20230701__20231231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;16,896&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8AF_zUozMHWSpZk9" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_ecustom--ManagementAndOtherFeeReceivablePolicyTextBlock_zXjWOO9c32X9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_863_zKeWDttgnjpe" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Management
and other fee receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;HMCA
generates revenues from providing comprehensive management services, including development, administration, accounting, billing and collection
services, together with office space, medical equipment, supplies and non-medical personnel to its clients. Revenues are in the form
of fees which are earned under annual management contracts with HMCA clients. Management fee receivable is related to the management
fees outstanding from the related and non-related professional corporations (&#x201c;PCs&#x201d;) under the management agreements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--EarningsPerSharePolicyTextBlock_znCGB8Glccd5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_863_zFFWWr33Y5O5" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Earnings
Per Share&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Basic
earnings per share (&#x201c;EPS&#x201d;) is computed based upon the weighted average number of shares of common stock and stock equivalents
outstanding, net of common stock. In accordance with ASC Topic 260-10, &#x201c;Participating Securities and the Two-Class method&#x201d;,
the Company used the Two-Class method for calculating basic income per share and applied the converted method in calculating diluted
income per share for the three and six months ended December 31, 2024 and 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Diluted
EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average
market price of common shares outstanding during the period. For the three and six months ended December 31, 2024 and 2023, diluted EPS
for common shareholders includes &lt;span id="xdx_90E_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20230701__20231231_z9QoejhFelni"&gt;128
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;shares
upon conversion of Class C Common.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



























&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_zvSuADktrMr1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8B3_zWIu7i8E4IPh" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Schedule
    of earning per share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Three
    months ended &lt;br/&gt; December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Three
    months ended &lt;br/&gt; December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Numerator:
    &lt;br/&gt; Net income available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20241001__20241231_ztTa1wwlnWDd" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,964&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zOf2aCRyKGJf" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,840&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zMUw31DAxzei" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;31&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20231001__20231231_zxID2v0G8pLh" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;3,759&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zjdCfLIuesc1" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Common Stock and Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;3,525&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zweySSu8W3Yl" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;59&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Weighted
    average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20241001__20241231_zVkAyP0a5yFb" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,686&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zobPQYC1HAV7" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,303&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z3jBeGlOPqt4" style="font: normal 11pt Times New Roman, Times, Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20231001__20231231_z6FfKz3syYVg" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,437&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z0Xpm9av716" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,437&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zAtOM6gjv5Z8" style="font: normal 11pt Times New Roman, Times, Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Basic
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20241001__20241231_zkUoT17qDZl3" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFfqm38RqGb7" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.29&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z6n52whbB474" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.08&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20231001__20231231_zyxsQRp4L6pd" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.58&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKO1ImWncDt8" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.55&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zHRgAfVOuBdh" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.16&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Denominator:
    &lt;br/&gt;
    Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zixYLlEfAWGf" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,303&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zhCScoo7cZ8i" style="font: normal 11pt Times New Roman, Times, Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zELp0cpWqRE1" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,437&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zNbaLYf5rIV5" style="font: normal 11pt Times New Roman, Times, Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Convertible
    Class C Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ConvertibleClassCStock_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zZMFXw6Dq7lh" style="font: normal 11pt Times New Roman, Times, Serif"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ConvertibleClassCStock_pn3n3_d0_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zyO3CHookUdb" style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ConvertibleClassCStock_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zUvmoPZSrzwa" style="font: normal 11pt Times New Roman, Times, Serif"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ConvertibleClassCStock_pn3n3_d0_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zha7t8rJIDG3" style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Total
    Denominator for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zicEmHf5MvJf" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,431&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_906_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zWL9xD6Js6k9" style="font: normal 11pt Times New Roman, Times, Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zocz0Ddf5Lxa" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,565&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_904_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zv8RsJ5XOfq1" style="font: normal 11pt Times New Roman, Times, Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Diluted
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--EarningsPerShareDiluted_pip0_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKjdQMnTyOKd" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.29&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--EarningsPerShareDiluted_pip0_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zo2e9dER4va1" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.08&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--EarningsPerShareDiluted_pip0_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zNYREjn4QC94" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.54&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--EarningsPerShareDiluted_pip0_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zdX8taCtG7x3" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.16&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Six
    months ended &lt;br/&gt; December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Six
    months ended &lt;br/&gt; December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Numerator:
    &lt;br/&gt; Net income available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20240701__20241231_zUYItGA2tivc" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;5,099&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zCBPfN32iqRd" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;4,775&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zfGRoSD7DnI7" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;83&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20231231_zAu6tNscy156" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;7,865&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z25N3f8IwFq3" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Common Stock and Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;7,375&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z39Ly1ZxxTdb" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;125&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Weighted
    average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20240701__20241231_zYwD3YAJ5rwj" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,696&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zwVPrZqX6W7i" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,313&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zKmXnF1ZPk5b" style="font: normal 11pt Times New Roman, Times, Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20231231_zMtQCmFp8RQg" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,448&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsymdHwEt081" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,448&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zUaLrSiJ4oW2" style="font: normal 11pt Times New Roman, Times, Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Basic
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20240701__20241231_zwHIYbIkQc5a" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.81&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zeZ8c3bHHjcb" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.76&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zd1gkLEBpid5" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.22&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20231231_zewRQ7HypSj2" style="font: normal 11pt Times New Roman, Times, Serif"&gt;1.22&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zmSgeA9ml2x9" style="font: normal 11pt Times New Roman, Times, Serif"&gt;1.14&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zbz4B56NEhO8" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.33&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Denominator:
    &lt;br/&gt;
    Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z6I7pQfx89Kf" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,313&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zC6thKXWDBT" style="font: normal 11pt Times New Roman, Times, Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zq7I6DGVsxv1" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,448&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z7lO4NhLTXT" style="font: normal 11pt Times New Roman, Times, Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Convertible
    Class C Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ConvertibleClassCStock_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z38YTp5LspV8" style="font: normal 11pt Times New Roman, Times, Serif"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ConvertibleClassCStock_pn3n3_d0_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zl2aWvQISKl" style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ConvertibleClassCStock_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zNGs04uCaZF8" style="font: normal 11pt Times New Roman, Times, Serif"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ConvertibleClassCStock_pn3n3_d0_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zVWHVdr5Bdh8" style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Total
    Denominator for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zYd2uol9Mkn4" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,441&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zZIbJkgYMhXf" style="font: normal 11pt Times New Roman, Times, Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zm6Vydg7fSyl" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,576&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zvspvf0JtAzk" style="font: normal 11pt Times New Roman, Times, Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Diluted
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--EarningsPerShareDiluted_pip0_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVDisZxHxga4" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.74&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pip0_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zPzXBe83AY8i" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.22&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--EarningsPerShareDiluted_pip0_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zBUHA1ZB096b" style="font: normal 11pt Times New Roman, Times, Serif"&gt;1.12&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pip0_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zdQZ3ehBp5D7" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.33&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8AC_zzOIAfL0t6lj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;/p&gt;





















&lt;p id="xdx_84C_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z3iwg8LUJeek" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span id="xdx_860_zaxSgFmUHCb4" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Correction
of immaterial errors&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;In
conjunction with preparing its interim financial statements for the three and six months ended December 31, 2024, the Company determined
that its calculation of Right to Use Assets and Operating Lease Liabilities at the end of the past two annual periods and at September
30, 2024 and 2023 contained three immaterial errors. The Company evaluated the errors, both qualitatively and quantitatively, and determined
that no prior interim or annual periods were materially misstated. The Company then evaluated whether the cumulative amount of the misstatement
was material to its projected fiscal 2025 results of operations, and determined the cumulative amount was not material. Therefore, the
Condensed Consolidated Financial Statements for the six and three months ended December 31, 2024 include an out-of-period correction
of the following three items; a) a reclass of a software license of $&lt;span id="xdx_90E_ecustom--RightToUseAssetToIntangibleAsset_pn3n3_dm_c20240701__20241231_zxhPpzIF4r77"&gt;1.3
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;million
from Right to Use Asset/Liabilities to an intangible asset, b) a decrease to ROU of $&lt;span id="xdx_90B_eus-gaap--IncreaseDecreaseInOperatingLeaseLiability_pn3n3_dm_c20240701__20241231_zkIBhlBv2jyb"&gt;1.7
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;million
and an increase to Lease Liability of $&lt;span id="xdx_90D_eus-gaap--OperatingLeasePayments_pn3n3_dm_c20240701__20241231_zJtdLAwjr0P7"&gt;1.1
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;million
to correct the discounting of future lease payments and c) correct the accounting for 6 lease modifications.. The correction of these
three errors resulted in an out of period charge to expenses of $&lt;span id="xdx_90D_eus-gaap--IncomeTaxExpenseBenefitIntraperiodTaxAllocation_pn3n3_c20240701__20241231_zFYOxIgox9Gd"&gt;116
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;to pre-tax
income for the three and six months ended December 31, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zxNQfhqQxiw" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span id="xdx_865_z7SoHmRgVHk8" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Recent
Accounting Standards&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;In
December 2023, The Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued ASU 2023-09, &#x201c;Income Taxes (Topic 740) Improvements
to Income Tax Disclosures, which requires the annual financial statements to include consistent categories and great disaggregation of
information in the rate reconciliation and income taxes paid disaggregated by jurisdiction. ASU 2023-09 is effective for the Company&#x2019;s
annual reporting beginning after December 15, 2024, with early adoption permitted, and should be applied on a prospective basis, with
a retrospective option. The Company is currently evaluating the effect that the adoption of ASU 2023-09 will have on its disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;In
November 2023, FASB issued ASU 2023-07, &#x201c;Segment Reporting (Topic 280)&#x201d;, which is intended to improve reportable segment
disclosure requirements through enhanced disclosures about significant segment expenses. The amendments require disclosure of significant
segment expenses regularly provided to the chief operating decision maker (&#x201c;CODM&#x201d;) as well as other segment items, extended
certain annual disclosures to interim periods, clarify the applicability to single reportable segment entities, permit more than one
measure of profit or loss to be reported under certain conditions, and require disclosure of the title and position of the CODM. The
effective date for public entities is for fiscal years beginning after December 15, 2023 and interim periods with fiscal years beginning
after December 15, 2024. The Company is expected to adopt the new disclosures as required and are currently evaluating the impact on
the related disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;























&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Recent
Accounting Standards&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of December 31,
2024 that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly
affected our financial accounting measures or disclosures had they been in effect during 2024 or 2023, and it does not believe that any
of those standards will have a significant impact on our unaudited consolidated condensed financial statements at the time they become
effective.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2024-07-01to2024-12-31" id="Fact000853">&lt;p id="xdx_841_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zQxMpzIdddeb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span id="xdx_861_zh0MhL9MYTzf" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Basis
of Presentation&lt;/span&gt; &lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(Continued)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;The
Company evaluates theses estimates and judgements on an ongoing basis. The Company bases estimates and judgements on historical experience
and on various other factors that are believed to be reasonable under the circumstances. The results of operations for any interim period
are not necessarily indicative of the results of operations for a full year.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2024-07-01to2024-12-31" id="Fact000855">&lt;p id="xdx_84A_eus-gaap--ConsolidationPolicyTextBlock_z4ZlKuNI17Si" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span id="xdx_86B_zc7HOogWPoOd" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Principles
of Consolidation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;The
unaudited condensed consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries
and partnerships (collectively, the &#x201c;Company&#x201d;). All significant intercompany accounts and transactions have been eliminated
in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2024-07-01to2024-12-31" id="Fact000857">&lt;p id="xdx_84B_eus-gaap--RevenueRecognitionPolicyTextBlock_zb1qsGCBxFXa" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span id="xdx_86F_z04AOfkiJI19" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Revenue
Recognition&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;The
Company&#x2019;s revenues generally relate to net patient fees&#160;received from various payers and patients themselves under contracts
in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our
obligations to provide diagnostic services are satisfied. The Company&#x2019;s performance obligations for diagnostic services are generally
satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party
payer (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance
exchanges) and the transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated
with (managed care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party
payers for the services we provide to the related patients typically specify payments at amounts less than the Company&#x2019;s standard
charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates.
Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the
frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;The
Company&#x2019;s patient fee revenue, net of contractual allowances and discounts for the three and six months ended December 31, 2024
and 2023 are summarized in the following table:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--DisaggregationOfRevenueTableTextBlock_pn3n3_zL3DJiQxVnde" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span id="xdx_8BD_zlEmX5Fwg5k5" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Schedule
    of patient fee revenue - net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;For
    the Three Months Ended&lt;br/&gt; December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Commercial
    Insurance/Managed Care&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NetPatientFeeRevenue_pn3n3_c20241001__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_z18Xcauvc52g" style="width: 12%; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,174&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--NetPatientFeeRevenue_pn3n3_c20231001__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zK8wWpjbWbjh" style="width: 12%; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,243&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Medicare/Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--NetPatientFeeRevenue_pn3n3_c20241001__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zZRbS1gC7hzd" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;301&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--NetPatientFeeRevenue_pn3n3_c20231001__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zu8U0uK35Gs5" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;284&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Workers&#x2019;
    Compensation/Personal Injury&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetPatientFeeRevenue_pn3n3_c20241001__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_z1j0hmlMJQob" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;4,683&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetPatientFeeRevenue_pn3n3_c20231001__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zvblavHXJkE4" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;4,907&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--NetPatientFeeRevenue_pn3n3_c20241001__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zLfcHqiMhZg4" style="border-bottom: Black 1pt solid; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,786&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--NetPatientFeeRevenue_pn3n3_c20231001__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zYdnTWS83VXh" style="border-bottom: Black 1pt solid; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,787&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Patient
    Fee Revenue, net of contractual allowances and discounts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetPatientFeeRevenue_pn3n3_c20241001__20241231_zSf07rU5Y7ia" style="border-bottom: Black 2.5pt double; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;7,944&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--NetPatientFeeRevenue_pn3n3_c20231001__20231231_zm8zC3UOQeni" style="border-bottom: Black 2.5pt double; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;8,221&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;























&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Revenue
    Recognition (Continued)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;For
    the Six Months Ended&lt;br/&gt; December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Commercial
    Insurance/ Managed Care&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--NetPatientFeeRevenue_c20240701__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" style="width: 12%; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2,378&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NetPatientFeeRevenue_c20230701__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" style="width: 12%; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2,416&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Medicare/Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--NetPatientFeeRevenue_c20240701__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;562&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--NetPatientFeeRevenue_c20230701__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;555&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Workers&#x2019;
    Compensation/Personal Injury&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--NetPatientFeeRevenue_c20240701__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;9,382&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--NetPatientFeeRevenue_c20230701__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;10,044&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--NetPatientFeeRevenue_c20240701__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;3,109&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetPatientFeeRevenue_c20230701__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;3,881&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Patient
    Fee Revenue, net of contractual allowances and discounts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--NetPatientFeeRevenue_c20240701__20241231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;15,431&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--NetPatientFeeRevenue_c20230701__20231231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;16,896&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8AF_zUozMHWSpZk9" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="From2024-07-01to2024-12-31" id="Fact000859">&lt;table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--DisaggregationOfRevenueTableTextBlock_pn3n3_zL3DJiQxVnde" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span id="xdx_8BD_zlEmX5Fwg5k5" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Schedule
    of patient fee revenue - net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;For
    the Three Months Ended&lt;br/&gt; December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Commercial
    Insurance/Managed Care&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NetPatientFeeRevenue_pn3n3_c20241001__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_z18Xcauvc52g" style="width: 12%; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,174&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--NetPatientFeeRevenue_pn3n3_c20231001__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zK8wWpjbWbjh" style="width: 12%; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,243&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Medicare/Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--NetPatientFeeRevenue_pn3n3_c20241001__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zZRbS1gC7hzd" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;301&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--NetPatientFeeRevenue_pn3n3_c20231001__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zu8U0uK35Gs5" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;284&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Workers&#x2019;
    Compensation/Personal Injury&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetPatientFeeRevenue_pn3n3_c20241001__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_z1j0hmlMJQob" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;4,683&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetPatientFeeRevenue_pn3n3_c20231001__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zvblavHXJkE4" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;4,907&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--NetPatientFeeRevenue_pn3n3_c20241001__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zLfcHqiMhZg4" style="border-bottom: Black 1pt solid; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,786&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--NetPatientFeeRevenue_pn3n3_c20231001__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zYdnTWS83VXh" style="border-bottom: Black 1pt solid; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,787&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Patient
    Fee Revenue, net of contractual allowances and discounts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetPatientFeeRevenue_pn3n3_c20241001__20241231_zSf07rU5Y7ia" style="border-bottom: Black 2.5pt double; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;7,944&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--NetPatientFeeRevenue_pn3n3_c20231001__20231231_zm8zC3UOQeni" style="border-bottom: Black 2.5pt double; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;8,221&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;























&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Revenue
    Recognition (Continued)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;For
    the Six Months Ended&lt;br/&gt; December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Commercial
    Insurance/ Managed Care&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--NetPatientFeeRevenue_c20240701__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" style="width: 12%; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2,378&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NetPatientFeeRevenue_c20230701__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" style="width: 12%; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2,416&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Medicare/Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--NetPatientFeeRevenue_c20240701__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;562&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--NetPatientFeeRevenue_c20230701__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;555&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Workers&#x2019;
    Compensation/Personal Injury&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--NetPatientFeeRevenue_c20240701__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;9,382&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--NetPatientFeeRevenue_c20230701__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" style="text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;10,044&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--NetPatientFeeRevenue_c20240701__20241231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;3,109&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetPatientFeeRevenue_c20230701__20231231__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;3,881&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Patient
    Fee Revenue, net of contractual allowances and discounts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--NetPatientFeeRevenue_c20240701__20241231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;15,431&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--NetPatientFeeRevenue_c20230701__20231231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Patient Fee Revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;16,896&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <FONR:NetPatientFeeRevenue
      contextRef="From2024-10-012024-12-31_custom_CommercialInsuranceManagedCareMember"
      decimals="-3"
      id="Fact000861"
      unitRef="USD">1174000</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2023-10-012023-12-31_custom_CommercialInsuranceManagedCareMember"
      decimals="-3"
      id="Fact000863"
      unitRef="USD">1243000</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2024-10-012024-12-31_custom_MedicareMedicaidMember"
      decimals="-3"
      id="Fact000865"
      unitRef="USD">301000</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2023-10-012023-12-31_custom_MedicareMedicaidMember"
      decimals="-3"
      id="Fact000867"
      unitRef="USD">284000</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2024-10-012024-12-31_custom_WorkersCompensationPersonalInjuryMember"
      decimals="-3"
      id="Fact000869"
      unitRef="USD">4683000</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2023-10-012023-12-31_custom_WorkersCompensationPersonalInjuryMember"
      decimals="-3"
      id="Fact000871"
      unitRef="USD">4907000</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2024-10-012024-12-31_custom_OtherRevenueSourceMember"
      decimals="-3"
      id="Fact000873"
      unitRef="USD">1786000</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2023-10-012023-12-31_custom_OtherRevenueSourceMember"
      decimals="-3"
      id="Fact000875"
      unitRef="USD">1787000</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact000877"
      unitRef="USD">7944000</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact000879"
      unitRef="USD">8221000</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2024-07-012024-12-31_custom_CommercialInsuranceManagedCareMember"
      decimals="-3"
      id="Fact000891"
      unitRef="USD">2378000</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2023-07-012023-12-31_custom_CommercialInsuranceManagedCareMember"
      decimals="-3"
      id="Fact000893"
      unitRef="USD">2416000</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2024-07-012024-12-31_custom_MedicareMedicaidMember"
      decimals="-3"
      id="Fact000895"
      unitRef="USD">562000</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2023-07-012023-12-31_custom_MedicareMedicaidMember"
      decimals="-3"
      id="Fact000897"
      unitRef="USD">555000</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2024-07-012024-12-31_custom_WorkersCompensationPersonalInjuryMember"
      decimals="-3"
      id="Fact000899"
      unitRef="USD">9382000</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2023-07-012023-12-31_custom_WorkersCompensationPersonalInjuryMember"
      decimals="-3"
      id="Fact000901"
      unitRef="USD">10044000</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2024-07-012024-12-31_custom_OtherRevenueSourceMember"
      decimals="-3"
      id="Fact000903"
      unitRef="USD">3109000</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2023-07-012023-12-31_custom_OtherRevenueSourceMember"
      decimals="-3"
      id="Fact000905"
      unitRef="USD">3881000</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000907"
      unitRef="USD">15431000</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000909"
      unitRef="USD">16896000</FONR:NetPatientFeeRevenue>
    <FONR:ManagementAndOtherFeeReceivablePolicyTextBlock contextRef="From2024-07-01to2024-12-31" id="Fact000911">&lt;p id="xdx_849_ecustom--ManagementAndOtherFeeReceivablePolicyTextBlock_zXjWOO9c32X9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_863_zKeWDttgnjpe" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Management
and other fee receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;HMCA
generates revenues from providing comprehensive management services, including development, administration, accounting, billing and collection
services, together with office space, medical equipment, supplies and non-medical personnel to its clients. Revenues are in the form
of fees which are earned under annual management contracts with HMCA clients. Management fee receivable is related to the management
fees outstanding from the related and non-related professional corporations (&#x201c;PCs&#x201d;) under the management agreements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</FONR:ManagementAndOtherFeeReceivablePolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2024-07-01to2024-12-31" id="Fact000913">&lt;p id="xdx_840_eus-gaap--EarningsPerSharePolicyTextBlock_znCGB8Glccd5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_863_zFFWWr33Y5O5" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Earnings
Per Share&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Basic
earnings per share (&#x201c;EPS&#x201d;) is computed based upon the weighted average number of shares of common stock and stock equivalents
outstanding, net of common stock. In accordance with ASC Topic 260-10, &#x201c;Participating Securities and the Two-Class method&#x201d;,
the Company used the Two-Class method for calculating basic income per share and applied the converted method in calculating diluted
income per share for the three and six months ended December 31, 2024 and 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Diluted
EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average
market price of common shares outstanding during the period. For the three and six months ended December 31, 2024 and 2023, diluted EPS
for common shareholders includes &lt;span id="xdx_90E_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20230701__20231231_z9QoejhFelni"&gt;128
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;shares
upon conversion of Class C Common.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



























&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_zvSuADktrMr1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8B3_zWIu7i8E4IPh" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Schedule
    of earning per share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Three
    months ended &lt;br/&gt; December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Three
    months ended &lt;br/&gt; December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Numerator:
    &lt;br/&gt; Net income available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20241001__20241231_ztTa1wwlnWDd" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,964&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zOf2aCRyKGJf" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,840&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zMUw31DAxzei" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;31&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20231001__20231231_zxID2v0G8pLh" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;3,759&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zjdCfLIuesc1" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Common Stock and Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;3,525&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zweySSu8W3Yl" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;59&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Weighted
    average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20241001__20241231_zVkAyP0a5yFb" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,686&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zobPQYC1HAV7" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,303&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z3jBeGlOPqt4" style="font: normal 11pt Times New Roman, Times, Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20231001__20231231_z6FfKz3syYVg" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,437&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z0Xpm9av716" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,437&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zAtOM6gjv5Z8" style="font: normal 11pt Times New Roman, Times, Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Basic
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20241001__20241231_zkUoT17qDZl3" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFfqm38RqGb7" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.29&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z6n52whbB474" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.08&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20231001__20231231_zyxsQRp4L6pd" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.58&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKO1ImWncDt8" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.55&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zHRgAfVOuBdh" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.16&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Denominator:
    &lt;br/&gt;
    Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zixYLlEfAWGf" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,303&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zhCScoo7cZ8i" style="font: normal 11pt Times New Roman, Times, Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zELp0cpWqRE1" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,437&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zNbaLYf5rIV5" style="font: normal 11pt Times New Roman, Times, Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Convertible
    Class C Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ConvertibleClassCStock_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zZMFXw6Dq7lh" style="font: normal 11pt Times New Roman, Times, Serif"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ConvertibleClassCStock_pn3n3_d0_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zyO3CHookUdb" style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ConvertibleClassCStock_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zUvmoPZSrzwa" style="font: normal 11pt Times New Roman, Times, Serif"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ConvertibleClassCStock_pn3n3_d0_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zha7t8rJIDG3" style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Total
    Denominator for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zicEmHf5MvJf" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,431&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_906_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zWL9xD6Js6k9" style="font: normal 11pt Times New Roman, Times, Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zocz0Ddf5Lxa" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,565&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_904_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zv8RsJ5XOfq1" style="font: normal 11pt Times New Roman, Times, Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Diluted
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--EarningsPerShareDiluted_pip0_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKjdQMnTyOKd" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.29&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--EarningsPerShareDiluted_pip0_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zo2e9dER4va1" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.08&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--EarningsPerShareDiluted_pip0_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zNYREjn4QC94" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.54&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--EarningsPerShareDiluted_pip0_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zdX8taCtG7x3" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.16&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Six
    months ended &lt;br/&gt; December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Six
    months ended &lt;br/&gt; December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Numerator:
    &lt;br/&gt; Net income available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20240701__20241231_zUYItGA2tivc" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;5,099&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zCBPfN32iqRd" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;4,775&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zfGRoSD7DnI7" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;83&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20231231_zAu6tNscy156" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;7,865&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z25N3f8IwFq3" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Common Stock and Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;7,375&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z39Ly1ZxxTdb" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;125&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Weighted
    average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20240701__20241231_zYwD3YAJ5rwj" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,696&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zwVPrZqX6W7i" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,313&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zKmXnF1ZPk5b" style="font: normal 11pt Times New Roman, Times, Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20231231_zMtQCmFp8RQg" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,448&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsymdHwEt081" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,448&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zUaLrSiJ4oW2" style="font: normal 11pt Times New Roman, Times, Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Basic
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20240701__20241231_zwHIYbIkQc5a" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.81&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zeZ8c3bHHjcb" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.76&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zd1gkLEBpid5" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.22&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20231231_zewRQ7HypSj2" style="font: normal 11pt Times New Roman, Times, Serif"&gt;1.22&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zmSgeA9ml2x9" style="font: normal 11pt Times New Roman, Times, Serif"&gt;1.14&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zbz4B56NEhO8" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.33&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Denominator:
    &lt;br/&gt;
    Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z6I7pQfx89Kf" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,313&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zC6thKXWDBT" style="font: normal 11pt Times New Roman, Times, Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zq7I6DGVsxv1" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,448&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z7lO4NhLTXT" style="font: normal 11pt Times New Roman, Times, Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Convertible
    Class C Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ConvertibleClassCStock_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z38YTp5LspV8" style="font: normal 11pt Times New Roman, Times, Serif"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ConvertibleClassCStock_pn3n3_d0_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zl2aWvQISKl" style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ConvertibleClassCStock_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zNGs04uCaZF8" style="font: normal 11pt Times New Roman, Times, Serif"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ConvertibleClassCStock_pn3n3_d0_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zVWHVdr5Bdh8" style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Total
    Denominator for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zYd2uol9Mkn4" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,441&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zZIbJkgYMhXf" style="font: normal 11pt Times New Roman, Times, Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zm6Vydg7fSyl" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,576&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zvspvf0JtAzk" style="font: normal 11pt Times New Roman, Times, Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Diluted
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--EarningsPerShareDiluted_pip0_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVDisZxHxga4" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.74&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pip0_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zPzXBe83AY8i" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.22&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--EarningsPerShareDiluted_pip0_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zBUHA1ZB096b" style="font: normal 11pt Times New Roman, Times, Serif"&gt;1.12&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pip0_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zdQZ3ehBp5D7" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.33&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8AC_zzOIAfL0t6lj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;/p&gt;





















</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000914"
      unitRef="Shares">128000</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2024-07-01to2024-12-31" id="Fact000928">&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_zvSuADktrMr1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8B3_zWIu7i8E4IPh" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Schedule
    of earning per share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Three
    months ended &lt;br/&gt; December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Three
    months ended &lt;br/&gt; December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Numerator:
    &lt;br/&gt; Net income available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20241001__20241231_ztTa1wwlnWDd" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,964&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zOf2aCRyKGJf" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,840&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zMUw31DAxzei" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;31&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20231001__20231231_zxID2v0G8pLh" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;3,759&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zjdCfLIuesc1" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Common Stock and Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;3,525&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zweySSu8W3Yl" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;59&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Weighted
    average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20241001__20241231_zVkAyP0a5yFb" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,686&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zobPQYC1HAV7" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,303&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z3jBeGlOPqt4" style="font: normal 11pt Times New Roman, Times, Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20231001__20231231_z6FfKz3syYVg" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,437&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z0Xpm9av716" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,437&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zAtOM6gjv5Z8" style="font: normal 11pt Times New Roman, Times, Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Basic
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20241001__20241231_zkUoT17qDZl3" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFfqm38RqGb7" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.29&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z6n52whbB474" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.08&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20231001__20231231_zyxsQRp4L6pd" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.58&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKO1ImWncDt8" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.55&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zHRgAfVOuBdh" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.16&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Denominator:
    &lt;br/&gt;
    Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zixYLlEfAWGf" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,303&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zhCScoo7cZ8i" style="font: normal 11pt Times New Roman, Times, Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zELp0cpWqRE1" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,437&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zNbaLYf5rIV5" style="font: normal 11pt Times New Roman, Times, Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Convertible
    Class C Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ConvertibleClassCStock_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zZMFXw6Dq7lh" style="font: normal 11pt Times New Roman, Times, Serif"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ConvertibleClassCStock_pn3n3_d0_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zyO3CHookUdb" style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ConvertibleClassCStock_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zUvmoPZSrzwa" style="font: normal 11pt Times New Roman, Times, Serif"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ConvertibleClassCStock_pn3n3_d0_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zha7t8rJIDG3" style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Total
    Denominator for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zicEmHf5MvJf" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,431&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_906_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zWL9xD6Js6k9" style="font: normal 11pt Times New Roman, Times, Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zocz0Ddf5Lxa" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,565&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_904_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zv8RsJ5XOfq1" style="font: normal 11pt Times New Roman, Times, Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Diluted
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--EarningsPerShareDiluted_pip0_c20241001__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKjdQMnTyOKd" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.29&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--EarningsPerShareDiluted_pip0_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zo2e9dER4va1" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.08&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--EarningsPerShareDiluted_pip0_c20231001__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zNYREjn4QC94" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.54&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--EarningsPerShareDiluted_pip0_c20231001__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zdX8taCtG7x3" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.16&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Six
    months ended &lt;br/&gt; December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Six
    months ended &lt;br/&gt; December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Numerator:
    &lt;br/&gt; Net income available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20240701__20241231_zUYItGA2tivc" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;5,099&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zCBPfN32iqRd" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;4,775&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zfGRoSD7DnI7" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;83&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20231231_zAu6tNscy156" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;7,865&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z25N3f8IwFq3" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Common Stock and Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;7,375&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z39Ly1ZxxTdb" style="border-bottom: Black 2.5pt double; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;125&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Weighted
    average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20240701__20241231_zYwD3YAJ5rwj" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,696&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zwVPrZqX6W7i" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,313&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zKmXnF1ZPk5b" style="font: normal 11pt Times New Roman, Times, Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20231231_zMtQCmFp8RQg" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,448&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsymdHwEt081" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,448&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zUaLrSiJ4oW2" style="font: normal 11pt Times New Roman, Times, Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Basic
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20240701__20241231_zwHIYbIkQc5a" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.81&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zeZ8c3bHHjcb" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.76&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zd1gkLEBpid5" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.22&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20231231_zewRQ7HypSj2" style="font: normal 11pt Times New Roman, Times, Serif"&gt;1.22&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zmSgeA9ml2x9" style="font: normal 11pt Times New Roman, Times, Serif"&gt;1.14&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zbz4B56NEhO8" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.33&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Denominator:
    &lt;br/&gt;
    Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z6I7pQfx89Kf" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,313&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zC6thKXWDBT" style="font: normal 11pt Times New Roman, Times, Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zq7I6DGVsxv1" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,448&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z7lO4NhLTXT" style="font: normal 11pt Times New Roman, Times, Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Convertible
    Class C Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ConvertibleClassCStock_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z38YTp5LspV8" style="font: normal 11pt Times New Roman, Times, Serif"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ConvertibleClassCStock_pn3n3_d0_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zl2aWvQISKl" style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ConvertibleClassCStock_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zNGs04uCaZF8" style="font: normal 11pt Times New Roman, Times, Serif"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ConvertibleClassCStock_pn3n3_d0_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zVWHVdr5Bdh8" style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Total
    Denominator for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zYd2uol9Mkn4" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,441&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zZIbJkgYMhXf" style="font: normal 11pt Times New Roman, Times, Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zm6Vydg7fSyl" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,576&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zvspvf0JtAzk" style="font: normal 11pt Times New Roman, Times, Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Diluted
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--EarningsPerShareDiluted_pip0_c20240701__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVDisZxHxga4" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.74&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pip0_c20240701__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zPzXBe83AY8i" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.22&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--EarningsPerShareDiluted_pip0_c20230701__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zBUHA1ZB096b" style="font: normal 11pt Times New Roman, Times, Serif"&gt;1.12&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pip0_c20230701__20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zdQZ3ehBp5D7" style="font: normal 11pt Times New Roman, Times, Serif"&gt;0.33&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact000930"
      unitRef="USD">1964000</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000932"
      unitRef="USD">1840000</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2024-10-012024-12-31_us-gaap_CommonClassCMember"
      decimals="-3"
      id="Fact000934"
      unitRef="USD">31000</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact000936"
      unitRef="USD">3759000</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000938"
      unitRef="USD">3525000</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2023-10-012023-12-31_us-gaap_CommonClassCMember"
      decimals="-3"
      id="Fact000940"
      unitRef="USD">59000</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact000941"
      unitRef="Shares">6686000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000942"
      unitRef="Shares">6303000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-10-012024-12-31_us-gaap_CommonClassCMember"
      decimals="-3"
      id="Fact000943"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact000944"
      unitRef="Shares">6437000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000945"
      unitRef="Shares">6437000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-10-012023-12-31_us-gaap_CommonClassCMember"
      decimals="-3"
      id="Fact000946"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2024-10-012024-12-31"
      decimals="INF"
      id="Fact000947"
      unitRef="USDPShares">0.31</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000948"
      unitRef="USDPShares">0.29</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2024-10-012024-12-31_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000949"
      unitRef="USDPShares">0.08</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2023-10-012023-12-31"
      decimals="INF"
      id="Fact000950"
      unitRef="USDPShares">0.58</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000951"
      unitRef="USDPShares">0.55</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2023-10-012023-12-31_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000952"
      unitRef="USDPShares">0.16</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000953"
      unitRef="Shares">6303000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-10-012024-12-31_us-gaap_CommonClassCMember"
      decimals="-3"
      id="Fact000954"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000955"
      unitRef="Shares">6437000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-10-012023-12-31_us-gaap_CommonClassCMember"
      decimals="-3"
      id="Fact000956"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <FONR:ConvertibleClassCStock
      contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000957"
      unitRef="Shares">128000</FONR:ConvertibleClassCStock>
    <FONR:ConvertibleClassCStock
      contextRef="From2024-10-012024-12-31_us-gaap_CommonClassCMember"
      decimals="-3"
      id="Fact000958"
      unitRef="Shares">0</FONR:ConvertibleClassCStock>
    <FONR:ConvertibleClassCStock
      contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000959"
      unitRef="Shares">128000</FONR:ConvertibleClassCStock>
    <FONR:ConvertibleClassCStock
      contextRef="From2023-10-012023-12-31_us-gaap_CommonClassCMember"
      decimals="-3"
      id="Fact000960"
      unitRef="Shares">0</FONR:ConvertibleClassCStock>
    <FONR:WeightedAverageNumberOfDilutedEarningsPerShare
      contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000961"
      unitRef="Shares">6431000</FONR:WeightedAverageNumberOfDilutedEarningsPerShare>
    <FONR:WeightedAverageNumberOfDilutedEarningsPerShare
      contextRef="From2024-10-012024-12-31_us-gaap_CommonClassCMember"
      decimals="-3"
      id="Fact000962"
      unitRef="Shares">383000</FONR:WeightedAverageNumberOfDilutedEarningsPerShare>
    <FONR:WeightedAverageNumberOfDilutedEarningsPerShare
      contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000963"
      unitRef="Shares">6565000</FONR:WeightedAverageNumberOfDilutedEarningsPerShare>
    <FONR:WeightedAverageNumberOfDilutedEarningsPerShare
      contextRef="From2023-10-012023-12-31_us-gaap_CommonClassCMember"
      decimals="-3"
      id="Fact000964"
      unitRef="Shares">383000</FONR:WeightedAverageNumberOfDilutedEarningsPerShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000965"
      unitRef="USDPShares">0.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-10-012024-12-31_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000966"
      unitRef="USDPShares">0.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000967"
      unitRef="USDPShares">0.54</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-10-012023-12-31_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000968"
      unitRef="USDPShares">0.16</us-gaap:EarningsPerShareDiluted>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000970"
      unitRef="USD">5099000</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2024-07-012024-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000972"
      unitRef="USD">4775000</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2024-07-012024-12-31_us-gaap_CommonClassCMember"
      decimals="-3"
      id="Fact000974"
      unitRef="USD">83000</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000976"
      unitRef="USD">7865000</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2023-07-012023-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000978"
      unitRef="USD">7375000</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2023-07-012023-12-31_us-gaap_CommonClassCMember"
      decimals="-3"
      id="Fact000980"
      unitRef="USD">125000</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact000981"
      unitRef="Shares">6696000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-07-012024-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000982"
      unitRef="Shares">6313000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-07-012024-12-31_us-gaap_CommonClassCMember"
      decimals="-3"
      id="Fact000983"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact000984"
      unitRef="Shares">6448000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-07-012023-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000985"
      unitRef="Shares">6448000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-07-012023-12-31_us-gaap_CommonClassCMember"
      decimals="-3"
      id="Fact000986"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2024-07-01to2024-12-31"
      decimals="INF"
      id="Fact000987"
      unitRef="USDPShares">0.81</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2024-07-012024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000988"
      unitRef="USDPShares">0.76</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2024-07-012024-12-31_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000989"
      unitRef="USDPShares">0.22</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2023-07-012023-12-31"
      decimals="INF"
      id="Fact000990"
      unitRef="USDPShares">1.22</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2023-07-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000991"
      unitRef="USDPShares">1.14</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2023-07-012023-12-31_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000992"
      unitRef="USDPShares">0.33</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-07-012024-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000993"
      unitRef="Shares">6313000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-07-012024-12-31_us-gaap_CommonClassCMember"
      decimals="-3"
      id="Fact000994"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-07-012023-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000995"
      unitRef="Shares">6448000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-07-012023-12-31_us-gaap_CommonClassCMember"
      decimals="-3"
      id="Fact000996"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <FONR:ConvertibleClassCStock
      contextRef="From2024-07-012024-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000997"
      unitRef="Shares">128000</FONR:ConvertibleClassCStock>
    <FONR:ConvertibleClassCStock
      contextRef="From2024-07-012024-12-31_us-gaap_CommonClassCMember"
      decimals="-3"
      id="Fact000998"
      unitRef="Shares">0</FONR:ConvertibleClassCStock>
    <FONR:ConvertibleClassCStock
      contextRef="From2023-07-012023-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000999"
      unitRef="Shares">128000</FONR:ConvertibleClassCStock>
    <FONR:ConvertibleClassCStock
      contextRef="From2023-07-012023-12-31_us-gaap_CommonClassCMember"
      decimals="-3"
      id="Fact001000"
      unitRef="Shares">0</FONR:ConvertibleClassCStock>
    <FONR:WeightedAverageNumberOfDilutedEarningsPerShare
      contextRef="From2024-07-012024-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact001001"
      unitRef="Shares">6441000</FONR:WeightedAverageNumberOfDilutedEarningsPerShare>
    <FONR:WeightedAverageNumberOfDilutedEarningsPerShare
      contextRef="From2024-07-012024-12-31_us-gaap_CommonClassCMember"
      decimals="-3"
      id="Fact001002"
      unitRef="Shares">383000</FONR:WeightedAverageNumberOfDilutedEarningsPerShare>
    <FONR:WeightedAverageNumberOfDilutedEarningsPerShare
      contextRef="From2023-07-012023-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact001003"
      unitRef="Shares">6576000</FONR:WeightedAverageNumberOfDilutedEarningsPerShare>
    <FONR:WeightedAverageNumberOfDilutedEarningsPerShare
      contextRef="From2023-07-012023-12-31_us-gaap_CommonClassCMember"
      decimals="-3"
      id="Fact001004"
      unitRef="Shares">383000</FONR:WeightedAverageNumberOfDilutedEarningsPerShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-07-012024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001005"
      unitRef="USDPShares">0.74</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-07-012024-12-31_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact001006"
      unitRef="USDPShares">0.22</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-07-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001007"
      unitRef="USDPShares">1.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-07-012023-12-31_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact001008"
      unitRef="USDPShares">0.33</us-gaap:EarningsPerShareDiluted>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="From2024-07-01to2024-12-31" id="Fact001019">&lt;p id="xdx_84C_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z3iwg8LUJeek" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span id="xdx_860_zaxSgFmUHCb4" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Correction
of immaterial errors&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;In
conjunction with preparing its interim financial statements for the three and six months ended December 31, 2024, the Company determined
that its calculation of Right to Use Assets and Operating Lease Liabilities at the end of the past two annual periods and at September
30, 2024 and 2023 contained three immaterial errors. The Company evaluated the errors, both qualitatively and quantitatively, and determined
that no prior interim or annual periods were materially misstated. The Company then evaluated whether the cumulative amount of the misstatement
was material to its projected fiscal 2025 results of operations, and determined the cumulative amount was not material. Therefore, the
Condensed Consolidated Financial Statements for the six and three months ended December 31, 2024 include an out-of-period correction
of the following three items; a) a reclass of a software license of $&lt;span id="xdx_90E_ecustom--RightToUseAssetToIntangibleAsset_pn3n3_dm_c20240701__20241231_zxhPpzIF4r77"&gt;1.3
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;million
from Right to Use Asset/Liabilities to an intangible asset, b) a decrease to ROU of $&lt;span id="xdx_90B_eus-gaap--IncreaseDecreaseInOperatingLeaseLiability_pn3n3_dm_c20240701__20241231_zkIBhlBv2jyb"&gt;1.7
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;million
and an increase to Lease Liability of $&lt;span id="xdx_90D_eus-gaap--OperatingLeasePayments_pn3n3_dm_c20240701__20241231_zJtdLAwjr0P7"&gt;1.1
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;million
to correct the discounting of future lease payments and c) correct the accounting for 6 lease modifications.. The correction of these
three errors resulted in an out of period charge to expenses of $&lt;span id="xdx_90D_eus-gaap--IncomeTaxExpenseBenefitIntraperiodTaxAllocation_pn3n3_c20240701__20241231_zFYOxIgox9Gd"&gt;116
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;to pre-tax
income for the three and six months ended December 31, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <FONR:RightToUseAssetToIntangibleAsset
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact001020"
      unitRef="USD">1300000</FONR:RightToUseAssetToIntangibleAsset>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact001021"
      unitRef="USD">1700000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:OperatingLeasePayments
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact001022"
      unitRef="USD">1100000</us-gaap:OperatingLeasePayments>
    <us-gaap:IncomeTaxExpenseBenefitIntraperiodTaxAllocation
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact001023"
      unitRef="USD">116000</us-gaap:IncomeTaxExpenseBenefitIntraperiodTaxAllocation>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2024-07-01to2024-12-31" id="Fact001025">&lt;p id="xdx_845_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zxNQfhqQxiw" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span id="xdx_865_z7SoHmRgVHk8" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Recent
Accounting Standards&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;In
December 2023, The Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued ASU 2023-09, &#x201c;Income Taxes (Topic 740) Improvements
to Income Tax Disclosures, which requires the annual financial statements to include consistent categories and great disaggregation of
information in the rate reconciliation and income taxes paid disaggregated by jurisdiction. ASU 2023-09 is effective for the Company&#x2019;s
annual reporting beginning after December 15, 2024, with early adoption permitted, and should be applied on a prospective basis, with
a retrospective option. The Company is currently evaluating the effect that the adoption of ASU 2023-09 will have on its disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;In
November 2023, FASB issued ASU 2023-07, &#x201c;Segment Reporting (Topic 280)&#x201d;, which is intended to improve reportable segment
disclosure requirements through enhanced disclosures about significant segment expenses. The amendments require disclosure of significant
segment expenses regularly provided to the chief operating decision maker (&#x201c;CODM&#x201d;) as well as other segment items, extended
certain annual disclosures to interim periods, clarify the applicability to single reportable segment entities, permit more than one
measure of profit or loss to be reported under certain conditions, and require disclosure of the title and position of the CODM. The
effective date for public entities is for fiscal years beginning after December 15, 2023 and interim periods with fiscal years beginning
after December 15, 2024. The Company is expected to adopt the new disclosures as required and are currently evaluating the impact on
the related disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;























&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Recent
Accounting Standards&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of December 31,
2024 that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly
affected our financial accounting measures or disclosures had they been in effect during 2024 or 2023, and it does not believe that any
of those standards will have a significant impact on our unaudited consolidated condensed financial statements at the time they become
effective.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock contextRef="From2024-07-01to2024-12-31" id="Fact001037">&lt;p id="xdx_803_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zxKOpEEyGGM7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;NOTE
3 &#x2013; &lt;span id="xdx_822_zL9n8kAU2hWj"&gt;ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Receivables,
net are comprised of the following at December 31, 2024, and June 30, 2024:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_pn3n3_z8bd1OG0LX96" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8BB_zp1GhDq6yE6j" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Schedule
    of financing receivable noncurrent allowance for credit loss&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49A_20241231__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z0RBRf7wwER3" style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_493_20241231__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zvXSVmvYjjFa" style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_498_20241231_zSDSREaE2xR3" style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;December
    31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Gross
    Receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Allowance
    for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--AccountsReceivableNet_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 46%; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Accounts
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;3,663&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;273&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;3,390&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--AccountsReceivableNetRelatedParty_iI_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Accounts
    receivable - related party&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;60&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1046"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;60&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--NontradeReceivables_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Medical
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;23,496&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1050"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;23,496&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Management
    and other fees receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;55,148&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;12,663&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;42,485&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Management
    and other fees receivable from related medical practices (&#x201c;PC&#x2019;s&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;16,666&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,989&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;9,677&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_494_20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zB9JXYN3V1k1" style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_493_20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_ziASn6lVxep1" style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49B_20240630_zWOBFj4GtxU2" style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;June
    30, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Gross
    Receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Allowance
    for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--AccountsReceivableNet_iI_pn3n3_zuWXkbN34zhl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 46%; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Accounts
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;4,201&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;166&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;4,035&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--NontradeReceivables_iI_pn3n3_zADsAvQzSfo1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Medical
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;23,992&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1066"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;23,992&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_zmX6owK18J8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Management
    and other fees receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;54,324&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;12,370&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;41,954&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_ziRgeoenE1Ej" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Management
    and other fees receivable from related medical practices (&#x201c;PC&#x2019;s&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;15,975&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,110&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;9,865&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8A5_z8u9XdpqKvl1" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;The
Company&#x2019;s customers are concentrated in the healthcare industry.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;























&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Accounts
Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Credit
risk with respect to the Company&#x2019;s accounts receivable related to product sales and service and repair fees is limited due to the
customer advances received prior to the commencement of work performed and the billing of amounts to customers as sub-assemblies are
completed. Service and repair fees are billed on a monthly or quarterly basis and the Company does not continue providing these services
if accounts receivable become past due. The Company has established a current expected credit loss (&#x201c;CECL&#x201d;) to address the
risk that a portion of these fees will not be paid. The Company controls credit risk with respect to accounts receivable from service
and repair fees through its credit evaluation process, credit limits, monitoring procedures and reasonably short collection terms. The
Company performs ongoing credit authorizations before a product sales contract is entered into or service and repair fees are provided.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Long
Term-Accounts Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Long
term-accounts receivable balances at December 31, 2024 and June 30, 2024 amounted to approximately $&lt;span id="xdx_90A_eus-gaap--IncreaseDecreaseInAccountsAndOtherReceivables_pn3n3_c20240701__20241231_zjjc5VzZsEjl"&gt;724
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;and
$&lt;span id="xdx_902_eus-gaap--IncreaseDecreaseInAccountsAndOtherReceivables_pn3n3_c20230701__20240630_zLgzvCanbhz5"&gt;830 &lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;respectively.
The Company will generate revenue from long-term, non-cancellable contracts to provide service and repair services. Future revenue to
be recognized over the following four years as of December 31, 2024 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--LongTermPurchaseCommitmentTextBlock_pn3n3_znuwEuARe03l" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Future Revenue (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"&gt;&lt;span id="xdx_8B7_zmpitxKBUFql" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Schedule
    of future revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 44%; text-align: right; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ContractReceivableDueOneToTwoYears_iI_pn3n3_c20241231_z5Tohm8lWPjh" style="width: 43%; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;677&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pn3n3_c20241231_zClkZxZ6BGU1" style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;242&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ContractReceivableDueThreeToFourYears_iI_pn3n3_c20241231_zKybmD13r44i" style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;87&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ContractReceivableDueFourToFiveYears_iI_pn3n3_c20241231_zgJgvGHDrpw8" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;44&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_pn3n3_c20241231_zcukdl8FyWpa" style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,050&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A6_zL6NKvyxND37" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Medical
Receivables&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Medical
receivables are due under fee-for-service contracts from third party payors, such as hospitals, government sponsored healthcare programs,
patient&#x2019;s legal counsel and directly from patients. Substantially all the revenue relates to patients residing in Florida. Medical
receivables are recorded at net realizable value based on the estimated amounts the Company expects to receive from patients and third-party
payors. The medical receivable is reduced by contractual adjustments based on the historical experience with each payor class at each
location.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;























&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Management
and Other Fees Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; color: #212529"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Management
fees receivable is related to management fees outstanding from the related and non related PCs under management agreements. The Company
has established a CECL to address the risk that a portion of the contractually obligated management fees receivable from the PCs may
not be paid. The PC&#x2019;s may be limited in their ability to pay the full management fee receivable if they do not collect sufficient
expected fees from third-party payers and patients. The Company&#x2019;s management fees are collateralized, individually and collectively,
by the assets of the PCs. The CECL is determined based on the difference between the management fee receivable and the current amount
of outstanding fees estimated to be collected by the PCs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Management
and Other Fees Receivable (Continued)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;The
Company&#x2019;s considerations into the estimate of the PC&#x2019;s fee collection is based on a combination of factors. As each management
agreement specifies the Company&#x2019;s ultimate collateral for unpaid management fees are the patient fee receivables owned by each
PC, the Company considers the historical loss rates to pools of receivables with similar risks characteristics, aging of the patient
fee receivables, and the financial condition of each PC. In addition, the Company subjectively adjusts its estimated expected credit
losses for current and forward-looking economic conditions which would include trends seen within the industry and newly enacted regulation.
The Company also incorporates qualitative factors, such as changes in the nature and volume of receivables, regulatory changes, and other
relevant factors. Specifically, insurance carriers covering automobile no-fault and workers compensation claims incur longer payment
cycles and rigorous informational requirements and certain other disallowed claims. Approximately &lt;span id="xdx_90C_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_pip0_dp_c20241001__20241231_z5ccBn2cRVya"&gt;58.2&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;%
and &lt;span id="xdx_909_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_pip0_dp_c20231001__20231231_z1YtUwiVPcDl"&gt;54.4&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;%
of the Company&#x2019;s owned PCs&#x2019; net revenues were derived from no-fault and personal injury protection claims for the three months
ending December 31, 2024 and 2023, respectively. In addition, &lt;span id="xdx_904_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_pip0_dp_c20240701__20241231_zWKW9CZnMfpc"&gt;59.3&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;%
and &lt;span id="xdx_904_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_pip0_dp_c20230701__20231231_zaSvVOdRtX4g"&gt;57.5&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;%
of the Company&#x2019;s owned PC&#x2019;s net revenues were derived from no-fault and personal injury protection claims for the six months
ending December 31, 2024 and 2023, respectively. Also approximately &lt;span id="xdx_90F_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1_pip0_dp_c20241001__20241231_zsobWHLM2KKf"&gt;72.5&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;%
and &lt;span id="xdx_909_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1_pip0_dp_c20231001__20231231_z1yWlLdBUiB5"&gt;71.7&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;%
of the Company&#x2019;s managed PCs&#x2019; net revenues were derived from no-fault and personal injury protection claims for the three
months ending December 31, 2024 and 2023, respectively. In addition &lt;span id="xdx_90C_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1_pip0_dp_c20240701__20241231_zmeew03pjEy8"&gt;72.2&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;%
and &lt;span id="xdx_909_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1_pip0_dp_c20230701__20231231_zXlqGjbwFFfk"&gt;71.8&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;%
of the Company&#x2019;s net revenues were derived from no-fault and personal injury protection claims for the six months ending December
31, 2024 and 2023, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;The
Company combines an objective and subjective loss-rate methodology to estimate expected credit losses based on the collateral owned by
each PC. This involves objectively using historical loss rates to pools of receivables with similar risk characteristics (i.e. various
insurance payors) and then subjectively adjusting for current and forward-looking economic conditions which would include trends seen
within the industry and newly enacted regulation. The Company also incorporates qualitative factors, such as changes in the nature and
volume of the receivables, regulatory changes, and other relevant factors. Additional Company managed entities also operate under a guaranty
agreement, pursuant to which management fees are payable to the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;























&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Net
revenues from management and other fees charged to the related PCs accounted for approximately &lt;span id="xdx_903_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_pip0_dp_c20241001__20241231_z66qqLsno2Of"&gt;12.0&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;%
and &lt;span id="xdx_909_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_pip0_dp_c20231001__20231231_zfGLIrZ0eSV7"&gt;11.8&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;%
of the consolidated net revenues for the three months ended December 31, 2024 and 2023, respectively. Net revenues from management and
other fees charges to the related PCs accounted for approximately &lt;span id="xdx_90A_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_pip0_dp_c20240701__20241231_zPvFRPsjOa8"&gt;12.0&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;%
and &lt;span id="xdx_903_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_pip0_dp_c20230701__20231231_zCC45mEQQDk7"&gt;11.7&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;%
of the consolidated net revenues for the six months ended December 31, 2024 and 2023, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
    <us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock contextRef="From2024-07-01to2024-12-31" id="Fact001039">&lt;table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_pn3n3_z8bd1OG0LX96" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8BB_zp1GhDq6yE6j" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Schedule
    of financing receivable noncurrent allowance for credit loss&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49A_20241231__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z0RBRf7wwER3" style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_493_20241231__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zvXSVmvYjjFa" style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_498_20241231_zSDSREaE2xR3" style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;December
    31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Gross
    Receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Allowance
    for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--AccountsReceivableNet_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 46%; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Accounts
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;3,663&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;273&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;3,390&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--AccountsReceivableNetRelatedParty_iI_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Accounts
    receivable - related party&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;60&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1046"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;60&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--NontradeReceivables_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Medical
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;23,496&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1050"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;23,496&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Management
    and other fees receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;55,148&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;12,663&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;42,485&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Management
    and other fees receivable from related medical practices (&#x201c;PC&#x2019;s&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;16,666&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,989&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;9,677&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_494_20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zB9JXYN3V1k1" style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_493_20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_ziASn6lVxep1" style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49B_20240630_zWOBFj4GtxU2" style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;June
    30, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Gross
    Receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Allowance
    for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--AccountsReceivableNet_iI_pn3n3_zuWXkbN34zhl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 46%; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Accounts
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;4,201&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;166&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;4,035&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--NontradeReceivables_iI_pn3n3_zADsAvQzSfo1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Medical
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;23,992&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1066"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;23,992&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_zmX6owK18J8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Management
    and other fees receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;54,324&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;12,370&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;41,954&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_ziRgeoenE1Ej" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Management
    and other fees receivable from related medical practices (&#x201c;PC&#x2019;s&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;15,975&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;6,110&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;9,865&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2024-12-31_us-gaap_AccountsReceivableMember"
      decimals="-3"
      id="Fact001041"
      unitRef="USD">3663000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2024-12-31_us-gaap_DoubtfulMember"
      decimals="-3"
      id="Fact001042"
      unitRef="USD">273000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001043"
      unitRef="USD">3390000</us-gaap:AccountsReceivableNet>
    <FONR:AccountsReceivableNetRelatedParty
      contextRef="AsOf2024-12-31_us-gaap_AccountsReceivableMember"
      decimals="-3"
      id="Fact001045"
      unitRef="USD">60000</FONR:AccountsReceivableNetRelatedParty>
    <FONR:AccountsReceivableNetRelatedParty
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001047"
      unitRef="USD">60000</FONR:AccountsReceivableNetRelatedParty>
    <us-gaap:NontradeReceivables
      contextRef="AsOf2024-12-31_us-gaap_AccountsReceivableMember"
      decimals="-3"
      id="Fact001049"
      unitRef="USD">23496000</us-gaap:NontradeReceivables>
    <us-gaap:NontradeReceivables
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001051"
      unitRef="USD">23496000</us-gaap:NontradeReceivables>
    <FONR:ManagementAndOtherFeesNonRelatedParties
      contextRef="AsOf2024-12-31_us-gaap_AccountsReceivableMember"
      decimals="-3"
      id="Fact001053"
      unitRef="USD">55148000</FONR:ManagementAndOtherFeesNonRelatedParties>
    <FONR:ManagementAndOtherFeesNonRelatedParties
      contextRef="AsOf2024-12-31_us-gaap_DoubtfulMember"
      decimals="-3"
      id="Fact001054"
      unitRef="USD">12663000</FONR:ManagementAndOtherFeesNonRelatedParties>
    <FONR:ManagementAndOtherFeesNonRelatedParties
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001055"
      unitRef="USD">42485000</FONR:ManagementAndOtherFeesNonRelatedParties>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances
      contextRef="AsOf2024-12-31_us-gaap_AccountsReceivableMember"
      decimals="-3"
      id="Fact001057"
      unitRef="USD">16666000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances
      contextRef="AsOf2024-12-31_us-gaap_DoubtfulMember"
      decimals="-3"
      id="Fact001058"
      unitRef="USD">6989000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001059"
      unitRef="USD">9677000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2024-06-30_us-gaap_AccountsReceivableMember"
      decimals="-3"
      id="Fact001061"
      unitRef="USD">4201000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2024-06-30_us-gaap_DoubtfulMember"
      decimals="-3"
      id="Fact001062"
      unitRef="USD">166000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001063"
      unitRef="USD">4035000</us-gaap:AccountsReceivableNet>
    <us-gaap:NontradeReceivables
      contextRef="AsOf2024-06-30_us-gaap_AccountsReceivableMember"
      decimals="-3"
      id="Fact001065"
      unitRef="USD">23992000</us-gaap:NontradeReceivables>
    <us-gaap:NontradeReceivables
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001067"
      unitRef="USD">23992000</us-gaap:NontradeReceivables>
    <FONR:ManagementAndOtherFeesNonRelatedParties
      contextRef="AsOf2024-06-30_us-gaap_AccountsReceivableMember"
      decimals="-3"
      id="Fact001069"
      unitRef="USD">54324000</FONR:ManagementAndOtherFeesNonRelatedParties>
    <FONR:ManagementAndOtherFeesNonRelatedParties
      contextRef="AsOf2024-06-30_us-gaap_DoubtfulMember"
      decimals="-3"
      id="Fact001070"
      unitRef="USD">12370000</FONR:ManagementAndOtherFeesNonRelatedParties>
    <FONR:ManagementAndOtherFeesNonRelatedParties
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001071"
      unitRef="USD">41954000</FONR:ManagementAndOtherFeesNonRelatedParties>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances
      contextRef="AsOf2024-06-30_us-gaap_AccountsReceivableMember"
      decimals="-3"
      id="Fact001073"
      unitRef="USD">15975000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances
      contextRef="AsOf2024-06-30_us-gaap_DoubtfulMember"
      decimals="-3"
      id="Fact001074"
      unitRef="USD">6110000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001075"
      unitRef="USD">9865000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact001086"
      unitRef="USD">724000</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
    <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact001087"
      unitRef="USD">830000</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
    <us-gaap:LongTermPurchaseCommitmentTextBlock contextRef="From2024-07-01to2024-12-31" id="Fact001089">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--LongTermPurchaseCommitmentTextBlock_pn3n3_znuwEuARe03l" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Future Revenue (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"&gt;&lt;span id="xdx_8B7_zmpitxKBUFql" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Schedule
    of future revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 44%; text-align: right; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ContractReceivableDueOneToTwoYears_iI_pn3n3_c20241231_z5Tohm8lWPjh" style="width: 43%; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;677&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pn3n3_c20241231_zClkZxZ6BGU1" style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;242&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ContractReceivableDueThreeToFourYears_iI_pn3n3_c20241231_zKybmD13r44i" style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;87&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ContractReceivableDueFourToFiveYears_iI_pn3n3_c20241231_zgJgvGHDrpw8" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;44&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_pn3n3_c20241231_zcukdl8FyWpa" style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,050&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:LongTermPurchaseCommitmentTextBlock>
    <us-gaap:ContractReceivableDueOneToTwoYears
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001090"
      unitRef="USD">677000</us-gaap:ContractReceivableDueOneToTwoYears>
    <us-gaap:ContractReceivableDueTwoToThreeYears
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001091"
      unitRef="USD">242000</us-gaap:ContractReceivableDueTwoToThreeYears>
    <us-gaap:ContractReceivableDueThreeToFourYears
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001092"
      unitRef="USD">87000</us-gaap:ContractReceivableDueThreeToFourYears>
    <us-gaap:ContractReceivableDueFourToFiveYears
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001093"
      unitRef="USD">44000</us-gaap:ContractReceivableDueFourToFiveYears>
    <us-gaap:AccountsReceivableBilledForLongTermContractsOrPrograms
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001094"
      unitRef="USD">1050000</us-gaap:AccountsReceivableBilledForLongTermContractsOrPrograms>
    <FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims
      contextRef="From2024-10-012024-12-31"
      decimals="INF"
      id="Fact001105"
      unitRef="Pure">0.582</FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims>
    <FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims
      contextRef="From2023-10-012023-12-31"
      decimals="INF"
      id="Fact001106"
      unitRef="Pure">0.544</FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims>
    <FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims
      contextRef="From2024-07-01to2024-12-31"
      decimals="INF"
      id="Fact001107"
      unitRef="Pure">0.593</FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims>
    <FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims
      contextRef="From2023-07-012023-12-31"
      decimals="INF"
      id="Fact001108"
      unitRef="Pure">0.575</FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims>
    <FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1
      contextRef="From2024-10-012024-12-31"
      decimals="INF"
      id="Fact001109"
      unitRef="Pure">0.725</FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1>
    <FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1
      contextRef="From2023-10-012023-12-31"
      decimals="INF"
      id="Fact001110"
      unitRef="Pure">0.717</FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1>
    <FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1
      contextRef="From2024-07-01to2024-12-31"
      decimals="INF"
      id="Fact001111"
      unitRef="Pure">0.722</FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1>
    <FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1
      contextRef="From2023-07-012023-12-31"
      decimals="INF"
      id="Fact001112"
      unitRef="Pure">0.718</FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims1>
    <FONR:PercentageOfConsolidatedNetRevenueFromManagementFees
      contextRef="From2024-10-012024-12-31"
      decimals="INF"
      id="Fact001123"
      unitRef="Pure">0.120</FONR:PercentageOfConsolidatedNetRevenueFromManagementFees>
    <FONR:PercentageOfConsolidatedNetRevenueFromManagementFees
      contextRef="From2023-10-012023-12-31"
      decimals="INF"
      id="Fact001124"
      unitRef="Pure">0.118</FONR:PercentageOfConsolidatedNetRevenueFromManagementFees>
    <FONR:PercentageOfConsolidatedNetRevenueFromManagementFees
      contextRef="From2024-07-01to2024-12-31"
      decimals="INF"
      id="Fact001125"
      unitRef="Pure">0.120</FONR:PercentageOfConsolidatedNetRevenueFromManagementFees>
    <FONR:PercentageOfConsolidatedNetRevenueFromManagementFees
      contextRef="From2023-07-012023-12-31"
      decimals="INF"
      id="Fact001126"
      unitRef="Pure">0.117</FONR:PercentageOfConsolidatedNetRevenueFromManagementFees>
    <FONR:LesseeOperatingLeasesAndFinanceLeaseTextBlock contextRef="From2024-07-01to2024-12-31" id="Fact001128">&lt;p id="xdx_805_ecustom--LesseeOperatingLeasesAndFinanceLeaseTextBlock_zamZ6oSUQyO" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;NOTE
4 &#x2013; &lt;span id="xdx_822_z1kl8VJVawgg"&gt;OPERATING AND FINANCING LEASES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;The
Company accounts for its various operating leases in accordance with Accounting Standards Codification (ASC) 842 &#x2013; &#x201c;Leases&#x201d;,
as updated by ASU 2016-02. At the inception of a lease, the Company recognizes right-of-use lease assets and related lease liabilities
measured at present value of future lease payments on its balance sheet. Lease expense is recognized on a straight-line basis over the
term of the lease. The Company most common initial term varies in length from 2 to 19 years. Including renewal options negotiated with
the landlord, we have a total span of 2 to 16 years at the facilities we lease. The Company reviewed its contracts with vendors and customers,
determining that its right-to-use lease assets consisted of only office space operating leases. In determining the right-to-use lease
assets and liabilities, the Company did recognize lease extension options which the Company feels would be reasonably exercised. Our
incremental borrowing rate (&#x201c;IBR&#x201d;) used to discount the stream of operating lease payments is closely related to the interest
rates available to the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;A
reconciliation of operating and financing lease payments undiscounted cash flows to lease liabilities recognized as of December 31, 2024
is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_pn3n3_zytfQ93lppu7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Lease Payments (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span id="xdx_8B7_zrgoY2NwmBF" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Schedule
    of lessee operating leases liability maturity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Twelve
    Months Ending&lt;br/&gt; December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Operating
    Lease&lt;br/&gt; Payments&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Financing
    Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 27%; text-align: right; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="width: 26%; text-align: right" title="2025"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;5,584&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="width: 26%; text-align: right" title="2025"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;244&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="text-align: right" title="2026"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;5,388&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="text-align: right" title="2026"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;244&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="text-align: right" title="2027"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;5,371&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="text-align: right" title="2027"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;61&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="text-align: right" title="2028"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;5,019&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_iI_pn3n3_d0_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_z75D5Qjhrzic" style="text-align: right" title="2028"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="text-align: right" title="2029"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;4,876&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_pn3n3_d0_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zKGemonbDrvi" style="text-align: right" title="2029"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="text-align: right" title="Thereafter"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;26,841&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_iI_pn3n3_d0_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zYdNNieE4te1" style="text-align: right" title="Thereafter"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Present
                                            value discount&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--PresentValueDiscount_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Present value discount"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(14,893&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--PresentValueDiscountFinancingLease_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Present value discount"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(15&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Total
                                            lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--OperatingLeaseLiability_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating Lease, Liability"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;38,186&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FinanceLeaseLiability_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Finance Lease, Liability"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;534&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8A8_zGWSg06hXHil" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;























&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Weighted
Average Remaining Lease Term&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock_pn3n3_zBX9eKrkHgPh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8BC_zzStWqTbube1" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Schedule
    of weighted average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 70%; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Operating
    leases - years&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20241231_zu6b4AUiB196" style="font: normal 11pt Times New Roman, Times, Serif"&gt;10.6&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Finance
    lease - years&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--FinanceLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20241231_zm6RJ9MkEECd" style="font: normal 11pt Times New Roman, Times, Serif"&gt;2.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Weighted
    Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Operating
    leases&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pip0_dp_c20241231_ztzDBNXnEY8" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Finance
    lease&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--FinanceLeaseWeightedAverageDiscountRatePercent_iI_pip0_dp_c20241231_zZSAoawyfMod" style="font: normal 11pt Times New Roman, Times, Serif"&gt;3.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_zien8TJiwFR2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;The
components of lease expense were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--LeaseCostTableTextBlock_pn3n3_zSSD0KJ9T22f" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8BD_zRXWrP9tobWa" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Components
    of lease expense&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49F_20240701__20241231_zYUEbGBhDME5" style="text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49E_20230701__20231231_zweC4Lzxt2Lh" style="text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;For
    the six months ended Dec.31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--OperatingLeaseCost_pn3n3_zo2KYggax5El" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Operating
    lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;3,190&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2,865&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--FinanceLeaseCostsAbstract_iB_zKhjZXR9Yz15" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Finance
    lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--DepreciationOfLeasedEquipment_i01_pn3n3_zP7Zw1OPGPHd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Depreciation
    of leased equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--FinanceLeaseInterestExpense_i01_pn3n3_zVCWL9KIkLZ4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Interest
    on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--FinanceLeaseCost_i01_pn3n3_zBRBwGlHafN6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Total
    finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;105&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;114&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8A7_z4MqkZ4FCLE2" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Supplemental
cash flow information related to leases was as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_pn3n3_zv22ZU9izFM1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure -  OPERATING &amp;amp; FINANCING LEASES (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8BF_zU6hV9BuBgL" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Supplemental
    cash flow information related to leases&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49F_20240701__20241231_zgIXIEmxP1s5" style="text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49E_20230701__20231231_zsXLlWN0wOQ1" style="text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;For
    the six months ended Dec. 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Cash
    paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--OperatingCashFlowsFromOperatingLeases_zYsccWh63qKc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Operating
    cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2,541&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;3,164&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--FinancingCashFlowsFromFinancingLeases_zbSB6ZuGtWT5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Financing
    cash flows from financing leases&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;122&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;122&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract_iB_zKdnXriZjHSl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Right-of-use
    and equipment assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_ztrAUcoQpSkg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Operating
    leases&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;359&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,212&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8A7_ze62rNaIXQk2" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;

















</FONR:LesseeOperatingLeasesAndFinanceLeaseTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="From2024-07-01to2024-12-31" id="Fact001130">&lt;table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_pn3n3_zytfQ93lppu7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Lease Payments (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span id="xdx_8B7_zrgoY2NwmBF" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Schedule
    of lessee operating leases liability maturity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Twelve
    Months Ending&lt;br/&gt; December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Operating
    Lease&lt;br/&gt; Payments&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Financing
    Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 27%; text-align: right; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="width: 26%; text-align: right" title="2025"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;5,584&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="width: 26%; text-align: right" title="2025"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;244&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="text-align: right" title="2026"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;5,388&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="text-align: right" title="2026"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;244&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="text-align: right" title="2027"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;5,371&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="text-align: right" title="2027"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;61&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="text-align: right" title="2028"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;5,019&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_iI_pn3n3_d0_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_z75D5Qjhrzic" style="text-align: right" title="2028"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="text-align: right" title="2029"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;4,876&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_pn3n3_d0_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zKGemonbDrvi" style="text-align: right" title="2029"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="text-align: right" title="Thereafter"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;26,841&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_iI_pn3n3_d0_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zYdNNieE4te1" style="text-align: right" title="Thereafter"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Present
                                            value discount&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--PresentValueDiscount_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Present value discount"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(14,893&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--PresentValueDiscountFinancingLease_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Present value discount"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(15&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Total
                                            lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--OperatingLeaseLiability_c20241231__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating Lease, Liability"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;38,186&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FinanceLeaseLiability_c20241231__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Finance Lease, Liability"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;534&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="AsOf2024-12-31_custom_OperatingLeasePaymentsMember"
      decimals="-3"
      id="Fact001132"
      unitRef="USD">5584000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="AsOf2024-12-31_custom_FinancingLeasePaymentsMember"
      decimals="-3"
      id="Fact001134"
      unitRef="USD">244000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="AsOf2024-12-31_custom_OperatingLeasePaymentsMember"
      decimals="-3"
      id="Fact001136"
      unitRef="USD">5388000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="AsOf2024-12-31_custom_FinancingLeasePaymentsMember"
      decimals="-3"
      id="Fact001138"
      unitRef="USD">244000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="AsOf2024-12-31_custom_OperatingLeasePaymentsMember"
      decimals="-3"
      id="Fact001140"
      unitRef="USD">5371000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="AsOf2024-12-31_custom_FinancingLeasePaymentsMember"
      decimals="-3"
      id="Fact001142"
      unitRef="USD">61000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="AsOf2024-12-31_custom_OperatingLeasePaymentsMember"
      decimals="-3"
      id="Fact001144"
      unitRef="USD">5019000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="AsOf2024-12-31_custom_FinancingLeasePaymentsMember"
      decimals="-3"
      id="Fact001146"
      unitRef="USD">0</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="AsOf2024-12-31_custom_OperatingLeasePaymentsMember"
      decimals="-3"
      id="Fact001148"
      unitRef="USD">4876000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="AsOf2024-12-31_custom_FinancingLeasePaymentsMember"
      decimals="-3"
      id="Fact001150"
      unitRef="USD">0</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="AsOf2024-12-31_custom_OperatingLeasePaymentsMember"
      decimals="-3"
      id="Fact001152"
      unitRef="USD">26841000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="AsOf2024-12-31_custom_FinancingLeasePaymentsMember"
      decimals="-3"
      id="Fact001154"
      unitRef="USD">0</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <FONR:PresentValueDiscount
      contextRef="AsOf2024-12-31_custom_OperatingLeasePaymentsMember"
      decimals="-3"
      id="Fact001156"
      unitRef="USD">-14893000</FONR:PresentValueDiscount>
    <FONR:PresentValueDiscountFinancingLease
      contextRef="AsOf2024-12-31_custom_FinancingLeasePaymentsMember"
      decimals="-3"
      id="Fact001158"
      unitRef="USD">-15000</FONR:PresentValueDiscountFinancingLease>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2024-12-31_custom_OperatingLeasePaymentsMember"
      decimals="-3"
      id="Fact001160"
      unitRef="USD">38186000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="AsOf2024-12-31_custom_FinancingLeasePaymentsMember"
      decimals="-3"
      id="Fact001162"
      unitRef="USD">534000</us-gaap:FinanceLeaseLiability>
    <FONR:ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock contextRef="From2024-07-01to2024-12-31" id="Fact001174">&lt;table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock_pn3n3_zBX9eKrkHgPh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8BC_zzStWqTbube1" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Schedule
    of weighted average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 70%; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Operating
    leases - years&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20241231_zu6b4AUiB196" style="font: normal 11pt Times New Roman, Times, Serif"&gt;10.6&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Finance
    lease - years&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--FinanceLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20241231_zm6RJ9MkEECd" style="font: normal 11pt Times New Roman, Times, Serif"&gt;2.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Weighted
    Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Operating
    leases&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pip0_dp_c20241231_ztzDBNXnEY8" style="font: normal 11pt Times New Roman, Times, Serif"&gt;6.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Finance
    lease&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--FinanceLeaseWeightedAverageDiscountRatePercent_iI_pip0_dp_c20241231_zZSAoawyfMod" style="font: normal 11pt Times New Roman, Times, Serif"&gt;3.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</FONR:ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2024-12-31" id="Fact001175">P10Y7M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2024-12-31" id="Fact001176">P2Y1M6D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact001177"
      unitRef="Pure">0.065</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact001178"
      unitRef="Pure">0.036</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LeaseCostTableTextBlock contextRef="From2024-07-01to2024-12-31" id="Fact001180">&lt;table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--LeaseCostTableTextBlock_pn3n3_zSSD0KJ9T22f" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8BD_zRXWrP9tobWa" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Components
    of lease expense&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49F_20240701__20241231_zYUEbGBhDME5" style="text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49E_20230701__20231231_zweC4Lzxt2Lh" style="text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;For
    the six months ended Dec.31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--OperatingLeaseCost_pn3n3_zo2KYggax5El" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Operating
    lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;3,190&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2,865&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--FinanceLeaseCostsAbstract_iB_zKhjZXR9Yz15" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Finance
    lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--DepreciationOfLeasedEquipment_i01_pn3n3_zP7Zw1OPGPHd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Depreciation
    of leased equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--FinanceLeaseInterestExpense_i01_pn3n3_zVCWL9KIkLZ4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Interest
    on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--FinanceLeaseCost_i01_pn3n3_zBRBwGlHafN6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Total
    finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;105&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;114&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact001182"
      unitRef="USD">3190000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact001183"
      unitRef="USD">2865000</us-gaap:OperatingLeaseCost>
    <FONR:DepreciationOfLeasedEquipment
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact001188"
      unitRef="USD">100000</FONR:DepreciationOfLeasedEquipment>
    <FONR:DepreciationOfLeasedEquipment
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact001189"
      unitRef="USD">100000</FONR:DepreciationOfLeasedEquipment>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact001191"
      unitRef="USD">5000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact001192"
      unitRef="USD">14000</us-gaap:FinanceLeaseInterestExpense>
    <FONR:FinanceLeaseCost
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact001194"
      unitRef="USD">105000</FONR:FinanceLeaseCost>
    <FONR:FinanceLeaseCost
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact001195"
      unitRef="USD">114000</FONR:FinanceLeaseCost>
    <FONR:SupplementalCashFlowInformationRelatedToLeasesTableTextBlock contextRef="From2024-07-01to2024-12-31" id="Fact001197">&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_pn3n3_zv22ZU9izFM1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure -  OPERATING &amp;amp; FINANCING LEASES (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8BF_zU6hV9BuBgL" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Supplemental
    cash flow information related to leases&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49F_20240701__20241231_zgIXIEmxP1s5" style="text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49E_20230701__20231231_zsXLlWN0wOQ1" style="text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;For
    the six months ended Dec. 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Cash
    paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--OperatingCashFlowsFromOperatingLeases_zYsccWh63qKc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Operating
    cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2,541&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;3,164&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--FinancingCashFlowsFromFinancingLeases_zbSB6ZuGtWT5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Financing
    cash flows from financing leases&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;122&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;122&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract_iB_zKdnXriZjHSl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Right-of-use
    and equipment assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_ztrAUcoQpSkg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Operating
    leases&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;359&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,212&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</FONR:SupplementalCashFlowInformationRelatedToLeasesTableTextBlock>
    <FONR:OperatingCashFlowsFromOperatingLeases
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact001199"
      unitRef="USD">2541000</FONR:OperatingCashFlowsFromOperatingLeases>
    <FONR:OperatingCashFlowsFromOperatingLeases
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact001200"
      unitRef="USD">3164000</FONR:OperatingCashFlowsFromOperatingLeases>
    <FONR:FinancingCashFlowsFromFinancingLeases
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact001202"
      unitRef="USD">122000</FONR:FinancingCashFlowsFromFinancingLeases>
    <FONR:FinancingCashFlowsFromFinancingLeases
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact001203"
      unitRef="USD">122000</FONR:FinancingCashFlowsFromFinancingLeases>
    <FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact001208"
      unitRef="USD">359000</FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases>
    <FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact001209"
      unitRef="USD">1212000</FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2024-07-01to2024-12-31" id="Fact001218">&lt;p id="xdx_80D_eus-gaap--InventoryDisclosureTextBlock_zVMGuHgV7ha1" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE
5 - &lt;span id="xdx_824_zSDNoBjj1IV1"&gt;INVENTORIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Inventories
included in the accompanying condensed consolidated balance sheets consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_pn3n3_zeGDeJwevqRd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-indent: -10pt"&gt;&lt;span id="xdx_8BA_zr6ZVnBFTz4j" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Schedule
    of inventories&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_499_20241231_zKIawok9SSxd" style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_491_20240630_zoNNStkb4kR3" style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;December
    31,&lt;br/&gt; 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;June
    30,&lt;br/&gt; 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--OtherInventorySupplies_iI_maIFGAWzdt0_zU1xG5uwxAEe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Purchased
    parts, components and supplies&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2,583&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2,524&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--InventoryWorkInProcess_iI_maIFGAWzdt0_zFoczDa3Bvu3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;275&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;191&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--InventoryNet_iTI_mtIFGAWzdt0_zQ8O4Qu1uqLj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Total
    Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2,858&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2,715&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2024-07-01to2024-12-31" id="Fact001220">&lt;table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_pn3n3_zeGDeJwevqRd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-indent: -10pt"&gt;&lt;span id="xdx_8BA_zr6ZVnBFTz4j" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Schedule
    of inventories&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_499_20241231_zKIawok9SSxd" style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_491_20240630_zoNNStkb4kR3" style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;December
    31,&lt;br/&gt; 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;June
    30,&lt;br/&gt; 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--OtherInventorySupplies_iI_maIFGAWzdt0_zU1xG5uwxAEe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Purchased
    parts, components and supplies&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2,583&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2,524&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--InventoryWorkInProcess_iI_maIFGAWzdt0_zFoczDa3Bvu3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;275&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;191&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--InventoryNet_iTI_mtIFGAWzdt0_zQ8O4Qu1uqLj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Total
    Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2,858&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2,715&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:OtherInventorySupplies
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001222"
      unitRef="USD">2583000</us-gaap:OtherInventorySupplies>
    <us-gaap:OtherInventorySupplies
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001223"
      unitRef="USD">2524000</us-gaap:OtherInventorySupplies>
    <us-gaap:InventoryWorkInProcess
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001225"
      unitRef="USD">275000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001226"
      unitRef="USD">191000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryNet
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001228"
      unitRef="USD">2858000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001229"
      unitRef="USD">2715000</us-gaap:InventoryNet>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2024-07-01to2024-12-31" id="Fact001231">&lt;p id="xdx_808_eus-gaap--IntangibleAssetsDisclosureTextBlock_z01m3GSJamy4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE
6 &#x2013; &lt;span id="xdx_826_z054P3mriy64"&gt;OTHER INTANGIBLE ASSETS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Other
intangible assets, net of accumulated amortization, in the accompanying condensed consolidated balance sheets consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_pn3n3_zoa8HS5I6cUk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure -  OTHER INTANGIBLE ASSETS (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8B9_zvCmY5nnJH53" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Schedule
    of other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Weighted
    average useful lives&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Gross
    carrying amount &#x2013; December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Accumulated
    amortization &#x2013; December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Net
    carrying amount &#x2013; December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Capitalized
    software development costs&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%; text-align: center"&gt;&lt;span id="xdx_90D_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zuOgvJbo0sAb" style="font: normal 11pt Times New Roman, Times, Serif"&gt;5
                                            &lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;years&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zSMGe5ZhVwRb" style="width: 10%; text-align: right" title="Gross carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;7,005&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zDhkRmDjIaFj" style="width: 10%; text-align: right" title="Accumulated amortization intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(7,005&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zWGwYxTQxTe2" style="width: 10%; text-align: right" title="Net carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1240"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Software
    License&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_900_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_zpMsHY9YSou7" style="font: normal 11pt Times New Roman, Times, Serif"&gt;3
                                            &lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_z7yfeQTcbjOa" style="text-align: right" title="Gross carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,260&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_zSA5eePW4P44" style="text-align: right" title="Accumulated amortization intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(567&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_zoxuC3EnwFN3" style="text-align: right" title="Net carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;693&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Patents
    and copy rights&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_90B_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zBnTAz3MBZWf" style="font: normal 11pt Times New Roman, Times, Serif"&gt;15
                                            &lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zmRhXzD9AXKj" style="text-align: right" title="Gross carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;5,280&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zriiQuIm7zB5" style="text-align: right" title="Accumulated amortization intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(4,180&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zskrWHIfldx" style="text-align: right" title="Net carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Non-compete&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_90B_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zHlh8MkVo0bg" style="font: normal 11pt Times New Roman, Times, Serif"&gt;7
                                            &lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zAWGEImeexz5" style="text-align: right" title="Gross carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;4,150&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zgNjX0ISAODf" style="text-align: right" title="Accumulated amortization intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(4,150&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_d0_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zT3sOx8MNlph" style="text-align: right" title="Net carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Customer
    relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_90D_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zyOOFtJqB4Vh" style="font: normal 11pt Times New Roman, Times, Serif"&gt;20
                                            &lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;years&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zlWOjgwulIZ1" style="border-bottom: Black 1pt solid; text-align: right" title="Gross carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;3,900&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zn514S0v8gwk" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated amortization intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(2,286&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zKDqHfGgrHI1" style="border-bottom: Black 1pt solid; text-align: right" title="Net carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,614&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20241231_zsROI8wQYTji" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;21,595&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20241231_zrPbHDgvMIea" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated amortization intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(18,188&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20241231_zzD7VWLzjNYj" style="border-bottom: Black 2.5pt double; text-align: right" title="Net carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;3,407&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;























&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Weighted
    average useful lives&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Gross
    carrying amount &#x2013; June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Accumulated
    amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Net
    carrying amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Capitalized
    software development costs&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_z9hyDTLaQPi4" style="font: normal 11pt Times New Roman, Times, Serif"&gt;5
                                            &lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;years&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zyOjKKCz6YOf" style="width: 10%; text-align: right" title="Gross carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;7,005&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zzVdNT1TaP5a" style="width: 10%; text-align: right" title="Accumulated amortization intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(7,005&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zhYAuVwULF31" style="width: 10%; text-align: right" title="Net carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1291"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Patents
    and copy rights&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zow9pwIMzb9g" style="font: normal 11pt Times New Roman, Times, Serif"&gt;15
                                            &lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_za9fs2E2Y20i" style="text-align: right" title="Gross carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;5,260&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zZsfMtt2K1a1" style="text-align: right" title="Accumulated amortization intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(4,104&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zVU6RAC8ljH" style="text-align: right" title="Net carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,156&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Non-compete&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zrFG4NLr6P36" style="font: normal 11pt Times New Roman, Times, Serif"&gt;7
                                            &lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zu8Wf5pVAOQ3" style="text-align: right" title="Gross carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;4,150&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_z9kyx76t2BFb" style="text-align: right" title="Accumulated amortization intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(4,150&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_d0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zfuMXou8EK7e" style="text-align: right" title="Net carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Customer
    relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zdz3MqKtFvid" style="font: normal 11pt Times New Roman, Times, Serif"&gt;20
                                            &lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;years&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zhFVZ3Sh1nXa" style="border-bottom: Black 1pt solid; text-align: right" title="Gross carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;3,900&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zKDX8EhfhdTl" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated amortization intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(2,186&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zNl0CxAndfNg" style="border-bottom: Black 1pt solid; text-align: right" title="Net carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,714&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20240630_zLHtBSUhebjg" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;20,315&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20240630_zLMYcQfE7n8a" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated amortization intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(17,445&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20240630_zmqzJxKLgLH7" style="border-bottom: Black 2.5pt double; text-align: right" title="Net carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2,870&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8AB_zqwkamRw3he9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Amortization
of patents and copyrights for the three months ended December 31, 2024 and 2023 amounted to $&lt;span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20241001__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zEOqH6prnW7c"&gt;37
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;and
$&lt;span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20231001__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zREHpi7jeGq9"&gt;43&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Amortization
of customer relationships for the three months ended December 31, 2024 and 2023 amounted to $&lt;span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20241001__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zbu2OoPrAAL2"&gt;50
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;and
$&lt;span id="xdx_90E_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20231001__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z92xCaTvO523"&gt;50&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Amortization
of patents and copyrights for the six months ended December 31, 2024 and 2023 amounted to $&lt;span id="xdx_900_eus-gaap--AmortizationOfIntangibleAssets_c20240701__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3"&gt;76
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;and
$&lt;span id="xdx_906_eus-gaap--AmortizationOfIntangibleAssets_c20230701__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3"&gt;86&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Amortization
of customer relationships for the six months ended December 31, 2024 and 2023 amounted to $&lt;span id="xdx_90B_eus-gaap--AmortizationOfIntangibleAssets_c20240701__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3"&gt;100
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;and
$&lt;span id="xdx_905_eus-gaap--AmortizationOfIntangibleAssets_c20230701__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3"&gt;100&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Amortization
expense for reach of the next five years and thereafter as of December 31, 2024 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_pn3n3_zAocYU0caLF3" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 40%; margin-right: auto" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS (Details 1)"&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 44%; text-align: right; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pn3n3_c20241231_zeCa6dwE0e44" style="width: 43%; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;723&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pn3n3_c20241231_zrDJdQRdjKj1" style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;650&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pn3n3_c20241231_z8zbW0NOgyY9" style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;321&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pn3n3_c20241231_zr70CM00YPMi" style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;317&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pn3n3_c20241231_z81xc37J5ltk" style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;314&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pn3n3_c20241231_zZ2j3yH5tTEa" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1082&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_pn3n3_c20241231_zOYqppaOdbP8" style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;3,407&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_zqvS13e4NxLj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



















</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock contextRef="From2024-07-01to2024-12-31" id="Fact001233">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_pn3n3_zoa8HS5I6cUk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure -  OTHER INTANGIBLE ASSETS (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8B9_zvCmY5nnJH53" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Schedule
    of other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Weighted
    average useful lives&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Gross
    carrying amount &#x2013; December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Accumulated
    amortization &#x2013; December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Net
    carrying amount &#x2013; December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Capitalized
    software development costs&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%; text-align: center"&gt;&lt;span id="xdx_90D_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zuOgvJbo0sAb" style="font: normal 11pt Times New Roman, Times, Serif"&gt;5
                                            &lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;years&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zSMGe5ZhVwRb" style="width: 10%; text-align: right" title="Gross carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;7,005&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zDhkRmDjIaFj" style="width: 10%; text-align: right" title="Accumulated amortization intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(7,005&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zWGwYxTQxTe2" style="width: 10%; text-align: right" title="Net carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1240"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Software
    License&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_900_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_zpMsHY9YSou7" style="font: normal 11pt Times New Roman, Times, Serif"&gt;3
                                            &lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_z7yfeQTcbjOa" style="text-align: right" title="Gross carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,260&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_zSA5eePW4P44" style="text-align: right" title="Accumulated amortization intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(567&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_zoxuC3EnwFN3" style="text-align: right" title="Net carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;693&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Patents
    and copy rights&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_90B_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zBnTAz3MBZWf" style="font: normal 11pt Times New Roman, Times, Serif"&gt;15
                                            &lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zmRhXzD9AXKj" style="text-align: right" title="Gross carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;5,280&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zriiQuIm7zB5" style="text-align: right" title="Accumulated amortization intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(4,180&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zskrWHIfldx" style="text-align: right" title="Net carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Non-compete&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_90B_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zHlh8MkVo0bg" style="font: normal 11pt Times New Roman, Times, Serif"&gt;7
                                            &lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zAWGEImeexz5" style="text-align: right" title="Gross carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;4,150&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zgNjX0ISAODf" style="text-align: right" title="Accumulated amortization intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(4,150&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_d0_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zT3sOx8MNlph" style="text-align: right" title="Net carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Customer
    relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_90D_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zyOOFtJqB4Vh" style="font: normal 11pt Times New Roman, Times, Serif"&gt;20
                                            &lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;years&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zlWOjgwulIZ1" style="border-bottom: Black 1pt solid; text-align: right" title="Gross carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;3,900&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zn514S0v8gwk" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated amortization intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(2,286&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zKDqHfGgrHI1" style="border-bottom: Black 1pt solid; text-align: right" title="Net carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,614&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20241231_zsROI8wQYTji" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;21,595&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20241231_zrPbHDgvMIea" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated amortization intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(18,188&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20241231_zzD7VWLzjNYj" style="border-bottom: Black 2.5pt double; text-align: right" title="Net carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;3,407&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;























&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Weighted
    average useful lives&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Gross
    carrying amount &#x2013; June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Accumulated
    amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Net
    carrying amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Capitalized
    software development costs&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_z9hyDTLaQPi4" style="font: normal 11pt Times New Roman, Times, Serif"&gt;5
                                            &lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;years&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zyOjKKCz6YOf" style="width: 10%; text-align: right" title="Gross carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;7,005&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zzVdNT1TaP5a" style="width: 10%; text-align: right" title="Accumulated amortization intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(7,005&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zhYAuVwULF31" style="width: 10%; text-align: right" title="Net carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1291"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Patents
    and copy rights&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zow9pwIMzb9g" style="font: normal 11pt Times New Roman, Times, Serif"&gt;15
                                            &lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_za9fs2E2Y20i" style="text-align: right" title="Gross carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;5,260&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zZsfMtt2K1a1" style="text-align: right" title="Accumulated amortization intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(4,104&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zVU6RAC8ljH" style="text-align: right" title="Net carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,156&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Non-compete&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zrFG4NLr6P36" style="font: normal 11pt Times New Roman, Times, Serif"&gt;7
                                            &lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zu8Wf5pVAOQ3" style="text-align: right" title="Gross carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;4,150&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_z9kyx76t2BFb" style="text-align: right" title="Accumulated amortization intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(4,150&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_d0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zfuMXou8EK7e" style="text-align: right" title="Net carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Customer
    relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zdz3MqKtFvid" style="font: normal 11pt Times New Roman, Times, Serif"&gt;20
                                            &lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;years&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zhFVZ3Sh1nXa" style="border-bottom: Black 1pt solid; text-align: right" title="Gross carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;3,900&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zKDX8EhfhdTl" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated amortization intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(2,186&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zNl0CxAndfNg" style="border-bottom: Black 1pt solid; text-align: right" title="Net carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,714&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20240630_zLHtBSUhebjg" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;20,315&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20240630_zLMYcQfE7n8a" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated amortization intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(17,445&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20240630_zmqzJxKLgLH7" style="border-bottom: Black 2.5pt double; text-align: right" title="Net carrying amount intangible assets"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2,870&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="From2024-07-012024-12-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"
      id="Fact001234">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-12-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"
      decimals="-3"
      id="Fact001236"
      unitRef="USD">7005000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2024-12-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"
      decimals="-3"
      id="Fact001238"
      unitRef="USD">-7005000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="From2024-07-012024-12-31_us-gaap_LicenseMember"
      id="Fact001241">P3Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-12-31_us-gaap_LicenseMember"
      decimals="-3"
      id="Fact001243"
      unitRef="USD">1260000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2024-12-31_us-gaap_LicenseMember"
      decimals="-3"
      id="Fact001245"
      unitRef="USD">-567000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2024-12-31_us-gaap_LicenseMember"
      decimals="-3"
      id="Fact001247"
      unitRef="USD">693000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="From2024-07-012024-12-31_custom_PatentsAndCopyrightsMember"
      id="Fact001248">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-12-31_custom_PatentsAndCopyrightsMember"
      decimals="-3"
      id="Fact001250"
      unitRef="USD">5280000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2024-12-31_custom_PatentsAndCopyrightsMember"
      decimals="-3"
      id="Fact001252"
      unitRef="USD">-4180000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2024-12-31_custom_PatentsAndCopyrightsMember"
      decimals="-3"
      id="Fact001254"
      unitRef="USD">1100000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="From2024-07-012024-12-31_us-gaap_NoncompeteAgreementsMember"
      id="Fact001255">P7Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-12-31_us-gaap_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact001257"
      unitRef="USD">4150000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2024-12-31_us-gaap_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact001259"
      unitRef="USD">-4150000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2024-12-31_us-gaap_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact001261"
      unitRef="USD">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="From2024-07-012024-12-31_us-gaap_CustomerRelationshipsMember"
      id="Fact001262">P20Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-12-31_us-gaap_CustomerRelationshipsMember"
      decimals="-3"
      id="Fact001264"
      unitRef="USD">3900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2024-12-31_us-gaap_CustomerRelationshipsMember"
      decimals="-3"
      id="Fact001266"
      unitRef="USD">-2286000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2024-12-31_us-gaap_CustomerRelationshipsMember"
      decimals="-3"
      id="Fact001268"
      unitRef="USD">1614000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001270"
      unitRef="USD">21595000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001272"
      unitRef="USD">-18188000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001274"
      unitRef="USD">3407000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="From2023-07-012024-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"
      id="Fact001285">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"
      decimals="-3"
      id="Fact001287"
      unitRef="USD">7005000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2024-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"
      decimals="-3"
      id="Fact001289"
      unitRef="USD">-7005000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="From2023-07-012024-06-30_custom_PatentsAndCopyrightsMember"
      id="Fact001292">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-06-30_custom_PatentsAndCopyrightsMember"
      decimals="-3"
      id="Fact001294"
      unitRef="USD">5260000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2024-06-30_custom_PatentsAndCopyrightsMember"
      decimals="-3"
      id="Fact001296"
      unitRef="USD">-4104000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2024-06-30_custom_PatentsAndCopyrightsMember"
      decimals="-3"
      id="Fact001298"
      unitRef="USD">1156000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="From2023-07-012024-06-30_us-gaap_NoncompeteAgreementsMember"
      id="Fact001299">P7Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-06-30_us-gaap_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact001301"
      unitRef="USD">4150000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2024-06-30_us-gaap_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact001303"
      unitRef="USD">-4150000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2024-06-30_us-gaap_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact001305"
      unitRef="USD">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="From2023-07-012024-06-30_us-gaap_CustomerRelationshipsMember"
      id="Fact001306">P20Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="-3"
      id="Fact001308"
      unitRef="USD">3900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2024-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="-3"
      id="Fact001310"
      unitRef="USD">-2186000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2024-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="-3"
      id="Fact001312"
      unitRef="USD">1714000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001314"
      unitRef="USD">20315000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001316"
      unitRef="USD">-17445000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001318"
      unitRef="USD">2870000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2024-10-012024-12-31_custom_PatentsAndCopyrightsMember"
      decimals="-3"
      id="Fact001319"
      unitRef="USD">37000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2023-10-012023-12-31_custom_PatentsAndCopyrightsMember"
      decimals="-3"
      id="Fact001320"
      unitRef="USD">43000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2024-10-012024-12-31_us-gaap_CustomerRelationshipsMember"
      decimals="-3"
      id="Fact001321"
      unitRef="USD">50000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2023-10-012023-12-31_us-gaap_CustomerRelationshipsMember"
      decimals="-3"
      id="Fact001322"
      unitRef="USD">50000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2024-07-012024-12-31_custom_PatentsAndCopyrightsMember"
      decimals="-3"
      id="Fact001323"
      unitRef="USD">76000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2023-07-012023-12-31_custom_PatentsAndCopyrightsMember"
      decimals="-3"
      id="Fact001324"
      unitRef="USD">86000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2024-07-012024-12-31_us-gaap_CustomerRelationshipsMember"
      decimals="-3"
      id="Fact001325"
      unitRef="USD">100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2023-07-012023-12-31_us-gaap_CustomerRelationshipsMember"
      decimals="-3"
      id="Fact001326"
      unitRef="USD">100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="From2024-07-01to2024-12-31" id="Fact001328">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_pn3n3_zAocYU0caLF3" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 40%; margin-right: auto" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS (Details 1)"&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 44%; text-align: right; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pn3n3_c20241231_zeCa6dwE0e44" style="width: 43%; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;723&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pn3n3_c20241231_zrDJdQRdjKj1" style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;650&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pn3n3_c20241231_z8zbW0NOgyY9" style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;321&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pn3n3_c20241231_zr70CM00YPMi" style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;317&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pn3n3_c20241231_z81xc37J5ltk" style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;314&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pn3n3_c20241231_zZ2j3yH5tTEa" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1082&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_pn3n3_c20241231_zOYqppaOdbP8" style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;3,407&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001329"
      unitRef="USD">723000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001330"
      unitRef="USD">650000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001331"
      unitRef="USD">321000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001332"
      unitRef="USD">317000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001333"
      unitRef="USD">314000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001334"
      unitRef="USD">1082000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001335"
      unitRef="USD">3407000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock contextRef="From2024-07-01to2024-12-31" id="Fact001345">&lt;p id="xdx_806_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zBottQqPbveh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE
7 &#x2013; &lt;span id="xdx_823_zs7bghJuC262"&gt;OTHER CURRENT LIABILITIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Other
current liabilities in the accompanying condensed consolidated balance sheets consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_pn3n3_z8H95YZKmxF3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8B0_zmewYkyOxNY5" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Schedule
    of other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_490_20241231_zUHSd0BseHid" style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_497_20240630_zv9akfW2dwue" style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;December
    31,&lt;br/&gt; 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;June
    30,&lt;br/&gt; 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AccruedSalariesCurrent_iI_pn3n3_maOLCzdop_zikMYErCYEJk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Accrued
    salaries, commissions and payroll taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,541&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;4,678&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pn3n3_maOLCzdop_zfgmq7aK6eA5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Sales
    tax payable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;183&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;197&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AccruedPayrollTaxesCurrent_iI_pn3n3_maOLCzdop_z3ehj54qmLha" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Federal
    and state income taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1355"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,461&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--SelffundedHealthInsuranceReserve_iI_pn3n3_maOLCzdop_z3fz6TGCpfxh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Self-funded
    health insurance reserve&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;168&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;121&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--SoftwareLicenses_iI_pn3n3_z5pMnuieRC8a" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Software
    Licenses&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;252&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1362"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pn3n3_maOLCzdop_zUCODa2QQI07" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Other
    general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,768&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,484&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--OtherLiabilitiesCurrent_iTI_pn3n3_mtOLCzdop_zGIZ13tmpgTf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Other
    Current Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;3,912&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;7,941&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2024-07-01to2024-12-31" id="Fact001347">&lt;table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_pn3n3_z8H95YZKmxF3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8B0_zmewYkyOxNY5" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Schedule
    of other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_490_20241231_zUHSd0BseHid" style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_497_20240630_zv9akfW2dwue" style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;December
    31,&lt;br/&gt; 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;June
    30,&lt;br/&gt; 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AccruedSalariesCurrent_iI_pn3n3_maOLCzdop_zikMYErCYEJk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Accrued
    salaries, commissions and payroll taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,541&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;4,678&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pn3n3_maOLCzdop_zfgmq7aK6eA5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Sales
    tax payable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;183&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;197&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AccruedPayrollTaxesCurrent_iI_pn3n3_maOLCzdop_z3ehj54qmLha" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Federal
    and state income taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1355"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,461&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--SelffundedHealthInsuranceReserve_iI_pn3n3_maOLCzdop_z3fz6TGCpfxh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Self-funded
    health insurance reserve&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;168&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;121&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--SoftwareLicenses_iI_pn3n3_z5pMnuieRC8a" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Software
    Licenses&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;252&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1362"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pn3n3_maOLCzdop_zUCODa2QQI07" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Other
    general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,768&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,484&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--OtherLiabilitiesCurrent_iTI_pn3n3_mtOLCzdop_zGIZ13tmpgTf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Other
    Current Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;3,912&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;7,941&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedSalariesCurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001349"
      unitRef="USD">1541000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001350"
      unitRef="USD">4678000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001352"
      unitRef="USD">183000</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001353"
      unitRef="USD">197000</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:AccruedPayrollTaxesCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001356"
      unitRef="USD">1461000</us-gaap:AccruedPayrollTaxesCurrent>
    <FONR:SelffundedHealthInsuranceReserve
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001358"
      unitRef="USD">168000</FONR:SelffundedHealthInsuranceReserve>
    <FONR:SelffundedHealthInsuranceReserve
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001359"
      unitRef="USD">121000</FONR:SelffundedHealthInsuranceReserve>
    <FONR:SoftwareLicenses
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001361"
      unitRef="USD">252000</FONR:SoftwareLicenses>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001364"
      unitRef="USD">1768000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001365"
      unitRef="USD">1484000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001367"
      unitRef="USD">3912000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001368"
      unitRef="USD">7941000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2024-07-01to2024-12-31" id="Fact001370">&lt;p id="xdx_801_eus-gaap--SegmentReportingDisclosureTextBlock_zptfoUDKi6Ef" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE
8 - &lt;span id="xdx_82D_zB66pAl4E1O5"&gt;SEGMENT AND RELATED INFORMATION&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;The
Company operates in two industry segments - manufacturing and the servicing of medical equipment and management of diagnostic imaging
centers. The accounting policies of the segments are the same as those described in the summary of significant accounting policies as
disclosed in the Company&#x2019;s 10-K as of June 30, 2024. All inter segment sales are market-based. The Company evaluates performance
based on income or loss from operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Summarized
financial information concerning the Company&#x2019;s reportable segments is shown in the following table:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_pn3n3_ziO5u5Cqwiba" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Summarized Segments - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8B9_zj6XJ57Ltw81" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Schedule
    of summarized segment financial information&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Manufacturing
    and Service of MRI Equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Management
    of Diagnostic Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;For
    the three months ended December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 46%; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Net
    revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zqoyNHe2R5Ii" style="width: 11%; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,829&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zLjcbEjDro24" style="width: 11%; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;23,121&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Revenues_pn3n3_c20241001__20241231_zjsbg6sAZ4fl" style="width: 11%; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;24,950&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Inter-segment
    net revenues&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--IntersegmentNetRevenues_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zru1txtcsWBc" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;294&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--IntersegmentNetRevenues_pn3n3_d0_c20241001__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zI9RiDiZws79" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--IntersegmentNetRevenues_pn3n3_c20241001__20241231_zodU8SHHQWs6" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;294&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(Loss)
    Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zP6rPQgqyWMk" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(1,291&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zOYc445bZx9a" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;3,726&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20241001__20241231_zL1BymUXABw5" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2,435&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Depreciation
    and amortization&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zRca5VP2lrvj" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;54&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zpYaV7Vmcjvf" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,181&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20241001__20241231_z4Xfk5ehyXdj" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,235&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Capital
    expenditures&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_z3VAJ6J87m29" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;23&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zi40VVKqnAwg" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;731&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20241001__20241231_z8KRIarlKWQ3" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;754&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;For
    the three months ended December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Net
    revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_z7VSkIJPQTx" style="text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,861&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Revenues_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zbzusP5xFYhf" style="text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;23,525&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Revenues_pn3n3_c20231001__20231231_zFqsOWjpzNN5" style="text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;25,386&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Inter-segment
    net revenues&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--IntersegmentNetRevenues_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_z4p3S0ElHEtc" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;254&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--IntersegmentNetRevenues_pn3n3_d0_c20231001__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zuzjTVgdI8P3" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--IntersegmentNetRevenues_pn3n3_c20231001__20231231_zxTCTGpw7g5b" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;254&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(Loss)
    Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zmAl3hnryYie" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(993&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zYaTj8A4GG44" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;5,878&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20231001__20231231_zMhFoeeGe71c" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;4,885&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Depreciation
    and amortization&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zBMDNEytuZph" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;60&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zsmhsZdetKh9" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,160&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20231001__20231231_zGFMXu32QBHc" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,220&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Capital
    expenditures&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zI0cp9rcMBMf" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_z9VJtVX5yjs9" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;129&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20231001__20231231_zMTjKOlL5QVl" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;133&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;























&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Manufacturing
    and Service of MRI Equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Management
    of Diagnostic Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;For
    the six months ended December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 46%; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Net
    revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Revenues_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_z6rTfOyUeHx5" style="width: 11%; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;3,986&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Revenues_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zVdQ9YdB7FE2" style="width: 11%; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;45,924&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_pn3n3_c20240701__20241231_zOAnJjpq6wRe" style="width: 11%; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;49,910&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Inter-segment
    net revenues&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--IntersegmentNetRevenues_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zvFt0W2XpZAc" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;583&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--IntersegmentNetRevenues_pn3n3_d0_c20240701__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zSPNhFx6ooS2" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--IntersegmentNetRevenues_pn3n3_c20240701__20241231_zNovGROUlx81" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;583&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(Loss)
    Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zIeJiG93EX4l" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(2,335&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zDgFO1C9ERce" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;9,376&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20240701__20241231_ziaZirzu7d94" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;7,041&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Depreciation
    and amortization&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zDnnIO1vJht6" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;103&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zLeFMY1hgjcf" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2,195&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20240701__20241231_zT3IGbMgMFdk" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2,298&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Capital
    expenditures&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zKZclh3mbo6i" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;95&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zoq1aTNbWS0b" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2,477&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20240701__20241231_zp2UGg8VGrre" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2,572&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Manufacturing
    and Service of MRI Equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Management
    of Diagnostic Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;For
    the six months ended December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 46%; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Net
    revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zWHnaVjNziBl" style="width: 11%; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;3,917&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Revenues_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zdYVE2jw5V53" style="width: 11%; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;47,307&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Revenues_pn3n3_c20230701__20231231_zFhRemx8lEgd" style="width: 11%; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;51,224&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Inter-segment
    net revenues&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--IntersegmentNetRevenues_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zcQm4gard3ac" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;508&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--IntersegmentNetRevenues_pn3n3_d0_c20230701__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zNEjy50sfMb1" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--IntersegmentNetRevenues_pn3n3_c20230701__20231231_z6xvPabKi0af" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;508&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(Loss)
    Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zPZPA8DkH9Jf" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(1,731&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_z7JferkQ3J87" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;13,187&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20230701__20231231_z6QNhsIBfkHe" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;11,456&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Depreciation
    and amortization&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zZTChwdwzBCj" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;121&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_ztmdrKBbkba3" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2,294&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20230701__20231231_zvduOz0Rgvt8" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2,415&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Capital
    expenditures&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zqTOG5L0kDp" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zQdeURN2oCxa" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;192&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20230701__20231231_zSKV4qOHnYa9" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;212&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_zRsxJk2VGJil" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="From2024-07-01to2024-12-31" id="Fact001372">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_pn3n3_ziO5u5Cqwiba" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Summarized Segments - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8B9_zj6XJ57Ltw81" style="font: normal 11pt Times New Roman, Times, Serif"&gt;Schedule
    of summarized segment financial information&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Manufacturing
    and Service of MRI Equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Management
    of Diagnostic Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;For
    the three months ended December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 46%; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Net
    revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zqoyNHe2R5Ii" style="width: 11%; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,829&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zLjcbEjDro24" style="width: 11%; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;23,121&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Revenues_pn3n3_c20241001__20241231_zjsbg6sAZ4fl" style="width: 11%; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;24,950&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Inter-segment
    net revenues&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--IntersegmentNetRevenues_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zru1txtcsWBc" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;294&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--IntersegmentNetRevenues_pn3n3_d0_c20241001__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zI9RiDiZws79" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--IntersegmentNetRevenues_pn3n3_c20241001__20241231_zodU8SHHQWs6" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;294&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(Loss)
    Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zP6rPQgqyWMk" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(1,291&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zOYc445bZx9a" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;3,726&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20241001__20241231_zL1BymUXABw5" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2,435&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Depreciation
    and amortization&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zRca5VP2lrvj" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;54&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zpYaV7Vmcjvf" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,181&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20241001__20241231_z4Xfk5ehyXdj" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,235&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Capital
    expenditures&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_z3VAJ6J87m29" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;23&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20241001__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zi40VVKqnAwg" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;731&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20241001__20241231_z8KRIarlKWQ3" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;754&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;For
    the three months ended December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Net
    revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_z7VSkIJPQTx" style="text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,861&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Revenues_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zbzusP5xFYhf" style="text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;23,525&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Revenues_pn3n3_c20231001__20231231_zFqsOWjpzNN5" style="text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;25,386&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Inter-segment
    net revenues&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--IntersegmentNetRevenues_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_z4p3S0ElHEtc" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;254&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--IntersegmentNetRevenues_pn3n3_d0_c20231001__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zuzjTVgdI8P3" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--IntersegmentNetRevenues_pn3n3_c20231001__20231231_zxTCTGpw7g5b" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;254&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(Loss)
    Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zmAl3hnryYie" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(993&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zYaTj8A4GG44" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;5,878&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20231001__20231231_zMhFoeeGe71c" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;4,885&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Depreciation
    and amortization&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zBMDNEytuZph" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;60&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zsmhsZdetKh9" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,160&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20231001__20231231_zGFMXu32QBHc" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;1,220&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Capital
    expenditures&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zI0cp9rcMBMf" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20231001__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_z9VJtVX5yjs9" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;129&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20231001__20231231_zMTjKOlL5QVl" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;133&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;























&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Manufacturing
    and Service of MRI Equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Management
    of Diagnostic Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;For
    the six months ended December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 46%; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Net
    revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Revenues_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_z6rTfOyUeHx5" style="width: 11%; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;3,986&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Revenues_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zVdQ9YdB7FE2" style="width: 11%; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;45,924&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_pn3n3_c20240701__20241231_zOAnJjpq6wRe" style="width: 11%; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;49,910&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Inter-segment
    net revenues&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--IntersegmentNetRevenues_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zvFt0W2XpZAc" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;583&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--IntersegmentNetRevenues_pn3n3_d0_c20240701__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zSPNhFx6ooS2" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--IntersegmentNetRevenues_pn3n3_c20240701__20241231_zNovGROUlx81" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;583&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(Loss)
    Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zIeJiG93EX4l" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(2,335&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zDgFO1C9ERce" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;9,376&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20240701__20241231_ziaZirzu7d94" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;7,041&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Depreciation
    and amortization&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zDnnIO1vJht6" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;103&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zLeFMY1hgjcf" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2,195&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20240701__20241231_zT3IGbMgMFdk" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2,298&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Capital
    expenditures&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zKZclh3mbo6i" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;95&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20240701__20241231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zoq1aTNbWS0b" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2,477&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20240701__20241231_zp2UGg8VGrre" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2,572&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Manufacturing
    and Service of MRI Equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Management
    of Diagnostic Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;For
    the six months ended December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 46%; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Net
    revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zWHnaVjNziBl" style="width: 11%; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;3,917&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Revenues_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zdYVE2jw5V53" style="width: 11%; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;47,307&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Revenues_pn3n3_c20230701__20231231_zFhRemx8lEgd" style="width: 11%; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;51,224&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Inter-segment
    net revenues&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--IntersegmentNetRevenues_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zcQm4gard3ac" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;508&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--IntersegmentNetRevenues_pn3n3_d0_c20230701__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zNEjy50sfMb1" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--IntersegmentNetRevenues_pn3n3_c20230701__20231231_z6xvPabKi0af" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;508&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(Loss)
    Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zPZPA8DkH9Jf" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;(1,731&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_z7JferkQ3J87" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;13,187&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20230701__20231231_z6QNhsIBfkHe" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;11,456&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Depreciation
    and amortization&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zZTChwdwzBCj" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;121&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_ztmdrKBbkba3" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2,294&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20230701__20231231_zvduOz0Rgvt8" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;2,415&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Capital
    expenditures&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__custom--ManufacturingAndServiceOfMRIEquipmentMember_zqTOG5L0kDp" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20230701__20231231__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zQdeURN2oCxa" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;192&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20230701__20231231_zSKV4qOHnYa9" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;212&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="From2024-10-012024-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember"
      decimals="-3"
      id="Fact001374"
      unitRef="USD">1829000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-10-012024-12-31_us-gaap_HealthCareOtherMember"
      decimals="-3"
      id="Fact001376"
      unitRef="USD">23121000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact001378"
      unitRef="USD">24950000</us-gaap:Revenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2024-10-012024-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember"
      decimals="-3"
      id="Fact001380"
      unitRef="USD">294000</FONR:IntersegmentNetRevenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2024-10-012024-12-31_us-gaap_HealthCareOtherMember"
      decimals="-3"
      id="Fact001382"
      unitRef="USD">0</FONR:IntersegmentNetRevenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact001384"
      unitRef="USD">294000</FONR:IntersegmentNetRevenues>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2024-10-012024-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember"
      decimals="-3"
      id="Fact001386"
      unitRef="USD">-1291000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2024-10-012024-12-31_us-gaap_HealthCareOtherMember"
      decimals="-3"
      id="Fact001388"
      unitRef="USD">3726000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact001390"
      unitRef="USD">2435000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2024-10-012024-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember"
      decimals="-3"
      id="Fact001392"
      unitRef="USD">54000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2024-10-012024-12-31_us-gaap_HealthCareOtherMember"
      decimals="-3"
      id="Fact001394"
      unitRef="USD">1181000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact001396"
      unitRef="USD">1235000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2024-10-012024-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember"
      decimals="-3"
      id="Fact001398"
      unitRef="USD">23000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2024-10-012024-12-31_us-gaap_HealthCareOtherMember"
      decimals="-3"
      id="Fact001400"
      unitRef="USD">731000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact001402"
      unitRef="USD">754000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:Revenues
      contextRef="From2023-10-012023-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember"
      decimals="-3"
      id="Fact001404"
      unitRef="USD">1861000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-10-012023-12-31_us-gaap_HealthCareOtherMember"
      decimals="-3"
      id="Fact001406"
      unitRef="USD">23525000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact001408"
      unitRef="USD">25386000</us-gaap:Revenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2023-10-012023-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember"
      decimals="-3"
      id="Fact001410"
      unitRef="USD">254000</FONR:IntersegmentNetRevenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2023-10-012023-12-31_us-gaap_HealthCareOtherMember"
      decimals="-3"
      id="Fact001412"
      unitRef="USD">0</FONR:IntersegmentNetRevenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact001414"
      unitRef="USD">254000</FONR:IntersegmentNetRevenues>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2023-10-012023-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember"
      decimals="-3"
      id="Fact001416"
      unitRef="USD">-993000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2023-10-012023-12-31_us-gaap_HealthCareOtherMember"
      decimals="-3"
      id="Fact001418"
      unitRef="USD">5878000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact001420"
      unitRef="USD">4885000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2023-10-012023-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember"
      decimals="-3"
      id="Fact001422"
      unitRef="USD">60000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2023-10-012023-12-31_us-gaap_HealthCareOtherMember"
      decimals="-3"
      id="Fact001424"
      unitRef="USD">1160000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact001426"
      unitRef="USD">1220000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2023-10-012023-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember"
      decimals="-3"
      id="Fact001428"
      unitRef="USD">4000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2023-10-012023-12-31_us-gaap_HealthCareOtherMember"
      decimals="-3"
      id="Fact001430"
      unitRef="USD">129000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact001432"
      unitRef="USD">133000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:Revenues
      contextRef="From2024-07-012024-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember"
      decimals="-3"
      id="Fact001444"
      unitRef="USD">3986000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-07-012024-12-31_us-gaap_HealthCareOtherMember"
      decimals="-3"
      id="Fact001446"
      unitRef="USD">45924000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact001448"
      unitRef="USD">49910000</us-gaap:Revenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2024-07-012024-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember"
      decimals="-3"
      id="Fact001450"
      unitRef="USD">583000</FONR:IntersegmentNetRevenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2024-07-012024-12-31_us-gaap_HealthCareOtherMember"
      decimals="-3"
      id="Fact001452"
      unitRef="USD">0</FONR:IntersegmentNetRevenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact001454"
      unitRef="USD">583000</FONR:IntersegmentNetRevenues>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2024-07-012024-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember"
      decimals="-3"
      id="Fact001456"
      unitRef="USD">-2335000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2024-07-012024-12-31_us-gaap_HealthCareOtherMember"
      decimals="-3"
      id="Fact001458"
      unitRef="USD">9376000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact001460"
      unitRef="USD">7041000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2024-07-012024-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember"
      decimals="-3"
      id="Fact001462"
      unitRef="USD">103000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2024-07-012024-12-31_us-gaap_HealthCareOtherMember"
      decimals="-3"
      id="Fact001464"
      unitRef="USD">2195000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact001466"
      unitRef="USD">2298000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2024-07-012024-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember"
      decimals="-3"
      id="Fact001468"
      unitRef="USD">95000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2024-07-012024-12-31_us-gaap_HealthCareOtherMember"
      decimals="-3"
      id="Fact001470"
      unitRef="USD">2477000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact001472"
      unitRef="USD">2572000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:Revenues
      contextRef="From2023-07-012023-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember"
      decimals="-3"
      id="Fact001474"
      unitRef="USD">3917000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-07-012023-12-31_us-gaap_HealthCareOtherMember"
      decimals="-3"
      id="Fact001476"
      unitRef="USD">47307000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact001478"
      unitRef="USD">51224000</us-gaap:Revenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2023-07-012023-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember"
      decimals="-3"
      id="Fact001480"
      unitRef="USD">508000</FONR:IntersegmentNetRevenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2023-07-012023-12-31_us-gaap_HealthCareOtherMember"
      decimals="-3"
      id="Fact001482"
      unitRef="USD">0</FONR:IntersegmentNetRevenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact001484"
      unitRef="USD">508000</FONR:IntersegmentNetRevenues>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2023-07-012023-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember"
      decimals="-3"
      id="Fact001486"
      unitRef="USD">-1731000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2023-07-012023-12-31_us-gaap_HealthCareOtherMember"
      decimals="-3"
      id="Fact001488"
      unitRef="USD">13187000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact001490"
      unitRef="USD">11456000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2023-07-012023-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember"
      decimals="-3"
      id="Fact001492"
      unitRef="USD">121000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2023-07-012023-12-31_us-gaap_HealthCareOtherMember"
      decimals="-3"
      id="Fact001494"
      unitRef="USD">2294000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact001496"
      unitRef="USD">2415000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2023-07-012023-12-31_custom_ManufacturingAndServiceOfMRIEquipmentMember"
      decimals="-3"
      id="Fact001498"
      unitRef="USD">20000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2023-07-012023-12-31_us-gaap_HealthCareOtherMember"
      decimals="-3"
      id="Fact001500"
      unitRef="USD">192000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact001502"
      unitRef="USD">212000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock contextRef="From2024-07-01to2024-12-31" id="Fact001504">&lt;p id="xdx_802_eus-gaap--CashFlowSupplementalDisclosuresTextBlock_zGVOuN4nhr5b" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE
9 &#x2013; &lt;span id="xdx_824_zvntBC6U1sFj"&gt;SUPPLEMENTAL CASH FLOW INFORMATION&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;During
the six months ended December 31, 2024 and December 31, 2023, the Company paid $&lt;span id="xdx_900_eus-gaap--InterestPaidNet_pn3n3_c20240701__20241231_zuYK5TSnsG41"&gt;14
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;and
$&lt;span id="xdx_90F_eus-gaap--InterestPaidNet_pn3n3_c20230701__20231231_zujyHAOd1QS2"&gt;58 &lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;for
interest, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;During
the six months ended December 31, 2024 and December 31, 2023, the Company paid $&lt;span id="xdx_906_eus-gaap--IncomeTaxesPaid_pn3n3_c20240701__20241231_z5JLBWZlqcU4"&gt;2,473
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;and
$&lt;span id="xdx_90A_eus-gaap--IncomeTaxesPaid_pn3n3_c20230701__20231231_zAD0LgjMfELh"&gt;150 &lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;for
income taxes, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;During
the six months ended December 31, 2024 and December 31, 2023, the Company obtained right-of-use and equipment assets in exchange for
lease obligations of $&lt;span id="xdx_90F_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_pn3n3_c20240701__20241231_zAA4TmmE9Ai2"&gt;359
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;and
$&lt;span id="xdx_905_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_pn3n3_c20230701__20231231_zss9pIctGUkh"&gt;1,212&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;During
the three months ended December 31, 2024, the Company sold a &lt;span id="xdx_90F_ecustom--RateOfInterestSold_pip0_dp_c20241001__20241231_zykVZPaR72ja"&gt;0.197&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;%
interest in HDM to an employee. The interest was sold for $&lt;span id="xdx_90F_eus-gaap--ConversionOfStockAmountConverted1_pn3n3_c20241001__20241231_zXd3OI3qMCse"&gt;132,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;in a
noncash transaction.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



















</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:InterestPaidNet
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact001505"
      unitRef="USD">14000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact001506"
      unitRef="USD">58000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact001507"
      unitRef="USD">2473000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact001508"
      unitRef="USD">150000</us-gaap:IncomeTaxesPaid>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact001509"
      unitRef="USD">359000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact001510"
      unitRef="USD">1212000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <FONR:RateOfInterestSold
      contextRef="From2024-10-012024-12-31"
      decimals="INF"
      id="Fact001511"
      unitRef="Pure">0.00197</FONR:RateOfInterestSold>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact001512"
      unitRef="USD">132000000</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2024-07-01to2024-12-31" id="Fact001522">&lt;p id="xdx_805_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z1jjQi59gbN" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE
10 &#x2013; &lt;span id="xdx_827_zw6Ixi3Dvh2a"&gt;COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Litigation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;The
Company is subject to legal proceedings and claims arising from the ordinary course of its business, including personal injury, customer
contract and employment claims. In the opinion of management, the aggregate liability, if any, with respect to such actions, will not
have a material adverse effect on the consolidated financial position or results of operations of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;In
the ordinary course of its business, the Company is a party to various lawsuits arising from the operations at the MRI sites and other
insurance related matters, which are generally handled by the Company&#x2019;s insurance carriers. Management believes, based in part
on the advice counsel, that the ultimate resolution of these matters will not have a material adverse effect on the Company&#x2019;s consolidated
financial position, results of operations or cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;There
were no material changes in litigation from that reported in our Form 10-K for the fiscal year ended June 30, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Other
Matters&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;On
September 13, 2022, the Company adopted a stock repurchase plan. The plan has no expiration date and cannot determine the number of shares
which will be repurchased. On September 26, 2022, the Board of Directors has approved up to $&lt;span id="xdx_900_esrt--StockRepurchaseProgramAuthorizedAmount1_iI_pn3n3_c20220926__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_znooPvvtoGc4"&gt;9,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;to be
repurchased under the plan which will be purchased on the publicly traded open market at prevailing prices. During the six months ended
December 31, 2024 and 2023, the Company repurchased &lt;span id="xdx_901_eus-gaap--StockRepurchasedDuringPeriodShares_pn3n3_c20240701__20241231__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_z5rV5vwLrwta"&gt;84
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;and
&lt;span id="xdx_90F_eus-gaap--StockRepurchasedDuringPeriodShares_pn3n3_c20230701__20231231__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zVkIBmmQBGIa"&gt;116
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;shares
at a cost of $&lt;span id="xdx_906_eus-gaap--StockRepurchasedDuringPeriodValue_pn3n3_c20240701__20241231__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zVfH13ldLav3"&gt;1,342
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;and
$&lt;span id="xdx_906_eus-gaap--StockRepurchasedDuringPeriodValue_pn3n3_c20230701__20231231__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zmHrbwh6Sgl5"&gt;1,885&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;,
respectively. The Company cancelled &lt;span id="xdx_909_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_pn3n3_c20240701__20241231__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zKfq3AxUgaF8"&gt;125
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;shares
and &lt;span id="xdx_90F_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_pn3n3_c20230701__20231231__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zlcU11vOy63i"&gt;123
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;shares
at a cost of $&lt;span id="xdx_907_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_pn3n3_c20240701__20241231__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_znxDloJMbJXh"&gt;1,963
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;and
$&lt;span id="xdx_908_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_pn3n3_c20230701__20231231__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zdVe54008bUc"&gt;2,005
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;for
the six months ended December 31, 2024 and 2023, respectively. As of December 31, 2024 the remaining balance under the repurchase plan
was $&lt;span id="xdx_907_eus-gaap--StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_iI_pn3n3_c20241231_zZkUsNBO7Fng"&gt;3,392&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;The
Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third-party insurer to limit the maximum
potential liability for individual claims to $&lt;span id="xdx_90D_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpense_iI_pn3n3_c20241231_z0A4HrGwez5b"&gt;150
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;per
person and for a maximum potential claim liability based on member enrollment. With respect to this program, the Company considers historical
and projected medical utilization data when estimating its health insurance program liability and related expense. As of December 31,
2024 and June 30, 2024, the Company had approximately $&lt;span id="xdx_90B_eus-gaap--SelfInsuranceReserve_iI_pn3n3_c20241231_zBKROCOAQFS1"&gt;168
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;and
$&lt;span id="xdx_906_eus-gaap--SelfInsuranceReserve_iI_pn3n3_c20240630_zHRNR6EF4VF1"&gt;86&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;,
respectively, in reserve for its self-funded health insurance programs. The reserves are included in &#x201c;Other current liabilities&#x201d;
in the condensed consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;The
Company regularly analyzes its reserves for incurred but not reported claims, and for reported but not paid claims related to its reinsurance
and self-funded insurance programs. The Company believes its reserves are adequate. However, significant judgment is involved in assessing
these reserves such as assessing historical paid claims, average lags between the claims&#x2019; incurred date, reported dates and paid
dates, and the frequency and severity of claims. There may be differences between actual settlement amounts and recorded reserves and
any resulting adjustments are included in expense once a probable amount is known. There were no significant adjustments recorded in
the periods covered by this report.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



















</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <srt:StockRepurchaseProgramAuthorizedAmount1
      contextRef="AsOf2022-09-26_srt_BoardOfDirectorsChairmanMember"
      decimals="-3"
      id="Fact001523"
      unitRef="USD">9000000</srt:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="From2024-07-012024-12-31_srt_BoardOfDirectorsChairmanMember"
      decimals="-3"
      id="Fact001524"
      unitRef="Shares">84000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="From2023-07-012023-12-31_srt_BoardOfDirectorsChairmanMember"
      decimals="-3"
      id="Fact001525"
      unitRef="Shares">116000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2024-07-012024-12-31_srt_BoardOfDirectorsChairmanMember"
      decimals="-3"
      id="Fact001526"
      unitRef="USD">1342000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-07-012023-12-31_srt_BoardOfDirectorsChairmanMember"
      decimals="-3"
      id="Fact001527"
      unitRef="USD">1885000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="From2024-07-012024-12-31_srt_BoardOfDirectorsChairmanMember"
      decimals="-3"
      id="Fact001528"
      unitRef="Shares">125000</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="From2023-07-012023-12-31_srt_BoardOfDirectorsChairmanMember"
      decimals="-3"
      id="Fact001529"
      unitRef="Shares">123000</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="From2024-07-012024-12-31_srt_BoardOfDirectorsChairmanMember"
      decimals="-3"
      id="Fact001530"
      unitRef="USD">1963000</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="From2023-07-012023-12-31_srt_BoardOfDirectorsChairmanMember"
      decimals="-3"
      id="Fact001531"
      unitRef="USD">2005000</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001532"
      unitRef="USD">3392000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001533"
      unitRef="USD">150000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SelfInsuranceReserve
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001534"
      unitRef="USD">168000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001535"
      unitRef="USD">86000</us-gaap:SelfInsuranceReserve>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2024-07-01to2024-12-31" id="Fact001545">&lt;p id="xdx_802_eus-gaap--IncomeTaxDisclosureTextBlock_zIAvIM0KbBci" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE
11 - &lt;span id="xdx_82A_zaGn0S1yZ4dd"&gt;INCOME TAXES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;In
accordance with ASC 740-270, &#x201c;Income Taxes &#x2013; Interim Reporting&#x201d;, the Company is required at the end of each interim
period to determine the best estimate of its annual effective tax rate and apply that rate to year-to-date ordinary income or loss. The
resulting tax expense (or benefit) is adjusted for the tax effect of specific events, if any, required to be discretely recognized in
the interim period as they occur. For the six months ended December 31, 2024 and 2023, the Company recorded income tax expense of $&lt;span id="xdx_901_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_pn3n3_c20240701__20241231_zm0zu1WccEGe"&gt;2,011
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;in 2024
as compared to $&lt;span id="xdx_909_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_pn3n3_c20230701__20231231_zEWptVzY14Ae"&gt;3,036
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;in 2023.
For the three months ended December 31, 2024 and 2023, the Company recorded income tax expense of $&lt;span id="xdx_90E_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_pn3n3_c20241001__20241231_zxnBt1dSQfog"&gt;762
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;and
$&lt;span id="xdx_90A_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_pn3n3_c20231001__20231231_zYxtQAbFfyIh"&gt;1,366&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;,
respectively. The six month and three month 2024 provision is comprised of a current income tax component of $&lt;span id="xdx_905_eus-gaap--ExtinguishmentOfDebtGainLossNetOfTax_pn3n3_c20241001__20241231_zaArqZR5zmQ4"&gt;900
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;and
a deferred income tax component of $&lt;span id="xdx_90E_ecustom--DeferredIncomeTaxComponent_pn3n3_c20241001__20241231_zlqWZzStf8Dd"&gt;1,111
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;and
a current income tax component of $&lt;span id="xdx_90C_eus-gaap--ExtinguishmentOfDebtGainLossNetOfTax_pn3n3_c20240701__20241231_zFQftXO4HOll"&gt;517
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;and
a deferred income tax component of $&lt;span id="xdx_908_ecustom--DeferredIncomeTaxComponent_pn3n3_c20240701__20241231_zsgxYyBSjbm9"&gt;245&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;,
respectively. Obligations for any liability associated with the current income tax provision has been reduced, primarily resulting from
the benefits and utilization of net operating loss carryforwards.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;ASC
Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax
positions taken or expected to be taken in a corporate tax return. For those benefits to be recognized, a tax position must be more-likely-than-not
to be sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return
and the benefit recognized and measured pursuant to the interpretation are referred to as unrecognized benefits. A liability is recognized
(or amount of net operating loss carryforward or amount of tax refundable is reduced) for an unrecognized tax benefit because it represents
an enterprise&#x2019;s potential future obligation to the taxing authority for a tax position that was not recognized as a result of applying
the provisions of ASC Topic 740. The Company believes there are no uncertain tax positions in prior year tax filings and therefore it
has not recorded a liability for unrecognized tax benefits.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;The
Company recorded a deferred tax asset of $&lt;span id="xdx_90C_eus-gaap--DeferredTaxAssetsNet_iI_pn3n3_c20241231_zgNN64Zs867j"&gt;6,113&lt;/span&gt;&lt;/span&gt;
&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;and a deferred tax
liability of $&lt;span id="xdx_907_eus-gaap--DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_iI_pn3n3_c20241231_z9VPwcNEHSbl"&gt;371
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;as of
December 31, 2024, primarily relating to allowance for credit losses and tax credits.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;The
Company files corporate income tax returns in the United States (federal) and in various state and local jurisdictions. In most instances,
the Company is no longer subject to federal, state and local income tax examinations by tax authorities for years prior to 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Future
ownership changes as determined under Section 382 of the Internal Revenue Code could further limit the utilization of net operating loss
carryforwards. As of December 31, 2024, no such changes in ownership have occurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;The
Inflation Reduction Act (&#x201c;IRA&#x201d;) was enacted on August 16, 2022. The IRA includes provisions imposing a &lt;span id="xdx_908_ecustom--PercentageOfExciseTax_pip0_dp_c20240701__20241231_zAm4uPdPzHfb"&gt;1&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;%
excise tax on share repurchases that occur after December 31, 2022 and introduces a &lt;span id="xdx_904_ecustom--CorporateAlternativeMinimumTaxPercentage_pip0_dp_c20240701__20241231_zZVa5sJmk6Ci"&gt;15&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;%
corporate alternative minimum tax (&#x201c;CAMT&#x201d;) on adjusted financial statement of income. The CAMT will be effective for tax
years beginning after December 31, 2022. Currently, the IRA did not have a material impact to the Company&#x2019;s financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



















</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact001546"
      unitRef="USD">2011000</us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability>
    <us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact001547"
      unitRef="USD">3036000</us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability>
    <us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact001548"
      unitRef="USD">762000</us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability>
    <us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact001549"
      unitRef="USD">1366000</us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability>
    <us-gaap:ExtinguishmentOfDebtGainLossNetOfTax
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact001550"
      unitRef="USD">900000</us-gaap:ExtinguishmentOfDebtGainLossNetOfTax>
    <FONR:DeferredIncomeTaxComponent
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact001551"
      unitRef="USD">1111000</FONR:DeferredIncomeTaxComponent>
    <us-gaap:ExtinguishmentOfDebtGainLossNetOfTax
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact001552"
      unitRef="USD">517000</us-gaap:ExtinguishmentOfDebtGainLossNetOfTax>
    <FONR:DeferredIncomeTaxComponent
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact001553"
      unitRef="USD">245000</FONR:DeferredIncomeTaxComponent>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001554"
      unitRef="USD">6113000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001555"
      unitRef="USD">371000</us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus>
    <FONR:PercentageOfExciseTax
      contextRef="From2024-07-01to2024-12-31"
      decimals="INF"
      id="Fact001556"
      unitRef="Pure">0.01</FONR:PercentageOfExciseTax>
    <FONR:CorporateAlternativeMinimumTaxPercentage
      contextRef="From2024-07-01to2024-12-31"
      decimals="INF"
      id="Fact001557"
      unitRef="Pure">0.15</FONR:CorporateAlternativeMinimumTaxPercentage>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2024-07-01to2024-12-31" id="Fact001567">&lt;p id="xdx_802_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zo7LEpQgiQQj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE
12 &#x2013; &lt;span id="xdx_82E_zSiHb1g03432"&gt;RELATED PARTY TRANSACTIONS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Tallahassee
Magnetic Resonance Imaging, Inc. Stand Up MRI of Boca Raton, PA and Stand Up MRI &amp;amp; Diagnostic Center, Inc. (all related medical practices)
entered into a guaranty agreement, pursuant to which they cross guaranteed all management fees which are payable to the Company, which
have arisen under each individual management agreement. During the six months ended December 31, 2024 and 2023, the net revenues received
by the Company was $&lt;span id="xdx_90F_ecustom--NetRevenues_pn3n3_c20240701__20241231_zErcmVKPf2tg"&gt;5,975&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Bensonhurst
MRI Limited Partnership (&#x201c;Bensonhurst&#x201d;), in which the CEO and President of the Company holds an interest, is party to an
agreement with the Company for the service and maintenance of its Upright MRI Scanner for a price of $&lt;span id="xdx_905_ecustom--ServiceAndMaintenancePrice_iI_pn3n3_c20241231_zwDYaqwMms79"&gt;110,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;per
annum. On February 1, 2024, Bensonhurst entered into a second contract with the Company for the service and maintenance of a High-Field
MRI Scanner for a price of $&lt;span id="xdx_90B_ecustom--ServiceAndMaintenancePrice_iI_pn3n3_c20240201_zzT091ULAfB5"&gt;70,000 &lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;per
annum. For the six months ended December 31, 2024 and 2023 the Company recorded service and repair fees of $&lt;span id="xdx_907_ecustom--ServiceAndRepairFees_pn3n3_c20240701__20241231_zjlB78Fenfjb"&gt;90
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;and
$&lt;span id="xdx_901_ecustom--ServiceAndRepairFees_pn3n3_c20230701__20231231_zGqFM62hfyCl"&gt;55&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;,
respectively from Bensonhurst. Also during the three months ended December 31, 2024 and 2023 the Company recorded service and repair
fees of $&lt;span id="xdx_90C_ecustom--ServiceAndRepairFees_pn3n3_c20241001__20241231_zJqoN3Rob3Gi"&gt;45&lt;/span&gt;&lt;/span&gt; &lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;and
$&lt;span id="xdx_90A_ecustom--ServiceAndRepairFees_pn3n3_c20231001__20231231_zwjbBAN0jRB3"&gt;28&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;Radian
Healthcare Management, LLC (&#x201c;Radian&#x201d;), which is owned by the son-in-law of the CEO and President of the Company provided
the Company with personnel recruitment of new employees at a fee of approximately $&lt;span id="xdx_90E_ecustom--EmployeesFee_pn3n3_c20241001__20241231_zidyaf4biOXf"&gt;68
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;and
$&lt;span id="xdx_90F_ecustom--EmployeesFee_pn3n3_c20231001__20231231_zqdyow07D3K"&gt;0 &lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;for
the six months ended December 31, 2024 and 2023, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;On
December 31, 2023, the Company entered into an agreement with Magnetic Resonance Management, LLC (&#x201c;MRM&#x201d;) for the sale of
a MRI scanner. MRM is owned by the CEO and President of the Company. The sales price of the equipment was $&lt;span id="xdx_907_eus-gaap--ConvertibleNotesPayable_iI_pn3n3_c20231231__us-gaap--TypeOfArrangementAxis__custom--MagneticResonanceManagementMember_zT6yk4qzBl04"&gt;577
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;which
is payable based upon a promissory note dated December 1, 2023. The note bears interest at a rate of &lt;span id="xdx_90C_eus-gaap--DerivativeFixedInterestRate_iI_pip0_dp_c20231231__us-gaap--TypeOfArrangementAxis__custom--MagneticResonanceManagementMember_zujBx1q0ELBj"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;%
and is payable in full at the maturity of the note in December 2028. During the six months ending December 31, 2024 the Company recorded
$&lt;span id="xdx_908_eus-gaap--InvestmentIncomeNet_pn3n3_c20240701__20241231__us-gaap--TypeOfArrangementAxis__custom--MagneticResonanceManagementMember_zWA4op3gh335"&gt;26
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;in investment
income on this promissory note. Also during the three months ending December 31, 2024, the Company recorded $&lt;span id="xdx_908_eus-gaap--InvestmentIncomeNet_pn3n3_c20241001__20241231__us-gaap--TypeOfArrangementAxis__custom--MagneticResonanceManagementMember_z6Pg8Kzv6k31"&gt;13
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;in investment
income on this promissory note. The MRI scanner had zero basis, which resulted in a gain of $&lt;span id="xdx_907_eus-gaap--DeferredGainOnSaleOfProperty_iI_pn3n3_c20240630__us-gaap--TypeOfArrangementAxis__custom--MagneticResonanceManagementMember_zpUuRMy9QPfb"&gt;577&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;,
which was recorded during the year ended June 30, 2024. The Company has the option but not the obligation to re-take possession of the
scanner in lieu of payment upon maturity of the note.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <FONR:NetRevenues
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact001568"
      unitRef="USD">5975000</FONR:NetRevenues>
    <FONR:ServiceAndMaintenancePrice
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001569"
      unitRef="USD">110000000</FONR:ServiceAndMaintenancePrice>
    <FONR:ServiceAndMaintenancePrice
      contextRef="AsOf2024-02-01"
      decimals="-3"
      id="Fact001570"
      unitRef="USD">70000000</FONR:ServiceAndMaintenancePrice>
    <FONR:ServiceAndRepairFees
      contextRef="From2024-07-01to2024-12-31"
      decimals="-3"
      id="Fact001571"
      unitRef="USD">90000</FONR:ServiceAndRepairFees>
    <FONR:ServiceAndRepairFees
      contextRef="From2023-07-012023-12-31"
      decimals="-3"
      id="Fact001572"
      unitRef="USD">55000</FONR:ServiceAndRepairFees>
    <FONR:ServiceAndRepairFees
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact001573"
      unitRef="USD">45000</FONR:ServiceAndRepairFees>
    <FONR:ServiceAndRepairFees
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact001574"
      unitRef="USD">28000</FONR:ServiceAndRepairFees>
    <FONR:EmployeesFee
      contextRef="From2024-10-012024-12-31"
      decimals="-3"
      id="Fact001575"
      unitRef="USD">68000</FONR:EmployeesFee>
    <FONR:EmployeesFee
      contextRef="From2023-10-012023-12-31"
      decimals="-3"
      id="Fact001576"
      unitRef="USD">0</FONR:EmployeesFee>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2023-12-31_custom_MagneticResonanceManagementMember"
      decimals="-3"
      id="Fact001577"
      unitRef="USD">577000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="AsOf2023-12-31_custom_MagneticResonanceManagementMember"
      decimals="INF"
      id="Fact001578"
      unitRef="Pure">0.09</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:InvestmentIncomeNet
      contextRef="From2024-07-012024-12-31_custom_MagneticResonanceManagementMember"
      decimals="-3"
      id="Fact001579"
      unitRef="USD">26000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="From2024-10-012024-12-31_custom_MagneticResonanceManagementMember"
      decimals="-3"
      id="Fact001580"
      unitRef="USD">13000</us-gaap:InvestmentIncomeNet>
    <us-gaap:DeferredGainOnSaleOfProperty
      contextRef="AsOf2024-06-30_custom_MagneticResonanceManagementMember"
      decimals="-3"
      id="Fact001581"
      unitRef="USD">577000</us-gaap:DeferredGainOnSaleOfProperty>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2024-07-01to2024-12-31" id="Fact001583">&lt;p id="xdx_800_eus-gaap--SubsequentEventsTextBlock_zfPruQxUqIX2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE
13 &#x2013; &lt;span id="xdx_82D_z7iW2NUdCF1"&gt;SUBSEQUENT EVENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;The
Company has evaluated events that occurred subsequent to December 31, 2024 and through the date the condensed consolidated financial
statements were issued.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;In
the subsequent period up to the date of filing, the Company repurchased &lt;span id="xdx_905_ecustom--StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchaseds_iI_pn3n3_c20241231_zJPtizoyNA9b"&gt;7
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;shares
of common stock at a cost of $&lt;span id="xdx_900_ecustom--StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount_iI_pn3n3_c20241231_zO0ilU4ztNwb"&gt;108
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif"&gt;which
was authorized under the stock repurchase plan adopted in September 2022.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <FONR:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchaseds
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001584"
      unitRef="Shares">7000</FONR:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchaseds>
    <FONR:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001585"
      unitRef="USD">108000</FONR:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="From2024-07-01to2024-12-31" id="Fact001586">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="From2024-07-01to2024-12-31" id="Fact001587">false</ecd:Rule10b51ArrTrmntdFlag>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
